<SEC-DOCUMENT>0000886163-22-000117.txt : 20220809
<SEC-HEADER>0000886163-22-000117.hdr.sgml : 20220809
<ACCEPTANCE-DATETIME>20220809161325
ACCESSION NUMBER:		0000886163-22-000117
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		67
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220809
DATE AS OF CHANGE:		20220809

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		221148456

	BUSINESS ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>lgnd-20220630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:6182e749-0dc5-4e16-af49-321ddbc4d263,g:44d35ef7-647e-41c8-b2ac-a9d4b32b2035,d:b69a4a9cb92a4725b58ada0b25efe540--><html xmlns:lgnd="http://www.ligand.com/20220630" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lgnd-20220630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80L2ZyYWc6NTM3Mjg0ZWRjMzA3NDhmYjhhZmYyYjcyZDczYzhmNzMvdGFibGU6YTY0ZTAxYWFhYjg1NDkxOWJmYjVmMTgwYTQ0NDkwYmQvdGFibGVyYW5nZTphNjRlMDFhYWFiODU0OTE5YmZiNWYxODBhNDQ0OTBiZF8yLTEtMS0xLTc3MTcx_9a688112-d25c-4b34-8746-170148d9cf6a">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80L2ZyYWc6NTM3Mjg0ZWRjMzA3NDhmYjhhZmYyYjcyZDczYzhmNzMvdGFibGU6YTY0ZTAxYWFhYjg1NDkxOWJmYjVmMTgwYTQ0NDkwYmQvdGFibGVyYW5nZTphNjRlMDFhYWFiODU0OTE5YmZiNWYxODBhNDQ0OTBiZF8zLTEtMS0xLTc3MTcx_0af9ea75-6838-4c20-b595-ad76445c58fc">2022</ix:nonNumeric><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80L2ZyYWc6NTM3Mjg0ZWRjMzA3NDhmYjhhZmYyYjcyZDczYzhmNzMvdGFibGU6YTY0ZTAxYWFhYjg1NDkxOWJmYjVmMTgwYTQ0NDkwYmQvdGFibGVyYW5nZTphNjRlMDFhYWFiODU0OTE5YmZiNWYxODBhNDQ0OTBiZF80LTEtMS0xLTc3MTcx_19e3e21b-36b0-4307-bd73-6c5a7a3d1e5c">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80L2ZyYWc6NTM3Mjg0ZWRjMzA3NDhmYjhhZmYyYjcyZDczYzhmNzMvdGFibGU6YTY0ZTAxYWFhYjg1NDkxOWJmYjVmMTgwYTQ0NDkwYmQvdGFibGVyYW5nZTphNjRlMDFhYWFiODU0OTE5YmZiNWYxODBhNDQ0OTBiZF81LTEtMS0xLTc3MTcx_026f02a8-d1fd-4fea-a55e-953d0b89e39b">0000886163</ix:nonNumeric><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80L2ZyYWc6NTM3Mjg0ZWRjMzA3NDhmYjhhZmYyYjcyZDczYzhmNzMvdGFibGU6YTY0ZTAxYWFhYjg1NDkxOWJmYjVmMTgwYTQ0NDkwYmQvdGFibGVyYW5nZTphNjRlMDFhYWFiODU0OTE5YmZiNWYxODBhNDQ0OTBiZF82LTEtMS0xLTc3MTcx_a3814069-5c98-4738-8ed8-f2c06ff27c65">December 31</ix:nonNumeric><ix:nonNumeric contextRef="i35897df76b71438cbfcc21f5fd8c25ba_D20210101-20211231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMy0wLTEtMS03NzE3MQ_d4683d88-94ef-4a22-8ed5-d4dd9b4356a7">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i1bdef6e83d484a31ae28be0288d4014a_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80Ni9mcmFnOjQ3ZmMyMjAxZWY1YjRmNjc5Y2Q4YWIzMjVlYWJjMGQwL3RhYmxlOjE0Y2NiYjg4YTAzZjQ2OTRiZGZlMzU3ZjRlZmVmYmI1L3RhYmxlcmFuZ2U6MTRjY2JiODhhMDNmNDY5NGJkZmUzNTdmNGVmZWZiYjVfMi0xLTEtMS03NzE3MQ_5db6052f-20bb-4d56-89b5-f52ee302db2d">0.0040244</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i9ed745872a5b4347aba60ffe4aed601f_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80Ni9mcmFnOjQ3ZmMyMjAxZWY1YjRmNjc5Y2Q4YWIzMjVlYWJjMGQwL3RhYmxlOjE0Y2NiYjg4YTAzZjQ2OTRiZGZlMzU3ZjRlZmVmYmI1L3RhYmxlcmFuZ2U6MTRjY2JiODhhMDNmNDY5NGJkZmUzNTdmNGVmZWZiYjVfNC0xLTEtMS03NzE3MQ_5bf2502a-b382-48f8-8442-2f5932f07e65">0.0052317</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lgnd-20220630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedc598dd9b154369925ac2b71e806c9f_I20220805"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-08-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i245a60f5c38a4697983ab57c4578e9d1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i4451c0bbe6454e30a9400b8f2b6b236b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadd0658df38142da9de49541fcf1e87b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36945e4ea3d94671ba79140fa3bfeed8_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc58590074134385916f9aa21fadb3a5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0dc4219be484ce8aa0ac5cb14f54a41_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06d3227a7eb74265aa981e7a0d0ff54a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iede13d72d60b42d785f8340ba1c81680_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f25445795154f5a93fcbfa2d95e4ca4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4abd7ed5056140b3a6f412c3dcf92315_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib690ef44f20c492ba685cf71add617d4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf5c36ba61894d93b55a210349a7ccf2_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75907dd7ed51403bb417727e96e225eb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85f8622834f34bd190af73c102a914cc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cfa0d1834f445a49fb6b65740cb4cd4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1c61c60b6194b22adf91c5e2cbe87ff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedb09b7e2fcb4ab7aebd9117745eb914_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35897df76b71438cbfcc21f5fd8c25ba_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f5459b627e84394b6d868b1c0657e63_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i362afaf034ae4672be24c81c6b93536c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76ae97986fac4a65aa555297c9706a05_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3e93db38a0c4a65a7538c436c978d22_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d94a99e36434ce3bcb95c74af16730c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0861fff98f443b690754c837f781b97_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i897aeacae0a54360ae9e4b7fef689689_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i611ca28f9b2b49b0ab2181e8b332d455_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida17f1e22fcc46d888527d5585b5db6a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a7ab73aa7904f7ebaf48f7dce5ab966_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if13fbe07ca154d04930101ff2e942a66_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cd03be6fae54778adda0e81e4ca4bb6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if12c3ec488ca49709a4421cb42f9abbb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i795e50fb1bd04eb1bed4a653ee8c754a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcedf9519070438b806357a9dd22600a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i372b4ca31b6148f580791f16233559c6_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i518323b49cf84a3596e600f5a1f4c5de_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66a4853ebfb84f1cbf13e26153087b0f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f1ead9f69da4d13ab756c627f382b38_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d5f804285544b3c85561c7025916c3d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85f076aef7744e2ba3466da10e42c30c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie007cd8b0d0a49a8b243568f89c18ee8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cceb54932694869a897f6267d1671d2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe339071fd4f412d97a4a4b4efe13b85_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i219e6f0c67584cdfb9cc97d98d4660f3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03c127685aa945a6ac245b4904e579a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1df447ab25dd46908c81e1e59a7690f4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4f3cf826076418d8df0ad8aa0976c1d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61b5666e80a3489388fb05d72e4d486a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53c139d692e24ecc9eebbd4f8f6a7986_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc2e728e65f543a0ab65714937be981b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a532b4ea5824e5e9ec5170d5b4c3fc7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd4986c032bd490fbee831d61a9cb80f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57a179932e3e460783c473c4033afd37_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie03542cce19b4e7dbd6fba43babfe9b6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4081bccf13b424e88e365ad46cac9da_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c30a433e75e4d8cacce52bacc437e16_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if658034f46704cf587bbef2048752ad8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cfad7f1f04049718d638cb007561413_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib892982e78324d6ca473f2fc2a6da00a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabed2424af8d4db5bfade373c80a8e1f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6f0ed8f7b464306ae6088a4c1723287_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieec58def6fea427489c80f3c77282f03_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibda621e9fcaa4a23bea03af000841d41_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic543f595905b456b86f091c41fcf15e9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99d5ee9673ec4131948b388970c8f765_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0f9248329c9468fb09df5396db98bf6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id15423cf11ad45caae992641de4875c1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eba3264dc6c4943a87106e878898597_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff72851b58aa45ffa732bbda41560b3d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib165267a91674f5987986a924b2120c4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70869135d3c34c1db5e1e22b66ea39ae_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic99e0c134900425886aaac7ceb463839_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfe69b74f9a142af8ba9b55191035604_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ab02c7bc2a9493ab64ac0276d32fdff_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id78b53631f2e4d38a201cb8afeffe74e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5a2dea7e0f94760977b89f0e7531354_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb6fe6bdce8242319de5782b9769f8db_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e8e45384b614e7c8354672d3699a80a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9775a3f35190447f9e3b5d21d55faad5_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i685f29c36ddc4fdfbdef1ce148091d2a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94fdbb4317f34a609cb534522aef7982_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id24caccafc6747c69868162bdd0769d2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82095dd45f8544edb3410b6b83bf52ab_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd89e80d3f3d44d4b5281b5916b0c8b2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c96b32616194c1b937efd406717542d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife30a3da671b425e9383ee095533c9bd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7768c766ed64817819e47086ac8e52f_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b46ae1b80044cff933ed7f5b6074bfd_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69264884c80f4de496ecd4d3871f13de_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f0ce6d74bbb404494d3b9ecd07c5c1d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a26669fd70d437e8dbf0d46744ee68b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e1cee720dbe4a518d1861c1471e0601_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac98dc8419824fccbffe08deef56431d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1b6772c114f4296b3710452fad3bbf0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac3e999d74914146b6972963646d77d3_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3af2fa579c8d4d0298cd4adaf64f562a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfe3cc306f014ceb8d03ee2a6e86a398_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3a848d86a33454d8e308d5c5596a288_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d72210a2a5943cf95ded5fa3f11f523_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i173a08fd950747df9d01f035da9f023d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c2a1b1ca5514671b9aba265dfb7b572_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38baca3871d94649bea9b951f8a95afc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia510a863a60a463ea460982ee2b575b2_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id554d23e5a4f40a5badd18e8f8b0a8b7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf0d6dad86164f7eaa342595027db37f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34e3ef31b9a84e509bed5d667042120e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a41570df267433d868066c140f59972_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a06723b9575442cbe0af518dda8db12_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia55aca14b36b43b491df2ecf96d2c1f3_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie323179691704681be1652faafc0e9a2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaf6ba28216b419e91b9fc13c3c06c9d_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i077a95de6c1246a0ac1df496ba8e517a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d5e8d1f727f43ec8ecd549503e85c2e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b9a9049f59047158b0b52d7d59b7745_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56f53586b69f4a9aa74c3e01f3093f45_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id64fbff1c6e448fe994106b92f9144b9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21b62bb4bd3243f98e9d6acb69bbd14d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i205fad57592a433b83307f6fea8119cc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c186e23a71a4fb793fc929a6f1bae65_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida960da78ddf459ca1c4198305520fb4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibce85fdb40ae4d199b3b166284807908_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5890ea92184146ffb7b0e8ae84bcf98b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0560066d2edf4834bad46274f6b43123_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e34e3b904034f19a68a68a7d815b0af_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie18284bcc4c545f2af6dd44ec4f776be_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ec9f7faaf814c3eb810dd8294a78adb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i010958049e69464b916484b2032627e5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="position"><xbrli:measure>lgnd:position</xbrli:measure></xbrli:unit><xbrli:context id="i3accfb128ab3447ca71c87b81da62c0f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86ab427a236f4147922fee98ff203990_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41836ea2320e4ecdbaed6d4b7e28b1bc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f1b65679e05403d90db551817862dd0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38d13f31c97741448d56e9f1fe72169f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0adfd09ddb864f8c9e65d502b415fbc1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c8b7e890d8e4b648961c025a2b1a977_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i411c360a01fd4666a436f4eafb9202d7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7bd5f1328d942879973ee2497a5b28d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia37ae682ab9d400d972e4f8f784305f9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="reporting_unit"><xbrli:measure>lgnd:reporting_unit</xbrli:measure></xbrli:unit><xbrli:context id="if91b70357fb44a83b104d251dcf482de_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c0ab083247d44e1ab92188a9e44c058_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i934ac72595594c6b994d97c0a1b7f89a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe59142403aa47d6801e8bc016edf9d7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i886a648c2410405ea2213afd1c7526cb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07d69c84f97e467a8586439168e3a979_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc20f2ad27ad4526a19a3ed221aa03e3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i634f77b02fdb422b81be6145a0ca48da_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5690281660a344fd9548591a6f266ac4_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8a73247f7a945ea9b05cf35b6cc0850_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6ac9689508e4114ba54882dec295d93_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6900c46450645478d0da3f5fb2d9670_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd353da9346c4eff9ef59fce65083fef_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29682bf3513f43abae73bf36fdc07869_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibca091886a1342b2acf333d5f3b78776_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i074a3e4a71c9476fba4587a19825900e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i94c20b531d9a49f3ba7f9be28e443ebb_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idde310731c5f4ddf8421b11a76439a76_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4653b493ab2c477f934120be3d321770_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab8c600366d6408f8d68011ffa0eefb3_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62f296ba5f6d4e0080870b494a4cb1f3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f4ae166f88f42b9ad465f19b7a2b5dd_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5ad93d1c25b4a4e91833014363da039_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4d8ee4a829e4a9b9b6b4a7a447bdb79_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aef4caca12a42dc91df79cbcf0581b8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d6a3560d8b34a5cbe1f0942263178b3_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4ad93b5e6dd4cd99dc35ab96510e147_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24cd0274970047cebd3b261d67019060_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if037b66c12a84486bd10aab5f91c4756_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad364541fb5f472591361e583d131e10_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbe273cd726b46b98c132ca315d75750_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e8af247251140e088c62af9f5e1be66_D20220101-20220322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>lgnd:segment</xbrli:measure></xbrli:unit><xbrli:context id="iebd5e1dca73546bab3c7f7e7fd807132_D20220323-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-23</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebdd064189bf40a1b0af7c11c05b508a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12b9af2332e24b278e251428d3112d54_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee885ce7e8c546a58c101265454c96b4_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i554afd03f39f48b1b340f2c1f5e63b38_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa01d917cb584f68ad23a0a988be1019_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cc3aca482094a8ea993165932b200f4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0323f8ac68c4e58abf54420181eb553_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53051290139d4df09cbb95cc83d65ca5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09a96cf6288542ffb7bf41f87f2f1513_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24d7aae3601941aca19f23d31f03721a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a04509ce52a4958bd559598330aa15e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c045aa28e3844fcb9eff412fe495b73_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic75dfe15187544a5842c26db724997b1_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id13f1a41d92a446e880e3b7f996d39bb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55d6c284cd324a37b54f99d3f372c0d3_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67ed19c1f7cc4ba5a898950694d6aad5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08264c293ad941d38c85c6df434e3b96_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17513104887747d094c8f90449ce26f3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fff928bd965435baa9430b0a51bc952_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i350d8bdb260b4f158bbe1c83371f08d1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3945ba7328d4488dbe199f8a6fb8806a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i996c3ee8de704c67a1f48c7b57639172_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11be9eb5ab6343b9abe0845805816826_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ef05994b78847b2b9a1ecd095ccd023_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb5402adc253464eb373188274f50300_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbbe17fffac4478caf19f21253a14fb4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i252d1e5433c94a97bc58b777f5a25e67_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5d7aab7d47f4e158191d415ae90524f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ada02c52f844af586bb3e63e4ec6411_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06363049796846649c3d730ee81b5bda_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c5fe50a04314348adf834a5587766ca_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b9c142e9fb346ec975852f818248861_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i267e2274bd584fe58769c5a1656b12db_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id61d812ca09145fcb40e16dbd4b8d9a8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a56e0d3e9a94dab9817eae0e11974be_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe938625cbc5444690c9b08e8e1f3fc6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib02472ad4a604f96aae20a25b68fd2fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic67146a8e91942cdba9ed20b277604c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14e0598617224fafbf13d5add97de1a6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i456aa02326a84161ab7d7363b6b524cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eea2d5922e24e8a9f8cf6052385e139_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0225b46271344284ad100ef90961626b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ebf4f8772924ada8190747259ee3c18_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3157c06168094203bfe558b4e6173ba6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45e9971abf3b469ea61649ddf4748670_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7d27b9f62664dffa76f1fe952c1f9ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3a7e52f19d64b8fa2a2e2476fa0bfa1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fd7b10617e343eca1d9556dffc4f114_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i225cccb2c22740ca8ac988545b58446a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bb2398d3a3048748fb70e3df8843949_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53f9632ba6184340b79bb0cd30ae04e2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i548c288771a540749668a107a155b125_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b44abccb2d044b2849d4fc6191d00dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecbe3fa2930442bb98e4b5b4bb9e5256_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21cc39d790414198a5384b22bc9f8914_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e1f31d766a7446d9b402aa372153d71_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a32d5c0d47d478abf53a297880bc04d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ebd32fe9f284200b88a29fe00e1c59e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75a462cc318440799e9195fc83206c6b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id70c6611cf0349bbaa43d7ca45e9e20e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib13e8f86f4bb4792a23bb3135840b332_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e4b0b1b1c134aef858b246643f58be5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1516fb25275e4bbcbaaca00a3711b3cf_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc548b28534c4e0aa35fef883c9ffd4c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i447b152d2cdc4923a33b76efe86e78f6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05ba522e2c8b438eb09faef77aac2491_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0671049fb2c74897aaed6cf1402f67e0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b39471746204503b6025c517a2740ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i084dd0497977421093be2aa2620a6cf0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a748e36f24545bc8aa6196a0de9b8ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e4644a9e4754293b2965e4853bb25b1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cfe5c65f77d4902805d7bd75bdafe01_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a7a292a775a4e939d542844f0e07327_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i625cf43be4a04d1296f91edac39e0b36_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i170fa4640e6342fb9e5d5b0994468676_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i602915a018774dab8faf3722799d8baa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64894a5f080e4b3f8b457334acdc1cd2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dea4d860bca4c7ba6c68ce71c7ff2d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc6f643b427d4d95b47f5f8bfbd1d696_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f541feaadce43de9b83e05a3cc81f9f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34af6b0108f84a96869a676335de8337_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbe8e10c0bfa405f91e4f5fd659e1ff4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i575234d878cc49f0b7c5fbf81531c46c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7263c122813549ad8e04254ba32ff7ca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1678eaf06a745c291b81999f992b9e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id87a26c787994153889a94e263789923_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2984eff859114415a857b8b3db2c96d5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7255b76317d34906aecab88a19308702_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e3c748d3af242daa261e5b79b0823b6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2c209582594436fa1bb0457e3e6696f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe0bed5f1c9144b18cb2a5768de65286_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cb7b230f33440da931414c29bbcf6cc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd9c6786655f4c92943a637689d9c95f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0ab0ebcdc664305a06c43149d516db8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide5f7ad99ed84ec48486190201956204_D20100101-20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="contingent_value_right"><xbrli:measure>lgnd:contingent_value_right</xbrli:measure></xbrli:unit><xbrli:context id="i704ccd2c79674fa98ab76165119a7944_D20100101-20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="contingent_value_right_series"><xbrli:measure>lgnd:contingent_value_right_series</xbrli:measure></xbrli:unit><xbrli:context id="i84a709f438684614a9dd32c76e70d210_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15b339fe796a4e2ba32e8dfbfdfa27aa_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd35f6c5d8e840969d67c38a72475508_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a9916b0d831414c99923be559940db0_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78d968b6172d467c8f046b7fe14c493d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia23c3aaaac85402db485305cdb6cc3f2_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b5f73a727824f0ca1db33f131e1d73a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1b59d9a96ec4375a669fbe2a05bd3b4_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf6982ebd2184a96b2c741ac8887e7ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic789c8af369747eba6fa7cf57d81c6ac_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd61ac74a7ff4488ac2e7e7b04b7a49c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i206dc67e487f44bfa1e9279e7b7981b7_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bdef6e83d484a31ae28be0288d4014a_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaa07f7868af4d3589b8f66d33b6f893_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a30dda7078441eaaca37acbf3037be6_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="i5de8a5b0c1fa4760b0f3c075d7b6c6db_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5474a312fb154f69820ca3cc97e950a7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0c4e811de974223a7854588c77071f0_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc028f1c7d9b45d5b5409ba862c9757c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbf91b4ebd6f491a92e85e1fc1d051d9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d97584fcd39416497ac8ddc28dccf83_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="option"><xbrli:measure>lgnd:option</xbrli:measure></xbrli:unit><xbrli:context id="i9ed745872a5b4347aba60ffe4aed601f_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i965fba54a35142f48c2ec3ae55ae973f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice70706143fc4fa587f3b05dfc86607f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if55454c1b587475f8f377fec9eb04748_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0275f925a31840af927726857ad4931a_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab997394326847b98b9a6709dde8df9e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81905d26e9e4434aa6c656e2d1a052fd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i898678e2c6ba4a73a10091c6fa20543d_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifae3653e5fe6429a946af263fcc4fd84_I20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93f3ccedcca8446095a986546e891de8_D20190911-20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-11</xbrli:startDate><xbrli:endDate>2019-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ad65c5ebdff424fb802e081f2da87ec_D20191031-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:USDistrictCourtForTheNorthernDistrictOfOhioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-31</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="civil_complaint"><xbrli:measure>lgnd:civil_complaint</xbrli:measure></xbrli:unit><xbrli:context id="ida31ec29c0a64e779c80ba3c979f2b18_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_1"></div><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C.  20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8xNzI_d35fca11-046b-4f34-9522-785a437375de">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">________________________________________________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6NzNiOTM2OTJmYjBlNDQ0ZTlhYjFiM2Y0NTQ0OWI4YzcvdGFibGVyYW5nZTo3M2I5MzY5MmZiMGU0NDRlOWFiMWIzZjQ1NDQ5YjhjN18wLTAtMS0xLTc3MTcx_fedd4a2c-5a88-413e-baba-2f5481b0de18">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8yOTY_4f392963-a184-49d3-b495-98839710c8a2">June&#160;30, 2022</ix:nonNumeric>  </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">or</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6YzgxZjQ1MzdlZDZlNDhjYWJjN2I1MTIxMGYwNzlhYTAvdGFibGVyYW5nZTpjODFmNDUzN2VkNmU0OGNhYmM3YjUxMjEwZjA3OWFhMF8wLTAtMS0xLTc3MTcx_9784fc66-d2e5-488f-bb9e-1a23cf944028">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the Transition Period From ______ to ______ .     </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8yMTg2_bba3194a-7504-4909-bfd4-293c1fc42dfa">001-33093</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><img src="lgnd-20220630_g1.jpg" alt="lgnd-20220630_g1.jpg" style="height:86px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"/></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8zOTg_bc1de14a-12c4-4192-8e6d-5f4bf45cd4e1">LIGAND PHARMACEUTICALS INCORPORATED</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:39.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6OGFmM2JhOGYxNWU3NGI5M2I3MTFlNWE2ZWQwNWI5MDgvdGFibGVyYW5nZTo4YWYzYmE4ZjE1ZTc0YjkzYjcxMWU1YTZlZDA1YjkwOF8wLTAtMS0xLTc3MTcx_785d43d3-e0a5-4e29-b5b4-87d6ad4ec16e">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6OGFmM2JhOGYxNWU3NGI5M2I3MTFlNWE2ZWQwNWI5MDgvdGFibGVyYW5nZTo4YWYzYmE4ZjE1ZTc0YjkzYjcxMWU1YTZlZDA1YjkwOF8wLTEtMS0xLTc3MTcx_3b70892f-3f65-46bb-954d-df4a81cead74">77-0160744</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Identification No.)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6OGFmM2JhOGYxNWU3NGI5M2I3MTFlNWE2ZWQwNWI5MDgvdGFibGVyYW5nZTo4YWYzYmE4ZjE1ZTc0YjkzYjcxMWU1YTZlZDA1YjkwOF8zLTAtMS0xLTc3MTcx_a320c6e0-d8fd-4fff-b707-a2d4ebe49104">5980 Horton Street, Suite 405</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6OGFmM2JhOGYxNWU3NGI5M2I3MTFlNWE2ZWQwNWI5MDgvdGFibGVyYW5nZTo4YWYzYmE4ZjE1ZTc0YjkzYjcxMWU1YTZlZDA1YjkwOF80LTAtMS0xLTc3MTcx_6d825a2b-c12e-4d47-aacf-a9bd1719b1b3">Emeryville</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6OGFmM2JhOGYxNWU3NGI5M2I3MTFlNWE2ZWQwNWI5MDgvdGFibGVyYW5nZTo4YWYzYmE4ZjE1ZTc0YjkzYjcxMWU1YTZlZDA1YjkwOF81LTAtMS0xLTc3MTcx_a9dc92b3-8017-49cd-9a5e-98145fd4bf04">CA</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6OGFmM2JhOGYxNWU3NGI5M2I3MTFlNWE2ZWQwNWI5MDgvdGFibGVyYW5nZTo4YWYzYmE4ZjE1ZTc0YjkzYjcxMWU1YTZlZDA1YjkwOF81LTEtMS0xLTc3MTcx_6950319e-89b4-4a08-bc1d-4b114e87742d">94608</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8yMTg3_4a777461-8977-4b7c-90c6-677499c7f7e6">858</ix:nonNumeric>) <ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8yMTg4_c8aa23f2-b4e4-44a3-b0f4-ed48c2f479a0">550-7500</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's Telephone Number, Including Area Code) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading symbol:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6ZjhjZWZhY2NjNjRlNGZiODhhNjU4YTkyYzE3MGQ2YjAvdGFibGVyYW5nZTpmOGNlZmFjY2M2NGU0ZmI4OGE2NThhOTJjMTcwZDZiMF8xLTAtMS0xLTc3MTcx_e694512b-2dd4-43c6-ad0f-ec5ba8f227ba">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6ZjhjZWZhY2NjNjRlNGZiODhhNjU4YTkyYzE3MGQ2YjAvdGFibGVyYW5nZTpmOGNlZmFjY2M2NGU0ZmI4OGE2NThhOTJjMTcwZDZiMF8xLTEtMS0xLTc3MTcx_61d17c89-ba9e-4157-8754-f1f1db414981">LGND</ix:nonNumeric></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6ZjhjZWZhY2NjNjRlNGZiODhhNjU4YTkyYzE3MGQ2YjAvdGFibGVyYW5nZTpmOGNlZmFjY2M2NGU0ZmI4OGE2NThhOTJjMTcwZDZiMF8xLTItMS0xLTc3MTcx_f449eeda-b7e6-4bec-8e11-8a030984f051">The Nasdaq Global Market</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    <ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8yMTg5_46bae869-2edd-42fb-90b3-685c446c93ac">Yes</ix:nonNumeric>  &#9746;    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    <ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8yMTkw_a979645f-5ad5-4c2d-bd8d-aa52e759a08f">Yes</ix:nonNumeric>  &#9746;    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See definitions of  &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;  &#8220;smaller reporting company,&#8221; </span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and "emerging growth company" in Rule 12b-2 of the Exchange Act.  (Check one)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"></td><td style="width:29.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6M2Q5NDQyZDNlZjdhNGZhZmE5ZmNlMmQ1NzRiM2E4NDMvdGFibGVyYW5nZTozZDk0NDJkM2VmN2E0ZmFmYTlmY2UyZDU3NGIzYTg0M18wLTAtMS0xLTc3MTcx_4a44330d-e86d-45ec-a8e3-425749cf450a">Large Accelerated Filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accelerated Filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Accelerated Filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller Reporting Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6M2Q5NDQyZDNlZjdhNGZhZmE5ZmNlMmQ1NzRiM2E4NDMvdGFibGVyYW5nZTozZDk0NDJkM2VmN2E0ZmFmYTlmY2UyZDU3NGIzYTg0M18xLTQtMS0xLTc3MTcx_e1df8e13-2014-475e-b001-8d3d51863626">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6M2Q5NDQyZDNlZjdhNGZhZmE5ZmNlMmQ1NzRiM2E4NDMvdGFibGVyYW5nZTozZDk0NDJkM2VmN2E0ZmFmYTlmY2UyZDU3NGIzYTg0M18yLTEtMS0xLTc3MTcx_cef79db1-a43a-4d8d-af0b-13ea868f03f5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8yMTkx_b0f8c845-f692-4b0c-88dd-0358a2335a7e">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    No  &#9746;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of August&#160;5, 2022, the registrant had <ix:nonFraction unitRef="shares" contextRef="iedc598dd9b154369925ac2b71e806c9f_I20220805" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8yMTQ5_95f2c32f-9c97-4a16-b90f-d19382684944">16,882,751</ix:nonFraction> shares of common stock outstanding.</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I.  FINANCIAL INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_13">ITEM 1.  Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_16">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_19">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_22">Condensed Consolidated Statements of Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_25">Condensed Consolidated Statements of Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_28">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_61">ITEM 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_61">24</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_73">ITEM 3.  Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_73">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_76">ITEM 4.  Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_76">32</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II.  OTHER INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_82">ITEM 1.  Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_82">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_85">ITEM 1A.  Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_85">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_88">ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_88">35</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_91">ITEM 3.  Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_91">35</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_94">ITEM 4.  Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_94">35</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_97">ITEM 5.  Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_97">35</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_100">ITEM 6.  Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_103">38</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_103">SIGNATURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib69a4a9cb92a4725b58ada0b25efe540_103">38</a></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GLOSSARY OF TERMS AND ABBREVIATIONS</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Abbreviation</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definition</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021 Annual Report</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Annual Report on Form 10-K for the year ended December&#160;31, 2021, filed with the SEC on February 28, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$750.0 million aggregate principal amount of convertible senior unsecured notes due 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ab Initio</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ab Initio Biotherapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amgen</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amgen, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Avista Public Acquisition Corp. II</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting Standards Codification</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASU</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting Standards Update</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVR</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent value right</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal Bioscience, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex Pharmaceuticals, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EMA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">European Medicines Agency</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan, as amended and restated</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Food and Drug Administration</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Generally accepted accounting principles in the United States</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gilead</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gilead Sciences, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen, LLC</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Merger Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated as of March 23, 2022, among APAC, Ligand, OmniAb and Merger Sub</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Merger Sub</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orwell Merger Sub, Inc., a wholly owned subsidiary of APAC</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">OmniAb</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">OmniAb, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">OmniAb Business</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Ligand's antibody discovery business</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Q2 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's fiscal quarter ended June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Q2 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's fiscal quarter ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Separation Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Separation and Distribution Agreement, dated as of March 23, 2022, among APAC, Ligand and OmniAb</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Travere</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Travere Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Viking Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">xCella Biosciences, Inc.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">YTD</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Year-to-date</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_13"></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">     Item 1. Condensed Consolidated Financial Statements</span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_16"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands, except par value)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMy0xLTEtMS03NzE3MQ_5dfae075-6c6d-4e91-a629-13de873a606e">5,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMy0zLTEtMS03NzE3MQ_5248ca8d-6022-48c9-83fa-dddcb6c1f2a1">19,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNC0xLTEtMS03NzE3MQ_79ceb9bd-45d4-4e2d-9119-1fadcdbf85a2">142,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNC0zLTEtMS03NzE3MQ_75c0b497-4640-40c6-b5d3-c48602b6e3a9">321,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNS0xLTEtMS03NzE3MQ_261b1299-6376-4032-bb36-f2882dfdd69e">62,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNS0zLTEtMS03NzE3MQ_40ae4cd0-0d5c-495c-8330-d47cd97819ee">85,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNi0xLTEtMS03NzE3MQ_212be0c4-ff4b-4870-9a2e-aa0154a04bab">24,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNi0zLTEtMS03NzE3MQ_ab4f81f8-790e-460c-a555-40ba0a584b06">27,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Income taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNy0xLTEtMS03NzE3MQ_7485388e-20a8-47c3-91f1-acf9f2bfa020">964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNy0zLTEtMS03NzE3MQ_f513ee36-2955-4104-8194-92da80bcb976">6,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfOC0xLTEtMS03NzE3MQ_eea90ff0-0007-4e2d-8f02-2be7ad3b5cfd">7,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfOC0zLTEtMS03NzE3MQ_46940772-635d-450b-8ea1-dcdaf7b0000a">4,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfOS0xLTEtMS03NzE3MQ_b2dc3933-7a4e-4063-9606-9310f20734f6">243,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfOS0zLTEtMS03NzE3MQ_e7f1664a-6077-4bc3-a7ef-fe88fbeefdfc">464,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTAtMS0xLTEtNzcxNzE_09420bac-dde9-49f6-ae92-48c892575a0f">35,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTAtMy0xLTEtNzcxNzE_dbec134e-37fe-47b1-8fa0-337c312ef279">34,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTEtMS0xLTEtNzcxNzE_9ff0c2de-4423-4606-885a-ee022c26d579">528,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTEtMy0xLTEtNzcxNzE_de25fed1-b264-44ec-92ce-526be85451cb">551,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTItMS0xLTEtNzcxNzE_2a145f8b-7f7c-41c3-89b7-dc1ffdf6643a">181,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTItMy0xLTEtNzcxNzE_67c430f8-6e17-4ee2-b514-1be6a4c3cd39">181,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Commercial license rights, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="lgnd:CommercialLicenseRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTMtMS0xLTEtNzcxNzE_284f637b-7a95-4d19-9ea2-a41fc525f784">10,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="lgnd:CommercialLicenseRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTMtMy0xLTEtNzcxNzE_8f684f35-d4f1-4ef3-ae98-45cbd488ba30">10,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTQtMS0xLTEtNzcxNzE_ed20e8de-5489-4c08-a07b-45db4cdb82b6">30,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTQtMy0xLTEtNzcxNzE_3f540ca3-a743-4a05-b747-e486ac5534b4">20,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTUtMS0xLTEtNzcxNzE_7b7e4018-99c3-4b02-9fd7-9e67903cbfd4">24,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTUtMy0xLTEtNzcxNzE_4cf175ab-0484-4297-adaf-0bf50ba7bfe0">16,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTYtMS0xLTEtNzcxNzE_95d07ca7-9cf4-4d35-ad46-b0d4dc3af058">15,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTYtMy0xLTEtNzcxNzE_c1c06f7f-f3f5-4c5a-a2e7-23d075bf644e">16,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTctMS0xLTEtNzcxNzE_f8c008b9-7b1b-46e7-be97-88bbb39c8a5a">6,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTctMy0xLTEtNzcxNzE_38d0bfde-3695-43a4-ab02-869bbea8810a">2,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTgtMS0xLTEtNzcxNzE_f06d5dde-24f6-4dc2-85d7-c5acdbbad160">1,076,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTgtMy0xLTEtNzcxNzE_1b3d25e6-68f3-439c-bbf0-b9e93432be51">1,297,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts payable </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjEtMS0xLTEtNzcxNzE_5859e4ac-15d5-41e2-b92d-dbec500f7d49">19,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjEtMy0xLTEtNzcxNzE_5ceceaef-c91d-44ac-84a9-3e711becf018">8,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjItMS0xLTEtNzcxNzE_67339292-2644-4be3-a4b6-3a32a9e319f6">14,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjItMy0xLTEtNzcxNzE_c5fe2dd3-575d-4d60-b122-ea483ca2852c">17,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjMtMS0xLTEtNzcxNzE_aab60843-5225-43bb-a0ea-8dfc9ae2aca1">3,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjMtMy0xLTEtNzcxNzE_64417b89-651b-4e40-b3e7-0ae36bb1b659">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjQtMS0xLTEtNzcxNzE_54b2829f-1b1e-4510-a061-19b10176821c">2,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjQtMy0xLTEtNzcxNzE_708f9b30-34cc-484a-bd30-257034502422">2,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjUtMS0xLTEtNzcxNzE_ee745af8-7077-43e9-b038-07c3e5821454">10,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjUtMy0xLTEtNzcxNzE_58293a14-aa40-45b0-acf3-878092f0d155">10,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjYtMS0xLTEtNzcxNzE_5d43c5cb-977b-479f-bf26-8a60db01d406">2,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjYtMy0xLTEtNzcxNzE_8a534c04-cdf3-4a88-b45f-b77c44866c15">2,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current financing lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjctMS0xLTEtNzcxNzE_e78a8be3-202e-45e0-987a-2c403fee7267">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjctMy0xLTEtNzcxNzE_a4b0dd4e-b0a2-4341-9965-79299cca34bd">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;2023 convertible senior notes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjgtMS0xLTEtODUxMDM_4a6354d7-dffd-4936-a4e2-053c04698183">114,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjgtMy0xLTEtODUxMDM_aaa7d86a-7300-4f01-88a0-7390c9fda751">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjgtMS0xLTEtNzcxNzE_abbe2a04-afeb-4b95-b657-28e952495438">167,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjgtMy0xLTEtNzcxNzE_380d8ac3-9f09-4d35-b494-d7499070ec32">41,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023 convertible senior notes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjktMS0xLTEtNzcxNzE_13a58d68-aea8-4514-ae43-55c4be6a88b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjktMy0xLTEtNzcxNzE_52ff14d1-9269-4820-8f0e-528d3251d9a8">320,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="lgnd:LiabilityForContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzAtMS0xLTEtNzcxNzE_1a2af53a-4236-4eb5-889f-caa323012074">6,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="lgnd:LiabilityForContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzAtMy0xLTEtNzcxNzE_da105cb6-29b1-4b76-934f-b9015a90ad0c">8,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzEtMS0xLTEtNzcxNzE_3761ed51-e927-4621-ba40-42a4c1a89ce7">42,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzEtMy0xLTEtNzcxNzE_43bb2298-608d-4c31-aafd-ae10d78ce305">59,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzItMS0xLTEtNzcxNzE_b99d0684-3706-41f2-8bff-da2226f6a98a">27,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzItMy0xLTEtNzcxNzE_0ab2af93-3eac-44d2-8a93-0b88b49ed052">15,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Long-term deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzQtMS0xLTEtOTIxNDg_499385bc-ff68-4316-8db4-1a63458e7279">7,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzQtMy0xLTEtOTIxNDA_3fce2138-a5d7-427f-b4e1-743f1143cb14">9,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzMtMS0xLTEtNzcxNzE_d6439e74-de19-452e-80aa-decaf2e68b61">21,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzMtMy0xLTEtNzcxNzE_97b65e5a-1dc8-40ad-8a8b-4fcdcdff8097">21,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzQtMS0xLTEtNzcxNzE_af2bac6f-f68b-4fe8-b74f-4e9350eaaba6">273,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzQtMy0xLTEtNzcxNzE_e6e4717d-d3df-4144-85fc-565340fd4774">476,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzUtMS0xLTEtNzcxNzE_ba589212-ae5a-44b9-8383-569292f7b896"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzUtMy0xLTEtNzcxNzE_12829468-f82c-4e85-a5cc-ce83a631aa73"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjphZTM0MzJjNDc4YzU0ZmJmOWZiMDZlMWZjNWYzZmU0Zl8yNA_1b4cbd33-7baa-4e1d-acf3-da8d7af69629"><ix:nonFraction unitRef="usdPerShare" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjphZTM0MzJjNDc4YzU0ZmJmOWZiMDZlMWZjNWYzZmU0Zl8yNA_8de06673-546a-4361-b9c1-0556f9645085">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjphZTM0MzJjNDc4YzU0ZmJmOWZiMDZlMWZjNWYzZmU0Zl8zOA_285d45b0-0c8f-441f-9e6d-52014d9ff47d"><ix:nonFraction unitRef="shares" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjphZTM0MzJjNDc4YzU0ZmJmOWZiMDZlMWZjNWYzZmU0Zl8zOA_ed84dab4-ea96-45dd-95cc-0b4f473e2a77">5,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjphZTM0MzJjNDc4YzU0ZmJmOWZiMDZlMWZjNWYzZmU0Zl82MA_31628f68-677e-4f06-b733-fc59f0c06984"><ix:nonFraction unitRef="shares" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjphZTM0MzJjNDc4YzU0ZmJmOWZiMDZlMWZjNWYzZmU0Zl82MA_433c805a-b3f7-40e8-aaa8-b30b34e733e1"><ix:nonFraction unitRef="shares" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjphZTM0MzJjNDc4YzU0ZmJmOWZiMDZlMWZjNWYzZmU0Zl82MA_496eb721-d5ac-4581-a753-0172f0d387bc"><ix:nonFraction unitRef="shares" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjphZTM0MzJjNDc4YzU0ZmJmOWZiMDZlMWZjNWYzZmU0Zl82MA_674668f2-9a45-4861-ae21-157d12c7edd5">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at June&#160;30, 2022 and December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMS0xLTEtNzcxNzE_bb60eee9-d57a-4ca9-a020-636b774331b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMy0xLTEtNzcxNzE_71032fae-4d18-403f-82c3-b777d399d514">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjozMGM1ODgyMTViZTg0OTUzODU2M2U3ZGI4Yjg4ZmIyY18yMQ_de863977-ae72-4ef6-b733-fba7bd33706b"><ix:nonFraction unitRef="usdPerShare" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjozMGM1ODgyMTViZTg0OTUzODU2M2U3ZGI4Yjg4ZmIyY18yMQ_e8690449-1a33-485e-92d1-246fe2352438">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjozMGM1ODgyMTViZTg0OTUzODU2M2U3ZGI4Yjg4ZmIyY18zNQ_83dc4d2e-3230-4892-8954-f70862dc2dfc"><ix:nonFraction unitRef="shares" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjozMGM1ODgyMTViZTg0OTUzODU2M2U3ZGI4Yjg4ZmIyY18zNQ_b272c944-a7c5-4672-a3ed-1690723dbda6">60,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjozMGM1ODgyMTViZTg0OTUzODU2M2U3ZGI4Yjg4ZmIyY181Nw_5468224f-5588-4f11-a50e-4f1c4fe6e894"><ix:nonFraction unitRef="shares" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjozMGM1ODgyMTViZTg0OTUzODU2M2U3ZGI4Yjg4ZmIyY181Nw_95919af9-d529-4803-bedf-9d50bec01a8b">16,882</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjozMGM1ODgyMTViZTg0OTUzODU2M2U3ZGI4Yjg4ZmIyY182NA_ad76d6ab-8803-47b0-948c-674b61d516cd"><ix:nonFraction unitRef="shares" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjozMGM1ODgyMTViZTg0OTUzODU2M2U3ZGI4Yjg4ZmIyY182NA_c9a8b954-d375-482f-a005-588dbb64405b">16,767</ix:nonFraction></ix:nonFraction>  shares issued and outstanding at June&#160;30, 2022 and December&#160;31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMS0xLTEtNzcxNzE_e85d4ec5-bc88-46ca-bff1-f4e07da15151">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMy0xLTEtNzcxNzE_59705ae7-d52c-4110-8b8e-6400804d26e2">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzktMS0xLTEtNzcxNzE_101c19aa-96a6-430f-8220-f0768846da5b">335,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzktMy0xLTEtNzcxNzE_c325d0b2-882e-49ec-a115-260c8c58cd6a">372,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNDAtMS0xLTEtNzcxNzE_55a16021-f1fe-47ae-9f03-02caafd7bbf7">1,066</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNDAtMy0xLTEtNzcxNzE_cd7f55f2-4ed1-454c-bee5-418908fd2800">917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Retained earnings </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNDEtMS0xLTEtNzcxNzE_2c82ad0f-2eaa-4559-ba1a-263569ddf242">467,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNDEtMy0xLTEtNzcxNzE_187641d2-51ef-4edc-8a46-650689dccfa3">449,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNDItMS0xLTEtNzcxNzE_f58885b8-7bae-46db-86d5-896556762eb3">802,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNDItMy0xLTEtNzcxNzE_781abc4a-ccab-42e3-82ce-ffcea45943c5">821,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders' equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNDMtMS0xLTEtNzcxNzE_c76721ad-d38e-4c37-a2db-4938abd67618">1,076,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNDMtMy0xLTEtNzcxNzE_d99eb45f-66e8-42c9-a1b5-55e2216b5deb">1,297,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_19"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:35.277%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4451c0bbe6454e30a9400b8f2b6b236b_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNC0xLTEtMS03NzE3MQ_79bf62e9-65ca-45c3-86cf-21127d0d27a7">17,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadd0658df38142da9de49541fcf1e87b_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNC0zLTEtMS03NzE3MQ_da6979bf-8331-4b95-ae0f-0e60880c6785">8,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36945e4ea3d94671ba79140fa3bfeed8_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNC01LTEtMS03NzE3MQ_1247e20a-9a46-41db-b29e-f540b9987c6e">31,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc58590074134385916f9aa21fadb3a5_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNC03LTEtMS03NzE3MQ_798974d0-303d-4956-9cb1-d9e9d0667a7a">15,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0dc4219be484ce8aa0ac5cb14f54a41_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNS0xLTEtMS03NzE3MQ_680756c6-02e8-4020-ae96-5f81baf6242f">29,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06d3227a7eb74265aa981e7a0d0ff54a_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNS0zLTEtMS03NzE3MQ_8a94aa42-6eba-4718-97c0-d7876a92a237">62,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iede13d72d60b42d785f8340ba1c81680_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNS01LTEtMS03NzE3MQ_b440a61b-dad4-4236-a4b9-a25822bbd40b">41,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f25445795154f5a93fcbfa2d95e4ca4_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNS03LTEtMS03NzE3MQ_0e72926f-e76d-4edf-aab2-6bf2b22a62a8">93,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Contract revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4abd7ed5056140b3a6f412c3dcf92315_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNi0xLTEtMS03NzE3MQ_7fe602a5-28a4-498d-9321-e32a99eb783a">9,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib690ef44f20c492ba685cf71add617d4_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNi0zLTEtMS03NzE3MQ_19a73268-cdd6-4a4b-bc9d-463e4aa1bf49">13,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf5c36ba61894d93b55a210349a7ccf2_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNi01LTEtMS03NzE3MQ_9e24b4a6-0b89-4a8a-911d-556efc47ede8">29,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75907dd7ed51403bb417727e96e225eb_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNi03LTEtMS03NzE3MQ_de3a38e0-3aa6-485a-9ff0-3932d739cd69">30,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNy0xLTEtMS03NzE3MQ_cd394087-dd8d-433c-b4c3-5ac9550f2250">57,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNy0zLTEtMS03NzE3MQ_5ae4c877-9f50-47aa-a90b-c61d4814b560">84,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNy01LTEtMS03NzE3MQ_e1aaf868-92e8-4f10-a92f-96783bf7e2da">103,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNy03LTEtMS03NzE3MQ_10f0ac12-9e02-45ee-99cf-a5090f53c630">139,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cost of Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:CostDirectMaterial" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfOS0xLTEtMS03NzE3MQ_b612a5bf-0fef-470a-aa28-c662b64b7834">12,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:CostDirectMaterial" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfOS0zLTEtMS03NzE3MQ_840e8267-337b-479b-afda-ecfbaf0686a0">30,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:CostDirectMaterial" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfOS01LTEtMS03NzE3MQ_defc2eb2-8e79-4913-a2a9-43e87d9c0fd6">17,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:CostDirectMaterial" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfOS03LTEtMS03NzE3MQ_0d059a91-3e94-40e5-ae99-04469b0b092e">38,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTAtMS0xLTEtNzcxNzE_431900b9-9d8a-4acb-9775-6676599450f9">11,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTAtMy0xLTEtNzcxNzE_a123c6be-3a42-4929-bdff-64e35a52c316">11,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTAtNS0xLTEtNzcxNzE_7bcaaea6-88e7-48e0-ade6-665b26e63fec">23,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTAtNy0xLTEtNzcxNzE_6ca3a8f1-d90a-4e3e-b769-e18a447f0b60">23,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTEtMS0xLTEtNzcxNzE_03524393-04c6-471d-9689-d327ba389257">19,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTEtMy0xLTEtNzcxNzE_ed6a78a3-5a06-49bd-945b-817825412bd5">15,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTEtNS0xLTEtNzcxNzE_7a909c88-d1bb-475e-bc6e-24c61925238b">39,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTEtNy0xLTEtNzcxNzE_8047e38e-4cd1-45ab-827d-d987d3f041b9">33,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTItMS0xLTEtNzcxNzE_09bb43be-98eb-4149-bf0f-f77d389b0d7b">14,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTItMy0xLTEtNzcxNzE_da9aa19d-f935-4101-a33b-3fbefbe10409">14,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTItNS0xLTEtNzcxNzE_88baa510-fa46-4764-bce4-b057c98b2a6c">32,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTItNy0xLTEtNzcxNzE_6c7f0719-477c-4690-b394-36e098ad3621">27,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other operating income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:OtherOperatingIncomeExpenseNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTMtMS0xLTEtODcwNTQ_41beb793-3a66-412d-ad16-fc2fccdbb19e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:OtherOperatingIncomeExpenseNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTMtMy0xLTEtODUxODU_350ea4ad-cb47-4bd6-94e3-e09141728b2e">34,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:OtherOperatingIncomeExpenseNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTMtNS0xLTEtODcwNTQ_6d994a27-5167-4391-b731-96f0cc62f215">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:OtherOperatingIncomeExpenseNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTMtNy0xLTEtODUxOTY_23c1722e-64e9-415a-a4ff-601c5b6f0ac0">33,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTMtMS0xLTEtNzcxNzE_16c04047-c5a5-40f2-866b-bccbc9624f74">57,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTMtMy0xLTEtNzcxNzE_4b54897c-1506-4063-aac3-7382f06f294a">38,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTMtNS0xLTEtNzcxNzE_3ecc1a15-fb06-4e7c-9fc9-bbfeb61c7256">112,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTMtNy0xLTEtNzcxNzE_33d0e297-e358-4510-8307-e94b715f5ca2">89,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTQtMS0xLTEtNzcxNzE_06338005-cb24-4425-aa0a-781b803e0533">469</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTQtMy0xLTEtNzcxNzE_820ea1a8-d0d7-41b7-8212-d7125115e133">45,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTQtNS0xLTEtNzcxNzE_df7771f6-fedc-4d0f-aaf6-239c7a32c148">9,775</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTQtNy0xLTEtNzcxNzE_e7a6e4f2-2c65-4b4f-be52-2c2103cfaafc">50,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Gain (loss) from short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTYtMS0xLTEtNzcxNzE_3138105b-f720-4710-ab4e-4f077e62f66e">1,909</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTYtMy0xLTEtNzcxNzE_d28f4f4a-e97f-45ae-9cb1-bea642f71672">6,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTYtNS0xLTEtNzcxNzE_808d4e5c-3d7b-498f-a5b8-b10d07219989">14,786</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTYtNy0xLTEtNzcxNzE_78dc1d01-203d-4882-92c0-60c3f5cc3d04">6,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTctMS0xLTEtNzcxNzE_a09eeb84-1810-43df-b6e3-90fa4a411acb">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTctMy0xLTEtNzcxNzE_ff71a600-4340-4cc1-91e2-39b5619a11fb">233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTctNS0xLTEtNzcxNzE_5df63e71-2d34-460a-8645-a6ef42e980f6">432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTctNy0xLTEtNzcxNzE_62e79522-3df9-4f3a-af89-225f3fe27f37">529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTgtMS0xLTEtNzcxNzE_34557f49-3fa5-42c7-b8db-abdd1bd3ac74">438</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTgtMy0xLTEtNzcxNzE_c4912c2e-cf31-466c-a8de-c4f75285b8be">4,883</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTgtNS0xLTEtNzcxNzE_f7dd1ad1-b961-4e85-af85-725de19a7e5b">1,227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTgtNy0xLTEtNzcxNzE_5401a5b9-ad83-4b7a-aa4b-d55d9b1ebe38">10,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTktMS0xLTEtNzcxNzE_82dbcfac-f9cc-4235-9cf7-b0a2bd702457">1,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTktMy0xLTEtNzcxNzE_8b89c39d-eb01-442d-b29a-18e196fc6803">924</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTktNS0xLTEtNzcxNzE_cba104bd-8cb7-403e-ae7f-75c54c65f793">4,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTktNy0xLTEtNzcxNzE_bb0fa541-e619-4d73-b04e-e342ad86c0bd">7,401</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjAtMS0xLTEtNzcxNzE_34213542-8b42-4ed4-877e-152d29b0b5e3">167</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjAtMy0xLTEtNzcxNzE_7d91f7ea-b6af-4bc3-ad2c-5d483212a790">12,438</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjAtNS0xLTEtNzcxNzE_bbd67a9c-e360-4cde-b841-c010454fd963">11,001</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjAtNy0xLTEtNzcxNzE_a4b389b6-f949-4179-8347-dbc097d8d1d1">11,389</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss)  before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjEtMS0xLTEtNzcxNzE_f4be53f8-8706-4f65-be23-8ba5eca49926">636</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjEtMy0xLTEtNzcxNzE_d04e518a-8bfc-4fdf-9d6f-bf0f8233125a">33,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjEtNS0xLTEtNzcxNzE_d9c179a5-63f5-4713-ac85-6637f8ddf35b">20,776</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjEtNy0xLTEtNzcxNzE_54a14571-dc6d-44cc-9d95-ba5f4bcab427">39,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjItMS0xLTEtNzcxNzE_dfd1cd2f-f378-44fb-8ac3-f6e667e20011">259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjItMy0xLTEtNzcxNzE_5f937db0-0603-443f-b2bb-f5821778780d">2,576</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjItNS0xLTEtNzcxNzE_70f8db84-07ff-4dcf-8058-bb1cbaa2fb65">4,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjItNy0xLTEtNzcxNzE_1173b26b-b1ce-44d0-af09-00b7ad0cc295">9,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjMtMS0xLTEtNzcxNzE_c9bceb39-a5ce-43e4-b6f9-5f7651fba08d">895</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjMtMy0xLTEtNzcxNzE_0a1df59b-61bf-49a2-99bd-d830d592718a">30,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjMtNS0xLTEtNzcxNzE_a139813b-3a32-4663-8fc1-b00135108e81">16,280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjMtNy0xLTEtNzcxNzE_f5a1be31-869c-48fc-b78a-d247c7faabc0">48,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic net (loss) income per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjUtMS0xLTEtNzcxNzE_b3c6b051-b95f-49ec-802a-d45d770ddd64">0.05</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjUtMy0xLTEtNzcxNzE_d6627e40-fc33-4ba7-89dd-2fc6e8efb753">1.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjUtNS0xLTEtNzcxNzE_0674d189-9a06-48c7-bc8f-d58227a1c364">0.97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjUtNy0xLTEtNzcxNzE_7106b002-8b60-4586-86d0-fcc84a48941c">2.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares used in basic per share calculations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjYtMS0xLTEtNzcxNzE_4f355016-eaa6-4ae7-abb4-4ffe45c51ecd">16,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjYtMy0xLTEtNzcxNzE_1954d795-a296-4a01-85be-989f9dd1342b">16,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjYtNS0xLTEtNzcxNzE_7284e52a-217c-47fb-9c85-44e8b7e81580">16,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjYtNy0xLTEtNzcxNzE_46df6e25-80eb-447e-bd13-fc9e4d9638d3">16,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted net (loss) income per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjgtMS0xLTEtNzcxNzE_e1e3f42b-f672-4106-acac-18b3998331cd">0.05</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjgtMy0xLTEtNzcxNzE_7df0bbb7-d9d6-456c-950a-35726356ac54">1.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjgtNS0xLTEtNzcxNzE_56a46bbe-983a-47b4-9d2b-ed9abc18888d">0.97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjgtNy0xLTEtNzcxNzE_12309b77-0e7a-4e89-8f06-816414cfe64a">2.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares used in diluted per share calculations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjktMS0xLTEtNzcxNzE_b2afb68c-bb58-4cda-8cb5-676c66ef2bc4">16,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjktMy0xLTEtNzcxNzE_433b381f-00fb-49c8-8af1-cf125a3086a5">17,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjktNS0xLTEtNzcxNzE_b6f185ff-da5c-4656-92da-d4f9f2c3897c">16,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjktNy0xLTEtNzcxNzE_8113ba33-f2f1-41de-a8f3-d9cc0ee701b5">17,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfMy0xLTEtMS03NzE3MQ_8cf77427-473e-47d4-9bee-b66ce6d20ae4">895</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfMy0zLTEtMS03NzE3MQ_b246f559-405c-4259-87be-294344abda32">30,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfMy01LTEtMS03NzE3MQ_6da0710d-ae02-4a1d-b3a9-2ea2d6c69e6b">16,280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfMy03LTEtMS03NzE3MQ_e0df99df-be2e-4474-8bee-6155718cdb57">48,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfNC0xLTEtMS03NzE3MQ_a2b1ebec-5d4f-4375-89e8-765928541c56">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfNC0zLTEtMS03NzE3MQ_b3f96851-b4d5-4737-930b-f1dd6eb16161">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfNC01LTEtMS03NzE3MQ_310c7699-b22e-4551-a4c5-325bc0d62c81">149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfNC03LTEtMS03NzE3MQ_4abd2fe6-3316-48e8-b4c8-ab6b90583491">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive (loss) income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfNS0xLTEtMS03NzE3MQ_9a727dda-5cd9-4c10-a8d3-570bccf0f05d">930</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfNS0zLTEtMS03NzE3MQ_e60043c7-73f4-4244-a947-d8c5e0b602c5">30,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfNS01LTEtMS03NzE3MQ_4944d038-102c-4d7d-9054-b9534fa38504">16,429</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfNS03LTEtMS03NzE3MQ_bf54e8cf-0876-4d4a-b8b8-f50971d6408b">48,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid in capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85f8622834f34bd190af73c102a914cc_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMi0xLTEtMS03NzE3MQ_c6cd9246-e3cd-4318-bdd4-ebea9d07d38e">16,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f8622834f34bd190af73c102a914cc_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMi0yLTEtMS03NzE3MQ_729356bf-6512-4d1f-a16d-c22dc5c8abae">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cfa0d1834f445a49fb6b65740cb4cd4_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMi0zLTEtMS03NzE3MQ_2e4e65bc-04f8-4d17-8f3f-4a9798c481f0">372,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1c61c60b6194b22adf91c5e2cbe87ff_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMi00LTEtMS03NzE3MQ_6e815a43-4ab9-4eb2-bb57-bd0cde16948c">917</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedb09b7e2fcb4ab7aebd9117745eb914_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMi01LTEtMS03NzE3MQ_b27c9c09-c8e9-4a4b-a102-57ce8230ef14">449,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMi02LTEtMS03NzE3MQ_8ba69914-837d-4738-be58-bcf8944d75a8">821,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMy0wLTEtMS03NzE3MQ_d4683d88-94ef-4a22-8ed5-d4dd9b4356a7">ASU 2020-06 adoption, net of tax (Note 1)</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5459b627e84394b6d868b1c0657e63_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMy0zLTEtMS03NzE3MQ_0ca6c653-ef49-4ad8-b6c1-fc9bcfc0e233">51,130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i362afaf034ae4672be24c81c6b93536c_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMy01LTEtMS03NzE3MQ_682ae87f-d538-4e10-a33c-1c312474988e">35,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76ae97986fac4a65aa555297c9706a05_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMy02LTEtMS03NzE3MQ_1d55d005-0d67-423d-8328-482008e24ddb">15,997</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id3e93db38a0c4a65a7538c436c978d22_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfNC0xLTEtMS03NzE3MQ_0d399dea-5da2-4355-afed-22646d5a9ba0">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d94a99e36434ce3bcb95c74af16730c_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfNC0zLTEtMS03NzE3MQ_bd685e11-58cc-4001-8259-6c6563d9298d">5,515</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0861fff98f443b690754c837f781b97_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfNC02LTEtMS03NzE3MQ_6ffe7901-3e62-46eb-87ec-5e417f28cdaa">5,515</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d94a99e36434ce3bcb95c74af16730c_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfNS0zLTEtMS03NzE3MQ_9c6c1943-e98e-4f84-8428-3511866e8a64">9,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0861fff98f443b690754c837f781b97_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfNS02LTEtMS03NzE3MQ_0d8049af-b7fa-40ce-9a8d-3d5f5133fb93">9,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897aeacae0a54360ae9e4b7fef689689_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfNi00LTEtMS03NzE3MQ_74647b42-ebb1-4d95-baa2-3017dd1e8605">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0861fff98f443b690754c837f781b97_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfNi02LTEtMS03NzE3MQ_a3ee54cd-898d-4de0-bd05-d88517838c71">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611ca28f9b2b49b0ab2181e8b332d455_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfOC01LTEtMS03NzE3MQ_5675ec26-de4f-472b-8595-618fc15ecb23">15,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0861fff98f443b690754c837f781b97_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfOC02LTEtMS03NzE3MQ_29eac3b3-325a-40c1-8f55-5c0527088c3f">15,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida17f1e22fcc46d888527d5585b5db6a_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfOS0xLTEtMS03NzE3MQ_7fdaeb9f-56ad-4fff-b161-1badf62be95c">16,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida17f1e22fcc46d888527d5585b5db6a_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfOS0yLTEtMS03NzE3MQ_6af5d378-f034-42b1-853c-6b64df48d3df">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a7ab73aa7904f7ebaf48f7dce5ab966_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfOS0zLTEtMS03NzE3MQ_187b6f6d-58db-4faa-9970-4a82c852d3ea">325,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if13fbe07ca154d04930101ff2e942a66_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfOS00LTEtMS03NzE3MQ_0f36468d-5a1e-40d6-b8d8-f188f148ba1a">1,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cd03be6fae54778adda0e81e4ca4bb6_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfOS01LTEtMS03NzE3MQ_dd9728a4-f90b-4c7b-afe9-01113e784bd6">468,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if12c3ec488ca49709a4421cb42f9abbb_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfOS02LTEtMS03NzE3MQ_c4061459-9ff2-4478-bfe3-f922865b8fcf">793,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i795e50fb1bd04eb1bed4a653ee8c754a_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTAtMS0xLTEtNzcxNzE_9f5c08ea-6d35-407c-8ff8-2402c06329ce">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcedf9519070438b806357a9dd22600a_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTAtMy0xLTEtNzcxNzE_6b5fdbb5-2bcc-4af9-8fc9-2ecc155acc71">604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTAtNi0xLTEtNzcxNzE_a2139bc9-b86b-4482-a2d1-0c5f36cee0d2">604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcedf9519070438b806357a9dd22600a_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTEtMy0xLTEtNzcxNzE_cc18d926-a4e4-4fb2-9ed6-18375c483d92">9,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTEtNi0xLTEtNzcxNzE_8666dc14-e382-4042-ae59-eec844d86e8b">9,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i372b4ca31b6148f580791f16233559c6_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTItNC0xLTEtNzcxNzE_0fd504f0-caa3-4efc-9e82-ef2e3914aab0">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTItNi0xLTEtNzcxNzE_cc87a84b-1aee-49f1-85c3-a2be5b39489d">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i518323b49cf84a3596e600f5a1f4c5de_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTUtNS0xLTEtNzcxNzE_a2aa24ac-95a0-4ddd-9685-8bb67831aff9">895</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTUtNi0xLTEtNzcxNzE_80bb680a-903d-4044-aa2e-f6954bb1e312">895</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66a4853ebfb84f1cbf13e26153087b0f_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTYtMS0xLTEtNzcxNzE_f103eb0b-c46d-47c6-98bb-64aa560b1603">16,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a4853ebfb84f1cbf13e26153087b0f_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTYtMi0xLTEtNzcxNzE_648f9a6e-c2e4-43b7-ba55-8d3882d4e811">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f1ead9f69da4d13ab756c627f382b38_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTYtMy0xLTEtNzcxNzE_6a035f4f-d8ed-483a-a2fe-7dd1db34840b">335,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d5f804285544b3c85561c7025916c3d_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTYtNC0xLTEtNzcxNzE_281b42e8-a1ed-4e33-9960-f67933e6cb10">1,066</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f076aef7744e2ba3466da10e42c30c_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTYtNS0xLTEtNzcxNzE_e3449d86-1803-46e3-b11a-8b4009390e88">467,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTYtNi0xLTEtNzcxNzE_ddc585a1-76c1-4ffb-9807-e0c152fb7d1e">802,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid in capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie007cd8b0d0a49a8b243568f89c18ee8_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMi0xLTEtMS03NzE3MQ_90ccadab-9790-4eb4-a3ba-437bc8bd3131">16,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie007cd8b0d0a49a8b243568f89c18ee8_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMi0yLTEtMS03NzE3MQ_0782497e-0ce2-4cef-a238-48a44df7b496">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cceb54932694869a897f6267d1671d2_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMi0zLTEtMS03NzE3MQ_cf0a6f4b-093f-435f-a51d-9c88f9448861">318,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe339071fd4f412d97a4a4b4efe13b85_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMi00LTEtMS03NzE3MQ_762c16b2-ee08-402d-9a3c-da99abbccb2c">801</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i219e6f0c67584cdfb9cc97d98d4660f3_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMi01LTEtMS03NzE3MQ_595be96b-29ba-49c1-9848-7f55a4ffedad">391,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c127685aa945a6ac245b4904e579a9_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMi02LTEtMS03NzE3MQ_e4777bac-30a9-41fe-8767-522bed88267d">709,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1df447ab25dd46908c81e1e59a7690f4_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMy0xLTEtMS03NzE3MQ_0eb88d38-900e-4732-bd06-49624ee226b1">572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1df447ab25dd46908c81e1e59a7690f4_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMy0yLTEtMS03NzE3MQ_b194f17a-4b79-458a-8f19-1c36404dba7c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f3cf826076418d8df0ad8aa0976c1d_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMy0zLTEtMS03NzE3MQ_1992dbda-c750-489f-aaee-4d669b1ff76c">20,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b5666e80a3489388fb05d72e4d486a_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMy02LTEtMS03NzE3MQ_967aecb1-503b-43e7-8657-0e66aa62f63f">20,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f3cf826076418d8df0ad8aa0976c1d_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfNC0zLTEtMS03NzE3MQ_7b0142d0-8181-43f8-91e0-a95ab356a072">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b5666e80a3489388fb05d72e4d486a_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfNC02LTEtMS03NzE3MQ_efe34ffb-69eb-4237-907a-2dd404982aaf">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53c139d692e24ecc9eebbd4f8f6a7986_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfNS00LTEtMS03NzE3MQ_193bf87a-2532-48a5-bc3c-9ef04ea4381b">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61b5666e80a3489388fb05d72e4d486a_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfNS02LTEtMS03NzE3MQ_3959e6dc-51d9-4e37-b02b-1bd1835475e6">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrant and bond hedge unwind transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4f3cf826076418d8df0ad8aa0976c1d_D20210101-20210331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfNi0zLTEtMS03NzE3MQ_49d735af-3dbe-4e04-900b-54a97b4f6ed8">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b5666e80a3489388fb05d72e4d486a_D20210101-20210331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfNi02LTEtMS03NzE3MQ_d587bd96-2b0d-4f82-86a4-3bcddfd37dee">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4f3cf826076418d8df0ad8aa0976c1d_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfNy0zLTEtMS03NzE3MQ_3f3d7d9b-d327-43fd-b764-bdd65d7e149d">11,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61b5666e80a3489388fb05d72e4d486a_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfNy02LTEtMS03NzE3MQ_0e463cb9-e14a-42e7-bed7-5a98500da30d">11,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc2e728e65f543a0ab65714937be981b_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfOS01LTEtMS03NzE3MQ_fcd4fd66-c670-4126-abdf-5dead963c49f">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b5666e80a3489388fb05d72e4d486a_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfOS02LTEtMS03NzE3MQ_3431bfe3-5575-434a-85c0-a0ce6382e689">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1a532b4ea5824e5e9ec5170d5b4c3fc7_I20210331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTAtMS0xLTEtNzcxNzE_8b08b3d7-6cf1-4e7b-913a-e2ad0bb4a55d">16,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a532b4ea5824e5e9ec5170d5b4c3fc7_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTAtMi0xLTEtNzcxNzE_9846468e-79bb-4b2a-bcd3-df60ba6f53ee">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd4986c032bd490fbee831d61a9cb80f_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTAtMy0xLTEtNzcxNzE_3df14ecc-b371-4ad4-8d2e-215d649eade5">336,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57a179932e3e460783c473c4033afd37_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTAtNC0xLTEtNzcxNzE_7c2683e5-dca0-45c2-b344-15ccb72f8a53">856</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie03542cce19b4e7dbd6fba43babfe9b6_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTAtNS0xLTEtNzcxNzE_c1f67425-3f69-49ef-ba89-bb5f55b944c5">410,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4081bccf13b424e88e365ad46cac9da_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTAtNi0xLTEtNzcxNzE_8d270624-23e5-48c9-a97f-aebd037246ca">745,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c30a433e75e4d8cacce52bacc437e16_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTEtMS0xLTEtNzcxNzE_48f4b523-7e53-4248-9335-a47ed58aa284">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if658034f46704cf587bbef2048752ad8_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTEtMy0xLTEtNzcxNzE_767a2910-5062-4786-a86f-f5cfb1b59a39">1,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTEtNi0xLTEtNzcxNzE_dadbaf97-7a9c-467f-9543-9c377b82d392">1,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if658034f46704cf587bbef2048752ad8_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTItMy0xLTEtNzcxNzE_c1006953-7469-41dc-9ea5-31da6ecbae42">10,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTItNi0xLTEtNzcxNzE_61d81568-6a9c-4723-bdf0-9216bd156dfe">10,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net gain on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cfad7f1f04049718d638cb007561413_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTMtNC0xLTEtNzcxNzE_8d2916c2-d10d-4b28-85eb-d4fa0cf889a1">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTMtNi0xLTEtNzcxNzE_2a627100-6744-41ab-9caf-603b67e1255c">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if658034f46704cf587bbef2048752ad8_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTUtMy0xLTEtNzcxNzE_c0f33ffc-ad8c-408f-8f73-00ef8e1cc1f1">1,362</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTUtNi0xLTEtNzcxNzE_34632a4b-b1ef-4a4d-b99f-5f48e3e2d1a5">1,362</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib892982e78324d6ca473f2fc2a6da00a_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTYtNS0xLTEtNzcxNzE_97c6f8e5-fb65-4ef0-9d8e-f6b3b6c88897">30,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTYtNi0xLTEtNzcxNzE_314ed211-7cf6-43eb-b349-eb35c5f73901">30,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iabed2424af8d4db5bfade373c80a8e1f_I20210630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTctMS0xLTEtNzcxNzE_0f1f5ef5-6a67-4895-9c1e-9098c0c9c370">16,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabed2424af8d4db5bfade373c80a8e1f_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTctMi0xLTEtNzcxNzE_09d35904-2986-477f-81cf-6e60601c23f7">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6f0ed8f7b464306ae6088a4c1723287_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTctMy0xLTEtNzcxNzE_84cfb754-2904-4a5a-8e1c-8d57aa9c3103">346,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieec58def6fea427489c80f3c77282f03_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTctNC0xLTEtNzcxNzE_d4701763-0d34-499a-86e8-626ed24fee30">861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda621e9fcaa4a23bea03af000841d41_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTctNS0xLTEtNzcxNzE_6cadf861-be09-46e5-81e1-3df0913f6b46">440,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic543f595905b456b86f091c41fcf15e9_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTctNi0xLTEtNzcxNzE_9a280d9b-7646-4ea3-b5cf-0f7c92d57210">786,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_28"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNC0xLTEtMS03NzE3MQ_85d2ec1a-d1a8-403a-a40f-be89d88d1580">16,280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNC0zLTEtMS03NzE3MQ_574555d3-2ee2-44c2-8388-ede9f568fa45">48,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in estimated fair value of contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNi0xLTEtMS03NzE3MQ_c46058db-0e76-4fbe-98af-cc5dc51eaf1b">1,266</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNi0zLTEtMS03NzE3MQ_e9a53ae7-4f0c-4d6c-8854-a17d7946519f">33,502</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNy0xLTEtMS03NzE3MQ_025dd1f4-75fc-446d-9673-5f94933ee344">26,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNy0zLTEtMS03NzE3MQ_dfccf083-c854-4504-ac33-18c08b5ab3ad">25,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of premium on investments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfOC0xLTEtMS03NzE3MQ_769b0cc1-a2e2-49fd-b66d-1f9866615a1a">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfOC0zLTEtMS03NzE3MQ_908faba0-5be5-42a9-82eb-a86e27d85921">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of debt discount and issuance fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfOS0xLTEtMS03NzE3MQ_224e07d2-73a6-45d5-b00d-5e452fce92a4">501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfOS0zLTEtMS03NzE3MQ_b9fa9297-33bc-4003-a793-b44b2f422de1">9,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of commercial license rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTAtMS0xLTEtNzcxNzE_a362a7c4-6e09-4e64-adee-10780e74ef41">190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTAtMy0xLTEtNzcxNzE_42565959-fa6e-4884-9c66-0db59c50a58c">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Loss (gain) on debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTEtMS0xLTEtNzcxNzE_b68b3553-2cf7-4f1d-a678-1cbc26927cdb">3,326</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTEtMy0xLTEtNzcxNzE_7149d65c-fe97-4cbc-ae44-7faf9c760cda">7,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTItMS0xLTEtNzcxNzE_76368c20-369e-40eb-a678-5be857824a41">18,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTItMy0xLTEtNzcxNzE_0dcf5a0e-7597-4d8f-bb06-5fd3c8398d02">18,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTMtMS0xLTEtNzcxNzE_bb59e9a0-2cce-4f4b-b774-2f756b4ada4e">12,925</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTMtMy0xLTEtNzcxNzE_3333c2e5-5bf7-4d98-8826-36c397c93074">9,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Loss (gain) from short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="lgnd:GainLossOnShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTQtMS0xLTEtNzcxNzE_688c5059-50cc-4766-bd49-8b14682c9cda">14,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="lgnd:GainLossOnShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTQtMy0xLTEtNzcxNzE_31692c41-a958-40af-97c5-292ae043df39">6,197</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lease amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTUtMS0xLTEtOTAyNDE_12e8ca68-dfb2-41ff-98c3-5a1406b348bc">3,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTUtMy0xLTEtOTAyNTk_a8127247-f41b-4eba-9450-c9999d4382d6">2,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTUtMS0xLTEtNzcxNzE_5939d0d3-0df5-4efc-b16a-d483064ee67f">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTUtMy0xLTEtNzcxNzE_e1b2712a-82f0-4f72-98a4-975bbb934ae0">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTctMS0xLTEtNzcxNzE_eade1b78-bea7-462b-a98f-d8516ddb296b">23,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTctMy0xLTEtNzcxNzE_5e0a55a5-2bb8-41a0-bd32-1be9dad0e96e">2,659</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTgtMS0xLTEtNzcxNzE_a2f6a770-8d8f-440b-95a7-4bd180808384">9,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTgtMy0xLTEtNzcxNzE_6815d497-fb56-4e42-b0c6-e3216c864cb7">2,326</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts payable and accrued liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTktMS0xLTEtNzcxNzE_ca877436-fa7e-4618-b281-5835a9b96b3e">4,357</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTktMy0xLTEtNzcxNzE_920b6257-e747-4deb-a21a-25fabad38784">4,340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income tax receivable and payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjAtMS0xLTEtNzcxNzE_9d3bb306-59b9-449a-b7ac-290da9808425">9,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjAtMy0xLTEtNzcxNzE_082b90e4-9906-4ac8-a038-d37c98dce40e">2,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjEtMS0xLTEtNzcxNzE_5c10b131-cbbd-45da-a0a7-bf155fe24e31">2,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjEtMy0xLTEtNzcxNzE_201f1681-eca2-4eca-a573-c2403354eeb6">14,605</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other assets and liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjItMS0xLTEtNzcxNzE_b1675243-625f-4dac-9dca-544becdbba19">1,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjItMy0xLTEtNzcxNzE_84ca9b83-956d-4f17-b1b6-08e575ed5562">4,899</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjMtMS0xLTEtNzcxNzE_d2c49c1e-6991-43e0-9d9b-4c98ba03efaf">63,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjMtMy0xLTEtNzcxNzE_b8835311-e0e3-4788-8ab8-4db9dd69a23e">31,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjYtMS0xLTEtNzcxNzE_1991adfa-9032-47bc-900d-e88ea62d9e9c">38,472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjYtMy0xLTEtNzcxNzE_31060b3d-7600-4024-afbe-9f1ab1110f7d">96,136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from sale of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjctMS0xLTEtNzcxNzE_842d7ea0-fcf7-4625-af5d-da63d165aa08">177,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjctMy0xLTEtNzcxNzE_af1d2567-ec59-4dce-bfd0-d2611d28664e">150,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from maturity of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjgtMS0xLTEtNzcxNzE_7a7df157-ec22-4f3f-8e12-5a346063b7ce">24,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjgtMy0xLTEtNzcxNzE_bb7574dc-2f6b-4852-8761-ef08708d6af8">34,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash paid for equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjktMS0xLTEtNzcxNzE_eeabfe1a-12da-439a-b42a-1302ba0280dd">750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjktMy0xLTEtNzcxNzE_3972ec5a-f843-4253-8888-bc9be5a30210">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzAtMS0xLTEtNzcxNzE_84456d25-a4dd-48ee-ac0b-934f84c44c99">11,463</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzAtMy0xLTEtNzcxNzE_6919aa3d-006d-469c-90c5-cac6ec6218ca">4,794</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzEtMS0xLTEtNzcxNzE_c19f35c6-a227-48f8-8089-4c174f7e1019">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzEtMy0xLTEtNzcxNzE_ac6d5182-1e44-4113-aa58-defb65291111">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzItMS0xLTEtNzcxNzE_bdb9ba1d-1658-411f-8551-076d1e9df0cc">151,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzItMy0xLTEtNzcxNzE_02126d48-10c3-43c8-9690-2bf7435f635d">84,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of 2023 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzUtMS0xLTEtNzcxNzE_3ca1690c-3718-48b5-a2bc-57bf76045b33">223,303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzUtMy0xLTEtNzcxNzE_bf9033c6-0bd2-4d43-8914-bb9616b456e8">153,381</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments under financing lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzYtMS0xLTEtNzcxNzE_12129766-3135-4848-b449-8d5a0605787f">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzYtMy0xLTEtNzcxNzE_5b200da9-6a6d-4d1e-b58b-c7c4632c3e9a">9,188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from convertible bond hedge settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromHedgeFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzctMS0xLTEtNzcxNzE_ad3ae743-9d4d-4069-a26c-d01b0961dad4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromHedgeFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzctMy0xLTEtNzcxNzE_8d838c36-f008-4e45-94d4-9217030d33d8">16,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to convertible bond holders for warrant purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsForHedgeFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzgtMS0xLTEtNzcxNzE_61359ea5-0847-45ab-99b2-3ed87bb3ca8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsForHedgeFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzgtMy0xLTEtNzcxNzE_545cc718-3ce5-4db9-87be-2f6f017089f1">16,459</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net proceeds from stock option exercises and ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzktMS0xLTEtNzcxNzE_8d7b83e9-7030-44a8-8687-c5bd911beeb8">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzktMy0xLTEtNzcxNzE_404d57bf-108d-4f25-8da8-c640beeeab0f">27,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDAtMS0xLTEtNzcxNzE_7dfc0cdf-0870-4a72-bcb9-21fd6e0945ff">5,922</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDAtMy0xLTEtNzcxNzE_ec3e8158-1b44-41d9-a1d6-9392a55dbbf7">5,901</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDEtMS0xLTEtNzcxNzE_9cef098b-735b-4f65-8ea7-24376cfb5c37">1,416</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDEtMy0xLTEtNzcxNzE_b023bc75-6fb9-401b-88f3-187fe37d95c5">1,050</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments for OmniAb transaction costs </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDItMS0xLTEtNzcxNzE_dd1b09d5-a458-4275-b71d-8f624b739af0">206</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDItMy0xLTEtNzcxNzE_8d385113-9828-4905-9bd4-4412ff8ae886">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDMtMS0xLTEtNzcxNzE_358e50ea-756d-4077-911d-07e31cd1ccf8">229,863</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDMtMy0xLTEtNzcxNzE_4e32877f-00d3-4cff-883b-79e049b2a575">141,540</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDQtMS0xLTEtNzcxNzE_277578f1-2b4a-4a1e-80fd-c5def28ad63c">14,242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDQtMy0xLTEtNzcxNzE_425c0faf-90f7-4c47-8c2e-370303200875">25,956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDUtMS0xLTEtNzcxNzE_2606d9da-e535-40b2-be6e-a36f8d919b38">19,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c127685aa945a6ac245b4904e579a9_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDUtMy0xLTEtNzcxNzE_8e96d984-7096-4de2-a569-11a96ef96c25">47,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDYtMS0xLTEtNzcxNzE_7bf2338d-b07a-4230-9d68-82981cf9ed35">5,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic543f595905b456b86f091c41fcf15e9_I20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDYtMy0xLTEtNzcxNzE_9ab0fadd-173b-4ad9-b54c-9cac2e257b63">22,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMS0xLTEtMS03NzE3MQ_8ec20f94-1bba-44e9-a599-3dde16177484">1,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMS0zLTEtMS03NzE3MQ_dd05f68b-3a8e-44bf-b8ae-47546d7fee86">1,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Taxes paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMi0xLTEtMS03NzE3MQ_41fa66ec-1c5c-4f9d-9242-d3625eaaa55a">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMi0zLTEtMS03NzE3MQ_5c69c2ad-e40a-4fca-b4d6-4700066fc0a8">3,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restricted cash in other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMy0xLTEtMS03NzE3MQ_e891219a-6157-4968-b53a-e80cc5adde9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic543f595905b456b86f091c41fcf15e9_I20210630" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMy0zLTEtMS03NzE3MQ_33c56e5f-e72e-4188-b66b-dab3fd89e09c">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Supplemental schedule of non-cash activity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued fixed asset purchases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfOS0xLTEtMS03NzE3MQ_3d820951-c86a-41ef-881b-3167925a621e">3,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfOS0zLTEtMS03NzE3MQ_7c8c9a42-96a1-49e8-b135-cf359a6d5eb2">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued inventory purchases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="lgnd:AccruedInventoryPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMTAtMS0xLTEtNzcxNzE_d3bce6e6-d047-4c2c-b007-c99a7e94f64d">9,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="lgnd:AccruedInventoryPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMTAtMy0xLTEtNzcxNzE_be6127f1-8405-4162-bce2-fcafd67c7422">12,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrealized loss on AFS investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMTItMS0xLTEtNzcxNzE_8f3c74b3-133a-4c6c-92fc-f8c2d8de6eba">149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMTItMy0xLTEtNzcxNzE_a86f3786-c8d5-4fa2-b4c8-d7d42dccb610">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:90%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_31"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_34"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless the context requires otherwise, references in this report to &#8220;Ligand,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; the &#8220;Company,&#8221; and &#8220;our&#8221; refer to Ligand Pharmaceuticals Incorporated and its consolidated subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">1.  <ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk4MDI_cf5a5eb2-c8ef-49fd-a809-2ccc80669e5f" continuedAt="i9d2e9b40e5804740be27118dcd65ab58" escape="true">Basis of Presentation and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9d2e9b40e5804740be27118dcd65ab58" continuedAt="i052e2375ec8f409cb67944bb29c320da"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3NzM_ff3f888f-d841-4dd2-95c9-1f58028c0300" continuedAt="ibf5cc0dc298b46a8accfb0647308c368" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibf5cc0dc298b46a8accfb0647308c368">Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2021 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.</ix:continuation>  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described our significant accounting policies in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2021 Annual Report. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3NTk_1ca53b5d-2886-4fcb-9b73-a4325ec8b568" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNzY5NjU4MTQxNjk3Ng_8fc64c26-89de-4455-b8e9-a55d81e0c729" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#8220;long-term deferred revenue&#8221; has been added to the condensed consolidated balance sheet, separated from &#8220;other long-term liabilities&#8221; in our prior period presentation.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3OTg_f445f26e-cc22-494f-873f-ec51cb19bb6e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Updates, Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8220;ASU 2020-06&#8221;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Consequently, a convertible debt instrument, such as the Company&#8217;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the condensed consolidated balance sheet for the period ended June&#160;30, 2022. Upon adoption of ASU 2020-06 on January 1 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $<ix:nonFraction unitRef="usd" contextRef="i99d5ee9673ec4131948b388970c8f765_I20211231" decimals="-5" name="us-gaap:ConvertibleNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNDA1OA_ff0eb994-0449-4c6b-af6d-f5d5ace091b4">20.4</ix:nonFraction>&#160;million, reduced deferred tax liabilities by $<ix:nonFraction unitRef="usd" contextRef="i99d5ee9673ec4131948b388970c8f765_I20211231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNDA5OA_643e3933-b0aa-4ed8-881d-e8798068a5e6">4.4</ix:nonFraction>&#160;million, reduced additional paid-in capital by $<ix:nonFraction unitRef="usd" contextRef="ia0f9248329c9468fb09df5396db98bf6_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNDE0MA_fb371f50-42b4-46df-b272-fa2d17baa244">51.1</ix:nonFraction>&#160;million and increased retained earnings by $<ix:nonFraction unitRef="usd" contextRef="id15423cf11ad45caae992641de4875c1_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNDE3OA_7d561afc-8e9b-40ab-bce9-028fc289905e">35.1</ix:nonFraction>&#160;million. The net balance of the 2023 Notes at January 1, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i6eba3264dc6c4943a87106e878898597_I20211231" decimals="-5" name="us-gaap:ConvertibleNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNDIzOA_f9c47486-d02c-4a7a-a78b-98f4f49073d9">341.1</ix:nonFraction>&#160;million which included an unamortized discount of $<ix:nonFraction unitRef="usd" contextRef="i6eba3264dc6c4943a87106e878898597_I20211231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNDI4Mw_f71786f5-816c-4b61-8aac-02a7c80d0cb2">2.2</ix:nonFraction>&#160;million.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><ix:continuation id="i052e2375ec8f409cb67944bb29c320da" continuedAt="i96578ab77ff84b2eb469b720e464a467"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk4MDg_48cb9cfe-285b-42ee-b3cf-94d036b29a19" continuedAt="i8a82dbd245ad4be28530dcf4a7ece755" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in accordance with ASC 606, Revenue from Contracts with Customers, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;D services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For R&amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i96578ab77ff84b2eb469b720e464a467" continuedAt="i6ed86e8939c24ae6a08c4ec73a785ed2"><ix:continuation id="i8a82dbd245ad4be28530dcf4a7ece755" continuedAt="ie1e5fa79b8f749dd908ea153f31d909c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. </span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie1e5fa79b8f749dd908ea153f31d909c">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.</ix:continuation> During the three months ended June&#160;30, 2022 and 2021, the amount recognized as revenue that was previously deferred was $<ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTY0OTI2NzQ0MzY3NTk_49d10058-d307-441b-88cd-19e5fe919311">4.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTY0OTI2NzQ0MzY3NzQ_5df2e959-6ce6-4dcd-aa82-37dbfeb5bdba">10.3</ix:nonFraction> million, respectively. During the six months ended  June&#160;30, 2022 and 2021, the amount recognized as revenue that was previously deferred was $<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTY0OTI2NzQ0MzY3Njc_bef7a826-47ce-4c6d-a6cd-e1a20d6d8c52">6.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTY0OTI2NzQ0MzY3ODE_b00ff1de-7511-44eb-b92b-f4a05bb77a59">16.1</ix:nonFraction> million, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation&#160;of&#160;Revenue </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3Nzk_a1259ba7-c383-4107-9434-03ebc006e353" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff72851b58aa45ffa732bbda41560b3d_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNC0xLTEtMS03NzE3MQ_61373315-9fd5-4382-9d6f-cca3a3c12891">7,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib165267a91674f5987986a924b2120c4_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNC0zLTEtMS03NzE3MQ_b0adfa2e-9e24-4e07-807b-ba430239d371">5,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70869135d3c34c1db5e1e22b66ea39ae_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNC01LTEtMS03NzE3MQ_1f39ae1a-732f-41f1-bfa0-88f86d68551a">11,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99e0c134900425886aaac7ceb463839_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNC03LTEtMS03NzE3MQ_1904965d-8f17-4d10-be25-a90b79c2021b">9,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfe69b74f9a142af8ba9b55191035604_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNS0xLTEtMS03NzE3MQ_e5589d49-67ad-469f-9629-4c212829d095">2,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ab02c7bc2a9493ab64ac0276d32fdff_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNS0zLTEtMS03NzE3MQ_d17f1b45-5d65-42b1-8da6-a1d2380eeaeb">2,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id78b53631f2e4d38a201cb8afeffe74e_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNS01LTEtMS03NzE3MQ_a64f0634-7563-4f7e-ac78-6934d70068aa">5,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5a2dea7e0f94760977b89f0e7531354_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNS03LTEtMS03NzE3MQ_a58442a9-c67e-41e4-b00a-976622da077e">4,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Teriparatide injection </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6fe6bdce8242319de5782b9769f8db_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNi0xLTEtMS03NzE3MQ_e0c39936-61aa-4713-832d-a3059bd4fe04">5,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8e45384b614e7c8354672d3699a80a_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNi0zLTEtMS03NzE3MQ_5051d438-f777-4cfe-bce1-24dfae9ab227">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9775a3f35190447f9e3b5d21d55faad5_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNi01LTEtMS04NjI4MA_084e7a29-cb66-48f5-a77e-ea91799bd708">8,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685f29c36ddc4fdfbdef1ce148091d2a_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNi03LTEtMS04NjMxOA_d425488f-fe8a-4890-a17e-be2bfaa571c5">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94fdbb4317f34a609cb534522aef7982_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNy0xLTEtMS03NzE3MQ_9f0cf29e-a7b3-45af-9aaa-af7a7478cf74">2,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id24caccafc6747c69868162bdd0769d2_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNy0zLTEtMS03NzE3MQ_04cc9400-6582-436a-b89d-1fa176d2532b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82095dd45f8544edb3410b6b83bf52ab_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNy01LTEtMS04NjI4MA_e39ddd66-5bdc-4644-8909-987290bb95b4">3,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd89e80d3f3d44d4b5281b5916b0c8b2_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNy03LTEtMS04NzA2Mw_7baa777a-731e-453e-a138-ee4797873e1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c96b32616194c1b937efd406717542d_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfOC0xLTEtMS03NzE3MQ_7a1e753e-fd4f-45c8-9120-7879e1724470">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife30a3da671b425e9383ee095533c9bd_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfOC0zLTEtMS03NzE3MQ_7680d285-54f8-429b-953a-b26f132634d4">719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7768c766ed64817819e47086ac8e52f_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfOC01LTEtMS03NzE3MQ_738d385b-b18d-4059-b587-1cb28ebb6609">2,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b46ae1b80044cff933ed7f5b6074bfd_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfOC03LTEtMS03NzE3MQ_09862826-41a5-469a-a8ae-41f112aaf3cd">1,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4451c0bbe6454e30a9400b8f2b6b236b_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfOS0xLTEtMS03NzE3MQ_f20334e8-ace1-4ede-bc59-c868b0e88e0e">17,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadd0658df38142da9de49541fcf1e87b_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfOS0zLTEtMS03NzE3MQ_cbae7819-68bb-4a44-9de9-74b2f14255d5">8,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36945e4ea3d94671ba79140fa3bfeed8_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfOS01LTEtMS03NzE3MQ_b50a4b20-af5c-4846-96ee-29d7fb26b585">31,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc58590074134385916f9aa21fadb3a5_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfOS03LTEtMS03NzE3MQ_9f99a288-f4c5-498a-bf67-e99dec3edc59">15,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - Core</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69264884c80f4de496ecd4d3871f13de_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTItMS0xLTEtNzcxNzE_47bfb678-12ee-41e3-8902-32da1d4c056a">3,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f0ce6d74bbb404494d3b9ecd07c5c1d_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTItMy0xLTEtNzcxNzE_5b3173c1-2046-4071-a9bf-60a144658c68">9,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a26669fd70d437e8dbf0d46744ee68b_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTItNS0xLTEtODUwMjQ_b71d6b57-ac82-4643-bee8-158d4b8746e6">9,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e1cee720dbe4a518d1861c1471e0601_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTItNy0xLTEtODYxNjM_dac6b192-f8dc-44f1-9ce9-9242f25ae9c5">10,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - COVID</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac98dc8419824fccbffe08deef56431d_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTMtMS0xLTEtNzcxNzE_6fb85fc6-33cc-4e1b-bb49-3c35f1a8ea39">26,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1b6772c114f4296b3710452fad3bbf0_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTMtMy0xLTEtNzcxNzE_24afeb82-ed7e-4b27-81c9-e94433399317">52,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac3e999d74914146b6972963646d77d3_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTMtNS0xLTEtODUwMjQ_f9f8bb57-364c-43e3-9f44-a07ac6777ecc">32,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af2fa579c8d4d0298cd4adaf64f562a_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTMtNy0xLTEtODYxNjM_ffcdd898-318f-470f-a0d2-890ca453efa0">82,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0dc4219be484ce8aa0ac5cb14f54a41_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTQtMS0xLTEtNzcxNzE_c4691c04-80ce-477f-acd0-52a6eee67b6b">29,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06d3227a7eb74265aa981e7a0d0ff54a_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTQtMy0xLTEtNzcxNzE_eff72419-2d63-4bc4-a113-772dcd40de60">62,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iede13d72d60b42d785f8340ba1c81680_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTQtNS0xLTEtNzcxNzE_2baf0429-6674-407a-9582-9fbd3c89a3b5">41,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f25445795154f5a93fcbfa2d95e4ca4_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTQtNy0xLTEtNzcxNzE_c1bf3621-8e07-4a50-bb9b-3edd815edf73">93,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe3cc306f014ceb8d03ee2a6e86a398_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTctMS0xLTEtNzcxNzE_f90d3362-6a90-4272-b4af-bbe5daefb823">5,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3a848d86a33454d8e308d5c5596a288_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTctMy0xLTEtNzcxNzE_e1006944-4353-4eaf-9827-21f34a68bf8a">7,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d72210a2a5943cf95ded5fa3f11f523_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTctNS0xLTEtNzcxNzE_2d32d2e1-fe7a-4a41-8808-39bb072894d4">10,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173a08fd950747df9d01f035da9f023d_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTctNy0xLTEtNzcxNzE_6f61a727-ec10-4c8b-b900-0bcb8a6fcd3f">12,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c2a1b1ca5514671b9aba265dfb7b572_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTgtMS0xLTEtNzcxNzE_c37fde71-40d8-4aa8-b97a-7fb6c6dd3aa5">1,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38baca3871d94649bea9b951f8a95afc_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTgtMy0xLTEtNzcxNzE_e6032214-054e-461b-899d-7f50f9b351cb">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia510a863a60a463ea460982ee2b575b2_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTgtNS0xLTEtNzcxNzE_01628820-5d0a-48a0-9a97-458dbd52872d">4,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id554d23e5a4f40a5badd18e8f8b0a8b7_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTgtNy0xLTEtNzcxNzE_90f30261-7f80-41cc-b17c-af78ffffb250">2,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0d6dad86164f7eaa342595027db37f_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTktMS0xLTEtNzcxNzE_af86cd0e-38f7-46a7-9900-2a68e1e3e4a6">1,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e3ef31b9a84e509bed5d667042120e_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTktMy0xLTEtNzcxNzE_2539a933-59b1-43fc-9f52-183f2ca768ed">3,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a41570df267433d868066c140f59972_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTktNS0xLTEtNzcxNzE_778e0d59-f2ec-4057-b186-c7bbe017f180">10,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a06723b9575442cbe0af518dda8db12_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTktNy0xLTEtNzcxNzE_8a00733a-e5f3-4c45-a907-6437625aa9ec">12,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia55aca14b36b43b491df2ecf96d2c1f3_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjAtMS0xLTEtNzcxNzE_e1faab9c-bb41-415d-9fe1-5a97063c153c">1,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie323179691704681be1652faafc0e9a2_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjAtMy0xLTEtNzcxNzE_f4b0b0f3-c69d-4d87-8863-6860fce7b244">1,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf6ba28216b419e91b9fc13c3c06c9d_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjAtNS0xLTEtNzcxNzE_03f0c6f6-96f7-44f2-b413-63bafebd9c34">4,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077a95de6c1246a0ac1df496ba8e517a_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjAtNy0xLTEtNzcxNzE_a0681727-95e7-40c0-ac77-35688e369cb4">3,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4abd7ed5056140b3a6f412c3dcf92315_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjEtMS0xLTEtNzcxNzE_5d5af232-6c55-4643-8473-81ee7eff39c9">9,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib690ef44f20c492ba685cf71add617d4_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjEtMy0xLTEtNzcxNzE_2b29c5f5-709a-46f1-bd23-1797c29a7040">13,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf5c36ba61894d93b55a210349a7ccf2_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjEtNS0xLTEtNzcxNzE_d1537e83-7ce4-415f-b5ec-b723d5b28b86">29,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75907dd7ed51403bb417727e96e225eb_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjEtNy0xLTEtNzcxNzE_d808a9ca-212a-47c2-a625-a91f0a1810ca">30,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjItMS0xLTEtNzcxNzE_c8718fc7-740d-4af7-be83-d329beb7e549">57,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjItMy0xLTEtNzcxNzE_885cf287-5cb8-4046-83dd-603cfbc6636c">84,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjItNS0xLTEtNzcxNzE_8b2d013e-9394-421b-b78b-5eac344540d9">103,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjItNy0xLTEtNzcxNzE_88094128-bdd5-4645-a328-cdbd60c1644e">139,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i6ed86e8939c24ae6a08c4ec73a785ed2" continuedAt="i2c3c860fe17149d188ce65f6d67d112e"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments </span></div><div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="lgnd:ScheduleOfShortTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3NjE_b18a72eb-5ae6-4eaf-b6db-2c5a6a545bce" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at June&#160;30, 2022 and December 31, 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:38.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.290%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.290%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.290%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.290%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d5e8d1f727f43ec8ecd549503e85c2e_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMi0xLTEtMS03NzE3MQ_b5efc260-0825-450e-a7ed-a4c14efb0247">2,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d5e8d1f727f43ec8ecd549503e85c2e_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMi00LTEtMS03NzE3MQ_1adbb3c8-1741-4fdc-ad6e-11b2728766e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d5e8d1f727f43ec8ecd549503e85c2e_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMi03LTEtMS03NzE3MQ_0b230c88-d825-4d16-811a-0f3b6030841c">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d5e8d1f727f43ec8ecd549503e85c2e_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMi0xMC0xLTEtNzcxNzE_d5db9fe5-eb29-4e24-be4e-408cbc5eef75">2,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b9a9049f59047158b0b52d7d59b7745_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMy0xLTEtMS03NzE3MQ_e08bb17e-dcfb-4ca3-b0a1-03e8a7180544">4,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b9a9049f59047158b0b52d7d59b7745_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMy00LTEtMS03NzE3MQ_3acdac35-aa5e-4392-ac2b-570bf627e718">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b9a9049f59047158b0b52d7d59b7745_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMy03LTEtMS03NzE3MQ_5bbf0def-006a-47a9-a130-2d75c22039b3">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b9a9049f59047158b0b52d7d59b7745_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMy0xMC0xLTEtNzcxNzE_8656d2fc-b9df-4c3b-a3af-557247cd1673">4,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56f53586b69f4a9aa74c3e01f3093f45_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfNi0xLTEtMS03NzE3MQ_4a264775-a10c-428b-bfa2-d14682c9153e">5,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56f53586b69f4a9aa74c3e01f3093f45_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfNi00LTEtMS03NzE3MQ_b4ef234d-c1a7-4afb-a568-61d79fcac478">307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56f53586b69f4a9aa74c3e01f3093f45_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfNi03LTEtMS03NzE3MQ_32e4b53e-00e5-4cf3-8fa0-5db9dd45573e">3,703</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56f53586b69f4a9aa74c3e01f3093f45_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfNi0xMC0xLTEtNzcxNzE_b35e2fe3-0a4e-430c-9890-1a0aec2675cd">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id64fbff1c6e448fe994106b92f9144b9_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfNy0xLTEtMS03NzE3MQ_e7694736-2b33-4ae4-bdc0-e7da63cfcb68">112,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id64fbff1c6e448fe994106b92f9144b9_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfNy00LTEtMS03NzE3MQ_3fb2e64c-4fae-4d66-8d49-e8b30cbba186">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id64fbff1c6e448fe994106b92f9144b9_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfNy03LTEtMS03NzE3MQ_4b696108-0f38-45d4-a6b4-e1c10019a54b">1,228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id64fbff1c6e448fe994106b92f9144b9_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfNy0xMC0xLTEtNzcxNzE_c893f6e3-7953-4a0f-b02a-43a659450165">111,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b62bb4bd3243f98e9d6acb69bbd14d_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfOC0xLTEtMS03NzE3MQ_8f957a53-98ca-48ec-af11-902ed3e9603f">2,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b62bb4bd3243f98e9d6acb69bbd14d_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfOC00LTEtMS03NzE3MQ_cfebfcd9-e261-4d31-b7f1-5d25959cf709">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b62bb4bd3243f98e9d6acb69bbd14d_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfOC03LTEtMS03NzE3MQ_28a6305c-f76c-4e39-b051-38c0164efe2c">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b62bb4bd3243f98e9d6acb69bbd14d_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfOC0xMC0xLTEtNzcxNzE_c218f779-857f-41dd-9bcd-4665717d35d6">2,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205fad57592a433b83307f6fea8119cc_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfOS0xLTEtMS03NzE3MQ_468c62b8-3607-4a92-ad79-ec021b291dc4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205fad57592a433b83307f6fea8119cc_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfOS00LTEtMS03NzE3MQ_446eb5b9-4999-4098-97f2-79080db50e38">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205fad57592a433b83307f6fea8119cc_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfOS03LTEtMS03NzE3MQ_993dbfc8-cf9b-490c-9449-7ac99a071619">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205fad57592a433b83307f6fea8119cc_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfOS0xMC0xLTEtNzcxNzE_e84331bd-6b53-4a06-9de1-5c02fe84a72e">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTAtMS0xLTEtNzcxNzE_c9a71ec8-69cb-45ee-acb9-155f02f9e738">127,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTAtNC0xLTEtNzcxNzE_4a4adbca-2c9f-40b5-8bc3-75e23f9f7a7e">436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTAtNy0xLTEtNzcxNzE_8e866e41-7c10-48ca-94a8-2bb129483d10">5,184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTAtMTAtMS0xLTc3MTcx_9c548f4d-10cd-455e-8bc3-34927fdabe11">123,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c186e23a71a4fb793fc929a6f1bae65_I20220630" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTEtMTAtMS0xLTc3MTcx_7a922b2a-a290-4b57-8625-7b6a38e2a49d">19,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTItMTAtMS0xLTc3MTcx_23dd799b-379a-49aa-a11c-b48adbaa801c">142,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida960da78ddf459ca1c4198305520fb4_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTUtMS0xLTEtNzcxNzE_6174ed2a-8256-4711-b0f1-544780b7008a">63,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida960da78ddf459ca1c4198305520fb4_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTUtNC0xLTEtNzcxNzE_f9ac5e16-9c87-4aa7-9ec3-fa171a409acd">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida960da78ddf459ca1c4198305520fb4_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTUtNy0xLTEtNzcxNzE_78b391cf-cd08-46e2-b92b-25d5b782a232">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida960da78ddf459ca1c4198305520fb4_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTUtMTAtMS0xLTc3MTcx_1b705417-3acb-4f69-a10c-6e2a5b404264">63,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce85fdb40ae4d199b3b166284807908_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTYtMS0xLTEtNzcxNzE_d802627c-59ad-4181-a961-59494519a2a8">29,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce85fdb40ae4d199b3b166284807908_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTYtNC0xLTEtNzcxNzE_53e49486-d9e7-4dee-99c0-9b972b8e9d4c">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce85fdb40ae4d199b3b166284807908_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTYtNy0xLTEtNzcxNzE_4bde6714-89d6-43bc-867b-9c60861b340c">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce85fdb40ae4d199b3b166284807908_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTYtMTAtMS0xLTc3MTcx_c5d1b482-a19d-43cc-8b3a-d95e3c8919c4">29,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ea92184146ffb7b0e8ae84bcf98b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTgtMS0xLTEtNzcxNzE_505ecf7d-081e-402d-8236-e41fcd1521d6">36,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ea92184146ffb7b0e8ae84bcf98b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTgtNC0xLTEtNzcxNzE_2b7f056c-7abb-47a9-aefd-2d5ab8bb4690">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5890ea92184146ffb7b0e8ae84bcf98b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTgtNy0xLTEtNzcxNzE_bfaeaba1-fb62-42b6-8bff-1e4b019fc162">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890ea92184146ffb7b0e8ae84bcf98b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTgtMTAtMS0xLTc3MTcx_aac05ad0-6856-4876-b9e7-0e4ad420c61a">35,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0560066d2edf4834bad46274f6b43123_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTktMS0xLTEtNzcxNzE_d460f22d-7c55-4a65-9a0f-b810dcac1972">5,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0560066d2edf4834bad46274f6b43123_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTktNC0xLTEtNzcxNzE_4e5e9e04-9daa-453c-8588-4c75123245d9">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0560066d2edf4834bad46274f6b43123_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTktNy0xLTEtNzcxNzE_2a94f67e-c4df-4f01-9f36-90e9164f996a">2,027</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0560066d2edf4834bad46274f6b43123_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTktMTAtMS0xLTc3MTcx_3a34e24d-6eca-434a-8a2a-000fb6f58700">4,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e34e3b904034f19a68a68a7d815b0af_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjAtMS0xLTEtNzcxNzE_f1d7d79c-c47a-4ce0-be8a-955520b18bf3">152,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e34e3b904034f19a68a68a7d815b0af_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjAtNC0xLTEtNzcxNzE_85d7242f-ee95-4cb0-842b-c7fd7b6025ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e34e3b904034f19a68a68a7d815b0af_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjAtNy0xLTEtNzcxNzE_6c367a58-7c5e-4278-bce2-9486fd54caba">249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e34e3b904034f19a68a68a7d815b0af_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjAtMTAtMS0xLTc3MTcx_bc101dde-6d5b-4302-bd3f-0d297c5cf4b3">151,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie18284bcc4c545f2af6dd44ec4f776be_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjEtMS0xLTEtNzcxNzE_7f771151-ea7e-4eac-8109-7e6dd71b1db3">5,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie18284bcc4c545f2af6dd44ec4f776be_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjEtNC0xLTEtNzcxNzE_5e900f74-70d4-48a3-b751-6db1ca157c13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie18284bcc4c545f2af6dd44ec4f776be_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjEtNy0xLTEtNzcxNzE_ae75c21d-4ee0-49c0-838c-b67e1852f35b">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie18284bcc4c545f2af6dd44ec4f776be_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjEtMTAtMS0xLTc3MTcx_daed5fda-6e54-44a9-b1d3-eaff13049dc5">5,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec9f7faaf814c3eb810dd8294a78adb_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjItMS0xLTEtNzcxNzE_ab84e1fe-3290-4213-bbf9-f43577621ebd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec9f7faaf814c3eb810dd8294a78adb_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjItNC0xLTEtNzcxNzE_0a245905-ffe9-4fb0-acb4-66296a586a98">408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec9f7faaf814c3eb810dd8294a78adb_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjItNy0xLTEtNzcxNzE_473b5bc2-dc07-42cf-9786-ee57cd1d1028">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ec9f7faaf814c3eb810dd8294a78adb_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjItMTAtMS0xLTc3MTcx_d4ac57df-2562-4dcf-9e0c-cdcbcd00aa07">408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjMtMS0xLTEtNzcxNzE_3bf7034c-848e-4c27-ba09-16ca0fc9df66">292,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjMtNC0xLTEtNzcxNzE_4de674c8-5d93-479f-b23b-0970713cc071">842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjMtNy0xLTEtNzcxNzE_96a2199f-ea40-4032-a5aa-35c3d2fd9717">2,370</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjMtMTAtMS0xLTc3MTcx_4e66e3fd-c28b-4658-8e4e-d87d55bb396a">290,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i010958049e69464b916484b2032627e5_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjQtMTAtMS0xLTc3MTcx_78bac3af-4da6-4af3-9cfe-e3f5745d1829">30,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjUtMTAtMS0xLTc3MTcx_8e057eb8-de43-4f0e-8e9f-d1a01f932125">321,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three and six months ended June&#160;30, 2022.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk4MDE_0d555b37-eeb8-46d7-9328-ef3f11839b89" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2Mjk1OGU1NDdiYzRmZGY4NjYxOWEyNTZmYjkzMTIwL3RhYmxlcmFuZ2U6NDYyOTU4ZTU0N2JjNGZkZjg2NjE5YTI1NmZiOTMxMjBfMi0xLTEtMS03NzE3MQ_42df75c1-683a-400c-b34e-661d74feeb65">6,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2Mjk1OGU1NDdiYzRmZGY4NjYxOWEyNTZmYjkzMTIwL3RhYmxlcmFuZ2U6NDYyOTU4ZTU0N2JjNGZkZjg2NjE5YTI1NmZiOTMxMjBfMi0zLTEtMS03NzE3MQ_9cd5c65e-e8cf-41ef-b9c8-9fac1140fee1">6,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2Mjk1OGU1NDdiYzRmZGY4NjYxOWEyNTZmYjkzMTIwL3RhYmxlcmFuZ2U6NDYyOTU4ZTU0N2JjNGZkZjg2NjE5YTI1NmZiOTMxMjBfMy0xLTEtMS03NzE3MQ_42aceb58-725e-4f3b-a535-669b08d2fe7f">3,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2Mjk1OGU1NDdiYzRmZGY4NjYxOWEyNTZmYjkzMTIwL3RhYmxlcmFuZ2U6NDYyOTU4ZTU0N2JjNGZkZjg2NjE5YTI1NmZiOTMxMjBfMy0zLTEtMS03NzE3MQ_1a374d8f-6822-44d6-a06a-647ef9f0701b">3,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2Mjk1OGU1NDdiYzRmZGY4NjYxOWEyNTZmYjkzMTIwL3RhYmxlcmFuZ2U6NDYyOTU4ZTU0N2JjNGZkZjg2NjE5YTI1NmZiOTMxMjBfNC0xLTEtMS03NzE3MQ_b22ce84b-c23a-48f3-a2e6-0f94d7f0a9ab">9,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2Mjk1OGU1NDdiYzRmZGY4NjYxOWEyNTZmYjkzMTIwL3RhYmxlcmFuZ2U6NDYyOTU4ZTU0N2JjNGZkZjg2NjE5YTI1NmZiOTMxMjBfNC0zLTEtMS03NzE3MQ_149320c7-7adc-4a18-b1a2-9440c1fec1f1">9,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invest in U.S.-dollar denominated investments. We held a total of <ix:nonFraction unitRef="position" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTIzNzI_a38d3e5d-2a06-401e-abaf-964c2876b9c0">8</ix:nonFraction> positions which were in an unrealized loss position as of June&#160;30, 2022. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, <ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTI5OTI_9335727e-4dc3-46a7-a5fd-c56349e68d2a">no</ix:nonFraction> credit losses were recognized for the three and six months ended June&#160;30, 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i2c3c860fe17149d188ce65f6d67d112e" continuedAt="ib18e9a13c0db45b6957f7a48431cbfd5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3NzA_fcd298e3-eb2c-4632-8892-8ea0c01ba270" continuedAt="i583e2cc5a70a48bb9df957a3403f01cf" escape="true">Accounts Receivable and Allowance for Credit Losses</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i583e2cc5a70a48bb9df957a3403f01cf">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.</ix:continuation> During the three and six months ended June&#160;30, 2022, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the COVID-19 pandemic on our business and recorded an adjustment of $(<ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-5" sign="-" name="lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTQwMjc_4db592ba-30ea-485e-967e-b32712bf35e4">0.1</ix:nonFraction>)&#160;million and $(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-5" sign="-" name="lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTY0OTI2NzQ0Mzc1NzI_b57d1164-b8f8-48af-a97e-0015e65a153b">0.2</ix:nonFraction>)&#160;million  of allowance for credit losses, respectively, as of June&#160;30, 2022.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk4MDQ_de1b28d1-03a2-49b4-a393-1933c1a4ed00" continuedAt="ib9df8f65954d4e7ab63aed9686b9b809" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method. </span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib9df8f65954d4e7ab63aed9686b9b809">We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs related to obsolete inventory recorded for the three and six months ended June&#160;30, 2022 and 2021. As of June&#160;30, 2022 inventory consists of Captisol prepayments of $<ix:nonFraction unitRef="usd" contextRef="i3accfb128ab3447ca71c87b81da62c0f_I20220630" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNzE0NjgyNTYwMDY1MA_57642e3e-23e3-4fb6-9da0-a95cd1bf697b">18.9</ix:nonFraction>&#160;million, and as of December 31, 2021 inventory consists of Captisol prepayments of $<ix:nonFraction unitRef="usd" contextRef="i86ab427a236f4147922fee98ff203990_I20211231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTQ3NjA_b8a57c68-b72d-40a1-a7b5-a9fa1e6d7efe">24.6</ix:nonFraction>&#160;million.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Identifiable Intangible Assets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3OTI_1775e93d-bf4a-4e01-a7c4-ea0366cf85e6" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMy0xLTEtMS03NzE3MQ_2a145f8b-7f7c-41c3-89b7-dc1ffdf6643a">181,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMy0zLTEtMS03NzE3MQ_a9d62e52-23eb-4def-8447-3832cc4d14c9">181,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41836ea2320e4ecdbaed6d4b7e28b1bc_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfNS0xLTEtMS03NzE3MQ_682c7b3c-9c6d-4167-9940-ee2f310ba258">281,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f1b65679e05403d90db551817862dd0_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfNS0zLTEtMS03NzE3MQ_b3e2666f-bdc8-4d18-82f4-4a02fbd4f12f">280,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41836ea2320e4ecdbaed6d4b7e28b1bc_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfNi0xLTEtMS03NzE3MQ_0b0aaec8-7ff5-4d13-b8e8-76734aaead7c">86,740</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f1b65679e05403d90db551817862dd0_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfNi0zLTEtMS03NzE3MQ_f5ffaf64-9e5f-4905-9dd4-b8c6504f20d3">78,991</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38d13f31c97741448d56e9f1fe72169f_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfNy0xLTEtMS03NzE3MQ_69f95945-d3f3-496d-8c5b-bfc5e9ecf035">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0adfd09ddb864f8c9e65d502b415fbc1_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfNy0zLTEtMS03NzE3MQ_9970aebd-9bb7-4bed-b3d5-20a2dfc438e4">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38d13f31c97741448d56e9f1fe72169f_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfOC0xLTEtMS03NzE3MQ_127ddb40-db77-4c22-acce-800d9d75af79">1,510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0adfd09ddb864f8c9e65d502b415fbc1_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfOC0zLTEtMS03NzE3MQ_2ec7d18b-be5b-49d1-9aa7-572e8b2890e0">1,444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c8b7e890d8e4b648961c025a2b1a977_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfOS0xLTEtMS03NzE3MQ_3c923559-103d-486f-b4cf-9f4585a3c770">40,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i411c360a01fd4666a436f4eafb9202d7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfOS0zLTEtMS03NzE3MQ_7d3dd8fb-51a3-4d7d-a760-06c71ccb6932">40,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c8b7e890d8e4b648961c025a2b1a977_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMTAtMS0xLTEtNzcxNzE_0d7b7476-1fab-4cd2-ad45-4e2d58df8b1d">19,602</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i411c360a01fd4666a436f4eafb9202d7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMTAtMy0xLTEtNzcxNzE_2f668c0c-a0b1-4484-aa32-176b404deabf">18,267</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bd5f1328d942879973ee2497a5b28d_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMTEtMS0xLTEtNzcxNzE_bf4890f8-d1c7-43ae-b11b-701034d31260">362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia37ae682ab9d400d972e4f8f784305f9_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMTEtMy0xLTEtNzcxNzE_c21a8705-bd3c-4559-b091-7f13095da385">362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7bd5f1328d942879973ee2497a5b28d_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMTItMS0xLTEtNzcxNzE_6493984f-26e7-4d85-a772-ae1b5544e1bd">50,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia37ae682ab9d400d972e4f8f784305f9_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMTItMy0xLTEtNzcxNzE_a5492160-7d07-434a-bc54-4a660d588d48">36,217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMTMtMS0xLTEtNzcxNzE_106c86ee-0ba1-499a-91e5-07dd2fe874e6">709,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMTMtMy0xLTEtNzcxNzE_0d08224c-305e-4053-b58e-362823f3c9fe">732,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 2022, we only had <ix:nonFraction unitRef="reporting_unit" contextRef="i35897df76b71438cbfcc21f5fd8c25ba_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNzY5NjU4MTQyMDA5OA_8b86928c-7907-4a61-b22d-105ea3af1150">one</ix:nonFraction> reporting unit and reportable segment. In connection with the announcement in March 2022 of our intention to separate the OmniAb business pursuant to a distribution to Ligand&#8217;s stockholders of Ligand&#8217;s shares in OmniAb followed by a merger with APAC, management concluded that we now had two reporting units and reportable segments - the OmniAb business and the Ligand core business. See Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information. We performed a fair value analysis utilizing a combination of income approach and market approach to determine the fair value of each segment in order to appropriately allocate the goodwill between the segments as of the announcement date. <ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNzY5NjU4MTQxNjk3Mg_cb76b79e-b74d-4e8b-8164-b16a755a2517" continuedAt="i3dfe08da80424a51bb201945343eba32" escape="true">The following table presents our allocation of goodwill balance by segment (in thousands): </ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="i3dfe08da80424a51bb201945343eba32"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:84.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Ligand core business</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="if91b70357fb44a83b104d251dcf482de_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2MTRlYzg5NzY4MzQ3N2I5ZTg1ODhiZDBkM2MzNjc1L3RhYmxlcmFuZ2U6NDYxNGVjODk3NjgzNDc3YjllODU4OGJkMGQzYzM2NzVfMy0xLTEtMS05MDQzOA_11798656-01f6-4419-a111-04649f1fd0c9">105,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">OmniAb business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i1c0ab083247d44e1ab92188a9e44c058_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2MTRlYzg5NzY4MzQ3N2I5ZTg1ODhiZDBkM2MzNjc1L3RhYmxlcmFuZ2U6NDYxNGVjODk3NjgzNDc3YjllODU4OGJkMGQzYzM2NzVfNC0xLTEtMS05MDQzOA_637cd9d0-e591-4390-bab2-249c1b8c68dc">75,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2MTRlYzg5NzY4MzQ3N2I5ZTg1ODhiZDBkM2MzNjc1L3RhYmxlcmFuZ2U6NDYxNGVjODk3NjgzNDc3YjllODU4OGJkMGQzYzM2NzVfNS0xLTEtMS05MDQzOA_8a36be76-b052-4d38-af46-e1994cbefc62">181,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ib18e9a13c0db45b6957f7a48431cbfd5" continuedAt="iefbd3cc94c5046bf8bdb434b10bc2d88"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="lgnd:CommercialLicenseRightsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3ODQ_9977414b-095c-4c8f-b21a-2044bf61e69c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Commercial License Rights</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3ODU_6f4ca3e8-7805-44a7-91d3-6d5edac97969" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i934ac72595594c6b994d97c0a1b7f89a_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMi0yLTEtMS03NzE3MQ_645c902d-45c5-432a-b3e1-74f272025c19">17,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i934ac72595594c6b994d97c0a1b7f89a_I20220630" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMi00LTEtMS03NzE3MQ_f7129c75-f0c1-4605-b2b8-d3405f3dc06a">9,425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i934ac72595594c6b994d97c0a1b7f89a_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMi02LTEtMS03NzE3MQ_c3f69210-534e-4400-af75-74b8ff34129d">8,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe59142403aa47d6801e8bc016edf9d7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMi04LTEtMS03NzE3MQ_f32d3d64-2258-46a8-8224-111e36470456">17,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe59142403aa47d6801e8bc016edf9d7_I20211231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMi0xMC0xLTEtNzcxNzE_441787c2-99f6-40de-84b9-54061db0301d">9,461</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe59142403aa47d6801e8bc016edf9d7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMi0xMi0xLTEtNzcxNzE_7be67693-d5f5-45e3-9fc8-6966e8b12482">8,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i886a648c2410405ea2213afd1c7526cb_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMy0yLTEtMS03NzE3MQ_d56f3d2f-162e-4e09-8487-d196e1bcadc9">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i886a648c2410405ea2213afd1c7526cb_I20220630" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMy00LTEtMS03NzE3MQ_b008031e-39ff-4948-acc7-8b75c433f8bc">8,606</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i886a648c2410405ea2213afd1c7526cb_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMy02LTEtMS03NzE3MQ_0d4d6079-4e15-44a7-b98b-98a96a7b4437">1,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d69c84f97e467a8586439168e3a979_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMy04LTEtMS03NzE3MQ_37ab28bd-a139-4207-b5e9-32626702da1c">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07d69c84f97e467a8586439168e3a979_I20211231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMy0xMC0xLTEtNzcxNzE_fa6b684f-093c-4405-821b-cdfe01fbaa72">8,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d69c84f97e467a8586439168e3a979_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMy0xMi0xLTEtNzcxNzE_84beff4f-0c34-4bd0-a416-39cfd8a79b28">1,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc20f2ad27ad4526a19a3ed221aa03e3_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfNC0yLTEtMS03NzE3MQ_92bf8f95-ee7b-4c90-b269-acf321c047c5">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc20f2ad27ad4526a19a3ed221aa03e3_I20220630" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfNC00LTEtMS03NzE3MQ_d559e721-76e4-41c1-9576-1e24bf0854b9">18,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc20f2ad27ad4526a19a3ed221aa03e3_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfNC02LTEtMS03NzE3MQ_5d962179-c7b2-4018-b840-de4628d7d96f">10,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i634f77b02fdb422b81be6145a0ca48da_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfNC04LTEtMS03NzE3MQ_1e2e91c5-055b-4a1c-a587-44c9be0e3593">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i634f77b02fdb422b81be6145a0ca48da_I20211231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfNC0xMC0xLTEtNzcxNzE_6e4a3fae-f8ba-4799-8a3e-72ca6107a60e">18,188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i634f77b02fdb422b81be6145a0ca48da_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfNC0xMi0xLTEtNzcxNzE_e856ca12-ddf2-4592-905f-78e210fe72a1">10,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $<ix:nonFraction unitRef="usd" contextRef="icc20f2ad27ad4526a19a3ed221aa03e3_I20220630" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTUwNzA_d4cecb23-9017-43a0-b67e-5f1370330af6">11.5</ix:nonFraction>&#160;million and credit loss adjustments of $<ix:nonFraction unitRef="usd" contextRef="icc20f2ad27ad4526a19a3ed221aa03e3_I20220630" decimals="-5" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTUxMDQ_060b7e6e-bd32-419e-906d-561d0e7d2dd4">6.5</ix:nonFraction> million as of June&#160;30, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $<ix:nonFraction unitRef="usd" contextRef="i634f77b02fdb422b81be6145a0ca48da_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTUxODA_c6457d1a-df76-4306-9c15-b1a10d386fdb">11.7</ix:nonFraction>&#160;million and credit loss adjustments of $<ix:nonFraction unitRef="usd" contextRef="i634f77b02fdb422b81be6145a0ca48da_I20211231" decimals="-5" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTUyMTQ_064c62aa-f211-4a64-b185-fc37304040a8">6.5</ix:nonFraction>&#160;million as of December&#160;31, 2021.</span></div></ix:nonNumeric><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. in January 2019. Commercial license rights acquired are accounted for as financial assets in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Receivables, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">as further discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Notes to Consolidated Financial Statements in our 2021 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three and six months ended June&#160;30, 2022, we further considered the current and expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of June&#160;30, 2022.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accrued Liabilities</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3Nzc_7e224be1-342b-4d9a-b0cc-fe66e8fefa27" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMi0xLTEtMS03NzE3MQ_527ad8c3-8400-4ca9-8a0f-dc5fea00044c">4,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMi0zLTEtMS03NzE3MQ_5987527b-f1db-40be-841f-9e67b7ec3b88">6,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMy0xLTEtMS03NzE3MQ_a95ceb89-b6c9-4945-a546-709a2bd74db8">1,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMy0zLTEtMS03NzE3MQ_d6554734-eab2-4aba-a404-770d9c8b70f4">2,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="lgnd:LicenseeAccrualCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfNC0xLTEtMS03NzE3MQ_d2a49ad9-5c46-48b0-b202-e58db2b24298">2,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="lgnd:LicenseeAccrualCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfNC0zLTEtMS03NzE3MQ_d4666140-5d3c-486c-b252-b4874e786735">630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfNS0xLTEtMS03NzE3MQ_ad8a3f4d-09f0-4fa4-964d-369090ae7840">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfNS0zLTEtMS03NzE3MQ_5883fa15-14ca-4ccd-bc5a-31be96d442af">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="lgnd:ReturnsAccrual" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfNi0xLTEtMS03NzE3MQ_8f03907d-6a47-4e3f-b535-24e13871754d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="lgnd:ReturnsAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfNi0zLTEtMS03NzE3MQ_3fee63b4-f98b-4f48-9959-bec75ddcbe40">2,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="lgnd:AccruedAssetAcquisitionsCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfNy0xLTEtMS03NzE3MQ_f9605132-0239-466a-8dc0-7a6ade61577d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="lgnd:AccruedAssetAcquisitionsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfNy0zLTEtMS03NzE3MQ_9c1f691f-dadc-4ac4-b570-82c98905a296">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="lgnd:AccruedSubcontractorExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfOC0xLTEtMS03NzE3MQ_6ff00db9-cd16-4b6d-a474-828097815296">1,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="lgnd:AccruedSubcontractorExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfOC0zLTEtMS03NzE3MQ_ba89f2bf-e33d-4e47-9303-f23a653c1ebd">1,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="lgnd:AccruedSupplierExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfOS0xLTEtMS03NzE3MQ_4d123bbb-c7da-452e-b0c9-f30f71a034f8">1,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="lgnd:AccruedSupplierExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfOS0zLTEtMS03NzE3MQ_bc911af7-4dd8-45f6-a481-54e39d512218">848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:InterestPayableCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMTAtMS0xLTEtNzcxNzE_3b1fc829-414b-4580-a15e-6a18bbfbd2ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMTAtMy0xLTEtNzcxNzE_632dd55a-96b2-4c4a-b764-adf36844ca10">291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMTEtMS0xLTEtNzcxNzE_6cc1b4af-1afb-4eed-9027-ead71146d885">1,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMTEtMy0xLTEtNzcxNzE_893148f5-d6c2-40da-9bb1-bb1032c64a01">1,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMTItMS0xLTEtNzcxNzE_45db8722-fc19-44d6-b71b-f7deb61246a0">14,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMTItMy0xLTEtNzcxNzE_345e483a-a507-4307-9208-ccfe2a3bf1e0">17,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3NjI_e210f24d-6dc3-404d-9869-903d7f7b652b" continuedAt="ia603f2ef404e471e8d3a9c04574692b0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. <ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3NTc_4aca959d-f843-4c0c-93f8-9060574a8643" continuedAt="if9953a81af2f46b8a27bb4c068ba93a6" escape="true">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="if9953a81af2f46b8a27bb4c068ba93a6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.870%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six  months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5690281660a344fd9548591a6f266ac4_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfMy0xLTEtMS03NzE3MQ_60cd1a4c-04c6-42d6-a060-2624239181b3">4,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a73247f7a945ea9b05cf35b6cc0850_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfMy0zLTEtMS03NzE3MQ_295a71b4-71e9-4f57-b79a-b15b409c2471">4,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6ac9689508e4114ba54882dec295d93_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfMy01LTEtMS04MzQxNg_483e06fe-e9a8-4a28-9053-ddb3f3e0d212"><ix:nonFraction unitRef="usd" contextRef="id6ac9689508e4114ba54882dec295d93_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfMy01LTEtMS04MzQxNg_595ae5b2-edef-42c0-862d-77bdc23dbee1">8,415</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6900c46450645478d0da3f5fb2d9670_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfMy03LTEtMS04MzQxNg_92c3f0ca-209c-40ff-9837-329ae620f75e">8,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd353da9346c4eff9ef59fce65083fef_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNC0xLTEtMS03NzE3MQ_194aae20-8209-42fb-9b1e-e088fd3c399f">4,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29682bf3513f43abae73bf36fdc07869_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNC0zLTEtMS03NzE3MQ_35c94c27-075c-4d0b-8e5d-9db4b7543cb6">5,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibca091886a1342b2acf333d5f3b78776_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNC01LTEtMS04MzQxNg_11cc0b60-3a6f-4266-824d-b36e893a38c4"><ix:nonFraction unitRef="usd" contextRef="ibca091886a1342b2acf333d5f3b78776_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNC01LTEtMS04MzQxNg_5c077862-db27-454b-831e-72c5a5108c05">10,128</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i074a3e4a71c9476fba4587a19825900e_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNC03LTEtMS04MzQxNg_055f5358-ba2f-4d43-8ea3-26ba916021f0">10,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNS0xLTEtMS03NzE3MQ_6a4dcbe8-bb78-46ed-b902-6346ece3a5f3">9,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNS0zLTEtMS03NzE3MQ_f0623269-d25b-4ef4-9063-9a2d49f6cd5a">10,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNS01LTEtMS04MzQxNg_affe9c57-60e6-452f-8b1a-65cb2b77a3d7">18,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNS03LTEtMS04MzQxNg_7df78792-3b2c-414f-8a5d-1f8d31358baa">18,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3NjM_a7e2479f-300a-42bd-8564-4a1b74960ad3" continuedAt="i3623052e9e6245ceb2d5c924eb75e772" escape="true">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</ix:nonNumeric></span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="iefbd3cc94c5046bf8bdb434b10bc2d88"><ix:continuation id="ia603f2ef404e471e8d3a9c04574692b0"><div><ix:continuation id="i3623052e9e6245ceb2d5c924eb75e772"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfMy0xLTEtMS03NzE3MQ_8f85f6db-79a4-4b03-a596-ae9be9c2c88c">3.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfMy0zLTEtMS03NzE3MQ_836a8228-0b47-4114-b61d-df76e9accf07">0.9</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfMy01LTEtMS04MzQyMA_4142f463-ef14-4175-b924-df2715c2c162"><ix:nonFraction unitRef="number" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfMy01LTEtMS04MzQyMA_61083fbe-fc59-4317-b63f-ae46fcb8a33f">3.0</ix:nonFraction></ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfMy03LTEtMS04MzQyMg_58b5a970-6c6a-459b-84b7-1cc4464c8d9c">0.5</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNC0xLTEtMS03NzE3MQ_5c010579-ad16-49f6-a7b3-5125b636830e">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNC0zLTEtMS03NzE3MQ_f46dbde1-b333-416d-8521-d2f605b43902">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNC01LTEtMS04MzQyMA_06af83aa-2f9f-4565-984b-420ef624c0ba"><ix:nonFraction unitRef="number" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNC01LTEtMS04MzQyMA_ade7f180-5ad3-430d-81af-f3a9c7a7c7ca">&#8212;</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNC03LTEtMS04MzQyMg_e1c6edb2-d340-4263-b5db-e4dd98a90969">&#8212;</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNS0xLTEtMS03NzE3MQ_917ac214-d990-486e-ae69-8274f3088ba5">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNS0zLTEtMS03NzE3MQ_24e6b62e-de81-4428-81ca-0ad23c3bc925">54</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNS01LTEtMS04MzQyMA_24cf44d3-6710-407e-9fe9-373a85e43f1c"><ix:nonFraction unitRef="number" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNS01LTEtMS04MzQyMA_58c3fef6-eba6-4abf-9411-beea2ef7a9a7">50</ix:nonFraction></ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNS03LTEtMS04MzQyMg_dbd8de06-f1fc-4128-a069-4334915791dc">62</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNi0xLTEtMS03NzE3MQ_6e046ede-468f-4704-b953-04327b46f745">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNi0zLTEtMS03NzE3MQ_6e47070c-e3ea-41f6-84c4-677478f51d4e">5.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNi01LTEtMS04MzQyMA_b27440f7-6bd5-4dee-94bf-8a34b3ff7a2d">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNi03LTEtMS04MzQyMg_65883656-86fa-47ab-a0ce-41798b16c056">5.0</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a <ix:nonNumeric contextRef="i94c20b531d9a49f3ba7f9be28e443ebb_D20220101-20220630" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk4MDY_d9ab9e63-5048-493c-8d96-b6d24e0e1400">three-year</ix:nonNumeric> performance period, with a range of <ix:nonFraction unitRef="number" contextRef="idde310731c5f4ddf8421b11a76439a76_D20220101-20220630" decimals="INF" name="lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTc1Nzc_e9596772-947a-4f22-81e4-406ead5c3625">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i4653b493ab2c477f934120be3d321770_D20220101-20220630" decimals="INF" name="lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTc1ODM_fb949e03-ecae-48b3-931f-4326bb5bd319">200</ix:nonFraction>% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3OTc_625520eb-4214-4681-a3b0-224f6f3bd191" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net (Loss) Income Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3ODg_64b71124-6f14-4ee7-8a11-ff1bd43ba90c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.289%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.289%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.289%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.293%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfMy0xLTEtMS03NzE3MQ_10c82f03-31e2-4a3e-8b78-6dd3c3501026"><ix:nonFraction unitRef="shares" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfMy0xLTEtMS03NzE3MQ_a1b1089f-b47c-4f7f-a728-8a4915e35f62">16,868</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfMy0zLTEtMS03NzE3MQ_0fbd6e4a-5594-40fb-b9ab-5bd04ec83457">16,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfMy01LTEtMS04MzQyNA_46969031-d92c-4cab-b734-ece05a7454f8"><ix:nonFraction unitRef="shares" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfMy01LTEtMS04MzQyNA_7db08726-19d5-4435-8084-d4777214dd30">16,846</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfMy03LTEtMS04MzQyNA_20911303-e733-4633-8a34-4f511e877aab">16,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab8c600366d6408f8d68011ffa0eefb3_D20220401-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfNS0xLTEtMS03NzE3MQ_47e42e7e-54e7-4ea8-9935-4f9412ebba0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62f296ba5f6d4e0080870b494a4cb1f3_D20210401-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfNS0zLTEtMS03NzE3MQ_59418faa-60f9-44f9-bfe4-47198310892c">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7f4ae166f88f42b9ad465f19b7a2b5dd_D20220101-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfNS01LTEtMS04MzQyNA_71613b5c-afb8-4a6c-b971-edb1e04fba5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5ad93d1c25b4a4e91833014363da039_D20210101-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfNS03LTEtMS04MzQyNA_c084f428-6f5f-4e3d-88e2-6399ad042002">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4d8ee4a829e4a9b9b6b4a7a447bdb79_D20220401-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfNi0xLTEtMS03NzE3MQ_37da9b15-10e6-4728-a1a8-6dd4f7302ed5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1aef4caca12a42dc91df79cbcf0581b8_D20210401-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfNi0zLTEtMS03NzE3MQ_65b6618e-f4b3-458d-967e-ce8ff81d5358">444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5d6a3560d8b34a5cbe1f0942263178b3_D20220101-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfNi01LTEtMS04MzQyNA_1d1cc780-370d-4fd7-96e1-375cedfc420b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia4ad93b5e6dd4cd99dc35ab96510e147_D20210101-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfNi03LTEtMS04MzQyNA_49d666db-d17c-4ab3-9c44-6c4ec80851d1">572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOC0xLTEtMS03NzE3MQ_2f50e738-8efb-4d8c-8132-5d3c77125d83">16,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOC0zLTEtMS03NzE3MQ_339d414c-ad39-415b-acc1-ab07dec298e7">17,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOC01LTEtMS04MzQyNA_74188db9-cb56-4ba2-b9d9-8b6fe81029c2">16,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOC03LTEtMS04MzQyNA_c35155b7-5267-4e62-a51f-f6d3e4f07147">17,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOS0xLTEtMS03NzE3MQ_c8161e96-1146-4212-b1d5-8d82d39fdbaa">6,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOS0zLTEtMS03NzE3MQ_959fa3b7-cbbd-4e5f-9bb6-04c1b9a268b6">5,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOS01LTEtMS04MzQyNA_a87aa62e-de86-4d88-abf3-8c0ddb31da74"><ix:nonFraction unitRef="shares" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOS01LTEtMS04MzQyNA_cb88b492-df5a-4790-b6d1-2f76ebf76794">6,400</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOS03LTEtMS04MzQyNA_1ca4a163-4741-4281-a6b5-f853a0034863">4,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2022, due to the net loss for the period, all of the <ix:nonFraction unitRef="shares" contextRef="i24cd0274970047cebd3b261d67019060_D20220401-20220630" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTY0OTI2NzQ0Mzc0MDA_672bb9d7-e7bf-4fc0-a71d-9ff6f4e5f7f5">0.2</ix:nonFraction>&#160;million weighted average equity awards and <ix:nonFraction unitRef="shares" contextRef="if037b66c12a84486bd10aab5f91c4756_D20220401-20220630" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTY0OTI2NzQ0Mzc0MTg_a6156936-8045-42bf-98e9-5e0cbbaf7269">0.9</ix:nonFraction>&#160;million of potentially dilutive shares in connection with the adoption of ASU 2020-06 were anti-dilutive. For the six months ended  June&#160;30, 2022, due to the net loss for the period, all of the <ix:nonFraction unitRef="shares" contextRef="iad364541fb5f472591361e583d131e10_D20220101-20220630" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTY0OTI2NzQ0MzY3OTI_57ec1c1d-8e9d-49d5-85e1-a70d3f27dfe5">0.3</ix:nonFraction>&#160;million weighted average equity awards and <ix:nonFraction unitRef="shares" contextRef="ifbe273cd726b46b98c132ca315d75750_D20220101-20220630" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk1MjA_04241086-061c-4550-86c7-77c359550adc">1.8</ix:nonFraction>&#160;million of potentially dilutive shares in connection with the adoption of ASU 2020-06 were anti-dilutive. Under the new standard, we are required to reflect the dilutive effect of the 2023 Notes by application of the if-converted method.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.  <ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RleHRyZWdpb246MzM2YTE0YmQzMWRiNDJjMzliZDliMWM3ODMxMzBhYjJfMzU0Nw_c08a55fb-6cd6-4c6c-931a-9c43be5aba83" continuedAt="i87a8207657204ce891748fbeafe28fa2" escape="true">Segment Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i87a8207657204ce891748fbeafe28fa2" continuedAt="i51f7a93d8e624b6ca8fd39886ec55109"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, establishes annual and interim reporting standards for an enterprise&#8217;s operating segments and related disclosures about its products, services, geographic areas and major customers. An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenue and incur expenses, and for which discrete financial information is regularly evaluated by the chief operating decision maker in deciding how to allocate resources and assess performance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our operating segments are identified in the same manner as they are reported internally and used by our chief operating decision maker for the purpose of evaluating performance and allocating resources. Historically, we have disclosed <ix:nonFraction unitRef="segment" contextRef="i6e8af247251140e088c62af9f5e1be66_D20220101-20220322" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RleHRyZWdpb246MzM2YTE0YmQzMWRiNDJjMzliZDliMWM3ODMxMzBhYjJfOTQ3_ec0585e0-642e-4734-9d6f-1990bf441c41">one</ix:nonFraction> reportable segment. On March 23, 2022, we entered into the Merger Agreement, pursuant to which APAC will combine with OmniAb, and acquire the OmniAb Business, in a Reverse Morris Trust transaction. Immediately prior to the Merger and pursuant to the Separation Agreement, we will, among other things, transfer the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc. to OmniAb (the &#8220;Reorganization&#8221;) and, in connection therewith, will distribute (the &#8220;Distribution&#8221;) to Ligand stockholders 100% of the common stock of OmniAb. Immediately following the Distribution, Merger Sub will merge with and into OmniAb (the &#8220;Merger&#8221;), with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of APAC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the execution of the Merger Agreement, we have made organizational changes to better align our organizational structure with our strategy and operations, and management has reorganized the reportable segments to better reflect how the business is evaluated by the chief operating decision maker. Beginning in the first quarter of 2022, we operate the following <ix:nonFraction unitRef="segment" contextRef="iebd5e1dca73546bab3c7f7e7fd807132_D20220323-20220331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RleHRyZWdpb246MzM2YTE0YmQzMWRiNDJjMzliZDliMWM3ODMxMzBhYjJfMjIwMg_db484c4e-5d62-44ff-926b-5dc4f55f7957">two</ix:nonFraction> reportable segments: (1) OmniAb business and (2) Ligand core business. The OmniAb business segment is focused on enabling the discovery of therapeutic candidates for our partners by pairing antibody repertoires generated from our proprietary transgenic animals with our OmniAb business platform screening tools. The Ligand core business segment is a biopharmaceutical business focused on developing or acquiring technologies that help pharmaceutical companies deliver and develop medicines. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income (loss) represents income (loss) before income taxes, interest income, interest expense, other income (expense), net, unallocated share-based compensation, and unallocated corporate overhead. Our management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RleHRyZWdpb246MzM2YTE0YmQzMWRiNDJjMzliZDliMWM3ODMxMzBhYjJfMzU0OA_5d7b7b03-0c0d-49e3-be0f-4f419e3c26e6" continuedAt="ib61382c2cb2c44cd98bd7f61f8c9aea2" escape="true">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#8217;s internal financial information as used for corporate management purposes (in thousands):</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><ix:continuation id="i51f7a93d8e624b6ca8fd39886ec55109"><ix:continuation id="ib61382c2cb2c44cd98bd7f61f8c9aea2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business revenue</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdd064189bf40a1b0af7c11c05b508a_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMy0xLTEtMS03NzE3MQ_7b9a0007-da09-410b-b858-8afd16d56e3b">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b9af2332e24b278e251428d3112d54_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMy0zLTEtMS03NzE3MQ_52d06c71-a0a1-4e83-898f-562d2b735c13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee885ce7e8c546a58c101265454c96b4_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMy01LTEtMS04MzQzMA_a6efbb73-7433-48a9-a3cb-ccc86c3dabd2">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i554afd03f39f48b1b340f2c1f5e63b38_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMy03LTEtMS04MzQzMw_9697812b-2c62-4ae3-8ff8-1bcb920fd3b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa01d917cb584f68ad23a0a988be1019_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNC0xLTEtMS03NzE3MQ_4db91924-9da0-405c-bd22-2e7e2d1d82b4">7,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc3aca482094a8ea993165932b200f4_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNC0zLTEtMS03NzE3MQ_10bae4f1-7261-4dd1-be5c-174006863a54">5,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0323f8ac68c4e58abf54420181eb553_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNC01LTEtMS04MzQzMA_8504a532-d4e0-40a7-a1ad-8e8c65247975">16,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53051290139d4df09cbb95cc83d65ca5_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNC03LTEtMS04MzQzMw_34dbad08-e14a-44c0-a99f-c8532bbea6f8">14,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total OmniAb business revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09a96cf6288542ffb7bf41f87f2f1513_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNS0xLTEtMS03NzE3MQ_87346893-3eb6-4d7f-afd4-296eafa5e4cb">7,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24d7aae3601941aca19f23d31f03721a_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNS0zLTEtMS03NzE3MQ_b734c92f-377e-4caf-8f13-c7f095c6f043">5,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a04509ce52a4958bd559598330aa15e_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNS01LTEtMS04MzQ2NA_eae4ac80-ac0b-4e4a-aaf4-6ddb6edac811">16,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c045aa28e3844fcb9eff412fe495b73_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNS03LTEtMS04MzQ2Ng_8bbf87ed-8f89-417c-aad4-e76a9ffa0675">14,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic75dfe15187544a5842c26db724997b1_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNy0xLTEtMS03NzE3MQ_2e52c1a8-fdaa-4576-a773-8f0fee238389">17,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id13f1a41d92a446e880e3b7f996d39bb_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNy0zLTEtMS03NzE3MQ_2ef18a05-3f96-481b-9a40-1c06c83e0c99">8,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d6c284cd324a37b54f99d3f372c0d3_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNy01LTEtMS04MzQzNQ_94cefa90-cdb3-4c0c-8f2f-a2405d50a451">31,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67ed19c1f7cc4ba5a898950694d6aad5_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNy03LTEtMS04MTIwOQ_3cecc0e6-3dcb-45b0-b518-e25c0c5121db">15,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - Core </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69264884c80f4de496ecd4d3871f13de_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfOC0xLTEtMS03NzE3MQ_47bfb678-12ee-41e3-8902-32da1d4c056a">3,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f0ce6d74bbb404494d3b9ecd07c5c1d_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfOC0zLTEtMS03NzE3MQ_5b3173c1-2046-4071-a9bf-60a144658c68">9,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a26669fd70d437e8dbf0d46744ee68b_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfOC01LTEtMS04MzQzNQ_b71d6b57-ac82-4643-bee8-158d4b8746e6">9,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e1cee720dbe4a518d1861c1471e0601_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfOC03LTEtMS04MzQzNw_dac6b192-f8dc-44f1-9ce9-9242f25ae9c5">10,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - COVID</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac98dc8419824fccbffe08deef56431d_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfOS0xLTEtMS03NzE3MQ_6fb85fc6-33cc-4e1b-bb49-3c35f1a8ea39">26,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1b6772c114f4296b3710452fad3bbf0_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfOS0zLTEtMS03NzE3MQ_24afeb82-ed7e-4b27-81c9-e94433399317">52,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac3e999d74914146b6972963646d77d3_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfOS01LTEtMS04MzQzNQ_f9f8bb57-364c-43e3-9f44-a07ac6777ecc">32,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af2fa579c8d4d0298cd4adaf64f562a_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfOS03LTEtMS04MzQzOQ_ffcdd898-318f-470f-a0d2-890ca453efa0">82,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08264c293ad941d38c85c6df434e3b96_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTAtMS0xLTEtNzcxNzE_4c8bd84e-45fd-4d94-b3f1-a4e9827b3395">2,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17513104887747d094c8f90449ce26f3_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTAtMy0xLTEtNzcxNzE_1bcdc439-0058-48a6-8256-1ad6694d77a2">7,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fff928bd965435baa9430b0a51bc952_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTAtNS0xLTEtODM0MzU_2c7e9225-6d87-45a2-ad7b-4e9676a5f8f1">13,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i350d8bdb260b4f158bbe1c83371f08d1_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTAtNy0xLTEtODEyMTI_8d5acad2-88cf-45ae-bfa6-51f9c4ef8894">15,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Total Ligand core business revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3945ba7328d4488dbe199f8a6fb8806a_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTEtMS0xLTEtNzcxNzE_f9ad05bc-c172-45dd-ae2b-f4948af49ef9">50,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996c3ee8de704c67a1f48c7b57639172_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTEtMy0xLTEtNzcxNzE_a2621879-88e3-46b2-a780-19936ae2928c">78,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11be9eb5ab6343b9abe0845805816826_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTEtNS0xLTEtODM0MzU_94e313c3-59bf-4ec5-ba97-0077a02bb5a9">86,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ef05994b78847b2b9a1ecd095ccd023_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTEtNy0xLTEtODM0NDE_71d313de-b60c-4521-8955-bb805f44dc83">125,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb5402adc253464eb373188274f50300_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTItMS0xLTEtNzcxNzE_e339df32-6f29-49bb-ac47-0c89489314ef">57,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbbe17fffac4478caf19f21253a14fb4_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTItMy0xLTEtNzcxNzE_caa3cf4b-4a4d-4b0e-affa-1dd116f18f41">84,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i252d1e5433c94a97bc58b777f5a25e67_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTItNS0xLTEtODM0MzU_b2504a0a-6dd6-4a4b-ad40-b37258e5d99e">103,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5d7aab7d47f4e158191d415ae90524f_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTItNy0xLTEtODM0NDM_a5f720bc-2220-4a87-9c2a-b1fb764e4134">139,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Segment operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09a96cf6288542ffb7bf41f87f2f1513_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTUtMS0xLTEtNzcxNzE_0961aeb6-03d1-462c-a9cf-f130d732ee35">8,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24d7aae3601941aca19f23d31f03721a_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTUtMy0xLTEtNzcxNzE_705fd30b-6901-45c0-93c1-d27eb725ca8c">7,806</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a04509ce52a4958bd559598330aa15e_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTUtNS0xLTEtODM0NDU_a6ad5fca-5815-47ed-9f2c-2ac216e96560">15,187</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c045aa28e3844fcb9eff412fe495b73_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTUtNy0xLTEtODM0NDk_1c1b1439-b382-4b62-bc50-fdb8e039d6fd">12,410</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3945ba7328d4488dbe199f8a6fb8806a_D20220401-20220630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTYtMS0xLTEtNzcxNzE_cc9d2354-f06d-44e2-9afa-29fb0c337001">17,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996c3ee8de704c67a1f48c7b57639172_D20210401-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTYtMy0xLTEtNzcxNzE_9fd02028-6a06-421b-b011-0503bb0a5ff4">61,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11be9eb5ab6343b9abe0845805816826_D20220101-20220630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTYtNS0xLTEtODM0NDU_2fa83c1d-0b29-41f8-9877-f98490fc61e7">27,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ef05994b78847b2b9a1ecd095ccd023_D20210101-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTYtNy0xLTEtODM0NDk_5544376c-39c5-4d4a-b114-653b1c8cb4f1">80,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb5402adc253464eb373188274f50300_D20220401-20220630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTctMS0xLTEtNzcxNzE_b3fc9871-c1e0-49d2-9585-5bd987a29c77">8,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbbe17fffac4478caf19f21253a14fb4_D20210401-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTctMy0xLTEtNzcxNzE_c564c8bf-5918-4e35-a414-98424701e292">54,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i252d1e5433c94a97bc58b777f5a25e67_D20220101-20220630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTctNS0xLTEtODM0NDU_2cb69aae-74fd-4c09-9c89-590c0c8718e5">11,843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5d7aab7d47f4e158191d415ae90524f_D20210101-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTctNy0xLTEtODM0NDk_fac3ab19-c914-476e-8dcb-f1b1f68f2306">67,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unallocated corporate items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shared-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ada02c52f844af586bb3e63e4ec6411_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjAtMS0xLTEtNzcxNzE_f54dcb09-c007-4d44-909a-e0918d665aec">5,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06363049796846649c3d730ee81b5bda_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjAtMy0xLTEtNzcxNzE_e0f56532-217b-47e2-9335-d739a4ff1d28">5,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c5fe50a04314348adf834a5587766ca_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjAtNS0xLTEtODM0NDc_1a27977e-665c-4669-84db-562b3fe47fc4">10,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b9c142e9fb346ec975852f818248861_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjAtNy0xLTEtODM0NTE_16ca9e39-73db-4044-82cf-027538d834d1">10,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ada02c52f844af586bb3e63e4ec6411_D20220401-20220630" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjEtMS0xLTEtNzcxNzE_413491c4-2547-49a7-a3c9-79c92c8ac8aa">3,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06363049796846649c3d730ee81b5bda_D20210401-20210630" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjEtMy0xLTEtNzcxNzE_ca5d4b86-70b4-40e8-a9a6-d3e0ae536cb4">2,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c5fe50a04314348adf834a5587766ca_D20220101-20220630" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjEtNS0xLTEtODM0NDc_9f9e0032-8e4a-47a3-b4ad-ba9586693fde">10,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b9c142e9fb346ec975852f818248861_D20210101-20210630" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjEtNy0xLTEtODM0NTE_188f80a4-8405-4389-9c70-8da8330edbb0">6,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total unallocated corporate items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ada02c52f844af586bb3e63e4ec6411_D20220401-20220630" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjItMS0xLTEtNzcxNzE_6d90e11c-839b-4b88-9481-5d3d94893451">8,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06363049796846649c3d730ee81b5bda_D20210401-20210630" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjItMy0xLTEtNzcxNzE_618504fa-6a46-414e-ab1e-9cb79099aa4c">8,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c5fe50a04314348adf834a5587766ca_D20220101-20220630" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjItNS0xLTEtODM0NDc_9b4a273d-50a6-4f78-b2c7-2b8320e83a9b">21,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b9c142e9fb346ec975852f818248861_D20210101-20210630" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjItNy0xLTEtODM0NTE_521d7a5e-11af-4a81-9404-8c4b58371db2">17,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjMtMS0xLTEtNzcxNzE_f0878a85-c639-4c38-a415-8310e9795907">469</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjMtMy0xLTEtNzcxNzE_67c5df99-498b-4a74-88a6-0990b2487db9">45,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjMtNS0xLTEtODM0NDc_4e29ace7-a1a7-4ab9-96df-2f94bafadc57">9,775</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjMtNy0xLTEtODM0NTE_cb03a1c4-3914-4719-9b20-6132e6fd9c61">50,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.  <ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfNTE5OA_a898a25a-da4f-4974-bcec-d427128bccd5" continuedAt="i478be31804ef4344afb3d4dbac9f1b45" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i478be31804ef4344afb3d4dbac9f1b45" continuedAt="i4d95fb44ef7e4f79a945fa1099e04339"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfNTE5NA_9372c3b2-81f4-4492-a17f-b0a0f90ea8d1" continuedAt="i98ed662bae244bd5a1c438a006b734e2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.830%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i267e2274bd584fe58769c5a1656b12db_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMy0yLTEtMS03NzE3MQ_e19d33d2-29a7-43e5-8925-1d5c0e1b951d">4,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61d812ca09145fcb40e16dbd4b8d9a8_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMy00LTEtMS03NzE3MQ_f09e73e7-d62c-4d97-b6a4-3786c02be872">118,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a56e0d3e9a94dab9817eae0e11974be_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMy02LTEtMS03NzE3MQ_b012dc16-28b9-44e8-bd92-695bbcbc0ac9">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe938625cbc5444690c9b08e8e1f3fc6_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMy04LTEtMS03NzE3MQ_f53cb91c-938d-400c-8f18-2842cb2624c2">123,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib02472ad4a604f96aae20a25b68fd2fc_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMy0xMC0xLTEtNzcxNzE_958cdb7c-5b12-4b7c-9c73-a8aeeed665b3">9,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67146a8e91942cdba9ed20b277604c6_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMy0xMi0xLTEtNzcxNzE_0ed704be-1041-4fef-9445-640fefb311e5">280,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14e0598617224fafbf13d5add97de1a6_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMy0xNC0xLTEtNzcxNzE_3625fe29-1425-43af-865e-e521022f59c3">409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i456aa02326a84161ab7d7363b6b524cd_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMy0xNi0xLTEtNzcxNzE_a70ff911-193a-491a-a4bd-3fcca6c4497c">290,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c186e23a71a4fb793fc929a6f1bae65_I20220630" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNC0yLTEtMS03NzE3MQ_7a922b2a-a290-4b57-8625-7b6a38e2a49d">19,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eea2d5922e24e8a9f8cf6052385e139_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNC00LTEtMS03NzE3MQ_a5041fa4-5e43-4ed4-89b8-9cec5b0111e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0225b46271344284ad100ef90961626b_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNC02LTEtMS03NzE3MQ_101a24b6-901d-4ff3-afd2-2d6bf5a0e11d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ebf4f8772924ada8190747259ee3c18_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNC04LTEtMS03NzE3MQ_e55db686-e35f-44f6-8109-369b7626a4d9">19,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3157c06168094203bfe558b4e6173ba6_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNC0xMC0xLTEtNzcxNzE_27e9547b-af29-4fd1-8906-7714ebd8fe17">30,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45e9971abf3b469ea61649ddf4748670_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNC0xMi0xLTEtNzcxNzE_26055f94-99e2-4a64-80ef-e548a57188ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d27b9f62664dffa76f1fe952c1f9ce_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNC0xNC0xLTEtNzcxNzE_895f60e8-cf8a-440e-af9c-4896b2189d99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i010958049e69464b916484b2032627e5_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNC0xNi0xLTEtNzcxNzE_78bac3af-4da6-4af3-9cfe-e3f5745d1829">30,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3a7e52f19d64b8fa2a2e2476fa0bfa1_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNi0yLTEtMS03NzE3MQ_e6ac8643-48ab-4274-a28f-35c1500d0023">23,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd7b10617e343eca1d9556dffc4f114_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNi00LTEtMS03NzE3MQ_86e98203-a156-4a1d-b6f7-7a1a388f0fc2">118,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225cccb2c22740ca8ac988545b58446a_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNi02LTEtMS03NzE3MQ_b212b684-0e70-48cc-b5fb-ba4d6ceda9c2">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb2398d3a3048748fb70e3df8843949_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNi04LTEtMS03NzE3MQ_dfbc4d2a-edfc-418a-a2c3-7b1cf45375b1">142,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f9632ba6184340b79bb0cd30ae04e2_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNi0xMC0xLTEtNzcxNzE_8c6ca1a4-534e-4aa7-98f5-88d124c2cd9b">40,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i548c288771a540749668a107a155b125_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNi0xMi0xLTEtNzcxNzE_fafe4d10-5a99-4412-9bac-233480c4eb30">280,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b44abccb2d044b2849d4fc6191d00dd_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNi0xNC0xLTEtNzcxNzE_458ab150-24a9-45e9-8309-78c777c4bcc6">409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecbe3fa2930442bb98e4b5b4bb9e5256_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNi0xNi0xLTEtNzcxNzE_ed9251b9-a731-4151-bf29-a52ff8e03581">321,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21cc39d790414198a5384b22bc9f8914_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfOS0yLTEtMS03NzE3MQ_50b58c98-497c-4179-8727-eea0bba93e97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e1f31d766a7446d9b402aa372153d71_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfOS00LTEtMS03NzE3MQ_414aef7c-5b3e-48a5-b734-5451245ddffc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a32d5c0d47d478abf53a297880bc04d_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfOS02LTEtMS03NzE3MQ_3c3b30f8-c831-49fe-bb5c-5daaefb8370c">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebd32fe9f284200b88a29fe00e1c59e_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfOS04LTEtMS03NzE3MQ_238a4810-aba9-4059-a017-f0d485472f63">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a462cc318440799e9195fc83206c6b_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfOS0xMC0xLTEtNzcxNzE_887d2bb6-6fcd-4975-891d-11bc17cc46a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id70c6611cf0349bbaa43d7ca45e9e20e_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfOS0xMi0xLTEtNzcxNzE_7b378a5b-a15c-441d-919d-ea6b4e4ddf90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13e8f86f4bb4792a23bb3135840b332_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfOS0xNC0xLTEtNzcxNzE_6ca0f82f-5354-40f8-a3df-175ab8c19029">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e4b0b1b1c134aef858b246643f58be5_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfOS0xNi0xLTEtNzcxNzE_3f966bd9-e06a-4533-831a-d6e25f0a4098">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1516fb25275e4bbcbaaca00a3711b3cf_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTAtMi0xLTEtNzcxNzE_7ebab010-1ec2-4ef7-a1dd-2f4090dc2aba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc548b28534c4e0aa35fef883c9ffd4c_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTAtNC0xLTEtNzcxNzE_596f522d-e531-4404-9095-46a5f878dd51">2,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i447b152d2cdc4923a33b76efe86e78f6_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTAtNi0xLTEtNzcxNzE_6eaacd4c-c7de-4860-bc79-e43a15257f8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05ba522e2c8b438eb09faef77aac2491_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTAtOC0xLTEtNzcxNzE_f62d5ae1-1670-48b6-a113-66a4abfe7bb1">2,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0671049fb2c74897aaed6cf1402f67e0_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTAtMTAtMS0xLTc3MTcx_6cf70d17-8396-4a3c-a841-b2800abbe497">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b39471746204503b6025c517a2740ed_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTAtMTItMS0xLTc3MTcx_9c3f882b-82da-409f-a5c7-fbc20361ea51">3,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084dd0497977421093be2aa2620a6cf0_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTAtMTQtMS0xLTc3MTcx_4a235cf3-827d-4203-bb71-2475a8eab9b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a748e36f24545bc8aa6196a0de9b8ad_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTAtMTYtMS0xLTc3MTcx_2d884411-e660-4791-81ea-00d73d19380c">3,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4644a9e4754293b2965e4853bb25b1_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTEtMi0xLTEtNzcxNzE_0c7a275a-5cc1-4ad5-924c-9d6eeeee79f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfe5c65f77d4902805d7bd75bdafe01_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTEtNC0xLTEtNzcxNzE_50104483-bd98-4319-b114-5a12451e45e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7a292a775a4e939d542844f0e07327_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTEtNi0xLTEtNzcxNzE_baed70d9-9caa-48ec-bff0-26c982ce22cb">5,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i625cf43be4a04d1296f91edac39e0b36_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTEtOC0xLTEtNzcxNzE_4b492a07-90f2-4d78-b52f-5d31ba44de9e">5,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i170fa4640e6342fb9e5d5b0994468676_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTEtMTAtMS0xLTc3MTcx_24b210c7-3b0c-473c-a066-eb5346429b75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i602915a018774dab8faf3722799d8baa_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTEtMTItMS0xLTc3MTcx_afc9a4b0-9081-4fa3-9343-0eaca6dc12f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64894a5f080e4b3f8b457334acdc1cd2_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTEtMTQtMS0xLTc3MTcx_8c53da7a-04a0-4719-a3f9-8ddfadb65380">7,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dea4d860bca4c7ba6c68ce71c7ff2d4_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTEtMTYtMS0xLTc3MTcx_fd73a0f3-8e81-49c9-aac6-00d089a5acda">7,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc6f643b427d4d95b47f5f8bfbd1d696_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTItMi0xLTEtNzcxNzE_3abd7cf6-edfa-41ad-aae1-f10db7e6dd96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f541feaadce43de9b83e05a3cc81f9f_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTItNC0xLTEtNzcxNzE_13ffb55b-abd2-4ff2-acab-a565365cb89a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34af6b0108f84a96869a676335de8337_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTItNi0xLTEtNzcxNzE_90accb0a-40d7-4c4f-a930-137afcb5ff7b">960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe8e10c0bfa405f91e4f5fd659e1ff4_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTItOC0xLTEtNzcxNzE_e49df0a0-4735-44c0-8010-4dcbf6204421">960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i575234d878cc49f0b7c5fbf81531c46c_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTItMTAtMS0xLTc3MTcx_cbf7f0f6-0554-439d-a949-998993462f1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7263c122813549ad8e04254ba32ff7ca_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTItMTItMS0xLTc3MTcx_851983be-2c15-492b-8735-fc736d6532a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1678eaf06a745c291b81999f992b9e7_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTItMTQtMS0xLTc3MTcx_a56c27ac-678e-4eaa-a09f-5e5e2efb64ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id87a26c787994153889a94e263789923_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTItMTYtMS0xLTc3MTcx_0e1d1ff4-d128-46ab-9eba-d1ab7230687c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2984eff859114415a857b8b3db2c96d5_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTMtMi0xLTEtNzcxNzE_163d65ca-cfd4-44c3-8612-2839c6111d1e">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7255b76317d34906aecab88a19308702_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTMtNC0xLTEtNzcxNzE_7dda66f2-bf63-4e1d-8c7a-fd36004f389a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3c748d3af242daa261e5b79b0823b6_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTMtNi0xLTEtNzcxNzE_3e3cda93-47f8-4d9f-a612-039be5c7d1d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c209582594436fa1bb0457e3e6696f_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTMtOC0xLTEtNzcxNzE_68676231-bdc0-4e85-9d7e-d9edaeabdc7b">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe0bed5f1c9144b18cb2a5768de65286_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTMtMTAtMS0xLTc3MTcx_dfba1a75-58f2-4bc8-9afb-b4fc2b030ea6">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cb7b230f33440da931414c29bbcf6cc_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTMtMTItMS0xLTc3MTcx_e9ab533c-c5cb-4583-bdfa-b70d20ce0a38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd9c6786655f4c92943a637689d9c95f_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTMtMTQtMS0xLTc3MTcx_62eaa958-ac5e-4419-aeaa-4564d0b0010e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ab0ebcdc664305a06c43149d516db8_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTMtMTYtMS0xLTc3MTcx_14f935ba-52cd-4dd8-b543-e9fdaf1a545d">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3a7e52f19d64b8fa2a2e2476fa0bfa1_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTQtMi0xLTEtNzcxNzE_90554ee4-f677-4040-9e0c-4524472ab7bf">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd7b10617e343eca1d9556dffc4f114_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTQtNC0xLTEtNzcxNzE_14437f6f-4e3a-4f35-8dda-f0b581f04c66">2,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225cccb2c22740ca8ac988545b58446a_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTQtNi0xLTEtNzcxNzE_1ce081c9-0e1a-437c-8ed2-80714ec6620a">6,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb2398d3a3048748fb70e3df8843949_I20220630" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTQtOC0xLTEtNzcxNzE_23bde8f0-63a9-4f0b-88d5-7f6b1dbfdb9b">9,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f9632ba6184340b79bb0cd30ae04e2_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTQtMTAtMS0xLTc3MTcx_f3749c86-db8a-4620-8d0a-a306adaaf3f2">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i548c288771a540749668a107a155b125_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTQtMTItMS0xLTc3MTcx_e8dc2fd0-4d1c-4d8f-a8a4-cee0d311b0f1">3,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b44abccb2d044b2849d4fc6191d00dd_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTQtMTQtMS0xLTc3MTcx_e75c58ed-8ca6-4154-8261-2cd9c5da4383">7,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecbe3fa2930442bb98e4b5b4bb9e5256_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTQtMTYtMS0xLTc3MTcx_42afa25b-7c01-43bf-a016-200652451963">11,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i4d95fb44ef7e4f79a945fa1099e04339" continuedAt="idf299ae022f845dc9fc102d3ea575df1"><ix:continuation id="i98ed662bae244bd5a1c438a006b734e2" continuedAt="id3162556d62643b0b591a449f5571542"><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders <ix:nonFraction unitRef="contingent_value_right" contextRef="ide5f7ad99ed84ec48486190201956204_D20100101-20100131" decimals="INF" name="lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMTQ0Mg_a1eeb4f7-3712-458a-9a69-07c4ec5f8e86">four</ix:nonFraction> tradable CVRs, <ix:nonFraction unitRef="contingent_value_right" contextRef="ide5f7ad99ed84ec48486190201956204_D20100101-20100131" decimals="INF" name="lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMTQ2MA_75fb7e95-77c7-4690-897a-361ffed7bc2f">one</ix:nonFraction> CVR from each of <ix:nonFraction unitRef="contingent_value_right_series" contextRef="i704ccd2c79674fa98ab76165119a7944_D20100101-20100131" decimals="INF" name="lgnd:NumberOfContingentValueRightsSeries" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMTQ4MA_c8c66cf2-3dc3-446e-821d-7066534f4bc4">four</ix:nonFraction> respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every <ix:nonNumeric contextRef="ide5f7ad99ed84ec48486190201956204_D20100101-20100131" name="lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMTYxNQ_e3b14a98-a4ab-4530-8e8d-dee52e37d748">six months</ix:nonNumeric> as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $<ix:nonFraction unitRef="usd" contextRef="i84a709f438684614a9dd32c76e70d210_I20220630" decimals="INF" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMjQxNw_cc572f91-9211-4283-8f51-bacdb9d250bc">375</ix:nonFraction> million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $<ix:nonFraction unitRef="usd" contextRef="i15b339fe796a4e2ba32e8dfbfdfa27aa_I20220630" decimals="-6" name="us-gaap:ContractWithCustomerAssetGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMjUzMg_bd7650ac-1035-4ba0-a3a9-04cf0b78c6cb">10</ix:nonFraction> million payment upon initiation of a Phase 3 clinical trial.  During the three and six months ended June&#160;30, 2022, we adjusted the balance of the Metabasis CVR liability $(<ix:nonFraction unitRef="usd" contextRef="ibd35f6c5d8e840969d67c38a72475508_D20220401-20220630" decimals="-5" sign="-" name="us-gaap:LiabilitiesFairValueAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMjY2NQ_5963577c-9c6c-4f1c-bb99-23826531bffa">0.4</ix:nonFraction>)&#160;million and $(<ix:nonFraction unitRef="usd" contextRef="i8a9916b0d831414c99923be559940db0_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:LiabilitiesFairValueAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfNzE0NjgyNTU4NTg4Mg_b88a7fad-1e0f-4d1d-a50d-a6d3626a49c4">1.0</ix:nonFraction>)&#160;million to mark to market, respectively.  </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the six months ended  June&#160;30, 2022, we paid $<ix:nonFraction unitRef="usd" contextRef="i78d968b6172d467c8f046b7fe14c493d_D20220401-20220630" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMzI0Mw_801354e3-7a86-4078-908f-2c40aa6d9c4a">1.5</ix:nonFraction>&#160;million contingent liability based on revenue milestones to former Icagen shareholders, respectively. During the three and six months ended June&#160;30, 2022, we adjusted the balance of the Icagen CVR liability $<ix:nonFraction unitRef="usd" contextRef="i78d968b6172d467c8f046b7fe14c493d_D20220401-20220630" decimals="-5" name="us-gaap:LiabilitiesFairValueAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMTY0OTI2NzQ0MjIzMzM_aa8160a0-258a-42c9-ba01-f397bebe408b">0.2</ix:nonFraction>&#160;million and $(<ix:nonFraction unitRef="usd" contextRef="ia23c3aaaac85402db485305cdb6cc3f2_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:LiabilitiesFairValueAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMTY0OTI2NzQ0MjIzMTE_d6cbf41d-1652-4ed8-8d80-2ad464ceffd9">0.3</ix:nonFraction>)&#160;million to mark to market, respectively.  </span></div></ix:continuation><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="id3162556d62643b0b591a449f5571542" continuedAt="i52c0e201bfe04483b44f01e6cc73f680">4.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"><ix:continuation id="i52c0e201bfe04483b44f01e6cc73f680">The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the three and six months ended June&#160;30, 2022, management recorded $<ix:nonFraction unitRef="usd" contextRef="i9b5f73a727824f0ca1db33f131e1d73a_D20220401-20220630" decimals="-5" name="lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMzYzOQ_5e985ed8-6f09-4d10-b9e7-06da47b949f2">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie1b59d9a96ec4375a669fbe2a05bd3b4_D20220101-20220630" decimals="-5" name="lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMTY0OTI2NzQ0MjIzNjY_3517ec1e-88e1-4121-9cb3-7e7fc647a9b3">1.0</ix:nonFraction> million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement, respectively.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfNTE5Ng_71e13e99-8a9f-442f-9113-6af3719dba86" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of June&#160;30, 2022 is as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2021</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf6982ebd2184a96b2c741ac8887e7ba_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjkwMjJmNDQ3ODgyNTQ0NzU4YmM5OTZlNzdmMzQyNDg3L3RhYmxlcmFuZ2U6OTAyMmY0NDc4ODI1NDQ3NThiYzk5NmU3N2YzNDI0ODdfMC0xLTEtMS03NzE3MQ_f7d93fee-1b0e-477b-b36f-54d12e285ce9">7,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingent payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic789c8af369747eba6fa7cf57d81c6ac_D20220101-20220630" decimals="-3" name="lgnd:PaymentsToContingentValueRightHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjkwMjJmNDQ3ODgyNTQ0NzU4YmM5OTZlNzdmMzQyNDg3L3RhYmxlcmFuZ2U6OTAyMmY0NDc4ODI1NDQ3NThiYzk5NmU3N2YzNDI0ODdfMS0xLTEtMS03NzE3MQ_532b604d-3090-4b2e-8683-298b1b00ce35">1,545</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic789c8af369747eba6fa7cf57d81c6ac_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjkwMjJmNDQ3ODgyNTQ0NzU4YmM5OTZlNzdmMzQyNDg3L3RhYmxlcmFuZ2U6OTAyMmY0NDc4ODI1NDQ3NThiYzk5NmU3N2YzNDI0ODdfMi0xLTEtMS03NzE3MQ_79fc2f66-2050-4517-b548-faa548fc9476">309</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic789c8af369747eba6fa7cf57d81c6ac_D20220101-20220630" decimals="-3" name="lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjkwMjJmNDQ3ODgyNTQ0NzU4YmM5OTZlNzdmMzQyNDg3L3RhYmxlcmFuZ2U6OTAyMmY0NDc4ODI1NDQ3NThiYzk5NmU3N2YzNDI0ODdfMy0xLTEtMS03NzE3MQ_01b809f2-a107-4ddb-8ed0-80ac84a1c434">960</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of June&#160;30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd61ac74a7ff4488ac2e7e7b04b7a49c_I20220630" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjkwMjJmNDQ3ODgyNTQ0NzU4YmM5OTZlNzdmMzQyNDg3L3RhYmxlcmFuZ2U6OTAyMmY0NDc4ODI1NDQ3NThiYzk5NmU3N2YzNDI0ODdfNC0xLTEtMS03NzE3MQ_00e959b4-1c1b-4122-be63-fca9d08180d2">6,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="text-indent:22pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the organizational changes to the Company&#8217;s reportable segments, we re-allocated goodwill between the <ix:nonFraction unitRef="reporting_unit" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfNDc3NA_391cd13d-edd3-4716-bdcc-260385dc6f41">two</ix:nonFraction> identified reporting units (OmniAb business and Ligand core business). We performed a goodwill impairment analysis immediately before and after the allocation of goodwill and concluded no impairment. At June 30, 2022, there were no indicators of impairment at either of the reporting units.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="idf299ae022f845dc9fc102d3ea575df1">At June 30, 2022, there were no indicators of impairment of our indefinite-lived intangible assets, or long-lived assets.</ix:continuation> </span></div><div><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.  <ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNzIxNA_ff89e3bc-1854-4fef-b89a-790bc17656e3" continuedAt="i0e78ec2421a148fd926fffdc8851decf" escape="true">Convertible Senior Notes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0e78ec2421a148fd926fffdc8851decf" continuedAt="ideba7039df294a91beb5852acfe55f31"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzU_059676e7-e03b-43bc-bfd7-03f22aa9bd68">0.75</ix:nonFraction>%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued&#160;$<ix:nonFraction unitRef="usd" contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfOTY_d4bfcb42-bc11-4f27-b1e8-62553d4c994f">750.0</ix:nonFraction>&#160;million&#160;aggregate principal amount of&#160;<ix:nonFraction unitRef="number" contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTI5_6df0c57a-8c80-4e7d-bd24-144450971a28">0.75</ix:nonFraction>%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $<ix:nonFraction unitRef="usd" contextRef="i1bdef6e83d484a31ae28be0288d4014a_D20180501-20180531" decimals="-5" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMjg1_32986736-508d-4b6d-8fd9-88b349e19ad5">733.1</ix:nonFraction> million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjA2_4cc217bc-bfb5-4b6d-a7fc-c32939c95e28">248.48</ix:nonFraction> per share.  The maximum conversion rate of the 2023 Notes is 5.2317 per $1,000 principal amount of the 2023 Notes which represents a maximum conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="idaa07f7868af4d3589b8f66d33b6f893_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNzc2_4e34e8a8-061e-420b-9c87-d5bfbee1e529">191.14</ix:nonFraction>. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="ideba7039df294a91beb5852acfe55f31" continuedAt="ic500440c838641d1b6198bb65dd0a0b3"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least <ix:nonFraction unitRef="d" contextRef="i9a30dda7078441eaaca37acbf3037be6_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTEwMA_952bc187-39ce-4fa0-ac35-7b36f36f5598">20</ix:nonFraction> trading days (whether or not consecutive) during the <ix:nonFraction unitRef="d" contextRef="i9a30dda7078441eaaca37acbf3037be6_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTE1Ng_6afc8928-6903-493f-ba64-54c9059da757">30</ix:nonFraction> consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than <ix:nonFraction unitRef="number" contextRef="i9a30dda7078441eaaca37acbf3037be6_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTM1MQ_f709eea9-81f8-4d7b-95ce-27dee5761050">130</ix:nonFraction>% of the conversion price on such trading day; </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the <ix:nonFraction unitRef="d" contextRef="i5de8a5b0c1fa4760b0f3c075d7b6c6db_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTQxNg_ca59e137-7e9b-4398-a08a-8136d44a1a4f">five</ix:nonFraction> business day period immediately following any <ix:nonFraction unitRef="d" contextRef="i5de8a5b0c1fa4760b0f3c075d7b6c6db_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTQ2NQ_7cbca803-d545-4e6a-b5b9-b9d8cfd0d0dc">10</ix:nonFraction> consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than <ix:nonFraction unitRef="number" contextRef="i5de8a5b0c1fa4760b0f3c075d7b6c6db_D20180501-20180531" decimals="INF" name="lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTU3NA_699c60dd-04b7-483b-8d3a-acdb40504f8a">98</ix:nonFraction>% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTk5OA_08885e11-e356-4956-87a5-1839b5af04ca">248.48</ix:nonFraction>. In connection with the issuance of the 2023 Notes, we incurred $<ix:nonFraction unitRef="usd" contextRef="i5474a312fb154f69820ca3cc97e950a7_I20220630" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMjA2NQ_842e7295-0e43-4dcc-9bd7-cf5e7c16b745">16.9</ix:nonFraction> million of issuance costs, which primarily consisted of underwriting, legal and other professional fees, is amortized to interest expense using the effective interest method over the <ix:nonNumeric contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNzIxNw_aa64845e-b60f-4ac0-aa71-98db1acb52a4">five year</ix:nonNumeric> expected life of the 2023 Notes, and the effective interest rate as of June&#160;30, 2022 is <ix:nonFraction unitRef="number" contextRef="i5474a312fb154f69820ca3cc97e950a7_I20220630" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMjM0MA_5da38220-b5af-4f2a-a578-10d1b852088a">0.5</ix:nonFraction>%.  During the three months ended June&#160;30, 2022 we recognized a total of $<ix:nonFraction unitRef="usd" contextRef="ic0c4e811de974223a7854588c77071f0_D20220401-20220630" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTY0OTI2NzQ0MjUzMjA_1ce91bad-e3cb-44f8-8bb1-a9303aa42d5d">0.4</ix:nonFraction>&#160;million in interest expense which includes $<ix:nonFraction unitRef="usd" contextRef="ic0c4e811de974223a7854588c77071f0_D20220401-20220630" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTY0OTI2NzQ0MjUzNDc_1d42890e-842f-4a3e-9a8e-f9bc448a482f">0.2</ix:nonFraction>&#160;million in contractual interest expense and $<ix:nonFraction unitRef="usd" contextRef="ic0c4e811de974223a7854588c77071f0_D20220401-20220630" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTY0OTI2NzQ0MjUzNzc_dead82b4-cfdf-4525-998c-5b2af69e1c51">0.2</ix:nonFraction>&#160;million in amortized issuance costs. During the six months ended  June&#160;30, 2022 we recognized a total of $<ix:nonFraction unitRef="usd" contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNzY5NjU4MTQwMjMyMw_bef8ccca-f1e1-4bfe-ab20-c9e4ba08445e">1.2</ix:nonFraction>&#160;million in interest expense which includes $<ix:nonFraction unitRef="usd" contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNzY5NjU4MTQwMjMzNw_931f7edc-7225-43dc-8100-f47a6e806e87">0.7</ix:nonFraction>&#160;million in contractual interest expense and $<ix:nonFraction unitRef="usd" contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNzY5NjU4MTQwMjM1MQ_5274ec75-6be3-47bf-88ef-3cfc108ffcc6">0.5</ix:nonFraction>&#160;million in amortized issuance costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2021, we repurchased $<ix:nonFraction unitRef="usd" contextRef="ibc028f1c7d9b45d5b5409ba862c9757c_D20210101-20211231" decimals="-5" name="lgnd:DebtInstrumentRepurchasedAmountDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMjgxNg_6a653b4b-172c-404e-8c8b-2c5cd61c9173">152.0</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ibc028f1c7d9b45d5b5409ba862c9757c_D20210101-20211231" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMjg1NA_f2f0817e-5484-4dd4-a255-340cd73818b5">156.0</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ibc028f1c7d9b45d5b5409ba862c9757c_D20210101-20211231" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMjg5Ng_14e718b5-08e5-4765-b00b-45393001056b">0.3</ix:nonFraction>&#160;million. After the repurchases, approximately $<ix:nonFraction unitRef="usd" contextRef="idbf91b4ebd6f491a92e85e1fc1d051d9_I20211231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMjkzNw_0ef2ccd4-cd48-4ab0-b0f6-03b78a529853">343.3</ix:nonFraction>&#160;million in principal amount of the 2023 Notes were outstanding as of December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three months ended June&#160;30, 2022, we repurchased $<ix:nonFraction unitRef="usd" contextRef="ic0c4e811de974223a7854588c77071f0_D20220401-20220630" decimals="-5" name="lgnd:DebtInstrumentRepurchasedAmountDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTY0OTI2NzQ0MjU4MTg_4a71e579-561e-4fbc-95fd-1a3c1f3e8ac7">62.0</ix:nonFraction>&#160;million in principal amount of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ic0c4e811de974223a7854588c77071f0_D20220401-20220630" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTY0OTI2NzQ0MjU4NTQ_94dc60ea-f25d-42c3-b17c-7c7888862948">60.0</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ic0c4e811de974223a7854588c77071f0_D20220401-20220630" decimals="-4" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTY0OTI2NzQ0MjU4OTE_71e09491-9372-4231-be69-258bef0f7253">0.01</ix:nonFraction>&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $<ix:nonFraction unitRef="usd" contextRef="ic0c4e811de974223a7854588c77071f0_D20220401-20220630" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTY0OTI2NzQ0MjU5MjE_f7e9c759-75f9-4f96-b1da-614d5673d512">1.8</ix:nonFraction>&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the three months ended June 30, 2022, and a $<ix:nonFraction unitRef="usd" contextRef="ic0c4e811de974223a7854588c77071f0_D20220401-20220630" decimals="-5" sign="-" name="lgnd:IncreaseDecreaseInDebtDiscount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTY0OTI2NzQ0MjU5NjE_c4498419-fd5f-43fc-be01-71077ef88c16">0.3</ix:nonFraction>&#160;million reduction in debt discount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the six months ended June&#160;30, 2022, we repurchased $<ix:nonFraction unitRef="usd" contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630" decimals="-5" name="lgnd:DebtInstrumentRepurchasedAmountDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzA4Mg_4c0a584f-a660-47cd-bdf1-c3a1f022d3fa">227.8</ix:nonFraction>&#160;million in principal amount of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzEyMA_009bc7ef-16c9-4925-a2a1-db2f9fd74b64">223.7</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzE2Mg_081bbb17-2e2a-483b-b13a-450a82e53e96">0.4</ix:nonFraction>&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $<ix:nonFraction unitRef="usd" contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzI1Mg_d1e58c77-4e61-4ecf-9c5f-f2e6b0296093">3.3</ix:nonFraction>&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the six months ended June 30, 2022, and a $<ix:nonFraction unitRef="usd" contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630" decimals="-5" sign="-" name="lgnd:IncreaseDecreaseInDebtDiscount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzQwMA_e0711de7-7b39-44bf-9e90-33be2caeac34">1.2</ix:nonFraction>&#160;million reduction in debt discount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering <ix:nonFraction unitRef="shares" contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzU5Nw_0bc9d8e3-1488-486b-ab8f-0f07686fc3da">3,018,327</ix:nonFraction> shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzg3MQ_7d68b408-9161-44ec-9c31-63db50f50778">248.48</ix:nonFraction> per share and are exercisable when and if the 2023 Notes are converted. We paid $<ix:nonFraction unitRef="usd" contextRef="i1bdef6e83d484a31ae28be0288d4014a_D20180501-20180531" decimals="-5" name="lgnd:PaymentsForConvertibleBondHedges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzk1NA_9ebf3c7e-fa91-477d-9bbd-1c1eb0fe1d68">140.3</ix:nonFraction> million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately <ix:nonFraction unitRef="shares" contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNDg1NA_4dd05c04-2b70-4a0a-baa5-947daa51dd6b">3,018,327</ix:nonFraction> shares of common stock with an exercise price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNDkyMA_556f8c0b-8f71-4320-9eca-284a69b92161">315.38</ix:nonFraction> per share, subject to certain adjustments. We received $<ix:nonFraction unitRef="usd" contextRef="i1bdef6e83d484a31ae28be0288d4014a_D20180501-20180531" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNDk3OA_565746ea-86de-48c4-af43-115d8f1752a6">90.0</ix:nonFraction> million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ic500440c838641d1b6198bb65dd0a0b3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, in connection with the repurchases of approximately $<ix:nonFraction unitRef="usd" contextRef="i7d97584fcd39416497ac8ddc28dccf83_D20210101-20210131" decimals="-5" name="lgnd:DebtInstrumentRepurchasedAmountDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNTYyMQ_10333565-ceb9-435f-848b-75c624375e6b">20.3</ix:nonFraction>&#160;million in principal of the 2023 Notes for approximately $<ix:nonFraction unitRef="usd" contextRef="i7d97584fcd39416497ac8ddc28dccf83_D20210101-20210131" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNTY3Mw_74a0084d-12f8-4063-ba9e-8cdfc393f632">19.1</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i7d97584fcd39416497ac8ddc28dccf83_D20210101-20210131" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNTcxNQ_827fc832-ca78-4cba-94e0-c9cf3d875d38">0.1</ix:nonFraction>&#160;million, during the quarter ended December 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, in connection with the repurchases of $<ix:nonFraction unitRef="usd" contextRef="ibc028f1c7d9b45d5b5409ba862c9757c_D20210101-20211231" decimals="-5" name="lgnd:DebtInstrumentRepurchasedAmountDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjI1Mg_6e451f7e-0991-4047-99c5-0ac93691bf48">152.0</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ibc028f1c7d9b45d5b5409ba862c9757c_D20210101-20211231" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjI5MA_30e02ea6-3192-4920-b734-c3371748343c">156.0</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ibc028f1c7d9b45d5b5409ba862c9757c_D20210101-20211231" decimals="-5" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjMzMg_dbeb3560-552c-4893-93c3-68cc16c96387">0.3</ix:nonFraction>&#160;million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $<ix:nonFraction unitRef="usd" contextRef="i35897df76b71438cbfcc21f5fd8c25ba_D20210101-20211231" decimals="-5" name="lgnd:PaymentsToUnwindWarrants" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjYzNg_34215cd8-f96e-4da0-8a29-cb157789a60e">18.4</ix:nonFraction>&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from <ix:nonFraction unitRef="shares" contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjc0NQ_0bc9d8e3-1488-486b-ab8f-0f07686fc3da">3,018,327</ix:nonFraction> to <ix:nonFraction unitRef="shares" contextRef="idbf91b4ebd6f491a92e85e1fc1d051d9_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjc1MQ_07016dbc-6423-4d71-929d-3708e467c022">2,559,254</ix:nonFraction>. We received $<ix:nonFraction unitRef="usd" contextRef="i35897df76b71438cbfcc21f5fd8c25ba_D20210101-20211231" decimals="-5" name="lgnd:ProceedsFromUnwindingConvertibleBondHedges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjc2Nw_7de30d43-c51b-4ca6-a252-f1436e93b101">18.9</ix:nonFraction>&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to <ix:nonFraction unitRef="option" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="INF" name="lgnd:NumberOfOptionsUnderConvertibleBondHedges" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjg4OA_2e5e283c-42ea-43cf-84d4-b2b7db9944c2">598,021</ix:nonFraction>. These unwind transactions resulted in a $<ix:nonFraction unitRef="usd" contextRef="i35897df76b71438cbfcc21f5fd8c25ba_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjkzMg_44e31381-d9f0-4966-b40c-7a70d0229cf0">0.5</ix:nonFraction>&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of December 31, 2021.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNzIxMw_63844e74-87d6-4795-8693-0405531917f5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:67.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.907%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5474a312fb154f69820ca3cc97e950a7_I20220630" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RhYmxlOjVhYmE4NWYzYWMxYzQ2ZTc4YTE2MjI4NjAwZjhhYmZmL3RhYmxlcmFuZ2U6NWFiYTg1ZjNhYzFjNDZlNzhhMTYyMjg2MDBmOGFiZmZfMS0xLTEtMS03NzE3MQ_db13b21c-74cc-41e8-bd24-350ee5659882">115,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbf91b4ebd6f491a92e85e1fc1d051d9_I20211231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RhYmxlOjVhYmE4NWYzYWMxYzQ2ZTc4YTE2MjI4NjAwZjhhYmZmL3RhYmxlcmFuZ2U6NWFiYTg1ZjNhYzFjNDZlNzhhMTYyMjg2MDBmOGFiZmZfMS0zLTEtMS03NzE3MQ_5ddc16af-e62b-4716-99fa-eec23bfa9ac1">343,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5474a312fb154f69820ca3cc97e950a7_I20220630" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RhYmxlOjVhYmE4NWYzYWMxYzQ2ZTc4YTE2MjI4NjAwZjhhYmZmL3RhYmxlcmFuZ2U6NWFiYTg1ZjNhYzFjNDZlNzhhMTYyMjg2MDBmOGFiZmZfMi0xLTEtMS03NzE3MQ_8753bf35-cfb0-4aea-aabd-6d2e93a786a8">525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbf91b4ebd6f491a92e85e1fc1d051d9_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RhYmxlOjVhYmE4NWYzYWMxYzQ2ZTc4YTE2MjI4NjAwZjhhYmZmL3RhYmxlcmFuZ2U6NWFiYTg1ZjNhYzFjNDZlNzhhMTYyMjg2MDBmOGFiZmZfMi0zLTEtMS03NzE3MQ_4ccb050e-245a-4ba6-8e3b-a7de5509d41a">22,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5474a312fb154f69820ca3cc97e950a7_I20220630" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RhYmxlOjVhYmE4NWYzYWMxYzQ2ZTc4YTE2MjI4NjAwZjhhYmZmL3RhYmxlcmFuZ2U6NWFiYTg1ZjNhYzFjNDZlNzhhMTYyMjg2MDBmOGFiZmZfMy0xLTEtMS03NzE3MQ_13bdd71a-9878-4f74-965f-b54324183a61">114,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbf91b4ebd6f491a92e85e1fc1d051d9_I20211231" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RhYmxlOjVhYmE4NWYzYWMxYzQ2ZTc4YTE2MjI4NjAwZjhhYmZmL3RhYmxlcmFuZ2U6NWFiYTg1ZjNhYzFjNDZlNzhhMTYyMjg2MDBmOGFiZmZfMy0zLTEtMS03NzE3MQ_acf4c557-d33d-4b6f-ac33-37f0af718ccf">320,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5474a312fb154f69820ca3cc97e950a7_I20220630" decimals="-3" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RhYmxlOjVhYmE4NWYzYWMxYzQ2ZTc4YTE2MjI4NjAwZjhhYmZmL3RhYmxlcmFuZ2U6NWFiYTg1ZjNhYzFjNDZlNzhhMTYyMjg2MDBmOGFiZmZfNi0xLTEtMS03NzE3MQ_ae39229e-358b-4841-ac79-153cb2d27839">110,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbf91b4ebd6f491a92e85e1fc1d051d9_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RhYmxlOjVhYmE4NWYzYWMxYzQ2ZTc4YTE2MjI4NjAwZjhhYmZmL3RhYmxlcmFuZ2U6NWFiYTg1ZjNhYzFjNDZlNzhhMTYyMjg2MDBmOGFiZmZfNi0zLTEtMS03NzE3MQ_cadc0b8d-78cb-4fb3-b49c-560d7c5c3cae">341,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) - Balances as of December 31, 2021 reported before the adoption of ASU 2020-06.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.  <ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80OS9mcmFnOjY5ZjBlNmExOGM4NzQyNjU5ZDM4NTkwZGU2NzI4MjdhL3RleHRyZWdpb246NjlmMGU2YTE4Yzg3NDI2NTlkMzg1OTBkZTY3MjgyN2FfMTExNg_aaa9106f-4472-4105-99ba-ff75f88818e4" continuedAt="i51d2a03c63c54b428f386881eb741473" escape="true">Income Tax</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i51d2a03c63c54b428f386881eb741473">Our effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three and six months ended June&#160;30, 2022 and 2021 was (<ix:nonFraction unitRef="number" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80OS9mcmFnOjY5ZjBlNmExOGM4NzQyNjU5ZDM4NTkwZGU2NzI4MjdhL3RleHRyZWdpb246NjlmMGU2YTE4Yzg3NDI2NTlkMzg1OTBkZTY3MjgyN2FfNDM4_92de70a4-f92a-4e30-bb4d-e3a8e9668a51">40.7</ix:nonFraction>)% and <ix:nonFraction unitRef="number" contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80OS9mcmFnOjY5ZjBlNmExOGM4NzQyNjU5ZDM4NTkwZGU2NzI4MjdhL3RleHRyZWdpb246NjlmMGU2YTE4Yzg3NDI2NTlkMzg1OTBkZTY3MjgyN2FfNDQ1_7b4e5de6-3db4-4ab8-8e5b-27daa0e33eed">7.7</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80OS9mcmFnOjY5ZjBlNmExOGM4NzQyNjU5ZDM4NTkwZGU2NzI4MjdhL3RleHRyZWdpb246NjlmMGU2YTE4Yzg3NDI2NTlkMzg1OTBkZTY3MjgyN2FfMjc0ODc3OTA3MDU3MQ_fa49bddf-769a-47df-95f8-ee12caa91ac3">21.6</ix:nonFraction>% and (<ix:nonFraction unitRef="number" contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80OS9mcmFnOjY5ZjBlNmExOGM4NzQyNjU5ZDM4NTkwZGU2NzI4MjdhL3RleHRyZWdpb246NjlmMGU2YTE4Yzg3NDI2NTlkMzg1OTBkZTY3MjgyN2FfMjc0ODc3OTA3MDU4Mg_ddf7b54b-8524-4de2-b23e-739d13c3d5af">25.0</ix:nonFraction>)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three and six months ended June&#160;30, 2022 was due primarily to the tax deductions related to foreign derived intangible income tax credit as well as the research and development tax credits, which were partially offset by Section 162(m) limitation and non-deductible ISO related stock compensation expense during the period. The variance from the U.S. federal tax rate of 21% for the three and six months ended June 30, 2021 was significantly impacted by tax benefits related to (1) a $<ix:nonFraction unitRef="usd" contextRef="i965fba54a35142f48c2ec3ae55ae973f_D20210401-20210630" decimals="-5" name="lgnd:EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80OS9mcmFnOjY5ZjBlNmExOGM4NzQyNjU5ZDM4NTkwZGU2NzI4MjdhL3RleHRyZWdpb246NjlmMGU2YTE4Yzg3NDI2NTlkMzg1OTBkZTY3MjgyN2FfMTY0OTI2NzQ0MjA2Nzc_5132a7cd-be12-4cba-9e64-83707b24ed33">34.1</ix:nonFraction>&#160;million Pfenex CVR adjustment recorded during Q2 2021 due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR, and (2) net excess tax benefits from share-based compensation resulting from increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period.</ix:continuation></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.  <ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfMTU1OA_cecb8c84-f4ad-40de-b2a8-06f5fad99f3f" continuedAt="i80a21afd697345788651117b8baa0c7b" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i80a21afd697345788651117b8baa0c7b" continuedAt="i06f81327f3524a48aad5126a3662b292"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements in our 2021 Annual Report.</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfMTU1OQ_b0879abf-e387-4b3b-924d-8d985e6dd938" escape="true"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfMTU2Mg_74c6c961-2185-49cf-be1a-bcadd8a58b5f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice70706143fc4fa587f3b05dfc86607f_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfMi0xLTEtMS03NzE3MQ_82c349e5-95bf-44de-883a-cc9b9a0a5f75">2,199,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ice70706143fc4fa587f3b05dfc86607f_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfMi0zLTEtMS03NzE3MQ_5238496c-d922-48aa-a870-339cb3cc5690">106.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if55454c1b587475f8f377fec9eb04748_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfMi01LTEtMS03NzE3MQ_2d72d923-d33a-4a80-b084-e6f8689db0cf">264,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if55454c1b587475f8f377fec9eb04748_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfMi03LTEtMS03NzE3MQ_af695132-c3ff-40ce-9b39-320757e0c3f5">138.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0275f925a31840af927726857ad4931a_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfMy0xLTEtMS03NzE3MQ_d85c1b34-b4f8-4a7a-9057-6b404b27faba">734,218</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0275f925a31840af927726857ad4931a_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfMy0zLTEtMS03NzE3MQ_adbda466-67da-4650-9adf-0ca242582ba8">91.58</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94c20b531d9a49f3ba7f9be28e443ebb_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfMy01LTEtMS03NzE3MQ_cfaa128e-6cda-4477-a6e9-28076bc2da29">186,526</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i94c20b531d9a49f3ba7f9be28e443ebb_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfMy03LTEtMS03NzE3MQ_3efd526b-3335-4f87-b2e6-a2fed19c70d1">87.32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0275f925a31840af927726857ad4931a_D20220101-20220630" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNC0xLTEtMS03NzE3MQ_27bc0027-10cf-4245-9f3b-3634005f7e7f">25,798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0275f925a31840af927726857ad4931a_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNC0zLTEtMS03NzE3MQ_6399b307-a324-4089-8cf2-ec8980553d2a">20.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i94c20b531d9a49f3ba7f9be28e443ebb_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNC01LTEtMS03NzE3MQ_af96120d-5afe-4574-a1b5-25a66a16b7c8">133,173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i94c20b531d9a49f3ba7f9be28e443ebb_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNC03LTEtMS03NzE3MQ_037bd503-635c-45ff-a630-662ac3274f76">120.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0275f925a31840af927726857ad4931a_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNS0xLTEtMS03NzE3MQ_852675db-1a59-4099-9a52-0285873dddad">30,417</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0275f925a31840af927726857ad4931a_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNS0zLTEtMS03NzE3MQ_034a4007-d96b-4f2e-a202-aecbf907cf8d">67.60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i94c20b531d9a49f3ba7f9be28e443ebb_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNS01LTEtMS03NzE3MQ_19972bee-516c-4f8c-8d95-83f95d00f307">1,378</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i94c20b531d9a49f3ba7f9be28e443ebb_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNS03LTEtMS03NzE3MQ_d238979c-3f30-40af-b747-d3175e4d94bc">137.16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab997394326847b98b9a6709dde8df9e_I20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNi0xLTEtMS03NzE3MQ_f014f0a4-8788-4e3a-9fe3-ab47dc5266c8">2,877,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab997394326847b98b9a6709dde8df9e_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNi0zLTEtMS03NzE3MQ_27ed8c55-3b45-4798-995c-0bf77497e494">103.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i81905d26e9e4434aa6c656e2d1a052fd_I20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNi01LTEtMS03NzE3MQ_8824ba0c-6b72-4a1a-9bed-b27912f664c0">316,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i81905d26e9e4434aa6c656e2d1a052fd_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNi03LTEtMS03NzE3MQ_82d19230-2b84-44f6-be6d-99f1259fbb42">115.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, outstanding options to purchase <ix:nonFraction unitRef="shares" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfNDUw_9b839e10-57fd-4f7d-b1ac-89979c77efe5">1.6</ix:nonFraction> million shares were exercisable with a weighted average exercise price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfNTI5_4b09e0e3-c5cc-412f-a086-0b534ca53465">102.10</ix:nonFraction>.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to <ix:nonFraction unitRef="number" contextRef="i898678e2c6ba4a73a10091c6fa20543d_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfNjc4_91598672-b83b-4721-97bb-d8f6a5402bf3">85</ix:nonFraction>% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of June&#160;30, 2022, <ix:nonFraction unitRef="shares" contextRef="i898678e2c6ba4a73a10091c6fa20543d_D20220101-20220630" decimals="INF" name="us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfODA1_c242b2e1-8aa9-4580-be35-b0fef6c5ae7a">38,007</ix:nonFraction> shares were available for future purchases under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i06f81327f3524a48aad5126a3662b292">On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="ifae3653e5fe6429a946af263fcc4fd84_I20190911" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfMTAyNg_06435fd6-f77a-4e36-bab3-4d2425fa9c35">500.0</ix:nonFraction> million of our common stock from time to time over the next <ix:nonNumeric contextRef="i93f3ccedcca8446095a986546e891de8_D20190911-20190911" name="us-gaap:StockRepurchaseProgramPeriodInForce1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfMTA4MQ_290d6990-c87a-4971-9a00-b0cf1d93b7b2">three years</ix:nonNumeric>. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. We did <ix:nonFraction unitRef="usd" contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfMTQyNw_3e9291a8-af08-4228-bbbf-efbe7cc5c0e4"><ix:nonFraction unitRef="usd" contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfMTQyNw_511565c0-d0c9-4051-8157-42ed680a3887">no</ix:nonFraction></ix:nonFraction>t have any share repurchases during the three and six months ended June&#160;30, 2022. Authorization to repurchase $<ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfMTUwNA_e92853d3-1d4d-4573-a8c4-262c1a860248">248.8</ix:nonFraction> million of our common stock remained available as of June&#160;30, 2022.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.  <ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81NS9mcmFnOmFjYTA4ZjAzMTNiYTRkMmNhNDlmYjJhNzdlYWY1NmM3L3RleHRyZWdpb246YWNhMDhmMDMxM2JhNGQyY2E0OWZiMmE3N2VhZjU2YzdfMjg5Ng_8948242b-b4a3-48ac-a788-6eb48e1b6b6b" continuedAt="if20ed6ea992c44c4bdc9f1a2d8b01d93" escape="true">Commitment and Contingencies: Legal Proceedings</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if20ed6ea992c44c4bdc9f1a2d8b01d93" continuedAt="if48c7b83c7f647498475d396b53be84c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received <ix:nonFraction unitRef="civil_complaint" contextRef="i2ad65c5ebdff424fb802e081f2da87ec_D20191031-20191031" decimals="INF" name="us-gaap:LossContingencyNewClaimsFiledNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81NS9mcmFnOmFjYTA4ZjAzMTNiYTRkMmNhNDlmYjJhNzdlYWY1NmM3L3RleHRyZWdpb246YWNhMDhmMDMxM2JhNGQyY2E0OWZiMmE3N2VhZjU2YzdfNjcw_89676062-a340-43bf-a900-f83cda9ca747">three</ix:nonFraction> civil complaints filed in the U.S. District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the Company and no individualized factual allegations have been advanced against us in any of the <ix:nonFraction unitRef="civil_complaint" contextRef="i2ad65c5ebdff424fb802e081f2da87ec_D20191031-20191031" decimals="INF" name="us-gaap:LossContingencyNewClaimsFiledNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81NS9mcmFnOmFjYTA4ZjAzMTNiYTRkMmNhNDlmYjJhNzdlYWY1NmM3L3RleHRyZWdpb246YWNhMDhmMDMxM2JhNGQyY2E0OWZiMmE3N2VhZjU2YzdfMTI1Nw_f1ad32a5-7bbd-4941-a9bd-de2a24935040">three</ix:nonFraction> complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CyDex and Baxter Healthcare Corp. (&#8220;Baxter&#8221;) are parties to a license agreement relating to Ligand&#8217;s Captisol technology and, more specifically, relating to Captisol-enabled Nexterone (amiodarone HCl premixed injection). Baxter contends that it has overpaid royalties for several years, and seeks both refunds of those overpayment and that its royalty payments end as of May 4, 2022, the expiration date of one of the patents licensed under the agreement. CyDex contends that Baxter has not paid the royalties due to CyDex under the terms of the license agreement. On April 6, 2021, Baxter initiated an arbitration with the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="if48c7b83c7f647498475d396b53be84c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">American Arbitration Association pursuant to the arbitration provision of the license agreement. On April 21, 2021, CyDex filed an Answering Statement and Counterdemand. On December 2, 2021, Baxter filed an Amended Notice of Arbitration Demand also seeking a declaration limiting the &#8220;royalty term&#8221; of the license agreement to &#8220;the later of i) the expiration of the licensed patent; or ii) when there are no longer any CyDex patents listed in the Orange Book for Nexterone.&#8221;  Baxter has subsequently clarified this position, and asserts that royalties ceased being due when CyDex&#8217;s U.S. Patent No. 6,869,939 expired on May 4, 2022. On December 16, 2021, CyDex filed an Answer to Baxter&#8217;s Amended Demand. The parties conducted a three-day arbitration hearing between May 24 and May 26, 2022, and subsequently submitted two sets of post-hearing briefs. The arbitrator&#8217;s decision is expected before the end of 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may also become subject to other legal proceedings or claims arising in the ordinary course of our business. We currently believe that none of the claims or actions pending against us is likely to have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Given the unpredictability inherent in litigation, however, we cannot predict the outcome of these matters.</span></div></ix:continuation><div><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.  <ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RleHRyZWdpb246MjhkZWU5NGU1YzhhNDU3NjkxYjkxN2IyYzdmYmE1ZTBfMjI2Mg_06679c26-bfa0-45a5-855a-ef8b1aa342ce" continuedAt="icf007549f6dc41439c9c5c6cd11e5d4e" escape="true"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RleHRyZWdpb246MjhkZWU5NGU1YzhhNDU3NjkxYjkxN2IyYzdmYmE1ZTBfMjI2Mg_7d451bae-14fc-4834-ab97-e1b9c2bd1661" continuedAt="i61b430571f2e490ca685589ae56409cf" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="icf007549f6dc41439c9c5c6cd11e5d4e" continuedAt="i5e3a498c42954a7eab8e116241645fe0"><ix:continuation id="i61b430571f2e490ca685589ae56409cf" continuedAt="i7183b0964a76421eb562acbeabb83903"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to <ix:nonNumeric contextRef="ida31ec29c0a64e779c80ba3c979f2b18_I20220630" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RleHRyZWdpb246MjhkZWU5NGU1YzhhNDU3NjkxYjkxN2IyYzdmYmE1ZTBfMTU4_c2b45d0f-f4b6-4561-8f08-4249e3e57df8">ten years</ix:nonNumeric>, some of which include options to extend the leases for up to <ix:nonNumeric contextRef="ida31ec29c0a64e779c80ba3c979f2b18_I20220630" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RleHRyZWdpb246MjhkZWU5NGU1YzhhNDU3NjkxYjkxN2IyYzdmYmE1ZTBfMjIz_daa6caf0-ed70-4299-bdb8-373da6f52d67">five years</ix:nonNumeric>. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="lgnd:AssetsAndLiabilitiesLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RleHRyZWdpb246MjhkZWU5NGU1YzhhNDU3NjkxYjkxN2IyYzdmYmE1ZTBfMjI2Mw_46050be6-4842-4c8b-9cef-6eab270581a0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.007%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMS0xLTEtMS03NzE3MQ_847623a4-ddc4-4d0f-b13b-08497b08900c">24,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMS0zLTEtMS03NzE3MQ_cc351b17-0a0f-40be-9e6e-2931f0670232">16,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMi0xLTEtMS03NzE3MQ_391a98e2-ddf8-406b-9d0d-baa5ae468ffa">15,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMi0zLTEtMS03NzE3MQ_b892d14d-8ad5-49f1-99aa-d56e91034f98">16,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="lgnd:LeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMy0xLTEtMS03NzE3MQ_5d0b1afc-42ee-4008-a449-0eef5bc7d239">39,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="lgnd:LeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMy0zLTEtMS03NzE3MQ_7e57e192-3149-468f-9805-ef52b2f9adeb">32,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfNi0xLTEtMS03NzE3MQ_756655ab-44f2-4402-94e6-87d359575cbb">2,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfNi0zLTEtMS03NzE3MQ_3c38bae6-0f83-4b3f-a7bc-f8d89fe03b37">2,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfNy0xLTEtMS03NzE3MQ_7deff037-8524-4c40-a69e-d31ca37412bf">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfNy0zLTEtMS03NzE3MQ_1ce99229-50ce-479e-ab66-31ee91a30a26">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="lgnd:LeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfOC0xLTEtMS03NzE3MQ_f3c4a5e5-bb24-4448-bf90-c52c01ffac98">2,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="lgnd:LeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfOC0zLTEtMS03NzE3MQ_03ca8850-eee9-499d-b22c-fca757367a69">2,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfOS0xLTEtMS03NzE3MQ_1b623de9-95ad-49bf-b7f2-718769408ddc">27,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfOS0zLTEtMS03NzE3MQ_2ec6a5f5-10f3-4630-9441-4a5e633eaa6e">15,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMTAtMS0xLTEtNzcxNzE_033478ab-c6e2-4b1f-ba51-3ce627f1fee5">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMTAtMy0xLTEtNzcxNzE_6eb76a1a-42ba-4ee5-a07c-7da6938ef85c">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="lgnd:LeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMTEtMS0xLTEtNzcxNzE_5da4b63c-d0e0-4953-a734-7c654b2976f0">29,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231" decimals="-3" name="lgnd:LeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMTEtMy0xLTEtNzcxNzE_7f4ddc7c-048c-45a6-ac77-6c46e8d04e7a">17,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RleHRyZWdpb246MjhkZWU5NGU1YzhhNDU3NjkxYjkxN2IyYzdmYmE1ZTBfMjI2MQ_eae8dcf1-14e9-42ee-81d6-4094b3e1446f" continuedAt="ib6b63d574830444f89f9bbc788b257bb" escape="true">Maturity of Operating and Finance Lease Liabilities as of June&#160;30, 2022 (in thousands): </ix:nonNumeric></span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><ix:continuation id="i5e3a498c42954a7eab8e116241645fe0"><ix:continuation id="i7183b0964a76421eb562acbeabb83903"><ix:continuation id="ib6b63d574830444f89f9bbc788b257bb"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:81.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.132%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remaining six months ending December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfMS0xLTEtMS03NzE3MQ_3c0d5ee3-4f7f-410f-b09b-dd26a88a290f">2,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfMi0xLTEtMS03NzE3MQ_e5cfd636-8b2a-4b93-a801-1c73eadd1f7b">4,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfMy0xLTEtMS03NzE3MQ_6d39599c-fb1f-4564-af86-82b672b6003b">3,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfNC0xLTEtMS03NzE3MQ_477de1ad-4aeb-4c8f-9d42-7987fa8ed392">3,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfNS0xLTEtMS03NzE3MQ_85521e48-9b25-4045-b60e-3c65e60d91fa">4,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfNi0xLTEtMS03NzE3MQ_b2cd22dd-546f-459b-ae53-d372dc6a5b1a">4,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfNy0xLTEtMS03NzE3MQ_e9620eee-153c-40b1-9f91-de7a12cdeb31">14,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfOC0xLTEtMS03NzE3MQ_170ab805-d6d4-4d79-88a4-f4afee734521">37,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less estimated tenant improvement allowance:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="lgnd:LesseeOperatingLeaseLiabilityTenantImprovementAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfOS0xLTEtMS05MDEyMA_e84e3f57-cfa1-4b18-8c22-36b4fcfdd328">1,358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfOS0xLTEtMS03NzE3MQ_6330c661-a701-4156-80e9-89328c63fee2">6,742</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfMTAtMS0xLTEtNzcxNzE_9470a3ed-2b41-4632-918c-4ed0fc0ef60d">29,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></ix:continuation></ix:continuation></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_61"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. &#160;&#160;&#160;&#160;Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Caution:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">  This discussion and analysis may contain predictions, estimates and other forward-looking statements that involve a number of risks and uncertainties, including those discussed in Part II, Item 1A. Risk Factors. This outlook represents our current judgment on the future direction of our business. These statements include those related to our Captisol-related revenues and manufacturing capacity, our Kyprolis and other product royalty revenues, the impact of COVID-19, product returns, product development, and the potential separation of the OmniAb Business. Actual events or results may differ materially from our expectations. For example, there can be no assurance that our revenues or expenses will meet any expectations or follow any trend(s), that we will be able to retain our key employees or that we will be able to enter into any strategic partnerships or other transactions. We cannot assure you that we will receive expected Kyprolis, Captisol and other product revenues to support our ongoing business or that our internal or partnered pipeline products will progress in their development, gain marketing approval or achieve success in the market. In addition, ongoing or future arbitration, litigation or disputes with third parties may have a material adverse effect on us. Such risks and uncertainties, and others, could cause actual results to differ materially from any future performance suggested. We undertake no obligation to make any revisions to these forward-looking statements to reflect events or circumstances arising after the date of this quarterly report. This caution is made under the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">We use our trademarks, trade names and services marks in this report as well as trademarks, trade names and service marks that are the property of other organizations. Solely for convenience, trademarks and trade names referred to in this report appear without the &#174; and &#8482; symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that the applicable owner will not assert its rights, to these trade marks and trade names.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References to &#8220;Ligand Pharmaceuticals Incorporated,&#8221; &#8220;Ligand,&#8221; the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;our&#8221; include Ligand Pharmaceuticals Incorporated and our wholly-owned subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt"><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We employ research technologies such as antibody discovery technologies, ion channel discovery technology, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pseudomonas fluorescens </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">protein expression technology, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. We currently have partnerships and license agreements with over 140 pharmaceutical and biotechnology companies. Over 400 programs are in various stages of commercialization, development or research and are fully funded by our collaboration partners and licensees. We have contributed novel research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and postpartum depression, among others. Our collaboration partners and licensees have programs currently in clinical development targeting cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others. We have over 1,600 issued patents worldwide.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have assembled our large portfolio of fully-funded programs either by licensing our own proprietary drug development programs, licensing our platform technologies such as Captisol or OmniAb to partners for use with their proprietary programs, or acquiring existing partnered programs from other companies. Fully-funded programs are those for which our partners pay all of the development and commercialization costs. For our internal programs, we generally plan to advance drug candidates through early-stage drug development or clinical proof-of-concept and then seek partners to continue development and potential commercialization.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Our business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation and partnering. We partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) to ultimately generate our revenue. We believe that focusing on discovery and early-stage drug development while benefiting from our partners&#8217; development and commercialization expertise will reduce our internal expenses and allow us to have a larger number of drug candidates progress to later stages of drug development.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue consists of three primary elements: royalties from commercialized products, sale of Captisol material, and contract revenue from license, milestone and other service payments. In addition to discovering and developing our own proprietary drugs, we selectively pursue acquisitions to bring in new assets, pipelines, and technologies to aid in generating additional potential new revenue streams.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Update on the OmniAb Separation Process</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, we announced plans to explore multiple paths for OmniAb to become a standalone public company. On March 23, 2022, we entered into the Merger Agreement, pursuant to which APAC will combine with OmniAb, and acquire the OmniAb Business, in a Reverse Morris Trust transaction. Immediately prior to the Merger and pursuant to the Separation Agreement, we will, among other things, transfer the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc. to OmniAb (the &#8220;Reorganization&#8221;) and, in connection therewith, will distribute (the &#8220;Distribution&#8221;) to Ligand stockholders 100% of the common stock of OmniAb.  Immediately following the Distribution, Merger Sub will merge with and into OmniAb (the &#8220;Merger&#8221;), with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of APAC. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the transaction, Avista Capital Partners (&#8220;Avista&#8221;), APAC&#8217;s sponsor has agreed to invest up to $115 million in the combined company, and Ligand will contribute $15 million (less certain transaction and other expenses). The combined company will have an initial pre-money equity valuation of $850 million. Ligand intends to distribute 100% of its equity in OmniAb to Ligand shareholders immediately prior to the business combination with APAC. The transaction is expected to be tax-free to Ligand and its shareholders for U.S. federal income tax purposes. The transaction is expected to close in the fourth quarter of 2022.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, OmniAb filed with the SEC a registration statement on Form 10 (the &#8220;Form 10&#8221;) registering shares of OmniAb common stock and APAC filed with the SEC a registration statement on Form S-4 (the &#8220;Form S-4&#8221;) registering shares of APAC common stock, warrants and certain equity awards. The Form S-4 filed by APAC includes a proxy statement/prospectus in connection with the APAC shareholder vote required for the proposed transaction. The Form 10 filed by OmniAb includes portions of the Form S-4 filed by APAC which will serve as an information statement/prospectus in connection with the spin-off of OmniAb. Ligand&#8217;s shareholders and other interested persons are advised to read the preliminary and definitive registration statements, and documents incorporated by reference therein, as these materials contain important information about APAC, OmniAb and the proposed business combination. The proxy statement/prospectus contained in the Form S-4 will be mailed to APAC shareholders as of a record date to be established for voting on the proposed business combination. In June 2022, OmniAb filed with the SEC a request to withdraw the Form 10 because APAC was in the process of responding to comments made by the staff of the Division of Corporation Finance (the &#8220;Staff&#8221;) with respect to the Form S-4. In the absence of this withdrawal request, pursuant to Section 12(g)(1) of the Securities Exchange Act of 1934, as amended, the Form 10 would have automatically become effective on June 27, 2022. Subsequently, the Staff issued additional comments on APAC&#8217;s Form S-4, and APAC filed amendments to the Form S-4 on June 13, 2022 and July 26, 2022 in response to the Staff&#8217;s comments. OmniAb intends to file a replacement registration statement on Form 10 with the SEC in connection with a future pre-effective amendment to the Form S-4 by APAC.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration statements, proxy statement/prospectus/information statement and other documents are also available at www.sec.gov, or by request to Avista Public Acquisition Corp. II, 65 East 55th Street, 18th Floor, New York, NY 10022.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Portfolio Program Updates </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OmniAb</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Platform and Partner Updates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, over 60 partners have access to OmniAb-derived antibodies and more than 270 programs are being actively pursued or commercialized by our partners. As of June 30, 2022, the platform has generated 25 clinical- or commercial- stage OmniAb-derived antibodies. As of the date of the filing of this Quarterly Report on Form 10-Q, there are two approved drugs in China that were derived from our OmniAb platform, and one under review by both the FDA and the EMA with action expected in the coming weeks. In addition, a partner very recently entered the clinic with the first antibody drug conjugate (ADC) that was discovered using our platform.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CStone and Pfizer announced China&#8217;s NMPA approval of sugemalimab in patients with unresectable stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent or sequential platinum-based chemoradiotherapy. Sugemalimab, an OmniAb derived monoclonal antibody, became the first anti-PD-1/PD-L1 monoclonal antibody approved for stage III NSCLC following concurrent or sequential chemoradiotherapy. It's also the only anti-PD-L1 </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">monoclonal antibody approved for both stage III and stage IV NSCLC. In May, CStone announced the pre-planned, final progression-free survival (PFS) analysis results from the registrational GEMSTONE-301 study of sugemalimab as consolidation therapy in patients with unresectable stage III NSCLC. The data showed that sugemalimab maintained a statistically significant and clinically meaningful improvement in PFS. Furthermore, on August 7, 2022, EQRx, which holds the development and commercialization rights to sugemalimab outside Greater China, announced that the updated, PFS analysis of the Phase 3 GEMSTONE-301 trial showed that sugemalimab continued to demonstrate improvement in PFS compared with placebo. This updated final data was presented in a late-breaking oral presentation at the International Association for the Study of Lung Cancer 2022 World Conference on Lung Cancer, taking place between August 6-9, 2022. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Janssen announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended conditional marketing authorization for TECVAYLI&#174; (teclistamab) as monotherapy for adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies. Teclistamab is an OmniAb-derived T-cell redirecting bispecific antibody. It targets both B-cell maturation antigen (BCMA), a marker found on multiple myeloma cells, and CD3, on T-cells. Teclistamab is currently under review by the FDA for potential approval in the U.S.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immunovant announced recruitment of patients has begun in the pivotal Phase 3 clinical trial of OmniAb-derived batoclimab in myasthenia gravis. Immunovant also announced that it has achieved alignment with the U.S. FDA on plans to initiate two placebo-controlled Phase 3 trials to evaluate batoclimab in thyroid eye disease in the second half of 2022.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Merck KGaA announced the initiation of a Phase 2 trial for M6223, an OmniAb-derived monoclonal antibody targeting TIGIT, in urothelial cancer. The study will evaluate BAVENCIO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (avelumab), a human anti-programmed death ligand-1 (PD-L1) antibody, as monotherapy versus the combination with M6223 or other molecules in the first-line maintenance setting in patients with advanced urothelial carcinoma whose disease did not progress with first-line platinum-containing chemotherapy.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Q2 2022, OmniAb entered into new platform licensing agreements with LifeArc, BioSynapse, Kaigene, and Recerise.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ligand Core Business Portfolio Updates</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Travere announced that the FDA accepted and granted priority review of its NDA under Subpart H for accelerated approval of sparsentan for the treatment of IgA nephropathy. The FDA assigned a Prescription Drug User Fee Act (PDUFA) target action date of November 17, 2022. Travere provided a regulatory update prior to their second quarter earnings call where they announced plans to submit a Conditional Marketing Authorization application with its partner Vifor Pharma for the treatment of IgA nephropathy in Europe with a review decision expected in the second half of 2023. Travere now plans to pursue traditional approval of sparsentan for focal segmental glomerulosclerosis (FSGS) in 2023 pending completion of the Phase 3 DUPLEX study.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Merck announced the FDA approval of VAXNEUVANCE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for infants and children 6 weeks through 17 years of age. Subsequently, the CDC&#8217;s ACIP voted unanimously to provisionally recommend use of VAXNEUVANCE as an option for pneumococcal vaccination in infants and children. VAXNEUVANCE is a 15-valent pneumococcal vaccine utilizing Ligand&#8217;s CRM197 vaccine carrier protein produced using the Pelican Expression Technology platform. Additionally, Merck announced positive results from a Phase 1/2 study evaluating V116, their investigational 21-valent pneumococcal conjugate vaccine utilizing Ligand&#8217;s CRM197 vaccine carrier protein. Merck started a broad Phase 3 program for V116 in July 2022.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jazz Pharmaceuticals presented positive data from a Phase 2/3 trial evaluating the intramuscular (IM) administration of Rylaze</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in adult and pediatric patients with acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) who have developed hypersensitivity to an E. coli-derived asparaginase at the 2022 ASCO Annual Meeting. The results confirmed patients achieved clinically meaningful nadir serum asparaginase activity throughout the course of Rylaze treatment with an IM regimen administered on Monday/Wednesday/Friday.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Novan announced positive results from the B-SIMPLE4 pivotal Phase 3 study of SB206 in patients with molluscum contagiosum. At the end of 12 weeks, 32.4% of patients in the SB206 group achieved complete clearance of lesions, as compared with 19.7% of patients in the vehicle group.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sermonix Pharmaceuticals presented updated data at the 2022 ASCO Annual Meeting from the ELAINE-2 open-label, Phase 2 clinical trial of lasofoxifene in combination with abemaciclib in women with locally advanced or metastatic ER+/HER2 breast cancer and an ESR1 mutation after progression on prior therapies. The combination produced encouraging results, with a median PFS of 13.9 months, along with acceptable tolerability. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Verona Pharma announced it completed patient enrollment with more than 800 subjects randomized in the ENHANCE-1 trial of ensifentrine in chronic obstructive pulmonary disease, concluding enrollment in the Phase 3 ENHANCE program. Top-line data are expected from ENHANCE-2 in the third quarter of 2022 and from ENHANCE-1 around year-end 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aldeyra Therapeutics announced achievement of the primary endpoint in the Phase 3 TRANQUILITY-2 trial of reproxalap for the treatment of dry eye disease. Reproxalap was statistically superior for both primary endpoints of Schirmer Test (p=0.0001) and &#8805;10 mm Schirmer Test responder proportions (p&lt;0.0001). Aldeyra subsequently announced achievement of the primary endpoints in a crossover trial showing reproxalap was statistical superior to vehicle for each of the two prespecified primary endpoints, ocular redness in a dry eye chamber (p=0.0004) and Schirmer test (p=0.0005). A Type B Pre-NDA meeting is expected to be held with the FDA in the third quarter of 2022, followed by a potential NDA submission.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:18.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.347%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q2 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q2 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,654&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol - Core</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,357)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,384)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol - COVID</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,419&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,675&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,256)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,112&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139,825&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,713)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Q2 2022 vs. Q2 2021</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total revenue decreased by $27.3 million, or (32)%, to $57.4 million in Q2 2022 compared to $84.7 million in Q2 2021 primarily due to the $26.6 million decrease in sales of COVID-related Captisol that is used in formulation with remdesivir.   Royalties increased in Q2 2022 by $9.3 million, or 108%, compared to the same period in 2021, with the increase primarily due to Kyprolis and sales of products using the Pelican platform. Core Captisol sales decreased by $6.4 million, or (66)%, to $3.3 million in Q2 2022 primarily due to the timing of customer orders. Captisol sales related to COVID-19 were $26.2&#160;million in Q2 2022, compared with $52.8&#160;million for the same period in 2021. The difference in sales is due to reduced demand for the pandemic-related treatment. Contract revenue decreased $3.6 million, or  (27)%, to $9.9 million in Q2 2022 primarily due to the achievement of two significant milestones tied to the Pelican platform in Q2 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenues attributable to the Ligand core business segment and OmniAb business segment were $50.1 million and $7.3 million, and $78.9 million and $5.8 million, respectively, for Q2 2022 and Q1 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">YTD 2022 vs. YTD 2021</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total revenue decreased by $36.7 million, or (26)%, to $103.1 million in YTD 2022 compared to $139.8 million compared to YTD 2021 primarily due to the $50.7 million decrease in sales of COVID-related Captisol that is used in formulation with remdesivir.  Royalties increased in YTD 2022 by $15.9 million compared to YTD 2021, with the increase primarily due to Kyprolis and sales of products using the Pelican platform. Core Captisol sales decreased by $1.4 million, or (13)%, to $9.6 million in YTD 2022 compared to YTD 2021 primarily due to the difference in sales is due to timing of customer orders. Captisol sales related to COVID-19 were $32.1&#160;million for the six months ended June 30, 2022, compared with $82.8&#160;million for the same period in 2021.  The lower sales are due to reduced demand for the pandemic-related treatment. Contract revenue decreased slightly in YTD 2022 compared to YTD 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenues attributable to the Ligand core business segment and OmniAb business segment were $86.6 million and $16.5 million, and $125.4 million and $14.4 million, respectively, for YTD 2022 and YTD 2021.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Royalty revenue is a function of our partners&#8217; product sales and the applicable royalty rate. Kyprolis royalty rates are under a tiered royalty rate structure with the highest tier being 3.0%. Evomela has a fixed royalty rate of 20%. Teriparatide injection has a tiered royalty between 25% and 40% on sales that have been adjusted for certain deductible items as defined in the respective license agreement. The Rylaze royalty rate is tiered between 3% and 5%. Contract revenue includes service revenue, license fees and development, regulatory and sales based milestone payments.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents royalty revenue by program (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2022 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2022 Royalty Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2021 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2021 Royalty Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">328.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Teriparatide injection</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">33.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">77.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">69.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">503.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2022 Estimated Partner Product Sales</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2022 Royalty Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021 Estimated Partner Product Sales</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021 Royalty Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">624.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">527.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">25.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Teriparatide injection</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">25.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">32.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rylaze</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">132.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">140.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">948.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">31.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">617.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:112%">(1) - Teriparatide injection sales have been adjusted for certain deductible items as defined in the respective license agreement.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Costs and Expenses</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.660%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of Captisol</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12,361</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">17,060</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,824</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">23,637</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">19,118</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">39,425</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14,585</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">32,765</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other operating income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(34,100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33,800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">57,888</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,936&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">112,887</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89,371&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Q2 2022 vs. Q2 2021</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total operating costs and expenses increased by $19.0 million, or 49%, to $57.9 million in Q2 2022 compared to $38.9 million in Q2 2021 primarily attributable to the a non-cash valuation adjustment of $(34.1)&#160;million recorded in Q2 2021 to reduce the Pfenex CVR liability due to an expected lower probability of achieving the required milestone under the Pfenex CVR Agreement. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cost of Capitsol decreased by $18.2 million, (60)%, to $12.4 million in Q2 2022 compared to $30.6 million in Q2 2021, with the decrease primarily due to lower total sales of Captisol. All of the cost of Capitsol is attributable to the Ligand core business segment. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangibles remained steady in Q2 2022 compared to the same period in 2021 as there have been no significant changes to the gross balance of intangible assets over these periods.  Amortization of intangibles were $8.3&#160;million and $3.5&#160;million for the Ligand core business segment and OmniAb business segment during Q2 2022, respectively, and $8.6&#160;million and $3.2&#160;million during Q2 2021, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any one time, we are working on multiple R&amp;D programs. As such, we generally do not track our R&amp;D expenses on a specific program basis. Research and development expenses were $19.1 million for Q2 2022, compared with $16.0 million for the same period of 2021, with the increase primarily due to continued investment in the OmniAb business which including facilities and headcount-related expenditures. Excluding $0.8&#160;million in unallocated corporate items, R&amp;D expenses were $7.5&#160;million and $10.8&#160;million for the Ligand core business segment and OmniAb business segment during Q2 2022, respectively. Excluding $0.9&#160;million in unallocated corporate items, R&amp;D expenses were $6.4&#160;million and $8.6&#160;million, for the Ligand core business segment and OmniAb business segment during Q2 2021, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses decreased slightly in Q2 2022 compared to Q2 2021. Excluding $7.8&#160;million in unallocated corporate items, general and administrative expenses were $4.9&#160;million and $1.9&#160;million for the Ligand core business segment and OmniAb business segment during Q2 2022, respectively. Excluding $7.4&#160;million in unallocated corporate items, general and administrative expenses were $5.6&#160;million and $1.8&#160;million for the Ligand core business segment and OmniAb business segment during Q2 2021, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no other operating income for Q2 2022, compared with $34.1 million for Q2 2021, which represented a non-cash valuation adjustment to reduce the Pfenex CVR liability due to an expected lower probability of achieving the required milestone under the Pfenex CVR Agreement. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">YTD 2022 vs. YTD 2021</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total operating costs and expenses increased by $23.5 million, or 26%, to $112.9 million in YTD 2022 compared to $89.4 million in YTD 2021 primarily attributable to the a non-cash valuation adjustment of $(33.8) million recorded in YTD 2021 to reduce the Pfenex CVR liability due to an expected lower probability of achieving the required milestone under the Pfenex CVR Agreement. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cost of Capitsol decreased by $21.7 million, (56)%, to $17.1 million in YTD 2022 compared to $38.7 million in YTD 2021, with the decrease primarily due to lower total sales of Captisol. All of the cost of Capitsol is attributable to the Ligand core business segment. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangibles remained steady in YTD 2022 compared to YTD 2021 as there have been no significant changes to the gross balance of intangible assets over these periods.  Amortization of intangibles were $17.1&#160;million and $6.5&#160;million for the Ligand core business segment and OmniAb business segment in YTD 2022, respectively, and $17.4&#160;million and $6.2&#160;million in YTD 2021, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any one time, we are working on multiple R&amp;D programs. As such, we generally do not track our R&amp;D expenses on a specific program basis. Research and development expenses were $39.4&#160;million in YTD 2022, compared with $33.8&#160;million in YTD 2021, with the increase primarily due to continued investment in the OmniAb business which includes facilities and headcount-related expenditures. Excluding $1.7&#160;million in unallocated corporate items, R&amp;D expenses were $15.7&#160;million and $22.0&#160;million for the Ligand core business segment and OmniAb business segment in YTD 2022, respectively. Excluding $1.7&#160;million in unallocated corporate items, R&amp;D expenses were $14.4&#160;million and $17.7&#160;million, for the Ligand core business segment and OmniAb business segment in YTD 2021, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased by $5.7&#160;million, or 21%, to $32.8&#160;million in YTD 2022 compared to $27.0&#160;million in YTD 2021, with the increase primarily due to $4.8&#160;million in transaction costs incurred during the first quarter of 2022 in connection with the planned spin-off of OmniAb. Excluding $20.0&#160;million in unallocated corporate items, general and administrative expenses were $9.7&#160;million and $3.1&#160;million for the Ligand core business segment and OmniAb business segment in YTD 2022, respectively. Excluding $15.4&#160;million in unallocated corporate items, general and administrative expenses were $8.7&#160;million and $2.9&#160;million for the Ligand core business segment and OmniAb business segment in YTD 2021, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no other operating income in YTD 2022, compared with $33.8 million in YTD 2021, which represented a non-cash valuation adjustment to reduce the Pfenex CVR liability due to an expected lower probability of achieving the required milestone under the Pfenex CVR Agreement. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other Income (Expense)</span></div><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.170%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) from short-term investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,909)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,864)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,955&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(14,786)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,197&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20,983)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">298</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">432</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(97)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,883)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10,714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,882</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(924)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,806&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,580</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,401)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,981&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(167)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,438)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,271&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(11,001)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,389)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">388&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Q2 2022 vs. Q2 2021</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fluctuation in the gain (loss) from short-term investments is primarily driven by the changes in the fair value of our ownership in Viking common stock and other equity security investments, contributing an unrealized loss of $1.5 million in Q2 2022 as compared to an unrealized loss of $6.8 million in Q2 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists primarily of interest earned on our short-term investments. The increase over the prior year was due to the increase in interest rate, partially offset by the decrease in our short-term investment balance.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the 0.75% coupon cash interest expense in addition to the non-cash accretion of discount (including the amortization of debt issuance cost) on our 2023 Notes in both Q2 2022 and Q2 2021. The decrease was primarily due to the adoption of ASU 2020-06 which significantly reduced the debt discount balance subject to amortization. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for detail on ASU 2020-06 adoption. In addition, we carried a lower average debt outstanding balance in Q2 2022 as compared to Q2 2021. During Q2 2022, we repurchased $62.0&#160;million in principal amount of the 2023 Notes. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net, in Q2 2022 increased by $2.8 million as compared to Q2 2021, primarily due to the $1.8&#160;million gain on extinguishment of debt during Q2 2022 compared to a $2.3&#160;million loss on extinguishment of debt offset by the $1.1&#160;million gain for the fair value adjustment of Metabasis, Icagen and CyDex CVRs during Q2 2021. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3, Fair Value Measurements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Note 4, Convertible Senior Notes.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">YTD 2022 vs. YTD 2021</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The fluctuation in the gain (loss) from short-term investments is primarily driven by the changes in the fair value of our ownership in Viking common stock and other equity security investments, contributing an unrealized loss of $13.5 million in YTD 2022 as compared to an unrealized gain of $10.1 million in YTD 2021.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists primarily of interest earned on our short-term investments. The decrease over the prior year was due to the decrease in our short-term investment balance.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the 0.75% coupon cash interest expense in addition to the non-cash accretion of discount (including the amortization of debt issuance cost) on our 2023 Notes in both YTD 2022 and YTD 2021. The decrease was primarily due to the adoption of ASU 2020-06 which significantly reduced the debt discount balance subject to amortization. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for detail on ASU 2020-06 adoption. In addition, we carried a lower average debt outstanding balance during YTD 2022 as compared YTD 2021. During YTD 2022, we repurchased $227.8&#160;million in principal amount of the 2023 Notes. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net, in YTD 2022 increased by $12.0 million as compared to YTD 2021, primarily due to a $3.3&#160;million gain on extinguishment of debt and $1.3&#160;million gain for the fair value adjustment of Metabasis, Icagen and CyDex CVRs during YTD 2022 compared to a $7.2&#160;million loss on extinguishment of debt and $0.3&#160;million loss for the fair value adjustment of Metabasis, Icagen and CyDex CVRs during YTD 2021. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3, Fair Value Measurements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Note 4, Convertible Senior Notes.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Benefit (Expense)</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:31.834%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.127%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.127%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.127%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.139%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(636)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33,937)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(20,776)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,065&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(59,841)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(259)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,576)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,317&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,496</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,766&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,270)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(895)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(31,620)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(16,280)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(65,111)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(40.7)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.6&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compute our income tax provision by applying the estimated annual effective tax rate to income from operations and adding the effects of any discrete income tax items specific to the period. The effective tax rate for the three and six months ended June&#160;30, 2022 and 2021 was (40.7)% and 7.7%, and 21.6% and (25.0)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three and six months ended June&#160;30, 2022 was due primarily to the tax deductions related to foreign derived intangible income tax credit as well as the research and development tax credits, which were partially offset by Section 162(m) limitation and non-deductible ISO related stock compensation expense during the period. The variance from the U.S. federal statutory tax rate of 21% for the three and six months ended June 30, 2021 was significantly impacted by tax benefits related to (1) a $34.1&#160;million Pfenex CVR adjustment recorded during Q2 2021 due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR, and (2) net </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">excess tax benefits from share-based compensation resulting from increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Liquidity and Capital Resources </span></div><div style="text-indent:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, our cash, cash equivalents, and short-term investments totaled $147.9 million, which decreased by $193.2&#160;million from the end of last year due to factors described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. Our primary source of liquidity, other than our holdings of cash, cash equivalents, and short-term investments, has been cash flows from operations. Our ability to generate cash from operations provides us with the financial flexibility we need to meet operating, investing, and financing needs.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have liquidated our short-term investments and/or issued debt and equity securities to finance our business needs as a supplement to cash provided by operating activities. Our short-term investments include U.S. government debt securities, investment-grade corporate debt securities, mutual funds and certificates of deposit. We have established guidelines relative to diversification and maturities of our investments in order to provide both safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates. Additionally, we own certain securities which are classified as short-term investments that we received as a result of a milestone and an upfront license payment as well as 6.7 million shares of common stock in Viking.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued an aggregate principal amount of $750.0 million of the 2023 Notes. During the six months ended June&#160;30, 2022, we repurchased $227.8&#160;million in principal amount of the 2023 Notes for $223.7&#160;million in cash, including accrued interest of $0.4&#160;million. After the repurchases, $115.5 million in principal amount of the 2023 Notes remain outstanding. We may continue to use cash on hand to repurchase additional 2023 Notes through open-market transactions, including through Rule 10b5-1 trading plans to facilitate open-market repurchases, or otherwise, from time to time. The timing and amount of repurchase transactions will be determined by management based on the evaluation of market conditions, trading price of the 2023 Notes, legal requirements and other factors. The 2023 Notes were not convertible as of June&#160;30, 2022. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing funds, cash generated from operations and existing sources of and access to financing are adequate to fund our need for working capital, capital expenditures, debt service requirements, continued advancement of research and development efforts, potential stock repurchases and other business initiatives we plan to strategically pursue, including acquisitions and strategic investments.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, we had $9.2 million in fair value of contingent consideration liabilities associated with prior acquisitions to be settled in future periods.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Summary</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:65.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.854%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q2 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Investing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Financing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(229,863)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(141,540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2022, we repurchased $62.0&#160;million in principal amount of the 2023 Notes for $60.0&#160;million in cash, including accrued interest of $0.01&#160;million. During the six months ended June&#160;30, 2022, we repurchased $227.8&#160;million in principal of the 2023 Notes for $223.7&#160;million in cash, including accrued interest of $0.4&#160;million. </span></div><div style="text-indent:18pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our policies require the application of management judgment in making estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Those estimates and assumptions are based on historical experience and various other factors deemed applicable and reasonable under the circumstances. The use of judgment in determining such estimates and assumptions is by nature, subject to a degree of uncertainty. Accordingly, actual results could differ materially from the estimates made. There have been no material changes in our critical accounting policies and estimates as compared to the critical accounting policies and estimates described in our 2021 Annual Report, other than the adoption of the Accounting Standards Updates described in Item 1. Condensed consolidated Financial Statements - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to convertible debt.</span></div><div style="text-indent:14pt"><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_73"></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="text-indent:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no substantial changes to our market risks in the six months ended June&#160;30, 2022, when compared to the disclosures in Item 7A of our 2021 Annual Report.</span></div><div><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_76"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures as of June&#160;30, 2022 were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the quarter ended June&#160;30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_79"></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information that updates the disclosures set forth under Part I. Item 3. Legal Proceedings in our 2021 Annual Report, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 7, Commitment and Contingencies: Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Condensed Consolidated Financial Statements contained in Part I. Item 1. of this report.</span></div><div><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as set forth below, we do not believe that there have been any material changes to the risk factors disclosed in Part I, Item 1A of our 2021 Annual Report. The risk factors described in our 2021 Annual Report and below are not the only risks we face. Factors we currently do not know, factors that we currently consider immaterial or factors that are not specific to us, such as general economic conditions, may also materially adversely affect our business or our consolidated operating results, financial condition or cash flows.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Merger is subject to the satisfaction of certain conditions, which may not be satisfied on a timely basis, if at all.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consummation of the Merger is subject to customary closing conditions for transactions involving special purpose acquisition companies, including, among others:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">receipt of required consents and approvals from certain governmental authorities;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">no agreement between Ligand or APAC and any governmental authority pursuant to which Ligand or APAC has agreed not to consummate the Merger shall have been effected;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">no governmental authority of competent jurisdiction shall have enacted, issued or granted any law (whether temporary, preliminary or permanent), in each case that is in effect and which has the effect of restraining, enjoining or prohibiting the consummation of the transaction;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">APAC shall have at least $5,000,001 of net tangible assets as of the Closing;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the APAC common stock issuable pursuant to the Merger shall have been approved for listing on Nasdaq, subject to official notice of issuance;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Ligand, OmniAb, APAC and Merger Sub shall each have performed and complied in all material respects with the obligations, covenants and agreements required by the Merger Agreement to be performed or complied with by it at or prior to filing, or a later date as agreed to by the parties;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">customary bring down conditions related to the accuracy of the parties&#8217; respective representations, warranties and pre-closing covenants in the Merger Agreement;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the consummation of the Distribution, Reorganization and other transactions contemplated by the Separation Agreement shall have occurred;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">each of APAC&#8217;s and OmniAb&#8217;s registration statements to be filed with the United States Securities and Exchange Commission shall have become effective;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">APAC&#8217;s shareholder approval; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the receipt by Ligand and APAC of certain tax opinions.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, APAC&#8217;s obligation to consummate the Business Combination is also subject to there having been no &#8220;Material Adverse Effect&#8221; on OmniAb since the date of the Merger Agreement.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the obligations of OmniAb to consummate or cause to be consummated the Merger is subject to the satisfaction of the following additional conditions, any one (1) or more of which may be waived in writing by the OmniAb, among other things:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the completion of the transactions contemplated by the Merger Agreement; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the resignation of all directors and all executive officers of APAC.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that such closing conditions will be satisfied or waived, or that the Merger will be consummated. Further, we cannot assure you that the approval of APAC&#8217;s stockholders will be obtained. We, OmniAb and APAC may be subject to shareholder lawsuits, or other actions filed in connection with or in opposition to the Merger, which could prevent or delay the consummation of the Merger.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the Distribution, together with certain related transactions, fails to qualify as a reorganization under Sections 355 and 368(a)(1)(D) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), or the Merger fails to qualify as a reorganization under Section 368(a) of the Code, Ligand and its stockholders could incur significant tax liabilities, and APAC and OmniAb could be required to indemnify Ligand for taxes that could be material pursuant to indemnification obligations under the tax matters agreement to be entered into in connection with the closing of the Merger (the &#8220;Tax Matters Agreement&#8221;).</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ligand expects to receive a tax opinion from Latham &amp; Watkins LLP, tax counsel to Ligand, which shall provide that the Distribution will qualify as a reorganization under Sections 355 and 368(a)(1)(D) of the Code and that the Merger will not cause Section 355(e) of the Code to apply to the Distribution. In addition, the obligations of Ligand and OmniAb to complete the Merger are conditioned upon, among other things, Ligand&#8217;s receipt of such tax opinion. The obligation of APAC to complete the Merger is conditioned upon, among other things, receipt of an opinion of Weil, Gotshal &amp; Manges LLP, tax counsel to APAC, that the Merger will be treated as a reorganization under Section 368(a) of the Code. The opinions will be based on, among other things, certain facts, assumptions, representations and undertakings from Ligand, OmniAb and APAC, including those regarding the past and future conduct of the companies&#8217; respective businesses and other matters. If any of these facts, assumptions, representations, or undertakings are incorrect or not satisfied, Ligand may not be able to rely on the opinions, and Ligand and its stockholders could be subject to significant U.S. federal income tax liabilities. In addition, the opinions will not be binding on the IRS or the courts. Notwithstanding the opinions, the IRS could determine on audit that the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distribution or Merger does not qualify as a reorganization if it determines that any of the facts, assumptions, representations or undertakings on which the opinions are based are not correct or have been violated or that the Distribution or Merger should be taxable for other reasons, including as a result of a significant change in stock or asset ownership after the Distribution.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Distribution, together with certain related transactions, is ultimately determined not to qualify as a reorganization, the Distribution could be treated as a taxable disposition of shares of OmniAb stock by Ligand and as a taxable dividend or capital gain to Ligand&#8217;s stockholders for U.S. federal income tax purposes. If the Merger is ultimately determined not to qualify as a reorganization, the Merger could be treated as a taxable disposition of OmniAb stock by Ligand stockholders. In either such case, Ligand and its stockholders that are subject to U.S. federal income tax could incur significant U.S. federal income tax liabilities. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Tax Matters Agreement that APAC and OmniAb will enter into with Ligand, APAC and OmniAb will generally be required to indemnify Ligand against taxes incurred by Ligand that arise as a result of certain actions or omissions by APAC or OmniAb that prevent the Distribution, together with certain related transactions, from qualifying as a reorganization under Sections 355 and 368(a)(1)(D) of the Code. Further, even if APAC and OmniAb are not responsible for tax liabilities of Ligand under the Tax Matters Agreement, OmniAb nonetheless could be liable under applicable U.S. federal tax law for such liabilities if Ligand were to fail to pay them. If APAC or OmniAb is required to pay any liabilities under the circumstances set forth in the Tax Matters Agreement or pursuant to applicable tax law, the amounts may be significant. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The anticipated benefits of the Separation and Merger may not be achieved.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to achieve the full strategic and financial benefits expected to result from the Separation and Merger, including the potential that the Separation and Merger Combination will:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">allow each business to pursue its own operational and strategic priorities and more quickly respond to trends, developments and opportunities in its respective markets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">create two separate and distinct management teams focused on each business&#8217;s unique strategic priorities, target markets and corporate development opportunities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">give each business opportunity and flexibility by pursuing its own investment, capital allocation and growth strategies consistent with its long-term objectives;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">allow investors to separately value each business based on the unique merits, performance and future prospects of each business, providing investors with two distinct investment opportunities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">enhance the ability of each business to attract and retain qualified management and to better align incentive-based compensation with the performance of each separate business; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">give each of OmniAb and Ligand its own equity currency for use in connection with acquisitions.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not achieve the anticipated benefits of the Separation and Merger for a variety of reasons. Further, such benefits, if ultimately achieved, may be delayed. In addition, the Separation and Merger could materially and adversely affect our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Separation and Distribution may expose Ligand and OmniAb to potential liabilities arising out of state and federal fraudulent conveyance laws and legal dividend requirements.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Separation and Distribution are subject to review under various state and federal fraudulent conveyance laws. Fraudulent conveyance laws generally provide that an entity engages in a constructive fraudulent conveyance when (i) the entity transfers assets and does not receive fair consideration or reasonably equivalent value in return; and (ii) the entity: (a) is insolvent at the time of the transfer or is rendered insolvent by the transfer; (b) has unreasonably small capital with which to carry on its business; or (c) intends to incur or believes it will incur debts beyond its ability to repay its debts as they mature. An unpaid creditor or an entity acting on behalf of a creditor (including without limitation a trustee or debtor-in-possession in a bankruptcy by OmniAb or Ligand or any of our respective subsidiaries) may bring an action alleging that the Separation or Distribution or any of the related transactions constituted a constructive fraudulent conveyance. If a court accepts these allegations, it could impose a number of remedies, including without limitation, voiding OmniAb&#8217;s claims against Ligand, requiring the future OmniAb stockholders to return to Ligand some or all of the shares of OmniAb common stock issued in the Distribution, or providing Ligand with a claim for money damages against OmniAb in an amount equal to the difference between the consideration received by Ligand and OmniAb fair market value at the time of the Distribution.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measure of insolvency for purposes of the fraudulent conveyance laws will vary depending on which jurisdiction&#8217;s law is applied. Generally, an entity would be considered insolvent if (i) the present fair saleable value of its assets is less than the amount of its liabilities (including contingent liabilities); (ii) the present fair saleable value of its assets is less than its probable liabilities on its debts as such debts become absolute and matured; (iii) it cannot pay its debts and other liabilities (including contingent liabilities and other commitments) as they mature; or (iv) it has unreasonably small capital for the business in which it is engaged. We cannot assure you what standard a court would apply to determine insolvency or that a court would determine that OmniAb or Ligand or any of our subsidiaries were solvent at the time of or after giving effect to the Distribution.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Distribution of OmniAb common stock is also subject to review under state corporate distribution statutes. Under the DGCL, a corporation may only pay dividends to its stockholders either (i) out of its surplus (net assets minus capital) or (ii) if there is no such surplus, out of its net profits for the fiscal year in which the dividend is declared or the preceding fiscal year. Although Ligand intends to make the Distribution of OmniAb common stock entirely from surplus, we cannot assure you that a court will not later determine that some or all of the Distribution to Ligand stockholders was unlawful.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The announcement of the proposed Separation and Merger could disrupt OmniAb&#8217;s relationships with its customers, suppliers, business partners and others, as well as its operating results and business generally.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risks relating to the impact of the announcement of the Separation and Merger on OmniAb&#8217;s business include the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">its employees may experience uncertainty about their future roles, which might adversely affect OmniAb&#8217;s ability to retain and hire key personnel and other employees;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">customers, suppliers, business partners and other parties with which OmniAb maintains business relationships may experience uncertainty about its future and seek alternative relationships with third parties, seek to alter their business relationships with OmniAb or fail to extend an existing relationship with OmniAb; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">OmniAb has expended and will continue to expend significant costs, fees and expenses for professional services and transaction costs in connection with the proposed Separation and Merger.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the aforementioned risks were to materialize, they could lead to significant costs which may impact the combined company&#8217;s results of operations and cash available to fund its business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will incur transaction costs in connection with the Separation and Merger</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OmniAb has both incurred and expects to incur significant, non-recurring costs in connection with consummating the Separation and Merger and operating as a public company following the consummation of the Separation and Merger. OmniAb may also incur additional costs to retain key employees. Although certain transaction expenses incurred in connection with the Merger Agreement, including all legal, accounting, consulting, investment banking and other fees, expenses and costs, will be paid by APAC following the closing of the Merger, OmniAb expects some increased operational costs as well.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will also bear all of OmniAb&#8217;s expenses if the Merger is not consummated.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_88"></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">None.</span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_91"></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_94"></div><div><span><br/></span></div><div style="text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">   Item 4.  Mine Safety Disclosures</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_97"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;Other Information</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.967%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Incorporated by Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Description of Exhibit</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Form</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">File Number</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Date of Filing</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Filed</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Herewith</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000886163/000119312522083443/d337089dex21.htm">2.1*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Agreement and Plan of Merger, dated as of March, 23, 2022, by and among Avista Public Acquisition Corp. II, Ligand Pharmaceuticals Incorporated, OmniAb, Inc. and Orwell Merger Sub Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 24, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000119312522083443/d337089dex22.htm">2.2*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Separation and Distribution Agreement, dated as of March 23, 2022, by and among Avista Public Acquisition Corp. II, Ligand Pharmaceuticals Incorporated and OmniAb, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 24, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2.2</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000119312522083443/d337089dex23.htm">2.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Sponsor Insider Agreement, dated March 23, 2022, by and among OmniAb, Inc., Avista Public Acquisition Corp. II and the other parties signatory thereto</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 24, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2.3</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000119312522083443/d337089dex24.htm">2.4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among Avista Public Acquisition Corp. II, Avista Acquisition LP II and OmniAb, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 24, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2.4</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/0000936392-98-001000.txt">3.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Amended and Restated Certificate of Incorporation of the Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">S-4</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">333-58823</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">July 9, 1998</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616301000008/0000886163-01-000008-0002.txt">3.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, dated June 14, 2000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">0-20720</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 29, 2001</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.5</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616304000015/ex3-6.txt">3.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, dated June 30, 2004</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">0-20720</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">August 5, 2004</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.6</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000119312510264942/dex31.htm">3.4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, dated November 17, 2010</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">November 19, 2010</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616319000157/exhibit36.htm">3.5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certificate of Amendment of the Amended and Restated Certification of Incorporation of the Company, dated June 19, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">S-8</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">333-233130</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">August 8, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.6</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616320000116/exhibit31-ligandxfourt.htm">3.6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Fourth Amended and Restated Bylaws of the Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">October 30, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616318000030/lgndexhibi41.htm">4.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Specimen stock certificate for shares of the common stock of the Company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 1, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616318000076/exhibit41.htm">4.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Indenture, dated as of May 22, 2018, between the Company and Wilmington Trust, National Association, as trustee, including the form of 0.75% Convertible Senior Notes due 2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">May 22, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616322000038/ligand-2022annualmeetingpr.htm#i858b093ea9a44e01b80bfe450a9cebf2_350">10.1</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616322000038/ligand-2022annualmeetingpr.htm#i858b093ea9a44e01b80bfe450a9cebf2_350">#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2002 Stock Incentive Plan (As Amended and Restated Effective June 10, 2022)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">DEF14A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">April 22, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Appendix A</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit_102xligand-2022ind.htm">10.2*</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline" href="exhibit_102xligand-2022ind.htm">#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2022 Employment Inducement Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit_103xligand-formofs.htm">10.3*</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline" href="exhibit_103xligand-formofs.htm">#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Form of Stock Option Agreement under the Company&#8217;s 2022 Employment Inducement Plan</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit104_ligand-formofrs.htm">10.4*</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline" href="exhibit104_ligand-formofrs.htm">#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Form of Restricted Stock Unit Award Agreement under the Company&#8217;s 2022 Employment Inducement Plan</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit_105xligand-formofp.htm">10.5*</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;text-decoration:underline;top:-3.15pt;vertical-align:baseline" href="exhibit_105xligand-formofp.htm">#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Form of Performance-Based Restricted Stock Unit Award Agreement under the Company&#8217;s 2022 Employment Inducement Plan</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="lgnd_63022exhibit311.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certification by Principal Executive Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="lgnd_63022exhibit312.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certification by Principal Financial Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.967%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="lgnd_63022exhibit321.htm">32.1**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certifications by Principal Executive Officer and Principal Financial Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">101</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The following financial information from our Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2022, formatted in iXBRL (inline eXtensible Business Reporting Language): (i) Consolidated Condensed Balance Sheets, (ii) Consolidated Condensed Statements of Operations, (iii) Consolidated Condensed Statement of Comprehensive Income, (iv) Consolidated Condensed Statements of Stockholders' Equity, (v) Consolidated Condensed Statements of Cash Flows, and (vi) the Notes to Consolidated Condensed Financial Statements.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">104</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2022, formatted in Inline XBRL and contained in Exhibit 101.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr></table></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">#</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Indicates management contract or compensatory plan.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">*   Schedules and exhibits omitted pursuant to Item 601(b)(2) of Regulation S-K. Ligand Pharmaceuticals Incorporated agrees to furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon request.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">** These certifications are deemed not filed for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div id="ib69a4a9cb92a4725b58ada0b25efe540_103"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 9, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Matthew Korenberg</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Korenberg</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Finance and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Duly Authorized Officer and Principal Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">38</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>exhibit_102xligand-2022ind.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i4c569442ea764f578fc25159052dc515_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS INCORPORATED</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022 EMPLOYMENT INDUCEMENT PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Article 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:31.41pt"><br><br>GENERAL PROVISIONS</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:28.97pt">PURPOSE OF THE PLAN</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This 2022 Employment Inducement Plan is intended to promote the interests of Ligand Pharmaceuticals Incorporated, a Delaware corporation, by providing Eligible Individuals in the Corporation&#8217;s and its Subsidiaries&#8217; service with the opportunity to acquire a proprietary interest in the Corporation as an incentive for them to commence and remain in such service. Only Eligible Individuals may receive Awards under the Plan. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Capitalized terms shall have the meanings assigned to such terms in the attached Appendix.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.69pt">STRUCTURE OF THE PLAN</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">The Plan shall be divided into three separate equity incentives programs&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">the Discretionary Option Grant Program under which Eligible Individuals may, at the discretion of the Plan Administrator, be granted options to purchase shares of Common Stock,</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">the Stock Issuance Program under which Eligible Individuals may, at the discretion of the Plan Administrator, be issued shares of Common Stock, and</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">the Other Stock Award Program under which Eligible Individuals may, at the discretion of the Plan Administrator, be granted restricted stock units, stock appreciation rights and dividend equivalents. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">The provisions of Article One and Article Six shall apply to all equity programs under the Plan and shall govern the interests of all persons under the Plan.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.41pt">ADMINISTRATION OF THE PLAN</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">The Committee shall be the Plan Administrator and shall have sole and exclusive authority to administer the Plan (except as otherwise permitted herein). Each member of the Committee shall be both an Independent Director and a &#8220;nonemployee director&#8221; (as defined in the regulations promulgated under Section 16 of the Exchange Act). Notwithstanding anything to the contrary provided herein, Awards shall be approved by (i)&#160;the Committee, which shall be comprised solely of Independent Directors, or (ii)&#160;a majority of the Corporation&#8217;s Independent Directors. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">The Plan Administrator shall, within the scope of its administrative functions under the Plan, have full power and authority (subject to the provisions of the Plan) to&#58; </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:29.67pt">adopt rules and regulations from time to time intended to ensure that an individual is an Eligible Individual prior to the granting of any Award to such individual under the Plan (including without limitation a requirement, if any, that each such individual certify to the Corporation prior to the receipt of an Award under the Plan that he or she has not been previously employed by the Corporation, Parent, Subsidiary or any of their affiliates, or if previously employed, has had a bona fide period of non-employment, and that the grant of Awards under the Plan is an inducement material to his or her agreement to enter into employment with the Corporation, Parent, Subsidiary or any of their affiliates)&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.34pt">establish such rules and regulations as it may deem appropriate for proper administration of the Plan and to make such determinations under&#59; and</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.01pt">issue such interpretations of, the provisions of those programs and any outstanding Awards thereunder as it may deem necessary or advisable.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Decisions of the Plan Administrator within the scope of its administrative functions under the Plan shall be final and binding on all parties who have an interest in the equity incentive programs under its jurisdiction or any Award thereunder.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">Service on the Committee shall constitute service as a Board member, and members of such committee shall accordingly be entitled to full indemnification and reimbursement as Board members for their service on such committee. No member of the Committee shall be liable for any act or omission made in good faith with respect to the Plan or any Awards under the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">Following the issuance of any Award under the Plan, the Corporation shall, in accordance with the listing requirement under the applicable securities exchange, (i)&#160;promptly issue a press release disclosing the material terms of the grant, including the recipient(s) of the grant and the number of shares involved and (ii) notify the applicable securities exchange of such grant no later than the earlier to occur of (A)&#160;five (5) calendar days after entering into the agreement to issue the Award or (B)&#160;the date of the public announcement of the Award. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.03pt">ELIGIBILITY</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">Only Eligible Individuals are eligible to participate in the Discretionary Option Grant, Stock Issuance and Other Stock Award Programs.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">The Plan Administrator shall, within the scope of its administrative jurisdiction under the Plan, have full authority to determine, (i) with respect to the option grants under the Discretionary Option Grant Program, which Eligible Individuals are to receive such grants, the time or times when those grants are to be made, the number of shares to be covered by each such grant, the time or times when each option is to become exercisable, the vesting schedule (if any) applicable to the option shares, the maximum term for which the option is to remain outstanding and such other terms and conditions of such option as the Plan Administrator determines are appropriate, (ii)&#160;with respect to stock issuances under the Stock Issuance Program, which Eligible Individuals are to receive such issuances, the time or times when the issuances are to be made, the number of shares to be issued to each Participant, the vesting schedule (if any) applicable to the issued shares, the purchase price, if any, and consideration for such shares and such other terms and conditions of such issued shares as the Plan Administrator determines are appropriate, and (iii)&#160;with respect to other Awards under the Other Stock Awards Program, which Eligible Individuals are to receive such Awards, the type of Award, the time or times when the issuances are to be made, the number of shares subject to such Award to be issued to each Participant, the vesting schedule (if any) applicable to the Awards, the consideration for such Awards and such other terms and conditions of such Awards as the Plan Administrator determines are appropriate.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:25.31pt">STOCK SUBJECT TO THE PLAN</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.54pt">Subject to adjustment pursuant to this Section&#160;V, the number of shares of Common Stock which may be issued or transferred pursuant to Awards under the Plan is 300,000 shares.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">F.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.14pt">To the extent all or a portion of an Award is forfeited, expires or such Award or portion thereof is settled for cash (in whole or in part), the shares of Common Stock subject to such Award or portion thereof, shall, to the extent of such forfeiture, expiration or cash settlement, again be available for future grants of Awards under the Plan.  In addition, the following shares of Common Stock shall be added to the shares of Common Stock authorized for grant under Section&#160;V.A and will be available for future grants of Awards&#58; (i)&#160;shares of Common Stock tendered by an Optionee or withheld by the Corporation in payment of the exercise price of an option&#59; and (ii) shares of Common Stock tendered by the Participant or withheld by the Corporation to satisfy any tax withholding obligation with respect to an </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Award. Notwithstanding the provisions of this Section V.B, no shares shall again be available for future grants of Awards under the Plan pursuant to this Section V.B to the extent that such return of shares would cause the Plan to constitute a &#8220;formula plan&#8221; or constitute a &#8220;material revision&#8221; of the Plan subject to shareholder approval under the then-applicable rules of the Nasdaq Stock Market (or any other applicable exchange or quotation system).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">G.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">Any shares of Common Stock forfeited by the Participant or repurchased by the Corporation under Article Three, Section I.C. at a price not greater than the price originally paid by the Participant so that such shares are returned to the Corporation will again be available for Awards under the Plan.  The payment of Dividend Equivalents in cash in conjunction with any outstanding Awards shall not be counted against the shares available for issuance under the Plan.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">H.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">If any change is made to the Common Stock by reason of any stock split, stock or cash dividend (other than normal cash dividends), recapitalization, combination of shares, exchange of shares or other change affecting the outstanding Common Stock as a class without the Corporation&#8217;s receipt of consideration, equitable adjustments shall be made by the Plan Administrator to (i)&#160;the maximum number and&#47;or class of securities issuable under the Plan, (ii)&#160; the number and&#47;or class of securities and the exercise or purchase price per share in effect under each outstanding Award under the Plan, and (iii)&#160;the terms and conditions of any outstanding Awards (including, without limitation, any applicable performance targets or criteria with respect thereto). Such adjustments to the outstanding Awards are to be effected in a manner which shall preclude the enlargement or dilution of rights and benefits under such Awards. The adjustments determined by the Plan Administrator shall be final, binding and conclusive.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:29.59pt">Subject to Article Two, Section&#160;II, Article Three, Section&#160;II and Article Four, Section&#160;V, in the event of any transaction or event described in Section&#160;V.D or any unusual or nonrecurring transactions or events affecting the Corporation, any affiliate of the Corporation, or the financial statements of the Corporation or any affiliate, or of changes in applicable laws, regulations or accounting principles, including, without limitation, a Change in Control or a Hostile Take-Over, the Plan Administrator, in its sole and absolute discretion, and on such terms and conditions as it deems appropriate, either by the terms of the Award or by action taken prior to the occurrence of such transaction or event and either automatically or upon the Optionee&#8217;s or Participant&#8217;s request, is hereby authorized to take any one or more of the following actions whenever the Plan Administrator determines that such action is appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan or with respect to any Award under the Plan, to facilitate such transactions or events or to give effect to such changes in laws, regulations or principles&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">To provide for either (A) termination of any such Award in exchange for an amount of cash, if any, equal to the amount that would have been attained upon the exercise of such Award or realization of the Optionee&#8217;s or Participant&#8217;s rights (and, for the avoidance of doubt, if as of the date of the occurrence of the transaction or event described in this Section&#160;V.E the Plan Administrator determines in good faith that no amount would have been attained upon the exercise of such Award or realization of the Optionee&#8217;s or Participant&#8217;s rights, then such Award may be terminated by the Corporation without payment) or (B) the replacement of such Award with other rights or property selected by the Plan Administrator in its sole discretion&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">To provide that such Award be assumed by the successor or survivor corporation, or a parent or subsidiary thereof, or shall be substituted for by similar Awards covering the stock of the successor or survivor corporation, or a parent or subsidiary thereof, with appropriate adjustments as to the number and kind of shares and prices&#59; </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">To make adjustments in the number and type of shares of Common Stock (or other securities or property) subject to outstanding Awards, and in the number and&#47;or in the terms and conditions of (including the grant or exercise price), and the criteria included in, outstanding Awards&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">To provide that such Award shall be exercisable or payable or fully vested with respect to all shares covered thereby, notwithstanding anything to the contrary in the Plan or the applicable award agreement&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">To provide that the Award cannot vest, be exercised or become payable after such event.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">In the event of any pending stock dividend, stock split, combination or exchange of shares, merger, consolidation or other distribution (other than normal cash dividends) of Corporation assets to stockholders, or any other change affecting the shares of Common Stock or the share price of the Common Stock, for reasons of administrative convenience, the Corporation in its sole discretion may refuse to permit the exercise of any Award during a period of thirty (30) days prior to the consummation of any such transaction.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Article 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:31.41pt"><br><br>DISCRETIONARY OPTION GRANT PROGRAM</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:28.97pt">OPTION TERMS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each option shall be a Non-Statutory Option evidenced by one or more documents in the form approved by the Plan Administrator&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that each such document shall comply with the terms specified below. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">EXERCISE PRICE.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">The exercise price per share shall be fixed by the Plan Administrator but shall not be less than one hundred percent (100%) of the Fair Market Value per share of Common Stock on the option grant date. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">The exercise price shall become immediately due upon exercise of the option and shall, subject to the provisions of the documents evidencing the option, be payable in one or more of the forms specified below&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.2pt">cash or check made payable to the Corporation, </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.15pt">shares of Common Stock held by the Optionee or otherwise issuable upon exercise of the option and valued at Fair Market Value on the Exercise Date, </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.1pt">to the extent the option is exercised for vested shares, through a special sale and remittance procedure pursuant to which the Optionee shall concurrently provide irrevocable instructions to (a) a Corporation-designated brokerage firm to effect the immediate sale of the purchased shares and remit to the Corporation, out of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate exercise price payable for the purchased shares plus all applicable income and employment taxes required to be withheld by the Corporation by reason of such exercise and (b)&#160;the Corporation to deliver the certificates for the purchased shares directly to such brokerage firm in order to complete the sale, or</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.7pt">with the consent of the Plan Administrator, a promissory note bearing interest at no less than such rate as shall then preclude the imputation of interest under the Code.</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">Except to the extent such sale and remittance procedure is utilized, payment of the exercise price for the purchased shares must be made on the Exercise Date. Notwithstanding any other provision of the Plan to the contrary, no Optionee who is a member of the Board or an &#8220;executive officer&#8221; of the Corporation within the meaning of Section&#160;13(k) of the Exchange Act shall be permitted to pay the exercise price of an option, or continue any extension of credit with respect to the exercise of an option, with a loan from the Corporation or a loan arranged by the Corporation in violation of Section&#160;13(k) of the Exchange Act.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">EXERCISE AND TERM OF OPTIONS. Each option shall be exercisable at such time or times, during such period and for such number of shares as shall be determined by the Plan Administrator </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and set forth in the documents evidencing the option. However, no option shall have a term in excess of ten (10) years measured from the option grant date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">EFFECT OF TERMINATION OF SERVICE.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">The following provisions shall govern the exercise of any options held by the Optionee at the time of cessation of Service or death&#58; </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.2pt">Any option outstanding at the time of the Optionee&#8217;s cessation of Service for any reason shall remain exercisable for such period of time thereafter as shall be determined by the Plan Administrator and set forth in the documents evidencing the option, but no such option shall be exercisable after the expiration of the option term. </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.15pt">Any option held by the Optionee at the time of death and exercisable in whole or in part at that time may be subsequently exercised by the personal representative of the Optionee&#8217;s estate or by the person or persons to whom the option is transferred pursuant to the Optionee&#8217;s will or the laws of inheritance or by the Optionee&#8217;s designated beneficiary or beneficiaries of that option. </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.1pt">During the applicable post-Service exercise period, the option may not be exercised in the aggregate for more than the number of vested shares for which the option is exercisable on the date of the Optionee&#8217;s cessation of Service. Upon the expiration of the applicable exercise period or (if earlier) upon the expiration of the option term, the option shall terminate and cease to be outstanding for any vested shares for which the option has not been exercised. However, the option shall, immediately upon the Optionee&#8217;s cessation of Service, terminate and cease to be outstanding to the extent the option is not otherwise at that time exercisable for vested shares.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">The Plan Administrator shall have complete discretion, exercisable either at the time an option is granted or at any time while the option remains outstanding, to&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.2pt">extend the period of time for which the option is to remain exercisable following the Optionee&#8217;s cessation of Service from the limited exercise period otherwise in effect for that option to such greater period of time as the Plan Administrator shall deem appropriate, but in no event beyond the expiration of the option term, and&#47;or </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.15pt">permit the option to be exercised, during the applicable post-Service exercise period, not only with respect to the number of vested shares of Common Stock for which such option is exercisable at the time of the Optionee&#8217;s cessation of Service but also with respect to one or more additional installments in which the Optionee would have vested had the Optionee continued in Service. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">STOCKHOLDER RIGHTS. The holder of an option shall have no stockholder rights with respect to the shares subject to the option until such person shall have exercised the option, paid the exercise price and become a holder of record of the purchased shares.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">REPURCHASE RIGHTS. The Plan Administrator shall have the discretion to grant options which are exercisable for unvested shares of Common Stock. Should the Optionee cease Service while holding such unvested shares, the Corporation shall have the right to repurchase any or all of those unvested shares. The terms upon which such repurchase right shall be exercisable (including the period and procedure for exercise and the appropriate vesting schedule for the purchased shares) shall be established by the Plan Administrator and set forth in the document evidencing such repurchase right. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">LIMITED TRANSFERABILITY OF OPTIONS. During the lifetime of the Optionee, a Non-Statutory Option shall be exercisable only by the Optionee and shall not be assignable or transferable other than by will or the laws of inheritance following the Optionee&#8217;s death.  However, a Non-Statutory Option may be assigned in whole or in part during the Optionee&#8217;s lifetime to one or more members of the Optionee&#8217;s family or to a trust established exclusively for one or more such family members or to Optionee&#8217;s former spouse, to the extent such assignment is in connection with the Optionee&#8217;s estate plan or pursuant to a domestic relations order. The assigned portion may only be exercised by the person or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">persons who acquire a proprietary interest in the option pursuant to the assignment. The terms applicable to the assigned portion shall be the same as those in effect for the option immediately prior to such assignment and shall be set forth in such documents issued to the assignee as the Plan Administrator may deem appropriate. Notwithstanding the foregoing, the Optionee may also designate one or more persons as the beneficiary or beneficiaries of his or her outstanding options under this Article Two, and those options shall, in accordance with such designation, automatically be transferred to such beneficiary or beneficiaries upon the Optionee&#8217;s death while holding those options. Such beneficiary or beneficiaries shall take the transferred options subject to all the terms and conditions of the applicable agreement evidencing each such transferred option, including (without limitation) the limited time period during which the option may be exercised following the Optionee&#8217;s death.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:28.97pt">CHANGE IN CONTROL&#47;HOSTILE TAKE-OVER</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.54pt">In the event of a Change in Control, each outstanding option under the Discretionary Option Grant Program shall automatically accelerate so that each such option shall, immediately prior to the effective date of that Change in Control, become exercisable for all the shares of Common Stock at the time subject to such option and may be exercised for any or all of those shares as fully vested shares of Common Stock. However, an outstanding option shall NOT become exercisable on such an accelerated basis if and to the extent&#58; (i) such option is to be assumed by the successor corporation (or parent thereof) or is otherwise to continue in full force and effect pursuant to the terms of the Change in Control transaction or (ii) such option is to be replaced with a cash incentive program of the successor corporation which preserves the spread existing at the time of the Change in Control on any shares for which the option is not otherwise at that time exercisable and provides for subsequent payout of that spread in accordance with the same exercise&#47;vesting schedule applicable to those option shares or (iii)&#160;the acceleration of such option is subject to other limitations imposed by the Plan Administrator at the time of the option grant. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">F.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.14pt">All outstanding repurchase rights under the Discretionary Option Grant Program shall automatically terminate, and the shares of Common Stock subject to those terminated rights shall immediately vest in full, in the event of a Change in Control, except to the extent&#58; (i)&#160;those repurchase rights are to be assigned to the successor corporation (or parent thereof) or are otherwise to continue in full force and effect pursuant to the terms of the Change in Control transaction or (ii)&#160;such accelerated vesting is precluded by other limitations imposed by the Plan Administrator at the time the repurchase right is issued. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">G.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">Immediately following the consummation of the Change in Control, all outstanding options under the Discretionary Option Grant Program shall terminate and cease to be outstanding, except to the extent assumed by the successor corporation (or parent thereof) or otherwise continued in full force and effect pursuant to the terms of the Change in Control transaction. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">H.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">Each option which is assumed in connection with a Change in Control or otherwise continued in effect shall be appropriately adjusted, immediately after such Change in Control, to apply to the number and class of securities which would have been issuable to the Optionee in consummation of such Change in Control had the option been exercised immediately prior to such Change in Control. Appropriate adjustments shall also be made to the exercise price payable per share under each outstanding option, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the aggregate exercise price payable for such securities shall remain the same (subject only to reduction by reason of rounding). To the extent the actual holders of the Corporation&#8217;s outstanding Common Stock receive cash consideration for their Common Stock in consummation of the Change in Control, the successor corporation may, in connection with the assumption of the outstanding options under the Discretionary Option Grant Program, substitute one or more shares of its own common stock with a fair market value equivalent to the cash consideration paid per share of Common Stock in such Change in Control transaction.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:29.59pt">The Plan Administrator shall have the discretionary authority to structure one or more outstanding options under the Discretionary Option Grant Program so that those options shall, immediately prior to the effective date of a Change in Control, become exercisable for all the shares of Common Stock at the time subject to those options and may be exercised for any or all of those shares as fully vested shares of Common Stock, whether or not those options are to be assumed in the Change in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Control transaction or otherwise continued in effect. In addition, the Plan Administrator shall have the discretionary authority to structure one or more of the Corporation&#8217;s repurchase rights under the Discretionary Option Grant Program so that those rights shall immediately terminate upon the consummation of the Change in Control transaction, and the shares subject to those terminated rights shall thereupon vest in full.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">J.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:28.97pt">The Plan Administrator shall have full power and authority to structure one or more outstanding options under the Discretionary Option Grant Program so that those options shall become exercisable for all the shares of Common Stock at the time subject to those options in the event the Optionee&#8217;s Service is subsequently terminated by reason of an Involuntary Termination within a designated period (not to exceed eighteen (18) months) following the effective date of any Change in Control transaction in which those options do not otherwise accelerate. In addition, the Plan Administrator may structure one or more of the Corporation&#8217;s repurchase rights so that those rights shall immediately terminate with respect to any shares held by the Optionee at the time of such Involuntary Termination, and the shares subject to those terminated repurchase rights shall accordingly vest in full at that time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">K.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">The Plan Administrator shall have the discretionary authority to structure one or more outstanding options under the Discretionary Option Grant Program so that those options shall, immediately prior to the effective date of a Hostile Take-Over, become exercisable for all the shares of Common Stock at the time subject to those options and may be exercised for any or all of those shares as fully vested shares of Common Stock. In addition, the Plan Administrator shall have the discretionary authority to structure one or more of the Corporation&#8217;s repurchase rights under the Discretionary Option Grant Program so that those rights shall terminate automatically upon the consummation of such Hostile Take-Over, and the shares subject to those terminated rights shall thereupon vest in full. Alternatively, the Plan Administrator may condition the automatic acceleration of one or more outstanding options under the Discretionary Option Grant Program and the termination of one or more of the Corporation&#8217;s outstanding repurchase rights under such program upon the subsequent termination of the Optionee&#8217;s Service by reason of an Involuntary Termination within a designated period (not to exceed eighteen (18) months) following the effective date of such Hostile Take-Over.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">L.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.54pt">The outstanding options shall in no way affect the right of the Corporation to adjust, reclassify, reorganize or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Article 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:31.41pt"><br><br>STOCK ISSUANCE PROGRAM</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:28.97pt">STOCK ISSUANCE TERMS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Shares of Common Stock may be issued under the Stock Issuance Program through direct and immediate issuances without any intervening option grants. Each such stock issuance shall be evidenced by a Stock Issuance Agreement which complies with the terms specified below. Shares of Common Stock may also be issued under the Stock Issuance Program pursuant to share right awards which entitle the recipients to receive those shares upon the attainment of designated performance goals or the satisfaction of specified Service requirements.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">PURCHASE PRICE.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">The purchase price per share, if any, shall be fixed by the Plan Administrator.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.75pt">Shares of Common Stock may be issued under the Stock Issuance Program for any form of consideration as the Plan Administrator may deem appropriate in each individual instance, including, without limitation&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.2pt">cash or check made payable to the Corporation, or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.15pt">future services to be rendered to the Corporation (or any Parent or Subsidiary).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">RESTRICTIONS. Shares of Common Stock issued under this Stock Issuance Program shall be subject to such restrictions on transferability and other restrictions as the Plan Administrator may impose (including, without limitation, limitations on the right to vote such shares or the right to receive dividends on such shares). These restrictions may lapse separately or in combination at such times, pursuant to such circumstances, in such installments, or otherwise, as the Plan Administrator determines at the time of the grant of the shares or thereafter. Notwithstanding the foregoing, with respect to shares of Common Stock issued under this Stock Issuance Program subject to vesting, dividends which are paid prior to vesting shall only be paid out to the Participant to the extent that the vesting conditions are subsequently satisfied and the share vests.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">FORFEITURE. Except as otherwise determined by the Plan Administrator at the time of the grant of the shares or thereafter, upon termination of employment during the applicable restriction period, shares of Common Stock issued under this Stock Issuance Program that are at that time subject to restrictions shall be forfeited&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that, the Plan Administrator may (a)&#160;provide in any award agreement that restrictions or forfeiture conditions relating to such shares will be waived in whole or in part in the event of terminations resulting from specified causes, and (b) in other cases waive in whole or in part restrictions or forfeiture conditions relating to such shares.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.69pt">CHANGE IN CONTROL&#47;HOSTILE TAKE-OVER</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">All of the Corporation&#8217;s outstanding forfeiture restrictions or repurchase rights on any shares of Common Stock issued under the Stock Issuance Program shall terminate automatically, and all the shares of Common Stock subject to those terminated rights shall immediately vest in full, in the event of any Change in Control, except to the extent (i)&#160;those forfeiture restrictions or repurchase rights are to be assigned to the successor corporation (or parent thereof) or are otherwise to continue in full force and effect pursuant to the terms of the Change in Control transaction or (ii) such accelerated vesting is precluded by other limitations imposed in the Stock Issuance Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">The Plan Administrator shall have the discretionary authority to structure one or more of the Corporation&#8217;s forfeiture restrictions or repurchase rights under the Stock Issuance Program so that those rights shall automatically terminate in whole or in part, and the shares of Common Stock subject to those terminated rights shall immediately vest, in the event the Participant&#8217;s Service should subsequently terminate by reason of an Involuntary Termination within a designated period (not to exceed eighteen (18) months) following the effective date of any Change in Control transaction in which those forfeiture restrictions or repurchase rights are assigned to the successor corporation (or parent thereof) or are otherwise continued in effect.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.54pt">The Plan Administrator shall also have the discretionary authority to structure one or more of the Corporation&#8217;s forfeiture restrictions or repurchase rights under the Stock Issuance Program so that those rights shall automatically terminate in whole or in part, and the shares of Common Stock subject to those terminated rights shall immediately vest, either upon the occurrence of a Hostile Take-Over or upon the subsequent termination of the Participant&#8217;s Service by reason of an Involuntary Termination within a designated period (not to exceed eighteen (18) months) following the effective date of that Hostile Take-Over.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:28.97pt">SHARE ESCROW&#47;LEGENDS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unvested shares may, in the Plan Administrator&#8217;s discretion, be held in escrow by the Corporation until the Participant&#8217;s interest in such shares vests or may be issued directly to the Participant with restrictive legends on the certificates evidencing those unvested shares. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Article 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:31.41pt"><br><br>OTHER STOCK AWARDS PROGRAM</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:28.97pt">STOCK APPRECIATION RIGHTS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">A stock appreciation right may be granted to any Eligible Individual selected by the Plan Administrator. A stock appreciation right shall be subject to such terms and conditions not inconsistent with the Plan as the Plan Administrator shall impose and shall be evidenced by a stock appreciation right agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">A stock appreciation right shall entitle the Participant (or other person entitled to exercise the stock appreciation right pursuant to the Plan) to exercise all or a specified portion of the stock appreciation right (to the extent then exercisable pursuant to its terms) and to receive from the Corporation an amount equal to the product of (i) the excess of (A) the Fair Market Value of the Common Stock on the date the stock appreciation right is exercised over (B) the Fair Market Value of the Common Stock on the date the stock appreciation right was granted and (ii) the number of shares of Common Stock with respect to which the stock appreciation right is exercised, subject to any limitations the Plan Administrator may impose. The exercise or base price per share of a stock appreciation right shall be fixed by the Plan Administrator but shall not be less than one hundred percent (100%) of the Fair Market Value per share of Common Stock on the date the stock appreciation right was granted. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">Subject to Section&#160;I.B above, payment of the amounts determined under Sections&#160;I.B. above shall be in cash, in Common Stock (based on its Fair Market Value as of the date the stock appreciation right is exercised) or a combination of both, as determined by the Plan Administrator. To the extent any payment is effected in Common Stock, it shall be made subject to satisfaction of all provisions of Article Two above pertaining to options.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">Each stock appreciation right shall be exercisable at such time or times, during such period and for such number of shares as shall be determined by the Plan Administrator and set forth in the documents evidencing the stock appreciation right. However, no stock appreciation right shall have a term in excess of ten (10) years measured from the date the stock appreciation right was granted.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.69pt">DIVIDEND EQUIVALENTS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any Eligible Individual selected by the Plan Administrator may be granted dividend equivalents based on the dividends declared on the shares of Common Stock that are subject to any Award, to be credited as of dividend payment dates, during the period between the date the Award is granted and the date the Award is exercised, vests or expires, as determined by the Plan Administrator. Such dividend equivalents shall be converted to cash or additional shares of Common Stock by such formula and at such time and subject to such limitations as may be determined by the Plan Administrator. Notwithstanding anything to the contrary, dividends or dividend equivalents with respect to an Award that is subject to vesting that are based on dividends paid prior to the vesting of such Award shall only be paid out to the extent that the vesting conditions are subsequently satisfied and the Award vests. In addition, notwithstanding anything to the contrary, no dividend equivalents shall be payable with respect to options or stock appreciation rights. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.41pt">RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Plan Administrator is authorized to make Awards of restricted stock units (a right to shares of Common Stock deliverable in the future) to any Eligible Individual selected by the Plan Administrator in such amounts and subject to such terms and conditions as determined by the Plan Administrator. At the time of grant, the Plan Administrator shall specify the date or dates on which the restricted stock units shall become fully vested and nonforfeitable, and may specify such conditions to vesting as it deems appropriate. At the time of grant, the Plan Administrator shall specify the maturity date applicable to each grant of restricted stock units which shall be no earlier than the vesting date or dates of the Award and may be determined at the election of the grantee. On the maturity date, the Corporation shall, subject to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Article Six, Section&#160;V, transfer to the Participant one unrestricted, fully transferable share of Common Stock for each restricted stock unit scheduled to be paid out on such date and not previously forfeited.  </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.03pt">OTHER TERMS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.54pt">Except as otherwise provided herein, the term of any award of stock appreciation rights, dividend equivalents or restricted stock units shall be set by the Plan Administrator in its discretion.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">F.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.14pt">Except as otherwise provided herein, the Plan Administrator may establish the exercise or purchase price, if any, of any award of stock appreciation rights, dividend equivalents or restricted stock units.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">G.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">An award of stock appreciation rights, dividend equivalents or restricted stock units shall only be exercisable or payable prior to the Participant&#8217;s termination of Service&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the Plan Administrator in its sole and absolute discretion may provide that an award of stock appreciation rights, dividend equivalents or restricted stock units may be exercised or paid subsequent to a termination of Service, as applicable, or following a Change in Control of the Corporation, or because of the Participant&#8217;s retirement, death or disability, or otherwise.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">H.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">Payments with respect to any Awards granted under this Article Four shall be made in cash, in Common Stock or a combination of both, as determined by the Plan Administrator.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:29.59pt">All Awards under this Article Four shall be subject to such additional terms and conditions as determined by the Plan Administrator and shall be evidenced by an award agreement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.41pt">CHANGE IN CONTROL&#47;HOSTILE TAKE-OVER</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">J.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:28.97pt">In the event of a Change in Control, each outstanding Award under the Other Stock Award Program shall automatically accelerate so that each such Award shall, immediately prior to the effective date of that Change in Control, become vested and exercisable and&#47;or payable with respect to all the shares of Common Stock at the time subject to such Award and may be exercised or paid for any or all of those shares as fully vested shares of Common Stock. However, an outstanding Award shall NOT become vested and exercisable and&#47;or payable on such an accelerated basis if and to the extent&#58; (i)&#160;such Award is to be assumed by the successor corporation (or parent thereof) or is otherwise to continue in full force and effect pursuant to the terms of the Change in Control transaction or (ii)&#160;such Award is to be replaced with a cash incentive program of the successor corporation which preserves the spread existing at the time of the Change in Control on any shares for which the Award is not otherwise at that time vested, exercisable or payable and provides for subsequent payout of that spread in accordance with the same exercise&#47;vesting&#47;payment schedule applicable to those Award shares or (iii)&#160;the acceleration of such Award is subject to other limitations imposed by the Plan Administrator at the time of the Award grant. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">K.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">Immediately following the consummation of the Change in Control, all outstanding Awards under the Other Stock Award Program shall terminate and cease to be outstanding, except to the extent assumed by the successor corporation (or parent thereof) or otherwise continued in full force and effect pursuant to the terms of the Change in Control transaction. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">L.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.54pt">Each Award which is assumed in connection with a Change in Control or otherwise continued in effect shall be appropriately adjusted, immediately after such Change in Control, to apply to the number and class of securities which would have been issuable to the Participant in consummation of such Change in Control had the Award been exercised or paid immediately prior to such Change in Control. Appropriate adjustments shall also be made to the exercise or purchase price payable per share under each outstanding Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the aggregate exercise or purchase price payable for such securities shall remain the same. To the extent the actual holders of the Corporation&#8217;s outstanding Common Stock receive cash consideration for their Common Stock in consummation of the Change in Control, the successor corporation may, in connection with the assumption of the outstanding Awards under the Other Stock Award Program, substitute one or more shares of its own common stock with a fair market value equivalent to the cash consideration paid per share of Common Stock in such Change in Control transaction.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">M.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.47pt">The Plan Administrator shall have the discretionary authority to structure one or more outstanding Awards under the Other Stock Award Program so that those Awards shall, immediately prior to the effective date of a Change in Control, become vested and exercisable and&#47;or payable exercisable for all the shares of Common Stock at the time subject to those Awards and may be exercised or paid for any or all of those shares as fully vested shares of Common Stock, whether or not those Awards are to be assumed in the Change in Control transaction or otherwise continued in effect. In addition, the Plan Administrator shall have the discretionary authority to structure one or more of the Corporation&#8217;s repurchase rights under the Other Stock Award Program so that those rights shall immediately terminate upon the consummation of the Change in Control transaction, and the shares subject to those terminated rights shall thereupon vest in full. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">N.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">The Plan Administrator shall have full power and authority to structure one or more outstanding Awards under the Other Stock Award Program so that those Awards shall become vested and exercisable and&#47;or payable for all the shares of Common Stock at the time subject to those Awards in the event the Participant&#8217;s Service is subsequently terminated by reason of an Involuntary Termination within a designated period (not to exceed eighteen (18) months) following the effective date of any Change in Control transaction in which those Awards do not otherwise accelerate. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">O.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">The Plan Administrator shall have the discretionary authority to structure one or more outstanding Awards under the Other Stock Award Program so that those Awards shall, immediately prior to the effective date of a Hostile Take-Over, become vested and exercisable and&#47;or payable for all the shares of Common Stock at the time subject to those Awards and may be exercised or paid for any or all of those shares as fully vested shares of Common Stock. Alternatively, the Plan Administrator may condition the automatic acceleration of one or more outstanding Awards under the Other Stock Award Program upon the subsequent termination of the Optionee&#8217;s Service by reason of an Involuntary Termination within a designated period (not to exceed eighteen (18) months) following the effective date of such Hostile Take-Over.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">P.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.14pt">The outstanding Awards shall in no way affect the right of the Corporation to adjust, reclassify, reorganize or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Article 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:31.41pt"><br><br>&#91;INTENTIONALLY OMITTED&#93;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Article 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:31.41pt"><br><br>MISCELLANEOUS</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:28.97pt">TAX WITHHOLDING</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">The Corporation&#8217;s obligation to deliver shares of Common Stock upon the exercise, vesting or payment of Awards under the Plan shall be subject to the satisfaction of all applicable income and employment tax withholding requirements.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">The Plan Administrator may, in its discretion, provide any or all holders of Awards under the Plan with the right to use shares of Common Stock in satisfaction of all or part of the Withholding Taxes to which such holders may become subject in connection with the exercise, vesting or payment of their Awards. Such right may be provided to any such holder in either or both of the following formats&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">Stock Withholding&#58; The election to have the Corporation withhold, from the shares of Common Stock otherwise issuable upon the exercise, vesting or payment of such Award, a portion of those shares with an aggregate Fair Market Value equal to the minimum required percentage of the Withholding Taxes.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock Delivery&#58; The election to deliver to the Corporation, at the time the Award is exercised, vests or is paid, one or more shares of Common Stock previously acquired by such holder </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(other than in connection with the exercise, vesting or payment triggering the Withholding Taxes) and held for at least six (6) months (or such other period determined by the Plan Administrator) with an aggregate Fair Market Value equal to the percentage of the Withholding Taxes (not to exceed one hundred percent (100%)) designated by the holder.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.54pt">Notwithstanding any other provision of the Plan, the number of shares of Common Stock which may be withheld or delivered by the Participant in order to satisfy the Withholding Taxes with respect to the exercise, vesting or payment of an Award shall be limited to the number of shares of Common Stock which have a Fair Market Value on the date of withholding or delivery equal to the aggregate amount of such Withholding Taxes based on the minimum statutory withholding rates for federal, state, local and foreign income tax and payroll tax purposes that are applicable to such supplemental taxable income or such higher rate as may approved by the Plan Administrator (which rates shall in no event exceed the maximum individual statutory tax rate in the applicable jurisdiction at the time of such withholding (or such other rate as may be required to avoid the liability classification of the applicable award under generally accepted accounting principles in the United States of America))&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, unless otherwise approved by the Plan Administrator, to the extent such shares of Common Stock were acquired by the Participant from the Corporation as compensation, the shares of Common Stock must have been held for the minimum period required by applicable accounting rules to avoid a charge to the Corporation&#8217;s earnings for financial reporting purposes&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the number of shares of Common Stock withheld or delivered shall be rounded up to the nearest whole share sufficient to cover the Withholding Taxes to the extent rounding up to the nearest whole share does not result in the liability classification of the applicable Award under generally accepted accounting principles in the United States of America.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:24.69pt">EFFECTIVE DATE AND TERM OF THE PLAN</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">This Plan became effective on the date it was adopted by the Board.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">The Plan shall remain in effect until the earliest to occur of (i) the termination of the Plan by the Board or the Committee, or (ii)&#160;the termination of all outstanding options in connection with a Change in Control. In the event of the termination of the Plan, then all option grants and unvested stock issuances outstanding at that time shall continue to have force and effect in accordance with the provisions of the documents evidencing such grants or issuances.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:20.41pt">AMENDMENT OF THE PLAN</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Board or the Committee shall have complete and exclusive power and authority to amend or modify the Plan in any or all respects. However, no such amendment or modification shall adversely affect the rights and obligations with respect to Awards at the time outstanding under the Plan unless the Optionee or the Participant consents to such amendment or modification. In addition, certain amendments may require stockholder approval pursuant to applicable laws or regulations. Except as permitted by Article One, Section&#160;V, Article Two, Section&#160;II or Article Four, Section&#160;V in connection with a transaction specified in Article One, Section&#160;V.D or V.E (including, without limitation, any Change in Control, Hostile Take-Over, stock dividend, stock split, extraordinary cash dividend, recapitalization, combination of shares or exchange of shares), the terms of outstanding Awards may not be amended to reduce the exercise price of outstanding options or stock appreciation rights or cancel, exchange, substitute, buyout or surrender outstanding options or stock appreciation rights in exchange for cash, other Awards or options or stock appreciation rights with an exercise price that is less than the exercise price of the original options or stock appreciation rights without stockholder approval.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.03pt">STOCKHOLDER APPROVAL NOT REQUIRED</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">It is expressly intended that the approval of the Corporation&#8217;s stockholders not be required as a condition of the effectiveness of the Plan, and the Plan&#8217;s provisions shall be interpreted in a manner consistent with such intent for all purposes. Specifically, Nasdaq Stock Market Rule 5635(c) generally requires stockholder approval for stock option plans or other equity compensation arrangements adopted by companies whose securities are listed on the Nasdaq Stock Market pursuant to which stock awards or stock may be acquired by officers, directors, employees or consultants of such companies. Nasdaq Stock </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Market Rule 5635(c)(4) provides an exemption in certain circumstances for &#8220;employment inducement&#8221; awards (within the meaning of Nasdaq Stock Market Rule 5635(c)(4)). Notwithstanding anything to the contrary herein, if the Corporation&#8217;s securities are traded on the Nasdaq Stock Market, then Awards under the Plan may only be made to Employees who have not previously been an Employee or director of the Corporation or an affiliate, or following a bona fide period of non-employment by the Corporation or an affiliate, in each case as an inducement material to the Employee&#8217;s entering into employment with the Corporation or an affiliate. Awards under the Plan will be approved by the Plan Administrator. Accordingly, pursuant to Nasdaq Stock Market Rule 5635(c)(4), the issuance of Awards and the Common Stock issuable upon exercise or vesting of such Awards pursuant to the Plan are not subject to the approval of the Corporation&#8217;s stockholders. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:25.31pt">USE OF PROCEEDS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any cash proceeds received by the Corporation from the sale of shares of Common Stock under the Plan shall be used for general corporate purposes.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.03pt">REGULATORY APPROVALS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">The implementation of the Plan, the granting of any Award under the Plan and the issuance of any shares of Common Stock under the Plan shall be subject to the Corporation&#8217;s procurement of all approvals and permits required by regulatory authorities having jurisdiction over the Plan, the Awards granted under it and the shares of Common Stock issued pursuant to it. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">No shares of Common Stock or other assets shall be issued or delivered under the Plan unless and until there shall have been compliance with all applicable requirements of applicable securities laws, including the filing and effectiveness of the Form S-8 registration statement for the shares of Common Stock issuable under the Plan, and all applicable listing requirements of any stock exchange (or the Nasdaq Global Market, if applicable) on which Common Stock is then listed for trading.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">All stock certificates delivered pursuant to the Plan are subject to any stop-transfer orders and other restrictions as the Plan Administrator deems necessary or advisable to comply with federal, state, or foreign jurisdiction, securities or other laws, rules and regulations and the rules of any national securities exchange or automated quotation system on which the Common Stock is listed, quoted, or traded. The Plan Administrator may place legends on any stock certificate to reference restrictions applicable to the Common Stock. In addition to the terms and conditions provided herein, the Board may require that an Optionee or Participant make such reasonable covenants, agreements, and representations as the Board, in its discretion, deems advisable in order to comply with any such laws, regulations, or requirements. The Plan Administrator shall have the right to require any Optionee or Participant to comply with any timing or other restrictions with respect to the settlement or exercise of any Award, including a window-period limitation, as may be imposed in the discretion of the Plan Administrator.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">Notwithstanding any other provision of the Plan, unless otherwise determined by the Plan Administrator or required by any applicable law, rule or regulation, the Corporation shall not deliver to any Optionee or Participant certificates evidencing shares of Common Stock issued in connection with any award and instead such shares of Common Stock shall be recorded in the books of the Corporation (or, as applicable, its transfer agent or stock plan administrator).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.54pt">In the event that the Corporation establishes, for itself or using the services of a third party, an automated system for the documentation, granting or exercise of Awards, such as a system using an internet website or interactive voice response, then the paperless documentation, granting or exercise of Awards by an Optionee or a Participant may be permitted through the use of such an automated system.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:16.75pt">NO EMPLOYMENT&#47;SERVICE RIGHTS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Nothing in the Plan shall confer upon the Optionee or the Participant any right to continue in Service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Corporation (or any Parent or Subsidiary employing or retaining such person) or of the Optionee or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Participant, which rights are hereby expressly reserved by each, to terminate such person&#8217;s Service at any time for any reason, with or without cause.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">VIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:12.47pt">COMPLIANCE WITH SECTION 409A OF THE CODE  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To the extent that the Plan Administrator determines that any Award granted under the Plan is subject to Section&#160;409A of the Code, the agreement evidencing such Award shall incorporate the terms and conditions required by Section&#160;409A of the Code. To the extent applicable, the Plan and Award agreements shall be interpreted in accordance with Section&#160;409A of the Code and Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the adoption of the Plan. Notwithstanding any provision of the Plan to the contrary, in the event that following the adoption of the Plan the Plan Administrator determines that any Award may be subject to Section&#160;409A of the Code and related Department of Treasury guidance (including such Department of Treasury guidance as may be issued after the adoption of the Plan), the Plan Administrator may adopt such amendments to the Plan and the applicable Award agreement or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Plan Administrator determines are necessary or appropriate to (a) exempt the Award from Section&#160;409A of the Code and&#47;or preserve the intended tax treatment of the benefits provided with respect to the Award, or (b)&#160;comply with the requirements of Section&#160;409A of the Code and related Department of Treasury guidance.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IX.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.03pt">FORFEITURE AND CLAW-BACK PROVISIONS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">Pursuant to its general authority to determine the terms and conditions applicable to Awards under the Plan, the Plan Administrator shall have the right to provide, in the terms of Awards made under the Plan, or to require a participant to agree by separate written or electronic instrument, that&#58; (1)&#160;any proceeds, gains or other economic benefit actually or constructively received by the participant upon any receipt or exercise of the Award, or upon the receipt or resale of any shares underlying the Award, must be paid to the Corporation, and (2)&#160;the Award shall terminate and any unexercised portion of the Award (whether or not vested) shall be forfeited, if (i)&#160;a termination of Service occurs prior to a specified date, or within a specified time period following receipt or exercise of the Award, (ii)&#160;the participant at any time, or during a specified time period, engages in any activity in competition with the Corporation, or which is inimical, contrary or harmful to the interests of the Corporation, as further defined by the Plan Administrator or (iii) the participant incurs a termination of Service for Misconduct&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">All Awards (including any proceeds, gains or other economic benefit actually or constructively received by a participant upon any receipt or exercise of any Award or upon the receipt or resale of any shares underlying the Award) shall be subject to the applicable provisions of any claw-back policy implemented by the Corporation, whether implemented prior to or after the grant of such Award, including without limitation, any claw-back policy adopted to comply with the requirements of applicable law, including without limitation, the Dodd-Frank Wall Street Reform and Consumer Protection Act and any rules or regulations promulgated thereunder, to the extent set forth in such claw-back policy and&#47;or in the applicable Award agreement.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><div id="i4c569442ea764f578fc25159052dc515_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">APPENDIX</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The following definitions shall be in effect under the Plan&#58; </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">AWARD shall mean an option, stock issuance award, stock appreciation right award, restricted stock unit award or dividend equivalent award granted pursuant to the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">BOARD shall mean the Corporation&#8217;s Board of Directors. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">CHANGE IN CONTROL shall mean a change in ownership or control of the Corporation effected through any of the following transactions&#58; </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">a merger, consolidation or other reorganization approved by the Corporation&#8217;s stockholders, unless securities representing more than fifty percent (50%) of the total combined voting power of the voting securities of the successor corporation are immediately thereafter beneficially owned, directly or indirectly and in substantially the same proportion, by the persons who beneficially owned the Corporation&#8217;s outstanding voting securities immediately prior to such transaction, or </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">the sale, transfer or other disposition of all or substantially all of the Corporation&#8217;s assets in complete liquidation or dissolution of the Corporation, or</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">the acquisition, directly or indirectly by any person or related group of persons (other than the Corporation or a person that directly or indirectly controls, is controlled by, or is under common control with, the Corporation), of beneficial ownership (within the meaning of Rule 13d-3 of the 1934 Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Corporation&#8217;s outstanding securities pursuant to a tender or exchange offer made directly to the Corporation&#8217;s stockholders. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">CODE shall mean the Internal Revenue Code of 1986, as amended. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">COMMITTEE shall mean the Corporation&#8217;s Human Capital Management and Compensation Committee, which shall consistent solely of two or more Independent Directors appointed and holding office at the pleasure of the Board, each of whom is intended to qualify as a &#8220;non-employee&#8221; director as defined by Rule 16b-3 of the Exchange Act and an &#8220;independent director&#8221; under the rules of any securities exchange or automated quotation system on which the Common Stock are listed, quoted or traded, in each case, to the extent required under such provision.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">COMMON STOCK shall mean the Corporation&#8217;s common stock. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">CORPORATION shall mean Ligand Pharmaceuticals Incorporated, a Delaware corporation, and any corporate successor to all or substantially all of the assets or voting stock of Ligand Pharmaceuticals Incorporated which shall by appropriate action adopt the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.54pt">DISCRETIONARY OPTION GRANT PROGRAM shall mean the discretionary option grant program in effect under Article Two of the Plan. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">F.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.14pt">EFFECTIVE DATE shall mean the date the Plan is approved by the Board.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">G.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">ELIGIBLE INDIVIDUAL shall mean any prospective Employee who has not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">previously been an Employee or director of the Corporation, Parent, Subsidiary or any of their affiliates, or who is commencing employment with the Corporation, Parent, Subsidiary or any of their affiliates, as applicable, following a bona fide period of non-employment by the Corporation, Parent, Subsidiary or any of their affiliates, if he or she is granted an Award in connection with his or her commencement of employment with the Corporation, Parent, Subsidiary or any of their affiliates, as applicable, and such grant is an inducement material to his or her entering into employment with the Corporation, Parent, Subsidiary or any of their affiliates, as applicable, (within the meaning of Nasdaq Stock Market Rule IM-5636-1 or any successor rule, if the Corporation&#8217;s securities are traded on the Nasdaq Stock Market, and&#47;or the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A-1</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">applicable requirements of any other established stock exchange on which the Corporation&#8217;s securities are traded, as applicable, as such rules and requirements may be amended from time to time). The Plan Administrator may in its discretion adopt procedures from time to time to ensure that a prospective Employee is eligible to participate in the Plan prior to the granting of any Awards to such individual under the Plan (including without limitation a requirement that each such prospective Employee certify to the Corporation prior to the receipt of an Award under the Plan that he or she has not been previously employed by the Corporation, Parent, Subsidiary or any of their affiliates, or if previously employed, has had a bona fide period of non-employment, and that the grant of Awards under the Plan is an inducement material to his or her agreement to enter into employment with the Corporation, Parent, Subsidiary or any of their affiliates, as applicable).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">H.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">EMPLOYEE shall mean an individual who is in the employ of the Corporation (or any Parent or Subsidiary), subject to the control and direction of the employer entity as to both the work to be performed and the manner and method of performance.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:29.59pt">EXERCISE DATE shall mean the date on which the Corporation shall have received written notice of the option exercise.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">J.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:28.97pt">FAIR MARKET VALUE per share of Common Stock on any relevant date shall be determined in accordance with the following provisions&#58; </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">If the Common Stock is at the time traded on the Nasdaq Global Market, then the Fair Market Value shall be the closing selling price per share of Common Stock on the date in question, as such price is reported by the National Association of Securities Dealers on the Nasdaq Global Market and published in The Wall Street Journal. If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value shall be the closing selling price on the last preceding date for which such quotation exists.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">If the Common Stock is at the time listed for trading on any stock exchange, then the Fair Market Value shall be the closing selling price per share of Common Stock on the date in question on the stock exchange determined by the Plan Administrator to be the primary market for the Common Stock, as such price is officially quoted in the composite tape of transactions on such exchange and published in The Wall Street Journal. If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value shall be the closing selling price on the last preceding date for which such quotation exists. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">K.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">HOSTILE TAKE-OVER shall mean a change in ownership or control of the Corporation effected through either of the following transactions&#58; </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">a change in the composition of the Board over a period of thirty-six (36) consecutive months or less such that a majority of the Board members ceases, by reason of one or more contested elections for Board membership, to be comprised of individuals who either (A)&#160;have been Board members continuously since the beginning of such period or (B)&#160;have been elected or nominated for election as Board members during such period by at least a majority of the Board members described in clause (A) who were still in office at the time the Board approved such election or nomination, or</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">a Hostile Tender-Offer.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">L.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.54pt">HOSTILE TENDER-OFFER shall mean the acquisition, directly or indirectly, by any person or related group of persons (other than the Corporation or a person that directly or indirectly controls, is controlled by, or is under common control with, the Corporation) of beneficial ownership (within the meaning of Rule 13d-3 of the 1934 Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Corporation&#8217;s outstanding securities pursuant to a tender or exchange offer made directly to the Corporation&#8217;s stockholders which the Board does not recommend such stockholders to accept.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">M.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.47pt">INDEPENDENT DIRECTOR shall mean a director of the Corporation who is not an Employee of the Corporation or an affiliate and who qualifies as &#8220;independent&#8221; within the meaning of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A-2</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NASDAQ Stock Market Rule 5605(a)(2), or any successor rule, if the Corporation&#8217;s securities are traded on the NASDAQ Stock Market, and&#47;or the applicable requirements of any other established stock exchange on which the Corporation&#8217;s securities are traded, as applicable, as such rules and requirements may be amended from time to time. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">N.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">INVOLUNTARY TERMINATION shall mean the termination of the Service of any individual which occurs by reason of&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">such individual&#8217;s involuntary dismissal or discharge by the Corporation for reasons other than Misconduct, or</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">such individual&#8217;s voluntary resignation following (A) a change in his or her position with the Corporation which materially reduces his or her duties and responsibilities or the level of management to which he or she reports, (B) a reduction in his or her level of compensation (including base salary, fringe benefits and target bonus under any corporate-performance based bonus or incentive programs) by more than fifteen percent (15%) or (C)&#160;a relocation of such individual&#8217;s place of employment by more than fifty (50) miles, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and only if such change, reduction or relocation is effected by the Corporation without the individual&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">O.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">MISCONDUCT shall mean the commission of any act of fraud, embezzlement or dishonesty by the Optionee or Participant, any unauthorized use or disclosure by such person of confidential information or trade secrets of the Corporation (or any Parent or Subsidiary), or any other intentional misconduct by such person adversely affecting the business or affairs of the Corporation (or any Parent or Subsidiary) in a material manner. The foregoing definition shall not in any way preclude or restrict the right of the Corporation (or any Parent or Subsidiary) to discharge or dismiss any Optionee, Participant or other person in the Service of the Corporation (or any Parent or Subsidiary) for any other acts or omissions, but such other acts or omissions shall not be deemed, for purposes of the Plan, to constitute grounds for termination for Misconduct. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">P.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.14pt">1934 ACT shall mean the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Q.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">NON-STATUTORY OPTION shall mean an option not intended to satisfy the requirements of Code Section&#160;422.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">R.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.92pt">OPTIONEE shall mean any person to whom an option is granted under the Discretionary Option Grant Program.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">S.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.14pt">OTHER STOCK AWARD PROGRAM shall mean the discretionary stock award grant program in effect under Article Four of the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">T.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.54pt">PARENT shall mean any corporation (other than the Corporation) in an unbroken chain of corporations ending with the Corporation, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> each corporation in the unbroken chain (other than the Corporation) owns, at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">PARTICIPANT shall mean any Eligible Individual who is issued an Award under the Plan other than an option.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">PERMANENT DISABILITY OR PERMANENTLY DISABLED shall mean the inability of the Optionee or the Participant to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment expected to result in death or to be of continuous duration of twelve (12) months or more. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">W.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.87pt">PLAN shall mean the Corporation&#8217;s 2022 Employment Inducement Plan, as set forth in this document.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A-3</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">X.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">PLAN ADMINISTRATOR shall mean the particular entity that conducts the general administration of the Plan as provided in Article One, Section&#160;III hereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Y.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.31pt">SERVICE shall mean the performance of services for the Corporation (or any Parent or Subsidiary) by a person in the capacity of an Employee, a non-employee member of the board of directors or a consultant or independent advisor, except to the extent otherwise specifically provided in the documents evidencing the option grant or stock issuance.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Z.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.54pt">STOCK ISSUANCE AGREEMENT shall mean the agreement entered into by the Corporation and the Participant at the time of issuance of shares of Common Stock under the Stock Issuance Program.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AA.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.37pt">STOCK ISSUANCE PROGRAM shall mean the stock issuance program in effect under Article Three of the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AB.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.98pt">SUBSIDIARY shall mean any corporation (other than the Corporation) in an unbroken chain of corporations beginning with the Corporation, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> each corporation (other than the last corporation) in the unbroken chain owns, at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AC.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.98pt">WITHHOLDING TAXES shall mean the applicable income and employment withholding taxes to which the holder of Non-Statutory Options or unvested shares of Common Stock may become subject in connection with the exercise of those options or the vesting of those shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A-4</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>3
<FILENAME>exhibit_103xligand-formofs.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i622a60ed010d4a79ab51adcb0d9991d8_1"></div><div style="min-height:67.68pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Exhibit 10.3</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">LIGAND PHARMACEUTICALS INCORPORATED<br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">2022 EMPLOYMENT INDUCEMENT PLAN</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">NOTICE OF GRANT OF STOCK OPTION <br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#160;&#160;&#160;&#160;Ligand Pharmaceuticals Incorporated, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#8221;), pursuant to its 2022 Employment Inducement Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#8221;), hereby grants to the holder listed below (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Optionee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#8221;) a stock option to purchase the number of shares (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#8221;) of Common Stock of the Corporation set forth below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#8221;).  This Option is subject to all of the terms and conditions as set forth in this Notice of Grant of Stock Option Grant (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#8221;) and the Stock Option Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Stock Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#8221;) attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">, and the Plan, each of which are incorporated herein by reference.  Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Grant Notice and the Stock Option Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Optionee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#58;&#160;&#160;&#160;&#160;___________________</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Grant Number&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#160;&#160;&#160;&#160;___________________</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Grant Date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#160;&#160;&#160;&#160;___________________</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Vesting Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#58;&#160;&#160;&#160;&#160;___________________</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Exercise Price&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#160;&#160;&#160;&#160;$___________________</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Number of Option Shares&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#160;&#160;&#160;&#160;___________________</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Expiration Date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#160;&#160;&#160;&#160;___________________</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Type of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#58;&#160;&#160;&#160;&#160;Non-Statutory Option</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify;text-indent:-180pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Exercise Schedule&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#160;&#160;&#160;&#160;The Option will vest as follows, subject to Optionee&#8217;s continued Service through each such vesting date&#58;</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-180pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">  </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.120%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.120%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt dashed #929292;border-top:1pt dashed #929292;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:10.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Shares</font></div></td><td colspan="3" style="border-left:1pt dashed #929292;border-top:1pt dashed #929292;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Vest Type</font></td><td colspan="3" style="border-left:1pt dashed #929292;border-right:1pt dashed #929292;border-top:1pt dashed #929292;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Full Vest</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt dashed #929292;border-left:1pt dashed #929292;border-top:1pt dashed #929292;padding:0 1pt"><div style="padding-left:2.75pt;padding-right:10.9pt"><font><br></font></div></td><td colspan="3" style="border-bottom:1pt dashed #929292;border-left:1pt dashed #929292;border-top:1pt dashed #929292;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt dashed #929292;border-left:1pt dashed #929292;border-right:1pt dashed #929292;border-top:1pt dashed #929292;padding:0 1pt"></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#160;&#160;&#160;&#160;Optionee understands and agrees that the Option is granted subject to and in accordance with the terms of the Plan.  By electronically accepting this Option, Optionee further agrees to be bound by the terms of the Plan and the terms of the Option as set forth in the Stock Option Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">.  Optionee hereby acknowledges that he or she has been provided with a copy or electronic access to the Plan and the prospectus for the Plan.  A printed copy of the Plan and&#47;or prospectus is available upon request made to the Secretary of the Corporation at the Corporation&#8217;s principal offices.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Employment at Will</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">.  Nothing in this Grant Notice, in the attached Stock Option Agreement or in the Plan shall confer upon Optionee any right to continue in Service for any period of specific duration or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:8pt;font-weight:400;line-height:174%">&#124;&#124;</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:8pt;font-weight:400;line-height:174%">&#124; </font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Exhibit 10.3</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">interfere with or otherwise restrict in any way the rights of the Corporation (or any Parent or Subsidiary employing or retaining Optionee) or of Optionee, which rights are hereby expressly reserved by each, to terminate Optionee&#8217;s Service at any time for any reason, with or without cause.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">.  All capitalized terms in this Grant Notice shall have the meaning assigned to them in this Grant Notice or in the attached Stock Option Agreement.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:127%">By accepting Optionee&#8217;s signature below, Optionee agrees to be bound by the terms and conditions of this Grant Notice, the Stock Option Agreement and the Plan.  Optionee has reviewed this Grant Notice, the Stock Option Agreement and the Plan in their entirety, has had an opportunity to obtain the advice of counsel prior to executing the Grant Notice and fully understands all provisions of this Grant Notice, the Stock Option Agreement and the Plan.  Optionee hereby agrees to accept as binding, conclusive and final all decision and interpretations of the Plan Administrator upon any questions arising under this Grant Notice, the Stock Option Agreement and the Plan.  </font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS INCORPORATED</font></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">OPTIONEE</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Print Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Print Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:8pt;font-weight:400;line-height:174%">&#124;&#124;</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:8pt;font-weight:400;line-height:174%">&#124; </font></div></div></div><div id="i622a60ed010d4a79ab51adcb0d9991d8_4"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font></div></div><div style="margin-bottom:12pt;margin-top:3.35pt;padding-right:-7.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div style="padding-right:-7.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS INCORPORATED</font></div><div style="margin-top:0.1pt;padding-right:-15pt"><font><br></font></div><div style="padding-right:-7.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STOCK OPTION AGREEMENT</font></div><div style="padding-right:-15pt"><font><br></font></div><div style="margin-top:0.3pt;padding-right:-15pt"><font><br></font></div><div style="margin-top:1.4pt;padding-right:-7.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">RECITALS</font></div><div style="margin-top:0.45pt;padding-right:-15pt;text-indent:36pt"><font><br></font></div><div style="margin-top:1.4pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">The Board has adopted the Plan as an incentive for Eligible Individuals (as defined in the Plan) to commence and remain in service to the Corporation (or a Parent or Subsidiary).</font></div><div style="margin-top:1.4pt;padding-left:36pt;padding-right:-1pt;text-align:justify"><font><br></font></div><div style="margin-top:1.4pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.84pt">In consideration of Optionee&#8217;s agreement to commence employment with and remain in the employ of the Corporation (or a Parent or Subsidiary), and for other good and valuable considseration, effective as of the Grant Date set forth in the Grant Notice, the Corporation has granted to Optionee an Option to purchase the Shares set forth in the Grant Notice.</font></div><div style="margin-top:1.4pt;padding-left:36pt;padding-right:-1pt;text-align:justify"><font><br></font></div><div style="margin-top:1.4pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.84pt">Optionee is to render valuable services to the Corporation (or a Parent or Subsidiary), and this Agreement is executed pursuant to, and is intended to carry out the purposes of, the Plan in connection with the Corporation&#8217;s grant of an Option to Optionee.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%;padding-left:26.28pt">All capitalized terms in this Agreement shall have the meaning assigned to them in the attached Appendix.</font></div><div style="margin-top:0.45pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOW, THEREFORE, it is hereby agreed as follows&#58;</font></div><div style="margin-top:0.1pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt"> GRANT OF OPTION.  The Corporation hereby grants to Optionee, as of the Grant Date, an Option to purchase up to the number of Option Shares specified in the Grant Notice.  The Option Shares shall be purchasable from time to time during the Option term specified in Paragraph 2 at the Exercise Price. </font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">The Option is intended to constitute an &#8220;employment inducement grant&#8221; under NASDAQ Listing Rule 5635(c)(4), and consequently is intended to be exempt from the NASDAQ rules regarding stockholder approval of stock option and stock purchase plans.  This Agreement and the terms and conditions of the Option shall be interpreted in accordance and consistent with such exemption.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">OPTION TERM.  This Option shall have a maximum term of ten (10) years measured from the Grant Date and shall accordingly expire at the close of business on the Expiration Date, unless sooner terminated in accordance with Paragraph 5 or 6.</font></div><div style="margin-top:0.15pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">LIMITED TRANSFERABILITY.</font></div><div style="margin-top:0.1pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">This Option shall be neither transferable nor assignable by Optionee other than by will or the laws of inheritance following Optionee&#8217;s death and may be exercised, during Optionee&#8217;s lifetime, only by Optionee.  However, Optionee may designate one or more persons as the beneficiary or beneficiaries of this Option, and this Option shall, in accordance with such designation, automatically be transferred to such beneficiary or beneficiaries upon the Optionee&#8217;s death while holding this Option.  Such beneficiary or beneficiaries shall take the transferred Option subject to all the terms and conditions of this Agreement, including (without limitation) the limited time period during which this Option may, pursuant to Paragraph 5, be exercised following Optionee&#8217;s death.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">This Option may be assigned in whole or in part during Optionee&#8217;s lifetime to one or more members of Optionee&#8217;s family or to a trust established for the exclusive benefit of one or more such family members or to Optionee&#8217;s former spouse, to the extent such assignment is in connection with the Optionee&#8217;s estate plan or pursuant to a domestic relations order.  The assigned portion shall be exercisable only by the person or persons who acquire a proprietary interest in the Option pursuant to such assignment.  The terms applicable to the assigned portion shall be the same as those in effect for this Option immediately prior to such assignment.</font></div><div style="margin-top:0.15pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">DATES OF EXERCISE.  This Option shall become exercisable for the Option Shares in one or more installments as specified in the Grant Notice.  As the Option becomes exercisable for such installments, those installments shall accumulate, and the Option shall remain exercisable for the accumulated installments until the Expiration Date or sooner termination of the Option term under Paragraph 5 or 6.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">A-1</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:8pt;font-weight:400;line-height:174%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font></div></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">CESSATION OF SERVICE.  The Option term specified in Paragraph 2 shall terminate (and this Option shall cease to be outstanding) prior to the Expiration Date should any of the following provisions become applicable&#58;</font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">Should Optionee cease to remain in Service for any reason (other than death or Permanent Disability) while this Option is outstanding, then Optionee (or any person or persons to whom this Option is transferred pursuant to a permitted transfer under Paragraph 3) shall have a period of three (3) months (commencing with the date of such cessation of Service) during which to exercise this Option, but in no event shall this Option be exercisable at any time after the Expiration Date.</font></div><div style="padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Should Optionee die while this Option is outstanding, then the personal representative of Optionee&#8217;s estate or the person or persons to whom the Option is transferred pursuant to Optionee&#8217;s will or the laws of inheritance following Optionee&#8217;s death or to whom the Option is transferred during Optionee&#8217;s lifetime pursuant to a permitted transfer under Paragraph 3 shall have the right to exercise this Option.  However, if Optionee dies while holding this Option and has an effective beneficiary designation in effect for this Option at the time of his or her death, then the designated beneficiary or beneficiaries shall have the exclusive right to exercise this Option following Optionee&#8217;s death.  Any such right to exercise this Option shall lapse, and this Option shall cease to be outstanding, upon the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">earlier</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> of (i) the expiration of the twelve (12)-month period measured from the date of Optionee&#8217;s death or (ii) the Expiration Date.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">Should Optionee cease Service by reason of Permanent Disability while this Option is outstanding, then Optionee (or any person or persons to whom this Option is transferred pursuant to a permitted transfer under Paragraph 3) shall have a period of twelve (12) months (commencing with the date of such cessation of Service) during which to exercise this Option.  In no event shall this Option be exercisable at any time after the Expiration Date.</font></div><div style="padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">During the limited period of post-Service exercisability, this Option may not be exercised in the aggregate for more than the number of Option Shares for which the Option is exercisable at the time of Optionee&#8217;s cessation of Service.  Upon the expiration of such limited exercise period or (if earlier) upon the Expiration Date, this Option shall terminate and cease to be outstanding for any exercisable Option Shares for which the Option has not been exercised.  However, this Option shall, immediately upon Optionee&#8217;s cessation of Service for any reason, terminate and cease to be outstanding with respect to any Option Shares for which this Option is not otherwise at that time exercisable.</font></div><div style="padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">SPECIAL ACCELERATION OF OPTION.</font></div><div style="margin-top:0.1pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">This Option, to the extent outstanding at the time of a Change in Control but not otherwise fully exercisable, shall automatically accelerate so that this Option shall, immediately prior to the effective date of such Change in Control, become exercisable for all of the Option Shares at the time subject to this Option and may be exercised for any or all of those Option Shares as fully vested shares of Common Stock.  However, this Option shall not become exercisable on such an accelerated basis, if and to the extent&#58; (i) this Option is to be assumed by the successor corporation (or parent thereof) or is otherwise to be continued in full force and effect pursuant to the terms of the Change in Control transaction or (ii) this Option is to be replaced with a cash incentive program of the successor corporation which preserves the spread existing at the time of the Change in Control on any Option Shares for which this Option is not otherwise at that time exercisable (the excess of the Fair Market Value of those Option Shares over the aggregate Exercise Price payable for such shares) and provides for subsequent payout of that spread in accordance with the same Option exercise&#47;vesting schedule for those Option Shares set forth in the Grant Notice.</font></div><div style="margin-top:0.15pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">Immediately following the Change in Control, this Option shall terminate and cease to be outstanding, except to the extent assumed by the successor corporation (or parent thereof) or otherwise continued in effect pursuant to the terms of the Change in Control transaction.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.01pt">If this Option is assumed in connection with a Change in Control or otherwise continued in effect, then this Option shall be appropriately adjusted, immediately after such Change in Control, to apply to the number and class of securities which would have been issuable to Optionee in consummation of such Change in Control had the Option been exercised immediately prior to such Change in Control, and appropriate adjustments shall also be made to the Exercise Price, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> the aggregate Exercise Price shall remain the same.  To the extent the actual holders of the Corporation&#8217;s outstanding Common Stock receive cash consideration for their Common Stock in consummation of the Change in Control, the successor corporation may, in connection with the assumption of this Option, substitute one or more shares of its own common stock with a fair market value equivalent to the cash consideration paid per share of Common Stock in such Change in Control.</font></div><div style="margin-top:0.15pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">This Agreement shall not in any way affect the right of the Corporation to adjust, reclassify, reorganize or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">A-2</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:8pt;font-weight:400;line-height:174%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font></div></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">ADJUSTMENT IN OPTION SHARES.  The Option shall be subject to adjustment as provided in Article One, Section V of the Plan.</font></div><div style="padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">STOCKHOLDER RIGHTS.  The holder of this Option shall not have any stockholder rights with respect to the Option Shares until such person shall have exercised the Option, paid the Exercise Price and become a holder of record of the purchased shares.</font></div><div style="padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">MANNER OF EXERCISING OPTION.</font></div><div style="margin-top:0.2pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">In order to exercise this Option with respect to all or any part of the Option Shares for which this Option is at the time exercisable, Optionee (or any other person or persons exercising the Option) must take the following actions&#58;</font></div><div style="margin-top:0.2pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">Execute and deliver to the Corporation a Notice of Exercise for the Option Shares for which the Option is exercised.</font></div><div style="padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.8pt">Pay the aggregate Exercise Price for the purchased shares in one or more of the following forms&#58;</font></div><div style="margin-top:0.1pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.12pt">cash or check made payable to the Corporation (includes cash paid from Optionee&#8217;s brokerage pursuant to a presale of shares in a so-called &#8220;cashless&#8221; exercise)&#59;</font></div><div style="margin-top:0.1pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.68pt">subject to the consent of the Plan Administrator, shares of Common Stock held by Optionee (or any other person or persons exercising the Option) for the requisite period necessary to avoid a charge to the Corporation&#8217;s earnings for financial reporting purposes and valued at Fair Market Value on the Exercise Date&#59;</font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.68pt">shares of Common Stock issuable upon the exercise of the Option having a Fair Market Value on the Exercise Date equal to the aggregate exercise price of the Option Shares with respect to which the Option or portion thereof is being exercised&#59; or</font></div><div style="padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.12pt">through a special sale and remittance procedure pursuant to which Optionee (or any other person or persons exercising the Option) shall concurrently provide irrevocable instructions (i) to a brokerage firm to effect the immediate sale of the purchased shares and remit to the Corporation, out of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate Exercise Price payable for the purchased shares plus all applicable income and employment taxes required to be withheld by the Corporation by reason of such exercise and (ii) to the Corporation to deliver the certificates for the purchased shares directly to such brokerage firm in order to complete the sale.</font></div><div style="margin-top:0.4pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="margin-top:3pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">Except to the extent the sale and remittance procedure is utilized in connection with the Option exercise, payment of the Exercise Price must accompany the Notice of Exercise delivered to the Corporation in connection with the Option exercise.</font></div><div style="margin-top:0.1pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.03pt">Furnish to the Corporation appropriate documentation that the person or persons exercising the Option (if other than Optionee) have the right to exercise this Option.</font></div><div style="margin-top:0.2pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">Make appropriate arrangements with the Corporation (or Parent or Subsidiary employing or retaining Optionee) for the satisfaction of all applicable income and employment tax withholding requirements applicable to the Option exercise, which amounts may be paid in on or more of the forms of consideration permitted under clause (ii) above, subject to Article Six, Section I of the Plan and any required consent of the Plan Administrator under clause (ii) above.  To the extent any employment tax withholding will be satisfied by Optionee pursuant to clause (B) or (C) under clause (ii) above, the shares to be surrendered to the Corporation or withheld from the shares of Common Stock otherwise issuable upon the exercise shall be limited to those shares with a Fair Market Value not exceeding the amount necessary to satisfy the tax withholding obligation of the Corporation with respect to the exercise of the Option based on the minimum applicable statutory withholding rates.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">As soon as practical after the Exercise Date, the Corporation shall issue to or on behalf of Optionee (or any other person or persons exercising this Option) a certificate for the purchased Option Shares, with the appropriate legends affixed thereto.</font></div><div style="padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">In no event may this Option be exercised for any fractional shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">A-3</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:8pt;font-weight:400;line-height:174%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font></div></div><div style="margin-top:0.1pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">COMPLIANCE WITH LAWS AND REGULATIONS.</font></div><div style="margin-top:0.2pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">The exercise of this Option and the issuance of the Option Shares upon such exercise shall be subject to compliance by the Corporation and Optionee with all applicable requirements of law relating thereto and with all applicable regulations of any stock exchange (including The Nasdaq Stock Market, if applicable) on which the Common Stock may be listed for trading at the time of such exercise and issuance.</font></div><div style="margin-top:0.2pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">The inability of the Corporation to obtain approval from any regulatory body having authority deemed by the Corporation to be necessary to the lawful issuance and sale of any Common Stock pursuant to this Option shall relieve the Corporation of any liability with respect to the non-issuance or sale of the Common Stock as to which such approval shall not have been obtained.  The Corporation, however, shall use its best efforts to obtain all such approvals.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.5pt">SUCCESSORS AND ASSIGNS.  Except to the extent otherwise provided in Paragraphs 3 and 6, the provisions of this Agreement shall inure to the benefit of, and be binding upon, the Corporation and its successors and assigns and Optionee, Optionee&#8217;s assigns, the legal representatives, heirs and legatees of Optionee&#8217;s estate and any beneficiaries of this Option designated by Optionee.</font></div><div style="margin-top:12pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.5pt">NOTICES.  Any notice required to be given or delivered to the Corporation under the terms of this Agreement shall be in writing and addressed to the Corporation at its principal corporate offices.  Any notice required to be given or delivered to Optionee shall be in writing and addressed to Optionee at the most recent address for Optionee on the Corporation&#8217;s payroll records.  All notices shall be deemed effective upon personal delivery or upon deposit in the U.S. mail, postage prepaid and properly addressed to the party to be notified.</font></div><div style="padding-right:-15pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">CONSTRUCTION.  This Agreement and the Option evidenced hereby are made and granted pursuant to the Plan and are in all respects limited by and subject to the terms of the Plan. All decisions of the Plan Administrator with respect to any question or issue arising under the Plan, the Option, the Grant Notice or this Agreement shall be conclusive and binding on all persons having an interest in this Option.</font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">GOVERNING LAW.  The interpretation, performance and enforcement of this Agreement shall be governed by the laws of the State of California without resort to that State&#8217;s conflict-of-laws rules.</font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">A-4</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:8pt;font-weight:400;line-height:174%">&#124;</font></div></div></div><div id="i622a60ed010d4a79ab51adcb0d9991d8_7"></div><hr style="page-break-after:always"><div style="min-height:58.32pt;width:100%"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font></div></div><div style="margin-top:3.35pt;padding-right:-7.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">APPENDIX</font></div><div style="margin-top:0.5pt;padding-right:-15pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-15pt;text-indent:36pt"><font><br></font></div><div style="margin-top:1.4pt;padding-right:-15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:218%">The following definitions shall be in effect under the Agreement&#58; </font></div><div style="margin-bottom:10pt;padding-right:-15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">AGREEMENT shall mean this Stock Option Agreement.</font></div><div style="margin-bottom:10pt;padding-right:-15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.84pt">BOARD shall mean the Corporation&#8217;s Board of Directors.</font></div><div style="margin-bottom:10pt;padding-right:-15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.84pt">CHANGE IN CONTROL shall mean a change in ownership or control of the Corporation effected through any of the following transactions&#58;</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">a merger, consolidation or other reorganization approved by the Corporation&#8217;s stockholders, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">unless</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> securities representing more than fifty percent (50%) of the total combined voting power of the voting securities of the successor corporation are immediately thereafter beneficially owned, directly or indirectly and in substantially the same proportion, by the persons who beneficially owned the Corporation&#8217;s outstanding voting securities immediately prior to such transaction, or</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.8pt">the sale, transfer or other disposition of all or substantially all of the Corporation&#8217;s assets in complete liquidation or dissolution of the Corporation, or</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.03pt">the acquisition, directly or indirectly by any person or related group of persons (other than the Corporation or a person that directly or indirectly controls, is controlled by, or is under common control with, the Corporation), of beneficial ownership (within the meaning of Rule 13d-3 of the 1934 Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Corporation&#8217;s outstanding securities pursuant to a tender or exchange offer made directly to the Corporation&#8217;s stockholders.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:27.4pt">COMMON STOCK shall mean shares of the Corporation&#8217;s common stock. </font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:27.94pt">CODE shall mean the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">G.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">CORPORATION shall mean Ligand Pharmaceuticals Incorporated, a Delaware corporation, and any successor corporation to all or substantially all of the assets or voting stock of Ligand Pharmaceuticals Incorporated which shall by appropriate action adopt the Plan.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">H.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">EMPLOYEE shall mean an individual who is in the employ of the Corporation (or any Parent or Subsidiary), subject to the control and direction of the employer entity as to both the work to be performed and the manner and method of performance.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:30.17pt">EXERCISE DATE shall mean the date on which the Option shall have been exercised in accordance with Paragraph 9 of the Agreement.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:29.61pt">EXERCISE PRICE shall mean the exercise price per Option Share as specified in the Grant Notice.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">EXPIRATION DATE shall mean the date on which the Option expires as specified in the Grant Notice.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">L.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:27.4pt">FAIR MARKET VALUE per share of Common Stock on any relevant date shall be determined in accordance with the following provisions&#58;</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">If the Common Stock is at the time traded on The Nasdaq Stock Market, then the Fair Market Value shall be deemed equal to the closing selling price per share of Common Stock on the date in question, as the price is reported by the National Association of Securities Dealers on The Nasdaq Stock Market and published in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value shall be the closing selling price on the last preceding date for which such quotation exists, or</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.8pt">If the Common Stock is at the time listed on any stock exchange, then the Fair Market Value shall be deemed equal to the closing selling price per share of Common Stock on the date in question on the stock exchange determined by the Plan Administrator to be the primary market for the Common Stock, as such price is officially quoted in the composite tape of transactions on such exchange and published in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value shall be the closing selling price on the last preceding date for which such quotation exists.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.61pt">GRANT DATE shall mean the date of grant of the Option as specified in the Grant Notice.</font></div><div style="height:79.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:155%">A-1</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:8pt;font-weight:400;line-height:155%"> &#124;</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:8pt;font-weight:400;line-height:174%">&#124; &#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.32pt;width:100%"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:115%"> </font></div></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">GRANT NOTICE shall mean the Notice of Grant of Stock Option accompanying the Agreement, pursuant to which Optionee has been informed of the basic terms of the Option evidenced hereby.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">O.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">NON-STATUTORY OPTION shall mean an option not intended to satisfy the requirements of Code Section 422.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">P.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:27.94pt">NOTICE OF EXERCISE shall mean the notice of exercise in the form approved by the Plan Administrator from time to time.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Q.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt"> OPTION SHARES shall mean the number of shares of Common Stock subject to the Option as specified in the Grant Notice.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.84pt"> OPTIONEE shall mean the person to whom the Option is granted as specified in the Grant Notice.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:27.94pt">PARENT shall mean any corporation (other than the Corporation) in an unbroken chain of corporations ending with the Corporation, provided each corporation in the unbroken chain (other than the Corporation) owns, at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">T.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:27.4pt">PERMANENT DISABILITY shall mean the inability of Optionee to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which is expected to result in death or has lasted or can be expected to last for a continuous period of twelve (12) months or more.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">PLAN shall mean the Corporation&#8217;s 2022 Employment Inducement Plan, as may amended from time to time.</font></div><div style="margin-bottom:10pt;padding-right:-15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">PLAN ADMINISTRATOR shall have the meaning set forth in the Plan.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">W.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.07pt">SERVICE shall mean the Optionee&#8217;s performance of services for the Corporation (or any Parent or Subsidiary) in the capacity of an Employee, a non-employee member of the board of directors or a consultant or independent advisor. Except to the extent otherwise required by law, no Service credit shall be given for vesting purposes hereunder for any period the Optionee is on a leave of absence.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">SUBSIDIARY shall mean any corporation (other than the Corporation) in an unbroken chain of corporations beginning with the Corporation, provided each corporation (other than the last corporation) in the unbroken chain owns, at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:79.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:155%">A-2</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:8pt;font-weight:400;line-height:155%"> &#124;</font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:8pt;font-weight:400;line-height:174%">&#124; &#124;&#124;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>4
<FILENAME>exhibit104_ligand-formofrs.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ib27f181a2c734556bc0c7c70d45c2352_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.4</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS INCORPORATED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><br>2022 EMPLOYMENT INDUCEMENT PLAN</font></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RESTRICTED STOCK UNIT GRANT NOTICE AND<br>RESTRICTED STOCK UNIT AGREEMENT</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), pursuant to its 2022 Employment Inducement Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), hereby grants to the holder listed below (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">an award of restricted stock units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) with respect to the number of shares of the Corporation&#8217;s common stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  This award for Restricted Stock Units (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">RSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is subject to all of the terms and conditions as set forth herein and in the Restricted Stock Unit Award Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Stock Unit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and the Plan, each of which are incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Grant Notice and the Restricted Stock Unit Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.775%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.025%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt dashed #929292;border-top:1pt dashed #929292;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participant&#58;</font></td><td colspan="3" style="border-left:1pt dashed #929292;border-right:1pt dashed #929292;border-top:1pt dashed #929292;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt dashed #929292;border-top:1pt dashed #929292;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Grant Date&#58;</font></td><td colspan="3" style="border-left:1pt dashed #929292;border-right:1pt dashed #929292;border-top:1pt dashed #929292;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt dashed #929292;border-top:1pt dashed #929292;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Grant Number&#58;</font></td><td colspan="3" style="border-left:1pt dashed #929292;border-right:1pt dashed #929292;border-top:1pt dashed #929292;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt dashed #929292;border-top:1pt dashed #929292;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Vesting Commencement Date&#58;</font></td><td colspan="3" style="border-left:1pt dashed #929292;border-right:1pt dashed #929292;border-top:1pt dashed #929292;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt dashed #929292;border-top:1pt dashed #929292;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Total Number of RSUs Subject to Award&#58;</font></td><td colspan="3" style="border-left:1pt dashed #929292;border-right:1pt dashed #929292;border-top:1pt dashed #929292;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt dashed #929292;border-left:1pt dashed #929292;border-top:1pt dashed #929292;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Distribution Schedule&#58;</font></td><td colspan="3" style="border-bottom:1pt dashed #929292;border-left:1pt dashed #929292;border-right:1pt dashed #929292;border-top:1pt dashed #929292;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The RSUs shall be distributable as they vest pursuant to the Vesting Schedule.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.775%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.775%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt dashed #929292;border-left:1pt dashed #929292;border-top:1pt dashed #929292;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Vesting Schedule&#58;</font></td><td colspan="3" style="border-bottom:1pt dashed #929292;border-left:1pt dashed #929292;border-top:1pt dashed #929292;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Shares</font></td><td colspan="3" style="border-bottom:1pt dashed #929292;border-left:1pt dashed #929292;border-right:1pt dashed #929292;border-top:1pt dashed #929292;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Vest Date</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By his or her acceptance of this Restricted Stock Unit Grant, Participant agrees to be bound by the terms and conditions of the Plan, the Restricted Stock Unit Agreement and this Grant Notice. Participant has reviewed the Restricted Stock Unit Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of this Grant Notice, the Restricted Stock Unit Agreement and the Plan.  Participant has been provided with a copy or electronic access to a copy of the prospectus for the Plan. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Plan Administrator upon any questions arising under the Plan, this Grant Notice or the Restricted Stock Unit Agreement. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;( Restricted Stock Unit Grant Notice 03-2018.doc)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><div id="ib27f181a2c734556bc0c7c70d45c2352_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.4</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT A<br>TO RESTRICTED STOCK UNIT AWARD GRANT NOTICE<br><br>LIGAND PHARMACEUTICALS, INCORPORATED<br>RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pursuant to the Restricted Stock Unit Award Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to which this Restricted Stock Unit Award Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is attached, Ligand Pharmaceuticals Incorporated, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), has granted to Participant the right to receive the number of RSUs under the Corporation&#8217;s 2022 Employment Inducement Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) indicated in the Grant Notice, with respect to the number of shares of the Corporation&#8217;s common stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The RSU Award and this Agreement are subject to the Plan, the terms and conditions of which are incorporated herein by reference.  In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%">ARTICLE I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%;padding-left:12.13pt"><br>AWARD OF RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Award of Restricted Stock Units&#59; Employment Inducement Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In consideration of Participant&#8217;s agreement to commence employment with and remain in the employ of the Corporation (or a Parent or Subsidiary), and for other good and valuable consideration, the Corporation hereby grants to Participant the right to receive the number of RSUs set forth in the Grant Notice, subject to all of the terms and conditions set forth in this Agreement, the Grant Notice and the Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">RSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  Each RSU represents the right to receive one Share.  Prior to actual issuance of any Shares, the RSUs and the RSU Award represent an unsecured obligation of the Corporation, payable only from the general assets of the Corporation. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">The RSUs are intended to constitute an &#8220;employment inducement&#8221; award NASDAQ Listing Rule 5635(c)(4), and consequently are intended to be exempt from the NASDAQ rules regarding shareholder approval of stock option and stock purchase plans or other equity compensation arrangements. This Agreement and the terms and conditions of the RSUs shall be interpreted in accordance and consistent with such exemption.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The RSUs subject to the RSU Award shall vest in accordance with the Vesting Schedule set forth in the Grant Notice.  Unless and until the RSUs have vested in accordance with the vesting schedule set forth in the Grant Notice, Participant will have no right to any distribution with respect to such RSUs.  In the event of Participant&#8217;s cessation of Service for any reason, including as a result of Participant&#8217;s death or Permanent Disability, prior to the vesting of all of the RSUs, any unvested RSUs will terminate automatically without any further action by the Corporation and be forfeited without further notice and at no cost to the Corporation.</font></div><div style="margin-bottom:12pt;padding-left:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.8pt;text-decoration:underline">Distribution of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">Stock shall be distributed to Participant (or in the event of Participant&#8217;s death, to his or her estate) with respect to such Participant&#8217;s vested RSUs granted to Participant pursuant to this Restricted Stock Unit Agreement, subject to the terms and provisions of the Plan and this Restricted Stock Unit Agreement, within ten (10) days following each vesting date as the RSU vests pursuant to the Vesting Schedule set forth in the Grant Notice.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">All distributions shall be made by the Corporation in the form of whole shares of Stock.  In no event will fractional shares be issued upon settlement of the RSU Award.  No fractional Shares shall be issued and any such fractional Shares shall be cancelled automatically and without any further action by Participant or the Corporation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A-1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;( Restricted Stock Unit Grant Notice 03-2018.doc)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.4</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">Notwithstanding the foregoing, shares of Stock shall be issuable pursuant to an RSU at such times and upon such events as are specified in this Agreement only to the extent issuance under such terms will not cause the RSUs or the shares of Stock issuable pursuant to the RSUs to be includible in the gross income of Participant under Section 409A of the Code prior to such times or the occurrence of such events, as permitted by the Code and the regulations and other guidance thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Stock issued under the RSU Award shall be issued to Participant or Participant&#8217;s beneficiaries, as the case may be, at the sole discretion of the Plan Administrator, in either (i) uncertificated form, with the Shares recorded in the name of Participant in the books and records of the Corporation&#8217;s transfer agent with appropriate notations regarding the restrictions on transfer imposed pursuant to this Agreement&#59; or (ii) certificate form.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Taxation Representations&#59; Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding any other provision of this Agreement (including, without limitation, Section 1.1(b) hereof)&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Taxation Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Participant has reviewed with his or her own tax advisors the federal, state, local and foreign tax consequences of this investment and the transactions contemplated by this Agreement.  Participant is relying solely on such advisors and not on any statements or representations of the Corporation or any of its agents.  Participant understands that Participant (and not the Corporation) shall be responsible for his or her own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Tax Withholding Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Corporation shall not be obligated to deliver any certificate representing Shares issuable with respect to the RSUs to Participant or his or her legal representative unless and until Participant or his or her legal representative shall have paid or otherwise satisfied in full the amount of all federal, state, local and foreign taxes applicable with respect to the taxable income of Participant resulting from the vesting of the RSUs, the distribution of the Shares issuable with respect thereto, or any other taxable event related to the RSUs (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Withholding Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that no payment shall be delayed under this Section 1.2(b) if such delay will result in a violation of Section 409A of the Code.  To the maximum extent permitted by applicable law, the Corporation and its Subsidiaries have the authority to deduct or withhold, or require Participant to remit to the Corporation or the applicable Subsidiary, an amount sufficient to satisfy the Tax Withholding Obligation.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt;text-decoration:underline">Withholding of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  With respect to any Tax Withholding Obligation arising in connection with the RSUs, the Corporation shall automatically withhold a net number of vested Shares otherwise issuable pursuant to the RSUs having a then current Fair Market Value not exceeding the amount necessary to satisfy the Tax Withholding Obligation of the Corporation and its Subsidiaries based on the minimum applicable statutory withholding rates for federal, state, local and foreign income tax and payroll tax purposes that are applicable to such supplemental taxable income (or such higher rate as may be determined by the Plan Administrator, which higher rate shall in no event exceed the maximum individual statutory tax rate in the applicable jurisdiction at the time of such withholding (or such other rate as may be required to avoid the liability classification of the applicable award under generally accepted accounting principles in the United States of America)), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Shares shall be rounded up to the nearest whole Share sufficient to cover the Tax Withholding Obligation to the extent rounding up to the nearest whole share does not result in the liability classification of the applicable Award under generally accepted accounting principles in the United States of America.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Broker Sale</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In the event any </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tax Withholding Obligation </font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">arising in connection with the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">RSUs</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> will be satisfied under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.2(c),</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> then the Corporation may, upon approval of the Plan Administrator, elect to instruct any brokerage firm determined acceptable to the Corporation for such purpose to sell on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participant</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">'s behalf a whole number of shares from those Shares then issuable to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participant </font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">pursuant to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">RSUs</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> as the Corporation determines to be appropriate to generate cash proceeds sufficient to satisfy the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tax Withholding Obligation</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and to remit the proceeds of such sale to the Corporation or the Subsidiary with respect to which the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tax Withholding Obligation </font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">arises.  Participant&#8217;s acceptance of this Award constitutes </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participant</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">'s instruction and authorization to the Corporation and such brokerage firm to complete the transactions described in this Section 1.2(d), including the transactions described in the previous sentence, as applicable.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A-2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;( Restricted Stock Unit Grant Notice 03-2018.doc)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.4</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant Liable for Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Participant is ultimately liable and responsible for all taxes owed in connection with the RSUs, regardless of any action the Corporation or any Subsidiary takes with respect to any Tax Withholding Obligations that arise in connection with the RSUs.  Neither the Corporation nor any Subsidiary makes any representation or undertaking regarding the treatment of any Tax Withholding Obligation in connection with the awarding, vesting or payment of the RSUs or the subsequent sale of Shares.  The Corporation and the Subsidiaries do not commit and are under no obligation to structure the RSUs to reduce or eliminate Participant&#8217;s tax liability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Conditions to Issuance of Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> The Corporation shall not be required to issue or deliver any certificate or certificates for any Shares prior to the fulfillment of all of the following conditions&#58;  (a) the admission of the Shares to listing on all stock exchanges on which such Shares are then listed&#59; (b) the completion of any registration or other qualification of the Shares under any state or federal law or under rulings or regulations of the U.S. Securities and Exchange Commission or other governmental regulatory body, which the Plan Administrator shall, in its sole and absolute discretion, deem necessary and advisable&#59; (c) the obtaining of any approval or other clearance from any state or federal governmental agency that the Plan Administrator shall, in its absolute discretion, determine to be necessary or advisable&#59; and (d) the lapse of any such reasonable period of time following the date the RSUs vest as the Plan Administrator may from time to time establish for reasons of administrative convenience.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%">ARTICLE II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%;padding-left:7.85pt"><br>OTHER PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">RSU Award and Interests Not Transferable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This RSU Award and the rights and privileges conferred hereby, including the RSUs awarded hereunder, shall not be liable for the debts, contracts or engagements of Participant or his successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Rights as Shareholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Neither the Participant nor any person claiming under or through the Participant shall have any of the rights or privileges of a shareholder of the Corporation in respect of any Shares issuable hereunder unless and until certificates representing such Shares (which may be in uncertificated form) will have been issued and recorded on the books and records of the Corporation or its transfer agents or registrars, and delivered to the Participant (including through electronic delivery to a brokerage account).   After such issuance, recordation and delivery, the Participant shall have all the rights of a shareholder of the Corporation, including with respect to the right to vote the Shares and the right to receive any cash or share dividends or other distributions paid to or made with respect to the Shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that at the discretion of the Corporation, and prior to the delivery of Shares, Participant may be required to execute a shareholders agreement in such form as shall be determined by the Corporation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">No Right to Continued Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Nothing in the Plan or in this Agreement shall be interpreted to interfere with or limit in any way the right of the Corporation or any Parent or Subsidiary to terminate Participant&#8217;s employment at any time, nor confer upon Participant the right to continue in the employ of the Corporation or any Parent or Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.   This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, without giving effect to principles of conflicts of law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Conformity to Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Participant acknowledges that the Plan is intended to conform to the extent necessary with all provisions of the Securities Act and the Exchange Act and any and all regulations and rules promulgated by the Securities and Exchange Commission thereunder, and state securities laws and regulations.  Notwithstanding anything herein to the contrary, the Plan shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A-3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;( Restricted Stock Unit Grant Notice 03-2018.doc)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.4</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">administered, and the Shares are to be issued, only in such a manner as to conform to such laws, rules and regulations.  To the extent permitted by applicable law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such laws, rules and regulations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any notice required or permitted by this Agreement shall be in writing and shall be deemed sufficient when delivered personally or sent by electronic mail (with return receipt requested and received) or fax or forty-eight (48) hours after being deposited in the U.S. mail, as certified or registered mail, with postage prepaid, and addressed to the party to be notified, if to the Corporation, at its principal offices, and if to Participant, at Participant&#8217;s address, electronic mail address or fax number in the Corporation&#8217;s employee records or as subsequently modified by written notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith.  In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (a)&#160;such provision shall be excluded from this Agreement, (b)&#160;the balance of the Agreement shall be interpreted as if such provision were so excluded and (c)&#160;the balance of the Agreement shall be enforceable in accordance with its terms.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Entire Agreement&#59; Enforcement of Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.   This Agreement and the Plan set forth the entire agreement and understanding of the parties relating to the subject matter herein and merge all prior discussions between them.  No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing signed by the parties to this Agreement.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The rights and benefits of this Agreement shall inure to the benefit of, and be enforceable by the Corporation&#8217;s successors and assigns.  The Corporation may assign its rights under this Agreement to any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Corporation without the prior written consent of Participant. The rights and obligations of Participant under this Agreement may only be assigned with the prior written consent of the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This RSU Award is not intended to constitute &#8220;nonqualified deferred compensation&#8221; within the meaning of Section 409A of the Code (together with any Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the date hereof, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and, accordingly, the Shares issuable pursuant to the RSUs hereunder shall be distributed to Participant no later than the later of&#58; (i) the fifteenth (15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) day of the third month following Participant&#8217;s first taxable year in which such RSUs are no longer subject to a substantial risk of forfeiture, and (ii) the fifteenth (15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) day of the third month following first taxable year of the Corporation in which such RSUs are no longer subject to substantial risk of forfeiture, as determined in accordance with Section 409A and any Treasury Regulations and other guidance issued thereunder.  For purposes of Section 409A (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), each payment that Participant may be eligible to receive under this Agreement shall be treated as a separate and distinct payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Broker-Assisted Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In the event of any broker-assisted sale of Shares in connection with the payment of any Tax Withholding Obligation as provided in Section 1.2(c)&#58; (a) any Shares to be sold through a broker-assisted sale will be sold on the day the Tax Withholding Obligation arises or as soon thereafter as practicable&#59; (b) such Shares may be sold as part of a block trade with other participants in the Plan in which all participants receive an average price&#59; (c) Participant will be responsible for all broker&#8217;s fees and other costs of sale, and Participant agrees to indemnify and hold the Corporation harmless from any losses, costs, damages, or expenses relating to any such sale&#59; (d) to the extent the proceeds of such sale exceed the applicable Tax Withholding Obligation, the Corporation agrees to pay such excess in cash to Participant as soon as reasonably practicable&#59; (e) Participant acknowledges that the Corporation or its designee is under no obligation to arrange for such sale at any particular price, and that the proceeds of any such sale may not be sufficient to satisfy the applicable Tax Withholding Obligation&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A-4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;( Restricted Stock Unit Grant Notice 03-2018.doc)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.4</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and (f) in the event the proceeds of such sale are insufficient to satisfy the applicable Tax Withholding Obligation, Participant agrees to pay immediately upon demand to the Corporation or its Subsidiary with respect to which the Tax Withholding Obligation arises an amount in cash sufficient to satisfy any remaining portion of the Corporation&#8217;s or the applicable Subsidiary&#8217;s Tax Withholding Obligation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Paperless Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  By accepting this RSU Award, Participant hereby agrees to receive documentation related to the RSU Award by electronic delivery, such as a system using an internet website or interactive voice response, maintained by the Corporation or a third party designated by the Corporation. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A-5</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;( Restricted Stock Unit Grant Notice 03-2018.doc)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>5
<FILENAME>exhibit_105xligand-formofp.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="if2a5bc606d44401b9284c55a15add495_1"></div><div style="min-height:74.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.5</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Performance-Based RSU Form</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS INCORPORATED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><br>2022 EMPLOYMENT INDUCEMENT PLAN</font></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RESTRICTED STOCK UNIT GRANT NOTICE AND<br>RESTRICTED STOCK UNIT AGREEMENT</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), pursuant to its 2022 Employment Inducement Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), hereby grants to the holder listed below (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">an award of restricted stock units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) with respect to the number of shares of the Corporation&#8217;s common stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  This award for Restricted Stock Units (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">RSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is subject to all of the terms and conditions as set forth herein and in the Restricted Stock Unit Award Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Unit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and the Plan, each of which are incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Grant Notice and the Restricted Stock Unit Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.643%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.157%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt dashed #6d6d6d;border-top:1pt dashed #6d6d6d;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participant&#58;</font></td><td colspan="3" style="border-left:1pt dashed #6d6d6d;border-right:1pt dashed #6d6d6d;border-top:1pt dashed #6d6d6d;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt dashed #6d6d6d;border-top:1pt dashed #6d6d6d;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Grant Date&#58;</font></td><td colspan="3" style="border-left:1pt dashed #6d6d6d;border-right:1pt dashed #6d6d6d;border-top:1pt dashed #6d6d6d;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt dashed #6d6d6d;border-top:1pt dashed #6d6d6d;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Grant Number&#58;</font></td><td colspan="3" style="border-left:1pt dashed #6d6d6d;border-right:1pt dashed #6d6d6d;border-top:1pt dashed #6d6d6d;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt dashed #6d6d6d;border-top:1pt dashed #6d6d6d;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Target Number of RSUs Subject to Award (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Target RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#8221;)&#58;</font></div></td><td colspan="3" style="border-left:1pt dashed #6d6d6d;border-right:1pt dashed #6d6d6d;border-top:1pt dashed #6d6d6d;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt dashed #6d6d6d;border-top:1pt dashed #6d6d6d;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Maximum Number of RSUs Subject to Award (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Maximum RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#8221;)&#58;</font></div></td><td colspan="3" style="border-left:1pt dashed #6d6d6d;border-right:1pt dashed #6d6d6d;border-top:1pt dashed #6d6d6d;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt dashed #6d6d6d;border-top:1pt dashed #6d6d6d;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Vesting Schedule&#58;</font></td><td colspan="3" style="border-left:1pt dashed #6d6d6d;border-right:1pt dashed #6d6d6d;border-top:1pt dashed #6d6d6d;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The RSUs shall vest as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto.</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt dashed #6d6d6d;border-left:1pt dashed #6d6d6d;border-top:1pt dashed #6d6d6d;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Distribution Schedule&#58;</font></td><td colspan="3" style="border-bottom:1pt dashed #6d6d6d;border-left:1pt dashed #6d6d6d;border-right:1pt dashed #6d6d6d;border-top:1pt dashed #6d6d6d;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The RSUs shall be distributable as they vest pursuant to the Vesting Schedule.</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By his or her acceptance of this Restricted Stock Unit Grant, Participant agrees to be bound by the terms and conditions of the Plan, the Restricted Stock Unit Agreement and this Grant Notice. Participant has reviewed the Restricted Stock Unit Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of this Grant Notice, the Restricted Stock Unit Agreement and the Plan.  Participant has been provided with a copy or electronic access to a copy of the prospectus for the Plan.  Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Plan Administrator upon any questions arising under the Plan, this Grant Notice or the Restricted Stock Unit Agreement. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.019%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS INC.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">PARTICIPANT</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Print Name&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Print Name&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Address&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;&#124;</font></div></div></div><div id="if2a5bc606d44401b9284c55a15add495_4"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT A<br>TO RESTRICTED STOCK UNIT AWARD GRANT NOTICE<br><br>LIGAND PHARMACEUTICALS, INCORPORATED<br>RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pursuant to the Restricted Stock Unit Award Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to which this Restricted Stock Unit Award Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is attached, Ligand Pharmaceuticals Incorporated, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), has granted to Participant the right to receive the number of RSUs under the Corporation&#8217;s 2022 Employment Inducement Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) indicated in the Grant Notice, with respect to the number of shares of the Corporation&#8217;s common stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The RSU Award and this Agreement are subject to the Plan, the terms and conditions of which are incorporated herein by reference.  In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%">ARTICLE I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%;padding-left:12.13pt"><br>AWARD OF RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Award of Restricted Stock Units&#59; Employment Inducement Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In consideration of Participant&#8217;s agreement to commence employment with and remain in the employ of the Corporation (or a Parent or Subsidiary), and for other good and valuable consideration, the Corporation hereby grants to Participant the right to receive the number of RSUs set forth in the Grant Notice, subject to all of the terms and conditions set forth in this Agreement, the Grant Notice and the Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">RSU</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  Each RSU represents the right to receive one Share.  Prior to actual issuance of any Shares, the RSUs and the RSU Award represent an unsecured obligation of the Corporation, payable only from the general assets of the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:117pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.63pt">The RSUs are intended to constitute an &#8220;employment inducement&#8221; award NASDAQ Listing Rule 5635(c)(4), and consequently are intended to be exempt from the NASDAQ rules regarding shareholder approval of stock option and stock purchase plans or other equity compensation arrangements. This Agreement and the terms and conditions of the RSUs shall be interpreted in accordance and consistent with such exemption.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The RSUs subject to the RSU Award shall vest in accordance with the Vesting Schedule set forth in the Grant Notice.  Unless and until the RSUs have vested in accordance with the vesting schedule set forth in the Grant Notice, Participant will have no right to any distribution with respect to such RSUs.  In the event of Participant&#8217;s cessation of Service for any reason, including as a result of Participant&#8217;s death or Permanent Disability, prior to the vesting of all of the RSUs, any unvested RSUs will terminate automatically without any further action by the Corporation and be forfeited without further notice and at no cost to the Corporation.</font></div><div style="margin-bottom:12pt;padding-left:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.18pt;text-decoration:underline">Distribution of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">Stock shall be distributed to Participant (or in the event of Participant&#8217;s death, to his or her estate) with respect to such Participant&#8217;s vested RSUs granted to Participant pursuant to this Restricted Stock Unit Agreement, subject to the terms and provisions of the Plan and this Restricted Stock Unit Agreement, within ten (10) days following each vesting date as the RSU vests pursuant to the Vesting Schedule set forth in the Grant Notice.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">All distributions shall be made by the Corporation in the form of whole shares of Stock.  In no event will fractional shares be issued upon settlement of the RSU Award.  No fractional Shares shall be issued and any such fractional Shares shall be cancelled automatically and without any further action by Participant or the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">Notwithstanding the foregoing, shares of Stock shall be issuable pursuant to an RSU at such times and upon such events as are specified in this Agreement only to the extent issuance under such terms will not cause the RSUs or the shares of Stock issuable pursuant to the RSUs to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A-1</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">be includible in the gross income of Participant under Section 409A of the Code prior to such times or the occurrence of such events, as permitted by the Code and the regulations and other guidance thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Stock issued under the RSU Award shall be issued to Participant or Participant&#8217;s beneficiaries, as the case may be, at the sole discretion of the Plan Administrator, in either (i) uncertificated form, with the Shares recorded in the name of Participant in the books and records of the Corporation&#8217;s transfer agent with appropriate notations regarding the restrictions on transfer imposed pursuant to this Agreement&#59; or (ii) certificate form.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Taxation Representations&#59; Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding any other provision of this Agreement (including, without limitation, Section 1.1(b) hereof)&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Taxation Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Participant has reviewed with his or her own tax advisors the federal, state, local and foreign tax consequences of this investment and the transactions contemplated by this Agreement.  Participant is relying solely on such advisors and not on any statements or representations of the Corporation or any of its agents.  Participant understands that Participant (and not the Corporation) shall be responsible for his or her own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Tax Withholding Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Corporation shall not be obligated to deliver any certificate representing Shares issuable with respect to the RSUs to Participant or his or her legal representative unless and until Participant or his or her legal representative shall have paid or otherwise satisfied in full the amount of all federal, state, local and foreign taxes applicable with respect to the taxable income of Participant resulting from the vesting of the RSUs, the distribution of the Shares issuable with respect thereto, or any other taxable event related to the RSUs (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Tax Withholding Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that no payment shall be delayed under this Section 1.2(b) if such delay will result in a violation of Section 409A of the Code.  To the maximum extent permitted by applicable law, the Corporation and its Subsidiaries have the authority to deduct or withhold, or require Participant to remit to the Corporation or the applicable Subsidiary, an amount sufficient to satisfy the Tax Withholding Obligation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt;text-decoration:underline">Withholding of Shares</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. With respect to any Tax Withholding Obligation arising in connection with the RSUs, the Corporation shall automatically withhold a net number of vested Shares otherwise issuable pursuant to the RSUs having a then current Fair Market Value not exceeding the amount necessary to satisfy the Tax Withholding Obligation of the Corporation and its Subsidiaries based on the minimum applicable statutory withholding rates for federal, state, local and foreign income tax and payroll tax purposes that are applicable to such supplemental taxable income (or such higher rate as may be determined by the Plan Administrator, which higher rate shall in no event exceed the maximum individual statutory tax rate in the applicable jurisdiction at the time of such withholding (or such other rate as may be required to avoid the liability classification of the applicable award under generally accepted accounting principles in the United States of America)), provided that such Shares shall be rounded up to the nearest whole Share sufficient to cover the Tax Withholding Obligation to the extent rounding up to the nearest whole share does not result in the liability classification of the applicable Award under generally accepted accounting principles in the United States of America.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Broker Sale</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In the event any Tax Withholding Obligation arising in connection with the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">RSUs</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> will be satisfied under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.2(c),</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> then the Corporation may, upon approval of the Plan Administrator, elect to instruct any brokerage firm determined acceptable to the Corporation for such purpose to sell on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participant</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8217;s behalf a whole number of shares from those Shares then issuable to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participant </font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">pursuant to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">RSUs</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> as the Corporation determines to be appropriate to generate cash proceeds sufficient to satisfy the Tax Withholding Obligation and to remit the proceeds of such sale to the Corporation or the Subsidiary with respect to which the Tax Withholding Obligation arises.  Participant&#8217;s acceptance of this Award constitutes </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participant</font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8217;s instruction and authorization to the Corporation and such brokerage firm to complete the transactions described in this Section 1.2(d), including the transactions described in the previous sentence, as applicable.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant Liable for Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Participant is ultimately liable and responsible for all taxes owed in connection with the RSUs, regardless of any action the Corporation or any Subsidiary takes with respect to any </font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tax Withholding Obligations </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that arise in connection with the RSUs.  Neither the Corporation nor any Subsidiary makes any representation or undertaking regarding the treatment of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A-2</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">any </font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tax Withholding Obligation </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in connection with the awarding, vesting or payment of the RSUs or the subsequent sale of Shares.  The Corporation and the Subsidiaries do not commit and are under no obligation to structure the RSUs to reduce or eliminate Participant&#8217;s tax liability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Conditions to Issuance of Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> The Corporation shall not be required to issue or deliver any certificate or certificates for any Shares prior to the fulfillment of all of the following conditions&#58;  (a) the admission of the Shares to listing on all stock exchanges on which such Shares are then listed&#59; (b) the completion of any registration or other qualification of the Shares under any state or federal law or under rulings or regulations of the U.S. Securities and Exchange Commission or other governmental regulatory body, which the Plan Administrator shall, in its sole and absolute discretion, deem necessary and advisable&#59; (c) the obtaining of any approval or other clearance from any state or federal governmental agency that the Plan Administrator shall, in its absolute discretion, determine to be necessary or advisable&#59; and (d) the lapse of any such reasonable period of time following the date the RSUs vest as the Plan Administrator may from time to time establish for reasons of administrative convenience.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%">ARTICLE II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%;padding-left:7.85pt"><br>OTHER PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">RSU Award and Interests Not Transferable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This RSU Award and the rights and privileges conferred hereby, including the RSUs awarded hereunder, shall not be liable for the debts, contracts or engagements of Participant or his successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Rights as Shareholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Neither the Participant nor any person claiming under or through the Participant shall have any of the rights or privileges of a shareholder of the Corporation in respect of any Shares issuable hereunder unless and until certificates representing such Shares (which may be in uncertificated form) will have been issued and recorded on the books and records of the Corporation or its transfer agents or registrars, and delivered to the Participant (including through electronic delivery to a brokerage account).  After such issuance, recordation and delivery, the Participant shall have all the rights of a shareholder of the Corporation, including with respect to the right to vote the Shares and the right to receive any cash or share dividends or other distributions paid to or made with respect to the Shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that at the discretion of the Corporation, and prior to the delivery of Shares, Participant may be required to execute a shareholders agreement in such form as shall be determined by the Corporation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">No Right to Continued Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Nothing in the Plan or in this Agreement shall be interpreted to interfere with or limit in any way the right of the Corporation or any Parent or Subsidiary to terminate Participant&#8217;s employment at any time, nor confer upon Participant the right to continue in the employ of the Corporation or any Parent or Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.   This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, without giving effect to principles of conflicts of law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Conformity to Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Participant acknowledges that the Plan is intended to conform to the extent necessary with all provisions of the Securities Act and the Exchange Act and any and all regulations and rules promulgated by the Securities and Exchange Commission thereunder, and state securities laws and regulations.  Notwithstanding anything herein to the contrary, the Plan shall be administered, and the Shares are to be issued, only in such a manner as to conform to such laws, rules and regulations.  To the extent permitted by applicable law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such laws, rules and regulations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any notice required or permitted by this Agreement shall be in writing and shall be deemed sufficient when delivered personally or sent by electronic mail (with return receipt requested </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A-3</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and received) or fax or forty-eight (48) hours after being deposited in the U.S. mail, as certified or registered mail, with postage prepaid, and addressed to the party to be notified, if to the Corporation, at its principal offices, and if to Participant, at Participant&#8217;s address, electronic mail address or fax number in the Corporation&#8217;s employee records or as subsequently modified by written notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith.  In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (a)&#160;such provision shall be excluded from this Agreement, (b)&#160;the balance of the Agreement shall be interpreted as if such provision were so excluded and (c)&#160;the balance of the Agreement shall be enforceable in accordance with its terms.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Entire Agreement&#59; Enforcement of Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.   This Agreement and the Plan set forth the entire agreement and understanding of the parties relating to the subject matter herein and merge all prior discussions between them.  No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing signed by the parties to this Agreement.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The rights and benefits of this Agreement shall inure to the benefit of, and be enforceable by the Corporation&#8217;s successors and assigns.  The Corporation may assign its rights under this Agreement to any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Corporation without the prior written consent of Participant. The rights and obligations of Participant under this Agreement may only be assigned with the prior written consent of the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This RSU Award is not intended to constitute &#8220;nonqualified deferred compensation&#8221; within the meaning of Section 409A of the Code (together with any Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the date hereof, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and, accordingly, the Shares issuable pursuant to the RSUs hereunder shall be distributed to Participant no later than the later of&#58; (i) the fifteenth (15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) day of the third month following Participant&#8217;s first taxable year in which such RSUs are no longer subject to a substantial risk of forfeiture, and (ii) the fifteenth (15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) day of the third month following first taxable year of the Corporation in which such RSUs are no longer subject to substantial risk of forfeiture, as determined in accordance with Section 409A and any Treasury Regulations and other guidance issued thereunder.  For purposes of Section 409A (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), each payment that Participant may be eligible to receive under this Agreement shall be treated as a separate and distinct payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Broker-Assisted Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In the event of any broker-assisted sale of Shares in connection with the payment of any </font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tax Withholding Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> as provided in Section 1.2(c)&#58; (a) any Shares to be sold through a broker-assisted sale will be sold on the day the </font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tax Withholding Obligation </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">arises or as soon thereafter as practicable&#59; (b) such Shares may be sold as part of a block trade with other participants in the Plan in which all participants receive an average price&#59; (c) Participant will be responsible for all broker&#8217;s fees and other costs of sale, and Participant agrees to indemnify and hold the Corporation harmless from any losses, costs, damages, or expenses relating to any such sale&#59; (d) to the extent the proceeds of such sale exceed the applicable </font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tax Withholding Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Corporation agrees to pay such excess in cash to Participant as soon as reasonably practicable&#59; (e) Participant acknowledges that the Corporation or its designee is under no obligation to arrange for such sale at any particular price, and that the proceeds of any such sale may not be sufficient to satisfy the applicable </font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tax Withholding Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; and (f) in the event the proceeds of such sale are insufficient to satisfy the applicable </font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tax Withholding Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, Participant agrees to pay immediately upon demand to the Corporation or its Subsidiary with respect to which the </font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tax Withholding Obligation </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">arises an amount in cash sufficient to satisfy any remaining portion of the Corporation&#8217;s or the applicable Subsidiary&#8217;s </font><font style="color:#000000;font-family:'Times',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tax Withholding Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Paperless Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  By accepting this RSU Award, Participant hereby agrees to receive documentation related to the RSU Award by electronic delivery, such as a system using an </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A-4</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">internet website or interactive voice response, maintained by the Corporation or a third party designated by the Corporation. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A-5</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;</font></div></div></div><div id="if2a5bc606d44401b9284c55a15add495_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT B<br>TO RESTRICTED STOCK UNIT AWARD GRANT NOTICE<br><br>PERFORMANCE-BASED VESTING <br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Capitalized terms used in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and not defined in Section 3 below shall have the meanings given them in the Agreement to which this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> is attached.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Vesting to be specified in individual award agreement&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Insert vesting.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B-1</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;&#124;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>lgnd_63022exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id9729c211a6b4833a60217f7276c2354_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, John L. Higgins, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.064%"><tr><td style="width:1.0%"></td><td style="width:11.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form 10-Q of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;&#160;&#160;&#160;August&#160;9, 2022 </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.166%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:-2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John L. Higgins</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John L. Higgins</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:-2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>lgnd_63022exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i906654c72467425fa969fdb8216a34df_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, Matthew Korenberg, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form 10-Q of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;&#160;&#160;&#160;&#160;August&#160;9, 2022 </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.416%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Matthew Korenberg</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Korenberg</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Finance and Chief Financial Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>lgnd_63022exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i4e9668464a75480bba9b6f51f852c46c_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 32.1</font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">In connection with the Quarterly Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended June&#160;30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, John L. Higgins, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.944%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 9, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John L. Higgins</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John L. Higgins<br>Chief Executive Officer <br>(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">In connection with the Quarterly Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended June&#160;30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Matthew Korenberg, Executive Vice President, Finance and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:10.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 9, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Matthew Korenberg</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Matthew Korenberg<br>Executive Vice President, Finance and Chief Financial Officer<br>(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>lgnd-20220630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:6182e749-0dc5-4e16-af49-321ddbc4d263,g:44d35ef7-647e-41c8-b2ac-a9d4b32b2035-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lgnd="http://www.ligand.com/20220630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ligand.com/20220630">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.ligand.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails">
        <link:definition>2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails">
        <link:definition>2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails">
        <link:definition>2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails">
        <link:definition>2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails">
        <link:definition>2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails">
        <link:definition>2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails">
        <link:definition>2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails">
        <link:definition>2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails">
        <link:definition>2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails">
        <link:definition>2414411 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.ligand.com/role/SegmentInformation">
        <link:definition>2115102 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.ligand.com/role/SegmentInformationTables">
        <link:definition>2316302 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDetails" roleURI="http://www.ligand.com/role/SegmentInformationDetails">
        <link:definition>2417412 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.ligand.com/role/FairValueMeasurements">
        <link:definition>2118103 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.ligand.com/role/FairValueMeasurementsTables">
        <link:definition>2319303 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>2420413 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails">
        <link:definition>2421414 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2422415 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotes" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes">
        <link:definition>2123104 - Disclosure - Convertible Senior Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesTables" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables">
        <link:definition>2324304 - Disclosure - Convertible Senior Notes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNarrativeDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails">
        <link:definition>2425416 - Disclosure - Convertible Senior Notes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNotesPayableDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails">
        <link:definition>2426417 - Disclosure - Convertible Senior Notes - Notes Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTax" roleURI="http://www.ligand.com/role/IncomeTax">
        <link:definition>2127105 - Disclosure - Income Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxDetails" roleURI="http://www.ligand.com/role/IncomeTaxDetails">
        <link:definition>2428418 - Disclosure - Income Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.ligand.com/role/StockholdersEquity">
        <link:definition>2129106 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.ligand.com/role/StockholdersEquityTables">
        <link:definition>2330305 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails">
        <link:definition>2431419 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>2432420 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLegalProceedings" roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings">
        <link:definition>2133107 - Disclosure - Commitment and Contingencies: Legal Proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLegalProceedingsDetails" roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails">
        <link:definition>2434421 - Disclosure - Commitment and Contingencies: Legal Proceedings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.ligand.com/role/Leases">
        <link:definition>2135108 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.ligand.com/role/LeasesTables">
        <link:definition>2336306 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.ligand.com/role/LeasesNarrativeDetails">
        <link:definition>2437422 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" roleURI="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails">
        <link:definition>2438423 - Disclosure - Leases - Operating and Finance Lease Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturityofOperatingLeaseLiabilitiesDetails" roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails">
        <link:definition>2439424 - Disclosure - Leases - Maturity of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1">
        <link:definition>2439424 - Disclosure - Leases - Maturity of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" abstract="false" name="ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_CommercialLicenseRightsPolicyTextBlock" abstract="false" name="CommercialLicenseRightsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_AziyoAndCorMatrixMember" abstract="true" name="AziyoAndCorMatrixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_MetabasisMember" abstract="true" name="MetabasisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AccruedSupplierExpensesCurrent" abstract="false" name="AccruedSupplierExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRights" abstract="false" name="LiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BasisOfPresentationLineItems" abstract="true" name="BasisOfPresentationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_AccruedAssetAcquisitionsCurrent" abstract="false" name="AccruedAssetAcquisitionsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" abstract="true" name="LiabilityForContingentValueRightsCompanyXCellaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_MilestoneMember" abstract="true" name="MilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" abstract="false" name="PaymentsToContingentValueRightHoldersFinancingActivity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" abstract="false" name="BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_AccruedSubcontractorExpensesCurrent" abstract="false" name="AccruedSubcontractorExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LigandCoreBusinessSegmentMember" abstract="true" name="LigandCoreBusinessSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" abstract="false" name="ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_LicenseFeesMember" abstract="true" name="LicenseFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" abstract="true" name="LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ConvertibleSeniorNotesDue2023Member" abstract="true" name="ConvertibleSeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_PfenexMember" abstract="true" name="PfenexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LeaseLiabilityCurrent" abstract="false" name="LeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_OmniAbTechnologiesSegmentMember" abstract="true" name="OmniAbTechnologiesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" abstract="true" name="LicenseFeesMilestonesAndProductOtherProductOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_CurrentPortionOfLiabilityForContingentValueRights" abstract="false" name="CurrentPortionOfLiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_RepaymentsOfNotesPayableInterestPortion" abstract="false" name="RepaymentsOfNotesPayableInterestPortion" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_GainLossOnShortTermInvestments" abstract="false" name="GainLossOnShortTermInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_Phase3ClinicalTrialMember" abstract="true" name="Phase3ClinicalTrialMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" abstract="false" name="ScheduleOfShortTermInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_XCellaBiosciencesIncMember" abstract="true" name="XCellaBiosciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_NumberOfOptionsUnderConvertibleBondHedges" abstract="false" name="NumberOfOptionsUnderConvertibleBondHedges" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BasisOfPresentationTable" abstract="true" name="BasisOfPresentationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" abstract="true" name="EarnoutRightsForPartnerResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolCoreMember" abstract="true" name="MaterialSalesCaptisolCoreMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" abstract="false" name="BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolCOVIDMember" abstract="true" name="MaterialSalesCaptisolCOVIDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolMember" abstract="true" name="MaterialSalesCaptisolMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" abstract="false" name="DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_ContractRevenueServiceMember" abstract="true" name="ContractRevenueServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_RylazeMember" abstract="true" name="RylazeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_CommercialLicenseRights" abstract="false" name="CommercialLicenseRights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" abstract="false" name="DebtInstrumentRepurchasedAmountDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance" abstract="false" name="LesseeOperatingLeaseLiabilityTenantImprovementAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_EmployeeStockPurchasePlanAbstract" abstract="true" name="EmployeeStockPurchasePlanAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" abstract="false" name="COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_SelexisAndDianomiMember" abstract="true" name="SelexisAndDianomiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ReturnsAccrual" abstract="false" name="ReturnsAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" abstract="true" name="CommercialLicenseAndOtherEconomicRightsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_LicenseeAccrualCurrent" abstract="false" name="LicenseeAccrualCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyCydexMember" abstract="true" name="LiabilityForContingentValueRightsCompanyCydexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LeaseRightOfUseAsset" abstract="false" name="LeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsForConvertibleBondHedges" abstract="false" name="PaymentsForConvertibleBondHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHolders" abstract="false" name="PaymentsToContingentValueRightHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_IncreaseDecreaseInDebtDiscount" abstract="false" name="IncreaseDecreaseInDebtDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NumberOfContingentValueRightsSeries" abstract="false" name="NumberOfContingentValueRightsSeries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" abstract="false" name="FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" abstract="true" name="LiabilityForContingentValueRightsCompanyIcagenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" abstract="true" name="LiabilityForContingentValueRightsCompanyMetabasisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" abstract="false" name="AmortizationOfCommercialLicenseAndOtherEconomicRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" abstract="false" name="ScheduleOfCommercialLicenseRightsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" abstract="true" name="DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ProceedsFromUnwindingConvertibleBondHedges" abstract="false" name="ProceedsFromUnwindingConvertibleBondHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsToUnwindWarrants" abstract="false" name="PaymentsToUnwindWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_TeriparatideInjectionMember" abstract="true" name="TeriparatideInjectionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_RoyaltyOtherMember" abstract="true" name="RoyaltyOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AccruedInventoryPurchases" abstract="false" name="AccruedInventoryPurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_EvomelaMember" abstract="true" name="EvomelaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" abstract="false" name="NonCashChangeInEstimatedFairValueOfContingentValueRights" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" abstract="false" name="DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ContractRevenueMember" abstract="true" name="ContractRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_KyprolisMember" abstract="true" name="KyprolisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" abstract="false" name="BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" abstract="false" name="BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" abstract="true" name="USDistrictCourtForTheNorthernDistrictOfOhioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>lgnd-20220630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:6182e749-0dc5-4e16-af49-321ddbc4d263,g:44d35ef7-647e-41c8-b2ac-a9d4b32b2035-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="lgnd-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f5252f4d-7e6f-4da5-8651-cea082f21fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3f4e56ee-c462-485d-981d-cdf54dfd57bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f5252f4d-7e6f-4da5-8651-cea082f21fa2" xlink:to="loc_us-gaap_LiabilitiesCurrent_3f4e56ee-c462-485d-981d-cdf54dfd57bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_8ab0efb7-6930-4826-81c4-e741c1486584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f5252f4d-7e6f-4da5-8651-cea082f21fa2" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_8ab0efb7-6930-4826-81c4-e741c1486584" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_2523f0f3-876a-4781-b83b-62561f613a44" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f5252f4d-7e6f-4da5-8651-cea082f21fa2" xlink:to="loc_lgnd_LiabilityForContingentValueRights_2523f0f3-876a-4781-b83b-62561f613a44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9a8d512d-8d93-44f8-9dda-301f6b7fe902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f5252f4d-7e6f-4da5-8651-cea082f21fa2" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9a8d512d-8d93-44f8-9dda-301f6b7fe902" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ff98b72b-7354-429c-8ef1-0bee3692a81a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f5252f4d-7e6f-4da5-8651-cea082f21fa2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ff98b72b-7354-429c-8ef1-0bee3692a81a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5a3da41f-1e4e-4a45-b76b-2ee983c42881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f5252f4d-7e6f-4da5-8651-cea082f21fa2" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5a3da41f-1e4e-4a45-b76b-2ee983c42881" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_a41dc210-ad10-4fe7-9cd4-eb7c40c42d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f5252f4d-7e6f-4da5-8651-cea082f21fa2" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_a41dc210-ad10-4fe7-9cd4-eb7c40c42d0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_35725b0b-bc70-42f1-ba77-7539b2010eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c07478a3-2c8a-4907-b12a-d51806665a84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_35725b0b-bc70-42f1-ba77-7539b2010eb7" xlink:to="loc_us-gaap_Liabilities_c07478a3-2c8a-4907-b12a-d51806665a84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_41d200fa-bf57-4b04-93a8-6a55825e8fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_35725b0b-bc70-42f1-ba77-7539b2010eb7" xlink:to="loc_us-gaap_StockholdersEquity_41d200fa-bf57-4b04-93a8-6a55825e8fb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_137974dd-a9f2-4002-9e8d-7368b56453a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_35725b0b-bc70-42f1-ba77-7539b2010eb7" xlink:to="loc_us-gaap_CommitmentsAndContingencies_137974dd-a9f2-4002-9e8d-7368b56453a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d6635aec-f1d1-4701-81cf-80b267d27d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a1f977e8-c9ef-4f78-962f-158f120f4543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d6635aec-f1d1-4701-81cf-80b267d27d8c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a1f977e8-c9ef-4f78-962f-158f120f4543" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_01f64901-806c-4c5c-9865-6560882dd1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d6635aec-f1d1-4701-81cf-80b267d27d8c" xlink:to="loc_us-gaap_ShortTermInvestments_01f64901-806c-4c5c-9865-6560882dd1c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d7f560bc-6945-4b56-a913-a4d3e2d0f6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d6635aec-f1d1-4701-81cf-80b267d27d8c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d7f560bc-6945-4b56-a913-a4d3e2d0f6d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c24a7c85-a14f-45f9-ac39-9515cc87c7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d6635aec-f1d1-4701-81cf-80b267d27d8c" xlink:to="loc_us-gaap_InventoryNet_c24a7c85-a14f-45f9-ac39-9515cc87c7b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_6f38f379-d74f-4161-98d8-39e32087d52f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d6635aec-f1d1-4701-81cf-80b267d27d8c" xlink:to="loc_us-gaap_IncomeTaxesReceivable_6f38f379-d74f-4161-98d8-39e32087d52f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_593cab6f-fde0-4bef-97e3-6fd7ccb486d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d6635aec-f1d1-4701-81cf-80b267d27d8c" xlink:to="loc_us-gaap_OtherAssetsCurrent_593cab6f-fde0-4bef-97e3-6fd7ccb486d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9447a51f-f65a-4401-b2fc-ca8af7e34327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2dc74166-1130-48b8-a2b2-af64677ad76c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9447a51f-f65a-4401-b2fc-ca8af7e34327" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2dc74166-1130-48b8-a2b2-af64677ad76c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6a26297e-0956-4a9c-9f50-b5eeaf3da051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9447a51f-f65a-4401-b2fc-ca8af7e34327" xlink:to="loc_us-gaap_CommonStockValue_6a26297e-0956-4a9c-9f50-b5eeaf3da051" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_cd83ac7e-16a3-43ff-9647-52ad2bbe9d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9447a51f-f65a-4401-b2fc-ca8af7e34327" xlink:to="loc_us-gaap_AdditionalPaidInCapital_cd83ac7e-16a3-43ff-9647-52ad2bbe9d9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cc259044-4448-420e-9a58-37442ac0298e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9447a51f-f65a-4401-b2fc-ca8af7e34327" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cc259044-4448-420e-9a58-37442ac0298e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_d46b888f-45ce-40c4-b950-b8f6dc99953e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9447a51f-f65a-4401-b2fc-ca8af7e34327" xlink:to="loc_us-gaap_PreferredStockValue_d46b888f-45ce-40c4-b950-b8f6dc99953e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_644033ee-bda9-403e-af5e-0cfa740dbd20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a6f42cbc-12e4-4810-9701-623fffbe0e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_644033ee-bda9-403e-af5e-0cfa740dbd20" xlink:to="loc_us-gaap_Goodwill_a6f42cbc-12e4-4810-9701-623fffbe0e14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a8a81b24-edcc-4170-98b1-926e27eefbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_644033ee-bda9-403e-af5e-0cfa740dbd20" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a8a81b24-edcc-4170-98b1-926e27eefbd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_02fddbd5-fafe-4ae7-895f-df3a20f5717d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_644033ee-bda9-403e-af5e-0cfa740dbd20" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_02fddbd5-fafe-4ae7-895f-df3a20f5717d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_78db3fff-12bb-47d3-ac9b-a9e3e7c28cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_644033ee-bda9-403e-af5e-0cfa740dbd20" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_78db3fff-12bb-47d3-ac9b-a9e3e7c28cc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_9d75021e-1541-4f7b-96fd-3e744c91e440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_644033ee-bda9-403e-af5e-0cfa740dbd20" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_9d75021e-1541-4f7b-96fd-3e744c91e440" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_afe71013-57a7-432c-9885-352e3940b4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_644033ee-bda9-403e-af5e-0cfa740dbd20" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_afe71013-57a7-432c-9885-352e3940b4f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2d336fb3-e442-4336-932b-d3fe279dbeda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_644033ee-bda9-403e-af5e-0cfa740dbd20" xlink:to="loc_us-gaap_AssetsCurrent_2d336fb3-e442-4336-932b-d3fe279dbeda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_77fc02c7-38f3-4882-bd14-5e425559ca3f" xlink:href="lgnd-20220630.xsd#lgnd_CommercialLicenseRights"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_644033ee-bda9-403e-af5e-0cfa740dbd20" xlink:to="loc_lgnd_CommercialLicenseRights_77fc02c7-38f3-4882-bd14-5e425559ca3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4611f61d-a010-4781-90ec-df237821c9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_644033ee-bda9-403e-af5e-0cfa740dbd20" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4611f61d-a010-4781-90ec-df237821c9ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e7c6a6ad-dd45-40e2-8135-a3d1f43a3a01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e16d25be-3ea5-43f2-8ede-6d7375e6c823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e7c6a6ad-dd45-40e2-8135-a3d1f43a3a01" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e16d25be-3ea5-43f2-8ede-6d7375e6c823" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a051ab8a-2447-4ac4-a82d-9f9173faed14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e7c6a6ad-dd45-40e2-8135-a3d1f43a3a01" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a051ab8a-2447-4ac4-a82d-9f9173faed14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7ca31e99-23f0-4602-b4bb-9333fa677116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e7c6a6ad-dd45-40e2-8135-a3d1f43a3a01" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7ca31e99-23f0-4602-b4bb-9333fa677116" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_5bea8a18-cd1d-480b-9c70-afc51ba7c829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e7c6a6ad-dd45-40e2-8135-a3d1f43a3a01" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_5bea8a18-cd1d-480b-9c70-afc51ba7c829" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_2152338e-e232-4dd7-a978-6fcd31715e22" xlink:href="lgnd-20220630.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e7c6a6ad-dd45-40e2-8135-a3d1f43a3a01" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_2152338e-e232-4dd7-a978-6fcd31715e22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_86ea0b4f-b241-4461-9bdc-6771bae38c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e7c6a6ad-dd45-40e2-8135-a3d1f43a3a01" xlink:to="loc_us-gaap_AccountsPayableCurrent_86ea0b4f-b241-4461-9bdc-6771bae38c93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_89f9ae6c-5542-44a3-bc38-1e30f2bb1531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e7c6a6ad-dd45-40e2-8135-a3d1f43a3a01" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_89f9ae6c-5542-44a3-bc38-1e30f2bb1531" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_23469323-6d9c-4606-9f2c-663bb808a27e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e7c6a6ad-dd45-40e2-8135-a3d1f43a3a01" xlink:to="loc_us-gaap_TaxesPayableCurrent_23469323-6d9c-4606-9f2c-663bb808a27e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_95001627-e260-4882-89e9-67723f48bb93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c51fd74f-cbd2-4ecc-86e7-169d0179216f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_95001627-e260-4882-89e9-67723f48bb93" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c51fd74f-cbd2-4ecc-86e7-169d0179216f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_be471093-9297-4b70-9b47-fd192fa7ae2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_95001627-e260-4882-89e9-67723f48bb93" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_be471093-9297-4b70-9b47-fd192fa7ae2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_79da1881-6029-495f-831e-ab7f2f03f4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a16edbfd-aa2e-4e42-a406-38deeaabeb98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_79da1881-6029-495f-831e-ab7f2f03f4ff" xlink:to="loc_us-gaap_OperatingIncomeLoss_a16edbfd-aa2e-4e42-a406-38deeaabeb98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d234fd53-8622-4017-97fa-56fd41cbac20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_79da1881-6029-495f-831e-ab7f2f03f4ff" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d234fd53-8622-4017-97fa-56fd41cbac20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_2cc1a06d-5e6c-4557-9d09-ec9a674cd277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_09f500ae-53fc-4d48-9f42-996e149e56c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_2cc1a06d-5e6c-4557-9d09-ec9a674cd277" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_09f500ae-53fc-4d48-9f42-996e149e56c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_d84252d8-b168-49fc-a2b5-d0f436b8108e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_2cc1a06d-5e6c-4557-9d09-ec9a674cd277" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_d84252d8-b168-49fc-a2b5-d0f436b8108e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_78129c8f-41bc-4720-bc3f-f3a1b5d4d5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_2cc1a06d-5e6c-4557-9d09-ec9a674cd277" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_78129c8f-41bc-4720-bc3f-f3a1b5d4d5d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_fa8b28a7-faa8-47e5-b6e0-cd9959cc4746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostDirectMaterial"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_2cc1a06d-5e6c-4557-9d09-ec9a674cd277" xlink:to="loc_us-gaap_CostDirectMaterial_fa8b28a7-faa8-47e5-b6e0-cd9959cc4746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_6fb41fe8-7a40-4184-9a1a-7a82cd2bf7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_2cc1a06d-5e6c-4557-9d09-ec9a674cd277" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_6fb41fe8-7a40-4184-9a1a-7a82cd2bf7c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_3f0b827c-3c20-46bf-8fcd-fb4f6ce4483d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_29f64cfb-fc7b-4eb7-bd3c-4f08200ff1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_3f0b827c-3c20-46bf-8fcd-fb4f6ce4483d" xlink:to="loc_us-gaap_GainLossOnInvestments_29f64cfb-fc7b-4eb7-bd3c-4f08200ff1f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_abce8a71-da8a-49a0-b3e3-908c64431b09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_3f0b827c-3c20-46bf-8fcd-fb4f6ce4483d" xlink:to="loc_us-gaap_InvestmentIncomeInterest_abce8a71-da8a-49a0-b3e3-908c64431b09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_772c7495-651d-4105-846d-412762d2913c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_3f0b827c-3c20-46bf-8fcd-fb4f6ce4483d" xlink:to="loc_us-gaap_InterestExpense_772c7495-651d-4105-846d-412762d2913c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f7656fbd-db6f-4326-84f3-7a8b6b2a99ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_3f0b827c-3c20-46bf-8fcd-fb4f6ce4483d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f7656fbd-db6f-4326-84f3-7a8b6b2a99ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d8d8dbf3-1ae3-4e96-a930-88c9a575216b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3accac7c-cf33-447c-8e5f-50c1bb0bf80d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d8d8dbf3-1ae3-4e96-a930-88c9a575216b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3accac7c-cf33-447c-8e5f-50c1bb0bf80d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_b693ab80-756d-4624-8310-dffd6a09c637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d8d8dbf3-1ae3-4e96-a930-88c9a575216b" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_b693ab80-756d-4624-8310-dffd6a09c637" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="lgnd-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5141cba2-be30-4126-9678-60463f100372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e1958d2e-e61f-4d94-9e19-3364df4dad65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5141cba2-be30-4126-9678-60463f100372" xlink:to="loc_us-gaap_NetIncomeLoss_e1958d2e-e61f-4d94-9e19-3364df4dad65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_37e98502-63bf-4a47-85b4-ee80995000fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5141cba2-be30-4126-9678-60463f100372" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_37e98502-63bf-4a47-85b4-ee80995000fd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="lgnd-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41eb6732-050a-41db-b018-2c5c056c0eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_2e8c94c4-c383-4621-9a77-e6c44b40c122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41eb6732-050a-41db-b018-2c5c056c0eaa" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_2e8c94c4-c383-4621-9a77-e6c44b40c122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_148f9ddb-099c-408d-909c-d43b0f54db46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41eb6732-050a-41db-b018-2c5c056c0eaa" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_148f9ddb-099c-408d-909c-d43b0f54db46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3efd2810-cbda-4c1e-b70e-5b904cdc40bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41eb6732-050a-41db-b018-2c5c056c0eaa" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3efd2810-cbda-4c1e-b70e-5b904cdc40bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_529ece66-b7c7-4560-ac10-e542b721cec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41eb6732-050a-41db-b018-2c5c056c0eaa" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_529ece66-b7c7-4560-ac10-e542b721cec4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_9836c965-b363-4f91-8c4b-e1211924ee8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41eb6732-050a-41db-b018-2c5c056c0eaa" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_9836c965-b363-4f91-8c4b-e1211924ee8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_102e7b69-d0c0-4678-b19f-a47bf0769f20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_41eb6732-050a-41db-b018-2c5c056c0eaa" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_102e7b69-d0c0-4678-b19f-a47bf0769f20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c732fe8e-1593-405a-8101-36dcb5bc04e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9833cc1d-b485-4f08-9d62-0b1cfda6027b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c732fe8e-1593-405a-8101-36dcb5bc04e1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9833cc1d-b485-4f08-9d62-0b1cfda6027b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a8be1792-38d3-4cdc-8f12-50ab7bd14813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c732fe8e-1593-405a-8101-36dcb5bc04e1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a8be1792-38d3-4cdc-8f12-50ab7bd14813" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f50f6cf0-b837-4db7-93a0-5ba6ebaa3fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c732fe8e-1593-405a-8101-36dcb5bc04e1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f50f6cf0-b837-4db7-93a0-5ba6ebaa3fad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4b9a064a-6a8c-419f-b3b6-42dc17cef1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_us-gaap_ProfitLoss_4b9a064a-6a8c-419f-b3b6-42dc17cef1cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_12c9dcbf-e734-47ec-9246-abfd4014cf31" xlink:href="lgnd-20220630.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_12c9dcbf-e734-47ec-9246-abfd4014cf31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8398fe1e-d2c0-42f8-9a37-668a873b4012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8398fe1e-d2c0-42f8-9a37-668a873b4012" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_4b427f26-77e6-4399-90e6-e31caad0d77a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_4b427f26-77e6-4399-90e6-e31caad0d77a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2e79a528-c9a8-4298-900d-651a74bc38e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2e79a528-c9a8-4298-900d-651a74bc38e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_921214b9-ecf0-4030-be2d-323c37d5c079" xlink:href="lgnd-20220630.xsd#lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_921214b9-ecf0-4030-be2d-323c37d5c079" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_28460d2c-e629-413d-9d26-cf8cae4700b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_28460d2c-e629-413d-9d26-cf8cae4700b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c1ddec30-d81d-4053-bcb0-829aafdb8d79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_us-gaap_ShareBasedCompensation_c1ddec30-d81d-4053-bcb0-829aafdb8d79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_b5322cc8-057e-49f9-9d7f-377e6a21dbdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_b5322cc8-057e-49f9-9d7f-377e6a21dbdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_297e1f51-9ef2-4316-8df6-2f36079b8828" xlink:href="lgnd-20220630.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_297e1f51-9ef2-4316-8df6-2f36079b8828" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_301f2de3-3963-4d0d-871e-95e3731b1cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_301f2de3-3963-4d0d-871e-95e3731b1cd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c4dac4e7-364d-499a-961f-6757bc43c345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c4dac4e7-364d-499a-961f-6757bc43c345" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_44886c47-85d8-49d6-943e-b4564e5f640b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_44886c47-85d8-49d6-943e-b4564e5f640b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c630f8b0-2a95-46d5-82b1-17823160faa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c630f8b0-2a95-46d5-82b1-17823160faa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_fdc4a673-8047-4f36-bdb5-d38e6f771cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_fdc4a673-8047-4f36-bdb5-d38e6f771cf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b99090c7-dc9d-4348-8654-c3151bdf8dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b99090c7-dc9d-4348-8654-c3151bdf8dde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_14cc9858-b7e9-405e-89b2-0a8cf1a93e78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_14cc9858-b7e9-405e-89b2-0a8cf1a93e78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_5101b0b3-c7f3-4c06-b35b-b3bf0079b5d4" xlink:href="lgnd-20220630.xsd#lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c0d1c7c-0a73-4b03-b352-8e5aba0ddfbb" xlink:to="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_5101b0b3-c7f3-4c06-b35b-b3bf0079b5d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c41487e2-9f99-4930-b454-393fdf27b1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_92635f85-cd01-4bfd-80f7-f095ebb9ab7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c41487e2-9f99-4930-b454-393fdf27b1f3" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_92635f85-cd01-4bfd-80f7-f095ebb9ab7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_fdf50592-2f9d-4336-b989-140683440c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c41487e2-9f99-4930-b454-393fdf27b1f3" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_fdf50592-2f9d-4336-b989-140683440c55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_29d4feb9-9ff9-451d-bffd-180d1ea8c443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c41487e2-9f99-4930-b454-393fdf27b1f3" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_29d4feb9-9ff9-451d-bffd-180d1ea8c443" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_027b20c2-86f5-4313-af2e-80fef3260ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c41487e2-9f99-4930-b454-393fdf27b1f3" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_027b20c2-86f5-4313-af2e-80fef3260ae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_e0180877-a13b-4e30-853c-e454492b8383" xlink:href="lgnd-20220630.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c41487e2-9f99-4930-b454-393fdf27b1f3" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_e0180877-a13b-4e30-853c-e454492b8383" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_358ef79e-0eb2-42cc-9501-ac126214e051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c41487e2-9f99-4930-b454-393fdf27b1f3" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_358ef79e-0eb2-42cc-9501-ac126214e051" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_11552157-b8b6-44c4-b421-f025608f0d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c41487e2-9f99-4930-b454-393fdf27b1f3" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_11552157-b8b6-44c4-b421-f025608f0d16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_2587c142-5966-4d47-b3b7-7862a13aa91f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c41487e2-9f99-4930-b454-393fdf27b1f3" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_2587c142-5966-4d47-b3b7-7862a13aa91f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_4f31f21c-7a9d-4a37-833a-875d4b576fcc" xlink:href="lgnd-20220630.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7a137ada-d3fb-48a4-b697-9dc585f0b07a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_4f31f21c-7a9d-4a37-833a-875d4b576fcc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7a137ada-d3fb-48a4-b697-9dc585f0b07a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_a6274548-a45f-4735-8e05-658ca62617b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_4f31f21c-7a9d-4a37-833a-875d4b576fcc" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_a6274548-a45f-4735-8e05-658ca62617b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_68a00848-8ecf-45e4-b793-862fa92ff4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c62ab029-dc1a-483a-927f-9c086b2a630d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_68a00848-8ecf-45e4-b793-862fa92ff4f1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c62ab029-dc1a-483a-927f-9c086b2a630d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b5264c59-d62a-4a55-8d77-14cb26614f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_68a00848-8ecf-45e4-b793-862fa92ff4f1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b5264c59-d62a-4a55-8d77-14cb26614f19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c14fc84d-8a20-4b8d-91a4-fcf414bc546c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_68a00848-8ecf-45e4-b793-862fa92ff4f1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c14fc84d-8a20-4b8d-91a4-fcf414bc546c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_41fddab2-c821-42fc-b47d-87d7fe05f761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_d399cccb-093c-4a91-9980-30ef7bd6d412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_41fddab2-c821-42fc-b47d-87d7fe05f761" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_d399cccb-093c-4a91-9980-30ef7bd6d412" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_4f91ae14-5181-40f0-b999-eaf07d890cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_41fddab2-c821-42fc-b47d-87d7fe05f761" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_4f91ae14-5181-40f0-b999-eaf07d890cd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_8675b0e5-037d-4bba-9d44-c984da296594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_dd75ee71-8a09-4e3f-948c-e3f706d11df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_8675b0e5-037d-4bba-9d44-c984da296594" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_dd75ee71-8a09-4e3f-948c-e3f706d11df2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_8dd211a6-c0bf-40d7-a507-f2df0b195860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_8675b0e5-037d-4bba-9d44-c984da296594" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_8dd211a6-c0bf-40d7-a507-f2df0b195860" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_41abe47e-5a15-4277-a67b-102c639faecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c396f7b3-6634-4945-9c80-81ecf35b88c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_41abe47e-5a15-4277-a67b-102c639faecf" xlink:to="loc_us-gaap_Goodwill_c396f7b3-6634-4945-9c80-81ecf35b88c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2b011d05-4d38-41b0-94ab-e0d002993680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_41abe47e-5a15-4277-a67b-102c639faecf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2b011d05-4d38-41b0-94ab-e0d002993680" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a7189f2e-033f-48fb-8f6b-dbd7487b5aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_41abe47e-5a15-4277-a67b-102c639faecf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a7189f2e-033f-48fb-8f6b-dbd7487b5aaf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4322cd87-823f-42da-920c-ee41d4c2e55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_f4cdf7e8-6dbf-4c36-8c2e-bcd25ca39f66" xlink:href="lgnd-20220630.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4322cd87-823f-42da-920c-ee41d4c2e55b" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_f4cdf7e8-6dbf-4c36-8c2e-bcd25ca39f66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b2226cbe-0c19-4b76-9538-2c0e74fad0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4322cd87-823f-42da-920c-ee41d4c2e55b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b2226cbe-0c19-4b76-9538-2c0e74fad0dd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8f2abacd-01b9-43ff-805b-bcbf08f37aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9e978352-ceff-41e9-9cc4-e1c84d1953fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8f2abacd-01b9-43ff-805b-bcbf08f37aaa" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9e978352-ceff-41e9-9cc4-e1c84d1953fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_2689647d-4e1f-4c64-9f05-59d5df5e4c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8f2abacd-01b9-43ff-805b-bcbf08f37aaa" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_2689647d-4e1f-4c64-9f05-59d5df5e4c3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent_34ae2ef5-be3b-4c67-b71b-7f07fc865dba" xlink:href="lgnd-20220630.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8f2abacd-01b9-43ff-805b-bcbf08f37aaa" xlink:to="loc_lgnd_LicenseeAccrualCurrent_34ae2ef5-be3b-4c67-b71b-7f07fc865dba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_e42b0fb6-8ceb-4594-acf2-d45e41c8f5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8f2abacd-01b9-43ff-805b-bcbf08f37aaa" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_e42b0fb6-8ceb-4594-acf2-d45e41c8f5f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual_656eaf15-c238-45ff-9805-666f38ec7199" xlink:href="lgnd-20220630.xsd#lgnd_ReturnsAccrual"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8f2abacd-01b9-43ff-805b-bcbf08f37aaa" xlink:to="loc_lgnd_ReturnsAccrual_656eaf15-c238-45ff-9805-666f38ec7199" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent_c43fb960-4b48-43a7-9bb6-7fd54f7cff3f" xlink:href="lgnd-20220630.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8f2abacd-01b9-43ff-805b-bcbf08f37aaa" xlink:to="loc_lgnd_AccruedAssetAcquisitionsCurrent_c43fb960-4b48-43a7-9bb6-7fd54f7cff3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent_e0fc577f-0993-426f-82d6-fdb6b7b71b70" xlink:href="lgnd-20220630.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8f2abacd-01b9-43ff-805b-bcbf08f37aaa" xlink:to="loc_lgnd_AccruedSubcontractorExpensesCurrent_e0fc577f-0993-426f-82d6-fdb6b7b71b70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent_79da63a1-6e6f-4222-9fe1-7de4d2e135ad" xlink:href="lgnd-20220630.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8f2abacd-01b9-43ff-805b-bcbf08f37aaa" xlink:to="loc_lgnd_AccruedSupplierExpensesCurrent_79da63a1-6e6f-4222-9fe1-7de4d2e135ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_f5392a15-bb91-43bf-993a-750f05d04700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8f2abacd-01b9-43ff-805b-bcbf08f37aaa" xlink:to="loc_us-gaap_InterestPayableCurrent_f5392a15-bb91-43bf-993a-750f05d04700" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_adb38cd7-3bb9-4a44-9df3-f00d33cfbd8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8f2abacd-01b9-43ff-805b-bcbf08f37aaa" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_adb38cd7-3bb9-4a44-9df3-f00d33cfbd8f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06d26564-4db9-4e33-ad32-a634f84b0ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_02c88b75-1a84-448f-a651-97291cd6e063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06d26564-4db9-4e33-ad32-a634f84b0ad8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_02c88b75-1a84-448f-a651-97291cd6e063" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_da053443-1de4-45ee-8b04-29c89e2c8f36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06d26564-4db9-4e33-ad32-a634f84b0ad8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_da053443-1de4-45ee-8b04-29c89e2c8f36" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#SegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_b8410932-6260-4a4b-b86d-a71ff9aaa19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_ae995a2a-2f0f-4a74-b6a2-9792860d82a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_b8410932-6260-4a4b-b86d-a71ff9aaa19f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_ae995a2a-2f0f-4a74-b6a2-9792860d82a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_066c57cb-f23f-4903-a410-faa168585e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_b8410932-6260-4a4b-b86d-a71ff9aaa19f" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_066c57cb-f23f-4903-a410-faa168585e5b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_82e1226b-aa47-4568-bf4c-df20b5401383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_e1eb4f73-538f-4765-bb65-8c4f9bae1f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_82e1226b-aa47-4568-bf4c-df20b5401383" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_e1eb4f73-538f-4765-bb65-8c4f9bae1f8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_8dd5ae71-2776-4e52-ba44-f13fcd7978f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_82e1226b-aa47-4568-bf4c-df20b5401383" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_8dd5ae71-2776-4e52-ba44-f13fcd7978f1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiability_dddcd977-a83b-4980-b79c-ded0cdabb89e" xlink:href="lgnd-20220630.xsd#lgnd_LeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_fdf76bdc-eaa4-4f75-bd87-dd635a5a8bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiability_dddcd977-a83b-4980-b79c-ded0cdabb89e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_fdf76bdc-eaa4-4f75-bd87-dd635a5a8bf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent_2e336564-9073-44c2-83d8-51dd5e8e218b" xlink:href="lgnd-20220630.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiability_dddcd977-a83b-4980-b79c-ded0cdabb89e" xlink:to="loc_lgnd_LeaseLiabilityCurrent_2e336564-9073-44c2-83d8-51dd5e8e218b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f74bdf3f-6535-4195-8b55-ee6991afe8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiability_dddcd977-a83b-4980-b79c-ded0cdabb89e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f74bdf3f-6535-4195-8b55-ee6991afe8ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent_cf7567c6-4b04-4027-9c78-93eceaf3ee66" xlink:href="lgnd-20220630.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_396c8385-8a92-4f9e-a083-46751c86f778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiabilityCurrent_cf7567c6-4b04-4027-9c78-93eceaf3ee66" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_396c8385-8a92-4f9e-a083-46751c86f778" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d8b610b4-2a91-41f5-b1b1-59c9ba57451f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiabilityCurrent_cf7567c6-4b04-4027-9c78-93eceaf3ee66" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d8b610b4-2a91-41f5-b1b1-59c9ba57451f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseRightOfUseAsset_fdaa048e-352d-4f3c-a948-0e6d4aeef383" xlink:href="lgnd-20220630.xsd#lgnd_LeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_18d2b0dd-99e0-428f-a132-f38cbea0a669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseRightOfUseAsset_fdaa048e-352d-4f3c-a948-0e6d4aeef383" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_18d2b0dd-99e0-428f-a132-f38cbea0a669" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_047cb86e-84d9-4b68-9ad2-87089b46097b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseRightOfUseAsset_fdaa048e-352d-4f3c-a948-0e6d4aeef383" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_047cb86e-84d9-4b68-9ad2-87089b46097b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#LeasesMaturityofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_529be937-7ab8-4684-8174-0e425dec33cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance_badab686-e342-44ff-bab8-0b9fb92ede7e" xlink:href="lgnd-20220630.xsd#lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_529be937-7ab8-4684-8174-0e425dec33cc" xlink:to="loc_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance_badab686-e342-44ff-bab8-0b9fb92ede7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e9e37909-f9dd-4a76-971b-200baec37f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_529be937-7ab8-4684-8174-0e425dec33cc" xlink:to="loc_us-gaap_OperatingLeaseLiability_e9e37909-f9dd-4a76-971b-200baec37f04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_af66f366-430a-44dc-9640-a121f835396c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_529be937-7ab8-4684-8174-0e425dec33cc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_af66f366-430a-44dc-9640-a121f835396c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lgnd-20220630.xsd#LeasesMaturityofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_66dc1d57-9092-4198-a3ed-3e869bdaef2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_815c1284-3353-4e49-8394-501a974f9ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_66dc1d57-9092-4198-a3ed-3e869bdaef2e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_815c1284-3353-4e49-8394-501a974f9ec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_628ad398-a5bd-40f8-bc6d-605ee4a966cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_66dc1d57-9092-4198-a3ed-3e869bdaef2e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_628ad398-a5bd-40f8-bc6d-605ee4a966cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_24868be2-1a18-419d-9cc8-7035e8420edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_66dc1d57-9092-4198-a3ed-3e869bdaef2e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_24868be2-1a18-419d-9cc8-7035e8420edb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2b24b761-1896-4348-9013-51d743d6d6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_66dc1d57-9092-4198-a3ed-3e869bdaef2e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2b24b761-1896-4348-9013-51d743d6d6b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0cd3d89f-8f68-4538-a37f-ec093673e0df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_66dc1d57-9092-4198-a3ed-3e869bdaef2e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0cd3d89f-8f68-4538-a37f-ec093673e0df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b89088b6-7fbc-4696-b2ee-1725aa2a7878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_66dc1d57-9092-4198-a3ed-3e869bdaef2e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b89088b6-7fbc-4696-b2ee-1725aa2a7878" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_74342146-6dd0-4ce2-b8c2-7306b454f82c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_66dc1d57-9092-4198-a3ed-3e869bdaef2e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_74342146-6dd0-4ce2-b8c2-7306b454f82c" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>lgnd-20220630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:6182e749-0dc5-4e16-af49-321ddbc4d263,g:44d35ef7-647e-41c8-b2ac-a9d4b32b2035-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="i24dbb792a1a345d1b86635c868fdcc62_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_a0e740e6-2f6f-4a00-9062-5dee69681bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_RevenuesAbstract_a0e740e6-2f6f-4a00-9062-5dee69681bbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3672ade3-d71a-40ab-a445-0b1c94caa3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_a0e740e6-2f6f-4a00-9062-5dee69681bbe" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3672ade3-d71a-40ab-a445-0b1c94caa3b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_6afd97ea-2a48-4bf4-9f90-d45712789bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_6afd97ea-2a48-4bf4-9f90-d45712789bd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_e0448af6-0d0b-4b84-8a4d-beec0f834714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostDirectMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_6afd97ea-2a48-4bf4-9f90-d45712789bd1" xlink:to="loc_us-gaap_CostDirectMaterial_e0448af6-0d0b-4b84-8a4d-beec0f834714" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_ac944c01-4a81-4d6f-ae69-c6dbd4182ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_6afd97ea-2a48-4bf4-9f90-d45712789bd1" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_ac944c01-4a81-4d6f-ae69-c6dbd4182ca5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5f7c3ac0-c8e9-43f1-a2b5-7831c661627b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_6afd97ea-2a48-4bf4-9f90-d45712789bd1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5f7c3ac0-c8e9-43f1-a2b5-7831c661627b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_51676e19-6628-4fb6-80a4-40a678e1a30c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_6afd97ea-2a48-4bf4-9f90-d45712789bd1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_51676e19-6628-4fb6-80a4-40a678e1a30c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_dd1ec70e-9194-4977-ae7e-c6d376a9a4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_6afd97ea-2a48-4bf4-9f90-d45712789bd1" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_dd1ec70e-9194-4977-ae7e-c6d376a9a4b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_efb716f5-700a-4894-9da0-449a3fd74f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_6afd97ea-2a48-4bf4-9f90-d45712789bd1" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_efb716f5-700a-4894-9da0-449a3fd74f50" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_779400b5-16d0-44e5-be70-87684a45b055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_OperatingIncomeLoss_779400b5-16d0-44e5-be70-87684a45b055" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7d17383b-66fb-40ae-93ab-f19357f77f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7d17383b-66fb-40ae-93ab-f19357f77f3e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_ee7cb98d-ed7d-43a9-985e-3e2b0113d50d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7d17383b-66fb-40ae-93ab-f19357f77f3e" xlink:to="loc_us-gaap_GainLossOnInvestments_ee7cb98d-ed7d-43a9-985e-3e2b0113d50d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_3e2def2e-ad10-4f50-85d1-5d08a2502322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7d17383b-66fb-40ae-93ab-f19357f77f3e" xlink:to="loc_us-gaap_InvestmentIncomeInterest_3e2def2e-ad10-4f50-85d1-5d08a2502322" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2a584574-ac8c-4761-81a3-5af9c332427e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7d17383b-66fb-40ae-93ab-f19357f77f3e" xlink:to="loc_us-gaap_InterestExpense_2a584574-ac8c-4761-81a3-5af9c332427e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a2d11938-7176-4f3d-8eed-59904b708788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7d17383b-66fb-40ae-93ab-f19357f77f3e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a2d11938-7176-4f3d-8eed-59904b708788" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4be3bb3b-2cc5-4897-975f-20ab6d05c794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7d17383b-66fb-40ae-93ab-f19357f77f3e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_4be3bb3b-2cc5-4897-975f-20ab6d05c794" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_72a7ec23-2d17-4db7-bfd7-85f77460fe62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_72a7ec23-2d17-4db7-bfd7-85f77460fe62" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_47a41a9c-e5e2-4196-a8c8-ec5a44aea291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_47a41a9c-e5e2-4196-a8c8-ec5a44aea291" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_46b89667-0e2f-4b67-ba5b-28f470f32bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_NetIncomeLoss_46b89667-0e2f-4b67-ba5b-28f470f32bc0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f4b2846d-2faa-425f-8eab-80d1a3c82e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_EarningsPerShareAbstract_f4b2846d-2faa-425f-8eab-80d1a3c82e5e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_faf53d96-36e8-48ac-bc06-b2a80469da01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f4b2846d-2faa-425f-8eab-80d1a3c82e5e" xlink:to="loc_us-gaap_EarningsPerShareBasic_faf53d96-36e8-48ac-bc06-b2a80469da01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2ce0daa2-1887-4dd0-a85b-5c56dbbb5e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f4b2846d-2faa-425f-8eab-80d1a3c82e5e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2ce0daa2-1887-4dd0-a85b-5c56dbbb5e0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d8f8c416-91bb-4f5e-bd0e-9d41fd7872a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f4b2846d-2faa-425f-8eab-80d1a3c82e5e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d8f8c416-91bb-4f5e-bd0e-9d41fd7872a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d0381d21-3658-45cb-94d0-a0f7d5244d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f4b2846d-2faa-425f-8eab-80d1a3c82e5e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d0381d21-3658-45cb-94d0-a0f7d5244d80" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_00cdadac-1853-4f1e-b9ea-aed798103676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_StatementTable_00cdadac-1853-4f1e-b9ea-aed798103676" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_668adc4f-7c81-4ad5-bd05-e2df1454dcff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_00cdadac-1853-4f1e-b9ea-aed798103676" xlink:to="loc_srt_ProductOrServiceAxis_668adc4f-7c81-4ad5-bd05-e2df1454dcff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_668adc4f-7c81-4ad5-bd05-e2df1454dcff_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_668adc4f-7c81-4ad5-bd05-e2df1454dcff" xlink:to="loc_srt_ProductsAndServicesDomain_668adc4f-7c81-4ad5-bd05-e2df1454dcff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ee5bd900-9ff5-4b2b-8803-fde79b337a53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_668adc4f-7c81-4ad5-bd05-e2df1454dcff" xlink:to="loc_srt_ProductsAndServicesDomain_ee5bd900-9ff5-4b2b-8803-fde79b337a53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_b89bfc96-7cb8-485a-97e6-df4b72a7fc46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ee5bd900-9ff5-4b2b-8803-fde79b337a53" xlink:to="loc_us-gaap_RoyaltyMember_b89bfc96-7cb8-485a-97e6-df4b72a7fc46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_984cc823-b908-4acd-bdbb-904aafd5b883" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ee5bd900-9ff5-4b2b-8803-fde79b337a53" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_984cc823-b908-4acd-bdbb-904aafd5b883" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_0b828e2d-44ed-48c9-a690-2604d64184ba" xlink:href="lgnd-20220630.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ee5bd900-9ff5-4b2b-8803-fde79b337a53" xlink:to="loc_lgnd_ContractRevenueMember_0b828e2d-44ed-48c9-a690-2604d64184ba" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="lgnd-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i7a381db5171648d8856021eabb5d66a7_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5dd64870-4aaf-479e-8428-55fb742635fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5dd64870-4aaf-479e-8428-55fb742635fa" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f4b52427-c39b-45a3-8ec8-17b2d8bf5a22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f4b52427-c39b-45a3-8ec8-17b2d8bf5a22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3567afba-aae1-4785-aa0a-8ff9a236985e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_StockholdersEquity_3567afba-aae1-4785-aa0a-8ff9a236985e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_ec2f8607-d2a7-4a9d-9ed2-9824f08c1720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_ec2f8607-d2a7-4a9d-9ed2-9824f08c1720" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_20dfdcd7-0f8c-45d2-af71-2935e2455778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_20dfdcd7-0f8c-45d2-af71-2935e2455778" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_569bd56f-eefa-46ef-8d38-802097aef374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_569bd56f-eefa-46ef-8d38-802097aef374" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4591d8ed-b486-45f2-92e4-bf938646cbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4591d8ed-b486-45f2-92e4-bf938646cbe9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_60aa4797-654d-49aa-8aef-f4ffac19100c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_60aa4797-654d-49aa-8aef-f4ffac19100c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_cf8e8490-b1bb-45d5-baf7-18482ff30fcf" xlink:href="lgnd-20220630.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_cf8e8490-b1bb-45d5-baf7-18482ff30fcf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_60dbbc7c-4019-45c7-84c8-e93504c119e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_60dbbc7c-4019-45c7-84c8-e93504c119e5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_83e2f5f5-70ff-451b-ae10-0b91412bfd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_83e2f5f5-70ff-451b-ae10-0b91412bfd15" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2555406e-e83b-4a94-86f6-25fa1838e39c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_NetIncomeLoss_2555406e-e83b-4a94-86f6-25fa1838e39c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4e74f8f4-0db4-4474-a678-1a0f85a5b886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bda1ef19-eb62-4d84-b558-ed1bdf00df00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b4447c45-5897-46f8-b132-d3f9cc8e6751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5dd64870-4aaf-479e-8428-55fb742635fa" xlink:to="loc_us-gaap_StatementTable_b4447c45-5897-46f8-b132-d3f9cc8e6751" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ce115a8e-b325-4450-ac18-578653aa2218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b4447c45-5897-46f8-b132-d3f9cc8e6751" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ce115a8e-b325-4450-ac18-578653aa2218" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ce115a8e-b325-4450-ac18-578653aa2218_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ce115a8e-b325-4450-ac18-578653aa2218" xlink:to="loc_us-gaap_EquityComponentDomain_ce115a8e-b325-4450-ac18-578653aa2218_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_678dcce0-02d8-4697-ab4d-263e5fc5fba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ce115a8e-b325-4450-ac18-578653aa2218" xlink:to="loc_us-gaap_EquityComponentDomain_678dcce0-02d8-4697-ab4d-263e5fc5fba3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_648540c8-4213-48b7-b47f-d1ef26d0fb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_678dcce0-02d8-4697-ab4d-263e5fc5fba3" xlink:to="loc_us-gaap_CommonStockMember_648540c8-4213-48b7-b47f-d1ef26d0fb4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b28486c2-b6ab-4c83-852a-916bd0be7756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_678dcce0-02d8-4697-ab4d-263e5fc5fba3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b28486c2-b6ab-4c83-852a-916bd0be7756" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d0db4ab4-3751-4100-9f2e-bd26535c0205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_678dcce0-02d8-4697-ab4d-263e5fc5fba3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d0db4ab4-3751-4100-9f2e-bd26535c0205" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_634b19f4-e178-4764-8570-00901df0d8be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_678dcce0-02d8-4697-ab4d-263e5fc5fba3" xlink:to="loc_us-gaap_RetainedEarningsMember_634b19f4-e178-4764-8570-00901df0d8be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6de139aa-4da3-4f1b-b4b1-8421ae68df6e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b4447c45-5897-46f8-b132-d3f9cc8e6751" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6de139aa-4da3-4f1b-b4b1-8421ae68df6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6de139aa-4da3-4f1b-b4b1-8421ae68df6e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6de139aa-4da3-4f1b-b4b1-8421ae68df6e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6de139aa-4da3-4f1b-b4b1-8421ae68df6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e8c33bdf-32fd-4854-b761-0687dbd5fcf6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6de139aa-4da3-4f1b-b4b1-8421ae68df6e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e8c33bdf-32fd-4854-b761-0687dbd5fcf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_cf9f92ed-8e2e-4db2-8dba-38e3e45807ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e8c33bdf-32fd-4854-b761-0687dbd5fcf6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_cf9f92ed-8e2e-4db2-8dba-38e3e45807ee" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i93ade53af8104182a98530d86baca0fe_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_2d5dda45-6d9b-4aba-b8e2-5c8f948adf49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_ConvertibleNotesPayable_2d5dda45-6d9b-4aba-b8e2-5c8f948adf49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fccfa2f2-9f4a-4887-8067-7688308bf95e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fccfa2f2-9f4a-4887-8067-7688308bf95e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_68b0d191-cc0e-4f96-b079-93724f186a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_StockholdersEquity_68b0d191-cc0e-4f96-b079-93724f186a83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_f7536dcf-b4b8-46e8-ab4e-e9aeaca45f15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_f7536dcf-b4b8-46e8-ab4e-e9aeaca45f15" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_2bc6a3f6-c663-49d7-acb6-6efb857afdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_2bc6a3f6-c663-49d7-acb6-6efb857afdd5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_c3fbc5c9-b377-43f8-93bd-c67f5719e5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_c3fbc5c9-b377-43f8-93bd-c67f5719e5a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_680f0b78-5a3c-4f44-bb6d-e02175a69fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_680f0b78-5a3c-4f44-bb6d-e02175a69fb0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_67700027-d940-40bc-84ac-6bc4db7fd4df" xlink:href="lgnd-20220630.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_67700027-d940-40bc-84ac-6bc4db7fd4df" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1a1ba31f-3536-40b2-b773-7e06085f6124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_InventoryNet_1a1ba31f-3536-40b2-b773-7e06085f6124" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_0fc721ec-5595-4f23-94f5-8a66da465169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_NumberOfReportingUnits_0fc721ec-5595-4f23-94f5-8a66da465169" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_67939696-8f8f-4c57-b0c8-6a99048032bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_NumberOfReportableSegments_67939696-8f8f-4c57-b0c8-6a99048032bf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_2392d645-e220-4bb7-b92e-26661e2cc36e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_2392d645-e220-4bb7-b92e-26661e2cc36e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_77f6cd19-57dc-4a1a-b850-9a7066eca221" xlink:href="lgnd-20220630.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_77f6cd19-57dc-4a1a-b850-9a7066eca221" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e6a0f0cf-f72a-42ce-9060-0b5b64ac919d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e6a0f0cf-f72a-42ce-9060-0b5b64ac919d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2d3f8bfc-898f-41a5-96a9-98a126f4248c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2d3f8bfc-898f-41a5-96a9-98a126f4248c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2d3f8bfc-898f-41a5-96a9-98a126f4248c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2d3f8bfc-898f-41a5-96a9-98a126f4248c" xlink:to="loc_us-gaap_EquityComponentDomain_2d3f8bfc-898f-41a5-96a9-98a126f4248c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_25d245ba-8235-4529-93de-1bbcab679dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2d3f8bfc-898f-41a5-96a9-98a126f4248c" xlink:to="loc_us-gaap_EquityComponentDomain_25d245ba-8235-4529-93de-1bbcab679dca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_187014ad-11c9-485b-9285-ee57356881a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_25d245ba-8235-4529-93de-1bbcab679dca" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_187014ad-11c9-485b-9285-ee57356881a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_0cde13fe-171c-49d0-aa21-6ca2fd208b13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_25d245ba-8235-4529-93de-1bbcab679dca" xlink:to="loc_us-gaap_RetainedEarningsMember_0cde13fe-171c-49d0-aa21-6ca2fd208b13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_094d0e15-4dc6-4db2-ae52-581cef540888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_094d0e15-4dc6-4db2-ae52-581cef540888" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_094d0e15-4dc6-4db2-ae52-581cef540888_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_094d0e15-4dc6-4db2-ae52-581cef540888" xlink:to="loc_us-gaap_TypeOfAdoptionMember_094d0e15-4dc6-4db2-ae52-581cef540888_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_39091d11-56d4-4a26-ac89-7dca8efbb3d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_094d0e15-4dc6-4db2-ae52-581cef540888" xlink:to="loc_us-gaap_TypeOfAdoptionMember_39091d11-56d4-4a26-ac89-7dca8efbb3d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_862f3181-e8d2-4a3d-8efa-eccb1e7b2bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_39091d11-56d4-4a26-ac89-7dca8efbb3d7" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_862f3181-e8d2-4a3d-8efa-eccb1e7b2bd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3976755a-de3e-4a49-aa13-737a589b9f4e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3976755a-de3e-4a49-aa13-737a589b9f4e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3976755a-de3e-4a49-aa13-737a589b9f4e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3976755a-de3e-4a49-aa13-737a589b9f4e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3976755a-de3e-4a49-aa13-737a589b9f4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ec35f7d9-fc0e-4718-8b80-5d83f94a63d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3976755a-de3e-4a49-aa13-737a589b9f4e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ec35f7d9-fc0e-4718-8b80-5d83f94a63d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_141f4acf-665e-4a00-9e1a-7f869a2a9463" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ec35f7d9-fc0e-4718-8b80-5d83f94a63d8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_141f4acf-665e-4a00-9e1a-7f869a2a9463" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_c61be4de-e880-4d46-9d60-b9a5abc4a0f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ec35f7d9-fc0e-4718-8b80-5d83f94a63d8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_c61be4de-e880-4d46-9d60-b9a5abc4a0f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d5d367ad-1a5c-431a-aec8-c1e790b3e0cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_srt_RangeAxis_d5d367ad-1a5c-431a-aec8-c1e790b3e0cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d5d367ad-1a5c-431a-aec8-c1e790b3e0cf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d5d367ad-1a5c-431a-aec8-c1e790b3e0cf" xlink:to="loc_srt_RangeMember_d5d367ad-1a5c-431a-aec8-c1e790b3e0cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9d816ba2-f8e8-44bb-9230-4514e5aca5db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d5d367ad-1a5c-431a-aec8-c1e790b3e0cf" xlink:to="loc_srt_RangeMember_9d816ba2-f8e8-44bb-9230-4514e5aca5db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_35f713d7-fc41-4a8f-ad51-5b08081c374f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9d816ba2-f8e8-44bb-9230-4514e5aca5db" xlink:to="loc_srt_MinimumMember_35f713d7-fc41-4a8f-ad51-5b08081c374f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0fe8a55f-5801-4212-9ae3-54a653d95d74" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9d816ba2-f8e8-44bb-9230-4514e5aca5db" xlink:to="loc_srt_MaximumMember_0fe8a55f-5801-4212-9ae3-54a653d95d74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3b800d1d-f8a1-448f-8b19-9a7dacfb2f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_us-gaap_AwardTypeAxis_3b800d1d-f8a1-448f-8b19-9a7dacfb2f38" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3b800d1d-f8a1-448f-8b19-9a7dacfb2f38_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3b800d1d-f8a1-448f-8b19-9a7dacfb2f38" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3b800d1d-f8a1-448f-8b19-9a7dacfb2f38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04e678fc-c213-4b09-ba69-753cbda66563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3b800d1d-f8a1-448f-8b19-9a7dacfb2f38" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04e678fc-c213-4b09-ba69-753cbda66563" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_f69172aa-f988-499f-ba5a-25bb94629504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04e678fc-c213-4b09-ba69-753cbda66563" xlink:to="loc_us-gaap_RestrictedStockMember_f69172aa-f988-499f-ba5a-25bb94629504" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_653a8b7f-3f2a-4e46-85df-b6112a8f932c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_653a8b7f-3f2a-4e46-85df-b6112a8f932c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_653a8b7f-3f2a-4e46-85df-b6112a8f932c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_653a8b7f-3f2a-4e46-85df-b6112a8f932c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_653a8b7f-3f2a-4e46-85df-b6112a8f932c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ceaee396-c7d4-431f-94f8-9dd184b1e03a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_653a8b7f-3f2a-4e46-85df-b6112a8f932c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ceaee396-c7d4-431f-94f8-9dd184b1e03a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_823b5504-f5de-4c2e-b0c9-a840d12f7168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ceaee396-c7d4-431f-94f8-9dd184b1e03a" xlink:to="loc_us-gaap_StockCompensationPlanMember_823b5504-f5de-4c2e-b0c9-a840d12f7168" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a2d5757a-2a11-4601-afbc-32fbe2182ddb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_srt_ProductOrServiceAxis_a2d5757a-2a11-4601-afbc-32fbe2182ddb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a2d5757a-2a11-4601-afbc-32fbe2182ddb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a2d5757a-2a11-4601-afbc-32fbe2182ddb" xlink:to="loc_srt_ProductsAndServicesDomain_a2d5757a-2a11-4601-afbc-32fbe2182ddb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a2899c83-a388-4ead-af48-9e99f05ad626" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a2d5757a-2a11-4601-afbc-32fbe2182ddb" xlink:to="loc_srt_ProductsAndServicesDomain_a2899c83-a388-4ead-af48-9e99f05ad626" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_430503b8-95bc-4959-9ecd-cb40cd915bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a2899c83-a388-4ead-af48-9e99f05ad626" xlink:to="loc_us-gaap_RoyaltyMember_430503b8-95bc-4959-9ecd-cb40cd915bf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_f9891e64-b082-4e6a-b7d1-d8345608fa55" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a2899c83-a388-4ead-af48-9e99f05ad626" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_f9891e64-b082-4e6a-b7d1-d8345608fa55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_22355352-e7f6-4ada-8d9f-89e32ee27ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_22355352-e7f6-4ada-8d9f-89e32ee27ba5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_22355352-e7f6-4ada-8d9f-89e32ee27ba5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_22355352-e7f6-4ada-8d9f-89e32ee27ba5" xlink:to="loc_us-gaap_SegmentDomain_22355352-e7f6-4ada-8d9f-89e32ee27ba5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e32dd495-5aff-4b7f-a632-d78077de17f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_22355352-e7f6-4ada-8d9f-89e32ee27ba5" xlink:to="loc_us-gaap_SegmentDomain_e32dd495-5aff-4b7f-a632-d78077de17f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessSegmentMember_041606b3-8cfd-44c7-96b2-ac9525a3fb4c" xlink:href="lgnd-20220630.xsd#lgnd_LigandCoreBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e32dd495-5aff-4b7f-a632-d78077de17f5" xlink:to="loc_lgnd_LigandCoreBusinessSegmentMember_041606b3-8cfd-44c7-96b2-ac9525a3fb4c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended" id="i045059534dcd420b9a6d17ec4651f876_BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_acca047e-3bcc-42dd-ae63-d6225a6ff832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c292c4bf-ac06-466d-a1ac-f7b254e24f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_acca047e-3bcc-42dd-ae63-d6225a6ff832" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c292c4bf-ac06-466d-a1ac-f7b254e24f2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b9f7a163-a330-497d-bdab-1ca06cc6289d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_acca047e-3bcc-42dd-ae63-d6225a6ff832" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b9f7a163-a330-497d-bdab-1ca06cc6289d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6a820dc5-b583-4dc7-b8a0-a03c2b5de59e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b9f7a163-a330-497d-bdab-1ca06cc6289d" xlink:to="loc_srt_ProductOrServiceAxis_6a820dc5-b583-4dc7-b8a0-a03c2b5de59e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6a820dc5-b583-4dc7-b8a0-a03c2b5de59e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6a820dc5-b583-4dc7-b8a0-a03c2b5de59e" xlink:to="loc_srt_ProductsAndServicesDomain_6a820dc5-b583-4dc7-b8a0-a03c2b5de59e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_94e26bfd-171c-41b3-9079-20b891895698" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6a820dc5-b583-4dc7-b8a0-a03c2b5de59e" xlink:to="loc_srt_ProductsAndServicesDomain_94e26bfd-171c-41b3-9079-20b891895698" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_2cf9884f-b98f-4c88-9907-4a2ba4d10b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_94e26bfd-171c-41b3-9079-20b891895698" xlink:to="loc_us-gaap_RoyaltyMember_2cf9884f-b98f-4c88-9907-4a2ba4d10b6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember_72873c47-532f-4776-a339-3bc42289f324" xlink:href="lgnd-20220630.xsd#lgnd_KyprolisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_2cf9884f-b98f-4c88-9907-4a2ba4d10b6c" xlink:to="loc_lgnd_KyprolisMember_72873c47-532f-4776-a339-3bc42289f324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember_7a05d80e-0e70-4bd2-976f-6da3fc46a53c" xlink:href="lgnd-20220630.xsd#lgnd_EvomelaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_2cf9884f-b98f-4c88-9907-4a2ba4d10b6c" xlink:to="loc_lgnd_EvomelaMember_7a05d80e-0e70-4bd2-976f-6da3fc46a53c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TeriparatideInjectionMember_ca205ae7-f77a-4bba-ab7a-6314d1a16774" xlink:href="lgnd-20220630.xsd#lgnd_TeriparatideInjectionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_2cf9884f-b98f-4c88-9907-4a2ba4d10b6c" xlink:to="loc_lgnd_TeriparatideInjectionMember_ca205ae7-f77a-4bba-ab7a-6314d1a16774" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RylazeMember_49f2d64b-3aca-4a05-903a-50dfab857abb" xlink:href="lgnd-20220630.xsd#lgnd_RylazeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_2cf9884f-b98f-4c88-9907-4a2ba4d10b6c" xlink:to="loc_lgnd_RylazeMember_49f2d64b-3aca-4a05-903a-50dfab857abb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_924fafb7-704b-4a3a-a041-5d88df816ee4" xlink:href="lgnd-20220630.xsd#lgnd_RoyaltyOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_2cf9884f-b98f-4c88-9907-4a2ba4d10b6c" xlink:to="loc_lgnd_RoyaltyOtherMember_924fafb7-704b-4a3a-a041-5d88df816ee4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_6f035d68-e5f0-4140-93e3-870f822803f8" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_94e26bfd-171c-41b3-9079-20b891895698" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_6f035d68-e5f0-4140-93e3-870f822803f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember_600d7fdb-3b9b-4dc8-85e4-1ca1cbc2d314" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_6f035d68-e5f0-4140-93e3-870f822803f8" xlink:to="loc_lgnd_MaterialSalesCaptisolCoreMember_600d7fdb-3b9b-4dc8-85e4-1ca1cbc2d314" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember_1a5ca872-9718-4713-ba7c-898ab58d2627" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_6f035d68-e5f0-4140-93e3-870f822803f8" xlink:to="loc_lgnd_MaterialSalesCaptisolCOVIDMember_1a5ca872-9718-4713-ba7c-898ab58d2627" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_d046fe48-9220-4890-8992-77fc2b0eddb9" xlink:href="lgnd-20220630.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_94e26bfd-171c-41b3-9079-20b891895698" xlink:to="loc_lgnd_ContractRevenueMember_d046fe48-9220-4890-8992-77fc2b0eddb9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember_9665c6c3-2492-4349-83ad-3794504f68a3" xlink:href="lgnd-20220630.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_d046fe48-9220-4890-8992-77fc2b0eddb9" xlink:to="loc_lgnd_ContractRevenueServiceMember_9665c6c3-2492-4349-83ad-3794504f68a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_2add335b-cc67-4172-9dcb-b1f645b94037" xlink:href="lgnd-20220630.xsd#lgnd_LicenseFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_d046fe48-9220-4890-8992-77fc2b0eddb9" xlink:to="loc_lgnd_LicenseFeesMember_2add335b-cc67-4172-9dcb-b1f645b94037" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_d15974c6-55cc-4e08-b36d-833b089d143a" xlink:href="lgnd-20220630.xsd#lgnd_MilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_d046fe48-9220-4890-8992-77fc2b0eddb9" xlink:to="loc_lgnd_MilestoneMember_d15974c6-55cc-4e08-b36d-833b089d143a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_878a0e99-5cd1-4339-ac98-a8bd962ff799" xlink:href="lgnd-20220630.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_d046fe48-9220-4890-8992-77fc2b0eddb9" xlink:to="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_878a0e99-5cd1-4339-ac98-a8bd962ff799" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended" id="i6f794acdde23425b893975b0a9e91621_BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb69504-666a-4b04-9e2d-e6b88e2c2996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d5ef4d91-71b2-4630-a98d-b3cfbc77f3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb69504-666a-4b04-9e2d-e6b88e2c2996" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d5ef4d91-71b2-4630-a98d-b3cfbc77f3ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7682b3cd-0f31-4fe5-830c-11e732e65c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb69504-666a-4b04-9e2d-e6b88e2c2996" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7682b3cd-0f31-4fe5-830c-11e732e65c3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f399ff41-d5ab-4112-873c-4bc321fd418d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb69504-666a-4b04-9e2d-e6b88e2c2996" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f399ff41-d5ab-4112-873c-4bc321fd418d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a5c929d0-595d-4793-a8bf-6933880194bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb69504-666a-4b04-9e2d-e6b88e2c2996" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a5c929d0-595d-4793-a8bf-6933880194bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_66f92d15-5ae9-4166-876d-a8995bba3e10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb69504-666a-4b04-9e2d-e6b88e2c2996" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_66f92d15-5ae9-4166-876d-a8995bba3e10" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_c31002c2-78ae-4923-9851-515c70675ac7" xlink:href="lgnd-20220630.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb69504-666a-4b04-9e2d-e6b88e2c2996" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_c31002c2-78ae-4923-9851-515c70675ac7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a34ac30b-94ec-4fde-b404-d64b11b8b44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb69504-666a-4b04-9e2d-e6b88e2c2996" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a34ac30b-94ec-4fde-b404-d64b11b8b44e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6592be6a-aabb-41e0-89ba-5f8337510ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a34ac30b-94ec-4fde-b404-d64b11b8b44e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6592be6a-aabb-41e0-89ba-5f8337510ca4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6592be6a-aabb-41e0-89ba-5f8337510ca4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6592be6a-aabb-41e0-89ba-5f8337510ca4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6592be6a-aabb-41e0-89ba-5f8337510ca4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6592be6a-aabb-41e0-89ba-5f8337510ca4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_1e603a3a-18a9-423c-b6fb-eb7cc9b6c55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:to="loc_us-gaap_DemandDepositsMember_1e603a3a-18a9-423c-b6fb-eb7cc9b6c55b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_727e8d3c-d48a-4f8a-a945-fdba8b18c7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_727e8d3c-d48a-4f8a-a945-fdba8b18c7aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_04df7bf1-4741-400a-a339-6dcc51272753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:to="loc_us-gaap_CommercialPaperMember_04df7bf1-4741-400a-a339-6dcc51272753" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_7a40c4f6-5b11-4e1a-bfbe-e29fa022c1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:to="loc_us-gaap_EquitySecuritiesMember_7a40c4f6-5b11-4e1a-bfbe-e29fa022c1fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_e73a2a15-903a-4f79-b703-d239fa8505de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:to="loc_us-gaap_MutualFundMember_e73a2a15-903a-4f79-b703-d239fa8505de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_e8aaaa00-b979-47d2-af0a-90de61be2292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_e8aaaa00-b979-47d2-af0a-90de61be2292" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_eb8362d2-7f93-4586-9d78-8b53e4b2343a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:to="loc_us-gaap_WarrantMember_eb8362d2-7f93-4586-9d78-8b53e4b2343a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7a34862a-f77b-45c8-a551-d6c72f4efd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:to="loc_us-gaap_CommonStockMember_7a34862a-f77b-45c8-a551-d6c72f4efd6c" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended" id="ia6ef05ce07c44cacbf1bda13bfe227a4_BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28a1083-ffde-485f-ad2a-5298baaec12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_dfd0d1ad-6eaa-4eae-8206-aa63f2d8947b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28a1083-ffde-485f-ad2a-5298baaec12e" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_dfd0d1ad-6eaa-4eae-8206-aa63f2d8947b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_88201987-124d-4596-8f79-f6c0f00384fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_dfd0d1ad-6eaa-4eae-8206-aa63f2d8947b" xlink:to="loc_us-gaap_Goodwill_88201987-124d-4596-8f79-f6c0f00384fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_521dd5a8-8d8f-4cd6-9783-2f730530326f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_dfd0d1ad-6eaa-4eae-8206-aa63f2d8947b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_521dd5a8-8d8f-4cd6-9783-2f730530326f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dc3d133e-fa87-462c-a0e9-b63da707a4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_dfd0d1ad-6eaa-4eae-8206-aa63f2d8947b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dc3d133e-fa87-462c-a0e9-b63da707a4a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_9aed8929-4b8c-45b8-9eed-138ee27597de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_dfd0d1ad-6eaa-4eae-8206-aa63f2d8947b" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_9aed8929-4b8c-45b8-9eed-138ee27597de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0855654f-45bd-47ee-9c0d-95138716696f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28a1083-ffde-485f-ad2a-5298baaec12e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0855654f-45bd-47ee-9c0d-95138716696f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_040925a5-e626-4d1c-8862-aafe6755609a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0855654f-45bd-47ee-9c0d-95138716696f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_040925a5-e626-4d1c-8862-aafe6755609a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_040925a5-e626-4d1c-8862-aafe6755609a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_040925a5-e626-4d1c-8862-aafe6755609a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_040925a5-e626-4d1c-8862-aafe6755609a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c5b2ca7-55c2-473b-b74a-3c1442188638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_040925a5-e626-4d1c-8862-aafe6755609a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c5b2ca7-55c2-473b-b74a-3c1442188638" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_4e3d4e1b-e08f-4f15-822b-84613d58f5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c5b2ca7-55c2-473b-b74a-3c1442188638" xlink:to="loc_us-gaap_PatentedTechnologyMember_4e3d4e1b-e08f-4f15-822b-84613d58f5b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_9cffd85a-0799-48c4-beef-e0883df0a150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c5b2ca7-55c2-473b-b74a-3c1442188638" xlink:to="loc_us-gaap_TradeNamesMember_9cffd85a-0799-48c4-beef-e0883df0a150" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5a5bb28d-3e32-4dfb-9c6a-3ab1bdcba797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c5b2ca7-55c2-473b-b74a-3c1442188638" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5a5bb28d-3e32-4dfb-9c6a-3ab1bdcba797" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_a714073b-05e6-4cba-a2a4-a47574b59c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c5b2ca7-55c2-473b-b74a-3c1442188638" xlink:to="loc_us-gaap_ContractualRightsMember_a714073b-05e6-4cba-a2a4-a47574b59c90" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails" xlink:type="extended" id="iead86084e80d43898473cefe238b392e_BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_9f3d65aa-2c98-4463-a5bb-78768dbcd9c9" xlink:href="lgnd-20220630.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b4ce3796-bb76-48d8-99a8-a279bd28c871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_9f3d65aa-2c98-4463-a5bb-78768dbcd9c9" xlink:to="loc_us-gaap_Goodwill_b4ce3796-bb76-48d8-99a8-a279bd28c871" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_c012c078-2eb6-4c09-aab5-55ccfbf1447b" xlink:href="lgnd-20220630.xsd#lgnd_BasisOfPresentationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_lgnd_BasisOfPresentationLineItems_9f3d65aa-2c98-4463-a5bb-78768dbcd9c9" xlink:to="loc_lgnd_BasisOfPresentationTable_c012c078-2eb6-4c09-aab5-55ccfbf1447b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9756641e-bdc5-452a-bd5a-ed95153ae21f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_c012c078-2eb6-4c09-aab5-55ccfbf1447b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9756641e-bdc5-452a-bd5a-ed95153ae21f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9756641e-bdc5-452a-bd5a-ed95153ae21f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9756641e-bdc5-452a-bd5a-ed95153ae21f" xlink:to="loc_us-gaap_SegmentDomain_9756641e-bdc5-452a-bd5a-ed95153ae21f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_27cc24c2-c6aa-44a3-8d6a-ba4cba65c43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9756641e-bdc5-452a-bd5a-ed95153ae21f" xlink:to="loc_us-gaap_SegmentDomain_27cc24c2-c6aa-44a3-8d6a-ba4cba65c43b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessSegmentMember_b9f7e895-1b97-4429-b075-5e988683bb19" xlink:href="lgnd-20220630.xsd#lgnd_LigandCoreBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_27cc24c2-c6aa-44a3-8d6a-ba4cba65c43b" xlink:to="loc_lgnd_LigandCoreBusinessSegmentMember_b9f7e895-1b97-4429-b075-5e988683bb19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbTechnologiesSegmentMember_c4ac25c5-4279-419c-b21b-7ded9b120c48" xlink:href="lgnd-20220630.xsd#lgnd_OmniAbTechnologiesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_27cc24c2-c6aa-44a3-8d6a-ba4cba65c43b" xlink:to="loc_lgnd_OmniAbTechnologiesSegmentMember_c4ac25c5-4279-419c-b21b-7ded9b120c48" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="extended" id="i5717128e513b4cbe8a4326f8c054d67b_BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8e3c1c37-ee8c-431e-92c8-50011dac5a22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_d6cc40c7-8362-4fae-9404-e2222e34351f" xlink:href="lgnd-20220630.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8e3c1c37-ee8c-431e-92c8-50011dac5a22" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_d6cc40c7-8362-4fae-9404-e2222e34351f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6e691377-33e4-4ed3-9fab-fff4390e7739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_d6cc40c7-8362-4fae-9404-e2222e34351f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6e691377-33e4-4ed3-9fab-fff4390e7739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_93761ae1-306d-496d-b8d2-e87f5cdf6313" xlink:href="lgnd-20220630.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_d6cc40c7-8362-4fae-9404-e2222e34351f" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_93761ae1-306d-496d-b8d2-e87f5cdf6313" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2726ae4a-cbd7-40ed-899b-13b690be3d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_d6cc40c7-8362-4fae-9404-e2222e34351f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2726ae4a-cbd7-40ed-899b-13b690be3d85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0c539c68-29b3-4b4e-b468-6897ebe13d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_d6cc40c7-8362-4fae-9404-e2222e34351f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0c539c68-29b3-4b4e-b468-6897ebe13d10" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_5b44761a-866e-4a99-8680-2108d8d503dd" xlink:href="lgnd-20220630.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_d6cc40c7-8362-4fae-9404-e2222e34351f" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_5b44761a-866e-4a99-8680-2108d8d503dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a2ccf825-6ec0-4010-90b8-a8dc009e965b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8e3c1c37-ee8c-431e-92c8-50011dac5a22" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a2ccf825-6ec0-4010-90b8-a8dc009e965b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_60edd5d6-195e-49be-9a3b-215dbd8d3efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a2ccf825-6ec0-4010-90b8-a8dc009e965b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_60edd5d6-195e-49be-9a3b-215dbd8d3efe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_60edd5d6-195e-49be-9a3b-215dbd8d3efe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_60edd5d6-195e-49be-9a3b-215dbd8d3efe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_60edd5d6-195e-49be-9a3b-215dbd8d3efe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0bc1c3e8-6b81-4fa6-9b24-904e81d5d334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_60edd5d6-195e-49be-9a3b-215dbd8d3efe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0bc1c3e8-6b81-4fa6-9b24-904e81d5d334" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_341f5171-b7e9-4c7c-bf25-c707310dad4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0bc1c3e8-6b81-4fa6-9b24-904e81d5d334" xlink:to="loc_us-gaap_LicensingAgreementsMember_341f5171-b7e9-4c7c-bf25-c707310dad4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_92c0efe2-5488-4562-bac1-40ab76aaf5b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a2ccf825-6ec0-4010-90b8-a8dc009e965b" xlink:to="loc_srt_CounterpartyNameAxis_92c0efe2-5488-4562-bac1-40ab76aaf5b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_92c0efe2-5488-4562-bac1-40ab76aaf5b2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_92c0efe2-5488-4562-bac1-40ab76aaf5b2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_92c0efe2-5488-4562-bac1-40ab76aaf5b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9732eb87-d133-4b24-880c-95c0bccd7588" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_92c0efe2-5488-4562-bac1-40ab76aaf5b2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9732eb87-d133-4b24-880c-95c0bccd7588" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember_c26fc693-3e0f-4d72-8bee-ae937d76cb40" xlink:href="lgnd-20220630.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9732eb87-d133-4b24-880c-95c0bccd7588" xlink:to="loc_lgnd_AziyoAndCorMatrixMember_c26fc693-3e0f-4d72-8bee-ae937d76cb40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_eaa44e35-6727-44c1-b73a-3285835a1707" xlink:href="lgnd-20220630.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9732eb87-d133-4b24-880c-95c0bccd7588" xlink:to="loc_lgnd_SelexisAndDianomiMember_eaa44e35-6727-44c1-b73a-3285835a1707" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended" id="i01d70ce797e34d9f880d29fa6d876329_BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_ad72a70b-b2b1-44a5-8a3c-cfcf91e87c92" xlink:href="lgnd-20220630.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_984f62a8-8f40-4e39-ac9c-5d12d7cbf97c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_ad72a70b-b2b1-44a5-8a3c-cfcf91e87c92" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_984f62a8-8f40-4e39-ac9c-5d12d7cbf97c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_a9cb2f7e-e2e8-484e-a401-dba8c24ce909" xlink:href="lgnd-20220630.xsd#lgnd_BasisOfPresentationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_lgnd_BasisOfPresentationLineItems_ad72a70b-b2b1-44a5-8a3c-cfcf91e87c92" xlink:to="loc_lgnd_BasisOfPresentationTable_a9cb2f7e-e2e8-484e-a401-dba8c24ce909" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f78740a8-0ae4-4f1e-bbb0-65294dbaace0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_a9cb2f7e-e2e8-484e-a401-dba8c24ce909" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f78740a8-0ae4-4f1e-bbb0-65294dbaace0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f78740a8-0ae4-4f1e-bbb0-65294dbaace0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f78740a8-0ae4-4f1e-bbb0-65294dbaace0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f78740a8-0ae4-4f1e-bbb0-65294dbaace0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8fb3a940-501d-446c-97f2-705c16c59105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f78740a8-0ae4-4f1e-bbb0-65294dbaace0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8fb3a940-501d-446c-97f2-705c16c59105" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_81f9b9e7-c7d5-40cb-926c-1654ec2b6ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8fb3a940-501d-446c-97f2-705c16c59105" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_81f9b9e7-c7d5-40cb-926c-1654ec2b6ba5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_ce4e00a2-69f0-4652-b2e0-1c1bae96b3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8fb3a940-501d-446c-97f2-705c16c59105" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_ce4e00a2-69f0-4652-b2e0-1c1bae96b3c6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended" id="i6064d18f75f540ca8700b0249b59cae5_BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4e5852cc-354c-4247-9a84-843029241dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7e3f3236-eeac-4446-84ff-5beb9e38e5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4e5852cc-354c-4247-9a84-843029241dd2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7e3f3236-eeac-4446-84ff-5beb9e38e5e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_b3cd604e-4231-4c33-a1d2-f25676e19e37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4e5852cc-354c-4247-9a84-843029241dd2" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_b3cd604e-4231-4c33-a1d2-f25676e19e37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_301d8948-0bbc-4cbb-8bab-773947d145a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_b3cd604e-4231-4c33-a1d2-f25676e19e37" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_301d8948-0bbc-4cbb-8bab-773947d145a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0b37a8e9-8251-43f6-a849-dfc78125ec3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_b3cd604e-4231-4c33-a1d2-f25676e19e37" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0b37a8e9-8251-43f6-a849-dfc78125ec3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5fb1090b-1c92-42ba-96a9-81556c0e408a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4e5852cc-354c-4247-9a84-843029241dd2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5fb1090b-1c92-42ba-96a9-81556c0e408a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5ffd8309-4dcf-4842-aa68-acc10d6e1f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4e5852cc-354c-4247-9a84-843029241dd2" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5ffd8309-4dcf-4842-aa68-acc10d6e1f62" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_42436be5-b6b3-42f6-822d-d39d9c15ce1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5ffd8309-4dcf-4842-aa68-acc10d6e1f62" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_42436be5-b6b3-42f6-822d-d39d9c15ce1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_42436be5-b6b3-42f6-822d-d39d9c15ce1c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_42436be5-b6b3-42f6-822d-d39d9c15ce1c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_42436be5-b6b3-42f6-822d-d39d9c15ce1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d8d73b07-bf54-4a79-9edc-a1d176f21a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_42436be5-b6b3-42f6-822d-d39d9c15ce1c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d8d73b07-bf54-4a79-9edc-a1d176f21a7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_ac2d13b9-f926-449e-9868-c3d299d8e235" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d8d73b07-bf54-4a79-9edc-a1d176f21a7e" xlink:to="loc_us-gaap_RestrictedStockMember_ac2d13b9-f926-449e-9868-c3d299d8e235" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d035ce6a-b69e-42fe-ad87-79fa226e5327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d8d73b07-bf54-4a79-9edc-a1d176f21a7e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d035ce6a-b69e-42fe-ad87-79fa226e5327" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#SegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="extended" id="id5bec91bed8b4841804291d23e1b3342_SegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_1802a2de-035c-4eb1-800d-846ece044d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dcb09a9c-0721-4bf7-9519-1287646c4add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_1802a2de-035c-4eb1-800d-846ece044d01" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dcb09a9c-0721-4bf7-9519-1287646c4add" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2b9225e7-96f4-481c-9dfe-702e73caf396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_1802a2de-035c-4eb1-800d-846ece044d01" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2b9225e7-96f4-481c-9dfe-702e73caf396" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5b4d2658-de5f-495a-94f7-71d3326402cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_1802a2de-035c-4eb1-800d-846ece044d01" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5b4d2658-de5f-495a-94f7-71d3326402cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_48543487-e92e-4f33-8598-1163538f0dac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_1802a2de-035c-4eb1-800d-846ece044d01" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_48543487-e92e-4f33-8598-1163538f0dac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_e87f26e5-cdea-434f-b456-e1af5f348b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_1802a2de-035c-4eb1-800d-846ece044d01" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_e87f26e5-cdea-434f-b456-e1af5f348b1e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e9b85ec1-c1b8-4053-9a33-33cfec803554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_1802a2de-035c-4eb1-800d-846ece044d01" xlink:to="loc_us-gaap_OperatingIncomeLoss_e9b85ec1-c1b8-4053-9a33-33cfec803554" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_5611f262-1ec0-468d-92b5-f2de7a5c0dab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_1802a2de-035c-4eb1-800d-846ece044d01" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_5611f262-1ec0-468d-92b5-f2de7a5c0dab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6d0e5717-100d-4426-9b1e-bda59c7754d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_5611f262-1ec0-468d-92b5-f2de7a5c0dab" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6d0e5717-100d-4426-9b1e-bda59c7754d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6d0e5717-100d-4426-9b1e-bda59c7754d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6d0e5717-100d-4426-9b1e-bda59c7754d3" xlink:to="loc_us-gaap_SegmentDomain_6d0e5717-100d-4426-9b1e-bda59c7754d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0d9a2ff3-4956-4d0f-ac73-1206534031fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6d0e5717-100d-4426-9b1e-bda59c7754d3" xlink:to="loc_us-gaap_SegmentDomain_0d9a2ff3-4956-4d0f-ac73-1206534031fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbTechnologiesSegmentMember_f1c0d3e7-d005-434b-bb87-59653333bfe7" xlink:href="lgnd-20220630.xsd#lgnd_OmniAbTechnologiesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d9a2ff3-4956-4d0f-ac73-1206534031fc" xlink:to="loc_lgnd_OmniAbTechnologiesSegmentMember_f1c0d3e7-d005-434b-bb87-59653333bfe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessSegmentMember_dda9b64e-6316-4021-ba3e-023c57f0b42b" xlink:href="lgnd-20220630.xsd#lgnd_LigandCoreBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d9a2ff3-4956-4d0f-ac73-1206534031fc" xlink:to="loc_lgnd_LigandCoreBusinessSegmentMember_dda9b64e-6316-4021-ba3e-023c57f0b42b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_de6627db-9975-409a-bae5-43fce136b506" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_5611f262-1ec0-468d-92b5-f2de7a5c0dab" xlink:to="loc_srt_ProductOrServiceAxis_de6627db-9975-409a-bae5-43fce136b506" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_de6627db-9975-409a-bae5-43fce136b506_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_de6627db-9975-409a-bae5-43fce136b506" xlink:to="loc_srt_ProductsAndServicesDomain_de6627db-9975-409a-bae5-43fce136b506_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a559dbca-7cc4-4fa1-9340-7f75c0e605a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_de6627db-9975-409a-bae5-43fce136b506" xlink:to="loc_srt_ProductsAndServicesDomain_a559dbca-7cc4-4fa1-9340-7f75c0e605a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_829e72e4-2f3f-4578-9962-10c006497bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a559dbca-7cc4-4fa1-9340-7f75c0e605a9" xlink:to="loc_us-gaap_RoyaltyMember_829e72e4-2f3f-4578-9962-10c006497bef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember_afdcc68f-160b-475b-b9b4-19f90422eb26" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a559dbca-7cc4-4fa1-9340-7f75c0e605a9" xlink:to="loc_lgnd_MaterialSalesCaptisolCoreMember_afdcc68f-160b-475b-b9b4-19f90422eb26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember_1d6a1f54-f5db-4886-992b-a6cce4f97b0e" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a559dbca-7cc4-4fa1-9340-7f75c0e605a9" xlink:to="loc_lgnd_MaterialSalesCaptisolCOVIDMember_1d6a1f54-f5db-4886-992b-a6cce4f97b0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_96758604-d60d-40f5-9996-74eabbcd346e" xlink:href="lgnd-20220630.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a559dbca-7cc4-4fa1-9340-7f75c0e605a9" xlink:to="loc_lgnd_ContractRevenueMember_96758604-d60d-40f5-9996-74eabbcd346e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_bee8c65b-8075-4864-a328-05bab21484c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_5611f262-1ec0-468d-92b5-f2de7a5c0dab" xlink:to="loc_srt_ConsolidationItemsAxis_bee8c65b-8075-4864-a328-05bab21484c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_bee8c65b-8075-4864-a328-05bab21484c8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_bee8c65b-8075-4864-a328-05bab21484c8" xlink:to="loc_srt_ConsolidationItemsDomain_bee8c65b-8075-4864-a328-05bab21484c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a5a726c4-1452-4dd8-8d81-120244d00450" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_bee8c65b-8075-4864-a328-05bab21484c8" xlink:to="loc_srt_ConsolidationItemsDomain_a5a726c4-1452-4dd8-8d81-120244d00450" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_cd14e725-6ec6-4538-aa36-6f44419dab26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a5a726c4-1452-4dd8-8d81-120244d00450" xlink:to="loc_us-gaap_OperatingSegmentsMember_cd14e725-6ec6-4538-aa36-6f44419dab26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_313cd700-9004-4ba4-b43b-b70628c095a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a5a726c4-1452-4dd8-8d81-120244d00450" xlink:to="loc_us-gaap_CorporateNonSegmentMember_313cd700-9004-4ba4-b43b-b70628c095a7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="iaf0b1b5b26ad43d6abf52e07b98db174_FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b7b1339e-742e-4eef-8303-1608f08d8815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_b7b1339e-742e-4eef-8303-1608f08d8815" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_094f2088-0ffb-49c3-958d-d288ebc66507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_094f2088-0ffb-49c3-958d-d288ebc66507" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_7f80d72e-5a30-42f8-b455-3842af97230b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_7f80d72e-5a30-42f8-b455-3842af97230b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_a404bfbd-88e5-4786-a23c-1217433b17bc" xlink:href="lgnd-20220630.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_a404bfbd-88e5-4786-a23c-1217433b17bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_be950339-0bba-49c9-94a8-42cf90971cff" xlink:href="lgnd-20220630.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_be950339-0bba-49c9-94a8-42cf90971cff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries_4ad85923-3d15-4cb3-b90e-3fc772665c33" xlink:href="lgnd-20220630.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_lgnd_NumberOfContingentValueRightsSeries_4ad85923-3d15-4cb3-b90e-3fc772665c33" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_40384e72-9159-467a-ab3e-a6679ad7eba9" xlink:href="lgnd-20220630.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_40384e72-9159-467a-ab3e-a6679ad7eba9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_e609009c-95dd-4d89-9f59-c90663e78bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_us-gaap_Investments_e609009c-95dd-4d89-9f59-c90663e78bfc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_3e0eb4ec-b8ef-4452-9532-53fe452f0e61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_3e0eb4ec-b8ef-4452-9532-53fe452f0e61" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment_abbf64b8-4aeb-41e8-a9a7-c1366f3a4fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_us-gaap_LiabilitiesFairValueAdjustment_abbf64b8-4aeb-41e8-a9a7-c1366f3a4fb3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_a6c39dc6-7a41-489d-9b73-7c560997e6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_a6c39dc6-7a41-489d-9b73-7c560997e6c8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_00bdda72-e681-477d-9f4f-befd75ac6ff7" xlink:href="lgnd-20220630.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_00bdda72-e681-477d-9f4f-befd75ac6ff7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_116ca917-8374-425d-ac15-bbd4b9cb60c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_116ca917-8374-425d-ac15-bbd4b9cb60c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_116ca917-8374-425d-ac15-bbd4b9cb60c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_116ca917-8374-425d-ac15-bbd4b9cb60c3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_116ca917-8374-425d-ac15-bbd4b9cb60c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9456e7db-516a-4bac-a508-78f61f81f813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_116ca917-8374-425d-ac15-bbd4b9cb60c3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9456e7db-516a-4bac-a508-78f61f81f813" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d98b4797-742f-4575-9d0a-9b717cc4c44c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_9456e7db-516a-4bac-a508-78f61f81f813" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d98b4797-742f-4575-9d0a-9b717cc4c44c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1a440484-80d2-4d36-9d32-906ec45cc113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1a440484-80d2-4d36-9d32-906ec45cc113" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1a440484-80d2-4d36-9d32-906ec45cc113_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1a440484-80d2-4d36-9d32-906ec45cc113" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1a440484-80d2-4d36-9d32-906ec45cc113_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7e94f1a-9974-4d72-aa08-eb6e542c2026" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1a440484-80d2-4d36-9d32-906ec45cc113" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7e94f1a-9974-4d72-aa08-eb6e542c2026" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_dbaffd7c-a8d6-4590-9dce-12d87b045de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7e94f1a-9974-4d72-aa08-eb6e542c2026" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_dbaffd7c-a8d6-4590-9dce-12d87b045de9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5a97d126-8e84-41ce-86f2-dacbc401442d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7e94f1a-9974-4d72-aa08-eb6e542c2026" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5a97d126-8e84-41ce-86f2-dacbc401442d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_55177585-c3cd-477a-a4de-4d9d2ec1ccaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7e94f1a-9974-4d72-aa08-eb6e542c2026" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_55177585-c3cd-477a-a4de-4d9d2ec1ccaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b2b6c664-3b71-4311-bf90-b336adc6df55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b2b6c664-3b71-4311-bf90-b336adc6df55" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b2b6c664-3b71-4311-bf90-b336adc6df55_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b2b6c664-3b71-4311-bf90-b336adc6df55" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b2b6c664-3b71-4311-bf90-b336adc6df55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7b7e4f6b-88b5-483c-8eba-e727889bcc93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b2b6c664-3b71-4311-bf90-b336adc6df55" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7b7e4f6b-88b5-483c-8eba-e727889bcc93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_9e20478e-d983-4e42-9e44-9ac0a78e231b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7b7e4f6b-88b5-483c-8eba-e727889bcc93" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_9e20478e-d983-4e42-9e44-9ac0a78e231b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_c8e13f1b-61bb-4c2f-8f41-881b75795d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7b7e4f6b-88b5-483c-8eba-e727889bcc93" xlink:to="loc_us-gaap_EquitySecuritiesMember_c8e13f1b-61bb-4c2f-8f41-881b75795d5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_760722d2-a72f-4279-8006-cab79830ab8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_760722d2-a72f-4279-8006-cab79830ab8b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_760722d2-a72f-4279-8006-cab79830ab8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_760722d2-a72f-4279-8006-cab79830ab8b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_760722d2-a72f-4279-8006-cab79830ab8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8c4cb627-1881-41a2-b7f8-3e60f2524c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_760722d2-a72f-4279-8006-cab79830ab8b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8c4cb627-1881-41a2-b7f8-3e60f2524c31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_91991b91-c8c6-4b3d-a5ef-0c15f03fbb68" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8c4cb627-1881-41a2-b7f8-3e60f2524c31" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_91991b91-c8c6-4b3d-a5ef-0c15f03fbb68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_2b02fe01-adad-4579-9b43-2a186e2149ea" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8c4cb627-1881-41a2-b7f8-3e60f2524c31" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_2b02fe01-adad-4579-9b43-2a186e2149ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_4764ab9d-ffc3-41d5-9cbc-cff5d2ebc2db" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8c4cb627-1881-41a2-b7f8-3e60f2524c31" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_4764ab9d-ffc3-41d5-9cbc-cff5d2ebc2db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_14456880-a58f-4310-9c6f-98bda95ecaa9" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForContingentValueRightsCompanyXCellaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8c4cb627-1881-41a2-b7f8-3e60f2524c31" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_14456880-a58f-4310-9c6f-98bda95ecaa9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_c3d8e48d-9184-43a5-87c6-b36ad5c38d76" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8c4cb627-1881-41a2-b7f8-3e60f2524c31" xlink:to="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_c3d8e48d-9184-43a5-87c6-b36ad5c38d76" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1fb5d2fb-a892-422b-9afc-26df5129808e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1fb5d2fb-a892-422b-9afc-26df5129808e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1fb5d2fb-a892-422b-9afc-26df5129808e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1fb5d2fb-a892-422b-9afc-26df5129808e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1fb5d2fb-a892-422b-9afc-26df5129808e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42dfe8b4-090a-4257-9157-9b4d29ffc7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1fb5d2fb-a892-422b-9afc-26df5129808e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42dfe8b4-090a-4257-9157-9b4d29ffc7f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember_2b44d0df-3dc0-497b-8ad6-a6356678fe63" xlink:href="lgnd-20220630.xsd#lgnd_MetabasisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42dfe8b4-090a-4257-9157-9b4d29ffc7f1" xlink:to="loc_lgnd_MetabasisMember_2b44d0df-3dc0-497b-8ad6-a6356678fe63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember_ed801a6e-d0be-453e-98cb-096972122329" xlink:href="lgnd-20220630.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42dfe8b4-090a-4257-9157-9b4d29ffc7f1" xlink:to="loc_lgnd_XCellaBiosciencesIncMember_ed801a6e-d0be-453e-98cb-096972122329" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5efff677-5e6b-4115-8d8a-9fea15b47bc7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_srt_RangeAxis_5efff677-5e6b-4115-8d8a-9fea15b47bc7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5efff677-5e6b-4115-8d8a-9fea15b47bc7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5efff677-5e6b-4115-8d8a-9fea15b47bc7" xlink:to="loc_srt_RangeMember_5efff677-5e6b-4115-8d8a-9fea15b47bc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_73942026-b38c-4925-b2d0-2826ed2ecbc5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5efff677-5e6b-4115-8d8a-9fea15b47bc7" xlink:to="loc_srt_RangeMember_73942026-b38c-4925-b2d0-2826ed2ecbc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f572c482-5fbc-4f3d-8970-c83fb301a500" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_73942026-b38c-4925-b2d0-2826ed2ecbc5" xlink:to="loc_srt_MaximumMember_f572c482-5fbc-4f3d-8970-c83fb301a500" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_408c3725-e238-4104-a3aa-c8fe9732d55f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_408c3725-e238-4104-a3aa-c8fe9732d55f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_408c3725-e238-4104-a3aa-c8fe9732d55f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_408c3725-e238-4104-a3aa-c8fe9732d55f" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_408c3725-e238-4104-a3aa-c8fe9732d55f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_350f30a9-7136-4942-ba73-c3ee4827ab67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_408c3725-e238-4104-a3aa-c8fe9732d55f" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_350f30a9-7136-4942-ba73-c3ee4827ab67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_9583a008-641d-4618-93d8-cbcdc1e048d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_350f30a9-7136-4942-ba73-c3ee4827ab67" xlink:to="loc_us-gaap_TransferredOverTimeMember_9583a008-641d-4618-93d8-cbcdc1e048d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e1e5cc72-0eca-46bb-b03c-9a3a6dd07fe1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_srt_ProductOrServiceAxis_e1e5cc72-0eca-46bb-b03c-9a3a6dd07fe1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e1e5cc72-0eca-46bb-b03c-9a3a6dd07fe1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e1e5cc72-0eca-46bb-b03c-9a3a6dd07fe1" xlink:to="loc_srt_ProductsAndServicesDomain_e1e5cc72-0eca-46bb-b03c-9a3a6dd07fe1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4922cfb9-39ec-4ea9-ae0b-d2a955d2909d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e1e5cc72-0eca-46bb-b03c-9a3a6dd07fe1" xlink:to="loc_srt_ProductsAndServicesDomain_4922cfb9-39ec-4ea9-ae0b-d2a955d2909d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_ca1537d7-5225-41f1-a528-91fb7903b760" xlink:href="lgnd-20220630.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4922cfb9-39ec-4ea9-ae0b-d2a955d2909d" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_ca1537d7-5225-41f1-a528-91fb7903b760" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_5eef9561-6fa2-489f-afc5-3108d23eb99d" xlink:href="lgnd-20220630.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4922cfb9-39ec-4ea9-ae0b-d2a955d2909d" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_5eef9561-6fa2-489f-afc5-3108d23eb99d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_0ca78fc1-373a-46d4-90a6-9350ab301835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_0ca78fc1-373a-46d4-90a6-9350ab301835" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_0ca78fc1-373a-46d4-90a6-9350ab301835_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_0ca78fc1-373a-46d4-90a6-9350ab301835" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_0ca78fc1-373a-46d4-90a6-9350ab301835_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_a18e71e3-6dee-4cac-9c75-d47364e7582b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_0ca78fc1-373a-46d4-90a6-9350ab301835" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_a18e71e3-6dee-4cac-9c75-d47364e7582b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_a33aef83-7d5e-476e-8a91-050ca70e9711" xlink:href="lgnd-20220630.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_a18e71e3-6dee-4cac-9c75-d47364e7582b" xlink:to="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_a33aef83-7d5e-476e-8a91-050ca70e9711" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_bdb3ca80-9594-41e3-9cc8-f93d8d23d9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_FinancialInstrumentAxis_bdb3ca80-9594-41e3-9cc8-f93d8d23d9bd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bdb3ca80-9594-41e3-9cc8-f93d8d23d9bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_bdb3ca80-9594-41e3-9cc8-f93d8d23d9bd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bdb3ca80-9594-41e3-9cc8-f93d8d23d9bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_55d8a3c8-cbad-46e8-9691-5e983764ea48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_bdb3ca80-9594-41e3-9cc8-f93d8d23d9bd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_55d8a3c8-cbad-46e8-9691-5e983764ea48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_719a74e0-691e-4b29-8211-d0ff34c6160d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_55d8a3c8-cbad-46e8-9691-5e983764ea48" xlink:to="loc_us-gaap_CommonStockMember_719a74e0-691e-4b29-8211-d0ff34c6160d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended" id="i6b427aec69424ac5819480d72107ac00_FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7181e3a2-2bf0-4bc2-bc3a-25e58d37ad49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_94ca4a40-faff-48af-9e79-122d6034f1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7181e3a2-2bf0-4bc2-bc3a-25e58d37ad49" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_94ca4a40-faff-48af-9e79-122d6034f1fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_01225f93-be44-4418-a8dd-97b7a6b4c907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_94ca4a40-faff-48af-9e79-122d6034f1fa" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_01225f93-be44-4418-a8dd-97b7a6b4c907" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders_29118fc9-9dd3-405a-80a1-35e89c071a3f" xlink:href="lgnd-20220630.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_94ca4a40-faff-48af-9e79-122d6034f1fa" xlink:to="loc_lgnd_PaymentsToContingentValueRightHolders_29118fc9-9dd3-405a-80a1-35e89c071a3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_e0dcac85-17f6-487e-8032-8a10d83a37ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_94ca4a40-faff-48af-9e79-122d6034f1fa" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_e0dcac85-17f6-487e-8032-8a10d83a37ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_7c6eca8e-8648-4000-885d-07a6730ec281" xlink:href="lgnd-20220630.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_94ca4a40-faff-48af-9e79-122d6034f1fa" xlink:to="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_7c6eca8e-8648-4000-885d-07a6730ec281" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c2d53257-9c2c-4667-98e5-42d36f4c50a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f8dfa3ac-9d30-4f1b-ac62-908e36d766f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7181e3a2-2bf0-4bc2-bc3a-25e58d37ad49" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f8dfa3ac-9d30-4f1b-ac62-908e36d766f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6f560bd4-0ac6-4c00-ad0e-6c464c345d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f8dfa3ac-9d30-4f1b-ac62-908e36d766f2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6f560bd4-0ac6-4c00-ad0e-6c464c345d63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f560bd4-0ac6-4c00-ad0e-6c464c345d63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6f560bd4-0ac6-4c00-ad0e-6c464c345d63" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f560bd4-0ac6-4c00-ad0e-6c464c345d63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_805716c3-f31e-404d-aa93-48790e700a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6f560bd4-0ac6-4c00-ad0e-6c464c345d63" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_805716c3-f31e-404d-aa93-48790e700a1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_728da17e-3454-48da-9ff5-7048a6dbccee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_805716c3-f31e-404d-aa93-48790e700a1c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_728da17e-3454-48da-9ff5-7048a6dbccee" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended" id="i375685e76b2d4bb3aaaa2b2c48f9d665_ConvertibleSeniorNotesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1774361a-d0c4-4921-ab21-993d611a7f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1774361a-d0c4-4921-ab21-993d611a7f83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_49ea02d0-c3e1-4b09-8089-973c98c655ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_49ea02d0-c3e1-4b09-8089-973c98c655ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_80df23cc-ca5a-448d-98c8-5f6473e9eeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_80df23cc-ca5a-448d-98c8-5f6473e9eeb9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_e522add1-920f-4902-9191-3385f93e41a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_e522add1-920f-4902-9191-3385f93e41a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_d45ad621-325c-4b87-824b-c0d804f5e344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_d45ad621-325c-4b87-824b-c0d804f5e344" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_dc6a7ca0-607e-480f-a564-9b41d9e60244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_dc6a7ca0-607e-480f-a564-9b41d9e60244" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_af2d680a-a637-4543-ab70-89489ac4440e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_af2d680a-a637-4543-ab70-89489ac4440e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_2549aa0c-58f4-4841-9840-5d7b70c349fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_2549aa0c-58f4-4841-9840-5d7b70c349fb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_7b8e18ed-a122-4dc7-b14a-88370f3b265b" xlink:href="lgnd-20220630.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_7b8e18ed-a122-4dc7-b14a-88370f3b265b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_a559f01b-aacb-4240-82c9-15e06389f218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_a559f01b-aacb-4240-82c9-15e06389f218" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_e04a0146-c4fe-4d06-a90e-9f6456406e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentTerm_e04a0146-c4fe-4d06-a90e-9f6456406e7f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a8ca10b2-afa9-45b6-a9e1-9d5c5611461e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a8ca10b2-afa9-45b6-a9e1-9d5c5611461e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_d0e885f1-8bfc-45a7-aec8-e96fc43902ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_InterestExpenseDebt_d0e885f1-8bfc-45a7-aec8-e96fc43902ca" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_453b95c9-01fe-4f9d-94b9-2ee5a41b4c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_453b95c9-01fe-4f9d-94b9-2ee5a41b4c46" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_e21cfc92-9bf8-43d2-a7fb-21443f3e6226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_e21cfc92-9bf8-43d2-a7fb-21443f3e6226" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_1685eb41-244b-42b5-894d-d3ba5f92940d" xlink:href="lgnd-20220630.xsd#lgnd_DebtInstrumentRepurchasedAmountDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_1685eb41-244b-42b5-894d-d3ba5f92940d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_ca505be3-b812-4412-8203-7c534fb01559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_ca505be3-b812-4412-8203-7c534fb01559" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_3674c719-bed5-40ce-b3a7-57e6aa61eb3f" xlink:href="lgnd-20220630.xsd#lgnd_RepaymentsOfNotesPayableInterestPortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_3674c719-bed5-40ce-b3a7-57e6aa61eb3f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e56c0168-f87d-427e-88ed-8ff26aa0ccca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e56c0168-f87d-427e-88ed-8ff26aa0ccca" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c2db8db1-eab6-498f-bafc-77fab1e10b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c2db8db1-eab6-498f-bafc-77fab1e10b5a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_109c2ff7-35ef-455a-ade9-324eff902575" xlink:href="lgnd-20220630.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_109c2ff7-35ef-455a-ade9-324eff902575" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_d396ba72-b9c0-4b16-94e0-032a127a5db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_d396ba72-b9c0-4b16-94e0-032a127a5db6" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges_44de758f-2009-40e7-aa61-6416b5685653" xlink:href="lgnd-20220630.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_lgnd_PaymentsForConvertibleBondHedges_44de758f-2009-40e7-aa61-6416b5685653" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a0b37da5-cb5f-4383-9ece-4bc26c500d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a0b37da5-cb5f-4383-9ece-4bc26c500d2f" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1681ed55-573b-481f-8774-5cf42e57ffce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1681ed55-573b-481f-8774-5cf42e57ffce" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_85e07e21-a345-4a70-96c7-b6fd63052207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_85e07e21-a345-4a70-96c7-b6fd63052207" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants_2ee9fc1a-9366-4ae7-a429-60c1b010d44f" xlink:href="lgnd-20220630.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_lgnd_PaymentsToUnwindWarrants_2ee9fc1a-9366-4ae7-a429-60c1b010d44f" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_61ba949e-a06c-4762-be97-b07c4a957b2d" xlink:href="lgnd-20220630.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_61ba949e-a06c-4762-be97-b07c4a957b2d" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_82f89223-a75e-4303-ad67-64e97abb579f" xlink:href="lgnd-20220630.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_82f89223-a75e-4303-ad67-64e97abb579f" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ace528c0-df4c-48ff-9927-8260764d8388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentTable_ace528c0-df4c-48ff-9927-8260764d8388" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_57229596-53cc-44ff-87bc-9650affc134d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ace528c0-df4c-48ff-9927-8260764d8388" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_57229596-53cc-44ff-87bc-9650affc134d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_57229596-53cc-44ff-87bc-9650affc134d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_57229596-53cc-44ff-87bc-9650affc134d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_57229596-53cc-44ff-87bc-9650affc134d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6dad42b8-7c04-4fb3-ad6b-a3bcc9a49fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_57229596-53cc-44ff-87bc-9650affc134d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6dad42b8-7c04-4fb3-ad6b-a3bcc9a49fd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_d5d20e25-38ac-47fd-995c-a477a47eae8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6dad42b8-7c04-4fb3-ad6b-a3bcc9a49fd0" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_d5d20e25-38ac-47fd-995c-a477a47eae8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a89d1cba-b663-443b-8bf8-6405d93c0a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ace528c0-df4c-48ff-9927-8260764d8388" xlink:to="loc_us-gaap_DebtInstrumentAxis_a89d1cba-b663-443b-8bf8-6405d93c0a2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a89d1cba-b663-443b-8bf8-6405d93c0a2a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a89d1cba-b663-443b-8bf8-6405d93c0a2a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a89d1cba-b663-443b-8bf8-6405d93c0a2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_adfcf34a-c628-48b5-936b-a675fea543b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a89d1cba-b663-443b-8bf8-6405d93c0a2a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_adfcf34a-c628-48b5-936b-a675fea543b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_0cb94870-0000-4310-834a-7cd02406b16f" xlink:href="lgnd-20220630.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_adfcf34a-c628-48b5-936b-a675fea543b9" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_0cb94870-0000-4310-834a-7cd02406b16f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_c4b32a69-d20f-4738-b410-322f3f839e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ace528c0-df4c-48ff-9927-8260764d8388" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_c4b32a69-d20f-4738-b410-322f3f839e33" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_c4b32a69-d20f-4738-b410-322f3f839e33_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_c4b32a69-d20f-4738-b410-322f3f839e33" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_c4b32a69-d20f-4738-b410-322f3f839e33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fab64d43-f513-4f73-b0d2-5fe14279a62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_c4b32a69-d20f-4738-b410-322f3f839e33" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fab64d43-f513-4f73-b0d2-5fe14279a62a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_e436fa13-09ec-4c0e-8072-d995e9362964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fab64d43-f513-4f73-b0d2-5fe14279a62a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_e436fa13-09ec-4c0e-8072-d995e9362964" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_03cf4ac8-2507-4095-b4cd-161dc192864b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fab64d43-f513-4f73-b0d2-5fe14279a62a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_03cf4ac8-2507-4095-b4cd-161dc192864b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f606497c-90b5-4727-9f1f-c16cf243d26e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ace528c0-df4c-48ff-9927-8260764d8388" xlink:to="loc_srt_RangeAxis_f606497c-90b5-4727-9f1f-c16cf243d26e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f606497c-90b5-4727-9f1f-c16cf243d26e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f606497c-90b5-4727-9f1f-c16cf243d26e" xlink:to="loc_srt_RangeMember_f606497c-90b5-4727-9f1f-c16cf243d26e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_27a70614-b008-4187-a268-40de4128597f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f606497c-90b5-4727-9f1f-c16cf243d26e" xlink:to="loc_srt_RangeMember_27a70614-b008-4187-a268-40de4128597f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_541b24ec-f50d-469d-b367-8513d5a22468" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_27a70614-b008-4187-a268-40de4128597f" xlink:to="loc_srt_MaximumMember_541b24ec-f50d-469d-b367-8513d5a22468" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended" id="i3082843676f3408a9471ea246133347a_ConvertibleSeniorNotesNotesPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_41d4a6e8-2a7e-4539-8397-9c156066c8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_ef7d48bb-4232-471a-bf1b-232f12ffa10d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41d4a6e8-2a7e-4539-8397-9c156066c8a5" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_ef7d48bb-4232-471a-bf1b-232f12ffa10d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7cb2de0d-7ba4-44c8-9819-60c1eb4f7f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_ef7d48bb-4232-471a-bf1b-232f12ffa10d" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7cb2de0d-7ba4-44c8-9819-60c1eb4f7f47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_ff3ee69f-ec39-42b0-8380-3a85b11a604d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_ef7d48bb-4232-471a-bf1b-232f12ffa10d" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_ff3ee69f-ec39-42b0-8380-3a85b11a604d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_f6af0f9d-3437-47c7-be5a-c3615308f688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_ef7d48bb-4232-471a-bf1b-232f12ffa10d" xlink:to="loc_us-gaap_LongTermNotesPayable_f6af0f9d-3437-47c7-be5a-c3615308f688" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_4b826e2a-e714-4c51-9f9c-69c89e3ad583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41d4a6e8-2a7e-4539-8397-9c156066c8a5" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_4b826e2a-e714-4c51-9f9c-69c89e3ad583" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ccc151fc-3b12-45ab-a421-9b02b025098e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41d4a6e8-2a7e-4539-8397-9c156066c8a5" xlink:to="loc_us-gaap_DebtInstrumentTable_ccc151fc-3b12-45ab-a421-9b02b025098e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4630a3cb-414c-4c44-b5eb-9fbdf54c2b14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ccc151fc-3b12-45ab-a421-9b02b025098e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4630a3cb-414c-4c44-b5eb-9fbdf54c2b14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4630a3cb-414c-4c44-b5eb-9fbdf54c2b14_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4630a3cb-414c-4c44-b5eb-9fbdf54c2b14" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4630a3cb-414c-4c44-b5eb-9fbdf54c2b14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2da32bfa-299b-48a0-8778-06626d3280bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4630a3cb-414c-4c44-b5eb-9fbdf54c2b14" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2da32bfa-299b-48a0-8778-06626d3280bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_2f1890fc-2728-4b58-a720-75e92ba3df66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2da32bfa-299b-48a0-8778-06626d3280bc" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_2f1890fc-2728-4b58-a720-75e92ba3df66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6e4c1bd8-7e8f-41c0-b7c2-edb803878d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ccc151fc-3b12-45ab-a421-9b02b025098e" xlink:to="loc_us-gaap_DebtInstrumentAxis_6e4c1bd8-7e8f-41c0-b7c2-edb803878d89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6e4c1bd8-7e8f-41c0-b7c2-edb803878d89_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6e4c1bd8-7e8f-41c0-b7c2-edb803878d89" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6e4c1bd8-7e8f-41c0-b7c2-edb803878d89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c61d8965-acd2-42e7-b567-b729cf281297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6e4c1bd8-7e8f-41c0-b7c2-edb803878d89" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c61d8965-acd2-42e7-b567-b729cf281297" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_36de3366-f81d-47a4-8b0a-b8a42b5bf0a3" xlink:href="lgnd-20220630.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c61d8965-acd2-42e7-b567-b729cf281297" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_36de3366-f81d-47a4-8b0a-b8a42b5bf0a3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#IncomeTaxDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="extended" id="i94166d173a3f4a009a0468425fe350d4_IncomeTaxDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_87827938-5115-48bc-8957-d770d5a851b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cd4299ea-5f3b-4024-9004-a59a0cfabaab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_87827938-5115-48bc-8957-d770d5a851b5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cd4299ea-5f3b-4024-9004-a59a0cfabaab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount_aff6d0b8-0066-47b6-a5ff-9fe3beacd2e1" xlink:href="lgnd-20220630.xsd#lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_87827938-5115-48bc-8957-d770d5a851b5" xlink:to="loc_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount_aff6d0b8-0066-47b6-a5ff-9fe3beacd2e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_bd8dbe49-4a3b-419e-ab3a-4919e872fa97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_87827938-5115-48bc-8957-d770d5a851b5" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_bd8dbe49-4a3b-419e-ab3a-4919e872fa97" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_787b6671-71b1-45a8-a3d7-f7e271e8e97f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_bd8dbe49-4a3b-419e-ab3a-4919e872fa97" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_787b6671-71b1-45a8-a3d7-f7e271e8e97f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_787b6671-71b1-45a8-a3d7-f7e271e8e97f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_787b6671-71b1-45a8-a3d7-f7e271e8e97f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_787b6671-71b1-45a8-a3d7-f7e271e8e97f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cae37748-68bb-4a45-9459-816f36c2dd8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_787b6671-71b1-45a8-a3d7-f7e271e8e97f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cae37748-68bb-4a45-9459-816f36c2dd8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_c0d8e716-23f9-46cc-b860-a33c2b0451c8" xlink:href="lgnd-20220630.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cae37748-68bb-4a45-9459-816f36c2dd8e" xlink:to="loc_lgnd_PfenexMember_c0d8e716-23f9-46cc-b860-a33c2b0451c8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended" id="i6baf91317dc8468c851456882f8e6571_StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_3035470a-7510-445a-b38a-ba26dc0069c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e91a6a04-9bb0-46f0-8cfd-613e8b7fe686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3035470a-7510-445a-b38a-ba26dc0069c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e91a6a04-9bb0-46f0-8cfd-613e8b7fe686" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_516cb8c5-d9d8-4926-ae82-62c4a1dd626c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e91a6a04-9bb0-46f0-8cfd-613e8b7fe686" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_516cb8c5-d9d8-4926-ae82-62c4a1dd626c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_17798954-163f-4a56-afbb-3a11b0e9eb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e91a6a04-9bb0-46f0-8cfd-613e8b7fe686" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_17798954-163f-4a56-afbb-3a11b0e9eb8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a0d9344d-553a-4a88-b22f-2af59137a0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e91a6a04-9bb0-46f0-8cfd-613e8b7fe686" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a0d9344d-553a-4a88-b22f-2af59137a0e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1dfc0f17-69a9-40be-bdae-1031fb956997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e91a6a04-9bb0-46f0-8cfd-613e8b7fe686" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1dfc0f17-69a9-40be-bdae-1031fb956997" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6184c3f8-cdef-4e87-a43e-037b2221be82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_171020cf-267a-4305-94d9-63e82d84895c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3035470a-7510-445a-b38a-ba26dc0069c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_171020cf-267a-4305-94d9-63e82d84895c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c4e74a80-5391-495b-9716-a32ead24b992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_171020cf-267a-4305-94d9-63e82d84895c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c4e74a80-5391-495b-9716-a32ead24b992" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_47efeb9b-bd08-48e1-b8ef-fd8f619ea1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_171020cf-267a-4305-94d9-63e82d84895c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_47efeb9b-bd08-48e1-b8ef-fd8f619ea1d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_fbc2c3ae-b90f-49a3-b82d-b2a1663bd952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_171020cf-267a-4305-94d9-63e82d84895c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_fbc2c3ae-b90f-49a3-b82d-b2a1663bd952" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_ad956d49-18d6-4621-8a73-f6ce92f3cbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_171020cf-267a-4305-94d9-63e82d84895c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_ad956d49-18d6-4621-8a73-f6ce92f3cbf9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11ffd51d-0c8d-4be4-a4da-c10d1f240449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4d9b64f0-b01d-4291-868f-bee562c3db0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3035470a-7510-445a-b38a-ba26dc0069c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4d9b64f0-b01d-4291-868f-bee562c3db0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb773cf1-ce11-4cf3-a886-34858b159433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4d9b64f0-b01d-4291-868f-bee562c3db0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb773cf1-ce11-4cf3-a886-34858b159433" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_79fbbcd5-924e-4682-a242-d95e76a26a55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4d9b64f0-b01d-4291-868f-bee562c3db0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_79fbbcd5-924e-4682-a242-d95e76a26a55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_23d44c5b-2642-4be2-8362-13d0a1b449ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4d9b64f0-b01d-4291-868f-bee562c3db0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_23d44c5b-2642-4be2-8362-13d0a1b449ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_639b1bc1-048f-4fe4-a878-0b0a01d00161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4d9b64f0-b01d-4291-868f-bee562c3db0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_639b1bc1-048f-4fe4-a878-0b0a01d00161" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_46c2338e-a675-4f89-9324-cc602779ed5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69d67b26-aff3-47c2-afd6-b2c39006eb51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_3035470a-7510-445a-b38a-ba26dc0069c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69d67b26-aff3-47c2-afd6-b2c39006eb51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_66a9f9b4-3b23-4b5c-874b-9e0b1c3d8fac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69d67b26-aff3-47c2-afd6-b2c39006eb51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_66a9f9b4-3b23-4b5c-874b-9e0b1c3d8fac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4a15707b-7ec0-4839-8b9d-e3541566f10b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69d67b26-aff3-47c2-afd6-b2c39006eb51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4a15707b-7ec0-4839-8b9d-e3541566f10b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_104b43f4-071f-426b-825a-8cca957e9bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69d67b26-aff3-47c2-afd6-b2c39006eb51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_104b43f4-071f-426b-825a-8cca957e9bb6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a1cf6b29-1191-4848-9fff-ece1dfad8802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69d67b26-aff3-47c2-afd6-b2c39006eb51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a1cf6b29-1191-4848-9fff-ece1dfad8802" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4e3042dc-53b8-4bfa-b128-abb68db14446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_3a39ca54-cf14-4d66-ba24-6963021a4de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_3035470a-7510-445a-b38a-ba26dc0069c5" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_3a39ca54-cf14-4d66-ba24-6963021a4de8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_741f91ef-9526-4cbb-bf91-68143e7de834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_3a39ca54-cf14-4d66-ba24-6963021a4de8" xlink:to="loc_us-gaap_AwardTypeAxis_741f91ef-9526-4cbb-bf91-68143e7de834" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_741f91ef-9526-4cbb-bf91-68143e7de834_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_741f91ef-9526-4cbb-bf91-68143e7de834" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_741f91ef-9526-4cbb-bf91-68143e7de834_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f948a5e-d25b-4c42-8af5-9077104ca12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_741f91ef-9526-4cbb-bf91-68143e7de834" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f948a5e-d25b-4c42-8af5-9077104ca12e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9d12585a-0fd0-4964-a16c-9ff926b28749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f948a5e-d25b-4c42-8af5-9077104ca12e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9d12585a-0fd0-4964-a16c-9ff926b28749" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e628be11-6281-4480-8ce8-21bb3aae8094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f948a5e-d25b-4c42-8af5-9077104ca12e" xlink:to="loc_us-gaap_RestrictedStockMember_e628be11-6281-4480-8ce8-21bb3aae8094" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" id="iac8c7115e80249688058016cd8ef8e44_StockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_77e1d17c-16b1-44bd-b91d-51db721c2e51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_77e1d17c-16b1-44bd-b91d-51db721c2e51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5ba25655-ee36-484d-8815-c73926388040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5ba25655-ee36-484d-8815-c73926388040" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_abf506eb-a99e-469e-8c5c-ae2e17bc9ff9" xlink:href="lgnd-20220630.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_abf506eb-a99e-469e-8c5c-ae2e17bc9ff9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_f4b02bf2-d26c-4340-b655-5ab6de69998e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_abf506eb-a99e-469e-8c5c-ae2e17bc9ff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_f4b02bf2-d26c-4340-b655-5ab6de69998e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_16da9551-4ba5-41fa-95c0-510c40d6959b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_abf506eb-a99e-469e-8c5c-ae2e17bc9ff9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_16da9551-4ba5-41fa-95c0-510c40d6959b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_255a5c47-30dd-4d7f-bfc9-61f2f0549ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_255a5c47-30dd-4d7f-bfc9-61f2f0549ba8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_c477b86d-d542-41d2-9132-eb79771273a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_c477b86d-d542-41d2-9132-eb79771273a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_b1067196-7751-4746-a401-2871cc71ede0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_b1067196-7751-4746-a401-2871cc71ede0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_23c3e710-d1b9-4f62-85bb-6d5431956704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_23c3e710-d1b9-4f62-85bb-6d5431956704" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c0fd749-d953-4eb9-ac80-c2d389a6488a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c0fd749-d953-4eb9-ac80-c2d389a6488a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_0eb68a60-c159-4c9b-82fe-81eadfe7c88c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c0fd749-d953-4eb9-ac80-c2d389a6488a" xlink:to="loc_us-gaap_PlanNameAxis_0eb68a60-c159-4c9b-82fe-81eadfe7c88c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_0eb68a60-c159-4c9b-82fe-81eadfe7c88c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_0eb68a60-c159-4c9b-82fe-81eadfe7c88c" xlink:to="loc_us-gaap_PlanNameDomain_0eb68a60-c159-4c9b-82fe-81eadfe7c88c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d1597253-3582-47e6-8bee-fb7b2fb77b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_0eb68a60-c159-4c9b-82fe-81eadfe7c88c" xlink:to="loc_us-gaap_PlanNameDomain_d1597253-3582-47e6-8bee-fb7b2fb77b89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember_eca8218b-f4fa-462c-9335-a5a9cd33348e" xlink:href="lgnd-20220630.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d1597253-3582-47e6-8bee-fb7b2fb77b89" xlink:to="loc_lgnd_EmployeeStockPurchasePlanMember_eca8218b-f4fa-462c-9335-a5a9cd33348e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#CommitmentandContingenciesLegalProceedingsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="extended" id="i58b6f4a301d64d559e9519c06c1db23a_CommitmentandContingenciesLegalProceedingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_4d7b8b31-fbf6-47b1-b416-bab4506e775d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_0164ba37-cf42-46d6-aab7-b7f89081610f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_4d7b8b31-fbf6-47b1-b416-bab4506e775d" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_0164ba37-cf42-46d6-aab7-b7f89081610f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_09383624-3186-4338-87ed-e6d7194450d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_4d7b8b31-fbf6-47b1-b416-bab4506e775d" xlink:to="loc_us-gaap_LossContingenciesTable_09383624-3186-4338-87ed-e6d7194450d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_bf71c462-a3f0-4cc4-a109-1aae52bc8f50" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_09383624-3186-4338-87ed-e6d7194450d3" xlink:to="loc_srt_LitigationCaseAxis_bf71c462-a3f0-4cc4-a109-1aae52bc8f50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_bf71c462-a3f0-4cc4-a109-1aae52bc8f50_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_bf71c462-a3f0-4cc4-a109-1aae52bc8f50" xlink:to="loc_srt_LitigationCaseTypeDomain_bf71c462-a3f0-4cc4-a109-1aae52bc8f50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d76e3e10-6be3-49b3-9f25-f4611cf8b8df" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_bf71c462-a3f0-4cc4-a109-1aae52bc8f50" xlink:to="loc_srt_LitigationCaseTypeDomain_d76e3e10-6be3-49b3-9f25-f4611cf8b8df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_5aea71e8-5a63-4970-acaa-4ff3a3e5e478" xlink:href="lgnd-20220630.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_d76e3e10-6be3-49b3-9f25-f4611cf8b8df" xlink:to="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_5aea71e8-5a63-4970-acaa-4ff3a3e5e478" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i5b94256494ce4d05b824beb7ebb54b3d_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_4c60a555-ef32-4741-aa80-5c018d3ce588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_56d6ad3e-6b28-4c85-88e8-65090af764e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4c60a555-ef32-4741-aa80-5c018d3ce588" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_56d6ad3e-6b28-4c85-88e8-65090af764e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_31ea2ca6-8476-46a0-84a8-c59b8d57181c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4c60a555-ef32-4741-aa80-5c018d3ce588" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_31ea2ca6-8476-46a0-84a8-c59b8d57181c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_48342433-e7ce-4736-bede-3b75fabaea03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4c60a555-ef32-4741-aa80-5c018d3ce588" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_48342433-e7ce-4736-bede-3b75fabaea03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a7e521f1-3254-4acb-a346-009ebc7ea563" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_48342433-e7ce-4736-bede-3b75fabaea03" xlink:to="loc_srt_RangeAxis_a7e521f1-3254-4acb-a346-009ebc7ea563" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a7e521f1-3254-4acb-a346-009ebc7ea563_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a7e521f1-3254-4acb-a346-009ebc7ea563" xlink:to="loc_srt_RangeMember_a7e521f1-3254-4acb-a346-009ebc7ea563_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ec680807-1472-4734-8bd1-e48422a125a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a7e521f1-3254-4acb-a346-009ebc7ea563" xlink:to="loc_srt_RangeMember_ec680807-1472-4734-8bd1-e48422a125a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_62b6d410-d339-4b98-952e-6b2738daa410" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ec680807-1472-4734-8bd1-e48422a125a5" xlink:to="loc_srt_MaximumMember_62b6d410-d339-4b98-952e-6b2738daa410" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>lgnd-20220630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:6182e749-0dc5-4e16-af49-321ddbc4d263,g:44d35ef7-647e-41c8-b2ac-a9d4b32b2035-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_f9a59989-7bc1-42c0-99c8-78a314669b99_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:to="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PfenexMember_ba4b5b96-19d2-4e58-919c-ccb0c8b32e25_terseLabel_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex</link:label>
    <link:label id="lab_lgnd_PfenexMember_label_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex [Member]</link:label>
    <link:label id="lab_lgnd_PfenexMember_documentation_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember" xlink:href="lgnd-20220630.xsd#lgnd_PfenexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PfenexMember" xlink:to="lab_lgnd_PfenexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_76308d47-b3a5-4be5-ae77-2426ecdf99a1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_e04e5025-ff11-49c0-9ffb-3f8f5156c5bb_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8c0f0180-bbc4-4c55-b110-9200e6594738_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c790e802-9d6b-46fd-aff1-a62d323ec78e_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_fd51e717-7dfc-4b85-928f-86a3887bb318_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_4c3b5c5a-226d-4678-9160-d40b28752601_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_55df3a61-d11a-4dd0-b5a3-fd3d70da3e39_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding principal amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_935a2532-2a20-406e-b042-c33bd5615fdc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturity of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_f29256a5-e573-4ef1-87d1-f30a292017eb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_531558bd-ff9e-4bc9-9083-a3c9b7cd9831_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_94c080ba-b57f-42ae-9998-514c955c6f24_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_4cca3b30-19b4-4f4c-8af4-b62b65ad14ee_negatedLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:href="lgnd-20220630.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:to="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseRightsPolicyTextBlock_b8595023-7c90-4fb2-b04d-d7fb7eb17637_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRightsPolicyTextBlock_label_en-US" xlink:label="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights [Policy Text Block]</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRightsPolicyTextBlock_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:href="lgnd-20220630.xsd#lgnd_CommercialLicenseRightsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:to="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_efc86308-139e-43d9-a3d7-b0cda81c5608_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_c1b20168-11c3-4e04-9211-f50902688d3c_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) from short-term investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_a6afafea-48c9-4973-a6d6-e61a2349bf8d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_e13ce757-4bc0-401e-93f0-b32c764377a5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_9f7124d5-de03-4c8a-862a-7e123ecfad09_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_c4ccad0e-56cf-40ee-88c6-a154090e36bf_verboseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_label_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights [Abstract]</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:href="lgnd-20220630.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:to="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fe2a8207-07b6-4d72-8d8a-f296bd2e1f9f_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_66f14afd-1072-4831-835f-0507b63f560c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_646b70b8-27a3-4835-afe4-4ddb232bb92d_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d03725fc-dc16-425b-be05-e760e178bb19_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_6f680fc9-69af-481e-aea4-06bb967fa72e_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_1884d4d7-58be-492c-9813-cc5b796b8f95_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_86728840-b0ed-4f01-9d72-54094ecb039a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_7a0295e2-65c2-4d59-8af7-1eb8ea807b88_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_8aa8cc98-3aa2-4cca-b1f2-057635c5d4de_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_b11a15ac-dedb-4349-855c-fe3f86ae1abc_terseLabel_en-US" xlink:label="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease amortization expense</link:label>
    <link:label id="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease And Operating Lease, Right-of-Use Asset, Amortization</link:label>
    <link:label id="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_documentation_en-US" xlink:label="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease And Operating Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:href="lgnd-20220630.xsd#lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:to="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_4055e195-f3b2-467b-8bff-1006053b9b7f_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_4cea8300-0b93-4836-83ed-47a250976d06_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_968f4aa8-b8d7-4a0d-84cd-fb343aa9986c_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_3693081b-a6c4-41f4-b580-8e2003741017_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e55a78c1-3acd-45aa-b7d6-1caa978feb19_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_02a12070-032d-4e86-b22b-be4b86d7fffb_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair-Value Options Awarded to Employees and Directors</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_f5feee4d-6e53-458d-a328-e9b068b9eb04_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_6ec12791-d92d-494f-89ee-587ef3c4ae3b_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ebefab78-ba2b-4b20-b315-47ecc6def36b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_5a162815-1e5a-42ce-8b38-16c414cf099e_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_7efe3d00-afe7-4de7-af5c-1af662a91027_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_aa9ea928-8c6a-4302-952a-2ce40c69b782_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_5e9518c8-4900-440f-adaf-e655616fb52d_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_0455b416-e097-4573-a3d6-9de74b4586bb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_f91e0939-ebc5-4684-8019-d9577bbb22ef_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for convertible bond hedges</link:label>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges" xlink:href="lgnd-20220630.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsForConvertibleBondHedges" xlink:to="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_106e86c2-fe5b-4c4b-802a-360dc41ff7de_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_e2ed6991-6b04-4d12-a1b7-e5bcb410cce1_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_9e95f945-c007-41ea-843e-524f2f6d16ae_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_0b97f84a-b219-4a2a-94b1-fd9311c6a610_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares:</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:to="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9f56329a-04da-47c5-adaf-2bfbeccb70ce_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_200e4fb4-c8d3-4097-87d4-ef6364192255_terseLabel_en-US" xlink:label="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchased amount of debt instrument</link:label>
    <link:label id="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_label_en-US" xlink:label="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Amount During Period</link:label>
    <link:label id="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_documentation_en-US" xlink:label="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Amount During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:href="lgnd-20220630.xsd#lgnd_DebtInstrumentRepurchasedAmountDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:to="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_427f72e7-631a-4e4c-93e6-7b597cca573b_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2e0df9b7-c6de-4e0c-88be-131fa22bd079_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ReturnsAccrual_435a9deb-e223-40bd-ad83-4d9a2c3abea2_terseLabel_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return reserve</link:label>
    <link:label id="lab_lgnd_ReturnsAccrual_label_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns Accrual</link:label>
    <link:label id="lab_lgnd_ReturnsAccrual_documentation_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual" xlink:href="lgnd-20220630.xsd#lgnd_ReturnsAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ReturnsAccrual" xlink:to="lab_lgnd_ReturnsAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_e4baa018-2786-422a-94cd-24e900c8008a_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_113a3839-37a0-4bae-b94a-d6742e9325b0_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reacquisition of equity due to 2023 debt extinguishment, net of tax</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_584cc8ea-5903-4b94-af69-2f0912bd5f56_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining six months ending December 31, 2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_a52fb2b9-203e-40e2-818c-64ea0e9998bd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_17788c71-898b-40f4-b81a-e597961ebf75_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_dc73b2aa-d6d5-45a2-b54d-22c1cb9688bc_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_09092c07-0fc3-40fc-afdc-23844b5dd104_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_ae16c9c8-4439-4323-ae9e-910dcf4ae075_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_dfac71e0-7677-403c-be89-5c8f4cd7b4f7_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_53950a59-8646-4a4d-9fb8-646190105fb8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_d225d3c1-2ff4-423b-b349-dd46f2a7f5b0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_1c0822c0-9bb4-479e-a3a4-056a27fca466_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems" xlink:href="lgnd-20220630.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationLineItems" xlink:to="lab_lgnd_BasisOfPresentationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_048080b9-ec7e-4f78-b0d5-41d89a291b75_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9b036d05-c662-40ff-ba9c-12fea7dcfa45_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_f4ac6e82-6ce3-4632-846d-c5d09c1b4508_terseLabel_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts owed to former licensees</link:label>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_label_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensee Accrual, Current</link:label>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_documentation_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensee Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent" xlink:href="lgnd-20220630.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseeAccrualCurrent" xlink:to="lab_lgnd_LicenseeAccrualCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LeaseRightOfUseAsset_9a38e092-e203-4d61-9375-6efabcbdc391_totalLabel_en-US" xlink:label="lab_lgnd_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease assets</link:label>
    <link:label id="lab_lgnd_LeaseRightOfUseAsset_label_en-US" xlink:label="lab_lgnd_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right-Of-Use Asset</link:label>
    <link:label id="lab_lgnd_LeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_lgnd_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right-Of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseRightOfUseAsset" xlink:href="lgnd-20220630.xsd#lgnd_LeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LeaseRightOfUseAsset" xlink:to="lab_lgnd_LeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_d4193ca9-8bdb-4f8c-bbc3-d93d61d4c1da_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_721aa494-10f1-490b-9606-2e36dc33a1f4_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_26754b13-35b0-45ef-b441-428949e8eea4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_OmniAbTechnologiesSegmentMember_8440fc37-ae90-454e-b3af-fe4edf9f11d5_terseLabel_en-US" xlink:label="lab_lgnd_OmniAbTechnologiesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OmniAb Technologies</link:label>
    <link:label id="lab_lgnd_OmniAbTechnologiesSegmentMember_label_en-US" xlink:label="lab_lgnd_OmniAbTechnologiesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OmniAb Technologies Segment [Member]</link:label>
    <link:label id="lab_lgnd_OmniAbTechnologiesSegmentMember_documentation_en-US" xlink:label="lab_lgnd_OmniAbTechnologiesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OmniAb Technologies Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbTechnologiesSegmentMember" xlink:href="lgnd-20220630.xsd#lgnd_OmniAbTechnologiesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_OmniAbTechnologiesSegmentMember" xlink:to="lab_lgnd_OmniAbTechnologiesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_35cf9a17-8ed5-40f5-a5f1-0c86c7c350e6_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_98317943-3e57-4fcc-8167-7f4860ec75c6_terseLabel_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_label_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_documentation_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:href="lgnd-20220630.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:to="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bc1f461d-130b-4c6f-96d0-eec21a3fcbbb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d4f99cde-c525-4090-8f04-ca69e52dec8c_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ac1cebb8-20df-4627-adcb-998fc48f06d6_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6d14b8e8-7195-48a0-af35-f2cc14c8ac0c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_57b14dd2-a522-4e60-90b2-14b7869a63a0_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_66d26306-e22e-43ea-b84e-d3fb0b65cccd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_e438a891-0dfe-4908-8b51-6f1316616740_negatedLabel_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimated fair value of contingent liabilities</link:label>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_label_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NonCashChangeInEstimatedFairValueOfContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:href="lgnd-20220630.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:to="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_4081cc5e-05b5-49e6-8b68-ab62352f7309_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_8c961163-7a9d-4985-8d72-7449d8d9de24_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e672421c-a125-4a1e-b9cc-10b812a9374d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7f4f833f-24f7-4d51-8904-07d76ba1a4d5_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_37d40a7a-2617-4294-bd96-c44e03e7dffc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_cd0800ae-f6c7-4b69-8ed0-6f61a05a442f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a4c4f8f7-20d3-429e-80a2-26ef4322086b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_95550221-9ad1-410e-b8fc-b0de72e3ffbf_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_29947ab7-d969-48c0-b295-e97f167d68fd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_821a3391-57af-4ba9-b084-89d46bbb1135_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_9623c00a-4ece-41b2-8d4c-f1db3b99a5e6_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_fd073098-a71e-4409-9c6d-c081662bcacc_terseLabel_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from unwinding convertible bond hedges</link:label>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Unwinding Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Unwinding Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:href="lgnd-20220630.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:to="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_9d993459-995c-4a8d-b659-821bf9d2f68c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9726d659-0d67-4cfe-bde6-a20d4b91dbd8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_e65ba1af-b3d7-435c-b37a-1525e331d951_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_657ca65f-8585-4d6c-9e2f-936255d36898_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVRs issued per acquiree share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_label_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:href="lgnd-20220630.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:to="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_f9366968-669d-401b-ad03-c762b477c3b2_terseLabel_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_label_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial [Member]</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_documentation_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember" xlink:href="lgnd-20220630.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_Phase3ClinicalTrialMember" xlink:to="lab_lgnd_Phase3ClinicalTrialMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_a35cf9f3-e094-4c10-a8cf-ba104473c0c1_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_15fe5767-970d-43dd-9fc8-a0216d8c92ea_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_d17bfd5f-af0f-4048-b083-56541dc7e80c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_b94c4248-d5f3-47c0-85ec-0f96ca2e43b7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_0252f80c-8da1-4ca0-861f-8295d3abb15e_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_d0e59470-25ff-4fe0-808a-b93e0b3dcbd4_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_d796fa70-1a38-4dac-9190-d255fcbd5282_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_5a7361f5-e004-4a36-b595-15d0ff78cf56_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_c8f95bb1-15c4-454c-bd90-64ff87281e52_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viking common stock</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_87894619-24d7-423a-aa19-9a47a495aac1_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_a6995ffb-cd97-46e0-92b0-5ffab8880ff3_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_03f1dcc5-7ded-4563-ae1c-4000b73c468a_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8ba2181b-51ca-4002-a9be-bad039a078fa_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3ce75a24-03dc-492c-880a-01e45fb67b7b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_9dec75a9-4e77-4699-9844-8a6d832b4e18_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_87756b80-0e5f-4013-b24e-a5c90097972f_terseLabel_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related liabilities</link:label>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_label_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Asset Acquisitions, Current</link:label>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Asset Acquisitions, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent" xlink:href="lgnd-20220630.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedAssetAcquisitionsCurrent" xlink:to="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ee98d25a-60f9-4dc8-b396-34fe7477d140_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized stock repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_de48ae83-32b0-4be0-b105-baf6575b7ed7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_91562494-5c73-4b58-a9f0-2d9ef9b69658_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_d9bf2765-d8cd-4a59-a447-4f76d4446a1a_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes payable</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayable" xlink:to="lab_us-gaap_ConvertibleNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_59384fbf-a881-4eb6-9b4d-37dbd00013e1_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c11dbef1-7839-4242-80db-df47d1f3b0da_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total segment operating income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_3f5d1754-77e9-4285-8f30-c7492eb1233f_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_b3edf079-a3e1-478f-b8c5-992c6adc7d3a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_12d6b77e-faf9-406f-8567-85b412241056_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_84c41b49-200f-41a7-b9ff-e2198e713d46_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount and issuance fees</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_b01a3e07-ee39-4dad-9f56-4672d23a36d8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_3ad81db8-9d62-4493-a8fd-d34082b8c205_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9acb070e-7184-4211-a3fc-6793590c5089_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_4cbda424-cc57-498f-8915-ddc00c0b7741_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants issued in public offering (shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_f3097dda-2bb4-48aa-8ece-e6cfce05bd94_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_f02220c3-27cb-408c-b7e1-102495d16ea4_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_383ddde3-737d-4b88-9f24-c10293f41c6d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_41ef7700-9cd8-4d3c-99c8-baa266833ad8_verboseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term contingent liabilities</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LiabilityForContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRights" xlink:to="lab_lgnd_LiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationTable_1e872d14-8b93-4f2d-be2c-e8fced655195_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable" xlink:href="lgnd-20220630.xsd#lgnd_BasisOfPresentationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationTable" xlink:to="lab_lgnd_BasisOfPresentationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_a932a431-e33b-46ee-b48b-c7e3aa7533de_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_fd112bd2-d25a-4ac0-9fb1-aaa7d9080d4d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_bb58c04a-9f4d-4b3f-ad1d-7417ae18cd1c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_d3760a7a-9e79-4a2e-bd60-a0dcf93eb6b5_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a08afe09-8d2f-4ff9-97bd-19f79487da21_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_b8ad7d2b-0c8d-41d1-942a-715f8c01ec83_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual fund</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7c282581-0582-47ce-8d2a-b4a7b713cc30_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_a2fc8eaf-1db3-4ea7-a61a-0bfbc28e7d07_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_3bb8e9de-9f56-4492-b6c8-1976e9d821a5_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_1bc5cce5-7d89-4caf-940b-2c9b02c184f9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate (shares per $1,000)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_bc027a8f-45df-4ad6-a8a6-506be9f7030c_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_2c3e7d90-9f40-4676-98d8-5399ebfdcce9_verboseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_348b8ef7-ee06-4947-a31e-607d6d8deea0_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_33def6dc-fe58-4d12-81d9-730895886465_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount_78159b4c-54c3-4ee7-9f05-f78c3a89b03a_terseLabel_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex CVR adjustment amount</link:label>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount_label_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, CVR Adjustment, Amount</link:label>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount_documentation_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, CVR Adjustment, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" xlink:href="lgnd-20220630.xsd#lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" xlink:to="lab_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_9c5f476e-dd5a-4f0d-893b-685fcd9331d5_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_d9a80d29-d576-4ebd-933c-16e8ef39841d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_aa8c4dca-4f17-4183-9c61-d58b96b50ff7_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_808ff87b-800b-422f-bfbb-28d66979668f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractRevenueMember_55511c1e-2a0b-40ba-adf0-12ccdc50eac8_terseLabel_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_label_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue [Member]</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_documentation_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember" xlink:href="lgnd-20220630.xsd#lgnd_ContractRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractRevenueMember" xlink:to="lab_lgnd_ContractRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_f87d63a7-c30f-4045-bfb8-933526438a22_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_bcd60f7c-c362-4a7d-ac6e-bf959758751a_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_6541ee1a-a397-46d3-8cae-43d031917b7f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_a99c8ee5-120a-421d-8904-be1156552c71_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_5f066494-eb00-4af6-bdba-b2df0098df8d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of short-term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_791f9504-3db0-4b9b-acc4-1b1335bfd431_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2565f32f-e409-46dd-9276-46b79ce626ae_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_eb85d918-f89e-4403-bf33-c30b616b06c2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_d07c939f-63e3-4864-853a-3f305c1bedca_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_80acd255-e2c3-4e4d-901e-474af5f3970c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_30492ee0-d2b7-486a-b128-4fdf782f24dc_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of level 3 financial instruments as of December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_73ab69bc-5e50-41d3-ac71-86e895b35abd_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of level 3 financial instruments as of June&#160;30, 2022</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LeaseLiabilityCurrent_0733daec-872f-45cc-8e11-729d7049188e_totalLabel_en-US" xlink:label="lab_lgnd_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease liabilities</link:label>
    <link:label id="lab_lgnd_LeaseLiabilityCurrent_label_en-US" xlink:label="lab_lgnd_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Current</link:label>
    <link:label id="lab_lgnd_LeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_lgnd_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent" xlink:href="lgnd-20220630.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LeaseLiabilityCurrent" xlink:to="lab_lgnd_LeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_39c34652-0134-4ef3-be05-5237bd9892e6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_60a36b05-5432-493f-9b0c-43a30a6f05d2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_b66143e8-9710-4797-9214-fa2ac6228667_terseLabel_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subcontractor</link:label>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_label_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Subcontractor Expenses, Current</link:label>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Subcontractor Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent" xlink:href="lgnd-20220630.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedSubcontractorExpensesCurrent" xlink:to="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_c9727806-f890-43d8-ada0-3190bb174d1e_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_5fe7f79b-7de9-420b-bffa-1e04be6946be_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options under convertible bond hedges</link:label>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options under Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options under Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:href="lgnd-20220630.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:to="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9d01ba2e-11cb-421b-90f5-54591a1090f6_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_958c463d-b359-49dc-8e4f-cbafdb216127_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_b1cb9eed-2d91-4052-a6b4-93d09126739c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_4069ffbc-5719-42b3-9d44-7432c16ae32d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_3c176364-c496-4c2a-ab22-a76880f32d15_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net (loss) income per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_be5b14e5-4106-49fa-9566-53821bfef669_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtCurrent" xlink:to="lab_us-gaap_ConvertibleDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_258f21c6-9086-476b-a504-5e323b0bc607_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_be747884-10a1-4cef-8edc-e6f20720a93d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period for awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_b4f85c7d-3de3-4cca-89cf-bac404ffaa99_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_f83ae2e6-8adb-4b3c-a335-95796be868e5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_b967f306-3a99-4556-b9bc-f79c892c415c_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_61a96cf4-e8d2-4c44-94e7-81ed445b6488_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_5045b57d-96cf-42f1-a1a8-9828b656fc59_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f45cdaa2-e071-4d5a-81ee-a3f3d6f7e137_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_484fe869-1ebf-40b3-8a17-8daf54131d21_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_215801df-85d9-4ebf-b0c9-89a8830ae711_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_ff7b44f2-a283-4e0f-b647-ab491b39e85a_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Product, Other, Product, Other [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Product, Other, Product, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:href="lgnd-20220630.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:to="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_1891ce31-a1a1-4b10-8565-e8778fd56567_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit losses related to available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_e5f2a318-b902-418f-86a3-5460cdf11f3a_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_83f91f50-131f-4ab4-bccd-30bef7c8a692_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_85692569-6778-456e-9547-2eefc4ff3967_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization on finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_TeriparatideInjectionMember_993577c9-4aea-4f18-ae3d-a3badb2adda5_terseLabel_en-US" xlink:label="lab_lgnd_TeriparatideInjectionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teriparatide injection</link:label>
    <link:label id="lab_lgnd_TeriparatideInjectionMember_label_en-US" xlink:label="lab_lgnd_TeriparatideInjectionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teriparatide Injection [Member]</link:label>
    <link:label id="lab_lgnd_TeriparatideInjectionMember_documentation_en-US" xlink:label="lab_lgnd_TeriparatideInjectionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teriparatide Injection</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TeriparatideInjectionMember" xlink:href="lgnd-20220630.xsd#lgnd_TeriparatideInjectionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_TeriparatideInjectionMember" xlink:to="lab_lgnd_TeriparatideInjectionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_ae2b1441-3329-4c01-aefd-71d3ae3f1ef8_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights</link:label>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:href="lgnd-20220630.xsd#lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:to="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5e5ec136-674a-4318-b978-22429e6ca7de_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cc91a8f0-d916-4b5d-a83b-ac8f6c30fe64_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_3b0183b0-8281-4117-9bbe-5f507fd4eb9c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Level 3 Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMember_7a68a629-9922-4bfc-b2c4-8718900f713f_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember" xlink:href="lgnd-20220630.xsd#lgnd_LicenseFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMember" xlink:to="lab_lgnd_LicenseFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_0973d50e-56c1-481e-9757-857345b155cc_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_6057675d-ce44-41b9-9d0b-c0264c8a50fb_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_b3544674-cd7e-43ed-ad04-d5257daa79bf_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_24a23d10-274c-489b-9356-abffd3ac12c7_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVRs issued from each CVR series</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_label_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:href="lgnd-20220630.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:to="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e63799e1-16aa-42a5-a848-e536881e0085_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_4d024c05-f810-404e-9e33-e88ddf6a7dd8_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_735eef7d-466a-40b7-ba74-1c197c10f8aa_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_be401cde-45a2-4386-aa2d-768d646e5130_negatedLabel_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in debt discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_label_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_documentation_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:href="lgnd-20220630.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:to="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest_e997a57f-7b1d-428b-80f6-515f880d5cb0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_5ab2c16e-6c39-4c19-b70a-4cb89cba1bbc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_98d2fa8f-98a9-45ba-ac25-a8b4a9f5f79a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_5c32baf3-99f9-4c77-9d1f-40812914d1d3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_bc7f90e1-660b-4fe7-a9ad-2f99af30366c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease renewal term of operating leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_e2e19b06-2ad6-4639-a793-6c3a38b05511_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_c26265af-d804-4be6-896e-b4b949cdb581_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_b807f044-e4bf-4fec-9a55-4c9820155a16_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_37891e13-85ed-415e-b5bc-9a2a1809df59_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_c7587732-7c76-4035-83c4-4cf209654551_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to unwind warrants</link:label>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_label_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Unwind Warrants</link:label>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_documentation_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Unwind Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants" xlink:href="lgnd-20220630.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToUnwindWarrants" xlink:to="lab_lgnd_PaymentsToUnwindWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_3b882313-1ef1-4cda-ba79-d222e90d10ec_verboseLabel_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current contingent liabilities</link:label>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CurrentPortionOfLiabilityForContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:href="lgnd-20220630.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:to="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_4863dcd0-b4ad-48ab-86f0-da172fdc3f6e_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_21e6243a-6cc2-4091-9f6a-bfdae5ae72af_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_d4a9324f-6183-4f01-934c-7e6f3475e6db_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0fbd979d-6178-4ee2-80c6-6d7a137ddb3f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_68f98618-8a9a-4501-80ff-d4acf37540d7_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the 2023 Notes outstanding (Level 2)</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_c60137c2-3e9a-48ec-9dde-dca9145a36b7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_a20631bf-68c9-46fb-8598-1efb3fee70d2_negatedTerseLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR holders and other contingent payments</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders" xlink:href="lgnd-20220630.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHolders" xlink:to="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_ee138ad0-42e8-4001-8293-971739049e87_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_973c7563-edb5-4004-a862-34999bb3afdb_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9fec3005-aae3-47b3-92a7-ffaa654294a5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding options that are exercisable, weighted average exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LeaseLiability_53901a62-66ba-4391-99cf-2a4e4aecb5f1_totalLabel_en-US" xlink:label="lab_lgnd_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_lgnd_LeaseLiability_label_en-US" xlink:label="lab_lgnd_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:label id="lab_lgnd_LeaseLiability_documentation_en-US" xlink:label="lab_lgnd_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiability" xlink:href="lgnd-20220630.xsd#lgnd_LeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LeaseLiability" xlink:to="lab_lgnd_LeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_73bba519-4b0d-41cf-9e02-29e467e97113_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance_1ecdaf94-c109-4fde-9353-9d3313101718_negatedTerseLabel_en-US" xlink:label="lab_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less estimated tenant improvement allowance:</link:label>
    <link:label id="lab_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance_label_en-US" xlink:label="lab_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Tenant Improvement Allowance</link:label>
    <link:label id="lab_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance_documentation_en-US" xlink:label="lab_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Tenant Improvement Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance" xlink:href="lgnd-20220630.xsd#lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance" xlink:to="lab_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_05e4ddc8-ba4e-4da9-982a-3764227c9381_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_38d7936c-90a2-473b-836d-cc3ddb758026_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_6a022989-6b32-42e2-a4cd-14c9fefaab80_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_de303d3a-519d-4a65-be49-d8cab4f5f242_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under financing lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1700becd-9b4b-489e-9e05-3126f08366ff_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_cdecd0e3-3c53-4cc6-a3f4-ab07b117e0e8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_52dd9529-1da8-4edb-aef8-9710290319d5_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_KyprolisMember_75efa55a-9da8-4ea7-b98c-2ec1ecc5b855_terseLabel_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:label id="lab_lgnd_KyprolisMember_label_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis [Member]</link:label>
    <link:label id="lab_lgnd_KyprolisMember_documentation_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember" xlink:href="lgnd-20220630.xsd#lgnd_KyprolisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_KyprolisMember" xlink:to="lab_lgnd_KyprolisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_38c17bc2-62d3-4a6d-bea2-2a3557a6f14a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_57da615e-4f00-47cc-b500-677b0775868d_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_767c4815-ab7c-4004-bf74-81d686fcc626_netLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_2df5d29e-511c-4e2d-9b69-ce4a3af64b4b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_7f4be9ea-e3b5-4254-aa72-3f3e8ac6251f_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties owed to third parties</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d8c15efd-fd6c-46b5-a1d9-e0902ba7f94f_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_57bc13dc-709c-422f-8c13-ff47bb64fbda_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_1229db3d-2916-4385-bff7-54fffccb210d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_ce74ba40-c646-41e0-970a-2050eb2410b5_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_891590fc-1b80-4694-b0c5-ca3475a33d75_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_d2b62b52-5229-45df-b2ff-41d9a57a51ae_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_fcab173e-9383-45c6-a459-a32292358b79_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_77c87837-20c7-46dc-81fb-f4ed1005a7c7_verboseLabel_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complete technology</link:label>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_label_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patented Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentedTechnologyMember" xlink:to="lab_us-gaap_PatentedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1929b513-3876-4a4d-ad70-e021e5ac68f5_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Plan Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2ac41382-18fb-41b2-a0d2-7bc153204480_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_fa1531d7-f832-4955-b1cb-b0b3c12d4bf4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_3ac70e7e-eb94-4567-b5dc-4cbcc1d92321_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_fcb39f19-600c-4ce0-aeac-41af0bc94edc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other corporate expenses</link:label>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_label_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost and Expense, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCostAndExpenseOperating" xlink:to="lab_us-gaap_OtherCostAndExpenseOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_baf05d76-ab63-4bf3-a60b-96a19c325cf5_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Updates, Recently Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_ba125c64-3c5e-4f88-b876-e93e71df3d8c_terseLabel_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payout range (as a percent)</link:label>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_label_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</link:label>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_documentation_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:href="lgnd-20220630.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:to="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_5e656a22-97c3-40b6-b6c6-c615e3f0004b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_fbc616f2-8c59-4a88-9b79-b4de328fa570_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount (including unamortized debt issuance cost)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_cc03e790-4c61-4222-a3fa-ebc27ba8a37e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9f106ed9-852c-48a9-8d43-0c5ad995ce59_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_f6091d8f-f93d-4199-b96a-65400d7a9695_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_dc0bcabb-6569-45fd-8458-4967bc80d0e8_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_ea50a14f-a390-46e4-a045-95f6495eac18_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_305022fb-fbad-43ce-b945-bf780c3a324e_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8317df0c-fa7e-4bbc-af51-171d125fb11e_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_07309fe6-cae7-4cb2-9096-99e122d79434_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_8b874903-02d0-4ae5-be69-fc118f6946ec_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_67d3d435-893d-462a-80dd-9bb658019afe_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_a57f32c2-c6b0-4516-9c7d-f321e8aae630_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3f25dbc5-375c-481b-9fc7-7488ae9dbd79_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_477cfdcf-2915-468b-bd90-01da1bcbeb98_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_f8144384-d1b7-4f69-a074-e11573689b7f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_31747fd8-907b-4578-869c-2352dbce3f1b_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license rights</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_886386a4-8fe6-4a9a-970a-04c83445d9f5_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_e055c55d-603c-447b-8a37-c74a1f1c79d5_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Balance</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_465439e9-578f-4a1d-adbc-cff3259098f1_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future purchases (shares)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Shares Expected to be Repurchased, Next Fiscal Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_0eb37b1f-9fe5-46cb-88bf-f0df91f472f5_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - xCella</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, xCella [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, xCella</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForContingentValueRightsCompanyXCellaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6eb1a1b0-a8a5-4699-b5c0-abc2705896e1_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in diluted per share calculations (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_964a8651-94a8-4855-841f-14a524f31dfa_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute diluted income per share (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9fd1cad2-1378-461b-8f00-a600ea8623f9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_ed02a47b-44b3-4477-9aa4-2aa6a6806a19_verboseLabel_en-US" xlink:label="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounting for Share-Based Compensation</link:label>
    <link:label id="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:href="lgnd-20220630.xsd#lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:to="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_3e2a9d21-7609-449a-8419-797255fb27f4_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseRights_c33fe23c-3a28-48e5-b2cd-713aa35dca88_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license rights, net</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRights_label_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights" xlink:href="lgnd-20220630.xsd#lgnd_CommercialLicenseRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseRights" xlink:to="lab_lgnd_CommercialLicenseRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_d35eb3b7-7712-4d82-9131-3c644772efae_terseLabel_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella</link:label>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_label_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella Biosciences, Inc. [Member]</link:label>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_documentation_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella Biosciences, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember" xlink:href="lgnd-20220630.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_XCellaBiosciencesIncMember" xlink:to="lab_lgnd_XCellaBiosciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EvomelaMember_8b64f80f-9e4e-4599-a50b-999e8eecfdb0_terseLabel_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:label id="lab_lgnd_EvomelaMember_label_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela [Member]</link:label>
    <link:label id="lab_lgnd_EvomelaMember_documentation_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember" xlink:href="lgnd-20220630.xsd#lgnd_EvomelaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EvomelaMember" xlink:to="lab_lgnd_EvomelaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_9691245b-9f2a-446a-8fcb-4b37b3dc4b69_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_782dec7a-cd68-49d2-81c0-abf82b732d61_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_5b0ff7c0-2716-43ed-9736-bfa79bad1479_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_4035dca4-8a38-4441-8bef-ba6c189763a4_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_b45bc767-af7c-49f0-96a4-7d9277cc1057_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; 60,000 shares authorized; 16,882 and 16,767 shares issued and outstanding at June&#160;30, 2022 and December&#160;31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_13c47003-0e35-4192-a44f-92e4afdfc9b3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_99361272-a42e-4a5f-bc35-33f63bbca39b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_130ffbb8-fedd-4642-96b0-e90f53996d4f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_ff400d38-be2a-4ce3-a9e9-963f6a3299ea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_b5dc047c-ec6d-4dbf-8d53-e6bdd49d9a9d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price (USD per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_1e99e48d-1117-4fb7-9cf6-2b416950a6e8_terseLabel_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued inventory purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_label_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_documentation_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases" xlink:href="lgnd-20220630.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedInventoryPurchases" xlink:to="lab_lgnd_AccruedInventoryPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_f9aa3ea9-8022-4cff-94bc-20b02d9781f9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_7500be01-7bf9-4c35-bc0d-36565a1581a2_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frequency of cash payments to CVR holders</link:label>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_label_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</link:label>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:href="lgnd-20220630.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:to="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_1718660b-2d23-4acd-932c-ef98dd353734_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_021e8a5a-0a13-4f4f-8d24-715398d10204_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f295fb76-4a94-4e6d-96d4-b705c6df68ff_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_a3d553cf-1d13-4f38-96e4-6bdc7920ba9f_terseLabel_en-US" xlink:label="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating and Finance Lease Assets and Liabilities</link:label>
    <link:label id="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_label_en-US" xlink:label="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Leases [Table Text Block]</link:label>
    <link:label id="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:href="lgnd-20220630.xsd#lgnd_AssetsAndLiabilitiesLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:to="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_bd80c48f-44d9-4874-8f92-efb0092bee9c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment and Contingencies: Legal Proceedings</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_0d6d8a38-fa1c-495a-a737-7870960437f5_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to additional paid-in-capital from warrants</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_497ea403-0d1a-44f8-91c8-66578e8b6f47_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_3a8740f2-eeca-4060-980c-1207e5b38c11_netLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCoreMember_f8928e10-788b-453f-865f-bf179d0ecdac_terseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol - Core</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCoreMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, Core [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCoreMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, Core</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolCoreMember" xlink:to="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_3353585f-0e8b-4302-8df3-bab440bdda5a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from stock option exercises and ESPP</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_938733a1-984c-44e8-9523-e216c5c2d631_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_15f57cee-29b5-451b-9eb2-fa565a34b698_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d05f3f2a-d772-4f78-af74-c8bda6974d34_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued fixed asset purchases</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_cbaf4fd0-c82e-448b-851f-12518b7d5661_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_d93ecc5b-be0c-4854-a617-28fac2a831eb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_d2d4ff0d-6b75-456b-b34c-c3774c901d9a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1b569aab-1faf-4890-9d11-71f0bfe2eab2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_c8dd4faf-6a42-46f2-aecd-d088710af383_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of positions in an unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_67ceb7b2-957a-42f2-b820-e85b265c84ba_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_fee4513f-1386-41cc-b6c2-88d2f1e7d6b0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term of operating leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_c6f7f3f0-285b-4675-b6ea-b7003efdd9c7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_78c87747-d8cc-4b74-b317-0cb0ab5c2576_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_e6e21512-b70d-4561-ad1b-8f6af2e53ede_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount of the 2023 Notes outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_abe76564-c641-448f-a05c-51e25c4c2e6b_terseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolMember" xlink:to="lab_lgnd_MaterialSalesCaptisolMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_20029177-bbe5-4220-a778-5ba49bbeb901_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of civil complaints filed against entity</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_4d92e5db-95c5-4dc6-aa44-6a110b2119b6_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_48517cc3-2894-42cd-a479-fed20ae7f739_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_21e86235-f4bc-4e0a-919c-3336d8c00a0e_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVR Series</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_label_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Series</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_documentation_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries" xlink:href="lgnd-20220630.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfContingentValueRightsSeries" xlink:to="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d8582e3b-f291-41be-a5fd-3db1cff71eca_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_245b0414-4656-49c0-a3b7-a00a966c3c62_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_6a763515-1170-4aaa-b2c0-4fa6a2154a51_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_0640dd56-0c81-448b-b8bd-4cecf662b13d_terseLabel_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional allowance for credit losses recorded related to COVID-19</link:label>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_label_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:href="lgnd-20220630.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:to="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_d3ac68d9-7644-487f-a1f5-e66b82573028_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding options that are exercisable (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_2b87a918-4713-46c8-ab23-b802166f516c_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_e124d152-b03e-4ae1-b4ba-fa982e56ea8e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_eda1b156-ca46-416e-b967-47931c07000f_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueAdjustment_aa701139-d5dc-463d-b23a-e7cda9be7706_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mark-to-market adjustment of CVR liability</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueAdjustment_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueAdjustment" xlink:to="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_3dc8249b-31d0-476a-9da2-d4ddaf59fb84_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_documentation_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:href="lgnd-20220630.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:to="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_4a613198-73b0-4150-8a2c-9ca077098cd9_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_35d600c8-a1bb-4a37-9a41-dd4eefce8d22_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_253f0f3a-652a-44ff-bbe0-409ad674ed60_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c0718646-52a4-448c-902b-42244f93b3c0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_ee0b0779-92b2-4339-aa3b-98f08fa5d5f2_verboseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - CyDex</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Cydex [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Cydex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RoyaltyOtherMember_aa72f0e0-963c-4ba1-b46f-af2fc6d7aaff_terseLabel_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_label_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other [Member]</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_documentation_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember" xlink:href="lgnd-20220630.xsd#lgnd_RoyaltyOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RoyaltyOtherMember" xlink:to="lab_lgnd_RoyaltyOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_cdb850ba-639c-48d8-88bd-f988305d2293_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_0ea22eaa-dd2f-4c05-b046-052a8a3b64ab_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total goodwill and other identifiable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_cd2787b8-229b-4016-8382-bd1dedd577aa_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_66b82357-427e-4ac2-884d-5f83ee285cd9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1be55cab-ee12-4fcc-9d35-d2f59479233d_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_6925baf4-c34d-4977-bb8d-e7a81f071edf_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_9c65cd29-d4a2-42fb-9251-88912af1b6e1_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of 2023 Notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_25e1a826-bce7-4675-a3c1-859acf9da2b4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments to contingent liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_ca004457-1022-4855-af0f-6350fe1a70de_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6c521c6e-ac5f-469e-8dc0-6dbd44723b3a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_4db2d66f-026e-4bb9-80e0-ac9cfa362329_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_be757ff3-9f32-4a59-8645-0d82214c5563_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_d5719ff4-045f-42bc-b92a-a92c2c483ac2_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_07ea55a8-d50d-4a5c-9432-802259dab66d_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net loss on available-for-sale securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_8740074c-70bd-4db9-ab49-51a5dae6f1d4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net loss on available-for-sale securities, net of deferred tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_4a07e087-b29f-48b6-88df-396d55d58a80_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_b464b9cc-e1e8-4c77-829a-c2b36e6bd254_terseLabel_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier</link:label>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_label_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Supplier Expenses, Current</link:label>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Supplier Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent" xlink:href="lgnd-20220630.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedSupplierExpensesCurrent" xlink:to="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_4f7d659d-1f9e-42ae-b719-c34eeffa3965_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f99350ec-c67c-4505-8cc2-d624fa752925_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_20f6121b-04ac-48c0-a2d7-ab64ece3ee01_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_c39be834-28e0-4623-ba8e-a0f389c7f5db_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_4f07c3dc-4f65-4e89-b97f-0e9e99b03bf5_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_df93b2a4-3610-4926-8e68-1ab0f85f7580_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_ec45cbb7-e396-48f7-9c66-f3a0a9e0d4c4_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized that was previously deferred</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_eee52ec3-9959-45c6-96e9-9a396a87e642_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MetabasisMember_7e82887d-204f-4a1b-b23d-a5a4aa63744d_terseLabel_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:label id="lab_lgnd_MetabasisMember_label_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis [Member]</link:label>
    <link:label id="lab_lgnd_MetabasisMember_documentation_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember" xlink:href="lgnd-20220630.xsd#lgnd_MetabasisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MetabasisMember" xlink:to="lab_lgnd_MetabasisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6bf9405a-9ad0-458c-bad6-655daece6eae_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_19397c63-b773-4af5-b89f-74d80196bc96_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_e37a3ea4-2d37-4773-9b2e-2cb79e1b5d9f_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_3b3042b0-1eac-4222-972b-90d50158c5bd_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_9e3bd07f-d89a-4660-a539-160f093ab223_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_7fc478f0-c967-42ab-a58f-d457bb1bf7f1_verboseLabel_en-US" xlink:label="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of commercial license rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_label_en-US" xlink:label="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Commercial License And Other Economic Rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_documentation_en-US" xlink:label="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Commercial License And Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:href="lgnd-20220630.xsd#lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:to="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_d8aa35f5-0b61-45a2-8cf8-745f7401da93_terseLabel_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development</link:label>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_label_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development [Member]</link:label>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:href="lgnd-20220630.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:to="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_2b1aaedf-6efb-4f11-a8e4-49bc0f589e8b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2a4315b0-ec31-4fc3-9ffc-ad063b172ee4_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_b819337d-14f7-408b-93cd-1f2738d9b1b5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_6f4b060e-3151-4c2d-98cd-8f8d5187a976_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_d5e450b6-45ed-46ea-b446-4d03ca64a52e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_label_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:to="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_dd5538eb-d551-433f-8c7b-314ee0a946a2_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_20cc3297-845e-492e-a188-b7d5eade0136_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_85668c0e-0fc4-4300-9d17-7a468166ac04_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_66da7070-2f96-4496-8fb2-52e63a99e107_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_05f64a25-0fe0-4c84-9e68-c1e21523e7c7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_ef279826-e215-4432-8178-41bd7bf794ad_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Metabasis</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Metabasis [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Metabasis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_f9b599fd-e2bc-4f08-b2e4-1cab0c3902a4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_94ac2f28-19a5-4b0c-97b1-f64e4f3d7448_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_573910ea-38ea-478b-9958-62dff9dea68d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_6eead287-d0d5-4672-83af-d394c4848005_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium on investments, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_01fcf10a-d314-471a-b3a8-ed566ce098d3_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_533e8d60-97bf-4b26-aae8-03867e6f4986_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reacquisition of equity due to 2023 debt extinguishment, net of tax</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ec1b46c5-39df-4547-a4d3-75567156f2ac_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_2983b8a7-6d3d-4710-bff8-509478efe98f_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US government securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_aa17ad53-b83f-46a0-b64a-a985815b1c03_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8af6f1f9-1b8d-4044-9b2c-af556b7fb58c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_488d926f-1d65-4214-aa72-2c50742182ec_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d243ce63-9429-4403-9599-ecf890fcb54b_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_911b666f-1b19-4848-864b-71fb469a134d_terseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant and bond hedge unwind transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:href="lgnd-20220630.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_960021bd-0f69-4eee-8110-8ed38568bca2_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual relationships</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_fc63c7c4-a552-4e8f-9840-a19839ecb50d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_88fbd05f-15be-4844-88cb-82acbc3250b6_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_a47e64fd-6a4b-44c5-983e-50c9ec1ad305_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_0c4dd189-400d-4dd4-b19d-b2a40657c1fe_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_478b8304-3e89-48a7-a212-b1244f1f74ed_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price trigger to classify convertible debt as current (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_ae0074cb-254f-4876-94f9-55c2cd3ed25d_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember" xlink:to="lab_us-gaap_ConvertibleNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_9699d4ca-1ccf-420d-b896-c9ca63984490_verboseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_767629a3-02d7-4314-92ac-6c5c0c0a8f92_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ff2a988c-71f6-4f34-8784-1c8df881720a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in basic per share calculations (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_92c7a3f4-1214-4b46-b72b-977b942ec524_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RylazeMember_6a882f2c-df83-45d1-b955-aa1067dc7e1e_terseLabel_en-US" xlink:label="lab_lgnd_RylazeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rylaze</link:label>
    <link:label id="lab_lgnd_RylazeMember_label_en-US" xlink:label="lab_lgnd_RylazeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rylaze [Member]</link:label>
    <link:label id="lab_lgnd_RylazeMember_documentation_en-US" xlink:label="lab_lgnd_RylazeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rylaze</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RylazeMember" xlink:href="lgnd-20220630.xsd#lgnd_RylazeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RylazeMember" xlink:to="lab_lgnd_RylazeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_130afba3-2263-4048-98ae-e62f2da8ced4_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout rights recognized</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:href="lgnd-20220630.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_54f91770-a63b-43d6-88e5-09ff30bda0b9_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Investments</link:label>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term investments [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:href="lgnd-20220630.xsd#lgnd_ScheduleOfShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:to="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_ec30f983-02fc-4073-8447-69154e6bb602_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shared-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ae0c3984-87ac-4584-b8b0-b9789df9eeba_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental schedule of non-cash activity:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_633747f0-3001-4717-97a4-8543efc47360_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_b0154e9b-d9a6-4cb2-900a-395a3e13c298_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Icagen</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Icagen [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Icagen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_769cfd34-9429-42cd-896b-d17cae0cabcd_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f88e462d-9385-4b44-941f-3a87811edfa3_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_fcab3add-1b80-4e6d-9b9c-a4d64e44b2c0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_31880c40-6c34-4493-b197-bed8a1c19df8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at June&#160;30, 2022 and December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_26e061da-0e5e-409d-b34d-f6b2520c7dfd_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Revenue from Segments to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_3ba894b7-4d23-422a-ab1c-78368509b630_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash in other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_843ade2a-7db9-4613-addd-94d4fbe20159_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_386fc4b0-449b-468d-a877-bb292fefeed5_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_d62a17b3-1138-433d-ac8e-b8b36f370cfe_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Coupon Rates on Financing Arrangements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_11d69372-cb17-4e97-b13b-4e4dad47144c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_6d0b63e4-ec00-4714-b83c-4c2b4234af6f_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SBC - General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_389522d2-a7e3-457b-ac84-9e99317b6671_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5e42e8fc-2b67-4361-ad4a-eb0ad8d0ff58_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_7834eb64-3fe9-4313-9b34-5b97d35381aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable and payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_a7dd768a-a031-4b1f-af7b-71f54d776f46_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_a74a3b02-b5a0-4119-82d2-55fbc55a9555_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts owed to former licensor</link:label>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_label_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Restricted Investments Owed to Former Licensees [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Restricted Investments Owed to Former Licensees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:to="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_3fe95871-e471-4116-a2a0-579c77ccfcaf_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_11a475bc-2411-4801-9cc0-b6436c7089ce_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_6c32f374-9b1f-46fe-9b4e-c1d0a913c7fc_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_47d2a37e-a95d-4e18-ade6-197d8acda775_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_36544189-a679-4e55-a473-c62a2465391c_terseLabel_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi</link:label>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_label_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi [Member]</link:label>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_documentation_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember" xlink:href="lgnd-20220630.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_SelexisAndDianomiMember" xlink:to="lab_lgnd_SelexisAndDianomiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_e12e2ad8-9799-4d70-8f7d-1cba8f92ff43_terseLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit loss adjustments of finite-lived intangible assets</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:href="lgnd-20220630.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_3b485466-e5f9-4919-8848-9711f7d8ccc5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_33f4c757-c483-4173-a912-02c2eda64bf7_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period in force of stock repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_4ea855d7-c373-4433-bc06-cf64bbceb43c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3d8bf9fc-dc3d-422f-aaf7-a7450bf6a09c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LigandCoreBusinessSegmentMember_d7c5f62a-e2ba-4d84-9612-61c809e1635c_terseLabel_en-US" xlink:label="lab_lgnd_LigandCoreBusinessSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ligand Core Business</link:label>
    <link:label id="lab_lgnd_LigandCoreBusinessSegmentMember_label_en-US" xlink:label="lab_lgnd_LigandCoreBusinessSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ligand Core Business Segment [Member]</link:label>
    <link:label id="lab_lgnd_LigandCoreBusinessSegmentMember_documentation_en-US" xlink:label="lab_lgnd_LigandCoreBusinessSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ligand Core Business Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessSegmentMember" xlink:href="lgnd-20220630.xsd#lgnd_LigandCoreBusinessSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LigandCoreBusinessSegmentMember" xlink:to="lab_lgnd_LigandCoreBusinessSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7e8271e3-449e-4537-8ee4-743a5f32f193_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostDirectMaterial_9c740d15-b485-41b7-96a5-f13d74dce646_terseLabel_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Captisol</link:label>
    <link:label id="lab_us-gaap_CostDirectMaterial_label_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Direct Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostDirectMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostDirectMaterial" xlink:to="lab_us-gaap_CostDirectMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_0a8c9f5f-72dc-45d0-9ffe-2c9b2a010861_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_dea36c25-9d33-4021-8e00-fa9101ab0492_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_d5b328c2-22ce-4001-b73a-401476ca7bde_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_b36f62b3-baff-4976-a1d1-7dbce72910ad_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5e665aba-2a04-40f1-ba34-6af4bc50f3e3_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f75bae34-5af6-465c-a34b-870b2b1102ab_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized stock repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7f0c61ad-b7a5-40e2-ba32-c4da0172cf5e_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_76250b2f-8e35-4bfd-a5b7-9728f1ca2c91_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_691a8223-939b-4782-95e5-0d375e11f080_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DemandDepositsMember_b367150b-5992-4122-806c-4360d2038302_terseLabel_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank deposits</link:label>
    <link:label id="lab_us-gaap_DemandDepositsMember_label_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demand Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DemandDepositsMember" xlink:to="lab_us-gaap_DemandDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_fe71543a-828e-408e-a030-464cdcbb3371_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f6c3865a-ce8a-4181-a968-645ba2f46f35_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MilestoneMember_5477e6b1-7dfb-42c9-9e1b-eb2cf86cc0b3_terseLabel_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:label id="lab_lgnd_MilestoneMember_label_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone [Member]</link:label>
    <link:label id="lab_lgnd_MilestoneMember_documentation_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember" xlink:href="lgnd-20220630.xsd#lgnd_MilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MilestoneMember" xlink:to="lab_lgnd_MilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_f9b64935-c44a-4f69-89f3-1ba34df79d9c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_c998b9ef-803e-467d-8bd9-3008ff4e89fd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net (loss) income per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_04d4040e-f28a-4535-a9b3-68f426d437d8_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_6b163ca3-6622-4f03-986b-b9fbe6252b78_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_db49f79c-6261-42c9-ab7c-789f892453b8_terseLabel_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum threshold of debt trading price trigger (as a percent)</link:label>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_label_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:href="lgnd-20220630.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:to="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_9305ea87-de04-45f9-8e48-a91d1e286208_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_43efa954-4130-40a1-b494-e51c944a64c2_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeFinancingActivities_062924e0-077c-4d0b-907c-81f04b6a0606_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from convertible bond hedge settlement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_4e021fa2-7cb2-4b44-b9d9-ba27f7975acd_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_e7d5cfce-a26c-4ba7-8e84-3cbbf89227e4_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9742e890-6192-4a30-b60c-6b95bdb55548_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_86ffc1fa-ed66-4000-bb22-468970dcd9ee_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_25b67fcf-e381-4667-9dfb-a97aad7cd7ce_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term portion of notes payable</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_31511867-ebb2-4f3d-9fed-46f23633f0e0_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_200de051-8ef9-401b-ac1f-d39191b61753_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Viking common stock</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_c06ef3ae-358c-4c20-ad13-0685cf17bd62_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_04f2056a-22a3-4e48-9906-c80bb6146705_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a7afd9d9-7f9d-487a-9365-58e7fa45892d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturity of Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1477f71e-6255-404f-9af2-47bc399019d3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_3297f687-79f1-453a-b2b5-ddacc941303c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGross" xlink:to="lab_us-gaap_ContractWithCustomerAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_3385414f-e143-43be-a05b-8ab653f3eb42_terseLabel_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Convertible Senior Notes</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_label_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023 [Member]</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_documentation_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:href="lgnd-20220630.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:to="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_10b4f5f4-7374-487d-9091-7760eb27d7d3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for OmniAb transaction costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanMember_ff84c0c6-37a4-480a-8822-cae43d7e7c8e_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EmployeeStockPurchasePlanMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember" xlink:href="lgnd-20220630.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanMember" xlink:to="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_ad0de64a-149e-4b19-b7b2-0fba6059d042_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on AFS investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_de48fd30-f2da-4849-93f4-abe5fd662594_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_ce5f42e9-ea68-4694-b562-2a4736e5700b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_a050b09b-d1f6-4b35-bbe0-dd07e59f60fc_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_0aeab439-7cef-49cb-a815-200555edcdb4_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_51360477-593b-40ee-80ce-ff1aa139ec5b_terseLabel_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_label_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue, Service [Member]</link:label>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_documentation_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue, Service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember" xlink:href="lgnd-20220630.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractRevenueServiceMember" xlink:to="lab_lgnd_ContractRevenueServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_33512f0e-b7a0-40cd-a664-8cb768184670_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5f4f131b-b3ae-4ac3-9311-451b4810337b_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_3037d2c7-abcc-4222-a23d-cb2144c251eb_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_e8c60e1f-dc72-4954-a56b-f3d9e45af2f3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share purchase price as percent of market price (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_cf58e074-c641-4839-9a13-85d7e9879d19_negatedLabel_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) from short-term investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_label_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-term Investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_documentation_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments" xlink:href="lgnd-20220630.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_GainLossOnShortTermInvestments" xlink:to="lab_lgnd_GainLossOnShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_103c2b0f-efdd-4df9-9d39-c32bf739f407_terseLabel_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix</link:label>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_label_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix [Member]</link:label>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_documentation_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember" xlink:href="lgnd-20220630.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AziyoAndCorMatrixMember" xlink:to="lab_lgnd_AziyoAndCorMatrixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_f62c919c-094f-419b-8de3-6aed997cb15b_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_54dd74e1-8cc5-46a7-8411-646b2f367c09_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Source</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_c10bdbe1-b53e-4d8a-97b8-91fe65f30c0d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to convertible bond holders for warrant purchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:to="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8700a27d-b15f-4bdd-9990-6c0d37359d1b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6fd3ba9e-b846-4216-af14-259a2b3cd179_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_3692d049-591a-4940-a125-4e8fa75d90ba_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_04c356d6-4a21-48de-ac7b-a661a96101fc_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_6afc5117-d1ff-451e-8422-94660892a9c4_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_ce3a7044-b97a-400f-8b09-9625e2e103d4_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_e9d1aeca-4053-4f68-8c2a-1b0bf1b2e004_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d8c6dc67-c130-484d-8a12-189e18444cc3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_490165ce-17e3-4780-82ed-6fd9eb665d8d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_64ea796a-c988-4419-a575-0bb9ece4c5ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_591bcb21-1d62-473b-a6c4-caca34556fd1_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_9da0d1ca-a90f-4f50-8611-4a734c2fa0e0_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5425b6a1-cc5f-45dd-a15d-ab409c0fa8d8_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_b0d87c07-ffb7-4c9b-98e8-4feff2c109eb_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_1af5b2c7-148e-4102-a58a-fbbd4b02d69c_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_c68b0bf6-c000-40e5-825e-6a2c9d2166d3_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_c2728133-e573-44ae-b2c3-27ae3b71c83d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_2ff3364e-b2e2-4465-b36c-61f27cbd6f33_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_29ee1a8f-23cd-47d6-9eba-ec0e721d1ea9_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_3f1f8f65-ba46-4438-af0b-cd25091b8316_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_61418ab1-1260-41a1-94b8-cffda5c8f307_terseLabel_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities from xCella asset acquisition</link:label>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_label_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</link:label>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_documentation_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:href="lgnd-20220630.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:to="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_347d18c2-ca6e-41ba-8f55-2b2a2bc2f715_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_33bd3235-54df-437c-bdb9-750ecd8f96e8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_8bed1ea3-cee2-4140-a4ca-b978682a337b_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (Loss) Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_4b880541-c06f-42c1-97e9-7a61d06a5cd1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_3cae4320-1d57-4356-9748-898214242298_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for equity method investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RepaymentsOfNotesPayableInterestPortion_96e9ed7f-aada-4bc3-a90c-dfc3f09b6d87_terseLabel_en-US" xlink:label="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest portion of repurchased amount of debt instrument</link:label>
    <link:label id="lab_lgnd_RepaymentsOfNotesPayableInterestPortion_label_en-US" xlink:label="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments Of Notes Payable, Interest Portion</link:label>
    <link:label id="lab_lgnd_RepaymentsOfNotesPayableInterestPortion_documentation_en-US" xlink:label="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments Of Notes Payable, Interest Portion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:href="lgnd-20220630.xsd#lgnd_RepaymentsOfNotesPayableInterestPortion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:to="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCOVIDMember_bde8f404-4f76-45d5-b69d-cbba59c8e134_terseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol - COVID</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCOVIDMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, COVID [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCOVIDMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, COVID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:to="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d4ec1fd6-335f-4cfa-8334-6ffef2f59c75_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_856b304b-f2b4-48e1-8d8e-52eb84385647_terseLabel_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio</link:label>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_label_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio [Member]</link:label>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_documentation_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:href="lgnd-20220630.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:to="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_793a67e9-0c92-4de9-b5b2-1765fef1a2b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_eb4c5d40-2a08-4d2b-ab88-adf95ab8f80f_negatedTerseLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:href="lgnd-20220630.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_b5f36dec-b976-4b9a-87fa-6d4d1b3d7ce9_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SBC - Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_045d3e7e-cfa1-4e44-bc53-d3ad1413e9c4_totalLabel_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total short-term investments</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_label_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities, FV-NI</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_documentation_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:href="lgnd-20220630.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:to="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_33b3d04b-a15a-4fd2-a3c8-9d6754969a0a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_a3aef833-74bd-49a2-8467-c20ef03103cc_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d16d9c6f-e866-445b-a62d-de2bfec672d5_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_c99caebf-f5f0-410b-8f01-a94b89be53e9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>lgnd-20220630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:6182e749-0dc5-4e16-af49-321ddbc4d263,g:44d35ef7-647e-41c8-b2ac-a9d4b32b2035-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/Cover" xlink:type="simple" xlink:href="lgnd-20220630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_02ffb61e-57c6-48e0-b01c-831b93227304" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_DocumentType_02ffb61e-57c6-48e0-b01c-831b93227304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_34c80a64-c8ba-4e83-9c2d-25196204dc5b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_DocumentQuarterlyReport_34c80a64-c8ba-4e83-9c2d-25196204dc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_116547e7-9aef-430e-a32a-9e8e10f4b95a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_DocumentPeriodEndDate_116547e7-9aef-430e-a32a-9e8e10f4b95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_b7727df1-5505-4503-afea-c4206938b373" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_DocumentTransitionReport_b7727df1-5505-4503-afea-c4206938b373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_93592197-3865-4b52-bbe3-95ac1ce5cffd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_EntityFileNumber_93592197-3865-4b52-bbe3-95ac1ce5cffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_af1356ca-c427-4534-a2e6-494f1214db62" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_EntityRegistrantName_af1356ca-c427-4534-a2e6-494f1214db62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d619553e-37e6-453d-93ef-82db2f55e828" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d619553e-37e6-453d-93ef-82db2f55e828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8816951c-abf2-432f-888a-bd2dcbc2e78c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_EntityTaxIdentificationNumber_8816951c-abf2-432f-888a-bd2dcbc2e78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_1ce0df8d-faf0-4149-9afa-36646a9c3b5d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_EntityAddressAddressLine1_1ce0df8d-faf0-4149-9afa-36646a9c3b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_afdab0b6-66f1-43a7-bcfe-fe7076c47eec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_EntityAddressCityOrTown_afdab0b6-66f1-43a7-bcfe-fe7076c47eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f7cf5de9-439f-40b6-9802-47bf631f8a13" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_EntityAddressStateOrProvince_f7cf5de9-439f-40b6-9802-47bf631f8a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_5d72e3e7-31ff-4cfb-b8a8-4f104eacf265" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_EntityAddressPostalZipCode_5d72e3e7-31ff-4cfb-b8a8-4f104eacf265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_59ea0831-bf16-4b40-b593-04399e281b0b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_CityAreaCode_59ea0831-bf16-4b40-b593-04399e281b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_c7778382-2fb3-4cd5-9165-1e7f1e760a2b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_LocalPhoneNumber_c7778382-2fb3-4cd5-9165-1e7f1e760a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f40142f1-1709-45dd-b72a-c0dcbd3dbc4c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_Security12bTitle_f40142f1-1709-45dd-b72a-c0dcbd3dbc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3a90306b-8684-4411-8086-e458eb8a7bc1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_TradingSymbol_3a90306b-8684-4411-8086-e458eb8a7bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_435f646c-f7b2-4e1f-91ca-0c715d6070ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_SecurityExchangeName_435f646c-f7b2-4e1f-91ca-0c715d6070ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_cd33afb6-0805-43b7-b21c-fa021a5a581b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_EntityCurrentReportingStatus_cd33afb6-0805-43b7-b21c-fa021a5a581b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_d86ed5c4-3352-455e-b89c-9270f6f9dced" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_EntityInteractiveDataCurrent_d86ed5c4-3352-455e-b89c-9270f6f9dced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_ebdf4aec-40ab-4ee1-be41-fdfdb724819f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_EntityFilerCategory_ebdf4aec-40ab-4ee1-be41-fdfdb724819f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_d1c9c382-952c-4e32-bac7-367e65dd8d2d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_EntitySmallBusiness_d1c9c382-952c-4e32-bac7-367e65dd8d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e75e245e-dbbd-4cc8-82b5-2cb67538f09e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_EntityEmergingGrowthCompany_e75e245e-dbbd-4cc8-82b5-2cb67538f09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_66f987d2-b50d-4a42-8ff6-d6b3caffc0ba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_EntityShellCompany_66f987d2-b50d-4a42-8ff6-d6b3caffc0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0ead31cb-13fd-484b-b2a7-41f8856c30a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0ead31cb-13fd-484b-b2a7-41f8856c30a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_3aad35cc-46fb-47c6-abef-8aaf29146e59" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_AmendmentFlag_3aad35cc-46fb-47c6-abef-8aaf29146e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_a15cc75b-4423-4ae4-be17-199748756598" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_DocumentFiscalYearFocus_a15cc75b-4423-4ae4-be17-199748756598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_998d7456-e5e0-4449-bfba-8aca4617db12" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_DocumentFiscalPeriodFocus_998d7456-e5e0-4449-bfba-8aca4617db12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f30d4353-4667-40f0-8982-53dba1f4bf45" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_EntityCentralIndexKey_f30d4353-4667-40f0-8982-53dba1f4bf45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c551e2d9-e791-449f-bc18-30d7c77ba7e9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f521d8f2-55fd-4ab6-8209-7c0763c6cfad" xlink:to="loc_dei_CurrentFiscalYearEndDate_c551e2d9-e791-449f-bc18-30d7c77ba7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="lgnd-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_106fedd1-6d0b-4d02-9ab4-27c93bdb2a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_48e4bad9-074b-4f68-9c54-65e9f71e4b11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_106fedd1-6d0b-4d02-9ab4-27c93bdb2a46" xlink:to="loc_us-gaap_AssetsAbstract_48e4bad9-074b-4f68-9c54-65e9f71e4b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_7d2c06e2-7b0e-4fe5-ae0f-f649cb564d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_48e4bad9-074b-4f68-9c54-65e9f71e4b11" xlink:to="loc_us-gaap_AssetsCurrentAbstract_7d2c06e2-7b0e-4fe5-ae0f-f649cb564d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3d785278-7d5f-4ec1-a00e-418bbd45f49c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7d2c06e2-7b0e-4fe5-ae0f-f649cb564d4c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3d785278-7d5f-4ec1-a00e-418bbd45f49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_3b4a7ebd-a3af-466a-a0a2-993136234926" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7d2c06e2-7b0e-4fe5-ae0f-f649cb564d4c" xlink:to="loc_us-gaap_ShortTermInvestments_3b4a7ebd-a3af-466a-a0a2-993136234926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_397e2f99-2247-4e6a-b238-124256a49296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7d2c06e2-7b0e-4fe5-ae0f-f649cb564d4c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_397e2f99-2247-4e6a-b238-124256a49296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d2865e65-8f94-4cab-ab9b-3571f3c395b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7d2c06e2-7b0e-4fe5-ae0f-f649cb564d4c" xlink:to="loc_us-gaap_InventoryNet_d2865e65-8f94-4cab-ab9b-3571f3c395b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_505da0de-5db9-4372-bfe2-93a496babffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7d2c06e2-7b0e-4fe5-ae0f-f649cb564d4c" xlink:to="loc_us-gaap_IncomeTaxesReceivable_505da0de-5db9-4372-bfe2-93a496babffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_997c8311-da77-41e3-97b9-80e2ca5c7300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7d2c06e2-7b0e-4fe5-ae0f-f649cb564d4c" xlink:to="loc_us-gaap_OtherAssetsCurrent_997c8311-da77-41e3-97b9-80e2ca5c7300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bb49114f-9a59-4d06-8001-263b776ecfd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7d2c06e2-7b0e-4fe5-ae0f-f649cb564d4c" xlink:to="loc_us-gaap_AssetsCurrent_bb49114f-9a59-4d06-8001-263b776ecfd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_7ec99f51-79d3-4bd5-80e7-1bc69d53712a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_48e4bad9-074b-4f68-9c54-65e9f71e4b11" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_7ec99f51-79d3-4bd5-80e7-1bc69d53712a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2f55628c-6acb-4904-83c7-745bfd4a44c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_48e4bad9-074b-4f68-9c54-65e9f71e4b11" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2f55628c-6acb-4904-83c7-745bfd4a44c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_87236658-8006-4594-b79f-5715a2e48404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_48e4bad9-074b-4f68-9c54-65e9f71e4b11" xlink:to="loc_us-gaap_Goodwill_87236658-8006-4594-b79f-5715a2e48404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_0b663089-026d-4aee-be90-16253b7fd91e" xlink:href="lgnd-20220630.xsd#lgnd_CommercialLicenseRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_48e4bad9-074b-4f68-9c54-65e9f71e4b11" xlink:to="loc_lgnd_CommercialLicenseRights_0b663089-026d-4aee-be90-16253b7fd91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fa08b6c5-1441-4795-b8c1-55794c7a6273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_48e4bad9-074b-4f68-9c54-65e9f71e4b11" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fa08b6c5-1441-4795-b8c1-55794c7a6273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b2b31c3d-a255-4e08-adaa-069994271bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_48e4bad9-074b-4f68-9c54-65e9f71e4b11" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b2b31c3d-a255-4e08-adaa-069994271bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_6fdb1a60-61ca-4cec-827a-5c21f5c7170f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_48e4bad9-074b-4f68-9c54-65e9f71e4b11" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_6fdb1a60-61ca-4cec-827a-5c21f5c7170f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_bc809cb9-ee36-4655-bdba-322f5d9286ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_48e4bad9-074b-4f68-9c54-65e9f71e4b11" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_bc809cb9-ee36-4655-bdba-322f5d9286ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4d2027d6-f79a-482c-92b5-933f5f0d586c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_48e4bad9-074b-4f68-9c54-65e9f71e4b11" xlink:to="loc_us-gaap_Assets_4d2027d6-f79a-482c-92b5-933f5f0d586c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a2483e3-92ff-4af2-b54a-9cbe5e66df86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_106fedd1-6d0b-4d02-9ab4-27c93bdb2a46" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a2483e3-92ff-4af2-b54a-9cbe5e66df86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_e7645387-5409-47f4-9095-a57b8810198b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a2483e3-92ff-4af2-b54a-9cbe5e66df86" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_e7645387-5409-47f4-9095-a57b8810198b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a3ab1514-93d2-4f65-9b41-a0c933cb3e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e7645387-5409-47f4-9095-a57b8810198b" xlink:to="loc_us-gaap_AccountsPayableCurrent_a3ab1514-93d2-4f65-9b41-a0c933cb3e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a1204825-2a5c-4cdc-ad90-448d276a23ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e7645387-5409-47f4-9095-a57b8810198b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a1204825-2a5c-4cdc-ad90-448d276a23ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_cfdf365c-cd92-47a4-88da-5d37c2571153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e7645387-5409-47f4-9095-a57b8810198b" xlink:to="loc_us-gaap_TaxesPayableCurrent_cfdf365c-cd92-47a4-88da-5d37c2571153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_80228397-c21d-4c20-932d-291adf5c6d18" xlink:href="lgnd-20220630.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e7645387-5409-47f4-9095-a57b8810198b" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_80228397-c21d-4c20-932d-291adf5c6d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_626f123a-69c1-4721-9266-935b45f0b603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e7645387-5409-47f4-9095-a57b8810198b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_626f123a-69c1-4721-9266-935b45f0b603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1fa8a9ea-65df-4f6c-acd1-83070b0c4420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e7645387-5409-47f4-9095-a57b8810198b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1fa8a9ea-65df-4f6c-acd1-83070b0c4420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_dd3c4fac-bb06-4650-87d0-b8318c5f31d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e7645387-5409-47f4-9095-a57b8810198b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_dd3c4fac-bb06-4650-87d0-b8318c5f31d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_b11b4721-0fa1-498f-944c-8193ca09d937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e7645387-5409-47f4-9095-a57b8810198b" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_b11b4721-0fa1-498f-944c-8193ca09d937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bce78fa6-59ff-4e63-85bb-48e405b24cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e7645387-5409-47f4-9095-a57b8810198b" xlink:to="loc_us-gaap_LiabilitiesCurrent_bce78fa6-59ff-4e63-85bb-48e405b24cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_d0c1996b-2b87-4e36-afb8-8e43d0391483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a2483e3-92ff-4af2-b54a-9cbe5e66df86" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_d0c1996b-2b87-4e36-afb8-8e43d0391483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_6cc47ec8-cacc-4b23-9241-9f9afa7ecee9" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a2483e3-92ff-4af2-b54a-9cbe5e66df86" xlink:to="loc_lgnd_LiabilityForContingentValueRights_6cc47ec8-cacc-4b23-9241-9f9afa7ecee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b81b0865-657f-4a49-908d-085632ae0844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a2483e3-92ff-4af2-b54a-9cbe5e66df86" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b81b0865-657f-4a49-908d-085632ae0844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_00797188-41e2-47fa-9d15-44d3159d476a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a2483e3-92ff-4af2-b54a-9cbe5e66df86" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_00797188-41e2-47fa-9d15-44d3159d476a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_bc56ab4a-dfe1-486a-a85c-b30df6ebd84e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a2483e3-92ff-4af2-b54a-9cbe5e66df86" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_bc56ab4a-dfe1-486a-a85c-b30df6ebd84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_92ff4c10-cb3b-481e-aa9e-97a232453cef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a2483e3-92ff-4af2-b54a-9cbe5e66df86" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_92ff4c10-cb3b-481e-aa9e-97a232453cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ef8a711f-04c6-41f3-bf00-340db931e648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a2483e3-92ff-4af2-b54a-9cbe5e66df86" xlink:to="loc_us-gaap_Liabilities_ef8a711f-04c6-41f3-bf00-340db931e648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_9ac652d0-efe7-494a-a6b4-4ab5b89d2a65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a2483e3-92ff-4af2-b54a-9cbe5e66df86" xlink:to="loc_us-gaap_CommitmentsAndContingencies_9ac652d0-efe7-494a-a6b4-4ab5b89d2a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_3a25fe46-fb2b-4250-b635-3c09413fe54c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a2483e3-92ff-4af2-b54a-9cbe5e66df86" xlink:to="loc_us-gaap_StockholdersEquityAbstract_3a25fe46-fb2b-4250-b635-3c09413fe54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_04c20a78-8624-48a4-b6d1-4444ee7080a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a25fe46-fb2b-4250-b635-3c09413fe54c" xlink:to="loc_us-gaap_PreferredStockValue_04c20a78-8624-48a4-b6d1-4444ee7080a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_99c0ba6f-9e51-4d6c-b20f-b260a5f850fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a25fe46-fb2b-4250-b635-3c09413fe54c" xlink:to="loc_us-gaap_CommonStockValue_99c0ba6f-9e51-4d6c-b20f-b260a5f850fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_be0cea0c-10ac-4588-a24c-e701c6938c45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a25fe46-fb2b-4250-b635-3c09413fe54c" xlink:to="loc_us-gaap_AdditionalPaidInCapital_be0cea0c-10ac-4588-a24c-e701c6938c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ba34477e-59fa-4d16-94d5-84e6551073a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a25fe46-fb2b-4250-b635-3c09413fe54c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ba34477e-59fa-4d16-94d5-84e6551073a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2b9d1cf8-66ac-4970-8953-e37de123538a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a25fe46-fb2b-4250-b635-3c09413fe54c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2b9d1cf8-66ac-4970-8953-e37de123538a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d6d04b6f-6d0c-4296-a2f7-d8a19792d56e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3a25fe46-fb2b-4250-b635-3c09413fe54c" xlink:to="loc_us-gaap_StockholdersEquity_d6d04b6f-6d0c-4296-a2f7-d8a19792d56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2ee23fb0-b757-4bec-b582-b36be406861c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a2483e3-92ff-4af2-b54a-9cbe5e66df86" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_2ee23fb0-b757-4bec-b582-b36be406861c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="lgnd-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_dea9f14a-f9e6-45d8-a2fa-88e42e07611b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_d1a490ee-f17f-4255-ac94-1afc3416a5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dea9f14a-f9e6-45d8-a2fa-88e42e07611b" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_d1a490ee-f17f-4255-ac94-1afc3416a5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_30c6711a-602f-42c4-ae45-df7385c9468a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dea9f14a-f9e6-45d8-a2fa-88e42e07611b" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_30c6711a-602f-42c4-ae45-df7385c9468a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_f86cf822-6bec-433e-b500-5d48bc735b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dea9f14a-f9e6-45d8-a2fa-88e42e07611b" xlink:to="loc_us-gaap_PreferredStockSharesIssued_f86cf822-6bec-433e-b500-5d48bc735b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_22059d24-efcd-46b4-90e9-f252ce65a88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dea9f14a-f9e6-45d8-a2fa-88e42e07611b" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_22059d24-efcd-46b4-90e9-f252ce65a88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_bf961d4f-ffd8-4d8e-9dfe-eddd99acf8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dea9f14a-f9e6-45d8-a2fa-88e42e07611b" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_bf961d4f-ffd8-4d8e-9dfe-eddd99acf8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_34697777-4a98-4d55-a7be-f961e6654efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dea9f14a-f9e6-45d8-a2fa-88e42e07611b" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_34697777-4a98-4d55-a7be-f961e6654efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_7f562ca3-8631-4c6d-8202-63c4c048c21f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dea9f14a-f9e6-45d8-a2fa-88e42e07611b" xlink:to="loc_us-gaap_CommonStockSharesIssued_7f562ca3-8631-4c6d-8202-63c4c048c21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_25ec205c-808f-4f68-9413-c8b271059228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dea9f14a-f9e6-45d8-a2fa-88e42e07611b" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_25ec205c-808f-4f68-9413-c8b271059228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_c970921b-8198-4a2f-8fac-4f99c53fdf9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_00cdadac-1853-4f1e-b9ea-aed798103676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c970921b-8198-4a2f-8fac-4f99c53fdf9f" xlink:to="loc_us-gaap_StatementTable_00cdadac-1853-4f1e-b9ea-aed798103676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_668adc4f-7c81-4ad5-bd05-e2df1454dcff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_00cdadac-1853-4f1e-b9ea-aed798103676" xlink:to="loc_srt_ProductOrServiceAxis_668adc4f-7c81-4ad5-bd05-e2df1454dcff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ee5bd900-9ff5-4b2b-8803-fde79b337a53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_668adc4f-7c81-4ad5-bd05-e2df1454dcff" xlink:to="loc_srt_ProductsAndServicesDomain_ee5bd900-9ff5-4b2b-8803-fde79b337a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_b89bfc96-7cb8-485a-97e6-df4b72a7fc46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ee5bd900-9ff5-4b2b-8803-fde79b337a53" xlink:to="loc_us-gaap_RoyaltyMember_b89bfc96-7cb8-485a-97e6-df4b72a7fc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_984cc823-b908-4acd-bdbb-904aafd5b883" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ee5bd900-9ff5-4b2b-8803-fde79b337a53" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_984cc823-b908-4acd-bdbb-904aafd5b883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_0b828e2d-44ed-48c9-a690-2604d64184ba" xlink:href="lgnd-20220630.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ee5bd900-9ff5-4b2b-8803-fde79b337a53" xlink:to="loc_lgnd_ContractRevenueMember_0b828e2d-44ed-48c9-a690-2604d64184ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_00cdadac-1853-4f1e-b9ea-aed798103676" xlink:to="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_a0e740e6-2f6f-4a00-9062-5dee69681bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_RevenuesAbstract_a0e740e6-2f6f-4a00-9062-5dee69681bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3672ade3-d71a-40ab-a445-0b1c94caa3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_a0e740e6-2f6f-4a00-9062-5dee69681bbe" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3672ade3-d71a-40ab-a445-0b1c94caa3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_6afd97ea-2a48-4bf4-9f90-d45712789bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_6afd97ea-2a48-4bf4-9f90-d45712789bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_e0448af6-0d0b-4b84-8a4d-beec0f834714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostDirectMaterial"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_6afd97ea-2a48-4bf4-9f90-d45712789bd1" xlink:to="loc_us-gaap_CostDirectMaterial_e0448af6-0d0b-4b84-8a4d-beec0f834714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_ac944c01-4a81-4d6f-ae69-c6dbd4182ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_6afd97ea-2a48-4bf4-9f90-d45712789bd1" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_ac944c01-4a81-4d6f-ae69-c6dbd4182ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5f7c3ac0-c8e9-43f1-a2b5-7831c661627b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_6afd97ea-2a48-4bf4-9f90-d45712789bd1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5f7c3ac0-c8e9-43f1-a2b5-7831c661627b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_51676e19-6628-4fb6-80a4-40a678e1a30c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_6afd97ea-2a48-4bf4-9f90-d45712789bd1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_51676e19-6628-4fb6-80a4-40a678e1a30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_dd1ec70e-9194-4977-ae7e-c6d376a9a4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_6afd97ea-2a48-4bf4-9f90-d45712789bd1" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_dd1ec70e-9194-4977-ae7e-c6d376a9a4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_efb716f5-700a-4894-9da0-449a3fd74f50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_6afd97ea-2a48-4bf4-9f90-d45712789bd1" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_efb716f5-700a-4894-9da0-449a3fd74f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_779400b5-16d0-44e5-be70-87684a45b055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_OperatingIncomeLoss_779400b5-16d0-44e5-be70-87684a45b055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7d17383b-66fb-40ae-93ab-f19357f77f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7d17383b-66fb-40ae-93ab-f19357f77f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_ee7cb98d-ed7d-43a9-985e-3e2b0113d50d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7d17383b-66fb-40ae-93ab-f19357f77f3e" xlink:to="loc_us-gaap_GainLossOnInvestments_ee7cb98d-ed7d-43a9-985e-3e2b0113d50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_3e2def2e-ad10-4f50-85d1-5d08a2502322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7d17383b-66fb-40ae-93ab-f19357f77f3e" xlink:to="loc_us-gaap_InvestmentIncomeInterest_3e2def2e-ad10-4f50-85d1-5d08a2502322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2a584574-ac8c-4761-81a3-5af9c332427e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7d17383b-66fb-40ae-93ab-f19357f77f3e" xlink:to="loc_us-gaap_InterestExpense_2a584574-ac8c-4761-81a3-5af9c332427e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a2d11938-7176-4f3d-8eed-59904b708788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7d17383b-66fb-40ae-93ab-f19357f77f3e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a2d11938-7176-4f3d-8eed-59904b708788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4be3bb3b-2cc5-4897-975f-20ab6d05c794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_7d17383b-66fb-40ae-93ab-f19357f77f3e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_4be3bb3b-2cc5-4897-975f-20ab6d05c794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_72a7ec23-2d17-4db7-bfd7-85f77460fe62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_72a7ec23-2d17-4db7-bfd7-85f77460fe62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_47a41a9c-e5e2-4196-a8c8-ec5a44aea291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_47a41a9c-e5e2-4196-a8c8-ec5a44aea291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_46b89667-0e2f-4b67-ba5b-28f470f32bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_NetIncomeLoss_46b89667-0e2f-4b67-ba5b-28f470f32bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f4b2846d-2faa-425f-8eab-80d1a3c82e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_458fda46-3348-4634-9959-25ca402fd605" xlink:to="loc_us-gaap_EarningsPerShareAbstract_f4b2846d-2faa-425f-8eab-80d1a3c82e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_faf53d96-36e8-48ac-bc06-b2a80469da01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f4b2846d-2faa-425f-8eab-80d1a3c82e5e" xlink:to="loc_us-gaap_EarningsPerShareBasic_faf53d96-36e8-48ac-bc06-b2a80469da01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2ce0daa2-1887-4dd0-a85b-5c56dbbb5e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f4b2846d-2faa-425f-8eab-80d1a3c82e5e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2ce0daa2-1887-4dd0-a85b-5c56dbbb5e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d8f8c416-91bb-4f5e-bd0e-9d41fd7872a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f4b2846d-2faa-425f-8eab-80d1a3c82e5e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d8f8c416-91bb-4f5e-bd0e-9d41fd7872a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d0381d21-3658-45cb-94d0-a0f7d5244d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f4b2846d-2faa-425f-8eab-80d1a3c82e5e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d0381d21-3658-45cb-94d0-a0f7d5244d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="lgnd-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6e18e157-d826-4ab3-833d-4d83eea8cd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_991bb26b-5960-43e0-8d4b-32478d815ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6e18e157-d826-4ab3-833d-4d83eea8cd2f" xlink:to="loc_us-gaap_NetIncomeLoss_991bb26b-5960-43e0-8d4b-32478d815ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_bc7ee448-71b2-4340-b561-39e398442f48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6e18e157-d826-4ab3-833d-4d83eea8cd2f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_bc7ee448-71b2-4340-b561-39e398442f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_49af8b57-712a-47f9-8b00-47b00fd6819e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6e18e157-d826-4ab3-833d-4d83eea8cd2f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_49af8b57-712a-47f9-8b00-47b00fd6819e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="lgnd-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3b505bbf-bdbe-4368-9f43-7dd792b12726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b4447c45-5897-46f8-b132-d3f9cc8e6751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3b505bbf-bdbe-4368-9f43-7dd792b12726" xlink:to="loc_us-gaap_StatementTable_b4447c45-5897-46f8-b132-d3f9cc8e6751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ce115a8e-b325-4450-ac18-578653aa2218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b4447c45-5897-46f8-b132-d3f9cc8e6751" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ce115a8e-b325-4450-ac18-578653aa2218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_678dcce0-02d8-4697-ab4d-263e5fc5fba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ce115a8e-b325-4450-ac18-578653aa2218" xlink:to="loc_us-gaap_EquityComponentDomain_678dcce0-02d8-4697-ab4d-263e5fc5fba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_648540c8-4213-48b7-b47f-d1ef26d0fb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_678dcce0-02d8-4697-ab4d-263e5fc5fba3" xlink:to="loc_us-gaap_CommonStockMember_648540c8-4213-48b7-b47f-d1ef26d0fb4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b28486c2-b6ab-4c83-852a-916bd0be7756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_678dcce0-02d8-4697-ab4d-263e5fc5fba3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b28486c2-b6ab-4c83-852a-916bd0be7756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d0db4ab4-3751-4100-9f2e-bd26535c0205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_678dcce0-02d8-4697-ab4d-263e5fc5fba3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d0db4ab4-3751-4100-9f2e-bd26535c0205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_634b19f4-e178-4764-8570-00901df0d8be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_678dcce0-02d8-4697-ab4d-263e5fc5fba3" xlink:to="loc_us-gaap_RetainedEarningsMember_634b19f4-e178-4764-8570-00901df0d8be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6de139aa-4da3-4f1b-b4b1-8421ae68df6e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b4447c45-5897-46f8-b132-d3f9cc8e6751" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6de139aa-4da3-4f1b-b4b1-8421ae68df6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e8c33bdf-32fd-4854-b761-0687dbd5fcf6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_6de139aa-4da3-4f1b-b4b1-8421ae68df6e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e8c33bdf-32fd-4854-b761-0687dbd5fcf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_cf9f92ed-8e2e-4db2-8dba-38e3e45807ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e8c33bdf-32fd-4854-b761-0687dbd5fcf6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_cf9f92ed-8e2e-4db2-8dba-38e3e45807ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5dd64870-4aaf-479e-8428-55fb742635fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b4447c45-5897-46f8-b132-d3f9cc8e6751" xlink:to="loc_us-gaap_StatementLineItems_5dd64870-4aaf-479e-8428-55fb742635fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5dd64870-4aaf-479e-8428-55fb742635fa" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f4b52427-c39b-45a3-8ec8-17b2d8bf5a22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f4b52427-c39b-45a3-8ec8-17b2d8bf5a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3567afba-aae1-4785-aa0a-8ff9a236985e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_StockholdersEquity_3567afba-aae1-4785-aa0a-8ff9a236985e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_ec2f8607-d2a7-4a9d-9ed2-9824f08c1720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_ec2f8607-d2a7-4a9d-9ed2-9824f08c1720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_20dfdcd7-0f8c-45d2-af71-2935e2455778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_20dfdcd7-0f8c-45d2-af71-2935e2455778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_569bd56f-eefa-46ef-8d38-802097aef374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_569bd56f-eefa-46ef-8d38-802097aef374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4591d8ed-b486-45f2-92e4-bf938646cbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4591d8ed-b486-45f2-92e4-bf938646cbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_60aa4797-654d-49aa-8aef-f4ffac19100c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_60aa4797-654d-49aa-8aef-f4ffac19100c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_cf8e8490-b1bb-45d5-baf7-18482ff30fcf" xlink:href="lgnd-20220630.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_cf8e8490-b1bb-45d5-baf7-18482ff30fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_60dbbc7c-4019-45c7-84c8-e93504c119e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_60dbbc7c-4019-45c7-84c8-e93504c119e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_83e2f5f5-70ff-451b-ae10-0b91412bfd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_83e2f5f5-70ff-451b-ae10-0b91412bfd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2555406e-e83b-4a94-86f6-25fa1838e39c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_NetIncomeLoss_2555406e-e83b-4a94-86f6-25fa1838e39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4e74f8f4-0db4-4474-a678-1a0f85a5b886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4e74f8f4-0db4-4474-a678-1a0f85a5b886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bda1ef19-eb62-4d84-b558-ed1bdf00df00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2569fcd-be25-440a-b159-a89818efb932" xlink:to="loc_us-gaap_StockholdersEquity_bda1ef19-eb62-4d84-b558-ed1bdf00df00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="lgnd-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_b9d2e8ca-ef2b-48ab-8c09-8cf2de14be10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_18900077-2664-4d6b-91dc-8c647b8e0baf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d2e8ca-ef2b-48ab-8c09-8cf2de14be10" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_18900077-2664-4d6b-91dc-8c647b8e0baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_de7e4f92-fcd7-4db9-b083-c3f9d7201060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_18900077-2664-4d6b-91dc-8c647b8e0baf" xlink:to="loc_us-gaap_ProfitLoss_de7e4f92-fcd7-4db9-b083-c3f9d7201060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1e2d2dc3-72c5-431d-b9cc-56a5e7ce6f85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_18900077-2664-4d6b-91dc-8c647b8e0baf" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1e2d2dc3-72c5-431d-b9cc-56a5e7ce6f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_840ad340-e730-4ba6-8a59-b7f9d8d60616" xlink:href="lgnd-20220630.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1e2d2dc3-72c5-431d-b9cc-56a5e7ce6f85" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_840ad340-e730-4ba6-8a59-b7f9d8d60616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_bbe3f4d2-58fd-4a63-81fd-8f861bc101c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1e2d2dc3-72c5-431d-b9cc-56a5e7ce6f85" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_bbe3f4d2-58fd-4a63-81fd-8f861bc101c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_26032004-4266-4605-8a49-0be9aec57360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1e2d2dc3-72c5-431d-b9cc-56a5e7ce6f85" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_26032004-4266-4605-8a49-0be9aec57360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_f1d60a26-6731-4f19-9827-a4010e54eb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1e2d2dc3-72c5-431d-b9cc-56a5e7ce6f85" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_f1d60a26-6731-4f19-9827-a4010e54eb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_8fef63f3-7122-4712-969a-bf2fca235a03" xlink:href="lgnd-20220630.xsd#lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1e2d2dc3-72c5-431d-b9cc-56a5e7ce6f85" xlink:to="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_8fef63f3-7122-4712-969a-bf2fca235a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a4c6630e-5666-4f09-ae6b-badf8dd07dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1e2d2dc3-72c5-431d-b9cc-56a5e7ce6f85" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a4c6630e-5666-4f09-ae6b-badf8dd07dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8fb71e10-8644-45d5-9b04-b27276a499e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1e2d2dc3-72c5-431d-b9cc-56a5e7ce6f85" xlink:to="loc_us-gaap_ShareBasedCompensation_8fb71e10-8644-45d5-9b04-b27276a499e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_b9319f31-e17b-44bf-aac1-61317024cfa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1e2d2dc3-72c5-431d-b9cc-56a5e7ce6f85" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_b9319f31-e17b-44bf-aac1-61317024cfa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_c8d5d349-4efb-4458-a99e-545be2c02e31" xlink:href="lgnd-20220630.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1e2d2dc3-72c5-431d-b9cc-56a5e7ce6f85" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_c8d5d349-4efb-4458-a99e-545be2c02e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_35ed4e28-fbbe-41d0-a567-18ac7efe83d5" xlink:href="lgnd-20220630.xsd#lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1e2d2dc3-72c5-431d-b9cc-56a5e7ce6f85" xlink:to="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_35ed4e28-fbbe-41d0-a567-18ac7efe83d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a2bfb7c6-9fde-4cff-b752-2e3753929eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1e2d2dc3-72c5-431d-b9cc-56a5e7ce6f85" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a2bfb7c6-9fde-4cff-b752-2e3753929eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_420ccd2a-db80-4248-af5f-64051cb0fb29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_18900077-2664-4d6b-91dc-8c647b8e0baf" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_420ccd2a-db80-4248-af5f-64051cb0fb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6e714f29-1c30-4bac-abee-7f2cf9a8736a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_420ccd2a-db80-4248-af5f-64051cb0fb29" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6e714f29-1c30-4bac-abee-7f2cf9a8736a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_2068fd61-fce5-40e4-8237-3de15444604e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_420ccd2a-db80-4248-af5f-64051cb0fb29" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_2068fd61-fce5-40e4-8237-3de15444604e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_0fc8cb70-26f8-4cfe-bca3-be875c936f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_420ccd2a-db80-4248-af5f-64051cb0fb29" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_0fc8cb70-26f8-4cfe-bca3-be875c936f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_9e0032c1-56cf-40eb-bbc2-49dec23524ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_420ccd2a-db80-4248-af5f-64051cb0fb29" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_9e0032c1-56cf-40eb-bbc2-49dec23524ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_88754f96-5a4b-48f7-b83c-5f59cfed70c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_420ccd2a-db80-4248-af5f-64051cb0fb29" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_88754f96-5a4b-48f7-b83c-5f59cfed70c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_d11ac328-7a6e-4a06-8871-5fa129636ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_420ccd2a-db80-4248-af5f-64051cb0fb29" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_d11ac328-7a6e-4a06-8871-5fa129636ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_70922b56-61f0-4d65-8c57-d603c6e9c734" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_18900077-2664-4d6b-91dc-8c647b8e0baf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_70922b56-61f0-4d65-8c57-d603c6e9c734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3319476f-5d18-44ca-a0a7-043921f8e6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d2e8ca-ef2b-48ab-8c09-8cf2de14be10" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3319476f-5d18-44ca-a0a7-043921f8e6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_d477065a-6598-4c1c-b425-a44eca889e11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3319476f-5d18-44ca-a0a7-043921f8e6c3" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_d477065a-6598-4c1c-b425-a44eca889e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_ccdc9b5a-a796-49e8-8b44-ba027614bc53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3319476f-5d18-44ca-a0a7-043921f8e6c3" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_ccdc9b5a-a796-49e8-8b44-ba027614bc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_2b68ee04-2fae-4e92-b664-29a1d4d9d539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3319476f-5d18-44ca-a0a7-043921f8e6c3" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_2b68ee04-2fae-4e92-b664-29a1d4d9d539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_73d4127e-88d5-4e8a-8bc4-1b2a6c8cd4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3319476f-5d18-44ca-a0a7-043921f8e6c3" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_73d4127e-88d5-4e8a-8bc4-1b2a6c8cd4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_44071ff1-3069-43c2-97a8-ed7059c98726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3319476f-5d18-44ca-a0a7-043921f8e6c3" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_44071ff1-3069-43c2-97a8-ed7059c98726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_70478b3f-425a-4282-b027-0bcf235b6dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3319476f-5d18-44ca-a0a7-043921f8e6c3" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_70478b3f-425a-4282-b027-0bcf235b6dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bcdb5760-f2eb-44c1-84cc-52f4dfbd2050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3319476f-5d18-44ca-a0a7-043921f8e6c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bcdb5760-f2eb-44c1-84cc-52f4dfbd2050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_31edb466-d45d-4da1-ae8d-11764d53ef97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d2e8ca-ef2b-48ab-8c09-8cf2de14be10" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_31edb466-d45d-4da1-ae8d-11764d53ef97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_8dc59efe-fee4-41e5-b864-834fbc8d7e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_31edb466-d45d-4da1-ae8d-11764d53ef97" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_8dc59efe-fee4-41e5-b864-834fbc8d7e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_c073bd5f-e866-4575-9719-f01eeac9ebac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_31edb466-d45d-4da1-ae8d-11764d53ef97" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_c073bd5f-e866-4575-9719-f01eeac9ebac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_64d91981-99f9-4555-b5f6-ef6931e8277d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_31edb466-d45d-4da1-ae8d-11764d53ef97" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_64d91981-99f9-4555-b5f6-ef6931e8277d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_6b2c0a67-e75f-41c4-830a-be3c9c7c2963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_31edb466-d45d-4da1-ae8d-11764d53ef97" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_6b2c0a67-e75f-41c4-830a-be3c9c7c2963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_9b7a58ad-dc24-4524-8e7e-aa2b7316adf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_31edb466-d45d-4da1-ae8d-11764d53ef97" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_9b7a58ad-dc24-4524-8e7e-aa2b7316adf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a80c7a75-49b4-4734-899c-941641c37c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_31edb466-d45d-4da1-ae8d-11764d53ef97" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a80c7a75-49b4-4734-899c-941641c37c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_d0b6b95b-a737-49d0-a1fb-4e60ea6fa5b2" xlink:href="lgnd-20220630.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_31edb466-d45d-4da1-ae8d-11764d53ef97" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_d0b6b95b-a737-49d0-a1fb-4e60ea6fa5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a2bc2ca7-5b6e-4a7d-a260-d3857343ddf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_31edb466-d45d-4da1-ae8d-11764d53ef97" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a2bc2ca7-5b6e-4a7d-a260-d3857343ddf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97c66b6c-0ac2-4963-93f9-90f19851426d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_31edb466-d45d-4da1-ae8d-11764d53ef97" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97c66b6c-0ac2-4963-93f9-90f19851426d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c02181c9-c197-427c-b60c-dbe3c366b6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d2e8ca-ef2b-48ab-8c09-8cf2de14be10" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c02181c9-c197-427c-b60c-dbe3c366b6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a23d3f7b-f663-44fb-92d5-daefe5528997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d2e8ca-ef2b-48ab-8c09-8cf2de14be10" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a23d3f7b-f663-44fb-92d5-daefe5528997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_67f686cb-c4fd-4744-b097-a59fc5c368d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d2e8ca-ef2b-48ab-8c09-8cf2de14be10" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_67f686cb-c4fd-4744-b097-a59fc5c368d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_92310464-f97d-4838-b577-708d3fb2437c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d2e8ca-ef2b-48ab-8c09-8cf2de14be10" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_92310464-f97d-4838-b577-708d3fb2437c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_ac1eafe6-513f-4efc-82b1-af3be36ea2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_92310464-f97d-4838-b577-708d3fb2437c" xlink:to="loc_us-gaap_InterestPaidNet_ac1eafe6-513f-4efc-82b1-af3be36ea2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_e4e61dde-dfa9-4329-9d74-a7a93bcfbac4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_92310464-f97d-4838-b577-708d3fb2437c" xlink:to="loc_us-gaap_IncomeTaxesPaid_e4e61dde-dfa9-4329-9d74-a7a93bcfbac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_34ffe2b1-905f-43a9-9e6c-e7bd72447093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_92310464-f97d-4838-b577-708d3fb2437c" xlink:to="loc_us-gaap_RestrictedCashCurrent_34ffe2b1-905f-43a9-9e6c-e7bd72447093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d9e1642e-3556-481d-9053-d6f570abba17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b9d2e8ca-ef2b-48ab-8c09-8cf2de14be10" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d9e1642e-3556-481d-9053-d6f570abba17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a5b5b946-2f0a-470b-b43d-e9d3468ed2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d9e1642e-3556-481d-9053-d6f570abba17" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a5b5b946-2f0a-470b-b43d-e9d3468ed2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases_9f42172b-923b-4ab9-8bbf-d92265fde815" xlink:href="lgnd-20220630.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d9e1642e-3556-481d-9053-d6f570abba17" xlink:to="loc_lgnd_AccruedInventoryPurchases_9f42172b-923b-4ab9-8bbf-d92265fde815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_aae76949-b458-4609-b51a-78831e482492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d9e1642e-3556-481d-9053-d6f570abba17" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_aae76949-b458-4609-b51a-78831e482492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_30ee95df-f9a2-4ae9-9f42-2aea998c53af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_56a22ca8-e79b-4941-8461-821f4c0065cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_30ee95df-f9a2-4ae9-9f42-2aea998c53af" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_56a22ca8-e79b-4941-8461-821f4c0065cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6bdde201-4044-4480-8bb2-662d8c31b750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a3948631-0241-4d5e-aef4-a713ac92f225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6bdde201-4044-4480-8bb2-662d8c31b750" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a3948631-0241-4d5e-aef4-a713ac92f225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_2fb56994-dcb0-4f6f-8fa7-139b92224db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6bdde201-4044-4480-8bb2-662d8c31b750" xlink:to="loc_us-gaap_UseOfEstimates_2fb56994-dcb0-4f6f-8fa7-139b92224db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_66495475-4a12-41e6-a7b5-13ab7ca85603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6bdde201-4044-4480-8bb2-662d8c31b750" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_66495475-4a12-41e6-a7b5-13ab7ca85603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ca338459-3177-4010-8866-8a0db1935bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6bdde201-4044-4480-8bb2-662d8c31b750" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ca338459-3177-4010-8866-8a0db1935bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_21c878e3-da7a-4732-98c1-6549d0aa0704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6bdde201-4044-4480-8bb2-662d8c31b750" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_21c878e3-da7a-4732-98c1-6549d0aa0704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_cd695ae7-31fd-419b-822e-7588b0eb8101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6bdde201-4044-4480-8bb2-662d8c31b750" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_cd695ae7-31fd-419b-822e-7588b0eb8101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_6bcacfb1-dccf-4767-bf50-0dd07bc924c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6bdde201-4044-4480-8bb2-662d8c31b750" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_6bcacfb1-dccf-4767-bf50-0dd07bc924c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRightsPolicyTextBlock_89fa9aad-9564-46ae-a10e-01604b0c3c5a" xlink:href="lgnd-20220630.xsd#lgnd_CommercialLicenseRightsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6bdde201-4044-4480-8bb2-662d8c31b750" xlink:to="loc_lgnd_CommercialLicenseRightsPolicyTextBlock_89fa9aad-9564-46ae-a10e-01604b0c3c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_be2e5a3f-090e-4839-81cb-5ce6fc39b6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6bdde201-4044-4480-8bb2-662d8c31b750" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_be2e5a3f-090e-4839-81cb-5ce6fc39b6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_b585b9c5-50f9-4abf-bd8f-8b6c830e20cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6bdde201-4044-4480-8bb2-662d8c31b750" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_b585b9c5-50f9-4abf-bd8f-8b6c830e20cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23154deb-b59b-4ab4-a6e4-7c5905511bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_de87a532-5424-43cf-8ac1-bff7488c3aad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23154deb-b59b-4ab4-a6e4-7c5905511bd7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_de87a532-5424-43cf-8ac1-bff7488c3aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_e838c564-260f-4c1c-8c10-c7b95556c5d6" xlink:href="lgnd-20220630.xsd#lgnd_ScheduleOfShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23154deb-b59b-4ab4-a6e4-7c5905511bd7" xlink:to="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_e838c564-260f-4c1c-8c10-c7b95556c5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_fad244d8-17b1-44a0-8c95-1e9b689b8e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23154deb-b59b-4ab4-a6e4-7c5905511bd7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_fad244d8-17b1-44a0-8c95-1e9b689b8e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_27f028db-71e3-4862-befe-89aac2692794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23154deb-b59b-4ab4-a6e4-7c5905511bd7" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_27f028db-71e3-4862-befe-89aac2692794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_df242830-5622-49ab-961b-7ec5adcdb93b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23154deb-b59b-4ab4-a6e4-7c5905511bd7" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_df242830-5622-49ab-961b-7ec5adcdb93b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_e24599d5-a771-430b-b304-f84a54b5fb78" xlink:href="lgnd-20220630.xsd#lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23154deb-b59b-4ab4-a6e4-7c5905511bd7" xlink:to="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_e24599d5-a771-430b-b304-f84a54b5fb78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_a1f22982-6a75-4c69-867f-04a7d7a5145d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23154deb-b59b-4ab4-a6e4-7c5905511bd7" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_a1f22982-6a75-4c69-867f-04a7d7a5145d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_0c920d37-1a91-436f-ab0a-c782bc0475ca" xlink:href="lgnd-20220630.xsd#lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23154deb-b59b-4ab4-a6e4-7c5905511bd7" xlink:to="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_0c920d37-1a91-436f-ab0a-c782bc0475ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_8790e0e5-2d62-497d-b92c-17df353cfa78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23154deb-b59b-4ab4-a6e4-7c5905511bd7" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_8790e0e5-2d62-497d-b92c-17df353cfa78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_359a6062-94b3-48c3-ab57-5299fa86b63f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23154deb-b59b-4ab4-a6e4-7c5905511bd7" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_359a6062-94b3-48c3-ab57-5299fa86b63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_63ebcfcf-2735-4125-8dcb-5c17ea7381bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_63ebcfcf-2735-4125-8dcb-5c17ea7381bb" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2d3f8bfc-898f-41a5-96a9-98a126f4248c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2d3f8bfc-898f-41a5-96a9-98a126f4248c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_25d245ba-8235-4529-93de-1bbcab679dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2d3f8bfc-898f-41a5-96a9-98a126f4248c" xlink:to="loc_us-gaap_EquityComponentDomain_25d245ba-8235-4529-93de-1bbcab679dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_187014ad-11c9-485b-9285-ee57356881a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_25d245ba-8235-4529-93de-1bbcab679dca" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_187014ad-11c9-485b-9285-ee57356881a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_0cde13fe-171c-49d0-aa21-6ca2fd208b13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_25d245ba-8235-4529-93de-1bbcab679dca" xlink:to="loc_us-gaap_RetainedEarningsMember_0cde13fe-171c-49d0-aa21-6ca2fd208b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_094d0e15-4dc6-4db2-ae52-581cef540888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_094d0e15-4dc6-4db2-ae52-581cef540888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_39091d11-56d4-4a26-ac89-7dca8efbb3d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_094d0e15-4dc6-4db2-ae52-581cef540888" xlink:to="loc_us-gaap_TypeOfAdoptionMember_39091d11-56d4-4a26-ac89-7dca8efbb3d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_862f3181-e8d2-4a3d-8efa-eccb1e7b2bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_39091d11-56d4-4a26-ac89-7dca8efbb3d7" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_862f3181-e8d2-4a3d-8efa-eccb1e7b2bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3976755a-de3e-4a49-aa13-737a589b9f4e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3976755a-de3e-4a49-aa13-737a589b9f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ec35f7d9-fc0e-4718-8b80-5d83f94a63d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3976755a-de3e-4a49-aa13-737a589b9f4e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ec35f7d9-fc0e-4718-8b80-5d83f94a63d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_141f4acf-665e-4a00-9e1a-7f869a2a9463" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ec35f7d9-fc0e-4718-8b80-5d83f94a63d8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_141f4acf-665e-4a00-9e1a-7f869a2a9463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_c61be4de-e880-4d46-9d60-b9a5abc4a0f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ec35f7d9-fc0e-4718-8b80-5d83f94a63d8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_c61be4de-e880-4d46-9d60-b9a5abc4a0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d5d367ad-1a5c-431a-aec8-c1e790b3e0cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_srt_RangeAxis_d5d367ad-1a5c-431a-aec8-c1e790b3e0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9d816ba2-f8e8-44bb-9230-4514e5aca5db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d5d367ad-1a5c-431a-aec8-c1e790b3e0cf" xlink:to="loc_srt_RangeMember_9d816ba2-f8e8-44bb-9230-4514e5aca5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_35f713d7-fc41-4a8f-ad51-5b08081c374f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9d816ba2-f8e8-44bb-9230-4514e5aca5db" xlink:to="loc_srt_MinimumMember_35f713d7-fc41-4a8f-ad51-5b08081c374f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0fe8a55f-5801-4212-9ae3-54a653d95d74" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9d816ba2-f8e8-44bb-9230-4514e5aca5db" xlink:to="loc_srt_MaximumMember_0fe8a55f-5801-4212-9ae3-54a653d95d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3b800d1d-f8a1-448f-8b19-9a7dacfb2f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_us-gaap_AwardTypeAxis_3b800d1d-f8a1-448f-8b19-9a7dacfb2f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04e678fc-c213-4b09-ba69-753cbda66563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3b800d1d-f8a1-448f-8b19-9a7dacfb2f38" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04e678fc-c213-4b09-ba69-753cbda66563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_f69172aa-f988-499f-ba5a-25bb94629504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04e678fc-c213-4b09-ba69-753cbda66563" xlink:to="loc_us-gaap_RestrictedStockMember_f69172aa-f988-499f-ba5a-25bb94629504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_653a8b7f-3f2a-4e46-85df-b6112a8f932c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_653a8b7f-3f2a-4e46-85df-b6112a8f932c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ceaee396-c7d4-431f-94f8-9dd184b1e03a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_653a8b7f-3f2a-4e46-85df-b6112a8f932c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ceaee396-c7d4-431f-94f8-9dd184b1e03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_823b5504-f5de-4c2e-b0c9-a840d12f7168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ceaee396-c7d4-431f-94f8-9dd184b1e03a" xlink:to="loc_us-gaap_StockCompensationPlanMember_823b5504-f5de-4c2e-b0c9-a840d12f7168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a2d5757a-2a11-4601-afbc-32fbe2182ddb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_srt_ProductOrServiceAxis_a2d5757a-2a11-4601-afbc-32fbe2182ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a2899c83-a388-4ead-af48-9e99f05ad626" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a2d5757a-2a11-4601-afbc-32fbe2182ddb" xlink:to="loc_srt_ProductsAndServicesDomain_a2899c83-a388-4ead-af48-9e99f05ad626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_430503b8-95bc-4959-9ecd-cb40cd915bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a2899c83-a388-4ead-af48-9e99f05ad626" xlink:to="loc_us-gaap_RoyaltyMember_430503b8-95bc-4959-9ecd-cb40cd915bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_f9891e64-b082-4e6a-b7d1-d8345608fa55" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a2899c83-a388-4ead-af48-9e99f05ad626" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_f9891e64-b082-4e6a-b7d1-d8345608fa55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_22355352-e7f6-4ada-8d9f-89e32ee27ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_22355352-e7f6-4ada-8d9f-89e32ee27ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e32dd495-5aff-4b7f-a632-d78077de17f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_22355352-e7f6-4ada-8d9f-89e32ee27ba5" xlink:to="loc_us-gaap_SegmentDomain_e32dd495-5aff-4b7f-a632-d78077de17f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessSegmentMember_041606b3-8cfd-44c7-96b2-ac9525a3fb4c" xlink:href="lgnd-20220630.xsd#lgnd_LigandCoreBusinessSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e32dd495-5aff-4b7f-a632-d78077de17f5" xlink:to="loc_lgnd_LigandCoreBusinessSegmentMember_041606b3-8cfd-44c7-96b2-ac9525a3fb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beb97879-20e4-4f12-b44e-1e02db394dfc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_2d5dda45-6d9b-4aba-b8e2-5c8f948adf49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_ConvertibleNotesPayable_2d5dda45-6d9b-4aba-b8e2-5c8f948adf49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fccfa2f2-9f4a-4887-8067-7688308bf95e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fccfa2f2-9f4a-4887-8067-7688308bf95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_68b0d191-cc0e-4f96-b079-93724f186a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_StockholdersEquity_68b0d191-cc0e-4f96-b079-93724f186a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_f7536dcf-b4b8-46e8-ab4e-e9aeaca45f15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_f7536dcf-b4b8-46e8-ab4e-e9aeaca45f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_2bc6a3f6-c663-49d7-acb6-6efb857afdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_2bc6a3f6-c663-49d7-acb6-6efb857afdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_c3fbc5c9-b377-43f8-93bd-c67f5719e5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_c3fbc5c9-b377-43f8-93bd-c67f5719e5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_680f0b78-5a3c-4f44-bb6d-e02175a69fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_680f0b78-5a3c-4f44-bb6d-e02175a69fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_67700027-d940-40bc-84ac-6bc4db7fd4df" xlink:href="lgnd-20220630.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_67700027-d940-40bc-84ac-6bc4db7fd4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1a1ba31f-3536-40b2-b773-7e06085f6124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_InventoryNet_1a1ba31f-3536-40b2-b773-7e06085f6124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_0fc721ec-5595-4f23-94f5-8a66da465169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_NumberOfReportingUnits_0fc721ec-5595-4f23-94f5-8a66da465169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_67939696-8f8f-4c57-b0c8-6a99048032bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_NumberOfReportableSegments_67939696-8f8f-4c57-b0c8-6a99048032bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_2392d645-e220-4bb7-b92e-26661e2cc36e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_2392d645-e220-4bb7-b92e-26661e2cc36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_77f6cd19-57dc-4a1a-b850-9a7066eca221" xlink:href="lgnd-20220630.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_77f6cd19-57dc-4a1a-b850-9a7066eca221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e6a0f0cf-f72a-42ce-9060-0b5b64ac919d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_277c3363-2bed-40eb-bdd0-0fe3aebe0716" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e6a0f0cf-f72a-42ce-9060-0b5b64ac919d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5e305c0c-fc54-422c-99d2-468dd9f4d565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b9f7a163-a330-497d-bdab-1ca06cc6289d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5e305c0c-fc54-422c-99d2-468dd9f4d565" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b9f7a163-a330-497d-bdab-1ca06cc6289d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6a820dc5-b583-4dc7-b8a0-a03c2b5de59e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b9f7a163-a330-497d-bdab-1ca06cc6289d" xlink:to="loc_srt_ProductOrServiceAxis_6a820dc5-b583-4dc7-b8a0-a03c2b5de59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_94e26bfd-171c-41b3-9079-20b891895698" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6a820dc5-b583-4dc7-b8a0-a03c2b5de59e" xlink:to="loc_srt_ProductsAndServicesDomain_94e26bfd-171c-41b3-9079-20b891895698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_2cf9884f-b98f-4c88-9907-4a2ba4d10b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_94e26bfd-171c-41b3-9079-20b891895698" xlink:to="loc_us-gaap_RoyaltyMember_2cf9884f-b98f-4c88-9907-4a2ba4d10b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember_72873c47-532f-4776-a339-3bc42289f324" xlink:href="lgnd-20220630.xsd#lgnd_KyprolisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_2cf9884f-b98f-4c88-9907-4a2ba4d10b6c" xlink:to="loc_lgnd_KyprolisMember_72873c47-532f-4776-a339-3bc42289f324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember_7a05d80e-0e70-4bd2-976f-6da3fc46a53c" xlink:href="lgnd-20220630.xsd#lgnd_EvomelaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_2cf9884f-b98f-4c88-9907-4a2ba4d10b6c" xlink:to="loc_lgnd_EvomelaMember_7a05d80e-0e70-4bd2-976f-6da3fc46a53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TeriparatideInjectionMember_ca205ae7-f77a-4bba-ab7a-6314d1a16774" xlink:href="lgnd-20220630.xsd#lgnd_TeriparatideInjectionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_2cf9884f-b98f-4c88-9907-4a2ba4d10b6c" xlink:to="loc_lgnd_TeriparatideInjectionMember_ca205ae7-f77a-4bba-ab7a-6314d1a16774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RylazeMember_49f2d64b-3aca-4a05-903a-50dfab857abb" xlink:href="lgnd-20220630.xsd#lgnd_RylazeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_2cf9884f-b98f-4c88-9907-4a2ba4d10b6c" xlink:to="loc_lgnd_RylazeMember_49f2d64b-3aca-4a05-903a-50dfab857abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_924fafb7-704b-4a3a-a041-5d88df816ee4" xlink:href="lgnd-20220630.xsd#lgnd_RoyaltyOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_2cf9884f-b98f-4c88-9907-4a2ba4d10b6c" xlink:to="loc_lgnd_RoyaltyOtherMember_924fafb7-704b-4a3a-a041-5d88df816ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_6f035d68-e5f0-4140-93e3-870f822803f8" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_94e26bfd-171c-41b3-9079-20b891895698" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_6f035d68-e5f0-4140-93e3-870f822803f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember_600d7fdb-3b9b-4dc8-85e4-1ca1cbc2d314" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_6f035d68-e5f0-4140-93e3-870f822803f8" xlink:to="loc_lgnd_MaterialSalesCaptisolCoreMember_600d7fdb-3b9b-4dc8-85e4-1ca1cbc2d314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember_1a5ca872-9718-4713-ba7c-898ab58d2627" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_6f035d68-e5f0-4140-93e3-870f822803f8" xlink:to="loc_lgnd_MaterialSalesCaptisolCOVIDMember_1a5ca872-9718-4713-ba7c-898ab58d2627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_d046fe48-9220-4890-8992-77fc2b0eddb9" xlink:href="lgnd-20220630.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_94e26bfd-171c-41b3-9079-20b891895698" xlink:to="loc_lgnd_ContractRevenueMember_d046fe48-9220-4890-8992-77fc2b0eddb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember_9665c6c3-2492-4349-83ad-3794504f68a3" xlink:href="lgnd-20220630.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_d046fe48-9220-4890-8992-77fc2b0eddb9" xlink:to="loc_lgnd_ContractRevenueServiceMember_9665c6c3-2492-4349-83ad-3794504f68a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_2add335b-cc67-4172-9dcb-b1f645b94037" xlink:href="lgnd-20220630.xsd#lgnd_LicenseFeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_d046fe48-9220-4890-8992-77fc2b0eddb9" xlink:to="loc_lgnd_LicenseFeesMember_2add335b-cc67-4172-9dcb-b1f645b94037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_d15974c6-55cc-4e08-b36d-833b089d143a" xlink:href="lgnd-20220630.xsd#lgnd_MilestoneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_d046fe48-9220-4890-8992-77fc2b0eddb9" xlink:to="loc_lgnd_MilestoneMember_d15974c6-55cc-4e08-b36d-833b089d143a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_878a0e99-5cd1-4339-ac98-a8bd962ff799" xlink:href="lgnd-20220630.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_d046fe48-9220-4890-8992-77fc2b0eddb9" xlink:to="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_878a0e99-5cd1-4339-ac98-a8bd962ff799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_acca047e-3bcc-42dd-ae63-d6225a6ff832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b9f7a163-a330-497d-bdab-1ca06cc6289d" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_acca047e-3bcc-42dd-ae63-d6225a6ff832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c292c4bf-ac06-466d-a1ac-f7b254e24f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_acca047e-3bcc-42dd-ae63-d6225a6ff832" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c292c4bf-ac06-466d-a1ac-f7b254e24f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_45e1030d-a046-4492-8fb3-a9e6800ffac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a34ac30b-94ec-4fde-b404-d64b11b8b44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_45e1030d-a046-4492-8fb3-a9e6800ffac0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a34ac30b-94ec-4fde-b404-d64b11b8b44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6592be6a-aabb-41e0-89ba-5f8337510ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a34ac30b-94ec-4fde-b404-d64b11b8b44e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6592be6a-aabb-41e0-89ba-5f8337510ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6592be6a-aabb-41e0-89ba-5f8337510ca4" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_1e603a3a-18a9-423c-b6fb-eb7cc9b6c55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:to="loc_us-gaap_DemandDepositsMember_1e603a3a-18a9-423c-b6fb-eb7cc9b6c55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_727e8d3c-d48a-4f8a-a945-fdba8b18c7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_727e8d3c-d48a-4f8a-a945-fdba8b18c7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_04df7bf1-4741-400a-a339-6dcc51272753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:to="loc_us-gaap_CommercialPaperMember_04df7bf1-4741-400a-a339-6dcc51272753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_7a40c4f6-5b11-4e1a-bfbe-e29fa022c1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:to="loc_us-gaap_EquitySecuritiesMember_7a40c4f6-5b11-4e1a-bfbe-e29fa022c1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_e73a2a15-903a-4f79-b703-d239fa8505de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:to="loc_us-gaap_MutualFundMember_e73a2a15-903a-4f79-b703-d239fa8505de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_e8aaaa00-b979-47d2-af0a-90de61be2292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_e8aaaa00-b979-47d2-af0a-90de61be2292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_eb8362d2-7f93-4586-9d78-8b53e4b2343a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:to="loc_us-gaap_WarrantMember_eb8362d2-7f93-4586-9d78-8b53e4b2343a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7a34862a-f77b-45c8-a551-d6c72f4efd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_258738d4-b62b-4566-9aaa-aa642911ddbe" xlink:to="loc_us-gaap_CommonStockMember_7a34862a-f77b-45c8-a551-d6c72f4efd6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb69504-666a-4b04-9e2d-e6b88e2c2996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a34ac30b-94ec-4fde-b404-d64b11b8b44e" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb69504-666a-4b04-9e2d-e6b88e2c2996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d5ef4d91-71b2-4630-a98d-b3cfbc77f3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb69504-666a-4b04-9e2d-e6b88e2c2996" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d5ef4d91-71b2-4630-a98d-b3cfbc77f3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7682b3cd-0f31-4fe5-830c-11e732e65c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb69504-666a-4b04-9e2d-e6b88e2c2996" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7682b3cd-0f31-4fe5-830c-11e732e65c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f399ff41-d5ab-4112-873c-4bc321fd418d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb69504-666a-4b04-9e2d-e6b88e2c2996" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f399ff41-d5ab-4112-873c-4bc321fd418d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a5c929d0-595d-4793-a8bf-6933880194bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb69504-666a-4b04-9e2d-e6b88e2c2996" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a5c929d0-595d-4793-a8bf-6933880194bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_66f92d15-5ae9-4166-876d-a8995bba3e10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb69504-666a-4b04-9e2d-e6b88e2c2996" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_66f92d15-5ae9-4166-876d-a8995bba3e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_c31002c2-78ae-4923-9851-515c70675ac7" xlink:href="lgnd-20220630.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb69504-666a-4b04-9e2d-e6b88e2c2996" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_c31002c2-78ae-4923-9851-515c70675ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d85ff40f-4021-477e-bed5-e142ddffb2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_604dc248-a18a-4826-bad5-650096c8271b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d85ff40f-4021-477e-bed5-e142ddffb2c7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_604dc248-a18a-4826-bad5-650096c8271b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_8bba8ec5-e79a-416e-a741-65900ad3291a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_604dc248-a18a-4826-bad5-650096c8271b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_8bba8ec5-e79a-416e-a741-65900ad3291a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_4223d5bb-a903-4a02-947a-83651d1be66a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_604dc248-a18a-4826-bad5-650096c8271b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_4223d5bb-a903-4a02-947a-83651d1be66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_e07bb62a-e423-4af7-929d-c5604216eb74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_604dc248-a18a-4826-bad5-650096c8271b" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_e07bb62a-e423-4af7-929d-c5604216eb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_80a690c7-4a39-4c9a-9ba1-18cc5dc6576a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d85ff40f-4021-477e-bed5-e142ddffb2c7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_80a690c7-4a39-4c9a-9ba1-18cc5dc6576a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_b63465d5-1e00-4940-bed6-a46d55e47e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_80a690c7-4a39-4c9a-9ba1-18cc5dc6576a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_b63465d5-1e00-4940-bed6-a46d55e47e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_831b8098-982b-48b3-82c7-6fa44f62f360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_80a690c7-4a39-4c9a-9ba1-18cc5dc6576a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_831b8098-982b-48b3-82c7-6fa44f62f360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_126c83f8-5785-4614-a9b4-badebe596e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_80a690c7-4a39-4c9a-9ba1-18cc5dc6576a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_126c83f8-5785-4614-a9b4-badebe596e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dbe18377-fc33-41f5-96dc-a4b26c70dbca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0855654f-45bd-47ee-9c0d-95138716696f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dbe18377-fc33-41f5-96dc-a4b26c70dbca" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0855654f-45bd-47ee-9c0d-95138716696f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_040925a5-e626-4d1c-8862-aafe6755609a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0855654f-45bd-47ee-9c0d-95138716696f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_040925a5-e626-4d1c-8862-aafe6755609a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c5b2ca7-55c2-473b-b74a-3c1442188638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_040925a5-e626-4d1c-8862-aafe6755609a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c5b2ca7-55c2-473b-b74a-3c1442188638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_4e3d4e1b-e08f-4f15-822b-84613d58f5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c5b2ca7-55c2-473b-b74a-3c1442188638" xlink:to="loc_us-gaap_PatentedTechnologyMember_4e3d4e1b-e08f-4f15-822b-84613d58f5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_9cffd85a-0799-48c4-beef-e0883df0a150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c5b2ca7-55c2-473b-b74a-3c1442188638" xlink:to="loc_us-gaap_TradeNamesMember_9cffd85a-0799-48c4-beef-e0883df0a150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5a5bb28d-3e32-4dfb-9c6a-3ab1bdcba797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c5b2ca7-55c2-473b-b74a-3c1442188638" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5a5bb28d-3e32-4dfb-9c6a-3ab1bdcba797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_a714073b-05e6-4cba-a2a4-a47574b59c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c5b2ca7-55c2-473b-b74a-3c1442188638" xlink:to="loc_us-gaap_ContractualRightsMember_a714073b-05e6-4cba-a2a4-a47574b59c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28a1083-ffde-485f-ad2a-5298baaec12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0855654f-45bd-47ee-9c0d-95138716696f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28a1083-ffde-485f-ad2a-5298baaec12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_dfd0d1ad-6eaa-4eae-8206-aa63f2d8947b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b28a1083-ffde-485f-ad2a-5298baaec12e" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_dfd0d1ad-6eaa-4eae-8206-aa63f2d8947b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_88201987-124d-4596-8f79-f6c0f00384fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_dfd0d1ad-6eaa-4eae-8206-aa63f2d8947b" xlink:to="loc_us-gaap_Goodwill_88201987-124d-4596-8f79-f6c0f00384fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_521dd5a8-8d8f-4cd6-9783-2f730530326f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_dfd0d1ad-6eaa-4eae-8206-aa63f2d8947b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_521dd5a8-8d8f-4cd6-9783-2f730530326f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dc3d133e-fa87-462c-a0e9-b63da707a4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_dfd0d1ad-6eaa-4eae-8206-aa63f2d8947b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dc3d133e-fa87-462c-a0e9-b63da707a4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_9aed8929-4b8c-45b8-9eed-138ee27597de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_dfd0d1ad-6eaa-4eae-8206-aa63f2d8947b" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_9aed8929-4b8c-45b8-9eed-138ee27597de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_77f901ad-fa6f-4e71-8913-88c5368f355e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_c012c078-2eb6-4c09-aab5-55ccfbf1447b" xlink:href="lgnd-20220630.xsd#lgnd_BasisOfPresentationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_77f901ad-fa6f-4e71-8913-88c5368f355e" xlink:to="loc_lgnd_BasisOfPresentationTable_c012c078-2eb6-4c09-aab5-55ccfbf1447b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9756641e-bdc5-452a-bd5a-ed95153ae21f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_c012c078-2eb6-4c09-aab5-55ccfbf1447b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9756641e-bdc5-452a-bd5a-ed95153ae21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_27cc24c2-c6aa-44a3-8d6a-ba4cba65c43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9756641e-bdc5-452a-bd5a-ed95153ae21f" xlink:to="loc_us-gaap_SegmentDomain_27cc24c2-c6aa-44a3-8d6a-ba4cba65c43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessSegmentMember_b9f7e895-1b97-4429-b075-5e988683bb19" xlink:href="lgnd-20220630.xsd#lgnd_LigandCoreBusinessSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_27cc24c2-c6aa-44a3-8d6a-ba4cba65c43b" xlink:to="loc_lgnd_LigandCoreBusinessSegmentMember_b9f7e895-1b97-4429-b075-5e988683bb19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbTechnologiesSegmentMember_c4ac25c5-4279-419c-b21b-7ded9b120c48" xlink:href="lgnd-20220630.xsd#lgnd_OmniAbTechnologiesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_27cc24c2-c6aa-44a3-8d6a-ba4cba65c43b" xlink:to="loc_lgnd_OmniAbTechnologiesSegmentMember_c4ac25c5-4279-419c-b21b-7ded9b120c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_9f3d65aa-2c98-4463-a5bb-78768dbcd9c9" xlink:href="lgnd-20220630.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_c012c078-2eb6-4c09-aab5-55ccfbf1447b" xlink:to="loc_lgnd_BasisOfPresentationLineItems_9f3d65aa-2c98-4463-a5bb-78768dbcd9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b4ce3796-bb76-48d8-99a8-a279bd28c871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_9f3d65aa-2c98-4463-a5bb-78768dbcd9c9" xlink:to="loc_us-gaap_Goodwill_b4ce3796-bb76-48d8-99a8-a279bd28c871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6861c9a-eae0-45c6-90ca-fecfbbaf5d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a2ccf825-6ec0-4010-90b8-a8dc009e965b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6861c9a-eae0-45c6-90ca-fecfbbaf5d40" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a2ccf825-6ec0-4010-90b8-a8dc009e965b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_60edd5d6-195e-49be-9a3b-215dbd8d3efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a2ccf825-6ec0-4010-90b8-a8dc009e965b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_60edd5d6-195e-49be-9a3b-215dbd8d3efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0bc1c3e8-6b81-4fa6-9b24-904e81d5d334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_60edd5d6-195e-49be-9a3b-215dbd8d3efe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0bc1c3e8-6b81-4fa6-9b24-904e81d5d334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_341f5171-b7e9-4c7c-bf25-c707310dad4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0bc1c3e8-6b81-4fa6-9b24-904e81d5d334" xlink:to="loc_us-gaap_LicensingAgreementsMember_341f5171-b7e9-4c7c-bf25-c707310dad4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_92c0efe2-5488-4562-bac1-40ab76aaf5b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a2ccf825-6ec0-4010-90b8-a8dc009e965b" xlink:to="loc_srt_CounterpartyNameAxis_92c0efe2-5488-4562-bac1-40ab76aaf5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9732eb87-d133-4b24-880c-95c0bccd7588" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_92c0efe2-5488-4562-bac1-40ab76aaf5b2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9732eb87-d133-4b24-880c-95c0bccd7588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember_c26fc693-3e0f-4d72-8bee-ae937d76cb40" xlink:href="lgnd-20220630.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9732eb87-d133-4b24-880c-95c0bccd7588" xlink:to="loc_lgnd_AziyoAndCorMatrixMember_c26fc693-3e0f-4d72-8bee-ae937d76cb40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_eaa44e35-6727-44c1-b73a-3285835a1707" xlink:href="lgnd-20220630.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9732eb87-d133-4b24-880c-95c0bccd7588" xlink:to="loc_lgnd_SelexisAndDianomiMember_eaa44e35-6727-44c1-b73a-3285835a1707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8e3c1c37-ee8c-431e-92c8-50011dac5a22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a2ccf825-6ec0-4010-90b8-a8dc009e965b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8e3c1c37-ee8c-431e-92c8-50011dac5a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_d6cc40c7-8362-4fae-9404-e2222e34351f" xlink:href="lgnd-20220630.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8e3c1c37-ee8c-431e-92c8-50011dac5a22" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_d6cc40c7-8362-4fae-9404-e2222e34351f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6e691377-33e4-4ed3-9fab-fff4390e7739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_d6cc40c7-8362-4fae-9404-e2222e34351f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6e691377-33e4-4ed3-9fab-fff4390e7739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_93761ae1-306d-496d-b8d2-e87f5cdf6313" xlink:href="lgnd-20220630.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_d6cc40c7-8362-4fae-9404-e2222e34351f" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_93761ae1-306d-496d-b8d2-e87f5cdf6313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2726ae4a-cbd7-40ed-899b-13b690be3d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_d6cc40c7-8362-4fae-9404-e2222e34351f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2726ae4a-cbd7-40ed-899b-13b690be3d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0c539c68-29b3-4b4e-b468-6897ebe13d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_d6cc40c7-8362-4fae-9404-e2222e34351f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0c539c68-29b3-4b4e-b468-6897ebe13d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_5b44761a-866e-4a99-8680-2108d8d503dd" xlink:href="lgnd-20220630.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_d6cc40c7-8362-4fae-9404-e2222e34351f" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_5b44761a-866e-4a99-8680-2108d8d503dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_10db2fdc-21f4-4e43-a30d-5f805d80de7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_adbbee47-cfde-4101-a2f8-dd9cce89bd47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_10db2fdc-21f4-4e43-a30d-5f805d80de7e" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_adbbee47-cfde-4101-a2f8-dd9cce89bd47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a1a359dc-5622-415a-95a4-46d4c27524d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_adbbee47-cfde-4101-a2f8-dd9cce89bd47" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a1a359dc-5622-415a-95a4-46d4c27524d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_57276417-614c-4aef-9427-61a52668b89b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_adbbee47-cfde-4101-a2f8-dd9cce89bd47" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_57276417-614c-4aef-9427-61a52668b89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent_548863e1-07bb-494f-9951-b114367dd967" xlink:href="lgnd-20220630.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_adbbee47-cfde-4101-a2f8-dd9cce89bd47" xlink:to="loc_lgnd_LicenseeAccrualCurrent_548863e1-07bb-494f-9951-b114367dd967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_919c286d-6b88-4e72-ba4d-7f892e5ea7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_adbbee47-cfde-4101-a2f8-dd9cce89bd47" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_919c286d-6b88-4e72-ba4d-7f892e5ea7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual_af8e23c1-3f1a-4ede-bb39-4e1b81ae9af9" xlink:href="lgnd-20220630.xsd#lgnd_ReturnsAccrual"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_adbbee47-cfde-4101-a2f8-dd9cce89bd47" xlink:to="loc_lgnd_ReturnsAccrual_af8e23c1-3f1a-4ede-bb39-4e1b81ae9af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent_f5fb1697-47a4-4c72-b4e9-f9a432c861ad" xlink:href="lgnd-20220630.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_adbbee47-cfde-4101-a2f8-dd9cce89bd47" xlink:to="loc_lgnd_AccruedAssetAcquisitionsCurrent_f5fb1697-47a4-4c72-b4e9-f9a432c861ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent_90ad6e93-ea5a-4239-9ba9-683f38b64917" xlink:href="lgnd-20220630.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_adbbee47-cfde-4101-a2f8-dd9cce89bd47" xlink:to="loc_lgnd_AccruedSubcontractorExpensesCurrent_90ad6e93-ea5a-4239-9ba9-683f38b64917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent_80f701d7-552d-4f71-aae0-23bc98ee6a41" xlink:href="lgnd-20220630.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_adbbee47-cfde-4101-a2f8-dd9cce89bd47" xlink:to="loc_lgnd_AccruedSupplierExpensesCurrent_80f701d7-552d-4f71-aae0-23bc98ee6a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_f3631e88-1499-4e69-8281-55f3e542c80d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_adbbee47-cfde-4101-a2f8-dd9cce89bd47" xlink:to="loc_us-gaap_InterestPayableCurrent_f3631e88-1499-4e69-8281-55f3e542c80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_93cb3425-85cf-4864-b78d-4528b42564bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_adbbee47-cfde-4101-a2f8-dd9cce89bd47" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_93cb3425-85cf-4864-b78d-4528b42564bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_16036d94-3df1-485c-8409-8fde84d7301f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_adbbee47-cfde-4101-a2f8-dd9cce89bd47" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_16036d94-3df1-485c-8409-8fde84d7301f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c6c9bb9a-1f2e-4283-a7e4-6a3b08f635b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_a9cb2f7e-e2e8-484e-a401-dba8c24ce909" xlink:href="lgnd-20220630.xsd#lgnd_BasisOfPresentationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c6c9bb9a-1f2e-4283-a7e4-6a3b08f635b2" xlink:to="loc_lgnd_BasisOfPresentationTable_a9cb2f7e-e2e8-484e-a401-dba8c24ce909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f78740a8-0ae4-4f1e-bbb0-65294dbaace0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_a9cb2f7e-e2e8-484e-a401-dba8c24ce909" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f78740a8-0ae4-4f1e-bbb0-65294dbaace0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8fb3a940-501d-446c-97f2-705c16c59105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f78740a8-0ae4-4f1e-bbb0-65294dbaace0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8fb3a940-501d-446c-97f2-705c16c59105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_81f9b9e7-c7d5-40cb-926c-1654ec2b6ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8fb3a940-501d-446c-97f2-705c16c59105" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_81f9b9e7-c7d5-40cb-926c-1654ec2b6ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_ce4e00a2-69f0-4652-b2e0-1c1bae96b3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8fb3a940-501d-446c-97f2-705c16c59105" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_ce4e00a2-69f0-4652-b2e0-1c1bae96b3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_ad72a70b-b2b1-44a5-8a3c-cfcf91e87c92" xlink:href="lgnd-20220630.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_a9cb2f7e-e2e8-484e-a401-dba8c24ce909" xlink:to="loc_lgnd_BasisOfPresentationLineItems_ad72a70b-b2b1-44a5-8a3c-cfcf91e87c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_984f62a8-8f40-4e39-ac9c-5d12d7cbf97c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_ad72a70b-b2b1-44a5-8a3c-cfcf91e87c92" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_984f62a8-8f40-4e39-ac9c-5d12d7cbf97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f9e78bbe-d8a5-4575-9c8f-c50d37f8ef13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3fac15ee-b78f-416e-9b72-62a94b3454ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f9e78bbe-d8a5-4575-9c8f-c50d37f8ef13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3fac15ee-b78f-416e-9b72-62a94b3454ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9513fd33-92e3-4d2a-9c80-bd8d3608b6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f9e78bbe-d8a5-4575-9c8f-c50d37f8ef13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9513fd33-92e3-4d2a-9c80-bd8d3608b6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7685f51e-4edc-4040-96dc-07cf40691fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f9e78bbe-d8a5-4575-9c8f-c50d37f8ef13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7685f51e-4edc-4040-96dc-07cf40691fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1dfa20c4-ac82-4954-8b0a-1302173e96f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f9e78bbe-d8a5-4575-9c8f-c50d37f8ef13" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1dfa20c4-ac82-4954-8b0a-1302173e96f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8860265a-b41b-4eb4-89c1-dc6ca1b9885f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5ffd8309-4dcf-4842-aa68-acc10d6e1f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8860265a-b41b-4eb4-89c1-dc6ca1b9885f" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5ffd8309-4dcf-4842-aa68-acc10d6e1f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_42436be5-b6b3-42f6-822d-d39d9c15ce1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5ffd8309-4dcf-4842-aa68-acc10d6e1f62" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_42436be5-b6b3-42f6-822d-d39d9c15ce1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d8d73b07-bf54-4a79-9edc-a1d176f21a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_42436be5-b6b3-42f6-822d-d39d9c15ce1c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d8d73b07-bf54-4a79-9edc-a1d176f21a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_ac2d13b9-f926-449e-9868-c3d299d8e235" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d8d73b07-bf54-4a79-9edc-a1d176f21a7e" xlink:to="loc_us-gaap_RestrictedStockMember_ac2d13b9-f926-449e-9868-c3d299d8e235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d035ce6a-b69e-42fe-ad87-79fa226e5327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d8d73b07-bf54-4a79-9edc-a1d176f21a7e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d035ce6a-b69e-42fe-ad87-79fa226e5327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4e5852cc-354c-4247-9a84-843029241dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5ffd8309-4dcf-4842-aa68-acc10d6e1f62" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4e5852cc-354c-4247-9a84-843029241dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7e3f3236-eeac-4446-84ff-5beb9e38e5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4e5852cc-354c-4247-9a84-843029241dd2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7e3f3236-eeac-4446-84ff-5beb9e38e5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_b3cd604e-4231-4c33-a1d2-f25676e19e37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4e5852cc-354c-4247-9a84-843029241dd2" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_b3cd604e-4231-4c33-a1d2-f25676e19e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_301d8948-0bbc-4cbb-8bab-773947d145a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_b3cd604e-4231-4c33-a1d2-f25676e19e37" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_301d8948-0bbc-4cbb-8bab-773947d145a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0b37a8e9-8251-43f6-a849-dfc78125ec3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_b3cd604e-4231-4c33-a1d2-f25676e19e37" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0b37a8e9-8251-43f6-a849-dfc78125ec3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5fb1090b-1c92-42ba-96a9-81556c0e408a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4e5852cc-354c-4247-9a84-843029241dd2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5fb1090b-1c92-42ba-96a9-81556c0e408a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SegmentInformation" xlink:type="simple" xlink:href="lgnd-20220630.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3d666ae2-82a8-49ef-8955-0ad4c0163322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_514da050-5ce8-4d95-9e26-d0c615d99e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3d666ae2-82a8-49ef-8955-0ad4c0163322" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_514da050-5ce8-4d95-9e26-d0c615d99e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="lgnd-20220630.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3bc2b4bc-f4b5-4463-a81a-068ec180f070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_3fc88178-919d-44f8-b0fd-7b3e677615af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3bc2b4bc-f4b5-4463-a81a-068ec180f070" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_3fc88178-919d-44f8-b0fd-7b3e677615af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#SegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_99e87522-f43a-484f-80b2-be8c98e9c55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_397271c7-4e1d-4440-8194-f8019a1657cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_99e87522-f43a-484f-80b2-be8c98e9c55b" xlink:to="loc_us-gaap_NumberOfReportableSegments_397271c7-4e1d-4440-8194-f8019a1657cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_5611f262-1ec0-468d-92b5-f2de7a5c0dab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_99e87522-f43a-484f-80b2-be8c98e9c55b" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_5611f262-1ec0-468d-92b5-f2de7a5c0dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6d0e5717-100d-4426-9b1e-bda59c7754d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_5611f262-1ec0-468d-92b5-f2de7a5c0dab" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6d0e5717-100d-4426-9b1e-bda59c7754d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0d9a2ff3-4956-4d0f-ac73-1206534031fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6d0e5717-100d-4426-9b1e-bda59c7754d3" xlink:to="loc_us-gaap_SegmentDomain_0d9a2ff3-4956-4d0f-ac73-1206534031fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbTechnologiesSegmentMember_f1c0d3e7-d005-434b-bb87-59653333bfe7" xlink:href="lgnd-20220630.xsd#lgnd_OmniAbTechnologiesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d9a2ff3-4956-4d0f-ac73-1206534031fc" xlink:to="loc_lgnd_OmniAbTechnologiesSegmentMember_f1c0d3e7-d005-434b-bb87-59653333bfe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessSegmentMember_dda9b64e-6316-4021-ba3e-023c57f0b42b" xlink:href="lgnd-20220630.xsd#lgnd_LigandCoreBusinessSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d9a2ff3-4956-4d0f-ac73-1206534031fc" xlink:to="loc_lgnd_LigandCoreBusinessSegmentMember_dda9b64e-6316-4021-ba3e-023c57f0b42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_de6627db-9975-409a-bae5-43fce136b506" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_5611f262-1ec0-468d-92b5-f2de7a5c0dab" xlink:to="loc_srt_ProductOrServiceAxis_de6627db-9975-409a-bae5-43fce136b506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a559dbca-7cc4-4fa1-9340-7f75c0e605a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_de6627db-9975-409a-bae5-43fce136b506" xlink:to="loc_srt_ProductsAndServicesDomain_a559dbca-7cc4-4fa1-9340-7f75c0e605a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_829e72e4-2f3f-4578-9962-10c006497bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a559dbca-7cc4-4fa1-9340-7f75c0e605a9" xlink:to="loc_us-gaap_RoyaltyMember_829e72e4-2f3f-4578-9962-10c006497bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember_afdcc68f-160b-475b-b9b4-19f90422eb26" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a559dbca-7cc4-4fa1-9340-7f75c0e605a9" xlink:to="loc_lgnd_MaterialSalesCaptisolCoreMember_afdcc68f-160b-475b-b9b4-19f90422eb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember_1d6a1f54-f5db-4886-992b-a6cce4f97b0e" xlink:href="lgnd-20220630.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a559dbca-7cc4-4fa1-9340-7f75c0e605a9" xlink:to="loc_lgnd_MaterialSalesCaptisolCOVIDMember_1d6a1f54-f5db-4886-992b-a6cce4f97b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_96758604-d60d-40f5-9996-74eabbcd346e" xlink:href="lgnd-20220630.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a559dbca-7cc4-4fa1-9340-7f75c0e605a9" xlink:to="loc_lgnd_ContractRevenueMember_96758604-d60d-40f5-9996-74eabbcd346e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_bee8c65b-8075-4864-a328-05bab21484c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_5611f262-1ec0-468d-92b5-f2de7a5c0dab" xlink:to="loc_srt_ConsolidationItemsAxis_bee8c65b-8075-4864-a328-05bab21484c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a5a726c4-1452-4dd8-8d81-120244d00450" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_bee8c65b-8075-4864-a328-05bab21484c8" xlink:to="loc_srt_ConsolidationItemsDomain_a5a726c4-1452-4dd8-8d81-120244d00450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_cd14e725-6ec6-4538-aa36-6f44419dab26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a5a726c4-1452-4dd8-8d81-120244d00450" xlink:to="loc_us-gaap_OperatingSegmentsMember_cd14e725-6ec6-4538-aa36-6f44419dab26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_313cd700-9004-4ba4-b43b-b70628c095a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a5a726c4-1452-4dd8-8d81-120244d00450" xlink:to="loc_us-gaap_CorporateNonSegmentMember_313cd700-9004-4ba4-b43b-b70628c095a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_1802a2de-035c-4eb1-800d-846ece044d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_5611f262-1ec0-468d-92b5-f2de7a5c0dab" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_1802a2de-035c-4eb1-800d-846ece044d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dcb09a9c-0721-4bf7-9519-1287646c4add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_1802a2de-035c-4eb1-800d-846ece044d01" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_dcb09a9c-0721-4bf7-9519-1287646c4add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2b9225e7-96f4-481c-9dfe-702e73caf396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_1802a2de-035c-4eb1-800d-846ece044d01" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2b9225e7-96f4-481c-9dfe-702e73caf396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5b4d2658-de5f-495a-94f7-71d3326402cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_1802a2de-035c-4eb1-800d-846ece044d01" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5b4d2658-de5f-495a-94f7-71d3326402cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_48543487-e92e-4f33-8598-1163538f0dac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_1802a2de-035c-4eb1-800d-846ece044d01" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_48543487-e92e-4f33-8598-1163538f0dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_e87f26e5-cdea-434f-b456-e1af5f348b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_1802a2de-035c-4eb1-800d-846ece044d01" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_e87f26e5-cdea-434f-b456-e1af5f348b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e9b85ec1-c1b8-4053-9a33-33cfec803554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_1802a2de-035c-4eb1-800d-846ece044d01" xlink:to="loc_us-gaap_OperatingIncomeLoss_e9b85ec1-c1b8-4053-9a33-33cfec803554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="lgnd-20220630.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_fb97fe5c-de47-4129-963f-30fafd8b8c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_ad374b82-0069-40b8-b562-bb36835d9191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fb97fe5c-de47-4129-963f-30fafd8b8c48" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_ad374b82-0069-40b8-b562-bb36835d9191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="lgnd-20220630.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ea5fffff-84e8-483a-9712-6199fcfcae8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_9b6a7e7c-d6da-4f1c-aecf-a82c24266972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ea5fffff-84e8-483a-9712-6199fcfcae8b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_9b6a7e7c-d6da-4f1c-aecf-a82c24266972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_667b7669-1020-477c-9db4-fcb177abef9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ea5fffff-84e8-483a-9712-6199fcfcae8b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_667b7669-1020-477c-9db4-fcb177abef9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1c71adc4-6122-4ddc-af66-a21cf7b435e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1c71adc4-6122-4ddc-af66-a21cf7b435e6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_116ca917-8374-425d-ac15-bbd4b9cb60c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_116ca917-8374-425d-ac15-bbd4b9cb60c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9456e7db-516a-4bac-a508-78f61f81f813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_116ca917-8374-425d-ac15-bbd4b9cb60c3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9456e7db-516a-4bac-a508-78f61f81f813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d98b4797-742f-4575-9d0a-9b717cc4c44c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_9456e7db-516a-4bac-a508-78f61f81f813" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d98b4797-742f-4575-9d0a-9b717cc4c44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1a440484-80d2-4d36-9d32-906ec45cc113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1a440484-80d2-4d36-9d32-906ec45cc113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7e94f1a-9974-4d72-aa08-eb6e542c2026" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1a440484-80d2-4d36-9d32-906ec45cc113" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7e94f1a-9974-4d72-aa08-eb6e542c2026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_dbaffd7c-a8d6-4590-9dce-12d87b045de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7e94f1a-9974-4d72-aa08-eb6e542c2026" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_dbaffd7c-a8d6-4590-9dce-12d87b045de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5a97d126-8e84-41ce-86f2-dacbc401442d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7e94f1a-9974-4d72-aa08-eb6e542c2026" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5a97d126-8e84-41ce-86f2-dacbc401442d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_55177585-c3cd-477a-a4de-4d9d2ec1ccaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7e94f1a-9974-4d72-aa08-eb6e542c2026" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_55177585-c3cd-477a-a4de-4d9d2ec1ccaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b2b6c664-3b71-4311-bf90-b336adc6df55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b2b6c664-3b71-4311-bf90-b336adc6df55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7b7e4f6b-88b5-483c-8eba-e727889bcc93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b2b6c664-3b71-4311-bf90-b336adc6df55" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7b7e4f6b-88b5-483c-8eba-e727889bcc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_9e20478e-d983-4e42-9e44-9ac0a78e231b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7b7e4f6b-88b5-483c-8eba-e727889bcc93" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_9e20478e-d983-4e42-9e44-9ac0a78e231b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_c8e13f1b-61bb-4c2f-8f41-881b75795d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7b7e4f6b-88b5-483c-8eba-e727889bcc93" xlink:to="loc_us-gaap_EquitySecuritiesMember_c8e13f1b-61bb-4c2f-8f41-881b75795d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_760722d2-a72f-4279-8006-cab79830ab8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_760722d2-a72f-4279-8006-cab79830ab8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8c4cb627-1881-41a2-b7f8-3e60f2524c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_760722d2-a72f-4279-8006-cab79830ab8b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8c4cb627-1881-41a2-b7f8-3e60f2524c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_91991b91-c8c6-4b3d-a5ef-0c15f03fbb68" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8c4cb627-1881-41a2-b7f8-3e60f2524c31" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_91991b91-c8c6-4b3d-a5ef-0c15f03fbb68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_2b02fe01-adad-4579-9b43-2a186e2149ea" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8c4cb627-1881-41a2-b7f8-3e60f2524c31" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_2b02fe01-adad-4579-9b43-2a186e2149ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_4764ab9d-ffc3-41d5-9cbc-cff5d2ebc2db" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8c4cb627-1881-41a2-b7f8-3e60f2524c31" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_4764ab9d-ffc3-41d5-9cbc-cff5d2ebc2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_14456880-a58f-4310-9c6f-98bda95ecaa9" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForContingentValueRightsCompanyXCellaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8c4cb627-1881-41a2-b7f8-3e60f2524c31" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_14456880-a58f-4310-9c6f-98bda95ecaa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_c3d8e48d-9184-43a5-87c6-b36ad5c38d76" xlink:href="lgnd-20220630.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8c4cb627-1881-41a2-b7f8-3e60f2524c31" xlink:to="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_c3d8e48d-9184-43a5-87c6-b36ad5c38d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1fb5d2fb-a892-422b-9afc-26df5129808e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1fb5d2fb-a892-422b-9afc-26df5129808e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42dfe8b4-090a-4257-9157-9b4d29ffc7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1fb5d2fb-a892-422b-9afc-26df5129808e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42dfe8b4-090a-4257-9157-9b4d29ffc7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember_2b44d0df-3dc0-497b-8ad6-a6356678fe63" xlink:href="lgnd-20220630.xsd#lgnd_MetabasisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42dfe8b4-090a-4257-9157-9b4d29ffc7f1" xlink:to="loc_lgnd_MetabasisMember_2b44d0df-3dc0-497b-8ad6-a6356678fe63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember_ed801a6e-d0be-453e-98cb-096972122329" xlink:href="lgnd-20220630.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42dfe8b4-090a-4257-9157-9b4d29ffc7f1" xlink:to="loc_lgnd_XCellaBiosciencesIncMember_ed801a6e-d0be-453e-98cb-096972122329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5efff677-5e6b-4115-8d8a-9fea15b47bc7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_srt_RangeAxis_5efff677-5e6b-4115-8d8a-9fea15b47bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_73942026-b38c-4925-b2d0-2826ed2ecbc5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5efff677-5e6b-4115-8d8a-9fea15b47bc7" xlink:to="loc_srt_RangeMember_73942026-b38c-4925-b2d0-2826ed2ecbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f572c482-5fbc-4f3d-8970-c83fb301a500" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_73942026-b38c-4925-b2d0-2826ed2ecbc5" xlink:to="loc_srt_MaximumMember_f572c482-5fbc-4f3d-8970-c83fb301a500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_408c3725-e238-4104-a3aa-c8fe9732d55f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_408c3725-e238-4104-a3aa-c8fe9732d55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_350f30a9-7136-4942-ba73-c3ee4827ab67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_408c3725-e238-4104-a3aa-c8fe9732d55f" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_350f30a9-7136-4942-ba73-c3ee4827ab67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_9583a008-641d-4618-93d8-cbcdc1e048d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_350f30a9-7136-4942-ba73-c3ee4827ab67" xlink:to="loc_us-gaap_TransferredOverTimeMember_9583a008-641d-4618-93d8-cbcdc1e048d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e1e5cc72-0eca-46bb-b03c-9a3a6dd07fe1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_srt_ProductOrServiceAxis_e1e5cc72-0eca-46bb-b03c-9a3a6dd07fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4922cfb9-39ec-4ea9-ae0b-d2a955d2909d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e1e5cc72-0eca-46bb-b03c-9a3a6dd07fe1" xlink:to="loc_srt_ProductsAndServicesDomain_4922cfb9-39ec-4ea9-ae0b-d2a955d2909d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_ca1537d7-5225-41f1-a528-91fb7903b760" xlink:href="lgnd-20220630.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4922cfb9-39ec-4ea9-ae0b-d2a955d2909d" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_ca1537d7-5225-41f1-a528-91fb7903b760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_5eef9561-6fa2-489f-afc5-3108d23eb99d" xlink:href="lgnd-20220630.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4922cfb9-39ec-4ea9-ae0b-d2a955d2909d" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_5eef9561-6fa2-489f-afc5-3108d23eb99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_0ca78fc1-373a-46d4-90a6-9350ab301835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_0ca78fc1-373a-46d4-90a6-9350ab301835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_a18e71e3-6dee-4cac-9c75-d47364e7582b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_0ca78fc1-373a-46d4-90a6-9350ab301835" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_a18e71e3-6dee-4cac-9c75-d47364e7582b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_a33aef83-7d5e-476e-8a91-050ca70e9711" xlink:href="lgnd-20220630.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_a18e71e3-6dee-4cac-9c75-d47364e7582b" xlink:to="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_a33aef83-7d5e-476e-8a91-050ca70e9711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_bdb3ca80-9594-41e3-9cc8-f93d8d23d9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_FinancialInstrumentAxis_bdb3ca80-9594-41e3-9cc8-f93d8d23d9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_55d8a3c8-cbad-46e8-9691-5e983764ea48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_bdb3ca80-9594-41e3-9cc8-f93d8d23d9bd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_55d8a3c8-cbad-46e8-9691-5e983764ea48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_719a74e0-691e-4b29-8211-d0ff34c6160d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_55d8a3c8-cbad-46e8-9691-5e983764ea48" xlink:to="loc_us-gaap_CommonStockMember_719a74e0-691e-4b29-8211-d0ff34c6160d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e559dda2-f8f4-4063-9943-79ac20162162" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b7b1339e-742e-4eef-8303-1608f08d8815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_b7b1339e-742e-4eef-8303-1608f08d8815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_094f2088-0ffb-49c3-958d-d288ebc66507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_094f2088-0ffb-49c3-958d-d288ebc66507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_7f80d72e-5a30-42f8-b455-3842af97230b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_7f80d72e-5a30-42f8-b455-3842af97230b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_a404bfbd-88e5-4786-a23c-1217433b17bc" xlink:href="lgnd-20220630.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_a404bfbd-88e5-4786-a23c-1217433b17bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_be950339-0bba-49c9-94a8-42cf90971cff" xlink:href="lgnd-20220630.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_be950339-0bba-49c9-94a8-42cf90971cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries_4ad85923-3d15-4cb3-b90e-3fc772665c33" xlink:href="lgnd-20220630.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_lgnd_NumberOfContingentValueRightsSeries_4ad85923-3d15-4cb3-b90e-3fc772665c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_40384e72-9159-467a-ab3e-a6679ad7eba9" xlink:href="lgnd-20220630.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_40384e72-9159-467a-ab3e-a6679ad7eba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_e609009c-95dd-4d89-9f59-c90663e78bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_us-gaap_Investments_e609009c-95dd-4d89-9f59-c90663e78bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_3e0eb4ec-b8ef-4452-9532-53fe452f0e61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_3e0eb4ec-b8ef-4452-9532-53fe452f0e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment_abbf64b8-4aeb-41e8-a9a7-c1366f3a4fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_us-gaap_LiabilitiesFairValueAdjustment_abbf64b8-4aeb-41e8-a9a7-c1366f3a4fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_a6c39dc6-7a41-489d-9b73-7c560997e6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_a6c39dc6-7a41-489d-9b73-7c560997e6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_00bdda72-e681-477d-9f4f-befd75ac6ff7" xlink:href="lgnd-20220630.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eebf3679-ecd9-4809-8939-f2b7031a6a2d" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_00bdda72-e681-477d-9f4f-befd75ac6ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ae6f01ba-bab6-4f84-afcf-7a1b338f295c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f8dfa3ac-9d30-4f1b-ac62-908e36d766f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ae6f01ba-bab6-4f84-afcf-7a1b338f295c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f8dfa3ac-9d30-4f1b-ac62-908e36d766f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6f560bd4-0ac6-4c00-ad0e-6c464c345d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f8dfa3ac-9d30-4f1b-ac62-908e36d766f2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6f560bd4-0ac6-4c00-ad0e-6c464c345d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_805716c3-f31e-404d-aa93-48790e700a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6f560bd4-0ac6-4c00-ad0e-6c464c345d63" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_805716c3-f31e-404d-aa93-48790e700a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_728da17e-3454-48da-9ff5-7048a6dbccee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_805716c3-f31e-404d-aa93-48790e700a1c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_728da17e-3454-48da-9ff5-7048a6dbccee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7181e3a2-2bf0-4bc2-bc3a-25e58d37ad49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f8dfa3ac-9d30-4f1b-ac62-908e36d766f2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7181e3a2-2bf0-4bc2-bc3a-25e58d37ad49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_94ca4a40-faff-48af-9e79-122d6034f1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7181e3a2-2bf0-4bc2-bc3a-25e58d37ad49" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_94ca4a40-faff-48af-9e79-122d6034f1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_01225f93-be44-4418-a8dd-97b7a6b4c907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_94ca4a40-faff-48af-9e79-122d6034f1fa" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_01225f93-be44-4418-a8dd-97b7a6b4c907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders_29118fc9-9dd3-405a-80a1-35e89c071a3f" xlink:href="lgnd-20220630.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_94ca4a40-faff-48af-9e79-122d6034f1fa" xlink:to="loc_lgnd_PaymentsToContingentValueRightHolders_29118fc9-9dd3-405a-80a1-35e89c071a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_e0dcac85-17f6-487e-8032-8a10d83a37ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_94ca4a40-faff-48af-9e79-122d6034f1fa" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_e0dcac85-17f6-487e-8032-8a10d83a37ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_7c6eca8e-8648-4000-885d-07a6730ec281" xlink:href="lgnd-20220630.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_94ca4a40-faff-48af-9e79-122d6034f1fa" xlink:to="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_7c6eca8e-8648-4000-885d-07a6730ec281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c2d53257-9c2c-4667-98e5-42d36f4c50a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_94ca4a40-faff-48af-9e79-122d6034f1fa" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c2d53257-9c2c-4667-98e5-42d36f4c50a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c565e31a-5db9-489d-84eb-8d8b2d1026a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_e2fb125b-565f-44a9-b4ea-349c315819f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c565e31a-5db9-489d-84eb-8d8b2d1026a7" xlink:to="loc_us-gaap_NumberOfReportingUnits_e2fb125b-565f-44a9-b4ea-349c315819f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="simple" xlink:href="lgnd-20220630.xsd#ConvertibleSeniorNotes"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_85f444e5-051f-41b2-b7e1-c4a035df29b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_7cc3b561-d7fc-4f83-b4f7-7c9c16a7c0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_85f444e5-051f-41b2-b7e1-c4a035df29b8" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_7cc3b561-d7fc-4f83-b4f7-7c9c16a7c0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="simple" xlink:href="lgnd-20220630.xsd#ConvertibleSeniorNotesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_97c32b5b-7542-4eba-9d54-7c45d282ae87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_76c28801-ec98-4bbf-8caa-86463542e716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_97c32b5b-7542-4eba-9d54-7c45d282ae87" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_76c28801-ec98-4bbf-8caa-86463542e716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5b121e1a-216d-40f8-a4bd-b793294a0b87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ace528c0-df4c-48ff-9927-8260764d8388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5b121e1a-216d-40f8-a4bd-b793294a0b87" xlink:to="loc_us-gaap_DebtInstrumentTable_ace528c0-df4c-48ff-9927-8260764d8388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_57229596-53cc-44ff-87bc-9650affc134d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ace528c0-df4c-48ff-9927-8260764d8388" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_57229596-53cc-44ff-87bc-9650affc134d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6dad42b8-7c04-4fb3-ad6b-a3bcc9a49fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_57229596-53cc-44ff-87bc-9650affc134d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6dad42b8-7c04-4fb3-ad6b-a3bcc9a49fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_d5d20e25-38ac-47fd-995c-a477a47eae8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6dad42b8-7c04-4fb3-ad6b-a3bcc9a49fd0" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_d5d20e25-38ac-47fd-995c-a477a47eae8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a89d1cba-b663-443b-8bf8-6405d93c0a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ace528c0-df4c-48ff-9927-8260764d8388" xlink:to="loc_us-gaap_DebtInstrumentAxis_a89d1cba-b663-443b-8bf8-6405d93c0a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_adfcf34a-c628-48b5-936b-a675fea543b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a89d1cba-b663-443b-8bf8-6405d93c0a2a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_adfcf34a-c628-48b5-936b-a675fea543b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_0cb94870-0000-4310-834a-7cd02406b16f" xlink:href="lgnd-20220630.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_adfcf34a-c628-48b5-936b-a675fea543b9" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_0cb94870-0000-4310-834a-7cd02406b16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_c4b32a69-d20f-4738-b410-322f3f839e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ace528c0-df4c-48ff-9927-8260764d8388" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_c4b32a69-d20f-4738-b410-322f3f839e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fab64d43-f513-4f73-b0d2-5fe14279a62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_c4b32a69-d20f-4738-b410-322f3f839e33" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fab64d43-f513-4f73-b0d2-5fe14279a62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_e436fa13-09ec-4c0e-8072-d995e9362964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fab64d43-f513-4f73-b0d2-5fe14279a62a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_e436fa13-09ec-4c0e-8072-d995e9362964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_03cf4ac8-2507-4095-b4cd-161dc192864b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fab64d43-f513-4f73-b0d2-5fe14279a62a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_03cf4ac8-2507-4095-b4cd-161dc192864b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f606497c-90b5-4727-9f1f-c16cf243d26e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ace528c0-df4c-48ff-9927-8260764d8388" xlink:to="loc_srt_RangeAxis_f606497c-90b5-4727-9f1f-c16cf243d26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_27a70614-b008-4187-a268-40de4128597f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f606497c-90b5-4727-9f1f-c16cf243d26e" xlink:to="loc_srt_RangeMember_27a70614-b008-4187-a268-40de4128597f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_541b24ec-f50d-469d-b367-8513d5a22468" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_27a70614-b008-4187-a268-40de4128597f" xlink:to="loc_srt_MaximumMember_541b24ec-f50d-469d-b367-8513d5a22468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ace528c0-df4c-48ff-9927-8260764d8388" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1774361a-d0c4-4921-ab21-993d611a7f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1774361a-d0c4-4921-ab21-993d611a7f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_49ea02d0-c3e1-4b09-8089-973c98c655ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_49ea02d0-c3e1-4b09-8089-973c98c655ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_80df23cc-ca5a-448d-98c8-5f6473e9eeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_80df23cc-ca5a-448d-98c8-5f6473e9eeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_e522add1-920f-4902-9191-3385f93e41a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_e522add1-920f-4902-9191-3385f93e41a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_d45ad621-325c-4b87-824b-c0d804f5e344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_d45ad621-325c-4b87-824b-c0d804f5e344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_dc6a7ca0-607e-480f-a564-9b41d9e60244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_dc6a7ca0-607e-480f-a564-9b41d9e60244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_af2d680a-a637-4543-ab70-89489ac4440e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_af2d680a-a637-4543-ab70-89489ac4440e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_2549aa0c-58f4-4841-9840-5d7b70c349fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_2549aa0c-58f4-4841-9840-5d7b70c349fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_7b8e18ed-a122-4dc7-b14a-88370f3b265b" xlink:href="lgnd-20220630.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_7b8e18ed-a122-4dc7-b14a-88370f3b265b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_a559f01b-aacb-4240-82c9-15e06389f218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_a559f01b-aacb-4240-82c9-15e06389f218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_e04a0146-c4fe-4d06-a90e-9f6456406e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentTerm_e04a0146-c4fe-4d06-a90e-9f6456406e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a8ca10b2-afa9-45b6-a9e1-9d5c5611461e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a8ca10b2-afa9-45b6-a9e1-9d5c5611461e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_d0e885f1-8bfc-45a7-aec8-e96fc43902ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_InterestExpenseDebt_d0e885f1-8bfc-45a7-aec8-e96fc43902ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_453b95c9-01fe-4f9d-94b9-2ee5a41b4c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_453b95c9-01fe-4f9d-94b9-2ee5a41b4c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_e21cfc92-9bf8-43d2-a7fb-21443f3e6226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_e21cfc92-9bf8-43d2-a7fb-21443f3e6226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_1685eb41-244b-42b5-894d-d3ba5f92940d" xlink:href="lgnd-20220630.xsd#lgnd_DebtInstrumentRepurchasedAmountDuringPeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_1685eb41-244b-42b5-894d-d3ba5f92940d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_ca505be3-b812-4412-8203-7c534fb01559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_ca505be3-b812-4412-8203-7c534fb01559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_3674c719-bed5-40ce-b3a7-57e6aa61eb3f" xlink:href="lgnd-20220630.xsd#lgnd_RepaymentsOfNotesPayableInterestPortion"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_3674c719-bed5-40ce-b3a7-57e6aa61eb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e56c0168-f87d-427e-88ed-8ff26aa0ccca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e56c0168-f87d-427e-88ed-8ff26aa0ccca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c2db8db1-eab6-498f-bafc-77fab1e10b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c2db8db1-eab6-498f-bafc-77fab1e10b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_109c2ff7-35ef-455a-ade9-324eff902575" xlink:href="lgnd-20220630.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_109c2ff7-35ef-455a-ade9-324eff902575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_d396ba72-b9c0-4b16-94e0-032a127a5db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_d396ba72-b9c0-4b16-94e0-032a127a5db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges_44de758f-2009-40e7-aa61-6416b5685653" xlink:href="lgnd-20220630.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_lgnd_PaymentsForConvertibleBondHedges_44de758f-2009-40e7-aa61-6416b5685653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a0b37da5-cb5f-4383-9ece-4bc26c500d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a0b37da5-cb5f-4383-9ece-4bc26c500d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1681ed55-573b-481f-8774-5cf42e57ffce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1681ed55-573b-481f-8774-5cf42e57ffce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_85e07e21-a345-4a70-96c7-b6fd63052207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_85e07e21-a345-4a70-96c7-b6fd63052207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants_2ee9fc1a-9366-4ae7-a429-60c1b010d44f" xlink:href="lgnd-20220630.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_lgnd_PaymentsToUnwindWarrants_2ee9fc1a-9366-4ae7-a429-60c1b010d44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_61ba949e-a06c-4762-be97-b07c4a957b2d" xlink:href="lgnd-20220630.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_61ba949e-a06c-4762-be97-b07c4a957b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_82f89223-a75e-4303-ad67-64e97abb579f" xlink:href="lgnd-20220630.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7736e089-2442-444b-8df5-94b07c64ecd5" xlink:to="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_82f89223-a75e-4303-ad67-64e97abb579f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6730b67b-1899-411b-a27d-8d8930735b60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ccc151fc-3b12-45ab-a421-9b02b025098e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6730b67b-1899-411b-a27d-8d8930735b60" xlink:to="loc_us-gaap_DebtInstrumentTable_ccc151fc-3b12-45ab-a421-9b02b025098e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4630a3cb-414c-4c44-b5eb-9fbdf54c2b14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ccc151fc-3b12-45ab-a421-9b02b025098e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4630a3cb-414c-4c44-b5eb-9fbdf54c2b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2da32bfa-299b-48a0-8778-06626d3280bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4630a3cb-414c-4c44-b5eb-9fbdf54c2b14" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2da32bfa-299b-48a0-8778-06626d3280bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_2f1890fc-2728-4b58-a720-75e92ba3df66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2da32bfa-299b-48a0-8778-06626d3280bc" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_2f1890fc-2728-4b58-a720-75e92ba3df66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6e4c1bd8-7e8f-41c0-b7c2-edb803878d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ccc151fc-3b12-45ab-a421-9b02b025098e" xlink:to="loc_us-gaap_DebtInstrumentAxis_6e4c1bd8-7e8f-41c0-b7c2-edb803878d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c61d8965-acd2-42e7-b567-b729cf281297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6e4c1bd8-7e8f-41c0-b7c2-edb803878d89" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c61d8965-acd2-42e7-b567-b729cf281297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_36de3366-f81d-47a4-8b0a-b8a42b5bf0a3" xlink:href="lgnd-20220630.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c61d8965-acd2-42e7-b567-b729cf281297" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_36de3366-f81d-47a4-8b0a-b8a42b5bf0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_41d4a6e8-2a7e-4539-8397-9c156066c8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ccc151fc-3b12-45ab-a421-9b02b025098e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_41d4a6e8-2a7e-4539-8397-9c156066c8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_ef7d48bb-4232-471a-bf1b-232f12ffa10d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41d4a6e8-2a7e-4539-8397-9c156066c8a5" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_ef7d48bb-4232-471a-bf1b-232f12ffa10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7cb2de0d-7ba4-44c8-9819-60c1eb4f7f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_ef7d48bb-4232-471a-bf1b-232f12ffa10d" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7cb2de0d-7ba4-44c8-9819-60c1eb4f7f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_ff3ee69f-ec39-42b0-8380-3a85b11a604d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_ef7d48bb-4232-471a-bf1b-232f12ffa10d" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_ff3ee69f-ec39-42b0-8380-3a85b11a604d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_f6af0f9d-3437-47c7-be5a-c3615308f688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_ef7d48bb-4232-471a-bf1b-232f12ffa10d" xlink:to="loc_us-gaap_LongTermNotesPayable_f6af0f9d-3437-47c7-be5a-c3615308f688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_4b826e2a-e714-4c51-9f9c-69c89e3ad583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_41d4a6e8-2a7e-4539-8397-9c156066c8a5" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_4b826e2a-e714-4c51-9f9c-69c89e3ad583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTax" xlink:type="simple" xlink:href="lgnd-20220630.xsd#IncomeTax"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTax" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_95327a5c-e8b7-4c01-ad24-b722e8f796a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_e3aaab12-bddb-4fa7-a422-c30032d6c25c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_95327a5c-e8b7-4c01-ad24-b722e8f796a8" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_e3aaab12-bddb-4fa7-a422-c30032d6c25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#IncomeTaxDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_09b0a762-f356-4241-bbbf-36a95e0dd7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_bd8dbe49-4a3b-419e-ab3a-4919e872fa97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_09b0a762-f356-4241-bbbf-36a95e0dd7dd" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_bd8dbe49-4a3b-419e-ab3a-4919e872fa97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_787b6671-71b1-45a8-a3d7-f7e271e8e97f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_bd8dbe49-4a3b-419e-ab3a-4919e872fa97" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_787b6671-71b1-45a8-a3d7-f7e271e8e97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cae37748-68bb-4a45-9459-816f36c2dd8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_787b6671-71b1-45a8-a3d7-f7e271e8e97f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cae37748-68bb-4a45-9459-816f36c2dd8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_c0d8e716-23f9-46cc-b860-a33c2b0451c8" xlink:href="lgnd-20220630.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cae37748-68bb-4a45-9459-816f36c2dd8e" xlink:to="loc_lgnd_PfenexMember_c0d8e716-23f9-46cc-b860-a33c2b0451c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_87827938-5115-48bc-8957-d770d5a851b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_bd8dbe49-4a3b-419e-ab3a-4919e872fa97" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_87827938-5115-48bc-8957-d770d5a851b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cd4299ea-5f3b-4024-9004-a59a0cfabaab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_87827938-5115-48bc-8957-d770d5a851b5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cd4299ea-5f3b-4024-9004-a59a0cfabaab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount_aff6d0b8-0066-47b6-a5ff-9fe3beacd2e1" xlink:href="lgnd-20220630.xsd#lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_87827938-5115-48bc-8957-d770d5a851b5" xlink:to="loc_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount_aff6d0b8-0066-47b6-a5ff-9fe3beacd2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lgnd-20220630.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_96561ded-1daf-4f35-a7c7-081977ce022d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c9f2979f-3501-4d65-a301-d3aa3df62e20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_96561ded-1daf-4f35-a7c7-081977ce022d" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c9f2979f-3501-4d65-a301-d3aa3df62e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="lgnd-20220630.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f4ef2653-34a3-4855-9f1f-ec70c756b8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_790442b7-7914-40e4-be33-212e12b6b255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f4ef2653-34a3-4855-9f1f-ec70c756b8a3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_790442b7-7914-40e4-be33-212e12b6b255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_eeff5eef-a66b-42d4-894b-03c93bc01b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f4ef2653-34a3-4855-9f1f-ec70c756b8a3" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_eeff5eef-a66b-42d4-894b-03c93bc01b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ab97b0f4-f979-491c-9528-2d654376213f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_3a39ca54-cf14-4d66-ba24-6963021a4de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ab97b0f4-f979-491c-9528-2d654376213f" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_3a39ca54-cf14-4d66-ba24-6963021a4de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_741f91ef-9526-4cbb-bf91-68143e7de834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_3a39ca54-cf14-4d66-ba24-6963021a4de8" xlink:to="loc_us-gaap_AwardTypeAxis_741f91ef-9526-4cbb-bf91-68143e7de834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f948a5e-d25b-4c42-8af5-9077104ca12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_741f91ef-9526-4cbb-bf91-68143e7de834" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f948a5e-d25b-4c42-8af5-9077104ca12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9d12585a-0fd0-4964-a16c-9ff926b28749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f948a5e-d25b-4c42-8af5-9077104ca12e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9d12585a-0fd0-4964-a16c-9ff926b28749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e628be11-6281-4480-8ce8-21bb3aae8094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f948a5e-d25b-4c42-8af5-9077104ca12e" xlink:to="loc_us-gaap_RestrictedStockMember_e628be11-6281-4480-8ce8-21bb3aae8094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_3035470a-7510-445a-b38a-ba26dc0069c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_3a39ca54-cf14-4d66-ba24-6963021a4de8" xlink:to="loc_us-gaap_ClassOfStockLineItems_3035470a-7510-445a-b38a-ba26dc0069c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e91a6a04-9bb0-46f0-8cfd-613e8b7fe686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3035470a-7510-445a-b38a-ba26dc0069c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e91a6a04-9bb0-46f0-8cfd-613e8b7fe686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_516cb8c5-d9d8-4926-ae82-62c4a1dd626c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e91a6a04-9bb0-46f0-8cfd-613e8b7fe686" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_516cb8c5-d9d8-4926-ae82-62c4a1dd626c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_17798954-163f-4a56-afbb-3a11b0e9eb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e91a6a04-9bb0-46f0-8cfd-613e8b7fe686" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_17798954-163f-4a56-afbb-3a11b0e9eb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a0d9344d-553a-4a88-b22f-2af59137a0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e91a6a04-9bb0-46f0-8cfd-613e8b7fe686" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a0d9344d-553a-4a88-b22f-2af59137a0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1dfc0f17-69a9-40be-bdae-1031fb956997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e91a6a04-9bb0-46f0-8cfd-613e8b7fe686" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1dfc0f17-69a9-40be-bdae-1031fb956997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6184c3f8-cdef-4e87-a43e-037b2221be82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e91a6a04-9bb0-46f0-8cfd-613e8b7fe686" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6184c3f8-cdef-4e87-a43e-037b2221be82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_171020cf-267a-4305-94d9-63e82d84895c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3035470a-7510-445a-b38a-ba26dc0069c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_171020cf-267a-4305-94d9-63e82d84895c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c4e74a80-5391-495b-9716-a32ead24b992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_171020cf-267a-4305-94d9-63e82d84895c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c4e74a80-5391-495b-9716-a32ead24b992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_47efeb9b-bd08-48e1-b8ef-fd8f619ea1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_171020cf-267a-4305-94d9-63e82d84895c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_47efeb9b-bd08-48e1-b8ef-fd8f619ea1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_fbc2c3ae-b90f-49a3-b82d-b2a1663bd952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_171020cf-267a-4305-94d9-63e82d84895c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_fbc2c3ae-b90f-49a3-b82d-b2a1663bd952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_ad956d49-18d6-4621-8a73-f6ce92f3cbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_171020cf-267a-4305-94d9-63e82d84895c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_ad956d49-18d6-4621-8a73-f6ce92f3cbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11ffd51d-0c8d-4be4-a4da-c10d1f240449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_171020cf-267a-4305-94d9-63e82d84895c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11ffd51d-0c8d-4be4-a4da-c10d1f240449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4d9b64f0-b01d-4291-868f-bee562c3db0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3035470a-7510-445a-b38a-ba26dc0069c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4d9b64f0-b01d-4291-868f-bee562c3db0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb773cf1-ce11-4cf3-a886-34858b159433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4d9b64f0-b01d-4291-868f-bee562c3db0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb773cf1-ce11-4cf3-a886-34858b159433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_79fbbcd5-924e-4682-a242-d95e76a26a55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4d9b64f0-b01d-4291-868f-bee562c3db0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_79fbbcd5-924e-4682-a242-d95e76a26a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_23d44c5b-2642-4be2-8362-13d0a1b449ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4d9b64f0-b01d-4291-868f-bee562c3db0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_23d44c5b-2642-4be2-8362-13d0a1b449ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_639b1bc1-048f-4fe4-a878-0b0a01d00161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4d9b64f0-b01d-4291-868f-bee562c3db0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_639b1bc1-048f-4fe4-a878-0b0a01d00161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_46c2338e-a675-4f89-9324-cc602779ed5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4d9b64f0-b01d-4291-868f-bee562c3db0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_46c2338e-a675-4f89-9324-cc602779ed5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69d67b26-aff3-47c2-afd6-b2c39006eb51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_3035470a-7510-445a-b38a-ba26dc0069c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69d67b26-aff3-47c2-afd6-b2c39006eb51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_66a9f9b4-3b23-4b5c-874b-9e0b1c3d8fac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69d67b26-aff3-47c2-afd6-b2c39006eb51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_66a9f9b4-3b23-4b5c-874b-9e0b1c3d8fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4a15707b-7ec0-4839-8b9d-e3541566f10b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69d67b26-aff3-47c2-afd6-b2c39006eb51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4a15707b-7ec0-4839-8b9d-e3541566f10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_104b43f4-071f-426b-825a-8cca957e9bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69d67b26-aff3-47c2-afd6-b2c39006eb51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_104b43f4-071f-426b-825a-8cca957e9bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a1cf6b29-1191-4848-9fff-ece1dfad8802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69d67b26-aff3-47c2-afd6-b2c39006eb51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a1cf6b29-1191-4848-9fff-ece1dfad8802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4e3042dc-53b8-4bfa-b128-abb68db14446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69d67b26-aff3-47c2-afd6-b2c39006eb51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4e3042dc-53b8-4bfa-b128-abb68db14446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_54af98cc-4821-4f32-9433-23acc732f8d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c0fd749-d953-4eb9-ac80-c2d389a6488a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_54af98cc-4821-4f32-9433-23acc732f8d2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c0fd749-d953-4eb9-ac80-c2d389a6488a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_0eb68a60-c159-4c9b-82fe-81eadfe7c88c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c0fd749-d953-4eb9-ac80-c2d389a6488a" xlink:to="loc_us-gaap_PlanNameAxis_0eb68a60-c159-4c9b-82fe-81eadfe7c88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d1597253-3582-47e6-8bee-fb7b2fb77b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_0eb68a60-c159-4c9b-82fe-81eadfe7c88c" xlink:to="loc_us-gaap_PlanNameDomain_d1597253-3582-47e6-8bee-fb7b2fb77b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember_eca8218b-f4fa-462c-9335-a5a9cd33348e" xlink:href="lgnd-20220630.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d1597253-3582-47e6-8bee-fb7b2fb77b89" xlink:to="loc_lgnd_EmployeeStockPurchasePlanMember_eca8218b-f4fa-462c-9335-a5a9cd33348e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c0fd749-d953-4eb9-ac80-c2d389a6488a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_77e1d17c-16b1-44bd-b91d-51db721c2e51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_77e1d17c-16b1-44bd-b91d-51db721c2e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5ba25655-ee36-484d-8815-c73926388040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5ba25655-ee36-484d-8815-c73926388040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_abf506eb-a99e-469e-8c5c-ae2e17bc9ff9" xlink:href="lgnd-20220630.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_abf506eb-a99e-469e-8c5c-ae2e17bc9ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_f4b02bf2-d26c-4340-b655-5ab6de69998e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_abf506eb-a99e-469e-8c5c-ae2e17bc9ff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_f4b02bf2-d26c-4340-b655-5ab6de69998e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_16da9551-4ba5-41fa-95c0-510c40d6959b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_abf506eb-a99e-469e-8c5c-ae2e17bc9ff9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_16da9551-4ba5-41fa-95c0-510c40d6959b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_255a5c47-30dd-4d7f-bfc9-61f2f0549ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_255a5c47-30dd-4d7f-bfc9-61f2f0549ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_c477b86d-d542-41d2-9132-eb79771273a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_c477b86d-d542-41d2-9132-eb79771273a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_b1067196-7751-4746-a401-2871cc71ede0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_b1067196-7751-4746-a401-2871cc71ede0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_23c3e710-d1b9-4f62-85bb-6d5431956704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b7d379b-ab47-4d72-acd8-2295241fe2b9" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_23c3e710-d1b9-4f62-85bb-6d5431956704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="simple" xlink:href="lgnd-20220630.xsd#CommitmentandContingenciesLegalProceedings"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b1548cad-f695-4b5b-95ab-41eaf0d410d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6e890301-8c3d-4068-b973-6cbf1f8b54dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b1548cad-f695-4b5b-95ab-41eaf0d410d4" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6e890301-8c3d-4068-b973-6cbf1f8b54dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#CommitmentandContingenciesLegalProceedingsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0eaca01d-cbe2-40f0-bc71-1df14222be7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_09383624-3186-4338-87ed-e6d7194450d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0eaca01d-cbe2-40f0-bc71-1df14222be7a" xlink:to="loc_us-gaap_LossContingenciesTable_09383624-3186-4338-87ed-e6d7194450d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_bf71c462-a3f0-4cc4-a109-1aae52bc8f50" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_09383624-3186-4338-87ed-e6d7194450d3" xlink:to="loc_srt_LitigationCaseAxis_bf71c462-a3f0-4cc4-a109-1aae52bc8f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d76e3e10-6be3-49b3-9f25-f4611cf8b8df" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_bf71c462-a3f0-4cc4-a109-1aae52bc8f50" xlink:to="loc_srt_LitigationCaseTypeDomain_d76e3e10-6be3-49b3-9f25-f4611cf8b8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_5aea71e8-5a63-4970-acaa-4ff3a3e5e478" xlink:href="lgnd-20220630.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_d76e3e10-6be3-49b3-9f25-f4611cf8b8df" xlink:to="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_5aea71e8-5a63-4970-acaa-4ff3a3e5e478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_4d7b8b31-fbf6-47b1-b416-bab4506e775d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_09383624-3186-4338-87ed-e6d7194450d3" xlink:to="loc_us-gaap_LossContingenciesLineItems_4d7b8b31-fbf6-47b1-b416-bab4506e775d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_0164ba37-cf42-46d6-aab7-b7f89081610f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_4d7b8b31-fbf6-47b1-b416-bab4506e775d" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_0164ba37-cf42-46d6-aab7-b7f89081610f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/Leases" xlink:type="simple" xlink:href="lgnd-20220630.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_44680fc6-6e28-4411-8403-3092721efa7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_426cc91b-193a-4c01-98bd-6ae91ad49fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_44680fc6-6e28-4411-8403-3092721efa7a" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_426cc91b-193a-4c01-98bd-6ae91ad49fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_48d222a0-6ea8-4f52-9599-7dd94b7e7250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_44680fc6-6e28-4411-8403-3092721efa7a" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_48d222a0-6ea8-4f52-9599-7dd94b7e7250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesTables" xlink:type="simple" xlink:href="lgnd-20220630.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_621e2947-eddd-4d25-ae7b-9b0749b972bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_5cf6710d-0e45-4dc0-ac86-b0ff3631926f" xlink:href="lgnd-20220630.xsd#lgnd_AssetsAndLiabilitiesLeasesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_621e2947-eddd-4d25-ae7b-9b0749b972bc" xlink:to="loc_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_5cf6710d-0e45-4dc0-ac86-b0ff3631926f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_22c4b910-3e63-482c-8154-027175c00415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_621e2947-eddd-4d25-ae7b-9b0749b972bc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_22c4b910-3e63-482c-8154-027175c00415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_efc6a547-b989-4ef5-a9e9-7bada431b69a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_48342433-e7ce-4736-bede-3b75fabaea03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_efc6a547-b989-4ef5-a9e9-7bada431b69a" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_48342433-e7ce-4736-bede-3b75fabaea03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a7e521f1-3254-4acb-a346-009ebc7ea563" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_48342433-e7ce-4736-bede-3b75fabaea03" xlink:to="loc_srt_RangeAxis_a7e521f1-3254-4acb-a346-009ebc7ea563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ec680807-1472-4734-8bd1-e48422a125a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a7e521f1-3254-4acb-a346-009ebc7ea563" xlink:to="loc_srt_RangeMember_ec680807-1472-4734-8bd1-e48422a125a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_62b6d410-d339-4b98-952e-6b2738daa410" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ec680807-1472-4734-8bd1-e48422a125a5" xlink:to="loc_srt_MaximumMember_62b6d410-d339-4b98-952e-6b2738daa410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_4c60a555-ef32-4741-aa80-5c018d3ce588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_48342433-e7ce-4736-bede-3b75fabaea03" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_4c60a555-ef32-4741-aa80-5c018d3ce588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_56d6ad3e-6b28-4c85-88e8-65090af764e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4c60a555-ef32-4741-aa80-5c018d3ce588" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_56d6ad3e-6b28-4c85-88e8-65090af764e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_31ea2ca6-8476-46a0-84a8-c59b8d57181c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4c60a555-ef32-4741-aa80-5c018d3ce588" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_31ea2ca6-8476-46a0-84a8-c59b8d57181c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d8522a36-714a-4a28-9452-95c9d8e8d34e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4757542a-a3c8-48bf-a4ea-7576452d699d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8522a36-714a-4a28-9452-95c9d8e8d34e" xlink:to="loc_us-gaap_AssetsAbstract_4757542a-a3c8-48bf-a4ea-7576452d699d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_043b9cb5-0a13-47b3-80e0-20a97b5c4166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4757542a-a3c8-48bf-a4ea-7576452d699d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_043b9cb5-0a13-47b3-80e0-20a97b5c4166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_379f1121-422a-44f8-8c2c-5f90ae88f98d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4757542a-a3c8-48bf-a4ea-7576452d699d" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_379f1121-422a-44f8-8c2c-5f90ae88f98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseRightOfUseAsset_880e66f5-aabe-4d57-8dc4-87beb66d5dbd" xlink:href="lgnd-20220630.xsd#lgnd_LeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4757542a-a3c8-48bf-a4ea-7576452d699d" xlink:to="loc_lgnd_LeaseRightOfUseAsset_880e66f5-aabe-4d57-8dc4-87beb66d5dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_0a88379c-9f03-451f-b253-917d12cc3bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8522a36-714a-4a28-9452-95c9d8e8d34e" xlink:to="loc_us-gaap_LiabilitiesAbstract_0a88379c-9f03-451f-b253-917d12cc3bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_741d2253-0f12-4399-929a-828bf4d0f88a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a88379c-9f03-451f-b253-917d12cc3bb6" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_741d2253-0f12-4399-929a-828bf4d0f88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b3a0ef9e-c0d4-4cf1-99ea-e2e59da16689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_741d2253-0f12-4399-929a-828bf4d0f88a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b3a0ef9e-c0d4-4cf1-99ea-e2e59da16689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_a2f730ae-e20b-4237-9683-b9ca2bb620ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_741d2253-0f12-4399-929a-828bf4d0f88a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_a2f730ae-e20b-4237-9683-b9ca2bb620ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent_c63fc2e2-f2dd-4ab4-a978-61e3a2eb46d0" xlink:href="lgnd-20220630.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_741d2253-0f12-4399-929a-828bf4d0f88a" xlink:to="loc_lgnd_LeaseLiabilityCurrent_c63fc2e2-f2dd-4ab4-a978-61e3a2eb46d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_1385fcd3-52d5-481d-be74-e5edb27065b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a88379c-9f03-451f-b253-917d12cc3bb6" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_1385fcd3-52d5-481d-be74-e5edb27065b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9399e1b6-1a1e-4b8e-992c-2e420147105e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_1385fcd3-52d5-481d-be74-e5edb27065b1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9399e1b6-1a1e-4b8e-992c-2e420147105e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c6253c80-1c0f-44d4-a36d-c2ee2de7f238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_1385fcd3-52d5-481d-be74-e5edb27065b1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c6253c80-1c0f-44d4-a36d-c2ee2de7f238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiability_779e1068-0df3-4f7a-9f44-d0d6fe96fe12" xlink:href="lgnd-20220630.xsd#lgnd_LeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8522a36-714a-4a28-9452-95c9d8e8d34e" xlink:to="loc_lgnd_LeaseLiability_779e1068-0df3-4f7a-9f44-d0d6fe96fe12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220630.xsd#LeasesMaturityofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_02f2ec2c-8335-4800-a62e-e91b8399cb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9c981050-cb19-4f73-ae1c-cdef69504f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_02f2ec2c-8335-4800-a62e-e91b8399cb6e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9c981050-cb19-4f73-ae1c-cdef69504f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_46bea1c9-b6c8-4722-8efb-25a15e189f59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_02f2ec2c-8335-4800-a62e-e91b8399cb6e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_46bea1c9-b6c8-4722-8efb-25a15e189f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_341e9f1b-8604-49e6-83d2-6a6946c7d9a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_02f2ec2c-8335-4800-a62e-e91b8399cb6e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_341e9f1b-8604-49e6-83d2-6a6946c7d9a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c994a62d-c299-4a69-9cea-44851aaf4faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_02f2ec2c-8335-4800-a62e-e91b8399cb6e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c994a62d-c299-4a69-9cea-44851aaf4faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e37a6686-6d79-4b77-8978-2f8df55edd8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_02f2ec2c-8335-4800-a62e-e91b8399cb6e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e37a6686-6d79-4b77-8978-2f8df55edd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_a0b3ac88-6445-45cf-bf8d-7701d1aefcba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_02f2ec2c-8335-4800-a62e-e91b8399cb6e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_a0b3ac88-6445-45cf-bf8d-7701d1aefcba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_f2da0153-f090-41ee-af43-53c99a8e54fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_02f2ec2c-8335-4800-a62e-e91b8399cb6e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_f2da0153-f090-41ee-af43-53c99a8e54fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_884b1ea4-cbd5-4c6f-8d0e-92b2beb30dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_02f2ec2c-8335-4800-a62e-e91b8399cb6e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_884b1ea4-cbd5-4c6f-8d0e-92b2beb30dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance_5ad1b069-e399-4442-b474-cbc5a4aa6d37" xlink:href="lgnd-20220630.xsd#lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_02f2ec2c-8335-4800-a62e-e91b8399cb6e" xlink:to="loc_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance_5ad1b069-e399-4442-b474-cbc5a4aa6d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_640e1762-2952-450f-be19-66c04d8a208b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_02f2ec2c-8335-4800-a62e-e91b8399cb6e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_640e1762-2952-450f-be19-66c04d8a208b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0a8be582-df49-4ed0-8a89-7fb7a3443dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_02f2ec2c-8335-4800-a62e-e91b8399cb6e" xlink:to="loc_us-gaap_OperatingLeaseLiability_0a8be582-df49-4ed0-8a89-7fb7a3443dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lgnd-20220630.xsd#LeasesMaturityofOperatingLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>lgnd-20220630_g1.jpg
<TEXT>
begin 644 lgnd-20220630_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!817AI9@  34T *@    @ ! $Q  (
M   1    /E$0  $    ! 0   %$1  0    !   N(U$2  0    !   N(P
M  !!9&]B92!);6%G95)E861Y  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" (+!<8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\IP<88*1\RY%?E!^TU\ /%G_  3Z_:3BM;74;J":PE74O#^M0#RS<Q;CM?N
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MIKEW/?W/A359-+M[B9R\CV_E1RQJS'DE2[*,]%"CM7UM7PQ_P09_Y-T\8_\
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M(UST 29R /0"OV;HI\P'YL? K_@@]?2WD5U\1_%UM#;J06T_05:1Y!GH9Y5
M7W C;KP1BOO[X/\ P4\+? /P7!X?\(Z+9Z)I<'/EP*2\S="\CG+2.?[S$G@<
M\5U-%%P"BBBD!_./1116@!1110 4444 ?JC_ ,$&?^3=/&/_ &,9_P#26&ON
M>OAC_@@S_P FZ>,?^QC/_I+#7W/4/< HHHI %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !6#XW^*/AKX:VPF\0Z_HVAQL-RF^O(X-X_V0Q!/X5\?_P#!0/\ X**Z
MCX*\37G@7P#="UO;%C#JVK( SPR=X(>H#+T9^H;(&"":^#]:UR]\2:I-?:C>
M75_>W#;Y;BYE:664^K,Q))^IK\CXH\5\+EV(E@\#3]K.+LVW:*?9;MVZ[+S9
M^Q<*>$6*S+#QQF/J>RA)722O)KHWLHWZ;OR1^KVN?\%'?@QH3LC^-(;B11D+
M;6%U,&^C+&5_6LK_ (>C?!K_ *&"_P#_  57/_Q%?E917P,_&7.F[QITDO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "OYQZ_HXK^<>JB 44450!1110 5^WG_!+S_DPOX=?]><
M_P#Z5S5^(=?MY_P2\_Y,+^'7_7G/_P"E<U*0'OE%%%0 4444 %%%% !1110
M4444 %%%% !1110!_./1116@!1110 4444 ?JC_P09_Y-T\8_P#8QG_TEAK[
MGKX8_P""#/\ R;IXQ_[&,_\ I+#7W/4/< HHHI %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7\X]?T<5_./51 ****H HHHH *_;S_@EY_P F%_#K
M_KSG_P#2N:OQ#K]O/^"7G_)A?PZ_Z\Y__2N:E(#WRBBBH **** "BBB@ HHH
MH **** "BBB@ HHHH _G'HHHK0 HHHH **** /U1_P""#/\ R;IXQ_[&,_\
MI+#7W/7PQ_P09_Y-T\8_]C&?_26&ON>H>X!1112 **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%<AXH_:"\!>!Y3'K7C?PAH[J<%;W6;>W(/T=Q0!U]%
M>/:A_P % _@IIJJ9/B9X2;?T\J]$OY[,X_&C3_\ @H'\%-25C'\3/"2[.OFW
MHB_+?C/X4 >PT5P.A?M6?"_Q.R+IWQ&\"WLCA2(X==M6?GH"H?(/L1FNVTS5
MK76K19[.YM[N!NDD,@D0]^HX[T 6**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BL_P 0>+=*\)VXFU74]/TR
M$\A[NX2%?S8@5PVL_MC_  E\/LRW?Q-\!Q2*0&C&NVSR+D9&55R1Q[4 >DT5
MXU>_\%#/@E83^7)\2_"S,!G,=SYJ_FH(JSIO[>WP7U98S%\3O!J>:VT>=J4<
M.#G'.\C ]S@4 >N45R_A7XW^"_';JNA^+_"^LL^-HL=5@N"V>F-C&NHH ***
M* "BBB@ HHHH *_G'K^CBOYQZJ(!1115 %%%% !7[>?\$O/^3"_AU_UYS_\
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MGFM;JV<2PS0N4DB<'(96'((/((K]9?\ @F)_P4I3]H[3X/ _C6XA@\<V,/\
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M $U^\?X=N-S?GW<W,E[<R332/+-*Q=W=BS.Q.223R23WIE%6D 4444 %%%%
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M $KFK\0Z_;S_ ()>?\F%_#K_ *\Y_P#TKFI2 ]\HHHJ "BBB@ HHHH ****
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M110 4444 ?SCT445H 4444 %%%% 'ZH_\$&?^3=/&/\ V,9_])8:^YZ^&/\
M@@S_ ,FZ>,?^QC/_ *2PU]SU#W ****0!1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!_/Y^TG_P G%^/O^QCU'_TJDKBJ[7]I/_DX
MOQ]_V,>H_P#I5)7%5H@"BBB@ HHHH _:K_@DG_RCY^'_ /W$?_3E=5]'5\X_
M\$D_^4?/P_\ ^XC_ .G*ZKZ.J& 4444@"BBB@ KX>_X+<?M*M\/?@SIOP^TV
MY,>I^,W\^_"'YH[")@=I[CS)=H]UCD!ZU]PU^&W_  47^.3?'[]K[Q?JT<YG
MTW3KDZ1IN#E!;VY,8*_[+N))/^VAII >(44458!1110 5/INFW&LZC;V=I!-
M=7=W(L,,,2%Y)78@*JJ.222  .I-05^AO_!%/]C.'7;R;XN^(K-98+*5[7PY
M%*N5:5<K+=8[[#E$/][>>"JFAL#W3_@FU_P3:T_]EWP_!XJ\506^H?$#4(0W
MS /'H<;#_51^LI'#R#W5>,E_K>BBLP"BBB@ HHHH **** "BBB@#Y#_X*2_\
M$U=-_:7\/7GB[PC9PV/Q#LX_,98\)'KR*/\ 529( E 'RR=_NMQ@I^1.H6$^
ME7\]K=036UU;2-%-#*A22)U.&5E/(((((/((K^C*OS*_X+5_L:Q^%M;@^+7A
MZT$=GJTRVOB&*-?EBN#Q%<X'028VL>!O"'DN:I,#\_****H HHHH *_6'_@B
M=^TG)\3/@3J'@74KCS-3\#2+]C+M\TEC,6*#GD^7('7T"M&*_)ZOH+_@E_\
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M]I/_ ).+\??]C'J/_I5)7%5H@"BBB@ HHHH **** "BBNK^"_P $_$W[07Q
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M544 ?@-^T3^S'XR_9:\;MH7C#2GLIGRUM=1YDM+] <;X9, ,.F1PPR,@'BN
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MS_Z2PU]SU#W ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!_/Y^TG_R<7X^_[&/4?_2J2N*KM?VD_P#DXOQ]_P!C'J/_ *52
M5Q5:( HHHH **** /VJ_X))_\H^?A_\ ]Q'_ -.5U7T=7SC_ ,$D_P#E'S\/
M_P#N(_\ IRNJ^CJA@%%%%( HHHH X#]JKXHM\%OV;_&WBB.017.CZ/<2VK$X
M'V@H5A'XR,@_&OP&)+$DDDGJ:_7_ /X+7>-SX6_8JETY6&?$NM6=@R[L$JA>
MY)QW&;=?S%?D!51 ****H HHHH W?AC\/K_XK_$70_#.EKOU#7KZ&P@XR%:1
MPNX^PSD^@!K]^_A5\-M,^#OPVT/PMHT0ATS0;..S@&.6"+@LWJS'+$]R2:_*
M?_@BA\)U\=_M=OKMQ%OMO!VES7J,1E1<2X@C!]]KRL/0I7Z\5,F 4445(!11
M10 4444 %%%% !1110 5ROQO^$^G_'3X1>(O"&J*ILM?L9+1F(SY+D920?[2
M.%<>ZBNJHH _G8\7>%KSP/XLU31=1C\G4-'NY;&ZC_N2Q.4<?@RFLZOIG_@K
MI\,Q\./VX?$DL4?E6WB6"WUF$8ZF1-DA_&:*4_C7S-6@!1110 5+87\VEWT-
MU;R-#<6TBRQ2*<%&4Y!'N"*BHH _H4^#OQ B^*_PE\,>)X=HC\0Z5;:B%4\)
MYL2N5^H+$8[8KI*^<?\ @DWXQ;QA^P?X+\Q]\^E_:M/D]A'<R;!_W[,=?1U9
M@%%%% !1110 C*&4@@$'@@]Z^?O'?_!+;X&_$3Q;-K5]X)B@N[J3S9TL;ZXL
MX)F)R28XW55SWV!>OK7T%10!RWPI^"/A'X&:"=,\(>'=*\/V;D&1;. (TQ'1
MG?[SGW8DUU-%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^9O_!=;
M]GB+1?%7AOXF6%N$36A_8^K,HP&GC0M;N?5FB5U^D*5^F5>#?\%-/A<OQ7_8
MD\=6BQA[G2;+^V;<XR4:U83.1[F-9%_X$:: _$"BBBK **** "NG^"?CMOA=
M\8_"GB169#H.KVNH$CN(IE<CW! (([@US%% ']&ZL&4$$$'D$=Z6N+_9O\5'
MQS^SSX$UIFWOJOAZPNW.>=SV\;,#R>02<\GFNTK, HHHH **** /Y_/VD_\
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M110 4444 %%%% !1110 4444 ?S^?M)_\G%^/O\ L8]1_P#2J2N*KM?VD_\
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M HHHH **** -CX?^ -8^*?C73?#N@6$^IZQJ\XM[6VB&6D8_H !DDG@ $D@
MU^UW["7[$VB_L9_"R.QB$%_XIU1%EUK4PO,TF/\ 51D@$0H<A0<9.6(!.!XI
M_P $6?V6-!\'_ RU^*,H%[XD\6_:+>&1UXTVVBN)(3&G^T[1%F;TVJ,8;=]N
MU+8!1114@%%%% !1110 4444 %%%% !1110 4444 ?B'_P %./A(GP>_;6\:
M6<$0AL=7N%UFU &U2MRHD? [ 2F51C^[^%>!U^@7_!?'P(ME\1/A]XF1!NU+
M3KK3)7 Z>1(DB G_ +>'Q]#7Y^U: ****8!1110!]>_\$2O%)T#]M(V>X@:Y
MH-Y9[>S%6BG_ /:)K]>Z_$;_ ();Z\?#O[>GP\GR )KJXM3D$@^;:31=O=Q^
M.#7[<U$MP"BBBD 4444 %?F-_P %Y?BXVI_$7P7X(@F_<Z392:O=(IX:6=O+
MC#>ZK$Y'M+[BOTYK\,O^"BWQ./Q9_;2^(&I+)YEO::FVEV^#E?+M0+<%?9C&
M6_X%3B!XI1115@%%%% !4MC93:E>PVUO&\T]PZQQQH,L[$X  ]2345?2'_!*
M/X*CXS_MH^'#/$)=/\*A]?N@>G[@J(?_ ".\)QZ T ?J_P#LB_ 2V_9H_9W\
M,>#X4C%SIUHKW\BX_?W<GSS/GN-Y('HH4=J])HHK, HHHH **** "BBB@ HH
MHH **** "BBB@ JAXI\+Z=XV\.7VD:O96^HZ7J4+6]U:SH'CGC8896!Z@BK]
M% 'XJ?\ !13]@_4/V./B3]HL$N+SP+KDK'2;Q@6-LV-QM96Z>8H!VG^-1GJ&
M"_.5?T'?&OX,Z!^T!\,M5\)^);07>E:M$8WQ@20..4EC/\+HV&!]1SD9%?SX
MU:8!1113 **** "OV\_X)>?\F%_#K_KSG_\ 2N:OQ#K]O/\ @EY_R87\.O\
MKSG_ /2N:E(#WRBBBH **** "BBB@ HHHH **** "BBB@ HHHH _G'HHHK0
MHHHH **** /U1_X(,_\ )NGC'_L8S_Z2PU]SU\,?\$&?^3=/&/\ V,9_])8:
M^YZA[@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH _G\_:3_ .3B_'W_ &,>H_\ I5)7%5VO[2?_ "<7X^_[&/4?_2J2N*K1
M %%%% !1110!^U7_  23_P"4?/P__P"XC_Z<KJOHZOG'_@DG_P H^?A__P!Q
M'_TY75?1U0P"BBBD 4444 ?FK_P7[M9$\2_#"<J1%);:DBMZLKVQ(_ ,OYU^
M>-?IC_P7W\/FY\$?#75=N5L[Z^M"W/!ECA;'I_RQ/OQ]:_,ZK6P!1113 ***
M* /UQ_X(<W4=Q^QOJ"(P9H/$UVD@_NMY%LV/R8'\:^QZ^ /^"!WC);OX9_$'
MP\9!OT_5+;40A)Z3Q-&2/_ <9Q[9[5]_U#W ****0!1110 4444 %%%% !11
M10 4444 ?FW_ ,%_=8CEU;X6Z>K'S8(=3N'7<.CM:JIQ]8WY_P#KU^==?8__
M  6^^(*^*?VO;71HI"8_#&AV]M(F<A9I6>=C[9CDB_(5\<5:V ****8!1110
M!^JW_!!RSD3]FGQ;<%<12^)GC5LCEEM;<D8Z]&7\Z^XJ^2/^"*7AHZ%^Q+!=
M;0/[:UN]O 0,;L;(,^_^I_2OK>H>X!1112 **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#\&_P!N2TCLOVR/B@D2[5;Q/?R$
M9)^9IW9C^))->5UZS^W=_P GF_$__L9+W_T:U>35H@"BBB@ HHHH _9C_@CO
M_P F&>&/^OR__P#2J2OJ"OE__@CO_P F&>&/^OR__P#2J2OJ"H8!1112 ***
M* /Y_/VD_P#DXOQ]_P!C'J/_ *525Q5=K^TG_P G%^/O^QCU'_TJDKBJT0!1
M110 4444 ?M5_P $D_\ E'S\/_\ N(_^G*ZKZ.KYQ_X))_\ */GX?_\ <1_]
M.5U7T=4, HHHI %%%% !1110 4444 %%%% !1110 4444 ?#G_!>'PT+W]FW
MPGJP0L^G^(UMR0"2B2VTQ)/H,Q*/J17Y55^P_P#P6CT?^T_V'K^;8'_L_5[*
MXSNQLRYCS[_ZS&/?VK\>*N(!1113 **** /5?V&M4_L?]LCX7R[I$W^)K"#*
M'!_>3I'CZ'=@^Q-?O'7X"_LIZA_9'[47PVN]GF?9?%.F2[,XW;;N(XSVZ5^_
M53( HHHJ0"BBB@#)\?>+(? 7@76M=N,?9]%L)[^7)P-L4;.?T6OYY-4U*?6=
M3N+RYD:6YNY6FE=NKNQ)8GZDFOV__P""E7C3_A _V&OB->!]CW6FC3E^;!;[
M3*EN0/7Y93QZ9[5^'-5$ HHHJ@"BBB@ K]-?^""GPM6Q\ ^.O&DL8,FI7T.C
MV[GJJPIYLF/9C/'^,?L:_,JOVR_X)6^ 1X _87\$1LN+C5HIM5F.,;O.F=D/
M_?KRQ^%)@?0U%%%0 4444 %%%% !1110 4444 %%%% !1110 4444 %?SCU_
M1Q7\X]5$ HHHJ@"BBB@ K]O/^"7G_)A?PZ_Z\Y__ $KFK\0Z_;S_ ()>?\F%
M_#K_ *\Y_P#TKFI2 ]\HHHJ "BBB@ HHHH **** "BBB@ HHHH **** /YQZ
M***T **** "BBB@#]4?^"#/_ ";IXQ_[&,_^DL-?<]?#'_!!G_DW3QC_ -C&
M?_26&ON>H>X!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG_TEAK[GJ'N 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@L/%>BVNI:7>VFHZ=>QB:WNK:5989T/1E=20P/J#4- 7****0!1110 4444
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M(Y]V/)JO113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F/\
M@CO_ ,F&>&/^OR__ /2J2OJ"OE__ (([_P#)AGAC_K\O_P#TJDKZ@J& 4444
M@"BBB@#^?S]I/_DXOQ]_V,>H_P#I5)7%5VO[2?\ R<7X^_[&/4?_ $JDKBJT
M0!1110 4444 ?M5_P23_ .4?/P__ .XC_P"G*ZKZ.KYQ_P""2?\ RCY^'_\
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M<=.5-? WQA^./BSX_>+7USQAKM_KNHL"J/</\D"YSLC086-,_P *@"N4HII
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MO_@YM/\ XNC_ (<[_'K_ *%?3?\ P<VG_P 71<#Y?HKZ@_X<[_'K_H5]-_\
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M% 'ZH_\ !!G_ )-T\8_]C&?_ $EAK[GKX8_X(,_\FZ>,?^QC/_I+#7W/4/<
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MA7>Y520BY R?09(&?<4R@ HHHH **** "BBB@ HHHH **** "BBB@ HH +$
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MX[U3XG^-M5\1:W=O>ZMK5T]W=3/U>1R2<#L!T '   ' K(JT@"BBBF 4444
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M"VABMX(AM2.- B(/0 <"I:*0!1110 4444 %%%% !1110!^$'[=W_)YOQ/\
M^QDO?_1K5Y-7K/[=W_)YOQ/_ .QDO?\ T:U>35H@"BBB@ HHHH _9C_@CO\
M\F&>&/\ K\O_ /TJDKZ@KY?_ ."._P#R89X8_P"OR_\ _2J2OJ"H8!1112 *
M*** /Y_/VD_^3B_'W_8QZC_Z525Q5=K^TG_R<7X^_P"QCU'_ -*I*XJM$ 44
M44 %%%% '[5?\$D_^4?/P_\ ^XC_ .G*ZKZ.KYQ_X))_\H^?A_\ ]Q'_ -.5
MU7T=4, HHHI %%%% !1110 4444 %%%% !1110 4444 ?./_  5L_P"4?/Q
M_P"X=_Z<K6OQ5K]JO^"MG_*/GX@?]P[_ -.5K7XJU<0"BBBF 4444 =K^S9_
MR<7X!_[&/3O_ $JCK^@.OY_/V;/^3B_ /_8QZ=_Z51U_0'4R ****D HHHH
M_-7_ (+]Z:8O$OPPO-J!9[;4H0P^\2CVQP?8>8,?4U^>-?IK_P %]=!^T?#W
MX<ZGLR+/4;RUW;,X\V*)L9[9\GIWQ[5^956M@"BBBF 4444 =I^S?K1\-_M$
M> M1!(-AXCT^Y! R1LN8VZ'KTK^@2OYS+"]?3;Z&XB($MO(LB9&1D'(_E7]%
M.AZO%X@T6SOX#F"]@2XC.<Y5U##]#4R M4445(!1110 4444 %%%% !1110
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MHJ "BBB@ HHHH **** "BBB@ HHHH **** /YQZ***T **** "BBB@#]4?\
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M%7P?PUI\N-;OX),KJLZ'(@0CK"C#)/1W QPH+?"-6D 4444P"BBB@ K]O/\
M@EY_R87\.O\ KSG_ /2N:OQ#K]O/^"7G_)A?PZ_Z\Y__ $KFI2 ]\HHHJ "B
MBB@ HHHH **** "BBB@ HHHH **** /YQZ***T **** "BBB@#]4?^"#/_)N
MGC'_ +&,_P#I+#7W/7PQ_P $&?\ DW3QC_V,9_\ 26&ON>H>X!1112 ****
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MW!'_ '[_ -[[OY5W-S)>W,DTTCRS2L7=W8LSL3DDD\DD]ZI(!E%%%4 4444
M%%%% !7[>?\ !+S_ ),+^'7_ %YS_P#I7-7XAU^WG_!+S_DPOX=?]><__I7-
M2D![Y1114 %%%% !1110 4444 %%%% !1110 4444 ?SCT445H 4444 %%%%
M 'ZH_P#!!G_DW3QC_P!C&?\ TEAK[GKX8_X(,_\ )NGC'_L8S_Z2PU]SU#W
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M@_;:_IS0VVL6H6#6=,#Y?3[C![=3&^"4;N,C[RL!Z[68!1110 4444 %%%%
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M:K_@DG_RCY^'_P#W$?\ TY75?1U?./\ P23_ .4?/P__ .XC_P"G*ZKZ.J&
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MDDD)9F8Y+$]23W--HHJ@"BBB@ HHHH **** "OV\_P""7G_)A?PZ_P"O.?\
M]*YJ_$.OV\_X)>?\F%_#K_KSG_\ 2N:E(#WRBBBH **** "BBB@ HHHH ***
M* "BBB@ HHHH _G'HHHK0 HHHH **** /:?V9_V^?B%^R9X4O]%\'W.E0V.I
M7?VV875DL[&38J<$G@84<5Z3_P /I/CA_P __AO_ ,%*?XU\FT4K ?67_#Z3
MXX?\_P#X;_\ !2G^-'_#Z3XX?\__ (;_ /!2G^-?)M%%D!]9?\/I/CA_S_\
MAO\ \%*?XT?\/I/CA_S_ /AO_P %*?XU\FT460'UE_P^D^.'_/\ ^&__  4I
M_C1_P^D^.'_/_P"&_P#P4I_C7R;119 ?67_#Z3XX?\__ (;_ /!2G^-'_#Z3
MXX?\_P#X;_\ !2G^-?)M%%D!]9?\/I/CA_S_ /AO_P %*?XT?\/I/CA_S_\
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MA!)%+$X=)5(R&5AP01W%35^+'[#O_!23Q=^R%JT.FW4EQXB\#ROB?2)I<M:
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M?_*/GX?_ /<1_P#3E=5]'5\X_P#!)/\ Y1\_#_\ [B/_ *<KJOHZH8!1112
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M$UXE10!_0]\.?B'H_P 6? VE^)/#]]%J.C:S;K<VMQ'T=3V(/*L#D%3RI!!
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M\_Y,+^'7_7G/_P"E<U?B'7[>?\$O/^3"_AU_UYS_ /I7-2D![Y1114 %%%%
M!1110 4444 %%%% !1110 4444 ?AK_P4.^ =W^SU^UCXKTR6W>+3-5NY-7T
MN0KA);:=V<!3WV,6C/O&:\1K]XOVL_V//"'[8G@1-'\302PWED6DTW4[;"W6
MGR,!DJ2,,C8&Y#PV!T(5A^8WQY_X(_?%[X1:G.^BZ;%XYT9,F.[TIE$^.P>V
M8^8&]DWC_:JTP/E:BO2'_8W^+L;E3\+/B-E3CCPW>$?GY=)_PQU\7?\ HE?Q
M'_\ ":O?_C=,#SBBO1_^&.OB[_T2OXC_ /A-7O\ \;H_X8Z^+O\ T2OXC_\
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M?%FAZ=KVF2\^3=Q!]C8QN1OO(WHRD$>M-,#^>JBOTI_:,_X(56=^]QJ'PO\
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MG>$_"6E^!/#MII&BZ?9Z5I=A&(K>UM85BAA4=E5>!6C114@9OC+_ )%#5?\
MKSF_] -?SLU_1I=VL=]:RP2J'BF0HZG^)2,$?E7XE_M9?\$Z?B'^S/XTU%8]
M U77O"BRL]EK%A;M<1&#/R^=L!,3@8!# #(.TD8-5$#Y_HH(*D@@@CJ**H H
MHKTCX$_LB_$3]I#58+?PGX6U.^MI7"OJ$D+0V, ]7G8!!CDX!+'!P#0!^J'_
M  1W_P"3#/#'_7Y?_P#I5)7U!7G/[)7P#C_9C_9X\,^"5N$O)M&MV^TW" A9
MYY)&EE9<\[=[L%SSM KT:LV 4444 %%%% '\_G[2?_)Q?C[_ +&/4?\ TJDK
MBJ^V_P#@HG_P3!\=>&?B_P"(O&?@O1[OQ5X:\0WDNIR06$?F7FG2RN7DC,(^
M=TW$E60' X(&,GXOUO0+[PUJ#VFHV5WI]U']Z&YA:*1><<JP!'(/Y5: J444
M4P"B@ L0 "2>@KV3]G[]@CXI?M'ZS;PZ+X6U&RTV5AYFK:E"]K8PKQEM[ ;\
M CY8PS<],<T ?J-_P23_ .4?/P__ .XC_P"G*ZKZ.KB?V<O@C8?LX_!#PYX)
MTZ9[JVT"U\DSL@0W$K,TDLFT?=W2.[8R<9QD]:[:LV 4444 %%%% !1110 4
M444 %%%% !1110 4444 ?./_  5L_P"4?/Q _P"X=_Z<K6OQ5K]__P!I;X'V
M?[2/P*\2^";V=K2'7K7RDG"[OL\J.LD4F.X61$)&1D#&1UK\8?C[^P;\4OV=
M-:N8-;\*:G=Z= Q":MIT#W5A,HZ-YBCY,CG:X5N#QQ51 \>HH(*D@@@CJ**H
M HHJYH7AW4/%.I)9Z98WFHWDGW(+6%II&^BJ"30!U/[-G_)Q?@'_ +&/3O\
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M#P3_ .".U_\ B*U?#WPG\*^$9$?2?#7A_2WCY5K33H8"O.>-JC'(!^HKH**
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M+_X(<^#FU[]KK4=49#Y.A>'[B4/C@222Q1*/Q5I#_P !-)@?K;1114 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^&?^"SG[&LO
MQ1\ P?$SP_:F76_"D!BU:&-,O=6 );S..2T)))_V&8Y^0"ON:FRQ+/&R.JNC
M@JRL,A@>H(H3 _G)HK[5_P""GW_!-.Y^ VKWOC[P19O/X(O93+?642DMH,C'
MGC_GW)/!_@)VGC:3\55H 4444 %%%% !1110!K>#_'FN?#S51?Z!K.K:'?+P
M+C3[N2VE'_ D(/ZU[W\.O^"L_P <_AY%'"?%J:];1=(M7LHKDGZR@+*?Q>OF
MZB@#[V\'_P#!>WQE8J@U_P !^&M3(^\;"ZGL=PR/[_G8XS^?X5Z'H'_!?/PS
M<*G]J?#O7;,G&_[+J45SMXYQN2///T_"OS&HI60'ZO6?_!=[X4O;@W'ACXA1
M2]UCM+.11^)N5_E6JG_!<+X,N@)L_&ZDC.#IL.1[<35^1E%'*@/UKU#_ (+G
M_!ZS91'I'C^[W=3%IUL-OUWW"_I6)J__  7F^'D)?[!X-\:7(!&W[1]F@R.^
M=LKX_6OROHHY4!^BWBC_ (+\SNI31?AG#&>TM[K1<'_@"0C_ -"KR3X@?\%K
MOC/XOA>+3'\,^%T8;0^GZ=YLH]\W#2#/T45\B4460'9_%/\ :+\>?&V4GQ9X
MN\0:]'NWK#=WKO A]5BSL7\%%<9113 **** "BBB@ HHJSHVBWGB/5K:PT^U
MN+Z^O)%A@MX(S)+,Y. JJ,DDGL* ((87N)DCC1I))"%55&2Q/0 =S7ZU?\$K
M?^">#?LX^'QXY\8V2+XYU>';:VLB@MH=NPY7VF<?>/55^7C+YRO^";W_  2M
MM_@D;+QS\1K6WO/&"E9].TTL)(=%XR'?^%YP3QC*H0""6P1]PU+8!1114@%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1WEG#J
M-G+;W$4<]O.ACEBD4,DBD8*L#P01P0:_.;]N[_@C:\EQ>>*_A!;H5<F:[\,L
MX7;W+6C'C_MDQ]=IZ)7Z.T4TP/YT=;T.]\-:O<Z?J-G=:??V<ABGMKF)HIH'
M'!5D8 J1Z$9JK7[N?M.?L/\ P[_:RTUAXIT55U9(_+M]8LB(+^W]/G (<#LL
M@9?:OSK_ &D?^"+OQ&^%,DU]X-EA\>Z,GS;(%%OJ,0]X6.']/W;%C_=%4F!\
M;T5=\1>&M1\(:Q-IVK:?>Z7J%LVV:VNX&@FB/HR, 0?J*I4P"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **]7^ 7[$?Q._:5EB?PMX5OYM.E/.
MIW0^RV*C."?-? ?'<)N;VK[[_9@_X(D>$OA^\&I_$C4?^$PU-"&&G6I>#38C
M_M'B2;GUV*>A4TFP/@+]F/\ 8R\??M:>(1:>%-(<V$3[+K5KO,5A9_[TF#N;
MD?(@9^^,9-?J]^Q9_P $Y/!7['NGQW\2#Q!XRECVW&M748!BR.4MTY$2=B<E
MFYRV, >\>'/#6G>#M#MM,TFPL]+TVR3R[>UM(5AA@7^ZJ*  /H*NU+8!1112
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\C'_ "RVX/OZ\]:.8#\)**_8GXP?\$O?@5I&@?;;7P'';W#SHA,>K7ZKC:>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116525424544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Aug. 05, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIGAND PHARMACEUTICALS INCORPORATED<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0160744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5980 Horton Street, Suite 405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Emeryville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">550-7500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LGND<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,882,751<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000886163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116523291376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 5,280<span></span>
</td>
<td class="nump">$ 19,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">142,655<span></span>
</td>
<td class="nump">321,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">62,308<span></span>
</td>
<td class="nump">85,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">24,773<span></span>
</td>
<td class="nump">27,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">964<span></span>
</td>
<td class="nump">6,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">7,804<span></span>
</td>
<td class="nump">4,671<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">243,784<span></span>
</td>
<td class="nump">464,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes, net</a></td>
<td class="nump">35,654<span></span>
</td>
<td class="nump">34,482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">528,364<span></span>
</td>
<td class="nump">551,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">181,206<span></span>
</td>
<td class="nump">181,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseRights', window );">Commercial license rights, net</a></td>
<td class="nump">10,267<span></span>
</td>
<td class="nump">10,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">30,954<span></span>
</td>
<td class="nump">20,511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">24,711<span></span>
</td>
<td class="nump">16,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Financing lease right-of-use assets</a></td>
<td class="nump">15,032<span></span>
</td>
<td class="nump">16,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">6,316<span></span>
</td>
<td class="nump">2,741<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,076,288<span></span>
</td>
<td class="nump">1,297,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">19,153<span></span>
</td>
<td class="nump">8,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">14,551<span></span>
</td>
<td class="nump">17,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income taxes payable</a></td>
<td class="nump">3,782<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights', window );">Current contingent liabilities</a></td>
<td class="nump">2,258<span></span>
</td>
<td class="nump">2,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">10,584<span></span>
</td>
<td class="nump">10,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">2,501<span></span>
</td>
<td class="nump">2,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current financing lease liabilities</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">2023 convertible senior notes, net</a></td>
<td class="nump">114,974<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">167,853<span></span>
</td>
<td class="nump">41,665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">2023 convertible senior notes, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">320,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LiabilityForContingentValueRights', window );">Long-term contingent liabilities</a></td>
<td class="nump">6,961<span></span>
</td>
<td class="nump">8,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes, net</a></td>
<td class="nump">42,669<span></span>
</td>
<td class="nump">59,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">27,088<span></span>
</td>
<td class="nump">15,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Long-term deferred revenue</a></td>
<td class="nump">7,428<span></span>
</td>
<td class="nump">9,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">21,924<span></span>
</td>
<td class="nump">21,707<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">273,923<span></span>
</td>
<td class="nump">476,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at June&#160;30, 2022 and December&#160;31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 60,000 shares authorized; 16,882 and 16,767 shares issued and outstanding at June&#160;30, 2022 and December&#160;31, 2021, respectively</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">335,471<span></span>
</td>
<td class="nump">372,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,066)<span></span>
</td>
<td class="num">(917)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">467,943<span></span>
</td>
<td class="nump">449,090<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">802,365<span></span>
</td>
<td class="nump">821,159<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 1,076,288<span></span>
</td>
<td class="nump">$ 1,297,590<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CurrentPortionOfLiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116526040944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (shares)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (shares)</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (shares)</a></td>
<td class="nump">16,882<span></span>
</td>
<td class="nump">16,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (shares)</a></td>
<td class="nump">16,882<span></span>
</td>
<td class="nump">16,767<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116523217840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 57,419<span></span>
</td>
<td class="nump">$ 84,675<span></span>
</td>
<td class="nump">$ 103,112<span></span>
</td>
<td class="nump">$ 139,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostDirectMaterial', window );">Cost of Captisol</a></td>
<td class="nump">12,361<span></span>
</td>
<td class="nump">30,593<span></span>
</td>
<td class="nump">17,060<span></span>
</td>
<td class="nump">38,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of intangibles</a></td>
<td class="nump">11,824<span></span>
</td>
<td class="nump">11,779<span></span>
</td>
<td class="nump">23,637<span></span>
</td>
<td class="nump">23,565<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">19,118<span></span>
</td>
<td class="nump">15,953<span></span>
</td>
<td class="nump">39,425<span></span>
</td>
<td class="nump">33,832<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">14,585<span></span>
</td>
<td class="nump">14,711<span></span>
</td>
<td class="nump">32,765<span></span>
</td>
<td class="nump">27,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating income</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(34,100)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(33,800)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">57,888<span></span>
</td>
<td class="nump">38,936<span></span>
</td>
<td class="nump">112,887<span></span>
</td>
<td class="nump">89,371<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="num">(469)<span></span>
</td>
<td class="nump">45,739<span></span>
</td>
<td class="num">(9,775)<span></span>
</td>
<td class="nump">50,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Gain (loss) from short-term investments</a></td>
<td class="num">(1,909)<span></span>
</td>
<td class="num">(6,864)<span></span>
</td>
<td class="num">(14,786)<span></span>
</td>
<td class="nump">6,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">233<span></span>
</td>
<td class="nump">432<span></span>
</td>
<td class="nump">529<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(438)<span></span>
</td>
<td class="num">(4,883)<span></span>
</td>
<td class="num">(1,227)<span></span>
</td>
<td class="num">(10,714)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">1,882<span></span>
</td>
<td class="num">(924)<span></span>
</td>
<td class="nump">4,580<span></span>
</td>
<td class="num">(7,401)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(167)<span></span>
</td>
<td class="num">(12,438)<span></span>
</td>
<td class="num">(11,001)<span></span>
</td>
<td class="num">(11,389)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="num">(636)<span></span>
</td>
<td class="nump">33,301<span></span>
</td>
<td class="num">(20,776)<span></span>
</td>
<td class="nump">39,065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">(259)<span></span>
</td>
<td class="num">(2,576)<span></span>
</td>
<td class="nump">4,496<span></span>
</td>
<td class="nump">9,766<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (895)<span></span>
</td>
<td class="nump">$ 30,725<span></span>
</td>
<td class="num">$ (16,280)<span></span>
</td>
<td class="nump">$ 48,831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net (loss) income per share (USD per share)</a></td>
<td class="num">$ (0.05)<span></span>
</td>
<td class="nump">$ 1.84<span></span>
</td>
<td class="num">$ (0.97)<span></span>
</td>
<td class="nump">$ 2.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in basic per share calculations (shares)</a></td>
<td class="nump">16,868<span></span>
</td>
<td class="nump">16,659<span></span>
</td>
<td class="nump">16,846<span></span>
</td>
<td class="nump">16,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net (loss) income per share (USD per share)</a></td>
<td class="num">$ (0.05)<span></span>
</td>
<td class="nump">$ 1.79<span></span>
</td>
<td class="num">$ (0.97)<span></span>
</td>
<td class="nump">$ 2.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in diluted per share calculations (shares)</a></td>
<td class="nump">16,868<span></span>
</td>
<td class="nump">17,172<span></span>
</td>
<td class="nump">16,846<span></span>
</td>
<td class="nump">17,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 17,959<span></span>
</td>
<td class="nump">$ 8,616<span></span>
</td>
<td class="nump">$ 31,654<span></span>
</td>
<td class="nump">$ 15,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">29,545<span></span>
</td>
<td class="nump">62,509<span></span>
</td>
<td class="nump">41,667<span></span>
</td>
<td class="nump">93,781<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 9,915<span></span>
</td>
<td class="nump">$ 13,550<span></span>
</td>
<td class="nump">$ 29,791<span></span>
</td>
<td class="nump">$ 30,316<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostDirectMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of material used for good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostDirectMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116523200672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (895)<span></span>
</td>
<td class="nump">$ 30,725<span></span>
</td>
<td class="num">$ (16,280)<span></span>
</td>
<td class="nump">$ 48,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net loss on available-for-sale securities, net of tax</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
<td class="num">(60)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive (loss) income</a></td>
<td class="num">$ (930)<span></span>
</td>
<td class="nump">$ 30,720<span></span>
</td>
<td class="num">$ (16,429)<span></span>
</td>
<td class="nump">$ 48,771<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116521271456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional paid in capital</div></th>
<th class="th">
<div>Additional paid in capital </div>
<div>Adjustment</div>
</th>
<th class="th"><div>Accumulated other comprehensive loss</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th">
<div>Retained earnings </div>
<div>Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">$ 709,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 318,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (801)<span></span>
</td>
<td class="nump">$ 391,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</a></td>
<td class="nump">20,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">20,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">8,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net loss on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions', window );">Warrant and bond hedge unwind transactions</a></td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(11,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">18,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2021</a></td>
<td class="nump">745,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">336,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(856)<span></span>
</td>
<td class="nump">410,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">709,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">318,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(801)<span></span>
</td>
<td class="nump">391,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net loss on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(60)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">48,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="nump">786,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">346,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(861)<span></span>
</td>
<td class="nump">440,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">$ 709,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">318,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(801)<span></span>
</td>
<td class="nump">391,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">Accounting Standards Update 2020-06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Dec. 31, 2021</a></td>
<td class="nump">16,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2021</a></td>
<td class="nump">$ 821,159<span></span>
</td>
<td class="num">$ (15,997)<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">372,969<span></span>
</td>
<td class="num">$ (51,130)<span></span>
</td>
<td class="num">(917)<span></span>
</td>
<td class="nump">449,090<span></span>
</td>
<td class="nump">$ 35,133<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Mar. 31, 2021</a></td>
<td class="nump">745,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">336,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(856)<span></span>
</td>
<td class="nump">410,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</a></td>
<td class="nump">1,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">10,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net loss on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(1,362)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,362)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">30,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="nump">$ 786,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">346,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(861)<span></span>
</td>
<td class="nump">440,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Dec. 31, 2021</a></td>
<td class="nump">16,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 821,159<span></span>
</td>
<td class="num">(15,997)<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">372,969<span></span>
</td>
<td class="num">(51,130)<span></span>
</td>
<td class="num">(917)<span></span>
</td>
<td class="nump">449,090<span></span>
</td>
<td class="nump">35,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</a></td>
<td class="num">(5,515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">9,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net loss on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(15,385)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,385)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2022</a></td>
<td class="nump">$ 793,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">325,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,031)<span></span>
</td>
<td class="nump">468,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Dec. 31, 2021</a></td>
<td class="nump">16,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 821,159<span></span>
</td>
<td class="num">$ (15,997)<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">372,969<span></span>
</td>
<td class="num">$ (51,130)<span></span>
</td>
<td class="num">(917)<span></span>
</td>
<td class="nump">449,090<span></span>
</td>
<td class="nump">$ 35,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net loss on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(149)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (16,280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Jun. 30, 2022</a></td>
<td class="nump">16,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2022</a></td>
<td class="nump">$ 802,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">335,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,066)<span></span>
</td>
<td class="nump">467,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Mar. 31, 2022</a></td>
<td class="nump">793,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">325,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,031)<span></span>
</td>
<td class="nump">468,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</a></td>
<td class="nump">604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">9,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net loss on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (895)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(895)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Jun. 30, 2022</a></td>
<td class="nump">16,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2022</a></td>
<td class="nump">$ 802,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 335,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,066)<span></span>
</td>
<td class="nump">$ 467,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=123466103&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116525915168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (16,280)<span></span>
</td>
<td class="nump">$ 48,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights', window );">Change in estimated fair value of contingent liabilities</a></td>
<td class="num">(1,266)<span></span>
</td>
<td class="num">(33,502)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">26,921<span></span>
</td>
<td class="nump">25,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premium on investments, net</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance fees</a></td>
<td class="nump">501<span></span>
</td>
<td class="nump">9,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights', window );">Amortization of commercial license rights</a></td>
<td class="num">(190)<span></span>
</td>
<td class="nump">206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss (gain) on debt extinguishment</a></td>
<td class="num">(3,326)<span></span>
</td>
<td class="nump">7,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">18,543<span></span>
</td>
<td class="nump">18,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="num">(12,925)<span></span>
</td>
<td class="num">(9,766)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_GainLossOnShortTermInvestments', window );">Loss (gain) from short-term investments</a></td>
<td class="nump">14,786<span></span>
</td>
<td class="num">(6,197)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization', window );">Lease amortization expense</a></td>
<td class="nump">3,054<span></span>
</td>
<td class="nump">2,113<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="num">(67)<span></span>
</td>
<td class="nump">595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">23,208<span></span>
</td>
<td class="num">(2,659)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">9,740<span></span>
</td>
<td class="num">(2,326)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(4,357)<span></span>
</td>
<td class="num">(4,340)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax receivable and payable</a></td>
<td class="nump">9,011<span></span>
</td>
<td class="num">(2,477)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(2,254)<span></span>
</td>
<td class="num">(14,605)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities</a></td>
<td class="num">(1,254)<span></span>
</td>
<td class="num">(4,899)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">63,889<span></span>
</td>
<td class="nump">31,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="num">(38,472)<span></span>
</td>
<td class="num">(96,136)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from sale of short-term investments</a></td>
<td class="nump">177,554<span></span>
</td>
<td class="nump">150,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Proceeds from maturity of short-term investments</a></td>
<td class="nump">24,830<span></span>
</td>
<td class="nump">34,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Cash paid for equity method investment</a></td>
<td class="num">(750)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(11,463)<span></span>
</td>
<td class="num">(4,794)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">151,732<span></span>
</td>
<td class="nump">84,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repurchase of 2023 Notes</a></td>
<td class="num">(223,303)<span></span>
</td>
<td class="num">(153,381)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments under financing lease obligations</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(9,188)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeFinancingActivities', window );">Proceeds from convertible bond hedge settlement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeFinancingActivities', window );">Payments to convertible bond holders for warrant purchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(16,459)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Net proceeds from stock option exercises and ESPP</a></td>
<td class="nump">1,011<span></span>
</td>
<td class="nump">27,584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(5,922)<span></span>
</td>
<td class="num">(5,901)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity', window );">Payments to CVR Holders</a></td>
<td class="num">(1,416)<span></span>
</td>
<td class="num">(1,050)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Payments for OmniAb transaction costs</a></td>
<td class="num">(206)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(229,863)<span></span>
</td>
<td class="num">(141,540)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents and restricted cash</a></td>
<td class="num">(14,242)<span></span>
</td>
<td class="num">(25,956)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">19,522<span></span>
</td>
<td class="nump">47,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">5,280<span></span>
</td>
<td class="nump">22,007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">1,038<span></span>
</td>
<td class="nump">1,737<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Taxes paid</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">3,552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash in other current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental schedule of non-cash activity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accrued fixed asset purchases</a></td>
<td class="nump">3,800<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedInventoryPurchases', window );">Accrued inventory purchases</a></td>
<td class="nump">9,161<span></span>
</td>
<td class="nump">12,695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss on AFS investments</a></td>
<td class="num">$ (149)<span></span>
</td>
<td class="num">$ (60)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedInventoryPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Inventory Purchases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedInventoryPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Commercial License And Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease And Operating Lease, Right-of-Use Asset, Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_GainLossOnShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Short-term Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_GainLossOnShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders, Financing Activity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHoldersFinancingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116525422928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Summary of Significant Accounting Policies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2021 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described our significant accounting policies in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2021 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#8220;long-term deferred revenue&#8221; has been added to the condensed consolidated balance sheet, separated from &#8220;other long-term liabilities&#8221; in our prior period presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Updates, Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8220;ASU 2020-06&#8221;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Consequently, a convertible debt instrument, such as the Company&#8217;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the condensed consolidated balance sheet for the period ended June&#160;30, 2022. Upon adoption of ASU 2020-06 on January 1 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $20.4&#160;million, reduced deferred tax liabilities by $4.4&#160;million, reduced additional paid-in capital by $51.1&#160;million and increased retained earnings by $35.1&#160;million. The net balance of the 2023 Notes at January 1, 2022 was $341.1&#160;million which included an unamortized discount of $2.2&#160;million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in accordance with ASC 606, Revenue from Contracts with Customers, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;D services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For R&amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three months ended June&#160;30, 2022 and 2021, the amount recognized as revenue that was previously deferred was $4.1 million, and $10.3 million, respectively. During the six months ended  June&#160;30, 2022 and 2021, the amount recognized as revenue that was previously deferred was $6.1 million, and $16.1 million, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation&#160;of&#160;Revenue </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Teriparatide injection </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,654&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - Core</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - COVID</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,545&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,509&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,667&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,781&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,316&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,419&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,675&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,112&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139,825&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at June&#160;30, 2022 and December 31, 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:38.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,703)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,996&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,184)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,248&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,655&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,027)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292,225&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,370)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three and six months ended June&#160;30, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,653&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invest in U.S.-dollar denominated investments. We held a total of 8 positions which were in an unrealized loss position as of June&#160;30, 2022. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the three and six months ended June&#160;30, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three and six months ended June&#160;30, 2022, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the COVID-19 pandemic on our business and recorded an adjustment of $(0.1)&#160;million and $(0.2)&#160;million  of allowance for credit losses, respectively, as of June&#160;30, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs related to obsolete inventory recorded for the three and six months ended June&#160;30, 2022 and 2021. As of June&#160;30, 2022 inventory consists of Captisol prepayments of $18.9&#160;million, and as of December 31, 2021 inventory consists of Captisol prepayments of $24.6&#160;million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Identifiable Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(86,740)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78,991)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,602)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,267)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,704)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,217)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">709,570&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">732,246&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 2022, we only had one reporting unit and reportable segment. In connection with the announcement in March 2022 of our intention to separate the OmniAb business pursuant to a distribution to Ligand&#8217;s stockholders of Ligand&#8217;s shares in OmniAb followed by a merger with APAC, management concluded that we now had two reporting units and reportable segments - the OmniAb business and the Ligand core business. See Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information. We performed a fair value analysis utilizing a combination of income approach and market approach to determine the fair value of each segment in order to appropriately allocate the goodwill between the segments as of the announcement date. The following table presents our allocation of goodwill balance by segment (in thousands): </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:84.298%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Ligand core business</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">105,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">OmniAb business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">75,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">181,206&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Commercial License Rights</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,425)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,031)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.5&#160;million and credit loss adjustments of $6.5 million as of June&#160;30, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. in January 2019. Commercial license rights acquired are accounted for as financial assets in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Receivables, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">as further discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Notes to Consolidated Financial Statements in our 2021 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three and six months ended June&#160;30, 2022, we further considered the current and expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of June&#160;30, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accrued Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,551&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,579&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six  months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,501&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,499&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,216&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,543&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,621&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net (Loss) Income Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.293%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,794&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,400&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,684&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2022, due to the net loss for the period, all of the 0.2&#160;million weighted average equity awards and 0.9&#160;million of potentially dilutive shares in connection with the adoption of ASU 2020-06 were anti-dilutive. For the six months ended  June&#160;30, 2022, due to the net loss for the period, all of the 0.3&#160;million weighted average equity awards and 1.8&#160;million of potentially dilutive shares in connection with the adoption of ASU 2020-06 were anti-dilutive. Under the new standard, we are required to reflect the dilutive effect of the 2023 Notes by application of the if-converted method.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116529740272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, establishes annual and interim reporting standards for an enterprise&#8217;s operating segments and related disclosures about its products, services, geographic areas and major customers. An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenue and incur expenses, and for which discrete financial information is regularly evaluated by the chief operating decision maker in deciding how to allocate resources and assess performance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our operating segments are identified in the same manner as they are reported internally and used by our chief operating decision maker for the purpose of evaluating performance and allocating resources. Historically, we have disclosed one reportable segment. On March 23, 2022, we entered into the Merger Agreement, pursuant to which APAC will combine with OmniAb, and acquire the OmniAb Business, in a Reverse Morris Trust transaction. Immediately prior to the Merger and pursuant to the Separation Agreement, we will, among other things, transfer the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc. to OmniAb (the &#8220;Reorganization&#8221;) and, in connection therewith, will distribute (the &#8220;Distribution&#8221;) to Ligand stockholders 100% of the common stock of OmniAb. Immediately following the Distribution, Merger Sub will merge with and into OmniAb (the &#8220;Merger&#8221;), with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of APAC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the execution of the Merger Agreement, we have made organizational changes to better align our organizational structure with our strategy and operations, and management has reorganized the reportable segments to better reflect how the business is evaluated by the chief operating decision maker. Beginning in the first quarter of 2022, we operate the following two reportable segments: (1) OmniAb business and (2) Ligand core business. The OmniAb business segment is focused on enabling the discovery of therapeutic candidates for our partners by pairing antibody repertoires generated from our proprietary transgenic animals with our OmniAb business platform screening tools. The Ligand core business segment is a biopharmaceutical business focused on developing or acquiring technologies that help pharmaceutical companies deliver and develop medicines. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income (loss) represents income (loss) before income taxes, interest income, interest expense, other income (expense), net, unallocated share-based compensation, and unallocated corporate overhead. Our management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#8217;s internal financial information as used for corporate management purposes (in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business revenue</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total OmniAb business revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,821&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,470&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,380&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - Core </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - COVID</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82,846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Total Ligand core business revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,127&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78,854&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125,445&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84,675&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103,112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Segment operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,998)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15,187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,410)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,041&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,028&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,843&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67,870&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unallocated corporate items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shared-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total unallocated corporate items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,618&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(469)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,739&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,775)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,454&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116529750592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,993&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118,533&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142,655&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,624&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,553&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">321,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,819&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,291&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,713&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,157&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial.  During the three and six months ended June&#160;30, 2022, we adjusted the balance of the Metabasis CVR liability $(0.4)&#160;million and $(1.0)&#160;million to mark to market, respectively.  </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the six months ended  June&#160;30, 2022, we paid $1.5&#160;million contingent liability based on revenue milestones to former Icagen shareholders, respectively. During the three and six months ended June&#160;30, 2022, we adjusted the balance of the Icagen CVR liability $0.2&#160;million and $(0.3)&#160;million to mark to market, respectively.  </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the three and six months ended June&#160;30, 2022, management recorded $0.5 million and $1.0 million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of June&#160;30, 2022 is as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2021</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingent payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(309)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">960</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of June&#160;30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,819&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="text-indent:22pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the organizational changes to the Company&#8217;s reportable segments, we re-allocated goodwill between the two identified reporting units (OmniAb business and Ligand core business). We performed a goodwill impairment analysis immediately before and after the allocation of goodwill and concluded no impairment. At June 30, 2022, there were no indicators of impairment at either of the reporting units.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>At June 30, 2022, there were no indicators of impairment of our indefinite-lived intangible assets, or long-lived assets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116529952080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Convertible Senior Notes</a></td>
<td class="text">Convertible Senior Notes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued&#160;$750.0&#160;million&#160;aggregate principal amount of&#160;0.75%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$248.48 per share.  The maximum conversion rate of the 2023 Notes is 5.2317 per $1,000 principal amount of the 2023 Notes which represents a maximum conversion price of approximately $191.14. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: </span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than 130% of the conversion price on such trading day; </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $248.48. In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees, is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes, and the effective interest rate as of June&#160;30, 2022 is 0.5%.  During the three months ended June&#160;30, 2022 we recognized a total of $0.4&#160;million in interest expense which includes $0.2&#160;million in contractual interest expense and $0.2&#160;million in amortized issuance costs. During the six months ended  June&#160;30, 2022 we recognized a total of $1.2&#160;million in interest expense which includes $0.7&#160;million in contractual interest expense and $0.5&#160;million in amortized issuance costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2021, we repurchased $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million. After the repurchases, approximately $343.3&#160;million in principal amount of the 2023 Notes were outstanding as of December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three months ended June&#160;30, 2022, we repurchased $62.0&#160;million in principal amount of the 2023 Notes for $60.0&#160;million in cash, including accrued interest of $0.01&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $1.8&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the three months ended June 30, 2022, and a $0.3&#160;million reduction in debt discount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the six months ended June&#160;30, 2022, we repurchased $227.8&#160;million in principal amount of the 2023 Notes for $223.7&#160;million in cash, including accrued interest of $0.4&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $3.3&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the six months ended June 30, 2022, and a $1.2&#160;million reduction in debt discount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $248.48 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately 3,018,327 shares of common stock with an exercise price of approximately $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, in connection with the repurchases of approximately $20.3&#160;million in principal of the 2023 Notes for approximately $19.1&#160;million in cash, including accrued interest of $0.1&#160;million, during the quarter ended December 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, in connection with the repurchases of $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $18.4&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from 3,018,327 to 2,559,254. We received $18.9&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 598,021. These unwind transactions resulted in a $0.5&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) - Balances as of December 31, 2021 reported before the adoption of ASU 2020-06.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116531451952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax</a></td>
<td class="text">Income TaxOur effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three and six months ended June&#160;30, 2022 and 2021 was (40.7)% and 7.7%, and 21.6% and (25.0)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three and six months ended June&#160;30, 2022 was due primarily to the tax deductions related to foreign derived intangible income tax credit as well as the research and development tax credits, which were partially offset by Section 162(m) limitation and non-deductible ISO related stock compensation expense during the period. The variance from the U.S. federal tax rate of 21% for the three and six months ended June 30, 2021 was significantly impacted by tax benefits related to (1) a $34.1&#160;million Pfenex CVR adjustment recorded during Q2 2021 due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR, and (2) net excess tax benefits from share-based compensation resulting from increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116530747936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements in our 2021 Annual Report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,199,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">734,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186,526&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(133,173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,417)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,378)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137.16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,877,601&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">316,118&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, outstanding options to purchase 1.6 million shares were exercisable with a weighted average exercise price per share of $102.10.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of June&#160;30, 2022, 38,007 shares were available for future purchases under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div>On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $500.0 million of our common stock from time to time over the next three years. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. We did not have any share repurchases during the three and six months ended June&#160;30, 2022. Authorization to repurchase $248.8 million of our common stock remained available as of June&#160;30, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116530721152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies: Legal Proceedings<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitment and Contingencies: Legal Proceedings</a></td>
<td class="text">Commitment and Contingencies: Legal Proceedings<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received three civil complaints filed in the U.S. District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the Company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CyDex and Baxter Healthcare Corp. (&#8220;Baxter&#8221;) are parties to a license agreement relating to Ligand&#8217;s Captisol technology and, more specifically, relating to Captisol-enabled Nexterone (amiodarone HCl premixed injection). Baxter contends that it has overpaid royalties for several years, and seeks both refunds of those overpayment and that its royalty payments end as of May 4, 2022, the expiration date of one of the patents licensed under the agreement. CyDex contends that Baxter has not paid the royalties due to CyDex under the terms of the license agreement. On April 6, 2021, Baxter initiated an arbitration with the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">American Arbitration Association pursuant to the arbitration provision of the license agreement. On April 21, 2021, CyDex filed an Answering Statement and Counterdemand. On December 2, 2021, Baxter filed an Amended Notice of Arbitration Demand also seeking a declaration limiting the &#8220;royalty term&#8221; of the license agreement to &#8220;the later of i) the expiration of the licensed patent; or ii) when there are no longer any CyDex patents listed in the Orange Book for Nexterone.&#8221;  Baxter has subsequently clarified this position, and asserts that royalties ceased being due when CyDex&#8217;s U.S. Patent No. 6,869,939 expired on May 4, 2022. On December 16, 2021, CyDex filed an Answer to Baxter&#8217;s Amended Demand. The parties conducted a three-day arbitration hearing between May 24 and May 26, 2022, and subsequently submitted two sets of post-hearing briefs. The arbitrator&#8217;s decision is expected before the end of 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may also become subject to other legal proceedings or claims arising in the ordinary course of our business. We currently believe that none of the claims or actions pending against us is likely to have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Given the unpredictability inherent in litigation, however, we cannot predict the outcome of these matters.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116525979872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,666&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating and Finance Lease Liabilities as of June&#160;30, 2022 (in thousands): </span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:81.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.132%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remaining six months ending December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,689&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less estimated tenant improvement allowance:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,742)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,666&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating and Finance Lease Liabilities as of June&#160;30, 2022 (in thousands): </span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:81.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.132%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remaining six months ending December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,689&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less estimated tenant improvement allowance:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,742)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116530831440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of PresentationOur condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2021 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#8220;long-term deferred revenue&#8221; has been added to the condensed consolidated balance sheet, separated from &#8220;other long-term liabilities&#8221; in our prior period presentation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Standards Updates, Recently Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Updates, Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8220;ASU 2020-06&#8221;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Consequently, a convertible debt instrument, such as the Company&#8217;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the condensed consolidated balance sheet for the period ended June&#160;30, 2022. Upon adoption of ASU 2020-06 on January 1 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $20.4&#160;million, reduced deferred tax liabilities by $4.4&#160;million, reduced additional paid-in capital by $51.1&#160;million and increased retained earnings by $35.1&#160;million. The net balance of the 2023 Notes at January 1, 2022 was $341.1&#160;million which included an unamortized discount of $2.2&#160;million.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in accordance with ASC 606, Revenue from Contracts with Customers, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;D services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For R&amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. </span></div>The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable and Allowance for Credit Losses</a></td>
<td class="text">Accounts Receivable and Allowance for Credit LossesOur accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method. </span></div>We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs related to obsolete inventory recorded for the three and six months ended June&#160;30, 2022 and 2021. As of June&#160;30, 2022 inventory consists of Captisol prepayments of $18.9&#160;million, and as of December 31, 2021 inventory consists of Captisol prepayments of $24.6&#160;million.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseRightsPolicyTextBlock', window );">Commercial License Rights</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Commercial License Rights</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,425)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,031)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.5&#160;million and credit loss adjustments of $6.5 million as of June&#160;30, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. in January 2019. Commercial license rights acquired are accounted for as financial assets in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Receivables, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">as further discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Notes to Consolidated Financial Statements in our 2021 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three and six months ended June&#160;30, 2022, we further considered the current and expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of June&#160;30, 2022.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six  months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,501&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,499&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,216&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,543&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,621&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net (Loss) Income Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net (Loss) Income Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseRightsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commercial License Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseRightsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116523024400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue by Source</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Teriparatide injection </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,654&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - Core</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - COVID</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,545&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,509&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,667&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,781&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,316&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,419&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,675&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,112&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139,825&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock', window );">Schedule of Short-Term Investments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at June&#160;30, 2022 and December 31, 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:38.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,703)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,996&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,184)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,248&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,655&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,027)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292,225&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,370)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Available-for-Sale Debt Securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,653&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill and Other Identifiable Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(86,740)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78,991)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,602)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,267)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,704)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,217)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">709,570&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">732,246&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis</a></td>
<td class="text">The following table presents our allocation of goodwill balance by segment (in thousands): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:84.298%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Ligand core business</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">105,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">OmniAb business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">75,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">181,206&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock', window );">Schedule of Commercial License Rights</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,425)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,031)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.5&#160;million and credit loss adjustments of $6.5 million as of June&#160;30, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,551&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,579&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock', window );">Schedule of Accounting for Share-Based Compensation</a></td>
<td class="text">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six  months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,501&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,499&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,216&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,543&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,621&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Fair-Value Options Awarded to Employees and Directors</a></td>
<td class="text">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Earnings per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.293%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,794&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,087&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,400&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,684&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Commercial License Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Short-Term investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleOfShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116608776528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Schedule of Reconciliation of Revenue from Segments to Consolidated</a></td>
<td class="text">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#8217;s internal financial information as used for corporate management purposes (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business revenue</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total OmniAb business revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,821&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,470&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,380&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - Core </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - COVID</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82,846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Total Ligand core business revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,127&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78,854&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125,445&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84,675&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103,112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Segment operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,998)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,806)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15,187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,410)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,041&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,028&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,843&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67,870&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unallocated corporate items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shared-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total unallocated corporate items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,618&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(469)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,739&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,775)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,454&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116529667536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,993&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118,533&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142,655&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,624&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,553&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">321,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,819&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,291&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,713&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,157&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial.  During the three and six months ended June&#160;30, 2022, we adjusted the balance of the Metabasis CVR liability $(0.4)&#160;million and $(1.0)&#160;million to mark to market, respectively.  </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the six months ended  June&#160;30, 2022, we paid $1.5&#160;million contingent liability based on revenue milestones to former Icagen shareholders, respectively. During the three and six months ended June&#160;30, 2022, we adjusted the balance of the Icagen CVR liability $0.2&#160;million and $(0.3)&#160;million to mark to market, respectively.  </span></div>4.The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the three and six months ended June&#160;30, 2022, management recorded $0.5 million and $1.0 million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Reconciliation of Level 3 Financial Instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of June&#160;30, 2022 is as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2021</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingent payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(309)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">960</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of June&#160;30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,819&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116530729728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Carrying Values and Coupon Rates on Financing Arrangements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) - Balances as of December 31, 2021 reported before the adoption of ASU 2020-06.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116529673392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Plan Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,199,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">734,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186,526&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(133,173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,417)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,378)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137.16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,877,601&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">316,118&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,199,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">734,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186,526&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(133,173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,417)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,378)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137.16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,877,601&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">316,118&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116529745760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock', window );">Schedule of Operating and Finance Lease Assets and Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,666&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Operating Lease Liabilities</a></td>
<td class="text">Maturity of Operating and Finance Lease Liabilities as of June&#160;30, 2022 (in thousands): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:81.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.132%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remaining six months ending December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,689&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less estimated tenant improvement allowance:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,742)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets and Liabilities Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AssetsAndLiabilitiesLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116521475888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>position </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 22, 2022 </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>reporting_unit </div>
<div>position </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>reporting_unit</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,669,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,669,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,095,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="nump">$ 793,192,000<span></span>
</td>
<td class="nump">802,365,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 786,517,000<span></span>
</td>
<td class="nump">802,365,000<span></span>
</td>
<td class="nump">$ 786,517,000<span></span>
</td>
<td class="nump">821,159,000<span></span>
</td>
<td class="nump">$ 745,840,000<span></span>
</td>
<td class="nump">$ 709,525,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized that was previously deferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,300,000<span></span>
</td>
<td class="nump">$ 6,100,000<span></span>
</td>
<td class="nump">$ 16,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of positions in an unrealized loss position | position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Credit losses related to available-for-sale debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease', window );">Additional allowance for credit losses recorded related to COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,773,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,773,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,326,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,087<span></span>
</td>
<td class="nump">6,400<span></span>
</td>
<td class="nump">4,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Share-based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Performance period for awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent', window );">Payout range (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent', window );">Payout range (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,997,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember', window );">Adjusted Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">341,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06 | Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="nump">$ 325,368,000<span></span>
</td>
<td class="nump">$ 335,471,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 346,578,000<span></span>
</td>
<td class="nump">$ 335,471,000<span></span>
</td>
<td class="nump">$ 346,578,000<span></span>
</td>
<td class="nump">372,969,000<span></span>
</td>
<td class="nump">336,621,000<span></span>
</td>
<td class="nump">318,358,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid in capital | Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,130,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid in capital | Accounting Standards Update 2020-06 | Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="nump">$ 468,838,000<span></span>
</td>
<td class="nump">$ 467,943,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 440,783,000<span></span>
</td>
<td class="nump">$ 467,943,000<span></span>
</td>
<td class="nump">$ 440,783,000<span></span>
</td>
<td class="nump">449,090,000<span></span>
</td>
<td class="nump">$ 410,058,000<span></span>
</td>
<td class="nump">$ 391,952,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained earnings | Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,133,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained earnings | Accounting Standards Update 2020-06 | Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116527542992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 57,419<span></span>
</td>
<td class="nump">$ 84,675<span></span>
</td>
<td class="nump">$ 103,112<span></span>
</td>
<td class="nump">$ 139,825<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">17,959<span></span>
</td>
<td class="nump">8,616<span></span>
</td>
<td class="nump">31,654<span></span>
</td>
<td class="nump">15,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_KyprolisMember', window );">Kyprolis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">7,127<span></span>
</td>
<td class="nump">5,440<span></span>
</td>
<td class="nump">11,749<span></span>
</td>
<td class="nump">9,727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_EvomelaMember', window );">Evomela</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,394<span></span>
</td>
<td class="nump">2,193<span></span>
</td>
<td class="nump">5,095<span></span>
</td>
<td class="nump">4,526<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_TeriparatideInjectionMember', window );">Teriparatide injection</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">5,502<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="nump">8,413<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RylazeMember', window );">Rylaze</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,317<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,966<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">619<span></span>
</td>
<td class="nump">719<span></span>
</td>
<td class="nump">2,431<span></span>
</td>
<td class="nump">1,211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">29,545<span></span>
</td>
<td class="nump">62,509<span></span>
</td>
<td class="nump">41,667<span></span>
</td>
<td class="nump">93,781<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember', window );">Captisol - Core</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,325<span></span>
</td>
<td class="nump">9,682<span></span>
</td>
<td class="nump">9,551<span></span>
</td>
<td class="nump">10,935<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember', window );">Captisol - COVID</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">26,220<span></span>
</td>
<td class="nump">52,827<span></span>
</td>
<td class="nump">32,116<span></span>
</td>
<td class="nump">82,846<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">9,915<span></span>
</td>
<td class="nump">13,550<span></span>
</td>
<td class="nump">29,791<span></span>
</td>
<td class="nump">30,316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember', window );">Service Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">5,453<span></span>
</td>
<td class="nump">7,360<span></span>
</td>
<td class="nump">10,599<span></span>
</td>
<td class="nump">12,822<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember', window );">License Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,608<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
<td class="nump">4,694<span></span>
</td>
<td class="nump">2,093<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember', window );">Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,275<span></span>
</td>
<td class="nump">3,600<span></span>
</td>
<td class="nump">10,364<span></span>
</td>
<td class="nump">12,017<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,579<span></span>
</td>
<td class="nump">$ 1,540<span></span>
</td>
<td class="nump">$ 4,134<span></span>
</td>
<td class="nump">$ 3,384<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_KyprolisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_KyprolisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_EvomelaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_EvomelaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_TeriparatideInjectionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_TeriparatideInjectionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RylazeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RylazeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116523326112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">$ 127,996<span></span>
</td>
<td class="nump">$ 292,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">436<span></span>
</td>
<td class="nump">842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(5,184)<span></span>
</td>
<td class="num">(2,370)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">123,248<span></span>
</td>
<td class="nump">290,697<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI', window );">Total short-term investments</a></td>
<td class="nump">142,655<span></span>
</td>
<td class="nump">321,586<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember', window );">Bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">2,504<span></span>
</td>
<td class="nump">63,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">2,443<span></span>
</td>
<td class="nump">63,381<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">4,904<span></span>
</td>
<td class="nump">29,308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(121)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">4,783<span></span>
</td>
<td class="nump">29,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Corporate equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">5,807<span></span>
</td>
<td class="nump">5,807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(3,703)<span></span>
</td>
<td class="num">(2,027)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">2,411<span></span>
</td>
<td class="nump">4,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember', window );">Mutual fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">112,535<span></span>
</td>
<td class="nump">152,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(1,228)<span></span>
</td>
<td class="num">(249)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">111,307<span></span>
</td>
<td class="nump">151,887<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">US government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">2,246<span></span>
</td>
<td class="nump">5,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(71)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">2,175<span></span>
</td>
<td class="nump">5,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Viking common stock</a></td>
<td class="nump">$ 19,407<span></span>
</td>
<td class="nump">$ 30,889<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Equity Securities, FV-NI</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116531414864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis', window );">Within one year</a></td>
<td class="nump">$ 6,423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis', window );">After one year through five years</a></td>
<td class="nump">3,230<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis', window );">Total</a></td>
<td class="nump">9,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue', window );">Within one year</a></td>
<td class="nump">6,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">After one year through five years</a></td>
<td class="nump">3,127<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total</a></td>
<td class="nump">$ 9,401<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116525850512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 181,206<span></span>
</td>
<td class="nump">$ 181,206<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total goodwill and other identifiable intangible assets, net</a></td>
<td class="nump">709,570<span></span>
</td>
<td class="nump">732,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember', window );">Complete technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">281,578<span></span>
</td>
<td class="nump">280,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(86,740)<span></span>
</td>
<td class="num">(78,991)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">2,642<span></span>
</td>
<td class="nump">2,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(1,510)<span></span>
</td>
<td class="num">(1,444)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">40,700<span></span>
</td>
<td class="nump">40,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(19,602)<span></span>
</td>
<td class="num">(18,267)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Contractual relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">362,000<span></span>
</td>
<td class="nump">362,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">$ (50,704)<span></span>
</td>
<td class="num">$ (36,217)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116523035104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 181,206<span></span>
</td>
<td class="nump">$ 181,206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember', window );">Ligand Core Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">105,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember', window );">OmniAb Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 75,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BasisOfPresentationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BasisOfPresentationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116520880576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details) - Commercial license rights - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">$ 28,298<span></span>
</td>
<td class="nump">$ 28,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(18,031)<span></span>
</td>
<td class="num">(18,188)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">10,267<span></span>
</td>
<td class="nump">10,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization on finite-lived intangible assets</a></td>
<td class="nump">11,500<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments', window );">Credit loss adjustments of finite-lived intangible assets</a></td>
<td class="nump">6,500<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Aziyo and CorMatrix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">17,696<span></span>
</td>
<td class="nump">17,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(9,425)<span></span>
</td>
<td class="num">(9,461)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">8,271<span></span>
</td>
<td class="nump">8,235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Selexis and Dianomi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">10,602<span></span>
</td>
<td class="nump">10,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(8,606)<span></span>
</td>
<td class="num">(8,727)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 1,996<span></span>
</td>
<td class="nump">$ 1,875<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commercial License and Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseAndOtherEconomicRightsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-lived Intangible Assets, Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_AziyoAndCorMatrixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_AziyoAndCorMatrixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116520856256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation</a></td>
<td class="nump">$ 4,669<span></span>
</td>
<td class="nump">$ 6,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">1,828<span></span>
</td>
<td class="nump">2,046<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LicenseeAccrualCurrent', window );">Amounts owed to former licensees</a></td>
<td class="nump">2,674<span></span>
</td>
<td class="nump">630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalties owed to third parties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ReturnsAccrual', window );">Return reserve</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedAssetAcquisitionsCurrent', window );">Acquisition related liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedSubcontractorExpensesCurrent', window );">Subcontractor</a></td>
<td class="nump">1,756<span></span>
</td>
<td class="nump">1,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedSupplierExpensesCurrent', window );">Supplier</a></td>
<td class="nump">1,995<span></span>
</td>
<td class="nump">848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,629<span></span>
</td>
<td class="nump">1,904<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 14,551<span></span>
</td>
<td class="nump">$ 17,579<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedAssetAcquisitionsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Asset Acquisitions, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedAssetAcquisitionsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedSubcontractorExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Subcontractor Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedSubcontractorExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedSupplierExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Supplier Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedSupplierExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LicenseeAccrualCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensee Accrual, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LicenseeAccrualCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ReturnsAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Returns Accrual</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ReturnsAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116531408608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 9,499<span></span>
</td>
<td class="nump">$ 10,216<span></span>
</td>
<td class="nump">$ 18,543<span></span>
</td>
<td class="nump">$ 18,621<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">SBC - Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">4,501<span></span>
</td>
<td class="nump">4,556<span></span>
</td>
<td class="nump">8,415<span></span>
</td>
<td class="nump">8,495<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">SBC - General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 4,998<span></span>
</td>
<td class="nump">$ 5,660<span></span>
</td>
<td class="nump">$ 10,128<span></span>
</td>
<td class="nump">$ 10,126<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BasisOfPresentationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BasisOfPresentationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116531416144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">54.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">62.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116530732624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding (shares)</a></td>
<td class="nump">16,868<span></span>
</td>
<td class="nump">16,659<span></span>
</td>
<td class="nump">16,846<span></span>
</td>
<td class="nump">16,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted income per share (shares)</a></td>
<td class="nump">16,868<span></span>
</td>
<td class="nump">17,172<span></span>
</td>
<td class="nump">16,846<span></span>
</td>
<td class="nump">17,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares)</a></td>
<td class="nump">6,794<span></span>
</td>
<td class="nump">5,087<span></span>
</td>
<td class="nump">6,400<span></span>
</td>
<td class="nump">4,684<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common shares (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common shares (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">444<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">572<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116522798480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 22, 2022 </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,675<span></span>
</td>
<td class="nump">$ 103,112<span></span>
</td>
<td class="nump">$ 139,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(636)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,301<span></span>
</td>
<td class="num">(20,776)<span></span>
</td>
<td class="nump">39,065<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,936<span></span>
</td>
<td class="nump">112,887<span></span>
</td>
<td class="nump">89,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(469)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,739<span></span>
</td>
<td class="num">(9,775)<span></span>
</td>
<td class="nump">50,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,675<span></span>
</td>
<td class="nump">103,112<span></span>
</td>
<td class="nump">139,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,028<span></span>
</td>
<td class="nump">11,843<span></span>
</td>
<td class="nump">67,870<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate, Non-Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Shared-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,748<span></span>
</td>
<td class="nump">10,793<span></span>
</td>
<td class="nump">10,618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Other corporate expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,541<span></span>
</td>
<td class="nump">10,825<span></span>
</td>
<td class="nump">6,798<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,289<span></span>
</td>
<td class="nump">21,618<span></span>
</td>
<td class="nump">17,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,616<span></span>
</td>
<td class="nump">31,654<span></span>
</td>
<td class="nump">15,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember', window );">Captisol - Core</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,682<span></span>
</td>
<td class="nump">9,551<span></span>
</td>
<td class="nump">10,935<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember', window );">Captisol - COVID</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,827<span></span>
</td>
<td class="nump">32,116<span></span>
</td>
<td class="nump">82,846<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,550<span></span>
</td>
<td class="nump">29,791<span></span>
</td>
<td class="nump">30,316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember', window );">OmniAb Technologies | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,821<span></span>
</td>
<td class="nump">16,470<span></span>
</td>
<td class="nump">14,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,998)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,806)<span></span>
</td>
<td class="num">(15,187)<span></span>
</td>
<td class="num">(12,410)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember', window );">OmniAb Technologies | Royalties | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">402<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember', window );">OmniAb Technologies | Contract | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,821<span></span>
</td>
<td class="nump">16,068<span></span>
</td>
<td class="nump">14,380<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember', window );">Ligand Core Business | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,854<span></span>
</td>
<td class="nump">86,642<span></span>
</td>
<td class="nump">125,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,834<span></span>
</td>
<td class="nump">27,030<span></span>
</td>
<td class="nump">80,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember', window );">Ligand Core Business | Royalties | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,616<span></span>
</td>
<td class="nump">31,252<span></span>
</td>
<td class="nump">15,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember', window );">Ligand Core Business | Contract | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,729<span></span>
</td>
<td class="nump">$ 13,723<span></span>
</td>
<td class="nump">$ 15,936<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116519287216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2010 </div>
<div>contingent_value_right </div>
<div>contingent_value_right_series</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NumberOfContingentValueRightsSeries', window );">Number of CVR Series | contingent_value_right_series</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,407,000<span></span>
</td>
<td class="nump">$ 19,407,000<span></span>
</td>
<td class="nump">$ 30,889,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Transferred over Time | Phase 3 Clinical Trial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGross', window );">Gross contract asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Transferred over Time | Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000,000<span></span>
</td>
<td class="nump">375,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember', window );">Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare', window );">Number of CVRs issued per acquiree share | contingent_value_right</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries', window );">Number of CVRs issued from each CVR series | contingent_value_right</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders', window );">Frequency of cash payments to CVR holders</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella | Earnout Rights for Partner Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency', window );">Earnout rights recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember', window );">Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Mark-to-market adjustment of CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(400,000)<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyIcagenMember', window );">Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Mark-to-market adjustment of CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities', window );">Payment for contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,655,000<span></span>
</td>
<td class="nump">142,655,000<span></span>
</td>
<td class="nump">321,586,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,291,000<span></span>
</td>
<td class="nump">9,291,000<span></span>
</td>
<td class="nump">11,157,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">317,000<span></span>
</td>
<td class="nump">317,000<span></span>
</td>
<td class="nump">349,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">3,358,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,542,000<span></span>
</td>
<td class="nump">5,542,000<span></span>
</td>
<td class="nump">7,364,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">960,000<span></span>
</td>
<td class="nump">960,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="nump">86,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,248,000<span></span>
</td>
<td class="nump">123,248,000<span></span>
</td>
<td class="nump">290,697,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,407,000<span></span>
</td>
<td class="nump">19,407,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,993,000<span></span>
</td>
<td class="nump">23,993,000<span></span>
</td>
<td class="nump">40,624,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="nump">86,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="nump">86,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,586,000<span></span>
</td>
<td class="nump">4,586,000<span></span>
</td>
<td class="nump">9,735,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,889,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,533,000<span></span>
</td>
<td class="nump">118,533,000<span></span>
</td>
<td class="nump">280,553,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">3,358,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">3,358,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,533,000<span></span>
</td>
<td class="nump">118,533,000<span></span>
</td>
<td class="nump">280,553,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,000<span></span>
</td>
<td class="nump">129,000<span></span>
</td>
<td class="nump">409,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,819,000<span></span>
</td>
<td class="nump">6,819,000<span></span>
</td>
<td class="nump">7,713,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">317,000<span></span>
</td>
<td class="nump">317,000<span></span>
</td>
<td class="nump">349,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,542,000<span></span>
</td>
<td class="nump">5,542,000<span></span>
</td>
<td class="nump">7,364,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">960,000<span></span>
</td>
<td class="nump">960,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,000<span></span>
</td>
<td class="nump">129,000<span></span>
</td>
<td class="nump">409,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfContingentValueRightsSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Contingent Value Rights Series</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfContingentValueRightsSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (ee)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyIcagenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyIcagenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCydexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCydexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyXCellaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyXCellaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116530879712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details) - Level 3<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value of level 3 financial instruments as of December&#160;31, 2021</a></td>
<td class="nump">$ 7,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHolders', window );">Payments to CVR holders and other contingent payments</a></td>
<td class="num">(1,545)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments to contingent liabilities</a></td>
<td class="num">(309)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition', window );">Contingent liabilities from xCella asset acquisition</a></td>
<td class="nump">960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value of level 3 financial instruments as of June&#160;30, 2022</a></td>
<td class="nump">$ 6,819<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116620738560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - reporting_unit<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116522830848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>option </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,326,000<span></span>
</td>
<td class="num">$ (7,175,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustments to additional paid-in-capital from warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToUnwindWarrants', window );">Payments to unwind warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ProceedsFromUnwindingConvertibleBondHedges', window );">Proceeds from unwinding convertible bond hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NumberOfOptionsUnderConvertibleBondHedges', window );">Number of options under convertible bond hedges | option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">598,021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="nump">$ 115,499,000<span></span>
</td>
<td class="nump">115,499,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 343,301,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 733,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate (shares per $1,000)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0040244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,900,000<span></span>
</td>
<td class="nump">$ 16,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortized issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod', window );">Repurchased amount of debt instrument</a></td>
<td class="nump">$ 20,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,000,000<span></span>
</td>
<td class="nump">227,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes</a></td>
<td class="nump">19,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
<td class="nump">223,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_RepaymentsOfNotesPayableInterestPortion', window );">Accrued interest portion of repurchased amount of debt instrument</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000.00<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 343,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_IncreaseDecreaseInDebtDiscount', window );">Increase (decrease) in debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued in public offering (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,018,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,559,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsForConvertibleBondHedges', window );">Payments for convertible bond hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 315.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustments to additional paid-in-capital from warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Accrued Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate (shares per $1,000)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0052317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 191.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Stock price trigger to classify convertible debt as current (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Debt Instrument, Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger', window );">Maximum threshold of debt trading price trigger (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Repurchased Amount During Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtInstrumentRepurchasedAmountDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_IncreaseDecreaseInDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Debt Discount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_IncreaseDecreaseInDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfOptionsUnderConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Options under Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfOptionsUnderConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsForConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsForConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToUnwindWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Unwind Warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToUnwindWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ProceedsFromUnwindingConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Unwinding Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ProceedsFromUnwindingConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_RepaymentsOfNotesPayableInterestPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Notes Payable, Interest Portion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_RepaymentsOfNotesPayableInterestPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116531161296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Senior Notes - Notes Payable (Details) - Convertible Notes - 2023 Convertible Senior Notes - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>May 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract', window );"><strong>Notes Payable, Current and Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of the 2023 Notes outstanding</a></td>
<td class="nump">$ 115,499,000<span></span>
</td>
<td class="nump">$ 343,301,000<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized discount (including unamortized debt issuance cost)</a></td>
<td class="num">(525,000)<span></span>
</td>
<td class="num">(22,584,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Total long-term portion of notes payable</a></td>
<td class="nump">114,974,000<span></span>
</td>
<td class="nump">320,717,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of the 2023 Notes outstanding (Level 2)</a></td>
<td class="nump">$ 110,590,000<span></span>
</td>
<td class="nump">$ 341,801,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116523152208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate (as a percent)</a></td>
<td class="num">(40.70%)<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
<td class="nump">21.60%<span></span>
</td>
<td class="num">(25.00%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount', window );">Pfenex CVR adjustment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, CVR Adjustment, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116519129024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at beginning of period (shares) | shares</a></td>
<td class="nump">2,199,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (shares) | shares</a></td>
<td class="nump">734,218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (shares) | shares</a></td>
<td class="num">(25,798)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(30,417)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at end of period (shares) | shares</a></td>
<td class="nump">2,877,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 106.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">91.58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (USD per share) | $ / shares</a></td>
<td class="nump">20.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">67.60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 103.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Stock Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (shares) | shares</a></td>
<td class="nump">264,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares) | shares</a></td>
<td class="nump">186,526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSUs vested (shares) | shares</a></td>
<td class="num">(133,173)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(1,378)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (shares) | shares</a></td>
<td class="nump">316,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 138.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">87.32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">RSUs vested (USD per share) | $ / shares</a></td>
<td class="nump">120.66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">137.16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 115.58<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116523132272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 11, 2019</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Outstanding options that are exercisable (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Outstanding options that are exercisable, weighted average exercise price (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102.1<span></span>
</td>
<td class="nump">$ 102.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized stock repurchase amount</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Period in force of stock repurchase program</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized stock repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248,800,000<span></span>
</td>
<td class="nump">$ 248,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate', window );">Share purchase price as percent of market price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod', window );">Shares available for future purchases (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,007<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EmployeeStockPurchasePlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EmployeeStockPurchasePlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares to be repurchased in accordance with a policy to use treasury stock to satisfy share-award conversions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on purchase date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116525442976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitment and Contingencies: Legal Proceedings (Details)<br></strong></div></th>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>civil_complaint</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember', window );">US District Court for the Northern District of Ohio</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of civil complaints filed against entity</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116526087136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Narrative (Details) - Maximum<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term of operating leases</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal term of operating leases</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116521252352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Operating and Finance Lease Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">$ 24,711<span></span>
</td>
<td class="nump">$ 16,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease assets</a></td>
<td class="nump">15,032<span></span>
</td>
<td class="nump">16,207<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LeaseRightOfUseAsset', window );">Total lease assets</a></td>
<td class="nump">39,743<span></span>
</td>
<td class="nump">32,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">2,501<span></span>
</td>
<td class="nump">2,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current financing lease liabilities</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LeaseLiabilityCurrent', window );">Current lease liabilities</a></td>
<td class="nump">2,551<span></span>
</td>
<td class="nump">2,099<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Noncurrent liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">27,088<span></span>
</td>
<td class="nump">15,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term finance lease liabilities</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 29,666<span></span>
</td>
<td class="nump">$ 17,651<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Right-Of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140116525874496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturity of Operating Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remaining six months ending December 31, 2022</a></td>
<td class="nump">$ 2,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">4,634<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">3,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">3,811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">4,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">4,128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">14,760<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">37,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance', window );">Less estimated tenant improvement allowance:</a></td>
<td class="num">(1,358)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(6,742)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 29,589<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, Tenant Improvement Allowance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>lgnd-20220630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lgnd="http://www.ligand.com/20220630"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lgnd-20220630.xsd" xlink:type="simple"/>
    <context id="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iedc598dd9b154369925ac2b71e806c9f_I20220805">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2022-08-05</instant>
        </period>
    </context>
    <context id="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i245a60f5c38a4697983ab57c4578e9d1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4451c0bbe6454e30a9400b8f2b6b236b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iadd0658df38142da9de49541fcf1e87b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i36945e4ea3d94671ba79140fa3bfeed8_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifc58590074134385916f9aa21fadb3a5_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie0dc4219be484ce8aa0ac5cb14f54a41_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i06d3227a7eb74265aa981e7a0d0ff54a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iede13d72d60b42d785f8340ba1c81680_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0f25445795154f5a93fcbfa2d95e4ca4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4abd7ed5056140b3a6f412c3dcf92315_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib690ef44f20c492ba685cf71add617d4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icf5c36ba61894d93b55a210349a7ccf2_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i75907dd7ed51403bb417727e96e225eb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i85f8622834f34bd190af73c102a914cc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3cfa0d1834f445a49fb6b65740cb4cd4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic1c61c60b6194b22adf91c5e2cbe87ff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iedb09b7e2fcb4ab7aebd9117745eb914_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i35897df76b71438cbfcc21f5fd8c25ba_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0f5459b627e84394b6d868b1c0657e63_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i362afaf034ae4672be24c81c6b93536c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76ae97986fac4a65aa555297c9706a05_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id3e93db38a0c4a65a7538c436c978d22_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3d94a99e36434ce3bcb95c74af16730c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id0861fff98f443b690754c837f781b97_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i897aeacae0a54360ae9e4b7fef689689_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i611ca28f9b2b49b0ab2181e8b332d455_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ida17f1e22fcc46d888527d5585b5db6a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9a7ab73aa7904f7ebaf48f7dce5ab966_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if13fbe07ca154d04930101ff2e942a66_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5cd03be6fae54778adda0e81e4ca4bb6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if12c3ec488ca49709a4421cb42f9abbb_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i795e50fb1bd04eb1bed4a653ee8c754a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idcedf9519070438b806357a9dd22600a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i372b4ca31b6148f580791f16233559c6_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i518323b49cf84a3596e600f5a1f4c5de_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i66a4853ebfb84f1cbf13e26153087b0f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2f1ead9f69da4d13ab756c627f382b38_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1d5f804285544b3c85561c7025916c3d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i85f076aef7744e2ba3466da10e42c30c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie007cd8b0d0a49a8b243568f89c18ee8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8cceb54932694869a897f6267d1671d2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibe339071fd4f412d97a4a4b4efe13b85_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i219e6f0c67584cdfb9cc97d98d4660f3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i03c127685aa945a6ac245b4904e579a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1df447ab25dd46908c81e1e59a7690f4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if4f3cf826076418d8df0ad8aa0976c1d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i61b5666e80a3489388fb05d72e4d486a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i53c139d692e24ecc9eebbd4f8f6a7986_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idc2e728e65f543a0ab65714937be981b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1a532b4ea5824e5e9ec5170d5b4c3fc7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibd4986c032bd490fbee831d61a9cb80f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i57a179932e3e460783c473c4033afd37_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie03542cce19b4e7dbd6fba43babfe9b6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia4081bccf13b424e88e365ad46cac9da_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2c30a433e75e4d8cacce52bacc437e16_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if658034f46704cf587bbef2048752ad8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1cfad7f1f04049718d638cb007561413_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib892982e78324d6ca473f2fc2a6da00a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iabed2424af8d4db5bfade373c80a8e1f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if6f0ed8f7b464306ae6088a4c1723287_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ieec58def6fea427489c80f3c77282f03_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibda621e9fcaa4a23bea03af000841d41_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic543f595905b456b86f091c41fcf15e9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i99d5ee9673ec4131948b388970c8f765_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia0f9248329c9468fb09df5396db98bf6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id15423cf11ad45caae992641de4875c1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6eba3264dc6c4943a87106e878898597_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iff72851b58aa45ffa732bbda41560b3d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib165267a91674f5987986a924b2120c4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i70869135d3c34c1db5e1e22b66ea39ae_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic99e0c134900425886aaac7ceb463839_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icfe69b74f9a142af8ba9b55191035604_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9ab02c7bc2a9493ab64ac0276d32fdff_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id78b53631f2e4d38a201cb8afeffe74e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic5a2dea7e0f94760977b89f0e7531354_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icb6fe6bdce8242319de5782b9769f8db_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6e8e45384b614e7c8354672d3699a80a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9775a3f35190447f9e3b5d21d55faad5_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i685f29c36ddc4fdfbdef1ce148091d2a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i94fdbb4317f34a609cb534522aef7982_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id24caccafc6747c69868162bdd0769d2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i82095dd45f8544edb3410b6b83bf52ab_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idd89e80d3f3d44d4b5281b5916b0c8b2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9c96b32616194c1b937efd406717542d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ife30a3da671b425e9383ee095533c9bd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if7768c766ed64817819e47086ac8e52f_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7b46ae1b80044cff933ed7f5b6074bfd_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i69264884c80f4de496ecd4d3871f13de_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5f0ce6d74bbb404494d3b9ecd07c5c1d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2a26669fd70d437e8dbf0d46744ee68b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1e1cee720dbe4a518d1861c1471e0601_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iac98dc8419824fccbffe08deef56431d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id1b6772c114f4296b3710452fad3bbf0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iac3e999d74914146b6972963646d77d3_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3af2fa579c8d4d0298cd4adaf64f562a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibfe3cc306f014ceb8d03ee2a6e86a398_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie3a848d86a33454d8e308d5c5596a288_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3d72210a2a5943cf95ded5fa3f11f523_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i173a08fd950747df9d01f035da9f023d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5c2a1b1ca5514671b9aba265dfb7b572_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i38baca3871d94649bea9b951f8a95afc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia510a863a60a463ea460982ee2b575b2_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id554d23e5a4f40a5badd18e8f8b0a8b7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaf0d6dad86164f7eaa342595027db37f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i34e3ef31b9a84e509bed5d667042120e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1a41570df267433d868066c140f59972_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1a06723b9575442cbe0af518dda8db12_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia55aca14b36b43b491df2ecf96d2c1f3_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie323179691704681be1652faafc0e9a2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaaf6ba28216b419e91b9fc13c3c06c9d_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i077a95de6c1246a0ac1df496ba8e517a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4d5e8d1f727f43ec8ecd549503e85c2e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3b9a9049f59047158b0b52d7d59b7745_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i56f53586b69f4a9aa74c3e01f3093f45_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id64fbff1c6e448fe994106b92f9144b9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i21b62bb4bd3243f98e9d6acb69bbd14d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i205fad57592a433b83307f6fea8119cc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4c186e23a71a4fb793fc929a6f1bae65_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ida960da78ddf459ca1c4198305520fb4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibce85fdb40ae4d199b3b166284807908_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5890ea92184146ffb7b0e8ae84bcf98b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0560066d2edf4834bad46274f6b43123_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0e34e3b904034f19a68a68a7d815b0af_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie18284bcc4c545f2af6dd44ec4f776be_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5ec9f7faaf814c3eb810dd8294a78adb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i010958049e69464b916484b2032627e5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3accfb128ab3447ca71c87b81da62c0f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i86ab427a236f4147922fee98ff203990_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i41836ea2320e4ecdbaed6d4b7e28b1bc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2f1b65679e05403d90db551817862dd0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i38d13f31c97741448d56e9f1fe72169f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0adfd09ddb864f8c9e65d502b415fbc1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8c8b7e890d8e4b648961c025a2b1a977_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i411c360a01fd4666a436f4eafb9202d7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id7bd5f1328d942879973ee2497a5b28d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia37ae682ab9d400d972e4f8f784305f9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if91b70357fb44a83b104d251dcf482de_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1c0ab083247d44e1ab92188a9e44c058_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i934ac72595594c6b994d97c0a1b7f89a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibe59142403aa47d6801e8bc016edf9d7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i886a648c2410405ea2213afd1c7526cb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i07d69c84f97e467a8586439168e3a979_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icc20f2ad27ad4526a19a3ed221aa03e3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i634f77b02fdb422b81be6145a0ca48da_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5690281660a344fd9548591a6f266ac4_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic8a73247f7a945ea9b05cf35b6cc0850_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id6ac9689508e4114ba54882dec295d93_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id6900c46450645478d0da3f5fb2d9670_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibd353da9346c4eff9ef59fce65083fef_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i29682bf3513f43abae73bf36fdc07869_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibca091886a1342b2acf333d5f3b78776_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i074a3e4a71c9476fba4587a19825900e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i94c20b531d9a49f3ba7f9be28e443ebb_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idde310731c5f4ddf8421b11a76439a76_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4653b493ab2c477f934120be3d321770_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iab8c600366d6408f8d68011ffa0eefb3_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i62f296ba5f6d4e0080870b494a4cb1f3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7f4ae166f88f42b9ad465f19b7a2b5dd_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib5ad93d1c25b4a4e91833014363da039_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id4d8ee4a829e4a9b9b6b4a7a447bdb79_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1aef4caca12a42dc91df79cbcf0581b8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5d6a3560d8b34a5cbe1f0942263178b3_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia4ad93b5e6dd4cd99dc35ab96510e147_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i24cd0274970047cebd3b261d67019060_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if037b66c12a84486bd10aab5f91c4756_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iad364541fb5f472591361e583d131e10_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifbe273cd726b46b98c132ca315d75750_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6e8af247251140e088c62af9f5e1be66_D20220101-20220322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-22</endDate>
        </period>
    </context>
    <context id="iebd5e1dca73546bab3c7f7e7fd807132_D20220323-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-03-23</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iebdd064189bf40a1b0af7c11c05b508a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i12b9af2332e24b278e251428d3112d54_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iee885ce7e8c546a58c101265454c96b4_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i554afd03f39f48b1b340f2c1f5e63b38_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaa01d917cb584f68ad23a0a988be1019_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5cc3aca482094a8ea993165932b200f4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if0323f8ac68c4e58abf54420181eb553_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i53051290139d4df09cbb95cc83d65ca5_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i09a96cf6288542ffb7bf41f87f2f1513_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i24d7aae3601941aca19f23d31f03721a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6a04509ce52a4958bd559598330aa15e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8c045aa28e3844fcb9eff412fe495b73_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic75dfe15187544a5842c26db724997b1_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id13f1a41d92a446e880e3b7f996d39bb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i55d6c284cd324a37b54f99d3f372c0d3_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i67ed19c1f7cc4ba5a898950694d6aad5_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i08264c293ad941d38c85c6df434e3b96_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i17513104887747d094c8f90449ce26f3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0fff928bd965435baa9430b0a51bc952_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i350d8bdb260b4f158bbe1c83371f08d1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3945ba7328d4488dbe199f8a6fb8806a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i996c3ee8de704c67a1f48c7b57639172_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i11be9eb5ab6343b9abe0845805816826_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1ef05994b78847b2b9a1ecd095ccd023_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifb5402adc253464eb373188274f50300_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idbbe17fffac4478caf19f21253a14fb4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i252d1e5433c94a97bc58b777f5a25e67_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib5d7aab7d47f4e158191d415ae90524f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5ada02c52f844af586bb3e63e4ec6411_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i06363049796846649c3d730ee81b5bda_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4c5fe50a04314348adf834a5587766ca_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7b9c142e9fb346ec975852f818248861_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i267e2274bd584fe58769c5a1656b12db_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id61d812ca09145fcb40e16dbd4b8d9a8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5a56e0d3e9a94dab9817eae0e11974be_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibe938625cbc5444690c9b08e8e1f3fc6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib02472ad4a604f96aae20a25b68fd2fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic67146a8e91942cdba9ed20b277604c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i14e0598617224fafbf13d5add97de1a6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i456aa02326a84161ab7d7363b6b524cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3eea2d5922e24e8a9f8cf6052385e139_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0225b46271344284ad100ef90961626b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1ebf4f8772924ada8190747259ee3c18_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3157c06168094203bfe558b4e6173ba6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i45e9971abf3b469ea61649ddf4748670_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia7d27b9f62664dffa76f1fe952c1f9ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id3a7e52f19d64b8fa2a2e2476fa0bfa1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2fd7b10617e343eca1d9556dffc4f114_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i225cccb2c22740ca8ac988545b58446a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4bb2398d3a3048748fb70e3df8843949_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i53f9632ba6184340b79bb0cd30ae04e2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i548c288771a540749668a107a155b125_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0b44abccb2d044b2849d4fc6191d00dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iecbe3fa2930442bb98e4b5b4bb9e5256_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i21cc39d790414198a5384b22bc9f8914_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2e1f31d766a7446d9b402aa372153d71_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0a32d5c0d47d478abf53a297880bc04d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3ebd32fe9f284200b88a29fe00e1c59e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i75a462cc318440799e9195fc83206c6b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id70c6611cf0349bbaa43d7ca45e9e20e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib13e8f86f4bb4792a23bb3135840b332_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4e4b0b1b1c134aef858b246643f58be5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1516fb25275e4bbcbaaca00a3711b3cf_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifc548b28534c4e0aa35fef883c9ffd4c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i447b152d2cdc4923a33b76efe86e78f6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i05ba522e2c8b438eb09faef77aac2491_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0671049fb2c74897aaed6cf1402f67e0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7b39471746204503b6025c517a2740ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i084dd0497977421093be2aa2620a6cf0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0a748e36f24545bc8aa6196a0de9b8ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8e4644a9e4754293b2965e4853bb25b1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2cfe5c65f77d4902805d7bd75bdafe01_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5a7a292a775a4e939d542844f0e07327_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i625cf43be4a04d1296f91edac39e0b36_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i170fa4640e6342fb9e5d5b0994468676_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i602915a018774dab8faf3722799d8baa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i64894a5f080e4b3f8b457334acdc1cd2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4dea4d860bca4c7ba6c68ce71c7ff2d4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibc6f643b427d4d95b47f5f8bfbd1d696_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8f541feaadce43de9b83e05a3cc81f9f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i34af6b0108f84a96869a676335de8337_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifbe8e10c0bfa405f91e4f5fd659e1ff4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i575234d878cc49f0b7c5fbf81531c46c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7263c122813549ad8e04254ba32ff7ca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if1678eaf06a745c291b81999f992b9e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id87a26c787994153889a94e263789923_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2984eff859114415a857b8b3db2c96d5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7255b76317d34906aecab88a19308702_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9e3c748d3af242daa261e5b79b0823b6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie2c209582594436fa1bb0457e3e6696f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibe0bed5f1c9144b18cb2a5768de65286_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7cb7b230f33440da931414c29bbcf6cc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icd9c6786655f4c92943a637689d9c95f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id0ab0ebcdc664305a06c43149d516db8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide5f7ad99ed84ec48486190201956204_D20100101-20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-01-31</endDate>
        </period>
    </context>
    <context id="i704ccd2c79674fa98ab76165119a7944_D20100101-20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-01-31</endDate>
        </period>
    </context>
    <context id="i84a709f438684614a9dd32c76e70d210_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i15b339fe796a4e2ba32e8dfbfdfa27aa_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibd35f6c5d8e840969d67c38a72475508_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8a9916b0d831414c99923be559940db0_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i78d968b6172d467c8f046b7fe14c493d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia23c3aaaac85402db485305cdb6cc3f2_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9b5f73a727824f0ca1db33f131e1d73a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie1b59d9a96ec4375a669fbe2a05bd3b4_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idf6982ebd2184a96b2c741ac8887e7ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic789c8af369747eba6fa7cf57d81c6ac_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifd61ac74a7ff4488ac2e7e7b04b7a49c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i206dc67e487f44bfa1e9279e7b7981b7_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="i1bdef6e83d484a31ae28be0288d4014a_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="idaa07f7868af4d3589b8f66d33b6f893_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="i9a30dda7078441eaaca37acbf3037be6_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i5de8a5b0c1fa4760b0f3c075d7b6c6db_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i5474a312fb154f69820ca3cc97e950a7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic0c4e811de974223a7854588c77071f0_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibc028f1c7d9b45d5b5409ba862c9757c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idbf91b4ebd6f491a92e85e1fc1d051d9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d97584fcd39416497ac8ddc28dccf83_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i9ed745872a5b4347aba60ffe4aed601f_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i965fba54a35142f48c2ec3ae55ae973f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ice70706143fc4fa587f3b05dfc86607f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if55454c1b587475f8f377fec9eb04748_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0275f925a31840af927726857ad4931a_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iab997394326847b98b9a6709dde8df9e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i81905d26e9e4434aa6c656e2d1a052fd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i898678e2c6ba4a73a10091c6fa20543d_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifae3653e5fe6429a946af263fcc4fd84_I20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2019-09-11</instant>
        </period>
    </context>
    <context id="i93f3ccedcca8446095a986546e891de8_D20190911-20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2019-09-11</startDate>
            <endDate>2019-09-11</endDate>
        </period>
    </context>
    <context id="i2ad65c5ebdff424fb802e081f2da87ec_D20191031-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:USDistrictCourtForTheNorthernDistrictOfOhioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-31</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ida31ec29c0a64e779c80ba3c979f2b18_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="position">
        <measure>lgnd:position</measure>
    </unit>
    <unit id="reporting_unit">
        <measure>lgnd:reporting_unit</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>lgnd:segment</measure>
    </unit>
    <unit id="contingent_value_right">
        <measure>lgnd:contingent_value_right</measure>
    </unit>
    <unit id="contingent_value_right_series">
        <measure>lgnd:contingent_value_right_series</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="option">
        <measure>lgnd:option</measure>
    </unit>
    <unit id="civil_complaint">
        <measure>lgnd:civil_complaint</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80L2ZyYWc6NTM3Mjg0ZWRjMzA3NDhmYjhhZmYyYjcyZDczYzhmNzMvdGFibGU6YTY0ZTAxYWFhYjg1NDkxOWJmYjVmMTgwYTQ0NDkwYmQvdGFibGVyYW5nZTphNjRlMDFhYWFiODU0OTE5YmZiNWYxODBhNDQ0OTBiZF8yLTEtMS0xLTc3MTcx_9a688112-d25c-4b34-8746-170148d9cf6a">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80L2ZyYWc6NTM3Mjg0ZWRjMzA3NDhmYjhhZmYyYjcyZDczYzhmNzMvdGFibGU6YTY0ZTAxYWFhYjg1NDkxOWJmYjVmMTgwYTQ0NDkwYmQvdGFibGVyYW5nZTphNjRlMDFhYWFiODU0OTE5YmZiNWYxODBhNDQ0OTBiZF8zLTEtMS0xLTc3MTcx_0af9ea75-6838-4c20-b595-ad76445c58fc">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80L2ZyYWc6NTM3Mjg0ZWRjMzA3NDhmYjhhZmYyYjcyZDczYzhmNzMvdGFibGU6YTY0ZTAxYWFhYjg1NDkxOWJmYjVmMTgwYTQ0NDkwYmQvdGFibGVyYW5nZTphNjRlMDFhYWFiODU0OTE5YmZiNWYxODBhNDQ0OTBiZF80LTEtMS0xLTc3MTcx_19e3e21b-36b0-4307-bd73-6c5a7a3d1e5c">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80L2ZyYWc6NTM3Mjg0ZWRjMzA3NDhmYjhhZmYyYjcyZDczYzhmNzMvdGFibGU6YTY0ZTAxYWFhYjg1NDkxOWJmYjVmMTgwYTQ0NDkwYmQvdGFibGVyYW5nZTphNjRlMDFhYWFiODU0OTE5YmZiNWYxODBhNDQ0OTBiZF81LTEtMS0xLTc3MTcx_026f02a8-d1fd-4fea-a55e-953d0b89e39b">0000886163</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80L2ZyYWc6NTM3Mjg0ZWRjMzA3NDhmYjhhZmYyYjcyZDczYzhmNzMvdGFibGU6YTY0ZTAxYWFhYjg1NDkxOWJmYjVmMTgwYTQ0NDkwYmQvdGFibGVyYW5nZTphNjRlMDFhYWFiODU0OTE5YmZiNWYxODBhNDQ0OTBiZF82LTEtMS0xLTc3MTcx_a3814069-5c98-4738-8ed8-f2c06ff27c65">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i35897df76b71438cbfcc21f5fd8c25ba_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMy0wLTEtMS03NzE3MQ_d4683d88-94ef-4a22-8ed5-d4dd9b4356a7">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i1bdef6e83d484a31ae28be0288d4014a_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80Ni9mcmFnOjQ3ZmMyMjAxZWY1YjRmNjc5Y2Q4YWIzMjVlYWJjMGQwL3RhYmxlOjE0Y2NiYjg4YTAzZjQ2OTRiZGZlMzU3ZjRlZmVmYmI1L3RhYmxlcmFuZ2U6MTRjY2JiODhhMDNmNDY5NGJkZmUzNTdmNGVmZWZiYjVfMi0xLTEtMS03NzE3MQ_5db6052f-20bb-4d56-89b5-f52ee302db2d"
      unitRef="number">0.0040244</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i9ed745872a5b4347aba60ffe4aed601f_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80Ni9mcmFnOjQ3ZmMyMjAxZWY1YjRmNjc5Y2Q4YWIzMjVlYWJjMGQwL3RhYmxlOjE0Y2NiYjg4YTAzZjQ2OTRiZGZlMzU3ZjRlZmVmYmI1L3RhYmxlcmFuZ2U6MTRjY2JiODhhMDNmNDY5NGJkZmUzNTdmNGVmZWZiYjVfNC0xLTEtMS03NzE3MQ_5bf2502a-b382-48f8-8442-2f5932f07e65"
      unitRef="number">0.0052317</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8xNzI_d35fca11-046b-4f34-9522-785a437375de">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6NzNiOTM2OTJmYjBlNDQ0ZTlhYjFiM2Y0NTQ0OWI4YzcvdGFibGVyYW5nZTo3M2I5MzY5MmZiMGU0NDRlOWFiMWIzZjQ1NDQ5YjhjN18wLTAtMS0xLTc3MTcx_fedd4a2c-5a88-413e-baba-2f5481b0de18">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8yOTY_4f392963-a184-49d3-b495-98839710c8a2">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6YzgxZjQ1MzdlZDZlNDhjYWJjN2I1MTIxMGYwNzlhYTAvdGFibGVyYW5nZTpjODFmNDUzN2VkNmU0OGNhYmM3YjUxMjEwZjA3OWFhMF8wLTAtMS0xLTc3MTcx_9784fc66-d2e5-488f-bb9e-1a23cf944028">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8yMTg2_bba3194a-7504-4909-bfd4-293c1fc42dfa">001-33093</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8zOTg_bc1de14a-12c4-4192-8e6d-5f4bf45cd4e1">LIGAND PHARMACEUTICALS INCORPORATED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6OGFmM2JhOGYxNWU3NGI5M2I3MTFlNWE2ZWQwNWI5MDgvdGFibGVyYW5nZTo4YWYzYmE4ZjE1ZTc0YjkzYjcxMWU1YTZlZDA1YjkwOF8wLTAtMS0xLTc3MTcx_785d43d3-e0a5-4e29-b5b4-87d6ad4ec16e">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6OGFmM2JhOGYxNWU3NGI5M2I3MTFlNWE2ZWQwNWI5MDgvdGFibGVyYW5nZTo4YWYzYmE4ZjE1ZTc0YjkzYjcxMWU1YTZlZDA1YjkwOF8wLTEtMS0xLTc3MTcx_3b70892f-3f65-46bb-954d-df4a81cead74">77-0160744</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6OGFmM2JhOGYxNWU3NGI5M2I3MTFlNWE2ZWQwNWI5MDgvdGFibGVyYW5nZTo4YWYzYmE4ZjE1ZTc0YjkzYjcxMWU1YTZlZDA1YjkwOF8zLTAtMS0xLTc3MTcx_a320c6e0-d8fd-4fff-b707-a2d4ebe49104">5980 Horton Street, Suite 405</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6OGFmM2JhOGYxNWU3NGI5M2I3MTFlNWE2ZWQwNWI5MDgvdGFibGVyYW5nZTo4YWYzYmE4ZjE1ZTc0YjkzYjcxMWU1YTZlZDA1YjkwOF80LTAtMS0xLTc3MTcx_6d825a2b-c12e-4d47-aacf-a9bd1719b1b3">Emeryville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6OGFmM2JhOGYxNWU3NGI5M2I3MTFlNWE2ZWQwNWI5MDgvdGFibGVyYW5nZTo4YWYzYmE4ZjE1ZTc0YjkzYjcxMWU1YTZlZDA1YjkwOF81LTAtMS0xLTc3MTcx_a9dc92b3-8017-49cd-9a5e-98145fd4bf04">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6OGFmM2JhOGYxNWU3NGI5M2I3MTFlNWE2ZWQwNWI5MDgvdGFibGVyYW5nZTo4YWYzYmE4ZjE1ZTc0YjkzYjcxMWU1YTZlZDA1YjkwOF81LTEtMS0xLTc3MTcx_6950319e-89b4-4a08-bc1d-4b114e87742d">94608</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8yMTg3_4a777461-8977-4b7c-90c6-677499c7f7e6">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8yMTg4_c8aa23f2-b4e4-44a3-b0f4-ed48c2f479a0">550-7500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6ZjhjZWZhY2NjNjRlNGZiODhhNjU4YTkyYzE3MGQ2YjAvdGFibGVyYW5nZTpmOGNlZmFjY2M2NGU0ZmI4OGE2NThhOTJjMTcwZDZiMF8xLTAtMS0xLTc3MTcx_e694512b-2dd4-43c6-ad0f-ec5ba8f227ba">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6ZjhjZWZhY2NjNjRlNGZiODhhNjU4YTkyYzE3MGQ2YjAvdGFibGVyYW5nZTpmOGNlZmFjY2M2NGU0ZmI4OGE2NThhOTJjMTcwZDZiMF8xLTEtMS0xLTc3MTcx_61d17c89-ba9e-4157-8754-f1f1db414981">LGND</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6ZjhjZWZhY2NjNjRlNGZiODhhNjU4YTkyYzE3MGQ2YjAvdGFibGVyYW5nZTpmOGNlZmFjY2M2NGU0ZmI4OGE2NThhOTJjMTcwZDZiMF8xLTItMS0xLTc3MTcx_f449eeda-b7e6-4bec-8e11-8a030984f051">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8yMTg5_46bae869-2edd-42fb-90b3-685c446c93ac">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8yMTkw_a979645f-5ad5-4c2d-bd8d-aa52e759a08f">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6M2Q5NDQyZDNlZjdhNGZhZmE5ZmNlMmQ1NzRiM2E4NDMvdGFibGVyYW5nZTozZDk0NDJkM2VmN2E0ZmFmYTlmY2UyZDU3NGIzYTg0M18wLTAtMS0xLTc3MTcx_4a44330d-e86d-45ec-a8e3-425749cf450a">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6M2Q5NDQyZDNlZjdhNGZhZmE5ZmNlMmQ1NzRiM2E4NDMvdGFibGVyYW5nZTozZDk0NDJkM2VmN2E0ZmFmYTlmY2UyZDU3NGIzYTg0M18xLTQtMS0xLTc3MTcx_e1df8e13-2014-475e-b001-8d3d51863626">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGFibGU6M2Q5NDQyZDNlZjdhNGZhZmE5ZmNlMmQ1NzRiM2E4NDMvdGFibGVyYW5nZTozZDk0NDJkM2VmN2E0ZmFmYTlmY2UyZDU3NGIzYTg0M18yLTEtMS0xLTc3MTcx_cef79db1-a43a-4d8d-af0b-13ea868f03f5">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8yMTkx_b0f8c845-f692-4b0c-88dd-0358a2335a7e">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="iedc598dd9b154369925ac2b71e806c9f_I20220805"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xL2ZyYWc6YWYyMTc2MzI5YmU1NGQ3Njk0N2E4MzE4MjdjYjI2NmEvdGV4dHJlZ2lvbjphZjIxNzYzMjliZTU0ZDc2OTQ3YTgzMTgyN2NiMjY2YV8yMTQ5_95f2c32f-9c97-4a16-b90f-d19382684944"
      unitRef="shares">16882751</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMy0xLTEtMS03NzE3MQ_5dfae075-6c6d-4e91-a629-13de873a606e"
      unitRef="usd">5280000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMy0zLTEtMS03NzE3MQ_5248ca8d-6022-48c9-83fa-dddcb6c1f2a1"
      unitRef="usd">19522000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNC0xLTEtMS03NzE3MQ_79ceb9bd-45d4-4e2d-9119-1fadcdbf85a2"
      unitRef="usd">142655000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNC0zLTEtMS03NzE3MQ_75c0b497-4640-40c6-b5d3-c48602b6e3a9"
      unitRef="usd">321586000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNS0xLTEtMS03NzE3MQ_261b1299-6376-4032-bb36-f2882dfdd69e"
      unitRef="usd">62308000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNS0zLTEtMS03NzE3MQ_40ae4cd0-0d5c-495c-8330-d47cd97819ee"
      unitRef="usd">85453000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNi0xLTEtMS03NzE3MQ_212be0c4-ff4b-4870-9a2e-aa0154a04bab"
      unitRef="usd">24773000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNi0zLTEtMS03NzE3MQ_ab4f81f8-790e-460c-a555-40ba0a584b06"
      unitRef="usd">27326000</us-gaap:InventoryNet>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNy0xLTEtMS03NzE3MQ_7485388e-20a8-47c3-91f1-acf9f2bfa020"
      unitRef="usd">964000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNy0zLTEtMS03NzE3MQ_f513ee36-2955-4104-8194-92da80bcb976"
      unitRef="usd">6193000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherAssetsCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfOC0xLTEtMS03NzE3MQ_eea90ff0-0007-4e2d-8f02-2be7ad3b5cfd"
      unitRef="usd">7804000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfOC0zLTEtMS03NzE3MQ_46940772-635d-450b-8ea1-dcdaf7b0000a"
      unitRef="usd">4671000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfOS0xLTEtMS03NzE3MQ_b2dc3933-7a4e-4063-9606-9310f20734f6"
      unitRef="usd">243784000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfOS0zLTEtMS03NzE3MQ_e7f1664a-6077-4bc3-a7ef-fe88fbeefdfc"
      unitRef="usd">464751000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTAtMS0xLTEtNzcxNzE_09420bac-dde9-49f6-ae92-48c892575a0f"
      unitRef="usd">35654000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTAtMy0xLTEtNzcxNzE_dbec134e-37fe-47b1-8fa0-337c312ef279"
      unitRef="usd">34482000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTEtMS0xLTEtNzcxNzE_9ff0c2de-4423-4606-885a-ee022c26d579"
      unitRef="usd">528364000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTEtMy0xLTEtNzcxNzE_de25fed1-b264-44ec-92ce-526be85451cb"
      unitRef="usd">551040000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTItMS0xLTEtNzcxNzE_2a145f8b-7f7c-41c3-89b7-dc1ffdf6643a"
      unitRef="usd">181206000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTItMy0xLTEtNzcxNzE_67c430f8-6e17-4ee2-b514-1be6a4c3cd39"
      unitRef="usd">181206000</us-gaap:Goodwill>
    <lgnd:CommercialLicenseRights
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTMtMS0xLTEtNzcxNzE_284f637b-7a95-4d19-9ea2-a41fc525f784"
      unitRef="usd">10267000</lgnd:CommercialLicenseRights>
    <lgnd:CommercialLicenseRights
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTMtMy0xLTEtNzcxNzE_8f684f35-d4f1-4ef3-ae98-45cbd488ba30"
      unitRef="usd">10110000</lgnd:CommercialLicenseRights>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTQtMS0xLTEtNzcxNzE_ed20e8de-5489-4c08-a07b-45db4cdb82b6"
      unitRef="usd">30954000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTQtMy0xLTEtNzcxNzE_3f540ca3-a743-4a05-b747-e486ac5534b4"
      unitRef="usd">20511000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTUtMS0xLTEtNzcxNzE_7b7e4018-99c3-4b02-9fd7-9e67903cbfd4"
      unitRef="usd">24711000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTUtMy0xLTEtNzcxNzE_4cf175ab-0484-4297-adaf-0bf50ba7bfe0"
      unitRef="usd">16542000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTYtMS0xLTEtNzcxNzE_95d07ca7-9cf4-4d35-ad46-b0d4dc3af058"
      unitRef="usd">15032000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTYtMy0xLTEtNzcxNzE_c1c06f7f-f3f5-4c5a-a2e7-23d075bf644e"
      unitRef="usd">16207000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTctMS0xLTEtNzcxNzE_f8c008b9-7b1b-46e7-be97-88bbb39c8a5a"
      unitRef="usd">6316000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTctMy0xLTEtNzcxNzE_38d0bfde-3695-43a4-ab02-869bbea8810a"
      unitRef="usd">2741000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTgtMS0xLTEtNzcxNzE_f06d5dde-24f6-4dc2-85d7-c5acdbbad160"
      unitRef="usd">1076288000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMTgtMy0xLTEtNzcxNzE_1b3d25e6-68f3-439c-bbf0-b9e93432be51"
      unitRef="usd">1297590000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjEtMS0xLTEtNzcxNzE_5859e4ac-15d5-41e2-b92d-dbec500f7d49"
      unitRef="usd">19153000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjEtMy0xLTEtNzcxNzE_5ceceaef-c91d-44ac-84a9-3e711becf018"
      unitRef="usd">8403000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjItMS0xLTEtNzcxNzE_67339292-2644-4be3-a4b6-3a32a9e319f6"
      unitRef="usd">14551000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjItMy0xLTEtNzcxNzE_c5fe2dd3-575d-4d60-b122-ea483ca2852c"
      unitRef="usd">17579000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjMtMS0xLTEtNzcxNzE_aab60843-5225-43bb-a0ea-8dfc9ae2aca1"
      unitRef="usd">3782000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjMtMy0xLTEtNzcxNzE_64417b89-651b-4e40-b3e7-0ae36bb1b659"
      unitRef="usd">0</us-gaap:TaxesPayableCurrent>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjQtMS0xLTEtNzcxNzE_54b2829f-1b1e-4510-a061-19b10176821c"
      unitRef="usd">2258000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjQtMy0xLTEtNzcxNzE_708f9b30-34cc-484a-bd30-257034502422"
      unitRef="usd">2588000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjUtMS0xLTEtNzcxNzE_ee745af8-7077-43e9-b038-07c3e5821454"
      unitRef="usd">10584000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjUtMy0xLTEtNzcxNzE_58293a14-aa40-45b0-acf3-878092f0d155"
      unitRef="usd">10996000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjYtMS0xLTEtNzcxNzE_5d43c5cb-977b-479f-bf26-8a60db01d406"
      unitRef="usd">2501000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjYtMy0xLTEtNzcxNzE_8a534c04-cdf3-4a88-b45f-b77c44866c15"
      unitRef="usd">2053000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjctMS0xLTEtNzcxNzE_e78a8be3-202e-45e0-987a-2c403fee7267"
      unitRef="usd">50000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjctMy0xLTEtNzcxNzE_a4b0dd4e-b0a2-4341-9965-79299cca34bd"
      unitRef="usd">46000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjgtMS0xLTEtODUxMDM_4a6354d7-dffd-4936-a4e2-053c04698183"
      unitRef="usd">114974000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjgtMy0xLTEtODUxMDM_aaa7d86a-7300-4f01-88a0-7390c9fda751"
      unitRef="usd">0</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjgtMS0xLTEtNzcxNzE_abbe2a04-afeb-4b95-b657-28e952495438"
      unitRef="usd">167853000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjgtMy0xLTEtNzcxNzE_380d8ac3-9f09-4d35-b494-d7499070ec32"
      unitRef="usd">41665000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjktMS0xLTEtNzcxNzE_13a58d68-aea8-4514-ae43-55c4be6a88b0"
      unitRef="usd">0</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMjktMy0xLTEtNzcxNzE_52ff14d1-9269-4820-8f0e-528d3251d9a8"
      unitRef="usd">320717000</us-gaap:ConvertibleDebtNoncurrent>
    <lgnd:LiabilityForContingentValueRights
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzAtMS0xLTEtNzcxNzE_1a2af53a-4236-4eb5-889f-caa323012074"
      unitRef="usd">6961000</lgnd:LiabilityForContingentValueRights>
    <lgnd:LiabilityForContingentValueRights
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzAtMy0xLTEtNzcxNzE_da105cb6-29b1-4b76-934f-b9015a90ad0c"
      unitRef="usd">8483000</lgnd:LiabilityForContingentValueRights>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzEtMS0xLTEtNzcxNzE_3761ed51-e927-4621-ba40-42a4c1a89ce7"
      unitRef="usd">42669000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzEtMy0xLTEtNzcxNzE_43bb2298-608d-4c31-aafd-ae10d78ce305"
      unitRef="usd">59095000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzItMS0xLTEtNzcxNzE_b99d0684-3706-41f2-8bff-da2226f6a98a"
      unitRef="usd">27088000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzItMy0xLTEtNzcxNzE_0ab2af93-3eac-44d2-8a93-0b88b49ed052"
      unitRef="usd">15494000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzQtMS0xLTEtOTIxNDg_499385bc-ff68-4316-8db4-1a63458e7279"
      unitRef="usd">7428000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzQtMy0xLTEtOTIxNDA_3fce2138-a5d7-427f-b4e1-743f1143cb14"
      unitRef="usd">9270000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzMtMS0xLTEtNzcxNzE_d6439e74-de19-452e-80aa-decaf2e68b61"
      unitRef="usd">21924000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzMtMy0xLTEtNzcxNzE_97b65e5a-1dc8-40ad-8a8b-4fcdcdff8097"
      unitRef="usd">21707000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzQtMS0xLTEtNzcxNzE_af2bac6f-f68b-4fe8-b74f-4e9350eaaba6"
      unitRef="usd">273923000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzQtMy0xLTEtNzcxNzE_e6e4717d-d3df-4144-85fc-565340fd4774"
      unitRef="usd">476431000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzUtMS0xLTEtNzcxNzE_ba589212-ae5a-44b9-8383-569292f7b896"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzUtMy0xLTEtNzcxNzE_12829468-f82c-4e85-a5cc-ce83a631aa73"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjphZTM0MzJjNDc4YzU0ZmJmOWZiMDZlMWZjNWYzZmU0Zl8yNA_1b4cbd33-7baa-4e1d-acf3-da8d7af69629"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjphZTM0MzJjNDc4YzU0ZmJmOWZiMDZlMWZjNWYzZmU0Zl8yNA_8de06673-546a-4361-b9c1-0556f9645085"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjphZTM0MzJjNDc4YzU0ZmJmOWZiMDZlMWZjNWYzZmU0Zl8zOA_285d45b0-0c8f-441f-9e6d-52014d9ff47d"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjphZTM0MzJjNDc4YzU0ZmJmOWZiMDZlMWZjNWYzZmU0Zl8zOA_ed84dab4-ea96-45dd-95cc-0b4f473e2a77"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjphZTM0MzJjNDc4YzU0ZmJmOWZiMDZlMWZjNWYzZmU0Zl82MA_31628f68-677e-4f06-b733-fc59f0c06984"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjphZTM0MzJjNDc4YzU0ZmJmOWZiMDZlMWZjNWYzZmU0Zl82MA_433c805a-b3f7-40e8-aaa8-b30b34e733e1"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjphZTM0MzJjNDc4YzU0ZmJmOWZiMDZlMWZjNWYzZmU0Zl82MA_496eb721-d5ac-4581-a753-0172f0d387bc"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjphZTM0MzJjNDc4YzU0ZmJmOWZiMDZlMWZjNWYzZmU0Zl82MA_674668f2-9a45-4861-ae21-157d12c7edd5"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMS0xLTEtNzcxNzE_bb60eee9-d57a-4ca9-a020-636b774331b3"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzctMy0xLTEtNzcxNzE_71032fae-4d18-403f-82c3-b777d399d514"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjozMGM1ODgyMTViZTg0OTUzODU2M2U3ZGI4Yjg4ZmIyY18yMQ_de863977-ae72-4ef6-b733-fba7bd33706b"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjozMGM1ODgyMTViZTg0OTUzODU2M2U3ZGI4Yjg4ZmIyY18yMQ_e8690449-1a33-485e-92d1-246fe2352438"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjozMGM1ODgyMTViZTg0OTUzODU2M2U3ZGI4Yjg4ZmIyY18zNQ_83dc4d2e-3230-4892-8954-f70862dc2dfc"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjozMGM1ODgyMTViZTg0OTUzODU2M2U3ZGI4Yjg4ZmIyY18zNQ_b272c944-a7c5-4672-a3ed-1690723dbda6"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjozMGM1ODgyMTViZTg0OTUzODU2M2U3ZGI4Yjg4ZmIyY181Nw_5468224f-5588-4f11-a50e-4f1c4fe6e894"
      unitRef="shares">16882000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjozMGM1ODgyMTViZTg0OTUzODU2M2U3ZGI4Yjg4ZmIyY181Nw_95919af9-d529-4803-bedf-9d50bec01a8b"
      unitRef="shares">16882000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjozMGM1ODgyMTViZTg0OTUzODU2M2U3ZGI4Yjg4ZmIyY182NA_ad76d6ab-8803-47b0-948c-674b61d516cd"
      unitRef="shares">16767000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMC0xLTEtNzcxNzEvdGV4dHJlZ2lvbjozMGM1ODgyMTViZTg0OTUzODU2M2U3ZGI4Yjg4ZmIyY182NA_c9a8b954-d375-482f-a005-588dbb64405b"
      unitRef="shares">16767000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMS0xLTEtNzcxNzE_e85d4ec5-bc88-46ca-bff1-f4e07da15151"
      unitRef="usd">17000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzgtMy0xLTEtNzcxNzE_59705ae7-d52c-4110-8b8e-6400804d26e2"
      unitRef="usd">17000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzktMS0xLTEtNzcxNzE_101c19aa-96a6-430f-8220-f0768846da5b"
      unitRef="usd">335471000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfMzktMy0xLTEtNzcxNzE_c325d0b2-882e-49ec-a115-260c8c58cd6a"
      unitRef="usd">372969000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNDAtMS0xLTEtNzcxNzE_55a16021-f1fe-47ae-9f03-02caafd7bbf7"
      unitRef="usd">-1066000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNDAtMy0xLTEtNzcxNzE_cd7f55f2-4ed1-454c-bee5-418908fd2800"
      unitRef="usd">-917000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNDEtMS0xLTEtNzcxNzE_2c82ad0f-2eaa-4559-ba1a-263569ddf242"
      unitRef="usd">467943000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNDEtMy0xLTEtNzcxNzE_187641d2-51ef-4edc-8a46-650689dccfa3"
      unitRef="usd">449090000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNDItMS0xLTEtNzcxNzE_f58885b8-7bae-46db-86d5-896556762eb3"
      unitRef="usd">802365000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNDItMy0xLTEtNzcxNzE_781abc4a-ccab-42e3-82ce-ffcea45943c5"
      unitRef="usd">821159000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNDMtMS0xLTEtNzcxNzE_c76721ad-d38e-4c37-a2db-4938abd67618"
      unitRef="usd">1076288000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xNi9mcmFnOjE0ZDFhNTY2NzFhMTRlZmU4M2Y3NjYwYmYwZjk4MDhjL3RhYmxlOmQ4OWNkM2M4NzEzMDRkOTY4MGRhN2E1ODJmM2U1NDkyL3RhYmxlcmFuZ2U6ZDg5Y2QzYzg3MTMwNGQ5NjgwZGE3YTU4MmYzZTU0OTJfNDMtMy0xLTEtNzcxNzE_d99eb45f-66e8-42c9-a1b5-55e2216b5deb"
      unitRef="usd">1297590000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4451c0bbe6454e30a9400b8f2b6b236b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNC0xLTEtMS03NzE3MQ_79bf62e9-65ca-45c3-86cf-21127d0d27a7"
      unitRef="usd">17959000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iadd0658df38142da9de49541fcf1e87b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNC0zLTEtMS03NzE3MQ_da6979bf-8331-4b95-ae0f-0e60880c6785"
      unitRef="usd">8616000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36945e4ea3d94671ba79140fa3bfeed8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNC01LTEtMS03NzE3MQ_1247e20a-9a46-41db-b29e-f540b9987c6e"
      unitRef="usd">31654000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc58590074134385916f9aa21fadb3a5_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNC03LTEtMS03NzE3MQ_798974d0-303d-4956-9cb1-d9e9d0667a7a"
      unitRef="usd">15728000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0dc4219be484ce8aa0ac5cb14f54a41_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNS0xLTEtMS03NzE3MQ_680756c6-02e8-4020-ae96-5f81baf6242f"
      unitRef="usd">29545000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i06d3227a7eb74265aa981e7a0d0ff54a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNS0zLTEtMS03NzE3MQ_8a94aa42-6eba-4718-97c0-d7876a92a237"
      unitRef="usd">62509000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iede13d72d60b42d785f8340ba1c81680_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNS01LTEtMS03NzE3MQ_b440a61b-dad4-4236-a4b9-a25822bbd40b"
      unitRef="usd">41667000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f25445795154f5a93fcbfa2d95e4ca4_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNS03LTEtMS03NzE3MQ_0e72926f-e76d-4edf-aab2-6bf2b22a62a8"
      unitRef="usd">93781000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4abd7ed5056140b3a6f412c3dcf92315_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNi0xLTEtMS03NzE3MQ_7fe602a5-28a4-498d-9321-e32a99eb783a"
      unitRef="usd">9915000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib690ef44f20c492ba685cf71add617d4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNi0zLTEtMS03NzE3MQ_19a73268-cdd6-4a4b-bc9d-463e4aa1bf49"
      unitRef="usd">13550000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf5c36ba61894d93b55a210349a7ccf2_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNi01LTEtMS03NzE3MQ_9e24b4a6-0b89-4a8a-911d-556efc47ede8"
      unitRef="usd">29791000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75907dd7ed51403bb417727e96e225eb_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNi03LTEtMS03NzE3MQ_de3a38e0-3aa6-485a-9ff0-3932d739cd69"
      unitRef="usd">30316000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNy0xLTEtMS03NzE3MQ_cd394087-dd8d-433c-b4c3-5ac9550f2250"
      unitRef="usd">57419000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNy0zLTEtMS03NzE3MQ_5ae4c877-9f50-47aa-a90b-c61d4814b560"
      unitRef="usd">84675000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNy01LTEtMS03NzE3MQ_e1aaf868-92e8-4f10-a92f-96783bf7e2da"
      unitRef="usd">103112000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfNy03LTEtMS03NzE3MQ_10f0ac12-9e02-45ee-99cf-a5090f53c630"
      unitRef="usd">139825000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostDirectMaterial
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfOS0xLTEtMS03NzE3MQ_b612a5bf-0fef-470a-aa28-c662b64b7834"
      unitRef="usd">12361000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfOS0zLTEtMS03NzE3MQ_840e8267-337b-479b-afda-ecfbaf0686a0"
      unitRef="usd">30593000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfOS01LTEtMS03NzE3MQ_defc2eb2-8e79-4913-a2a9-43e87d9c0fd6"
      unitRef="usd">17060000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfOS03LTEtMS03NzE3MQ_0d059a91-3e94-40e5-ae99-04469b0b092e"
      unitRef="usd">38746000</us-gaap:CostDirectMaterial>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTAtMS0xLTEtNzcxNzE_431900b9-9d8a-4acb-9775-6676599450f9"
      unitRef="usd">11824000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTAtMy0xLTEtNzcxNzE_a123c6be-3a42-4929-bdff-64e35a52c316"
      unitRef="usd">11779000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTAtNS0xLTEtNzcxNzE_7bcaaea6-88e7-48e0-ade6-665b26e63fec"
      unitRef="usd">23637000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTAtNy0xLTEtNzcxNzE_6ca3a8f1-d90a-4e3e-b769-e18a447f0b60"
      unitRef="usd">23565000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTEtMS0xLTEtNzcxNzE_03524393-04c6-471d-9689-d327ba389257"
      unitRef="usd">19118000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTEtMy0xLTEtNzcxNzE_ed6a78a3-5a06-49bd-945b-817825412bd5"
      unitRef="usd">15953000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTEtNS0xLTEtNzcxNzE_7a909c88-d1bb-475e-bc6e-24c61925238b"
      unitRef="usd">39425000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTEtNy0xLTEtNzcxNzE_8047e38e-4cd1-45ab-827d-d987d3f041b9"
      unitRef="usd">33832000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTItMS0xLTEtNzcxNzE_09bb43be-98eb-4149-bf0f-f77d389b0d7b"
      unitRef="usd">14585000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTItMy0xLTEtNzcxNzE_da9aa19d-f935-4101-a33b-3fbefbe10409"
      unitRef="usd">14711000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTItNS0xLTEtNzcxNzE_88baa510-fa46-4764-bce4-b057c98b2a6c"
      unitRef="usd">32765000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTItNy0xLTEtNzcxNzE_6c7f0719-477c-4690-b394-36e098ad3621"
      unitRef="usd">27028000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTMtMS0xLTEtODcwNTQ_41beb793-3a66-412d-ad16-fc2fccdbb19e"
      unitRef="usd">0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTMtMy0xLTEtODUxODU_350ea4ad-cb47-4bd6-94e3-e09141728b2e"
      unitRef="usd">34100000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTMtNS0xLTEtODcwNTQ_6d994a27-5167-4391-b731-96f0cc62f215"
      unitRef="usd">0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTMtNy0xLTEtODUxOTY_23c1722e-64e9-415a-a4ff-601c5b6f0ac0"
      unitRef="usd">33800000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTMtMS0xLTEtNzcxNzE_16c04047-c5a5-40f2-866b-bccbc9624f74"
      unitRef="usd">57888000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTMtMy0xLTEtNzcxNzE_4b54897c-1506-4063-aac3-7382f06f294a"
      unitRef="usd">38936000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTMtNS0xLTEtNzcxNzE_3ecc1a15-fb06-4e7c-9fc9-bbfeb61c7256"
      unitRef="usd">112887000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTMtNy0xLTEtNzcxNzE_33d0e297-e358-4510-8307-e94b715f5ca2"
      unitRef="usd">89371000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTQtMS0xLTEtNzcxNzE_06338005-cb24-4425-aa0a-781b803e0533"
      unitRef="usd">-469000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTQtMy0xLTEtNzcxNzE_820ea1a8-d0d7-41b7-8212-d7125115e133"
      unitRef="usd">45739000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTQtNS0xLTEtNzcxNzE_df7771f6-fedc-4d0f-aaf6-239c7a32c148"
      unitRef="usd">-9775000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTQtNy0xLTEtNzcxNzE_e7a6e4f2-2c65-4b4f-be52-2c2103cfaafc"
      unitRef="usd">50454000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnInvestments
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTYtMS0xLTEtNzcxNzE_3138105b-f720-4710-ab4e-4f077e62f66e"
      unitRef="usd">-1909000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTYtMy0xLTEtNzcxNzE_d28f4f4a-e97f-45ae-9cb1-bea642f71672"
      unitRef="usd">-6864000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTYtNS0xLTEtNzcxNzE_808d4e5c-3d7b-498f-a5b8-b10d07219989"
      unitRef="usd">-14786000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTYtNy0xLTEtNzcxNzE_78dc1d01-203d-4882-92c0-60c3f5cc3d04"
      unitRef="usd">6197000</us-gaap:GainLossOnInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTctMS0xLTEtNzcxNzE_a09eeb84-1810-43df-b6e3-90fa4a411acb"
      unitRef="usd">298000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTctMy0xLTEtNzcxNzE_ff71a600-4340-4cc1-91e2-39b5619a11fb"
      unitRef="usd">233000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTctNS0xLTEtNzcxNzE_5df63e71-2d34-460a-8645-a6ef42e980f6"
      unitRef="usd">432000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTctNy0xLTEtNzcxNzE_62e79522-3df9-4f3a-af89-225f3fe27f37"
      unitRef="usd">529000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTgtMS0xLTEtNzcxNzE_34557f49-3fa5-42c7-b8db-abdd1bd3ac74"
      unitRef="usd">438000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTgtMy0xLTEtNzcxNzE_c4912c2e-cf31-466c-a8de-c4f75285b8be"
      unitRef="usd">4883000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTgtNS0xLTEtNzcxNzE_f7dd1ad1-b961-4e85-af85-725de19a7e5b"
      unitRef="usd">1227000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTgtNy0xLTEtNzcxNzE_5401a5b9-ad83-4b7a-aa4b-d55d9b1ebe38"
      unitRef="usd">10714000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTktMS0xLTEtNzcxNzE_82dbcfac-f9cc-4235-9cf7-b0a2bd702457"
      unitRef="usd">1882000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTktMy0xLTEtNzcxNzE_8b89c39d-eb01-442d-b29a-18e196fc6803"
      unitRef="usd">-924000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTktNS0xLTEtNzcxNzE_cba104bd-8cb7-403e-ae7f-75c54c65f793"
      unitRef="usd">4580000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMTktNy0xLTEtNzcxNzE_bb0fa541-e619-4d73-b04e-e342ad86c0bd"
      unitRef="usd">-7401000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjAtMS0xLTEtNzcxNzE_34213542-8b42-4ed4-877e-152d29b0b5e3"
      unitRef="usd">-167000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjAtMy0xLTEtNzcxNzE_7d91f7ea-b6af-4bc3-ad2c-5d483212a790"
      unitRef="usd">-12438000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjAtNS0xLTEtNzcxNzE_bbd67a9c-e360-4cde-b841-c010454fd963"
      unitRef="usd">-11001000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjAtNy0xLTEtNzcxNzE_a4b389b6-f949-4179-8347-dbc097d8d1d1"
      unitRef="usd">-11389000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjEtMS0xLTEtNzcxNzE_f4be53f8-8706-4f65-be23-8ba5eca49926"
      unitRef="usd">-636000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjEtMy0xLTEtNzcxNzE_d04e518a-8bfc-4fdf-9d6f-bf0f8233125a"
      unitRef="usd">33301000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjEtNS0xLTEtNzcxNzE_d9c179a5-63f5-4713-ac85-6637f8ddf35b"
      unitRef="usd">-20776000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjEtNy0xLTEtNzcxNzE_54a14571-dc6d-44cc-9d95-ba5f4bcab427"
      unitRef="usd">39065000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjItMS0xLTEtNzcxNzE_dfd1cd2f-f378-44fb-8ac3-f6e667e20011"
      unitRef="usd">259000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjItMy0xLTEtNzcxNzE_5f937db0-0603-443f-b2bb-f5821778780d"
      unitRef="usd">2576000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjItNS0xLTEtNzcxNzE_70f8db84-07ff-4dcf-8058-bb1cbaa2fb65"
      unitRef="usd">-4496000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjItNy0xLTEtNzcxNzE_1173b26b-b1ce-44d0-af09-00b7ad0cc295"
      unitRef="usd">-9766000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjMtMS0xLTEtNzcxNzE_c9bceb39-a5ce-43e4-b6f9-5f7651fba08d"
      unitRef="usd">-895000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjMtMy0xLTEtNzcxNzE_0a1df59b-61bf-49a2-99bd-d830d592718a"
      unitRef="usd">30725000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjMtNS0xLTEtNzcxNzE_a139813b-3a32-4663-8fc1-b00135108e81"
      unitRef="usd">-16280000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjMtNy0xLTEtNzcxNzE_f5a1be31-869c-48fc-b78a-d247c7faabc0"
      unitRef="usd">48831000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjUtMS0xLTEtNzcxNzE_b3c6b051-b95f-49ec-802a-d45d770ddd64"
      unitRef="usdPerShare">-0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjUtMy0xLTEtNzcxNzE_d6627e40-fc33-4ba7-89dd-2fc6e8efb753"
      unitRef="usdPerShare">1.84</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjUtNS0xLTEtNzcxNzE_0674d189-9a06-48c7-bc8f-d58227a1c364"
      unitRef="usdPerShare">-0.97</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjUtNy0xLTEtNzcxNzE_7106b002-8b60-4586-86d0-fcc84a48941c"
      unitRef="usdPerShare">2.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjYtMS0xLTEtNzcxNzE_4f355016-eaa6-4ae7-abb4-4ffe45c51ecd"
      unitRef="shares">16868000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjYtMy0xLTEtNzcxNzE_1954d795-a296-4a01-85be-989f9dd1342b"
      unitRef="shares">16659000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjYtNS0xLTEtNzcxNzE_7284e52a-217c-47fb-9c85-44e8b7e81580"
      unitRef="shares">16846000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjYtNy0xLTEtNzcxNzE_46df6e25-80eb-447e-bd13-fc9e4d9638d3"
      unitRef="shares">16548000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjgtMS0xLTEtNzcxNzE_e1e3f42b-f672-4106-acac-18b3998331cd"
      unitRef="usdPerShare">-0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjgtMy0xLTEtNzcxNzE_7df0bbb7-d9d6-456c-950a-35726356ac54"
      unitRef="usdPerShare">1.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjgtNS0xLTEtNzcxNzE_56a46bbe-983a-47b4-9d2b-ed9abc18888d"
      unitRef="usdPerShare">-0.97</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjgtNy0xLTEtNzcxNzE_12309b77-0e7a-4e89-8f06-816414cfe64a"
      unitRef="usdPerShare">2.84</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjktMS0xLTEtNzcxNzE_b2afb68c-bb58-4cda-8cb5-676c66ef2bc4"
      unitRef="shares">16868000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjktMy0xLTEtNzcxNzE_433b381f-00fb-49c8-8af1-cf125a3086a5"
      unitRef="shares">17172000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjktNS0xLTEtNzcxNzE_b6f185ff-da5c-4656-92da-d4f9f2c3897c"
      unitRef="shares">16846000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8xOS9mcmFnOjkwOWY1Yzk4MjE1NjQ4NTE5ZGVmZjE3NTlkNzhlNjBkL3RhYmxlOmU5Y2Y1OGFlMGUyNzQzZjk4YWVlMDFiOWQxNDEyMmM1L3RhYmxlcmFuZ2U6ZTljZjU4YWUwZTI3NDNmOThhZWUwMWI5ZDE0MTIyYzVfMjktNy0xLTEtNzcxNzE_8113ba33-f2f1-41de-a8f3-d9cc0ee701b5"
      unitRef="shares">17210000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfMy0xLTEtMS03NzE3MQ_8cf77427-473e-47d4-9bee-b66ce6d20ae4"
      unitRef="usd">-895000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfMy0zLTEtMS03NzE3MQ_b246f559-405c-4259-87be-294344abda32"
      unitRef="usd">30725000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfMy01LTEtMS03NzE3MQ_6da0710d-ae02-4a1d-b3a9-2ea2d6c69e6b"
      unitRef="usd">-16280000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfMy03LTEtMS03NzE3MQ_e0df99df-be2e-4474-8bee-6155718cdb57"
      unitRef="usd">48831000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfNC0xLTEtMS03NzE3MQ_a2b1ebec-5d4f-4375-89e8-765928541c56"
      unitRef="usd">-35000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfNC0zLTEtMS03NzE3MQ_b3f96851-b4d5-4737-930b-f1dd6eb16161"
      unitRef="usd">-5000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfNC01LTEtMS03NzE3MQ_310c7699-b22e-4551-a4c5-325bc0d62c81"
      unitRef="usd">-149000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfNC03LTEtMS03NzE3MQ_4abd2fe6-3316-48e8-b4c8-ab6b90583491"
      unitRef="usd">-60000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfNS0xLTEtMS03NzE3MQ_9a727dda-5cd9-4c10-a8d3-570bccf0f05d"
      unitRef="usd">-930000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfNS0zLTEtMS03NzE3MQ_e60043c7-73f4-4244-a947-d8c5e0b602c5"
      unitRef="usd">30720000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfNS01LTEtMS03NzE3MQ_4944d038-102c-4d7d-9054-b9534fa38504"
      unitRef="usd">-16429000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yMi9mcmFnOmFjNmMwNjdhZDBhYzQ1YTE5ZTAzNWNlYjk5NTg3MzY5L3RhYmxlOjRmMTUwNDNjMjUxOTQxYTc5NDk4NmRjYzYzZmE4YmIxL3RhYmxlcmFuZ2U6NGYxNTA0M2MyNTE5NDFhNzk0OTg2ZGNjNjNmYThiYjFfNS03LTEtMS03NzE3MQ_bf54e8cf-0876-4d4a-b8b8-f50971d6408b"
      unitRef="usd">48771000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i85f8622834f34bd190af73c102a914cc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMi0xLTEtMS03NzE3MQ_c6cd9246-e3cd-4318-bdd4-ebea9d07d38e"
      unitRef="shares">16767000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i85f8622834f34bd190af73c102a914cc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMi0yLTEtMS03NzE3MQ_729356bf-6512-4d1f-a16d-c22dc5c8abae"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3cfa0d1834f445a49fb6b65740cb4cd4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMi0zLTEtMS03NzE3MQ_2e4e65bc-04f8-4d17-8f3f-4a9798c481f0"
      unitRef="usd">372969000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic1c61c60b6194b22adf91c5e2cbe87ff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMi00LTEtMS03NzE3MQ_6e815a43-4ab9-4eb2-bb57-bd0cde16948c"
      unitRef="usd">-917000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iedb09b7e2fcb4ab7aebd9117745eb914_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMi01LTEtMS03NzE3MQ_b27c9c09-c8e9-4a4b-a102-57ce8230ef14"
      unitRef="usd">449090000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMi02LTEtMS03NzE3MQ_8ba69914-837d-4738-be58-bcf8944d75a8"
      unitRef="usd">821159000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0f5459b627e84394b6d868b1c0657e63_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMy0zLTEtMS03NzE3MQ_0ca6c653-ef49-4ad8-b6c1-fc9bcfc0e233"
      unitRef="usd">-51130000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i362afaf034ae4672be24c81c6b93536c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMy01LTEtMS03NzE3MQ_682ae87f-d538-4e10-a33c-1c312474988e"
      unitRef="usd">35133000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i76ae97986fac4a65aa555297c9706a05_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMy02LTEtMS03NzE3MQ_1d55d005-0d67-423d-8328-482008e24ddb"
      unitRef="usd">-15997000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="id3e93db38a0c4a65a7538c436c978d22_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfNC0xLTEtMS03NzE3MQ_0d399dea-5da2-4355-afed-22646d5a9ba0"
      unitRef="shares">94000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3d94a99e36434ce3bcb95c74af16730c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfNC0zLTEtMS03NzE3MQ_bd685e11-58cc-4001-8259-6c6563d9298d"
      unitRef="usd">-5515000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="id0861fff98f443b690754c837f781b97_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfNC02LTEtMS03NzE3MQ_6ffe7901-3e62-46eb-87ec-5e417f28cdaa"
      unitRef="usd">-5515000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3d94a99e36434ce3bcb95c74af16730c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfNS0zLTEtMS03NzE3MQ_9c6c1943-e98e-4f84-8428-3511866e8a64"
      unitRef="usd">9044000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id0861fff98f443b690754c837f781b97_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfNS02LTEtMS03NzE3MQ_0d8049af-b7fa-40ce-9a8d-3d5f5133fb93"
      unitRef="usd">9044000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i897aeacae0a54360ae9e4b7fef689689_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfNi00LTEtMS03NzE3MQ_74647b42-ebb1-4d95-baa2-3017dd1e8605"
      unitRef="usd">-114000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="id0861fff98f443b690754c837f781b97_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfNi02LTEtMS03NzE3MQ_a3ee54cd-898d-4de0-bd05-d88517838c71"
      unitRef="usd">-114000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i611ca28f9b2b49b0ab2181e8b332d455_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfOC01LTEtMS03NzE3MQ_5675ec26-de4f-472b-8595-618fc15ecb23"
      unitRef="usd">-15385000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id0861fff98f443b690754c837f781b97_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfOC02LTEtMS03NzE3MQ_29eac3b3-325a-40c1-8f55-5c0527088c3f"
      unitRef="usd">-15385000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ida17f1e22fcc46d888527d5585b5db6a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfOS0xLTEtMS03NzE3MQ_7fdaeb9f-56ad-4fff-b161-1badf62be95c"
      unitRef="shares">16861000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ida17f1e22fcc46d888527d5585b5db6a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfOS0yLTEtMS03NzE3MQ_6af5d378-f034-42b1-853c-6b64df48d3df"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9a7ab73aa7904f7ebaf48f7dce5ab966_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfOS0zLTEtMS03NzE3MQ_187b6f6d-58db-4faa-9970-4a82c852d3ea"
      unitRef="usd">325368000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if13fbe07ca154d04930101ff2e942a66_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfOS00LTEtMS03NzE3MQ_0f36468d-5a1e-40d6-b8d8-f188f148ba1a"
      unitRef="usd">-1031000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5cd03be6fae54778adda0e81e4ca4bb6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfOS01LTEtMS03NzE3MQ_dd9728a4-f90b-4c7b-afe9-01113e784bd6"
      unitRef="usd">468838000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if12c3ec488ca49709a4421cb42f9abbb_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfOS02LTEtMS03NzE3MQ_c4061459-9ff2-4478-bfe3-f922865b8fcf"
      unitRef="usd">793192000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i795e50fb1bd04eb1bed4a653ee8c754a_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTAtMS0xLTEtNzcxNzE_9f5c08ea-6d35-407c-8ff8-2402c06329ce"
      unitRef="shares">21000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="idcedf9519070438b806357a9dd22600a_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTAtMy0xLTEtNzcxNzE_6b5fdbb5-2bcc-4af9-8fc9-2ecc155acc71"
      unitRef="usd">604000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTAtNi0xLTEtNzcxNzE_a2139bc9-b86b-4482-a2d1-0c5f36cee0d2"
      unitRef="usd">604000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="idcedf9519070438b806357a9dd22600a_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTEtMy0xLTEtNzcxNzE_cc18d926-a4e4-4fb2-9ed6-18375c483d92"
      unitRef="usd">9499000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTEtNi0xLTEtNzcxNzE_8666dc14-e382-4042-ae59-eec844d86e8b"
      unitRef="usd">9499000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i372b4ca31b6148f580791f16233559c6_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTItNC0xLTEtNzcxNzE_0fd504f0-caa3-4efc-9e82-ef2e3914aab0"
      unitRef="usd">-35000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTItNi0xLTEtNzcxNzE_cc87a84b-1aee-49f1-85c3-a2be5b39489d"
      unitRef="usd">-35000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i518323b49cf84a3596e600f5a1f4c5de_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTUtNS0xLTEtNzcxNzE_a2aa24ac-95a0-4ddd-9685-8bb67831aff9"
      unitRef="usd">-895000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTUtNi0xLTEtNzcxNzE_80bb680a-903d-4044-aa2e-f6954bb1e312"
      unitRef="usd">-895000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i66a4853ebfb84f1cbf13e26153087b0f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTYtMS0xLTEtNzcxNzE_f103eb0b-c46d-47c6-98bb-64aa560b1603"
      unitRef="shares">16882000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i66a4853ebfb84f1cbf13e26153087b0f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTYtMi0xLTEtNzcxNzE_648f9a6e-c2e4-43b7-ba55-8d3882d4e811"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2f1ead9f69da4d13ab756c627f382b38_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTYtMy0xLTEtNzcxNzE_6a035f4f-d8ed-483a-a2fe-7dd1db34840b"
      unitRef="usd">335471000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1d5f804285544b3c85561c7025916c3d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTYtNC0xLTEtNzcxNzE_281b42e8-a1ed-4e33-9960-f67933e6cb10"
      unitRef="usd">-1066000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i85f076aef7744e2ba3466da10e42c30c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTYtNS0xLTEtNzcxNzE_e3449d86-1803-46e3-b11a-8b4009390e88"
      unitRef="usd">467943000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOjEwM2Q5Mzk5Mzg4ODRmZWNhYzY2OTAzZjJkMzk2Zjk3L3RhYmxlcmFuZ2U6MTAzZDkzOTkzODg4NGZlY2FjNjY5MDNmMmQzOTZmOTdfMTYtNi0xLTEtNzcxNzE_ddc585a1-76c1-4ffb-9807-e0c152fb7d1e"
      unitRef="usd">802365000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie007cd8b0d0a49a8b243568f89c18ee8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMi0xLTEtMS03NzE3MQ_90ccadab-9790-4eb4-a3ba-437bc8bd3131"
      unitRef="shares">16080000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie007cd8b0d0a49a8b243568f89c18ee8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMi0yLTEtMS03NzE3MQ_0782497e-0ce2-4cef-a238-48a44df7b496"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8cceb54932694869a897f6267d1671d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMi0zLTEtMS03NzE3MQ_cf0a6f4b-093f-435f-a51d-9c88f9448861"
      unitRef="usd">318358000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibe339071fd4f412d97a4a4b4efe13b85_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMi00LTEtMS03NzE3MQ_762c16b2-ee08-402d-9a3c-da99abbccb2c"
      unitRef="usd">-801000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i219e6f0c67584cdfb9cc97d98d4660f3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMi01LTEtMS03NzE3MQ_595be96b-29ba-49c1-9848-7f55a4ffedad"
      unitRef="usd">391952000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i03c127685aa945a6ac245b4904e579a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMi02LTEtMS03NzE3MQ_e4777bac-30a9-41fe-8767-522bed88267d"
      unitRef="usd">709525000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i1df447ab25dd46908c81e1e59a7690f4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMy0xLTEtMS03NzE3MQ_0eb88d38-900e-4732-bd06-49624ee226b1"
      unitRef="shares">572000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1df447ab25dd46908c81e1e59a7690f4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMy0yLTEtMS03NzE3MQ_b194f17a-4b79-458a-8f19-1c36404dba7c"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if4f3cf826076418d8df0ad8aa0976c1d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMy0zLTEtMS03NzE3MQ_1992dbda-c750-489f-aaee-4d669b1ff76c"
      unitRef="usd">20580000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i61b5666e80a3489388fb05d72e4d486a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMy02LTEtMS03NzE3MQ_967aecb1-503b-43e7-8657-0e66aa62f63f"
      unitRef="usd">20581000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if4f3cf826076418d8df0ad8aa0976c1d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfNC0zLTEtMS03NzE3MQ_7b0142d0-8181-43f8-91e0-a95ab356a072"
      unitRef="usd">8405000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i61b5666e80a3489388fb05d72e4d486a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfNC02LTEtMS03NzE3MQ_efe34ffb-69eb-4237-907a-2dd404982aaf"
      unitRef="usd">8405000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i53c139d692e24ecc9eebbd4f8f6a7986_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfNS00LTEtMS03NzE3MQ_193bf87a-2532-48a5-bc3c-9ef04ea4381b"
      unitRef="usd">-55000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i61b5666e80a3489388fb05d72e4d486a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfNS02LTEtMS03NzE3MQ_3959e6dc-51d9-4e37-b02b-1bd1835475e6"
      unitRef="usd">-55000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="if4f3cf826076418d8df0ad8aa0976c1d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfNi0zLTEtMS03NzE3MQ_49d735af-3dbe-4e04-900b-54a97b4f6ed8"
      unitRef="usd">396000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="i61b5666e80a3489388fb05d72e4d486a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfNi02LTEtMS03NzE3MQ_d587bd96-2b0d-4f82-86a4-3bcddfd37dee"
      unitRef="usd">396000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="if4f3cf826076418d8df0ad8aa0976c1d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfNy0zLTEtMS03NzE3MQ_3f3d7d9b-d327-43fd-b764-bdd65d7e149d"
      unitRef="usd">-11118000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i61b5666e80a3489388fb05d72e4d486a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfNy02LTEtMS03NzE3MQ_0e463cb9-e14a-42e7-bed7-5a98500da30d"
      unitRef="usd">-11118000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:NetIncomeLoss
      contextRef="idc2e728e65f543a0ab65714937be981b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfOS01LTEtMS03NzE3MQ_fcd4fd66-c670-4126-abdf-5dead963c49f"
      unitRef="usd">18106000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i61b5666e80a3489388fb05d72e4d486a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfOS02LTEtMS03NzE3MQ_3431bfe3-5575-434a-85c0-a0ce6382e689"
      unitRef="usd">18106000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1a532b4ea5824e5e9ec5170d5b4c3fc7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTAtMS0xLTEtNzcxNzE_8b08b3d7-6cf1-4e7b-913a-e2ad0bb4a55d"
      unitRef="shares">16652000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i1a532b4ea5824e5e9ec5170d5b4c3fc7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTAtMi0xLTEtNzcxNzE_9846468e-79bb-4b2a-bcd3-df60ba6f53ee"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibd4986c032bd490fbee831d61a9cb80f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTAtMy0xLTEtNzcxNzE_3df14ecc-b371-4ad4-8d2e-215d649eade5"
      unitRef="usd">336621000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i57a179932e3e460783c473c4033afd37_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTAtNC0xLTEtNzcxNzE_7c2683e5-dca0-45c2-b344-15ccb72f8a53"
      unitRef="usd">-856000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie03542cce19b4e7dbd6fba43babfe9b6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTAtNS0xLTEtNzcxNzE_c1f67425-3f69-49ef-ba89-bb5f55b944c5"
      unitRef="usd">410058000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia4081bccf13b424e88e365ad46cac9da_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTAtNi0xLTEtNzcxNzE_8d270624-23e5-48c9-a97f-aebd037246ca"
      unitRef="usd">745840000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i2c30a433e75e4d8cacce52bacc437e16_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTEtMS0xLTEtNzcxNzE_48f4b523-7e53-4248-9335-a47ed58aa284"
      unitRef="shares">24000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if658034f46704cf587bbef2048752ad8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTEtMy0xLTEtNzcxNzE_767a2910-5062-4786-a86f-f5cfb1b59a39"
      unitRef="usd">1103000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTEtNi0xLTEtNzcxNzE_dadbaf97-7a9c-467f-9543-9c377b82d392"
      unitRef="usd">1103000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if658034f46704cf587bbef2048752ad8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTItMy0xLTEtNzcxNzE_c1006953-7469-41dc-9ea5-31da6ecbae42"
      unitRef="usd">10216000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTItNi0xLTEtNzcxNzE_61d81568-6a9c-4723-bdf0-9216bd156dfe"
      unitRef="usd">10216000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i1cfad7f1f04049718d638cb007561413_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTMtNC0xLTEtNzcxNzE_8d2916c2-d10d-4b28-85eb-d4fa0cf889a1"
      unitRef="usd">-5000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTMtNi0xLTEtNzcxNzE_2a627100-6744-41ab-9caf-603b67e1255c"
      unitRef="usd">-5000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="if658034f46704cf587bbef2048752ad8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTUtMy0xLTEtNzcxNzE_c0f33ffc-ad8c-408f-8f73-00ef8e1cc1f1"
      unitRef="usd">-1362000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTUtNi0xLTEtNzcxNzE_34632a4b-b1ef-4a4d-b99f-5f48e3e2d1a5"
      unitRef="usd">-1362000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:NetIncomeLoss
      contextRef="ib892982e78324d6ca473f2fc2a6da00a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTYtNS0xLTEtNzcxNzE_97c6f8e5-fb65-4ef0-9d8e-f6b3b6c88897"
      unitRef="usd">30725000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTYtNi0xLTEtNzcxNzE_314ed211-7cf6-43eb-b349-eb35c5f73901"
      unitRef="usd">30725000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iabed2424af8d4db5bfade373c80a8e1f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTctMS0xLTEtNzcxNzE_0f1f5ef5-6a67-4895-9c1e-9098c0c9c370"
      unitRef="shares">16676000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iabed2424af8d4db5bfade373c80a8e1f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTctMi0xLTEtNzcxNzE_09d35904-2986-477f-81cf-6e60601c23f7"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if6f0ed8f7b464306ae6088a4c1723287_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTctMy0xLTEtNzcxNzE_84cfb754-2904-4a5a-8e1c-8d57aa9c3103"
      unitRef="usd">346578000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieec58def6fea427489c80f3c77282f03_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTctNC0xLTEtNzcxNzE_d4701763-0d34-499a-86e8-626ed24fee30"
      unitRef="usd">-861000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibda621e9fcaa4a23bea03af000841d41_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTctNS0xLTEtNzcxNzE_6cadf861-be09-46e5-81e1-3df0913f6b46"
      unitRef="usd">440783000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic543f595905b456b86f091c41fcf15e9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yNS9mcmFnOjc3ODA4ZDdmZGY0YzQxMmI5NWE0ZjUwN2Q0MTAwMmQ3L3RhYmxlOmZhODhjMWJiOWY1ZTQ3NGRhMmUyNDJjMWZjMWU1OGM3L3RhYmxlcmFuZ2U6ZmE4OGMxYmI5ZjVlNDc0ZGEyZTI0MmMxZmMxZTU4YzdfMTctNi0xLTEtNzcxNzE_9a280d9b-7646-4ea3-b5cf-0f7c92d57210"
      unitRef="usd">786517000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNC0xLTEtMS03NzE3MQ_85d2ec1a-d1a8-403a-a40f-be89d88d1580"
      unitRef="usd">-16280000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNC0zLTEtMS03NzE3MQ_574555d3-2ee2-44c2-8388-ede9f568fa45"
      unitRef="usd">48831000</us-gaap:ProfitLoss>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNi0xLTEtMS03NzE3MQ_c46058db-0e76-4fbe-98af-cc5dc51eaf1b"
      unitRef="usd">1266000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNi0zLTEtMS03NzE3MQ_e9a53ae7-4f0c-4d6c-8854-a17d7946519f"
      unitRef="usd">33502000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNy0xLTEtMS03NzE3MQ_025dd1f4-75fc-446d-9673-5f94933ee344"
      unitRef="usd">26921000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNy0zLTEtMS03NzE3MQ_dfccf083-c854-4504-ac33-18c08b5ab3ad"
      unitRef="usd">25179000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfOC0xLTEtMS03NzE3MQ_769b0cc1-a2e2-49fd-b66d-1f9866615a1a"
      unitRef="usd">-44000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfOC0zLTEtMS03NzE3MQ_908faba0-5be5-42a9-82eb-a86e27d85921"
      unitRef="usd">-109000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfOS0xLTEtMS03NzE3MQ_224e07d2-73a6-45d5-b00d-5e452fce92a4"
      unitRef="usd">501000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfOS0zLTEtMS03NzE3MQ_b9fa9297-33bc-4003-a793-b44b2f422de1"
      unitRef="usd">9073000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTAtMS0xLTEtNzcxNzE_a362a7c4-6e09-4e64-adee-10780e74ef41"
      unitRef="usd">-190000</lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights>
    <lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTAtMy0xLTEtNzcxNzE_42565959-fa6e-4884-9c66-0db59c50a58c"
      unitRef="usd">206000</lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTEtMS0xLTEtNzcxNzE_b68b3553-2cf7-4f1d-a678-1cbc26927cdb"
      unitRef="usd">3326000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTEtMy0xLTEtNzcxNzE_7149d65c-fe97-4cbc-ae44-7faf9c760cda"
      unitRef="usd">-7175000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ShareBasedCompensation
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTItMS0xLTEtNzcxNzE_76368c20-369e-40eb-a678-5be857824a41"
      unitRef="usd">18543000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTItMy0xLTEtNzcxNzE_0dcf5a0e-7597-4d8f-bb06-5fd3c8398d02"
      unitRef="usd">18621000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTMtMS0xLTEtNzcxNzE_bb59e9a0-2cce-4f4b-b774-2f756b4ada4e"
      unitRef="usd">12925000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTMtMy0xLTEtNzcxNzE_3333c2e5-5bf7-4d98-8826-36c397c93074"
      unitRef="usd">9766000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTQtMS0xLTEtNzcxNzE_688c5059-50cc-4766-bd49-8b14682c9cda"
      unitRef="usd">-14786000</lgnd:GainLossOnShortTermInvestments>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTQtMy0xLTEtNzcxNzE_31692c41-a958-40af-97c5-292ae043df39"
      unitRef="usd">6197000</lgnd:GainLossOnShortTermInvestments>
    <lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTUtMS0xLTEtOTAyNDE_12e8ca68-dfb2-41ff-98c3-5a1406b348bc"
      unitRef="usd">3054000</lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization>
    <lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTUtMy0xLTEtOTAyNTk_a8127247-f41b-4eba-9450-c9999d4382d6"
      unitRef="usd">2113000</lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTUtMS0xLTEtNzcxNzE_5939d0d3-0df5-4efc-b16a-d483064ee67f"
      unitRef="usd">-67000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTUtMy0xLTEtNzcxNzE_e1b2712a-82f0-4f72-98a4-975bbb934ae0"
      unitRef="usd">595000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTctMS0xLTEtNzcxNzE_eade1b78-bea7-462b-a98f-d8516ddb296b"
      unitRef="usd">-23208000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTctMy0xLTEtNzcxNzE_5e0a55a5-2bb8-41a0-bd32-1be9dad0e96e"
      unitRef="usd">2659000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTgtMS0xLTEtNzcxNzE_a2f6a770-8d8f-440b-95a7-4bd180808384"
      unitRef="usd">-9740000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTgtMy0xLTEtNzcxNzE_6815d497-fb56-4e42-b0c6-e3216c864cb7"
      unitRef="usd">2326000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTktMS0xLTEtNzcxNzE_ca877436-fa7e-4618-b281-5835a9b96b3e"
      unitRef="usd">-4357000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMTktMy0xLTEtNzcxNzE_920b6257-e747-4deb-a21a-25fabad38784"
      unitRef="usd">-4340000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjAtMS0xLTEtNzcxNzE_9d3bb306-59b9-449a-b7ac-290da9808425"
      unitRef="usd">9011000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjAtMy0xLTEtNzcxNzE_082b90e4-9906-4ac8-a038-d37c98dce40e"
      unitRef="usd">-2477000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjEtMS0xLTEtNzcxNzE_5c10b131-cbbd-45da-a0a7-bf155fe24e31"
      unitRef="usd">-2254000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjEtMy0xLTEtNzcxNzE_201f1681-eca2-4eca-a573-c2403354eeb6"
      unitRef="usd">-14605000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjItMS0xLTEtNzcxNzE_b1675243-625f-4dac-9dca-544becdbba19"
      unitRef="usd">1254000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjItMy0xLTEtNzcxNzE_84ca9b83-956d-4f17-b1b6-08e575ed5562"
      unitRef="usd">4899000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjMtMS0xLTEtNzcxNzE_d2c49c1e-6991-43e0-9d9b-4c98ba03efaf"
      unitRef="usd">63889000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjMtMy0xLTEtNzcxNzE_b8835311-e0e3-4788-8ab8-4db9dd69a23e"
      unitRef="usd">31131000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjYtMS0xLTEtNzcxNzE_1991adfa-9032-47bc-900d-e88ea62d9e9c"
      unitRef="usd">38472000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjYtMy0xLTEtNzcxNzE_31060b3d-7600-4024-afbe-9f1ab1110f7d"
      unitRef="usd">96136000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjctMS0xLTEtNzcxNzE_842d7ea0-fcf7-4625-af5d-da63d165aa08"
      unitRef="usd">177554000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjctMy0xLTEtNzcxNzE_af1d2567-ec59-4dce-bfd0-d2611d28664e"
      unitRef="usd">150648000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjgtMS0xLTEtNzcxNzE_7a7df157-ec22-4f3f-8e12-5a346063b7ce"
      unitRef="usd">24830000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjgtMy0xLTEtNzcxNzE_bb7574dc-2f6b-4852-8761-ef08708d6af8"
      unitRef="usd">34600000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjktMS0xLTEtNzcxNzE_eeabfe1a-12da-439a-b42a-1302ba0280dd"
      unitRef="usd">750000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMjktMy0xLTEtNzcxNzE_3972ec5a-f843-4253-8888-bc9be5a30210"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzAtMS0xLTEtNzcxNzE_84456d25-a4dd-48ee-ac0b-934f84c44c99"
      unitRef="usd">11463000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzAtMy0xLTEtNzcxNzE_6919aa3d-006d-469c-90c5-cac6ec6218ca"
      unitRef="usd">4794000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzEtMS0xLTEtNzcxNzE_c19f35c6-a227-48f8-8089-4c174f7e1019"
      unitRef="usd">-33000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzEtMy0xLTEtNzcxNzE_ac6d5182-1e44-4113-aa58-defb65291111"
      unitRef="usd">-135000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzItMS0xLTEtNzcxNzE_bdb9ba1d-1658-411f-8551-076d1e9df0cc"
      unitRef="usd">151732000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzItMy0xLTEtNzcxNzE_02126d48-10c3-43c8-9690-2bf7435f635d"
      unitRef="usd">84453000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzUtMS0xLTEtNzcxNzE_3ca1690c-3718-48b5-a2bc-57bf76045b33"
      unitRef="usd">223303000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzUtMy0xLTEtNzcxNzE_bf9033c6-0bd2-4d43-8914-bb9616b456e8"
      unitRef="usd">153381000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzYtMS0xLTEtNzcxNzE_12129766-3135-4848-b449-8d5a0605787f"
      unitRef="usd">27000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzYtMy0xLTEtNzcxNzE_5b200da9-6a6d-4d1e-b58b-c7c4632c3e9a"
      unitRef="usd">9188000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzctMS0xLTEtNzcxNzE_ad3ae743-9d4d-4069-a26c-d01b0961dad4"
      unitRef="usd">0</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzctMy0xLTEtNzcxNzE_8d838c36-f008-4e45-94d4-9217030d33d8"
      unitRef="usd">16855000</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzgtMS0xLTEtNzcxNzE_61359ea5-0847-45ab-99b2-3ed87bb3ca8e"
      unitRef="usd">0</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzgtMy0xLTEtNzcxNzE_545cc718-3ce5-4db9-87be-2f6f017089f1"
      unitRef="usd">16459000</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzktMS0xLTEtNzcxNzE_8d7b83e9-7030-44a8-8687-c5bd911beeb8"
      unitRef="usd">1011000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfMzktMy0xLTEtNzcxNzE_404d57bf-108d-4f25-8da8-c640beeeab0f"
      unitRef="usd">27584000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDAtMS0xLTEtNzcxNzE_7dfc0cdf-0870-4a72-bcb9-21fd6e0945ff"
      unitRef="usd">5922000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDAtMy0xLTEtNzcxNzE_ec3e8158-1b44-41d9-a1d6-9392a55dbbf7"
      unitRef="usd">5901000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDEtMS0xLTEtNzcxNzE_9cef098b-735b-4f65-8ea7-24376cfb5c37"
      unitRef="usd">1416000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDEtMy0xLTEtNzcxNzE_b023bc75-6fb9-401b-88f3-187fe37d95c5"
      unitRef="usd">1050000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDItMS0xLTEtNzcxNzE_dd1b09d5-a458-4275-b71d-8f624b739af0"
      unitRef="usd">-206000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDItMy0xLTEtNzcxNzE_8d385113-9828-4905-9bd4-4412ff8ae886"
      unitRef="usd">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDMtMS0xLTEtNzcxNzE_358e50ea-756d-4077-911d-07e31cd1ccf8"
      unitRef="usd">-229863000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDMtMy0xLTEtNzcxNzE_4e32877f-00d3-4cff-883b-79e049b2a575"
      unitRef="usd">-141540000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDQtMS0xLTEtNzcxNzE_277578f1-2b4a-4a1e-80fd-c5def28ad63c"
      unitRef="usd">-14242000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDQtMy0xLTEtNzcxNzE_425c0faf-90f7-4c47-8c2e-370303200875"
      unitRef="usd">-25956000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDUtMS0xLTEtNzcxNzE_2606d9da-e535-40b2-be6e-a36f8d919b38"
      unitRef="usd">19522000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i03c127685aa945a6ac245b4904e579a9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDUtMy0xLTEtNzcxNzE_8e96d984-7096-4de2-a569-11a96ef96c25"
      unitRef="usd">47963000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDYtMS0xLTEtNzcxNzE_7bf2338d-b07a-4230-9d68-82981cf9ed35"
      unitRef="usd">5280000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic543f595905b456b86f091c41fcf15e9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOmUzMWExMzk5ZGIzODQ4NTM4NmZjZGIwZWVjY2M5ZjNmL3RhYmxlcmFuZ2U6ZTMxYTEzOTlkYjM4NDg1Mzg2ZmNkYjBlZWNjYzlmM2ZfNDYtMy0xLTEtNzcxNzE_9ab0fadd-173b-4ad9-b54c-9cac2e257b63"
      unitRef="usd">22007000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMS0xLTEtMS03NzE3MQ_8ec20f94-1bba-44e9-a599-3dde16177484"
      unitRef="usd">1038000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMS0zLTEtMS03NzE3MQ_dd05f68b-3a8e-44bf-b8ae-47546d7fee86"
      unitRef="usd">1737000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMi0xLTEtMS03NzE3MQ_41fa66ec-1c5c-4f9d-9242-d3625eaaa55a"
      unitRef="usd">20000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMi0zLTEtMS03NzE3MQ_5c69c2ad-e40a-4fca-b4d6-4700066fc0a8"
      unitRef="usd">3552000</us-gaap:IncomeTaxesPaid>
    <us-gaap:RestrictedCashCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMy0xLTEtMS03NzE3MQ_e891219a-6157-4968-b53a-e80cc5adde9b"
      unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="ic543f595905b456b86f091c41fcf15e9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMy0zLTEtMS03NzE3MQ_33c56e5f-e72e-4188-b66b-dab3fd89e09c"
      unitRef="usd">144000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfOS0xLTEtMS03NzE3MQ_3d820951-c86a-41ef-881b-3167925a621e"
      unitRef="usd">3800000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfOS0zLTEtMS03NzE3MQ_7c8c9a42-96a1-49e8-b135-cf359a6d5eb2"
      unitRef="usd">359000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <lgnd:AccruedInventoryPurchases
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMTAtMS0xLTEtNzcxNzE_d3bce6e6-d047-4c2c-b007-c99a7e94f64d"
      unitRef="usd">9161000</lgnd:AccruedInventoryPurchases>
    <lgnd:AccruedInventoryPurchases
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMTAtMy0xLTEtNzcxNzE_be6127f1-8405-4162-bce2-fcafd67c7422"
      unitRef="usd">12695000</lgnd:AccruedInventoryPurchases>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMTItMS0xLTEtNzcxNzE_8f3c74b3-133a-4c6c-92fc-f8c2d8de6eba"
      unitRef="usd">-149000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8yOC9mcmFnOjQ3MzRmM2E5ODQ5YzRmNmJiZGExZDZhZTY2Y2Q1N2VkL3RhYmxlOjYwZmFhZWQ1ZGRhMzQ0NWU4M2UzMzIxYWNlMDlhNzhhL3RhYmxlcmFuZ2U6NjBmYWFlZDVkZGEzNDQ1ZTgzZTMzMjFhY2UwOWE3OGFfMTItMy0xLTEtNzcxNzE_a86f3786-c8d5-4fa2-b4c8-d7d42dccb610"
      unitRef="usd">-60000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk4MDI_cf5a5eb2-c8ef-49fd-a809-2ccc80669e5f">Basis of Presentation and Summary of Significant Accounting Policies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2021 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have described our significant accounting policies in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 1, Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the Notes to Consolidated Financial Statements in our 2021 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#x201c;long-term deferred revenue&#x201d; has been added to the condensed consolidated balance sheet, separated from &#x201c;other long-term liabilities&#x201d; in our prior period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Updates, Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (&#x201c;ASU 2020-06&#x201d;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#x2019;s own equity. Consequently, a convertible debt instrument, such as the Company&#x2019;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the condensed consolidated balance sheet for the period ended June&#160;30, 2022. Upon adoption of ASU 2020-06 on January 1 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $20.4&#160;million, reduced deferred tax liabilities by $4.4&#160;million, reduced additional paid-in capital by $51.1&#160;million and increased retained earnings by $35.1&#160;million. The net balance of the 2023 Notes at January 1, 2022 was $341.1&#160;million which included an unamortized discount of $2.2&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply the following five-step model in accordance with ASC 606, Revenue from Contracts with Customers, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalties &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;amp;D services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For R&amp;amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three months ended June&#160;30, 2022 and 2021, the amount recognized as revenue that was previously deferred was $4.1 million, and $10.3 million, respectively. During the six months ended  June&#160;30, 2022 and 2021, the amount recognized as revenue that was previously deferred was $6.1 million, and $16.1 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation&#160;of&#160;Revenue &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Teriparatide injection &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rylaze &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - Core&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - COVID&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-term Investments &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term investments consist of the following at June&#160;30, 2022 and December 31, 2021 (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,027)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;292,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;321,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three and six months ended June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment policy is capital preservation and we only invest in U.S.-dollar denominated investments. We held a total of 8 positions which were in an unrealized loss position as of June&#160;30, 2022. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the three and six months ended June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three and six months ended June&#160;30, 2022, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the COVID-19 pandemic on our business and recorded an adjustment of $(0.1)&#160;million and $(0.2)&#160;million  of allowance for credit losses, respectively, as of June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs related to obsolete inventory recorded for the three and six months ended June&#160;30, 2022 and 2021. As of June&#160;30, 2022 inventory consists of Captisol prepayments of $18.9&#160;million, and as of December 31, 2021 inventory consists of Captisol prepayments of $24.6&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Other Identifiable Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;281,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(86,740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(78,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Contractual relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;709,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;732,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to 2022, we only had one reporting unit and reportable segment. In connection with the announcement in March 2022 of our intention to separate the OmniAb business pursuant to a distribution to Ligand&#x2019;s stockholders of Ligand&#x2019;s shares in OmniAb followed by a merger with APAC, management concluded that we now had two reporting units and reportable segments - the OmniAb business and the Ligand core business. See Note 2, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information. We performed a fair value analysis utilizing a combination of income approach and market approach to determine the fair value of each segment in order to appropriately allocate the goodwill between the segments as of the announcement date. The following table presents our allocation of goodwill balance by segment (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Ligand core business&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;105,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;OmniAb business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;75,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;181,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Commercial License Rights&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license rights consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,425)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,031)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.5&#160;million and credit loss adjustments of $6.5 million as of June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. in January 2019. Commercial license rights acquired are accounted for as financial assets in accordance with ASC 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Receivables, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;as further discussed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 1,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; of the Notes to Consolidated Financial Statements in our 2021 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three and six months ended June&#160;30, 2022, we further considered the current and expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties owed to third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Return reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subcontractor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six  months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net (Loss) Income Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 4, Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 6, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended June&#160;30, 2022, due to the net loss for the period, all of the 0.2&#160;million weighted average equity awards and 0.9&#160;million of potentially dilutive shares in connection with the adoption of ASU 2020-06 were anti-dilutive. For the six months ended  June&#160;30, 2022, due to the net loss for the period, all of the 0.3&#160;million weighted average equity awards and 1.8&#160;million of potentially dilutive shares in connection with the adoption of ASU 2020-06 were anti-dilutive. Under the new standard, we are required to reflect the dilutive effect of the 2023 Notes by application of the if-converted method.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3NzM_ff3f888f-d841-4dd2-95c9-1f58028c0300">Basis of PresentationOur condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2021 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3NTk_1ca53b5d-2886-4fcb-9b73-a4325ec8b568">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNzY5NjU4MTQxNjk3Ng_8fc64c26-89de-4455-b8e9-a55d81e0c729">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#x201c;long-term deferred revenue&#x201d; has been added to the condensed consolidated balance sheet, separated from &#x201c;other long-term liabilities&#x201d; in our prior period presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3OTg_f445f26e-cc22-494f-873f-ec51cb19bb6e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Updates, Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (&#x201c;ASU 2020-06&#x201d;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#x2019;s own equity. Consequently, a convertible debt instrument, such as the Company&#x2019;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the condensed consolidated balance sheet for the period ended June&#160;30, 2022. Upon adoption of ASU 2020-06 on January 1 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $20.4&#160;million, reduced deferred tax liabilities by $4.4&#160;million, reduced additional paid-in capital by $51.1&#160;million and increased retained earnings by $35.1&#160;million. The net balance of the 2023 Notes at January 1, 2022 was $341.1&#160;million which included an unamortized discount of $2.2&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConvertibleNotesPayable
      contextRef="i99d5ee9673ec4131948b388970c8f765_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNDA1OA_ff0eb994-0449-4c6b-af6d-f5d5ace091b4"
      unitRef="usd">20400000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i99d5ee9673ec4131948b388970c8f765_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNDA5OA_643e3933-b0aa-4ed8-881d-e8798068a5e6"
      unitRef="usd">-4400000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:StockholdersEquity
      contextRef="ia0f9248329c9468fb09df5396db98bf6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNDE0MA_fb371f50-42b4-46df-b272-fa2d17baa244"
      unitRef="usd">-51100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id15423cf11ad45caae992641de4875c1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNDE3OA_7d561afc-8e9b-40ab-bce9-028fc289905e"
      unitRef="usd">35100000</us-gaap:StockholdersEquity>
    <us-gaap:ConvertibleNotesPayable
      contextRef="i6eba3264dc6c4943a87106e878898597_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNDIzOA_f9c47486-d02c-4a7a-a78b-98f4f49073d9"
      unitRef="usd">341100000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i6eba3264dc6c4943a87106e878898597_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNDI4Mw_f71786f5-816c-4b61-8aac-02a7c80d0cb2"
      unitRef="usd">2200000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk4MDg_48cb9cfe-285b-42ee-b3cf-94d036b29a19">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply the following five-step model in accordance with ASC 606, Revenue from Contracts with Customers, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalties &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;amp;D services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For R&amp;amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. &lt;/span&gt;&lt;/div&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTY0OTI2NzQ0MzY3NTk_49d10058-d307-441b-88cd-19e5fe919311"
      unitRef="usd">4100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTY0OTI2NzQ0MzY3NzQ_5df2e959-6ce6-4dcd-aa82-37dbfeb5bdba"
      unitRef="usd">10300000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTY0OTI2NzQ0MzY3Njc_bef7a826-47ce-4c6d-a6cd-e1a20d6d8c52"
      unitRef="usd">6100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTY0OTI2NzQ0MzY3ODE_b00ff1de-7511-44eb-b92b-f4a05bb77a59"
      unitRef="usd">16100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3Nzk_a1259ba7-c383-4107-9434-03ebc006e353">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Teriparatide injection &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rylaze &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - Core&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - COVID&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff72851b58aa45ffa732bbda41560b3d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNC0xLTEtMS03NzE3MQ_61373315-9fd5-4382-9d6f-cca3a3c12891"
      unitRef="usd">7127000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib165267a91674f5987986a924b2120c4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNC0zLTEtMS03NzE3MQ_b0adfa2e-9e24-4e07-807b-ba430239d371"
      unitRef="usd">5440000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70869135d3c34c1db5e1e22b66ea39ae_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNC01LTEtMS03NzE3MQ_1f39ae1a-732f-41f1-bfa0-88f86d68551a"
      unitRef="usd">11749000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic99e0c134900425886aaac7ceb463839_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNC03LTEtMS03NzE3MQ_1904965d-8f17-4d10-be25-a90b79c2021b"
      unitRef="usd">9727000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icfe69b74f9a142af8ba9b55191035604_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNS0xLTEtMS03NzE3MQ_e5589d49-67ad-469f-9629-4c212829d095"
      unitRef="usd">2394000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ab02c7bc2a9493ab64ac0276d32fdff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNS0zLTEtMS03NzE3MQ_d17f1b45-5d65-42b1-8da6-a1d2380eeaeb"
      unitRef="usd">2193000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id78b53631f2e4d38a201cb8afeffe74e_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNS01LTEtMS03NzE3MQ_a64f0634-7563-4f7e-ac78-6934d70068aa"
      unitRef="usd">5095000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5a2dea7e0f94760977b89f0e7531354_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNS03LTEtMS03NzE3MQ_a58442a9-c67e-41e4-b00a-976622da077e"
      unitRef="usd">4526000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb6fe6bdce8242319de5782b9769f8db_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNi0xLTEtMS03NzE3MQ_e0c39936-61aa-4713-832d-a3059bd4fe04"
      unitRef="usd">5502000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e8e45384b614e7c8354672d3699a80a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNi0zLTEtMS03NzE3MQ_5051d438-f777-4cfe-bce1-24dfae9ab227"
      unitRef="usd">264000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9775a3f35190447f9e3b5d21d55faad5_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNi01LTEtMS04NjI4MA_084e7a29-cb66-48f5-a77e-ea91799bd708"
      unitRef="usd">8413000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i685f29c36ddc4fdfbdef1ce148091d2a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNi03LTEtMS04NjMxOA_d425488f-fe8a-4890-a17e-be2bfaa571c5"
      unitRef="usd">264000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94fdbb4317f34a609cb534522aef7982_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNy0xLTEtMS03NzE3MQ_9f0cf29e-a7b3-45af-9aaa-af7a7478cf74"
      unitRef="usd">2317000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id24caccafc6747c69868162bdd0769d2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNy0zLTEtMS03NzE3MQ_04cc9400-6582-436a-b89d-1fa176d2532b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82095dd45f8544edb3410b6b83bf52ab_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNy01LTEtMS04NjI4MA_e39ddd66-5bdc-4644-8909-987290bb95b4"
      unitRef="usd">3966000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idd89e80d3f3d44d4b5281b5916b0c8b2_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfNy03LTEtMS04NzA2Mw_7baa777a-731e-453e-a138-ee4797873e1f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c96b32616194c1b937efd406717542d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfOC0xLTEtMS03NzE3MQ_7a1e753e-fd4f-45c8-9120-7879e1724470"
      unitRef="usd">619000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife30a3da671b425e9383ee095533c9bd_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfOC0zLTEtMS03NzE3MQ_7680d285-54f8-429b-953a-b26f132634d4"
      unitRef="usd">719000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7768c766ed64817819e47086ac8e52f_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfOC01LTEtMS03NzE3MQ_738d385b-b18d-4059-b587-1cb28ebb6609"
      unitRef="usd">2431000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b46ae1b80044cff933ed7f5b6074bfd_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfOC03LTEtMS03NzE3MQ_09862826-41a5-469a-a8ae-41f112aaf3cd"
      unitRef="usd">1211000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4451c0bbe6454e30a9400b8f2b6b236b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfOS0xLTEtMS03NzE3MQ_f20334e8-ace1-4ede-bc59-c868b0e88e0e"
      unitRef="usd">17959000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iadd0658df38142da9de49541fcf1e87b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfOS0zLTEtMS03NzE3MQ_cbae7819-68bb-4a44-9de9-74b2f14255d5"
      unitRef="usd">8616000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36945e4ea3d94671ba79140fa3bfeed8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfOS01LTEtMS03NzE3MQ_b50a4b20-af5c-4846-96ee-29d7fb26b585"
      unitRef="usd">31654000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc58590074134385916f9aa21fadb3a5_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfOS03LTEtMS03NzE3MQ_9f99a288-f4c5-498a-bf67-e99dec3edc59"
      unitRef="usd">15728000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69264884c80f4de496ecd4d3871f13de_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTItMS0xLTEtNzcxNzE_47bfb678-12ee-41e3-8902-32da1d4c056a"
      unitRef="usd">3325000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f0ce6d74bbb404494d3b9ecd07c5c1d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTItMy0xLTEtNzcxNzE_5b3173c1-2046-4071-a9bf-60a144658c68"
      unitRef="usd">9682000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a26669fd70d437e8dbf0d46744ee68b_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTItNS0xLTEtODUwMjQ_b71d6b57-ac82-4643-bee8-158d4b8746e6"
      unitRef="usd">9551000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e1cee720dbe4a518d1861c1471e0601_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTItNy0xLTEtODYxNjM_dac6b192-f8dc-44f1-9ce9-9242f25ae9c5"
      unitRef="usd">10935000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac98dc8419824fccbffe08deef56431d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTMtMS0xLTEtNzcxNzE_6fb85fc6-33cc-4e1b-bb49-3c35f1a8ea39"
      unitRef="usd">26220000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1b6772c114f4296b3710452fad3bbf0_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTMtMy0xLTEtNzcxNzE_24afeb82-ed7e-4b27-81c9-e94433399317"
      unitRef="usd">52827000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac3e999d74914146b6972963646d77d3_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTMtNS0xLTEtODUwMjQ_f9f8bb57-364c-43e3-9f44-a07ac6777ecc"
      unitRef="usd">32116000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3af2fa579c8d4d0298cd4adaf64f562a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTMtNy0xLTEtODYxNjM_ffcdd898-318f-470f-a0d2-890ca453efa0"
      unitRef="usd">82846000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0dc4219be484ce8aa0ac5cb14f54a41_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTQtMS0xLTEtNzcxNzE_c4691c04-80ce-477f-acd0-52a6eee67b6b"
      unitRef="usd">29545000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i06d3227a7eb74265aa981e7a0d0ff54a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTQtMy0xLTEtNzcxNzE_eff72419-2d63-4bc4-a113-772dcd40de60"
      unitRef="usd">62509000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iede13d72d60b42d785f8340ba1c81680_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTQtNS0xLTEtNzcxNzE_2baf0429-6674-407a-9582-9fbd3c89a3b5"
      unitRef="usd">41667000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f25445795154f5a93fcbfa2d95e4ca4_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTQtNy0xLTEtNzcxNzE_c1bf3621-8e07-4a50-bb9b-3edd815edf73"
      unitRef="usd">93781000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibfe3cc306f014ceb8d03ee2a6e86a398_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTctMS0xLTEtNzcxNzE_f90d3362-6a90-4272-b4af-bbe5daefb823"
      unitRef="usd">5453000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3a848d86a33454d8e308d5c5596a288_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTctMy0xLTEtNzcxNzE_e1006944-4353-4eaf-9827-21f34a68bf8a"
      unitRef="usd">7360000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d72210a2a5943cf95ded5fa3f11f523_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTctNS0xLTEtNzcxNzE_2d32d2e1-fe7a-4a41-8808-39bb072894d4"
      unitRef="usd">10599000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i173a08fd950747df9d01f035da9f023d_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTctNy0xLTEtNzcxNzE_6f61a727-ec10-4c8b-b900-0bcb8a6fcd3f"
      unitRef="usd">12822000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c2a1b1ca5514671b9aba265dfb7b572_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTgtMS0xLTEtNzcxNzE_c37fde71-40d8-4aa8-b97a-7fb6c6dd3aa5"
      unitRef="usd">1608000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38baca3871d94649bea9b951f8a95afc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTgtMy0xLTEtNzcxNzE_e6032214-054e-461b-899d-7f50f9b351cb"
      unitRef="usd">1050000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia510a863a60a463ea460982ee2b575b2_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTgtNS0xLTEtNzcxNzE_01628820-5d0a-48a0-9a97-458dbd52872d"
      unitRef="usd">4694000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id554d23e5a4f40a5badd18e8f8b0a8b7_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTgtNy0xLTEtNzcxNzE_90f30261-7f80-41cc-b17c-af78ffffb250"
      unitRef="usd">2093000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf0d6dad86164f7eaa342595027db37f_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTktMS0xLTEtNzcxNzE_af86cd0e-38f7-46a7-9900-2a68e1e3e4a6"
      unitRef="usd">1275000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34e3ef31b9a84e509bed5d667042120e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTktMy0xLTEtNzcxNzE_2539a933-59b1-43fc-9f52-183f2ca768ed"
      unitRef="usd">3600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a41570df267433d868066c140f59972_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTktNS0xLTEtNzcxNzE_778e0d59-f2ec-4057-b186-c7bbe017f180"
      unitRef="usd">10364000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a06723b9575442cbe0af518dda8db12_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMTktNy0xLTEtNzcxNzE_8a00733a-e5f3-4c45-a907-6437625aa9ec"
      unitRef="usd">12017000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia55aca14b36b43b491df2ecf96d2c1f3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjAtMS0xLTEtNzcxNzE_e1faab9c-bb41-415d-9fe1-5a97063c153c"
      unitRef="usd">1579000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie323179691704681be1652faafc0e9a2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjAtMy0xLTEtNzcxNzE_f4b0b0f3-c69d-4d87-8863-6860fce7b244"
      unitRef="usd">1540000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaaf6ba28216b419e91b9fc13c3c06c9d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjAtNS0xLTEtNzcxNzE_03f0c6f6-96f7-44f2-b413-63bafebd9c34"
      unitRef="usd">4134000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i077a95de6c1246a0ac1df496ba8e517a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjAtNy0xLTEtNzcxNzE_a0681727-95e7-40c0-ac77-35688e369cb4"
      unitRef="usd">3384000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4abd7ed5056140b3a6f412c3dcf92315_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjEtMS0xLTEtNzcxNzE_5d5af232-6c55-4643-8473-81ee7eff39c9"
      unitRef="usd">9915000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib690ef44f20c492ba685cf71add617d4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjEtMy0xLTEtNzcxNzE_2b29c5f5-709a-46f1-bd23-1797c29a7040"
      unitRef="usd">13550000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf5c36ba61894d93b55a210349a7ccf2_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjEtNS0xLTEtNzcxNzE_d1537e83-7ce4-415f-b5ec-b723d5b28b86"
      unitRef="usd">29791000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75907dd7ed51403bb417727e96e225eb_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjEtNy0xLTEtNzcxNzE_d808a9ca-212a-47c2-a625-a91f0a1810ca"
      unitRef="usd">30316000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjItMS0xLTEtNzcxNzE_c8718fc7-740d-4af7-be83-d329beb7e549"
      unitRef="usd">57419000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjItMy0xLTEtNzcxNzE_885cf287-5cb8-4046-83dd-603cfbc6636c"
      unitRef="usd">84675000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjItNS0xLTEtNzcxNzE_8b2d013e-9394-421b-b78b-5eac344540d9"
      unitRef="usd">103112000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjM3YmFiNjk3YjM4YzRjZjdiZGY3ZDJiMTdiNWU5NDFjL3RhYmxlcmFuZ2U6MzdiYWI2OTdiMzhjNGNmN2JkZjdkMmIxN2I1ZTk0MWNfMjItNy0xLTEtNzcxNzE_88094128-bdd5-4645-a328-cdbd60c1644e"
      unitRef="usd">139825000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <lgnd:ScheduleOfShortTermInvestmentsTableTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3NjE_b18a72eb-5ae6-4eaf-b6db-2c5a6a545bce">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term investments consist of the following at June&#160;30, 2022 and December 31, 2021 (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;123,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,027)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;292,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;321,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</lgnd:ScheduleOfShortTermInvestmentsTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4d5e8d1f727f43ec8ecd549503e85c2e_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMi0xLTEtMS03NzE3MQ_b5efc260-0825-450e-a7ed-a4c14efb0247"
      unitRef="usd">2504000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4d5e8d1f727f43ec8ecd549503e85c2e_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMi00LTEtMS03NzE3MQ_1adbb3c8-1741-4fdc-ad6e-11b2728766e2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4d5e8d1f727f43ec8ecd549503e85c2e_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMi03LTEtMS03NzE3MQ_0b230c88-d825-4d16-811a-0f3b6030841c"
      unitRef="usd">61000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4d5e8d1f727f43ec8ecd549503e85c2e_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMi0xMC0xLTEtNzcxNzE_d5db9fe5-eb29-4e24-be4e-408cbc5eef75"
      unitRef="usd">2443000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3b9a9049f59047158b0b52d7d59b7745_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMy0xLTEtMS03NzE3MQ_e08bb17e-dcfb-4ca3-b0a1-03e8a7180544"
      unitRef="usd">4904000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3b9a9049f59047158b0b52d7d59b7745_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMy00LTEtMS03NzE3MQ_3acdac35-aa5e-4392-ac2b-570bf627e718"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3b9a9049f59047158b0b52d7d59b7745_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMy03LTEtMS03NzE3MQ_5bbf0def-006a-47a9-a130-2d75c22039b3"
      unitRef="usd">121000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3b9a9049f59047158b0b52d7d59b7745_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMy0xMC0xLTEtNzcxNzE_8656d2fc-b9df-4c3b-a3af-557247cd1673"
      unitRef="usd">4783000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i56f53586b69f4a9aa74c3e01f3093f45_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfNi0xLTEtMS03NzE3MQ_4a264775-a10c-428b-bfa2-d14682c9153e"
      unitRef="usd">5807000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i56f53586b69f4a9aa74c3e01f3093f45_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfNi00LTEtMS03NzE3MQ_b4ef234d-c1a7-4afb-a568-61d79fcac478"
      unitRef="usd">307000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i56f53586b69f4a9aa74c3e01f3093f45_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfNi03LTEtMS03NzE3MQ_32e4b53e-00e5-4cf3-8fa0-5db9dd45573e"
      unitRef="usd">3703000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i56f53586b69f4a9aa74c3e01f3093f45_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfNi0xMC0xLTEtNzcxNzE_b35e2fe3-0a4e-430c-9890-1a0aec2675cd"
      unitRef="usd">2411000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id64fbff1c6e448fe994106b92f9144b9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfNy0xLTEtMS03NzE3MQ_e7694736-2b33-4ae4-bdc0-e7da63cfcb68"
      unitRef="usd">112535000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id64fbff1c6e448fe994106b92f9144b9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfNy00LTEtMS03NzE3MQ_3fb2e64c-4fae-4d66-8d49-e8b30cbba186"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id64fbff1c6e448fe994106b92f9144b9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfNy03LTEtMS03NzE3MQ_4b696108-0f38-45d4-a6b4-e1c10019a54b"
      unitRef="usd">1228000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id64fbff1c6e448fe994106b92f9144b9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfNy0xMC0xLTEtNzcxNzE_c893f6e3-7953-4a0f-b02a-43a659450165"
      unitRef="usd">111307000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i21b62bb4bd3243f98e9d6acb69bbd14d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfOC0xLTEtMS03NzE3MQ_8f957a53-98ca-48ec-af11-902ed3e9603f"
      unitRef="usd">2246000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i21b62bb4bd3243f98e9d6acb69bbd14d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfOC00LTEtMS03NzE3MQ_cfebfcd9-e261-4d31-b7f1-5d25959cf709"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i21b62bb4bd3243f98e9d6acb69bbd14d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfOC03LTEtMS03NzE3MQ_28a6305c-f76c-4e39-b051-38c0164efe2c"
      unitRef="usd">71000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i21b62bb4bd3243f98e9d6acb69bbd14d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfOC0xMC0xLTEtNzcxNzE_c218f779-857f-41dd-9bcd-4665717d35d6"
      unitRef="usd">2175000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i205fad57592a433b83307f6fea8119cc_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfOS0xLTEtMS03NzE3MQ_468c62b8-3607-4a92-ad79-ec021b291dc4"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i205fad57592a433b83307f6fea8119cc_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfOS00LTEtMS03NzE3MQ_446eb5b9-4999-4098-97f2-79080db50e38"
      unitRef="usd">129000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i205fad57592a433b83307f6fea8119cc_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfOS03LTEtMS03NzE3MQ_993dbfc8-cf9b-490c-9449-7ac99a071619"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i205fad57592a433b83307f6fea8119cc_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfOS0xMC0xLTEtNzcxNzE_e84331bd-6b53-4a06-9de1-5c02fe84a72e"
      unitRef="usd">129000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTAtMS0xLTEtNzcxNzE_c9a71ec8-69cb-45ee-acb9-155f02f9e738"
      unitRef="usd">127996000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTAtNC0xLTEtNzcxNzE_4a4adbca-2c9f-40b5-8bc3-75e23f9f7a7e"
      unitRef="usd">436000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTAtNy0xLTEtNzcxNzE_8e866e41-7c10-48ca-94a8-2bb129483d10"
      unitRef="usd">5184000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTAtMTAtMS0xLTc3MTcx_9c548f4d-10cd-455e-8bc3-34927fdabe11"
      unitRef="usd">123248000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i4c186e23a71a4fb793fc929a6f1bae65_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTEtMTAtMS0xLTc3MTcx_7a922b2a-a290-4b57-8625-7b6a38e2a49d"
      unitRef="usd">19407000</us-gaap:EquitySecuritiesFvNi>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTItMTAtMS0xLTc3MTcx_23dd799b-379a-49aa-a11c-b48adbaa801c"
      unitRef="usd">142655000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ida960da78ddf459ca1c4198305520fb4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTUtMS0xLTEtNzcxNzE_6174ed2a-8256-4711-b0f1-544780b7008a"
      unitRef="usd">63389000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ida960da78ddf459ca1c4198305520fb4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTUtNC0xLTEtNzcxNzE_f9ac5e16-9c87-4aa7-9ec3-fa171a409acd"
      unitRef="usd">13000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ida960da78ddf459ca1c4198305520fb4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTUtNy0xLTEtNzcxNzE_78b391cf-cd08-46e2-b92b-25d5b782a232"
      unitRef="usd">21000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ida960da78ddf459ca1c4198305520fb4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTUtMTAtMS0xLTc3MTcx_1b705417-3acb-4f69-a10c-6e2a5b404264"
      unitRef="usd">63381000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibce85fdb40ae4d199b3b166284807908_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTYtMS0xLTEtNzcxNzE_d802627c-59ad-4181-a961-59494519a2a8"
      unitRef="usd">29308000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibce85fdb40ae4d199b3b166284807908_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTYtNC0xLTEtNzcxNzE_53e49486-d9e7-4dee-99c0-9b972b8e9d4c"
      unitRef="usd">17000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibce85fdb40ae4d199b3b166284807908_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTYtNy0xLTEtNzcxNzE_4bde6714-89d6-43bc-867b-9c60861b340c"
      unitRef="usd">38000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibce85fdb40ae4d199b3b166284807908_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTYtMTAtMS0xLTc3MTcx_c5d1b482-a19d-43cc-8b3a-d95e3c8919c4"
      unitRef="usd">29287000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5890ea92184146ffb7b0e8ae84bcf98b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTgtMS0xLTEtNzcxNzE_505ecf7d-081e-402d-8236-e41fcd1521d6"
      unitRef="usd">36008000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5890ea92184146ffb7b0e8ae84bcf98b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTgtNC0xLTEtNzcxNzE_2b7f056c-7abb-47a9-aefd-2d5ab8bb4690"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5890ea92184146ffb7b0e8ae84bcf98b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTgtNy0xLTEtNzcxNzE_bfaeaba1-fb62-42b6-8bff-1e4b019fc162"
      unitRef="usd">12000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5890ea92184146ffb7b0e8ae84bcf98b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTgtMTAtMS0xLTc3MTcx_aac05ad0-6856-4876-b9e7-0e4ad420c61a"
      unitRef="usd">35998000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0560066d2edf4834bad46274f6b43123_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTktMS0xLTEtNzcxNzE_d460f22d-7c55-4a65-9a0f-b810dcac1972"
      unitRef="usd">5807000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0560066d2edf4834bad46274f6b43123_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTktNC0xLTEtNzcxNzE_4e5e9e04-9daa-453c-8588-4c75123245d9"
      unitRef="usd">402000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0560066d2edf4834bad46274f6b43123_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTktNy0xLTEtNzcxNzE_2a94f67e-c4df-4f01-9f36-90e9164f996a"
      unitRef="usd">2027000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0560066d2edf4834bad46274f6b43123_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMTktMTAtMS0xLTc3MTcx_3a34e24d-6eca-434a-8a2a-000fb6f58700"
      unitRef="usd">4182000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0e34e3b904034f19a68a68a7d815b0af_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjAtMS0xLTEtNzcxNzE_f1d7d79c-c47a-4ce0-be8a-955520b18bf3"
      unitRef="usd">152136000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0e34e3b904034f19a68a68a7d815b0af_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjAtNC0xLTEtNzcxNzE_85d7242f-ee95-4cb0-842b-c7fd7b6025ad"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0e34e3b904034f19a68a68a7d815b0af_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjAtNy0xLTEtNzcxNzE_6c367a58-7c5e-4278-bce2-9486fd54caba"
      unitRef="usd">249000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0e34e3b904034f19a68a68a7d815b0af_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjAtMTAtMS0xLTc3MTcx_bc101dde-6d5b-4302-bd3f-0d297c5cf4b3"
      unitRef="usd">151887000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie18284bcc4c545f2af6dd44ec4f776be_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjEtMS0xLTEtNzcxNzE_7f771151-ea7e-4eac-8109-7e6dd71b1db3"
      unitRef="usd">5577000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie18284bcc4c545f2af6dd44ec4f776be_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjEtNC0xLTEtNzcxNzE_5e900f74-70d4-48a3-b751-6db1ca157c13"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie18284bcc4c545f2af6dd44ec4f776be_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjEtNy0xLTEtNzcxNzE_ae75c21d-4ee0-49c0-838c-b67e1852f35b"
      unitRef="usd">23000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie18284bcc4c545f2af6dd44ec4f776be_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjEtMTAtMS0xLTc3MTcx_daed5fda-6e54-44a9-b1d3-eaff13049dc5"
      unitRef="usd">5554000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5ec9f7faaf814c3eb810dd8294a78adb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjItMS0xLTEtNzcxNzE_ab84e1fe-3290-4213-bbf9-f43577621ebd"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5ec9f7faaf814c3eb810dd8294a78adb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjItNC0xLTEtNzcxNzE_0a245905-ffe9-4fb0-acb4-66296a586a98"
      unitRef="usd">408000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5ec9f7faaf814c3eb810dd8294a78adb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjItNy0xLTEtNzcxNzE_473b5bc2-dc07-42cf-9786-ee57cd1d1028"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5ec9f7faaf814c3eb810dd8294a78adb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjItMTAtMS0xLTc3MTcx_d4ac57df-2562-4dcf-9e0c-cdcbcd00aa07"
      unitRef="usd">408000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjMtMS0xLTEtNzcxNzE_3bf7034c-848e-4c27-ba09-16ca0fc9df66"
      unitRef="usd">292225000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjMtNC0xLTEtNzcxNzE_4de674c8-5d93-479f-b23b-0970713cc071"
      unitRef="usd">842000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjMtNy0xLTEtNzcxNzE_96a2199f-ea40-4032-a5aa-35c3d2fd9717"
      unitRef="usd">2370000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjMtMTAtMS0xLTc3MTcx_4e66e3fd-c28b-4658-8e4e-d87d55bb396a"
      unitRef="usd">290697000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i010958049e69464b916484b2032627e5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjQtMTAtMS0xLTc3MTcx_78bac3af-4da6-4af3-9cfe-e3f5745d1829"
      unitRef="usd">30889000</us-gaap:EquitySecuritiesFvNi>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOmU1NzIyMmZiNzhiOTRhMWY5Y2MxOWY1MDNjOTQyNGIxL3RhYmxlcmFuZ2U6ZTU3MjIyZmI3OGI5NGExZjljYzE5ZjUwM2M5NDI0YjFfMjUtMTAtMS0xLTc3MTcx_8e057eb8-de43-4f0e-8e9f-d1a01f932125"
      unitRef="usd">321586000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk4MDE_0d555b37-eeb8-46d7-9328-ef3f11839b89">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2Mjk1OGU1NDdiYzRmZGY4NjYxOWEyNTZmYjkzMTIwL3RhYmxlcmFuZ2U6NDYyOTU4ZTU0N2JjNGZkZjg2NjE5YTI1NmZiOTMxMjBfMi0xLTEtMS03NzE3MQ_42df75c1-683a-400c-b34e-661d74feeb65"
      unitRef="usd">6423000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2Mjk1OGU1NDdiYzRmZGY4NjYxOWEyNTZmYjkzMTIwL3RhYmxlcmFuZ2U6NDYyOTU4ZTU0N2JjNGZkZjg2NjE5YTI1NmZiOTMxMjBfMi0zLTEtMS03NzE3MQ_9cd5c65e-e8cf-41ef-b9c8-9fac1140fee1"
      unitRef="usd">6274000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2Mjk1OGU1NDdiYzRmZGY4NjYxOWEyNTZmYjkzMTIwL3RhYmxlcmFuZ2U6NDYyOTU4ZTU0N2JjNGZkZjg2NjE5YTI1NmZiOTMxMjBfMy0xLTEtMS03NzE3MQ_42aceb58-725e-4f3b-a535-669b08d2fe7f"
      unitRef="usd">3230000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2Mjk1OGU1NDdiYzRmZGY4NjYxOWEyNTZmYjkzMTIwL3RhYmxlcmFuZ2U6NDYyOTU4ZTU0N2JjNGZkZjg2NjE5YTI1NmZiOTMxMjBfMy0zLTEtMS03NzE3MQ_1a374d8f-6822-44d6-a06a-647ef9f0701b"
      unitRef="usd">3127000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2Mjk1OGU1NDdiYzRmZGY4NjYxOWEyNTZmYjkzMTIwL3RhYmxlcmFuZ2U6NDYyOTU4ZTU0N2JjNGZkZjg2NjE5YTI1NmZiOTMxMjBfNC0xLTEtMS03NzE3MQ_b22ce84b-c23a-48f3-a2e6-0f94d7f0a9ab"
      unitRef="usd">9653000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2Mjk1OGU1NDdiYzRmZGY4NjYxOWEyNTZmYjkzMTIwL3RhYmxlcmFuZ2U6NDYyOTU4ZTU0N2JjNGZkZjg2NjE5YTI1NmZiOTMxMjBfNC0zLTEtMS03NzE3MQ_149320c7-7adc-4a18-b1a2-9440c1fec1f1"
      unitRef="usd">9401000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTIzNzI_a38d3e5d-2a06-401e-abaf-964c2876b9c0"
      unitRef="position">8</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTI5OTI_9335727e-4dc3-46a7-a5fd-c56349e68d2a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3NzA_fcd298e3-eb2c-4632-8892-8ea0c01ba270">Accounts Receivable and Allowance for Credit LossesOur accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTQwMjc_4db592ba-30ea-485e-967e-b32712bf35e4"
      unitRef="usd">-100000</lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease>
    <lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTY0OTI2NzQ0Mzc1NzI_b57d1164-b8f8-48af-a97e-0015e65a153b"
      unitRef="usd">-200000</lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk4MDQ_de1b28d1-03a2-49b4-a393-1933c1a4ed00">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method. &lt;/span&gt;&lt;/div&gt;We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs related to obsolete inventory recorded for the three and six months ended June&#160;30, 2022 and 2021. As of June&#160;30, 2022 inventory consists of Captisol prepayments of $18.9&#160;million, and as of December 31, 2021 inventory consists of Captisol prepayments of $24.6&#160;million.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryNet
      contextRef="i3accfb128ab3447ca71c87b81da62c0f_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNzE0NjgyNTYwMDY1MA_57642e3e-23e3-4fb6-9da0-a95cd1bf697b"
      unitRef="usd">18900000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i86ab427a236f4147922fee98ff203990_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTQ3NjA_b8a57c68-b72d-40a1-a7b5-a9fa1e6d7efe"
      unitRef="usd">24600000</us-gaap:InventoryNet>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3OTI_1775e93d-bf4a-4e01-a7c4-ea0366cf85e6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;281,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(86,740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(78,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Contractual relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;709,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;732,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMy0xLTEtMS03NzE3MQ_2a145f8b-7f7c-41c3-89b7-dc1ffdf6643a"
      unitRef="usd">181206000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMy0zLTEtMS03NzE3MQ_a9d62e52-23eb-4def-8447-3832cc4d14c9"
      unitRef="usd">181206000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i41836ea2320e4ecdbaed6d4b7e28b1bc_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfNS0xLTEtMS03NzE3MQ_682c7b3c-9c6d-4167-9940-ee2f310ba258"
      unitRef="usd">281578000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2f1b65679e05403d90db551817862dd0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfNS0zLTEtMS03NzE3MQ_b3e2666f-bdc8-4d18-82f4-4a02fbd4f12f"
      unitRef="usd">280617000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i41836ea2320e4ecdbaed6d4b7e28b1bc_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfNi0xLTEtMS03NzE3MQ_0b0aaec8-7ff5-4d13-b8e8-76734aaead7c"
      unitRef="usd">86740000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2f1b65679e05403d90db551817862dd0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfNi0zLTEtMS03NzE3MQ_f5ffaf64-9e5f-4905-9dd4-b8c6504f20d3"
      unitRef="usd">78991000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i38d13f31c97741448d56e9f1fe72169f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfNy0xLTEtMS03NzE3MQ_69f95945-d3f3-496d-8c5b-bfc5e9ecf035"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0adfd09ddb864f8c9e65d502b415fbc1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfNy0zLTEtMS03NzE3MQ_9970aebd-9bb7-4bed-b3d5-20a2dfc438e4"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i38d13f31c97741448d56e9f1fe72169f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfOC0xLTEtMS03NzE3MQ_127ddb40-db77-4c22-acce-800d9d75af79"
      unitRef="usd">1510000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0adfd09ddb864f8c9e65d502b415fbc1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfOC0zLTEtMS03NzE3MQ_2ec7d18b-be5b-49d1-9aa7-572e8b2890e0"
      unitRef="usd">1444000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8c8b7e890d8e4b648961c025a2b1a977_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfOS0xLTEtMS03NzE3MQ_3c923559-103d-486f-b4cf-9f4585a3c770"
      unitRef="usd">40700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i411c360a01fd4666a436f4eafb9202d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfOS0zLTEtMS03NzE3MQ_7d3dd8fb-51a3-4d7d-a760-06c71ccb6932"
      unitRef="usd">40700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8c8b7e890d8e4b648961c025a2b1a977_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMTAtMS0xLTEtNzcxNzE_0d7b7476-1fab-4cd2-ad45-4e2d58df8b1d"
      unitRef="usd">19602000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i411c360a01fd4666a436f4eafb9202d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMTAtMy0xLTEtNzcxNzE_2f668c0c-a0b1-4484-aa32-176b404deabf"
      unitRef="usd">18267000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id7bd5f1328d942879973ee2497a5b28d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMTEtMS0xLTEtNzcxNzE_bf4890f8-d1c7-43ae-b11b-701034d31260"
      unitRef="usd">362000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia37ae682ab9d400d972e4f8f784305f9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMTEtMy0xLTEtNzcxNzE_c21a8705-bd3c-4559-b091-7f13095da385"
      unitRef="usd">362000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id7bd5f1328d942879973ee2497a5b28d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMTItMS0xLTEtNzcxNzE_6493984f-26e7-4d85-a772-ae1b5544e1bd"
      unitRef="usd">50704000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia37ae682ab9d400d972e4f8f784305f9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMTItMy0xLTEtNzcxNzE_a5492160-7d07-434a-bc54-4a660d588d48"
      unitRef="usd">36217000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMTMtMS0xLTEtNzcxNzE_106c86ee-0ba1-499a-91e5-07dd2fe874e6"
      unitRef="usd">709570000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjE4MzAzZmU0YzZkNTQxYTViYzA0MjcxYmYxMTE5ODZlL3RhYmxlcmFuZ2U6MTgzMDNmZTRjNmQ1NDFhNWJjMDQyNzFiZjExMTk4NmVfMTMtMy0xLTEtNzcxNzE_0d08224c-305e-4053-b58e-362823f3c9fe"
      unitRef="usd">732246000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:NumberOfReportingUnits
      contextRef="i35897df76b71438cbfcc21f5fd8c25ba_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNzY5NjU4MTQyMDA5OA_8b86928c-7907-4a61-b22d-105ea3af1150"
      unitRef="reporting_unit">1</us-gaap:NumberOfReportingUnits>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfNzY5NjU4MTQxNjk3Mg_cb76b79e-b74d-4e8b-8164-b16a755a2517">The following table presents our allocation of goodwill balance by segment (in thousands): &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Ligand core business&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;105,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;OmniAb business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;75,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;181,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="if91b70357fb44a83b104d251dcf482de_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2MTRlYzg5NzY4MzQ3N2I5ZTg1ODhiZDBkM2MzNjc1L3RhYmxlcmFuZ2U6NDYxNGVjODk3NjgzNDc3YjllODU4OGJkMGQzYzM2NzVfMy0xLTEtMS05MDQzOA_11798656-01f6-4419-a111-04649f1fd0c9"
      unitRef="usd">105673000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1c0ab083247d44e1ab92188a9e44c058_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2MTRlYzg5NzY4MzQ3N2I5ZTg1ODhiZDBkM2MzNjc1L3RhYmxlcmFuZ2U6NDYxNGVjODk3NjgzNDc3YjllODU4OGJkMGQzYzM2NzVfNC0xLTEtMS05MDQzOA_637cd9d0-e591-4390-bab2-249c1b8c68dc"
      unitRef="usd">75533000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjQ2MTRlYzg5NzY4MzQ3N2I5ZTg1ODhiZDBkM2MzNjc1L3RhYmxlcmFuZ2U6NDYxNGVjODk3NjgzNDc3YjllODU4OGJkMGQzYzM2NzVfNS0xLTEtMS05MDQzOA_8a36be76-b052-4d38-af46-e1994cbefc62"
      unitRef="usd">181206000</us-gaap:Goodwill>
    <lgnd:CommercialLicenseRightsPolicyTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3ODQ_9977414b-095c-4c8f-b21a-2044bf61e69c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Commercial License Rights&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license rights consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,425)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,031)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.5&#160;million and credit loss adjustments of $6.5 million as of June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. in January 2019. Commercial license rights acquired are accounted for as financial assets in accordance with ASC 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Receivables, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;as further discussed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 1,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; of the Notes to Consolidated Financial Statements in our 2021 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three and six months ended June&#160;30, 2022, we further considered the current and expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;</lgnd:CommercialLicenseRightsPolicyTextBlock>
    <lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3ODU_6f4ca3e8-7805-44a7-91d3-6d5edac97969">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license rights consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,425)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,031)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.5&#160;million and credit loss adjustments of $6.5 million as of June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i934ac72595594c6b994d97c0a1b7f89a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMi0yLTEtMS03NzE3MQ_645c902d-45c5-432a-b3e1-74f272025c19"
      unitRef="usd">17696000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i934ac72595594c6b994d97c0a1b7f89a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMi00LTEtMS03NzE3MQ_f7129c75-f0c1-4605-b2b8-d3405f3dc06a"
      unitRef="usd">9425000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i934ac72595594c6b994d97c0a1b7f89a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMi02LTEtMS03NzE3MQ_c3f69210-534e-4400-af75-74b8ff34129d"
      unitRef="usd">8271000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibe59142403aa47d6801e8bc016edf9d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMi04LTEtMS03NzE3MQ_f32d3d64-2258-46a8-8224-111e36470456"
      unitRef="usd">17696000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="ibe59142403aa47d6801e8bc016edf9d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMi0xMC0xLTEtNzcxNzE_441787c2-99f6-40de-84b9-54061db0301d"
      unitRef="usd">9461000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibe59142403aa47d6801e8bc016edf9d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMi0xMi0xLTEtNzcxNzE_7be67693-d5f5-45e3-9fc8-6966e8b12482"
      unitRef="usd">8235000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i886a648c2410405ea2213afd1c7526cb_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMy0yLTEtMS03NzE3MQ_d56f3d2f-162e-4e09-8487-d196e1bcadc9"
      unitRef="usd">10602000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i886a648c2410405ea2213afd1c7526cb_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMy00LTEtMS03NzE3MQ_b008031e-39ff-4948-acc7-8b75c433f8bc"
      unitRef="usd">8606000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i886a648c2410405ea2213afd1c7526cb_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMy02LTEtMS03NzE3MQ_0d4d6079-4e15-44a7-b98b-98a96a7b4437"
      unitRef="usd">1996000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i07d69c84f97e467a8586439168e3a979_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMy04LTEtMS03NzE3MQ_37ab28bd-a139-4207-b5e9-32626702da1c"
      unitRef="usd">10602000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i07d69c84f97e467a8586439168e3a979_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMy0xMC0xLTEtNzcxNzE_fa6b684f-093c-4405-821b-cdfe01fbaa72"
      unitRef="usd">8727000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i07d69c84f97e467a8586439168e3a979_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfMy0xMi0xLTEtNzcxNzE_84beff4f-0c34-4bd0-a416-39cfd8a79b28"
      unitRef="usd">1875000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icc20f2ad27ad4526a19a3ed221aa03e3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfNC0yLTEtMS03NzE3MQ_92bf8f95-ee7b-4c90-b269-acf321c047c5"
      unitRef="usd">28298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="icc20f2ad27ad4526a19a3ed221aa03e3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfNC00LTEtMS03NzE3MQ_d559e721-76e4-41c1-9576-1e24bf0854b9"
      unitRef="usd">18031000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="icc20f2ad27ad4526a19a3ed221aa03e3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfNC02LTEtMS03NzE3MQ_5d962179-c7b2-4018-b840-de4628d7d96f"
      unitRef="usd">10267000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i634f77b02fdb422b81be6145a0ca48da_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfNC04LTEtMS03NzE3MQ_1e2e91c5-055b-4a1c-a587-44c9be0e3593"
      unitRef="usd">28298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i634f77b02fdb422b81be6145a0ca48da_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfNC0xMC0xLTEtNzcxNzE_6e4a3fae-f8ba-4799-8a3e-72ca6107a60e"
      unitRef="usd">18188000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i634f77b02fdb422b81be6145a0ca48da_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyZWRhY2E3OGY0MTQ1OWNiM2E0MmE0MDNjNmIzNGRkL3RhYmxlcmFuZ2U6OTJlZGFjYTc4ZjQxNDU5Y2IzYTQyYTQwM2M2YjM0ZGRfNC0xMi0xLTEtNzcxNzE_e856ca12-ddf2-4592-905f-78e210fe72a1"
      unitRef="usd">10110000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icc20f2ad27ad4526a19a3ed221aa03e3_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTUwNzA_d4cecb23-9017-43a0-b67e-5f1370330af6"
      unitRef="usd">11500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="icc20f2ad27ad4526a19a3ed221aa03e3_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTUxMDQ_060b7e6e-bd32-419e-906d-561d0e7d2dd4"
      unitRef="usd">6500000</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i634f77b02fdb422b81be6145a0ca48da_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTUxODA_c6457d1a-df76-4306-9c15-b1a10d386fdb"
      unitRef="usd">11700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="i634f77b02fdb422b81be6145a0ca48da_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTUyMTQ_064c62aa-f211-4a64-b185-fc37304040a8"
      unitRef="usd">6500000</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3Nzc_7e224be1-342b-4d9a-b0cc-fe66e8fefa27">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties owed to third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Return reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subcontractor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMi0xLTEtMS03NzE3MQ_527ad8c3-8400-4ca9-8a0f-dc5fea00044c"
      unitRef="usd">4669000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMi0zLTEtMS03NzE3MQ_5987527b-f1db-40be-841f-9e67b7ec3b88"
      unitRef="usd">6532000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMy0xLTEtMS03NzE3MQ_a95ceb89-b6c9-4945-a546-709a2bd74db8"
      unitRef="usd">1828000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMy0zLTEtMS03NzE3MQ_d6554734-eab2-4aba-a404-770d9c8b70f4"
      unitRef="usd">2046000</us-gaap:AccruedProfessionalFeesCurrent>
    <lgnd:LicenseeAccrualCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfNC0xLTEtMS03NzE3MQ_d2a49ad9-5c46-48b0-b202-e58db2b24298"
      unitRef="usd">2674000</lgnd:LicenseeAccrualCurrent>
    <lgnd:LicenseeAccrualCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfNC0zLTEtMS03NzE3MQ_d4666140-5d3c-486c-b252-b4874e786735"
      unitRef="usd">630000</lgnd:LicenseeAccrualCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfNS0xLTEtMS03NzE3MQ_ad8a3f4d-09f0-4fa4-964d-369090ae7840"
      unitRef="usd">0</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfNS0zLTEtMS03NzE3MQ_5883fa15-14ca-4ccd-bc5a-31be96d442af"
      unitRef="usd">149000</us-gaap:AccruedRoyaltiesCurrent>
    <lgnd:ReturnsAccrual
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfNi0xLTEtMS03NzE3MQ_8f03907d-6a47-4e3f-b535-24e13871754d"
      unitRef="usd">0</lgnd:ReturnsAccrual>
    <lgnd:ReturnsAccrual
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfNi0zLTEtMS03NzE3MQ_3fee63b4-f98b-4f48-9959-bec75ddcbe40"
      unitRef="usd">2420000</lgnd:ReturnsAccrual>
    <lgnd:AccruedAssetAcquisitionsCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfNy0xLTEtMS03NzE3MQ_f9605132-0239-466a-8dc0-7a6ade61577d"
      unitRef="usd">0</lgnd:AccruedAssetAcquisitionsCurrent>
    <lgnd:AccruedAssetAcquisitionsCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfNy0zLTEtMS03NzE3MQ_9c1f691f-dadc-4ac4-b570-82c98905a296"
      unitRef="usd">1000000</lgnd:AccruedAssetAcquisitionsCurrent>
    <lgnd:AccruedSubcontractorExpensesCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfOC0xLTEtMS03NzE3MQ_6ff00db9-cd16-4b6d-a474-828097815296"
      unitRef="usd">1756000</lgnd:AccruedSubcontractorExpensesCurrent>
    <lgnd:AccruedSubcontractorExpensesCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfOC0zLTEtMS03NzE3MQ_ba89f2bf-e33d-4e47-9303-f23a653c1ebd"
      unitRef="usd">1759000</lgnd:AccruedSubcontractorExpensesCurrent>
    <lgnd:AccruedSupplierExpensesCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfOS0xLTEtMS03NzE3MQ_4d123bbb-c7da-452e-b0c9-f30f71a034f8"
      unitRef="usd">1995000</lgnd:AccruedSupplierExpensesCurrent>
    <lgnd:AccruedSupplierExpensesCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfOS0zLTEtMS03NzE3MQ_bc911af7-4dd8-45f6-a481-54e39d512218"
      unitRef="usd">848000</lgnd:AccruedSupplierExpensesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMTAtMS0xLTEtNzcxNzE_3b1fc829-414b-4580-a15e-6a18bbfbd2ad"
      unitRef="usd">0</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMTAtMy0xLTEtNzcxNzE_632dd55a-96b2-4c4a-b764-adf36844ca10"
      unitRef="usd">291000</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMTEtMS0xLTEtNzcxNzE_6cc1b4af-1afb-4eed-9027-ead71146d885"
      unitRef="usd">1629000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMTEtMy0xLTEtNzcxNzE_893148f5-d6c2-40da-9bb1-bb1032c64a01"
      unitRef="usd">1904000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMTItMS0xLTEtNzcxNzE_45db8722-fc19-44d6-b71b-f7deb61246a0"
      unitRef="usd">14551000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjA1OGE2NGVkNmU2NTRkOGU5MzBmYzczZmE4Mzc3NmQzL3RhYmxlcmFuZ2U6MDU4YTY0ZWQ2ZTY1NGQ4ZTkzMGZjNzNmYTgzNzc2ZDNfMTItMy0xLTEtNzcxNzE_345e483a-a507-4307-9208-ccfe2a3bf1e0"
      unitRef="usd">17579000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3NjI_e210f24d-6dc3-404d-9869-903d7f7b652b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six  months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3NTc_4aca959d-f843-4c0c-93f8-9060574a8643">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six  months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i5690281660a344fd9548591a6f266ac4_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfMy0xLTEtMS03NzE3MQ_60cd1a4c-04c6-42d6-a060-2624239181b3"
      unitRef="usd">4501000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ic8a73247f7a945ea9b05cf35b6cc0850_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfMy0zLTEtMS03NzE3MQ_295a71b4-71e9-4f57-b79a-b15b409c2471"
      unitRef="usd">4556000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="id6ac9689508e4114ba54882dec295d93_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfMy01LTEtMS04MzQxNg_483e06fe-e9a8-4a28-9053-ddb3f3e0d212"
      unitRef="usd">8415000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="id6ac9689508e4114ba54882dec295d93_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfMy01LTEtMS04MzQxNg_595ae5b2-edef-42c0-862d-77bdc23dbee1"
      unitRef="usd">8415000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="id6900c46450645478d0da3f5fb2d9670_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfMy03LTEtMS04MzQxNg_92c3f0ca-209c-40ff-9837-329ae620f75e"
      unitRef="usd">8495000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ibd353da9346c4eff9ef59fce65083fef_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNC0xLTEtMS03NzE3MQ_194aae20-8209-42fb-9b1e-e088fd3c399f"
      unitRef="usd">4998000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i29682bf3513f43abae73bf36fdc07869_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNC0zLTEtMS03NzE3MQ_35c94c27-075c-4d0b-8e5d-9db4b7543cb6"
      unitRef="usd">5660000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ibca091886a1342b2acf333d5f3b78776_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNC01LTEtMS04MzQxNg_11cc0b60-3a6f-4266-824d-b36e893a38c4"
      unitRef="usd">10128000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ibca091886a1342b2acf333d5f3b78776_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNC01LTEtMS04MzQxNg_5c077862-db27-454b-831e-72c5a5108c05"
      unitRef="usd">10128000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i074a3e4a71c9476fba4587a19825900e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNC03LTEtMS04MzQxNg_055f5358-ba2f-4d43-8ea3-26ba916021f0"
      unitRef="usd">10126000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNS0xLTEtMS03NzE3MQ_6a4dcbe8-bb78-46ed-b902-6346ece3a5f3"
      unitRef="usd">9499000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNS0zLTEtMS03NzE3MQ_f0623269-d25b-4ef4-9063-9a2d49f6cd5a"
      unitRef="usd">10216000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNS01LTEtMS04MzQxNg_affe9c57-60e6-452f-8b1a-65cb2b77a3d7"
      unitRef="usd">18543000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjIxNWQ4NDMyYjAyYjQwMTlhNGE3NzljNzBjYjI2MTQ2L3RhYmxlcmFuZ2U6MjE1ZDg0MzJiMDJiNDAxOWE0YTc3OWM3MGNiMjYxNDZfNS03LTEtMS04MzQxNg_7df78792-3b2c-414f-8a5d-1f8d31358baa"
      unitRef="usd">18621000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3NjM_a7e2479f-300a-42bd-8564-4a1b74960ad3">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfMy0xLTEtMS03NzE3MQ_8f85f6db-79a4-4b03-a596-ae9be9c2c88c"
      unitRef="number">0.030</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfMy0zLTEtMS03NzE3MQ_836a8228-0b47-4114-b61d-df76e9accf07"
      unitRef="number">0.009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfMy01LTEtMS04MzQyMA_4142f463-ef14-4175-b924-df2715c2c162"
      unitRef="number">0.030</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfMy01LTEtMS04MzQyMA_61083fbe-fc59-4317-b63f-ae46fcb8a33f"
      unitRef="number">0.030</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfMy03LTEtMS04MzQyMg_58b5a970-6c6a-459b-84b7-1cc4464c8d9c"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNC0xLTEtMS03NzE3MQ_5c010579-ad16-49f6-a7b3-5125b636830e"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNC0zLTEtMS03NzE3MQ_f46dbde1-b333-416d-8521-d2f605b43902"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNC01LTEtMS04MzQyMA_06af83aa-2f9f-4565-984b-420ef624c0ba"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNC01LTEtMS04MzQyMA_ade7f180-5ad3-430d-81af-f3a9c7a7c7ca"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNC03LTEtMS04MzQyMg_e1c6edb2-d340-4263-b5db-e4dd98a90969"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNS0xLTEtMS03NzE3MQ_917ac214-d990-486e-ae69-8274f3088ba5"
      unitRef="number">0.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNS0zLTEtMS03NzE3MQ_24e6b62e-de81-4428-81ca-0ad23c3bc925"
      unitRef="number">0.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNS01LTEtMS04MzQyMA_24cf44d3-6710-407e-9fe9-373a85e43f1c"
      unitRef="number">0.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNS01LTEtMS04MzQyMA_58c3fef6-eba6-4abf-9411-beea2ef7a9a7"
      unitRef="number">0.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNS03LTEtMS04MzQyMg_dbd8de06-f1fc-4128-a069-4334915791dc"
      unitRef="number">0.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNi0xLTEtMS03NzE3MQ_6e046ede-468f-4704-b953-04327b46f745">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNi0zLTEtMS03NzE3MQ_6e47070c-e3ea-41f6-84c4-677478f51d4e">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNi01LTEtMS04MzQyMA_b27440f7-6bd5-4dee-94bf-8a34b3ff7a2d">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjMzMzJlMDlhMjA5YjQzYzdhY2MzYWFiNmMzNDRhOGM0L3RhYmxlcmFuZ2U6MzMzMmUwOWEyMDliNDNjN2FjYzNhYWI2YzM0NGE4YzRfNi03LTEtMS04MzQyMg_65883656-86fa-47ab-a0ce-41798b16c056">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="i94c20b531d9a49f3ba7f9be28e443ebb_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk4MDY_d9ab9e63-5048-493c-8d96-b6d24e0e1400">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent
      contextRef="idde310731c5f4ddf8421b11a76439a76_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTc1Nzc_e9596772-947a-4f22-81e4-406ead5c3625"
      unitRef="number">0</lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent>
    <lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent
      contextRef="i4653b493ab2c477f934120be3d321770_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTc1ODM_fb949e03-ecae-48b3-931f-4326bb5bd319"
      unitRef="number">2</lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3OTc_625520eb-4214-4681-a3b0-224f6f3bd191">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net (Loss) Income Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 4, Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 6, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk3ODg_64b71124-6f14-4ee7-8a11-ff1bd43ba90c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfMy0xLTEtMS03NzE3MQ_10c82f03-31e2-4a3e-8b78-6dd3c3501026"
      unitRef="shares">16868000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfMy0xLTEtMS03NzE3MQ_a1b1089f-b47c-4f7f-a728-8a4915e35f62"
      unitRef="shares">16868000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfMy0zLTEtMS03NzE3MQ_0fbd6e4a-5594-40fb-b9ab-5bd04ec83457"
      unitRef="shares">16659000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfMy01LTEtMS04MzQyNA_46969031-d92c-4cab-b734-ece05a7454f8"
      unitRef="shares">16846000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfMy01LTEtMS04MzQyNA_7db08726-19d5-4435-8084-d4777214dd30"
      unitRef="shares">16846000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfMy03LTEtMS04MzQyNA_20911303-e733-4633-8a34-4f511e877aab"
      unitRef="shares">16548000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iab8c600366d6408f8d68011ffa0eefb3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfNS0xLTEtMS03NzE3MQ_47e42e7e-54e7-4ea8-9935-4f9412ebba0b"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i62f296ba5f6d4e0080870b494a4cb1f3_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfNS0zLTEtMS03NzE3MQ_59418faa-60f9-44f9-bfe4-47198310892c"
      unitRef="shares">69000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7f4ae166f88f42b9ad465f19b7a2b5dd_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfNS01LTEtMS04MzQyNA_71613b5c-afb8-4a6c-b971-edb1e04fba5e"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ib5ad93d1c25b4a4e91833014363da039_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfNS03LTEtMS04MzQyNA_c084f428-6f5f-4e3d-88e2-6399ad042002"
      unitRef="shares">90000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id4d8ee4a829e4a9b9b6b4a7a447bdb79_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfNi0xLTEtMS03NzE3MQ_37da9b15-10e6-4728-a1a8-6dd4f7302ed5"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1aef4caca12a42dc91df79cbcf0581b8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfNi0zLTEtMS03NzE3MQ_65b6618e-f4b3-458d-967e-ce8ff81d5358"
      unitRef="shares">444000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5d6a3560d8b34a5cbe1f0942263178b3_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfNi01LTEtMS04MzQyNA_1d1cc780-370d-4fd7-96e1-375cedfc420b"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia4ad93b5e6dd4cd99dc35ab96510e147_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfNi03LTEtMS04MzQyNA_49d666db-d17c-4ab3-9c44-6c4ec80851d1"
      unitRef="shares">572000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOC0xLTEtMS03NzE3MQ_2f50e738-8efb-4d8c-8132-5d3c77125d83"
      unitRef="shares">16868000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOC0zLTEtMS03NzE3MQ_339d414c-ad39-415b-acc1-ab07dec298e7"
      unitRef="shares">17172000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOC01LTEtMS04MzQyNA_74188db9-cb56-4ba2-b9d9-8b6fe81029c2"
      unitRef="shares">16846000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOC03LTEtMS04MzQyNA_c35155b7-5267-4e62-a51f-f6d3e4f07147"
      unitRef="shares">17210000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOS0xLTEtMS03NzE3MQ_c8161e96-1146-4212-b1d5-8d82d39fdbaa"
      unitRef="shares">6794000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOS0zLTEtMS03NzE3MQ_959fa3b7-cbbd-4e5f-9bb6-04c1b9a268b6"
      unitRef="shares">5087000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOS01LTEtMS04MzQyNA_a87aa62e-de86-4d88-abf3-8c0ddb31da74"
      unitRef="shares">6400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOS01LTEtMS04MzQyNA_cb88b492-df5a-4790-b6d1-2f76ebf76794"
      unitRef="shares">6400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RhYmxlOjkyMjdmZmRkODg1ZDQwMTliMDFlYjczNThlMThjN2IwL3RhYmxlcmFuZ2U6OTIyN2ZmZGQ4ODVkNDAxOWIwMWViNzM1OGUxOGM3YjBfOS03LTEtMS04MzQyNA_1ca4a163-4741-4281-a6b5-f853a0034863"
      unitRef="shares">4684000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i24cd0274970047cebd3b261d67019060_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTY0OTI2NzQ0Mzc0MDA_672bb9d7-e7bf-4fc0-a71d-9ff6f4e5f7f5"
      unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if037b66c12a84486bd10aab5f91c4756_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTY0OTI2NzQ0Mzc0MTg_a6156936-8045-42bf-98e9-5e0cbbaf7269"
      unitRef="shares">900000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iad364541fb5f472591361e583d131e10_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTY0OTI2NzQ0MzY3OTI_57ec1c1d-8e9d-49d5-85e1-a70d3f27dfe5"
      unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ifbe273cd726b46b98c132ca315d75750_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNC9mcmFnOmViMzhlOTJjYThkZDRjMGNhODcyNGM2NjhiNmIxMWRiL3RleHRyZWdpb246ZWIzOGU5MmNhOGRkNGMwY2E4NzI0YzY2OGI2YjExZGJfMTk1MjA_04241086-061c-4550-86c7-77c359550adc"
      unitRef="shares">1800000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RleHRyZWdpb246MzM2YTE0YmQzMWRiNDJjMzliZDliMWM3ODMxMzBhYjJfMzU0Nw_c08a55fb-6cd6-4c6c-931a-9c43be5aba83">Segment Information&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 280, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, establishes annual and interim reporting standards for an enterprise&#x2019;s operating segments and related disclosures about its products, services, geographic areas and major customers. An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenue and incur expenses, and for which discrete financial information is regularly evaluated by the chief operating decision maker in deciding how to allocate resources and assess performance. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our operating segments are identified in the same manner as they are reported internally and used by our chief operating decision maker for the purpose of evaluating performance and allocating resources. Historically, we have disclosed one reportable segment. On March 23, 2022, we entered into the Merger Agreement, pursuant to which APAC will combine with OmniAb, and acquire the OmniAb Business, in a Reverse Morris Trust transaction. Immediately prior to the Merger and pursuant to the Separation Agreement, we will, among other things, transfer the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc. to OmniAb (the &#x201c;Reorganization&#x201d;) and, in connection therewith, will distribute (the &#x201c;Distribution&#x201d;) to Ligand stockholders 100% of the common stock of OmniAb. Immediately following the Distribution, Merger Sub will merge with and into OmniAb (the &#x201c;Merger&#x201d;), with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of APAC.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the execution of the Merger Agreement, we have made organizational changes to better align our organizational structure with our strategy and operations, and management has reorganized the reportable segments to better reflect how the business is evaluated by the chief operating decision maker. Beginning in the first quarter of 2022, we operate the following two reportable segments: (1) OmniAb business and (2) Ligand core business. The OmniAb business segment is focused on enabling the discovery of therapeutic candidates for our partners by pairing antibody repertoires generated from our proprietary transgenic animals with our OmniAb business platform screening tools. The Ligand core business segment is a biopharmaceutical business focused on developing or acquiring technologies that help pharmaceutical companies deliver and develop medicines. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income (loss) represents income (loss) before income taxes, interest income, interest expense, other income (expense), net, unallocated share-based compensation, and unallocated corporate overhead. Our management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#x2019;s internal financial information as used for corporate management purposes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OmniAb business revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total OmniAb business revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ligand core business revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Captisol - Core &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Captisol - COVID&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;Total Ligand core business revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;78,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;57,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;84,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;103,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Segment operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OmniAb business &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,998)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15,187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12,410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ligand core business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;61,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;67,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unallocated corporate items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shared-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total unallocated corporate items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(469)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i6e8af247251140e088c62af9f5e1be66_D20220101-20220322"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RleHRyZWdpb246MzM2YTE0YmQzMWRiNDJjMzliZDliMWM3ODMxMzBhYjJfOTQ3_ec0585e0-642e-4734-9d6f-1990bf441c41"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="iebd5e1dca73546bab3c7f7e7fd807132_D20220323-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RleHRyZWdpb246MzM2YTE0YmQzMWRiNDJjMzliZDliMWM3ODMxMzBhYjJfMjIwMg_db484c4e-5d62-44ff-926b-5dc4f55f7957"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RleHRyZWdpb246MzM2YTE0YmQzMWRiNDJjMzliZDliMWM3ODMxMzBhYjJfMzU0OA_5d7b7b03-0c0d-49e3-be0f-4f419e3c26e6">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#x2019;s internal financial information as used for corporate management purposes (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OmniAb business revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total OmniAb business revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ligand core business revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Captisol - Core &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Captisol - COVID&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;Total Ligand core business revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;78,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;57,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;84,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;103,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Segment operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OmniAb business &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,998)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15,187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12,410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ligand core business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;61,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;67,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unallocated corporate items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shared-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total unallocated corporate items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(469)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebdd064189bf40a1b0af7c11c05b508a_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMy0xLTEtMS03NzE3MQ_7b9a0007-da09-410b-b858-8afd16d56e3b"
      unitRef="usd">139000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12b9af2332e24b278e251428d3112d54_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMy0zLTEtMS03NzE3MQ_52d06c71-a0a1-4e83-898f-562d2b735c13"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee885ce7e8c546a58c101265454c96b4_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMy01LTEtMS04MzQzMA_a6efbb73-7433-48a9-a3cb-ccc86c3dabd2"
      unitRef="usd">402000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i554afd03f39f48b1b340f2c1f5e63b38_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMy03LTEtMS04MzQzMw_9697812b-2c62-4ae3-8ff8-1bcb920fd3b7"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa01d917cb584f68ad23a0a988be1019_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNC0xLTEtMS03NzE3MQ_4db91924-9da0-405c-bd22-2e7e2d1d82b4"
      unitRef="usd">7153000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5cc3aca482094a8ea993165932b200f4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNC0zLTEtMS03NzE3MQ_10bae4f1-7261-4dd1-be5c-174006863a54"
      unitRef="usd">5821000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0323f8ac68c4e58abf54420181eb553_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNC01LTEtMS04MzQzMA_8504a532-d4e0-40a7-a1ad-8e8c65247975"
      unitRef="usd">16068000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i53051290139d4df09cbb95cc83d65ca5_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNC03LTEtMS04MzQzMw_34dbad08-e14a-44c0-a99f-c8532bbea6f8"
      unitRef="usd">14380000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09a96cf6288542ffb7bf41f87f2f1513_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNS0xLTEtMS03NzE3MQ_87346893-3eb6-4d7f-afd4-296eafa5e4cb"
      unitRef="usd">7292000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i24d7aae3601941aca19f23d31f03721a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNS0zLTEtMS03NzE3MQ_b734c92f-377e-4caf-8f13-c7f095c6f043"
      unitRef="usd">5821000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a04509ce52a4958bd559598330aa15e_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNS01LTEtMS04MzQ2NA_eae4ac80-ac0b-4e4a-aaf4-6ddb6edac811"
      unitRef="usd">16470000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c045aa28e3844fcb9eff412fe495b73_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNS03LTEtMS04MzQ2Ng_8bbf87ed-8f89-417c-aad4-e76a9ffa0675"
      unitRef="usd">14380000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic75dfe15187544a5842c26db724997b1_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNy0xLTEtMS03NzE3MQ_2e52c1a8-fdaa-4576-a773-8f0fee238389"
      unitRef="usd">17820000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id13f1a41d92a446e880e3b7f996d39bb_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNy0zLTEtMS03NzE3MQ_2ef18a05-3f96-481b-9a40-1c06c83e0c99"
      unitRef="usd">8616000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i55d6c284cd324a37b54f99d3f372c0d3_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNy01LTEtMS04MzQzNQ_94cefa90-cdb3-4c0c-8f2f-a2405d50a451"
      unitRef="usd">31252000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67ed19c1f7cc4ba5a898950694d6aad5_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfNy03LTEtMS04MTIwOQ_3cecc0e6-3dcb-45b0-b518-e25c0c5121db"
      unitRef="usd">15728000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69264884c80f4de496ecd4d3871f13de_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfOC0xLTEtMS03NzE3MQ_47bfb678-12ee-41e3-8902-32da1d4c056a"
      unitRef="usd">3325000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f0ce6d74bbb404494d3b9ecd07c5c1d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfOC0zLTEtMS03NzE3MQ_5b3173c1-2046-4071-a9bf-60a144658c68"
      unitRef="usd">9682000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a26669fd70d437e8dbf0d46744ee68b_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfOC01LTEtMS04MzQzNQ_b71d6b57-ac82-4643-bee8-158d4b8746e6"
      unitRef="usd">9551000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e1cee720dbe4a518d1861c1471e0601_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfOC03LTEtMS04MzQzNw_dac6b192-f8dc-44f1-9ce9-9242f25ae9c5"
      unitRef="usd">10935000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac98dc8419824fccbffe08deef56431d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfOS0xLTEtMS03NzE3MQ_6fb85fc6-33cc-4e1b-bb49-3c35f1a8ea39"
      unitRef="usd">26220000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1b6772c114f4296b3710452fad3bbf0_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfOS0zLTEtMS03NzE3MQ_24afeb82-ed7e-4b27-81c9-e94433399317"
      unitRef="usd">52827000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac3e999d74914146b6972963646d77d3_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfOS01LTEtMS04MzQzNQ_f9f8bb57-364c-43e3-9f44-a07ac6777ecc"
      unitRef="usd">32116000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3af2fa579c8d4d0298cd4adaf64f562a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfOS03LTEtMS04MzQzOQ_ffcdd898-318f-470f-a0d2-890ca453efa0"
      unitRef="usd">82846000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08264c293ad941d38c85c6df434e3b96_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTAtMS0xLTEtNzcxNzE_4c8bd84e-45fd-4d94-b3f1-a4e9827b3395"
      unitRef="usd">2762000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17513104887747d094c8f90449ce26f3_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTAtMy0xLTEtNzcxNzE_1bcdc439-0058-48a6-8256-1ad6694d77a2"
      unitRef="usd">7729000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0fff928bd965435baa9430b0a51bc952_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTAtNS0xLTEtODM0MzU_2c7e9225-6d87-45a2-ad7b-4e9676a5f8f1"
      unitRef="usd">13723000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i350d8bdb260b4f158bbe1c83371f08d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTAtNy0xLTEtODEyMTI_8d5acad2-88cf-45ae-bfa6-51f9c4ef8894"
      unitRef="usd">15936000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3945ba7328d4488dbe199f8a6fb8806a_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTEtMS0xLTEtNzcxNzE_f9ad05bc-c172-45dd-ae2b-f4948af49ef9"
      unitRef="usd">50127000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i996c3ee8de704c67a1f48c7b57639172_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTEtMy0xLTEtNzcxNzE_a2621879-88e3-46b2-a780-19936ae2928c"
      unitRef="usd">78854000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11be9eb5ab6343b9abe0845805816826_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTEtNS0xLTEtODM0MzU_94e313c3-59bf-4ec5-ba97-0077a02bb5a9"
      unitRef="usd">86642000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ef05994b78847b2b9a1ecd095ccd023_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTEtNy0xLTEtODM0NDE_71d313de-b60c-4521-8955-bb805f44dc83"
      unitRef="usd">125445000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb5402adc253464eb373188274f50300_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTItMS0xLTEtNzcxNzE_e339df32-6f29-49bb-ac47-0c89489314ef"
      unitRef="usd">57419000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idbbe17fffac4478caf19f21253a14fb4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTItMy0xLTEtNzcxNzE_caa3cf4b-4a4d-4b0e-affa-1dd116f18f41"
      unitRef="usd">84675000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i252d1e5433c94a97bc58b777f5a25e67_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTItNS0xLTEtODM0MzU_b2504a0a-6dd6-4a4b-ad40-b37258e5d99e"
      unitRef="usd">103112000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5d7aab7d47f4e158191d415ae90524f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTItNy0xLTEtODM0NDM_a5f720bc-2220-4a87-9c2a-b1fb764e4134"
      unitRef="usd">139825000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i09a96cf6288542ffb7bf41f87f2f1513_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTUtMS0xLTEtNzcxNzE_0961aeb6-03d1-462c-a9cf-f130d732ee35"
      unitRef="usd">-8998000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i24d7aae3601941aca19f23d31f03721a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTUtMy0xLTEtNzcxNzE_705fd30b-6901-45c0-93c1-d27eb725ca8c"
      unitRef="usd">-7806000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6a04509ce52a4958bd559598330aa15e_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTUtNS0xLTEtODM0NDU_a6ad5fca-5815-47ed-9f2c-2ac216e96560"
      unitRef="usd">-15187000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8c045aa28e3844fcb9eff412fe495b73_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTUtNy0xLTEtODM0NDk_1c1b1439-b382-4b62-bc50-fdb8e039d6fd"
      unitRef="usd">-12410000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3945ba7328d4488dbe199f8a6fb8806a_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTYtMS0xLTEtNzcxNzE_cc9d2354-f06d-44e2-9afa-29fb0c337001"
      unitRef="usd">17039000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i996c3ee8de704c67a1f48c7b57639172_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTYtMy0xLTEtNzcxNzE_9fd02028-6a06-421b-b011-0503bb0a5ff4"
      unitRef="usd">61834000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i11be9eb5ab6343b9abe0845805816826_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTYtNS0xLTEtODM0NDU_2fa83c1d-0b29-41f8-9877-f98490fc61e7"
      unitRef="usd">27030000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1ef05994b78847b2b9a1ecd095ccd023_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTYtNy0xLTEtODM0NDk_5544376c-39c5-4d4a-b114-653b1c8cb4f1"
      unitRef="usd">80280000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifb5402adc253464eb373188274f50300_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTctMS0xLTEtNzcxNzE_b3fc9871-c1e0-49d2-9585-5bd987a29c77"
      unitRef="usd">8041000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="idbbe17fffac4478caf19f21253a14fb4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTctMy0xLTEtNzcxNzE_c564c8bf-5918-4e35-a414-98424701e292"
      unitRef="usd">54028000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i252d1e5433c94a97bc58b777f5a25e67_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTctNS0xLTEtODM0NDU_2cb69aae-74fd-4c09-9c89-590c0c8718e5"
      unitRef="usd">11843000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib5d7aab7d47f4e158191d415ae90524f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMTctNy0xLTEtODM0NDk_fac3ab19-c914-476e-8dcb-f1b1f68f2306"
      unitRef="usd">67870000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5ada02c52f844af586bb3e63e4ec6411_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjAtMS0xLTEtNzcxNzE_f54dcb09-c007-4d44-909a-e0918d665aec"
      unitRef="usd">5136000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i06363049796846649c3d730ee81b5bda_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjAtMy0xLTEtNzcxNzE_e0f56532-217b-47e2-9335-d739a4ff1d28"
      unitRef="usd">5748000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4c5fe50a04314348adf834a5587766ca_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjAtNS0xLTEtODM0NDc_1a27977e-665c-4669-84db-562b3fe47fc4"
      unitRef="usd">10793000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7b9c142e9fb346ec975852f818248861_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjAtNy0xLTEtODM0NTE_16ca9e39-73db-4044-82cf-027538d834d1"
      unitRef="usd">10618000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i5ada02c52f844af586bb3e63e4ec6411_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjEtMS0xLTEtNzcxNzE_413491c4-2547-49a7-a3c9-79c92c8ac8aa"
      unitRef="usd">3374000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i06363049796846649c3d730ee81b5bda_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjEtMy0xLTEtNzcxNzE_ca5d4b86-70b4-40e8-a9a6-d3e0ae536cb4"
      unitRef="usd">2541000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i4c5fe50a04314348adf834a5587766ca_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjEtNS0xLTEtODM0NDc_9f9e0032-8e4a-47a3-b4ad-ba9586693fde"
      unitRef="usd">10825000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i7b9c142e9fb346ec975852f818248861_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjEtNy0xLTEtODM0NTE_188f80a4-8405-4389-9c70-8da8330edbb0"
      unitRef="usd">6798000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i5ada02c52f844af586bb3e63e4ec6411_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjItMS0xLTEtNzcxNzE_6d90e11c-839b-4b88-9481-5d3d94893451"
      unitRef="usd">8510000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i06363049796846649c3d730ee81b5bda_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjItMy0xLTEtNzcxNzE_618504fa-6a46-414e-ab1e-9cb79099aa4c"
      unitRef="usd">8289000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i4c5fe50a04314348adf834a5587766ca_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjItNS0xLTEtODM0NDc_9b4a273d-50a6-4f78-b2c7-2b8320e83a9b"
      unitRef="usd">21618000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i7b9c142e9fb346ec975852f818248861_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjItNy0xLTEtODM0NTE_521d7a5e-11af-4a81-9404-8c4b58371db2"
      unitRef="usd">17416000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjMtMS0xLTEtNzcxNzE_f0878a85-c639-4c38-a415-8310e9795907"
      unitRef="usd">-469000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjMtMy0xLTEtNzcxNzE_67c5df99-498b-4a74-88a6-0990b2487db9"
      unitRef="usd">45739000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjMtNS0xLTEtODM0NDc_4e29ace7-a1a7-4ab9-96df-2f94bafadc57"
      unitRef="usd">-9775000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF8zNy9mcmFnOjMzNmExNGJkMzFkYjQyYzM5YmQ5YjFjNzgzMTMwYWIyL3RhYmxlOjdiNGRjZmYwZTkyMjRjNDE5ZjdjNzZmMzI2OWFkMzU0L3RhYmxlcmFuZ2U6N2I0ZGNmZjBlOTIyNGM0MTlmN2M3NmYzMjY5YWQzNTRfMjMtNy0xLTEtODM0NTE_cb03a1c4-3914-4719-9b20-6132e6fd9c61"
      unitRef="usd">50454000</us-gaap:OperatingIncomeLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfNTE5OA_a898a25a-da4f-4974-bcec-d427128bccd5">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments, excluding Viking&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;118,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;123,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;290,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;118,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;142,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;321,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CyDex contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Icagen contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;xCella contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial.  During the three and six months ended June&#160;30, 2022, we adjusted the balance of the Metabasis CVR liability $(0.4)&#160;million and $(1.0)&#160;million to mark to market, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the six months ended  June&#160;30, 2022, we paid $1.5&#160;million contingent liability based on revenue milestones to former Icagen shareholders, respectively. During the three and six months ended June&#160;30, 2022, we adjusted the balance of the Icagen CVR liability $0.2&#160;million and $(0.3)&#160;million to mark to market, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the three and six months ended June&#160;30, 2022, management recorded $0.5 million and $1.0 million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of June&#160;30, 2022 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments to CVR holders and other contingent payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(309)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent liabilities from xCella asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;960&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Measured on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the organizational changes to the Company&#x2019;s reportable segments, we re-allocated goodwill between the two identified reporting units (OmniAb business and Ligand core business). We performed a goodwill impairment analysis immediately before and after the allocation of goodwill and concluded no impairment. At June 30, 2022, there were no indicators of impairment at either of the reporting units.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;At June 30, 2022, there were no indicators of impairment of our indefinite-lived intangible assets, or long-lived assets.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfNTE5NA_9372c3b2-81f4-4492-a17f-b0a0f90ea8d1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments, excluding Viking&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;118,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;123,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;290,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;118,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;142,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;321,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CyDex contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Icagen contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;xCella contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial.  During the three and six months ended June&#160;30, 2022, we adjusted the balance of the Metabasis CVR liability $(0.4)&#160;million and $(1.0)&#160;million to mark to market, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the six months ended  June&#160;30, 2022, we paid $1.5&#160;million contingent liability based on revenue milestones to former Icagen shareholders, respectively. During the three and six months ended June&#160;30, 2022, we adjusted the balance of the Icagen CVR liability $0.2&#160;million and $(0.3)&#160;million to mark to market, respectively.  &lt;/span&gt;&lt;/div&gt;4.The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the three and six months ended June&#160;30, 2022, management recorded $0.5 million and $1.0 million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement, respectively.</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i267e2274bd584fe58769c5a1656b12db_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMy0yLTEtMS03NzE3MQ_e19d33d2-29a7-43e5-8925-1d5c0e1b951d"
      unitRef="usd">4586000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id61d812ca09145fcb40e16dbd4b8d9a8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMy00LTEtMS03NzE3MQ_f09e73e7-d62c-4d97-b6a4-3786c02be872"
      unitRef="usd">118533000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5a56e0d3e9a94dab9817eae0e11974be_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMy02LTEtMS03NzE3MQ_b012dc16-28b9-44e8-bd92-695bbcbc0ac9"
      unitRef="usd">129000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibe938625cbc5444690c9b08e8e1f3fc6_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMy04LTEtMS03NzE3MQ_f53cb91c-938d-400c-8f18-2842cb2624c2"
      unitRef="usd">123248000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib02472ad4a604f96aae20a25b68fd2fc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMy0xMC0xLTEtNzcxNzE_958cdb7c-5b12-4b7c-9c73-a8aeeed665b3"
      unitRef="usd">9735000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic67146a8e91942cdba9ed20b277604c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMy0xMi0xLTEtNzcxNzE_0ed704be-1041-4fef-9445-640fefb311e5"
      unitRef="usd">280553000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i14e0598617224fafbf13d5add97de1a6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMy0xNC0xLTEtNzcxNzE_3625fe29-1425-43af-865e-e521022f59c3"
      unitRef="usd">409000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i456aa02326a84161ab7d7363b6b524cd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMy0xNi0xLTEtNzcxNzE_a70ff911-193a-491a-a4bd-3fcca6c4497c"
      unitRef="usd">290697000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i4c186e23a71a4fb793fc929a6f1bae65_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNC0yLTEtMS03NzE3MQ_7a922b2a-a290-4b57-8625-7b6a38e2a49d"
      unitRef="usd">19407000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3eea2d5922e24e8a9f8cf6052385e139_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNC00LTEtMS03NzE3MQ_a5041fa4-5e43-4ed4-89b8-9cec5b0111e8"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0225b46271344284ad100ef90961626b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNC02LTEtMS03NzE3MQ_101a24b6-901d-4ff3-afd2-2d6bf5a0e11d"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1ebf4f8772924ada8190747259ee3c18_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNC04LTEtMS03NzE3MQ_e55db686-e35f-44f6-8109-369b7626a4d9"
      unitRef="usd">19407000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3157c06168094203bfe558b4e6173ba6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNC0xMC0xLTEtNzcxNzE_27e9547b-af29-4fd1-8906-7714ebd8fe17"
      unitRef="usd">30889000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i45e9971abf3b469ea61649ddf4748670_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNC0xMi0xLTEtNzcxNzE_26055f94-99e2-4a64-80ef-e548a57188ab"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia7d27b9f62664dffa76f1fe952c1f9ce_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNC0xNC0xLTEtNzcxNzE_895f60e8-cf8a-440e-af9c-4896b2189d99"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i010958049e69464b916484b2032627e5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNC0xNi0xLTEtNzcxNzE_78bac3af-4da6-4af3-9cfe-e3f5745d1829"
      unitRef="usd">30889000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id3a7e52f19d64b8fa2a2e2476fa0bfa1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNi0yLTEtMS03NzE3MQ_e6ac8643-48ab-4274-a28f-35c1500d0023"
      unitRef="usd">23993000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2fd7b10617e343eca1d9556dffc4f114_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNi00LTEtMS03NzE3MQ_86e98203-a156-4a1d-b6f7-7a1a388f0fc2"
      unitRef="usd">118533000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i225cccb2c22740ca8ac988545b58446a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNi02LTEtMS03NzE3MQ_b212b684-0e70-48cc-b5fb-ba4d6ceda9c2"
      unitRef="usd">129000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4bb2398d3a3048748fb70e3df8843949_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNi04LTEtMS03NzE3MQ_dfbc4d2a-edfc-418a-a2c3-7b1cf45375b1"
      unitRef="usd">142655000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i53f9632ba6184340b79bb0cd30ae04e2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNi0xMC0xLTEtNzcxNzE_8c6ca1a4-534e-4aa7-98f5-88d124c2cd9b"
      unitRef="usd">40624000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i548c288771a540749668a107a155b125_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNi0xMi0xLTEtNzcxNzE_fafe4d10-5a99-4412-9bac-233480c4eb30"
      unitRef="usd">280553000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0b44abccb2d044b2849d4fc6191d00dd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNi0xNC0xLTEtNzcxNzE_458ab150-24a9-45e9-8309-78c777c4bcc6"
      unitRef="usd">409000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iecbe3fa2930442bb98e4b5b4bb9e5256_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfNi0xNi0xLTEtNzcxNzE_ed9251b9-a731-4151-bf29-a52ff8e03581"
      unitRef="usd">321586000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i21cc39d790414198a5384b22bc9f8914_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfOS0yLTEtMS03NzE3MQ_50b58c98-497c-4179-8727-eea0bba93e97"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2e1f31d766a7446d9b402aa372153d71_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfOS00LTEtMS03NzE3MQ_414aef7c-5b3e-48a5-b734-5451245ddffc"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0a32d5c0d47d478abf53a297880bc04d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfOS02LTEtMS03NzE3MQ_3c3b30f8-c831-49fe-bb5c-5daaefb8370c"
      unitRef="usd">317000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3ebd32fe9f284200b88a29fe00e1c59e_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfOS04LTEtMS03NzE3MQ_238a4810-aba9-4059-a017-f0d485472f63"
      unitRef="usd">317000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i75a462cc318440799e9195fc83206c6b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfOS0xMC0xLTEtNzcxNzE_887d2bb6-6fcd-4975-891d-11bc17cc46a3"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id70c6611cf0349bbaa43d7ca45e9e20e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfOS0xMi0xLTEtNzcxNzE_7b378a5b-a15c-441d-919d-ea6b4e4ddf90"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib13e8f86f4bb4792a23bb3135840b332_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfOS0xNC0xLTEtNzcxNzE_6ca0f82f-5354-40f8-a3df-175ab8c19029"
      unitRef="usd">349000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4e4b0b1b1c134aef858b246643f58be5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfOS0xNi0xLTEtNzcxNzE_3f966bd9-e06a-4533-831a-d6e25f0a4098"
      unitRef="usd">349000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1516fb25275e4bbcbaaca00a3711b3cf_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTAtMi0xLTEtNzcxNzE_7ebab010-1ec2-4ef7-a1dd-2f4090dc2aba"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ifc548b28534c4e0aa35fef883c9ffd4c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTAtNC0xLTEtNzcxNzE_596f522d-e531-4404-9095-46a5f878dd51"
      unitRef="usd">2400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i447b152d2cdc4923a33b76efe86e78f6_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTAtNi0xLTEtNzcxNzE_6eaacd4c-c7de-4860-bc79-e43a15257f8c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i05ba522e2c8b438eb09faef77aac2491_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTAtOC0xLTEtNzcxNzE_f62d5ae1-1670-48b6-a113-66a4abfe7bb1"
      unitRef="usd">2400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0671049fb2c74897aaed6cf1402f67e0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTAtMTAtMS0xLTc3MTcx_6cf70d17-8396-4a3c-a841-b2800abbe497"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7b39471746204503b6025c517a2740ed_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTAtMTItMS0xLTc3MTcx_9c3f882b-82da-409f-a5c7-fbc20361ea51"
      unitRef="usd">3358000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i084dd0497977421093be2aa2620a6cf0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTAtMTQtMS0xLTc3MTcx_4a235cf3-827d-4203-bb71-2475a8eab9b7"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0a748e36f24545bc8aa6196a0de9b8ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTAtMTYtMS0xLTc3MTcx_2d884411-e660-4791-81ea-00d73d19380c"
      unitRef="usd">3358000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8e4644a9e4754293b2965e4853bb25b1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTEtMi0xLTEtNzcxNzE_0c7a275a-5cc1-4ad5-924c-9d6eeeee79f2"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2cfe5c65f77d4902805d7bd75bdafe01_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTEtNC0xLTEtNzcxNzE_50104483-bd98-4319-b114-5a12451e45e0"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5a7a292a775a4e939d542844f0e07327_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTEtNi0xLTEtNzcxNzE_baed70d9-9caa-48ec-bff0-26c982ce22cb"
      unitRef="usd">5542000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i625cf43be4a04d1296f91edac39e0b36_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTEtOC0xLTEtNzcxNzE_4b492a07-90f2-4d78-b52f-5d31ba44de9e"
      unitRef="usd">5542000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i170fa4640e6342fb9e5d5b0994468676_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTEtMTAtMS0xLTc3MTcx_24b210c7-3b0c-473c-a066-eb5346429b75"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i602915a018774dab8faf3722799d8baa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTEtMTItMS0xLTc3MTcx_afc9a4b0-9081-4fa3-9343-0eaca6dc12f7"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i64894a5f080e4b3f8b457334acdc1cd2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTEtMTQtMS0xLTc3MTcx_8c53da7a-04a0-4719-a3f9-8ddfadb65380"
      unitRef="usd">7364000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4dea4d860bca4c7ba6c68ce71c7ff2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTEtMTYtMS0xLTc3MTcx_fd73a0f3-8e81-49c9-aac6-00d089a5acda"
      unitRef="usd">7364000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ibc6f643b427d4d95b47f5f8bfbd1d696_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTItMi0xLTEtNzcxNzE_3abd7cf6-edfa-41ad-aae1-f10db7e6dd96"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8f541feaadce43de9b83e05a3cc81f9f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTItNC0xLTEtNzcxNzE_13ffb55b-abd2-4ff2-acab-a565365cb89a"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i34af6b0108f84a96869a676335de8337_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTItNi0xLTEtNzcxNzE_90accb0a-40d7-4c4f-a930-137afcb5ff7b"
      unitRef="usd">960000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ifbe8e10c0bfa405f91e4f5fd659e1ff4_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTItOC0xLTEtNzcxNzE_e49df0a0-4735-44c0-8010-4dcbf6204421"
      unitRef="usd">960000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i575234d878cc49f0b7c5fbf81531c46c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTItMTAtMS0xLTc3MTcx_cbf7f0f6-0554-439d-a949-998993462f1f"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7263c122813549ad8e04254ba32ff7ca_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTItMTItMS0xLTc3MTcx_851983be-2c15-492b-8735-fc736d6532a2"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if1678eaf06a745c291b81999f992b9e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTItMTQtMS0xLTc3MTcx_a56c27ac-678e-4eaa-a09f-5e5e2efb64ab"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id87a26c787994153889a94e263789923_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTItMTYtMS0xLTc3MTcx_0e1d1ff4-d128-46ab-9eba-d1ab7230687c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2984eff859114415a857b8b3db2c96d5_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTMtMi0xLTEtNzcxNzE_163d65ca-cfd4-44c3-8612-2839c6111d1e"
      unitRef="usd">72000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7255b76317d34906aecab88a19308702_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTMtNC0xLTEtNzcxNzE_7dda66f2-bf63-4e1d-8c7a-fd36004f389a"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9e3c748d3af242daa261e5b79b0823b6_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTMtNi0xLTEtNzcxNzE_3e3cda93-47f8-4d9f-a612-039be5c7d1d9"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie2c209582594436fa1bb0457e3e6696f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTMtOC0xLTEtNzcxNzE_68676231-bdc0-4e85-9d7e-d9edaeabdc7b"
      unitRef="usd">72000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ibe0bed5f1c9144b18cb2a5768de65286_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTMtMTAtMS0xLTc3MTcx_dfba1a75-58f2-4bc8-9afb-b4fc2b030ea6"
      unitRef="usd">86000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7cb7b230f33440da931414c29bbcf6cc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTMtMTItMS0xLTc3MTcx_e9ab533c-c5cb-4583-bdfa-b70d20ce0a38"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="icd9c6786655f4c92943a637689d9c95f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTMtMTQtMS0xLTc3MTcx_62eaa958-ac5e-4419-aeaa-4564d0b0010e"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id0ab0ebcdc664305a06c43149d516db8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTMtMTYtMS0xLTc3MTcx_14f935ba-52cd-4dd8-b543-e9fdaf1a545d"
      unitRef="usd">86000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id3a7e52f19d64b8fa2a2e2476fa0bfa1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTQtMi0xLTEtNzcxNzE_90554ee4-f677-4040-9e0c-4524472ab7bf"
      unitRef="usd">72000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2fd7b10617e343eca1d9556dffc4f114_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTQtNC0xLTEtNzcxNzE_14437f6f-4e3a-4f35-8dda-f0b581f04c66"
      unitRef="usd">2400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i225cccb2c22740ca8ac988545b58446a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTQtNi0xLTEtNzcxNzE_1ce081c9-0e1a-437c-8ed2-80714ec6620a"
      unitRef="usd">6819000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4bb2398d3a3048748fb70e3df8843949_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTQtOC0xLTEtNzcxNzE_23bde8f0-63a9-4f0b-88d5-7f6b1dbfdb9b"
      unitRef="usd">9291000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i53f9632ba6184340b79bb0cd30ae04e2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTQtMTAtMS0xLTc3MTcx_f3749c86-db8a-4620-8d0a-a306adaaf3f2"
      unitRef="usd">86000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i548c288771a540749668a107a155b125_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTQtMTItMS0xLTc3MTcx_e8dc2fd0-4d1c-4d8f-a8a4-cee0d311b0f1"
      unitRef="usd">3358000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0b44abccb2d044b2849d4fc6191d00dd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTQtMTQtMS0xLTc3MTcx_e75c58ed-8ca6-4154-8261-2cd9c5da4383"
      unitRef="usd">7713000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iecbe3fa2930442bb98e4b5b4bb9e5256_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjZjYmIwMjA3NjcxNTRlNzc4MDY1M2E2OGZhOGFhOGEwL3RhYmxlcmFuZ2U6NmNiYjAyMDc2NzE1NGU3NzgwNjUzYTY4ZmE4YWE4YTBfMTQtMTYtMS0xLTc3MTcx_42afa25b-7c01-43bf-a016-200652451963"
      unitRef="usd">11157000</us-gaap:LiabilitiesFairValueDisclosure>
    <lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare
      contextRef="ide5f7ad99ed84ec48486190201956204_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMTQ0Mg_a1eeb4f7-3712-458a-9a69-07c4ec5f8e86"
      unitRef="contingent_value_right">4</lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare>
    <lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries
      contextRef="ide5f7ad99ed84ec48486190201956204_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMTQ2MA_75fb7e95-77c7-4690-897a-361ffed7bc2f"
      unitRef="contingent_value_right">1</lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries>
    <lgnd:NumberOfContingentValueRightsSeries
      contextRef="i704ccd2c79674fa98ab76165119a7944_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMTQ4MA_c8c66cf2-3dc3-446e-821d-7066534f4bc4"
      unitRef="contingent_value_right_series">4</lgnd:NumberOfContingentValueRightsSeries>
    <lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders
      contextRef="ide5f7ad99ed84ec48486190201956204_D20100101-20100131"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMTYxNQ_e3b14a98-a4ab-4530-8e8d-dee52e37d748">P6M</lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders>
    <us-gaap:Investments
      contextRef="i84a709f438684614a9dd32c76e70d210_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMjQxNw_cc572f91-9211-4283-8f51-bacdb9d250bc"
      unitRef="usd">375000000</us-gaap:Investments>
    <us-gaap:ContractWithCustomerAssetGross
      contextRef="i15b339fe796a4e2ba32e8dfbfdfa27aa_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMjUzMg_bd7650ac-1035-4ba0-a3a9-04cf0b78c6cb"
      unitRef="usd">10000000</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="ibd35f6c5d8e840969d67c38a72475508_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMjY2NQ_5963577c-9c6c-4f1c-bb99-23826531bffa"
      unitRef="usd">-400000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="i8a9916b0d831414c99923be559940db0_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfNzE0NjgyNTU4NTg4Mg_b88a7fad-1e0f-4d1d-a50d-a6d3626a49c4"
      unitRef="usd">-1000000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i78d968b6172d467c8f046b7fe14c493d_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMzI0Mw_801354e3-7a86-4078-908f-2c40aa6d9c4a"
      unitRef="usd">1500000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="i78d968b6172d467c8f046b7fe14c493d_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMTY0OTI2NzQ0MjIzMzM_aa8160a0-258a-42c9-ba01-f397bebe408b"
      unitRef="usd">200000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="ia23c3aaaac85402db485305cdb6cc3f2_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMTY0OTI2NzQ0MjIzMTE_d6cbf41d-1652-4ed8-8d80-2ad464ceffd9"
      unitRef="usd">-300000</us-gaap:LiabilitiesFairValueAdjustment>
    <lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency
      contextRef="i9b5f73a727824f0ca1db33f131e1d73a_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMzYzOQ_5e985ed8-6f09-4d10-b9e7-06da47b949f2"
      unitRef="usd">500000</lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency>
    <lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency
      contextRef="ie1b59d9a96ec4375a669fbe2a05bd3b4_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfMTY0OTI2NzQ0MjIzNjY_3517ec1e-88e1-4121-9cb3-7e7fc647a9b3"
      unitRef="usd">1000000</lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfNTE5Ng_71e13e99-8a9f-442f-9113-6af3719dba86">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of June&#160;30, 2022 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments to CVR holders and other contingent payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(309)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent liabilities from xCella asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;960&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="idf6982ebd2184a96b2c741ac8887e7ba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjkwMjJmNDQ3ODgyNTQ0NzU4YmM5OTZlNzdmMzQyNDg3L3RhYmxlcmFuZ2U6OTAyMmY0NDc4ODI1NDQ3NThiYzk5NmU3N2YzNDI0ODdfMC0xLTEtMS03NzE3MQ_f7d93fee-1b0e-477b-b36f-54d12e285ce9"
      unitRef="usd">7713000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <lgnd:PaymentsToContingentValueRightHolders
      contextRef="ic789c8af369747eba6fa7cf57d81c6ac_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjkwMjJmNDQ3ODgyNTQ0NzU4YmM5OTZlNzdmMzQyNDg3L3RhYmxlcmFuZ2U6OTAyMmY0NDc4ODI1NDQ3NThiYzk5NmU3N2YzNDI0ODdfMS0xLTEtMS03NzE3MQ_532b604d-3090-4b2e-8683-298b1b00ce35"
      unitRef="usd">1545000</lgnd:PaymentsToContingentValueRightHolders>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ic789c8af369747eba6fa7cf57d81c6ac_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjkwMjJmNDQ3ODgyNTQ0NzU4YmM5OTZlNzdmMzQyNDg3L3RhYmxlcmFuZ2U6OTAyMmY0NDc4ODI1NDQ3NThiYzk5NmU3N2YzNDI0ODdfMi0xLTEtMS03NzE3MQ_79fc2f66-2050-4517-b548-faa548fc9476"
      unitRef="usd">-309000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition
      contextRef="ic789c8af369747eba6fa7cf57d81c6ac_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjkwMjJmNDQ3ODgyNTQ0NzU4YmM5OTZlNzdmMzQyNDg3L3RhYmxlcmFuZ2U6OTAyMmY0NDc4ODI1NDQ3NThiYzk5NmU3N2YzNDI0ODdfMy0xLTEtMS03NzE3MQ_01b809f2-a107-4ddb-8ed0-80ac84a1c434"
      unitRef="usd">960000</lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ifd61ac74a7ff4488ac2e7e7b04b7a49c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RhYmxlOjkwMjJmNDQ3ODgyNTQ0NzU4YmM5OTZlNzdmMzQyNDg3L3RhYmxlcmFuZ2U6OTAyMmY0NDc4ODI1NDQ3NThiYzk5NmU3N2YzNDI0ODdfNC0xLTEtMS03NzE3MQ_00e959b4-1c1b-4122-be63-fca9d08180d2"
      unitRef="usd">6819000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:NumberOfReportingUnits
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80MC9mcmFnOjIxNGJkMDc4NzA0MjQwMjk5M2ZiMGI5NTJkMWJiZjMxL3RleHRyZWdpb246MjE0YmQwNzg3MDQyNDAyOTkzZmIwYjk1MmQxYmJmMzFfNDc3NA_391cd13d-edd3-4716-bdcc-260385dc6f41"
      unitRef="reporting_unit">2</us-gaap:NumberOfReportingUnits>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNzIxNA_ff89e3bc-1854-4fef-b89a-790bc17656e3">Convertible Senior Notes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2018, we issued&#160;$750.0&#160;million&#160;aggregate principal amount of&#160;0.75%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$248.48 per share.  The maximum conversion rate of the 2023 Notes is 5.2317 per $1,000 principal amount of the 2023 Notes which represents a maximum conversion price of approximately $191.14. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than 130% of the conversion price on such trading day; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $248.48. In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees, is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes, and the effective interest rate as of June&#160;30, 2022 is 0.5%.  During the three months ended June&#160;30, 2022 we recognized a total of $0.4&#160;million in interest expense which includes $0.2&#160;million in contractual interest expense and $0.2&#160;million in amortized issuance costs. During the six months ended  June&#160;30, 2022 we recognized a total of $1.2&#160;million in interest expense which includes $0.7&#160;million in contractual interest expense and $0.5&#160;million in amortized issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During 2021, we repurchased $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million. After the repurchases, approximately $343.3&#160;million in principal amount of the 2023 Notes were outstanding as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the three months ended June&#160;30, 2022, we repurchased $62.0&#160;million in principal amount of the 2023 Notes for $60.0&#160;million in cash, including accrued interest of $0.01&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $1.8&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the three months ended June 30, 2022, and a $0.3&#160;million reduction in debt discount.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the six months ended June&#160;30, 2022, we repurchased $227.8&#160;million in principal amount of the 2023 Notes for $223.7&#160;million in cash, including accrued interest of $0.4&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $3.3&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the six months ended June 30, 2022, and a $1.2&#160;million reduction in debt discount.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Bond Hedge and Warrant Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $248.48 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately 3,018,327 shares of common stock with an exercise price of approximately $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, in connection with the repurchases of approximately $20.3&#160;million in principal of the 2023 Notes for approximately $19.1&#160;million in cash, including accrued interest of $0.1&#160;million, during the quarter ended December 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp;amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2021, in connection with the repurchases of $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp;amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $18.4&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from 3,018,327 to 2,559,254. We received $18.9&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 598,021. These unwind transactions resulted in a $0.5&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the 2023 Notes (in thousands): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of the 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;343,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term portion of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of the 2023 Notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) - Balances as of December 31, 2021 reported before the adoption of ASU 2020-06.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzU_059676e7-e03b-43bc-bfd7-03f22aa9bd68"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfOTY_d4bfcb42-bc11-4f27-b1e8-62553d4c994f"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTI5_6df0c57a-8c80-4e7d-bd24-144450971a28"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i1bdef6e83d484a31ae28be0288d4014a_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMjg1_32986736-508d-4b6d-8fd9-88b349e19ad5"
      unitRef="usd">733100000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjA2_4cc217bc-bfb5-4b6d-a7fc-c32939c95e28"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="idaa07f7868af4d3589b8f66d33b6f893_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNzc2_4e34e8a8-061e-420b-9c87-d5bfbee1e529"
      unitRef="usdPerShare">191.14</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i9a30dda7078441eaaca37acbf3037be6_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTEwMA_952bc187-39ce-4fa0-ac35-7b36f36f5598"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i9a30dda7078441eaaca37acbf3037be6_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTE1Ng_6afc8928-6903-493f-ba64-54c9059da757"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i9a30dda7078441eaaca37acbf3037be6_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTM1MQ_f709eea9-81f8-4d7b-95ce-27dee5761050"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i5de8a5b0c1fa4760b0f3c075d7b6c6db_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTQxNg_ca59e137-7e9b-4398-a08a-8136d44a1a4f"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i5de8a5b0c1fa4760b0f3c075d7b6c6db_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTQ2NQ_7cbca803-d545-4e6a-b5b9-b9d8cfd0d0dc"
      unitRef="d">10</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger
      contextRef="i5de8a5b0c1fa4760b0f3c075d7b6c6db_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTU3NA_699c60dd-04b7-483b-8d3a-acdb40504f8a"
      unitRef="number">0.98</lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTk5OA_08885e11-e356-4956-87a5-1839b5af04ca"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i5474a312fb154f69820ca3cc97e950a7_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMjA2NQ_842e7295-0e43-4dcc-9bd7-cf5e7c16b745"
      unitRef="usd">16900000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentTerm
      contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNzIxNw_aa64845e-b60f-4ac0-aa71-98db1acb52a4">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i5474a312fb154f69820ca3cc97e950a7_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMjM0MA_5da38220-b5af-4f2a-a578-10d1b852088a"
      unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestExpenseDebt
      contextRef="ic0c4e811de974223a7854588c77071f0_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTY0OTI2NzQ0MjUzMjA_1ce91bad-e3cb-44f8-8bb1-a9303aa42d5d"
      unitRef="usd">400000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="ic0c4e811de974223a7854588c77071f0_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTY0OTI2NzQ0MjUzNDc_1d42890e-842f-4a3e-9a8e-f9bc448a482f"
      unitRef="usd">200000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ic0c4e811de974223a7854588c77071f0_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTY0OTI2NzQ0MjUzNzc_dead82b4-cfdf-4525-998c-5b2af69e1c51"
      unitRef="usd">200000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestExpenseDebt
      contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNzY5NjU4MTQwMjMyMw_bef8ccca-f1e1-4bfe-ab20-c9e4ba08445e"
      unitRef="usd">1200000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNzY5NjU4MTQwMjMzNw_931f7edc-7225-43dc-8100-f47a6e806e87"
      unitRef="usd">700000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNzY5NjU4MTQwMjM1MQ_5274ec75-6be3-47bf-88ef-3cfc108ffcc6"
      unitRef="usd">500000</us-gaap:AmortizationOfFinancingCosts>
    <lgnd:DebtInstrumentRepurchasedAmountDuringPeriod
      contextRef="ibc028f1c7d9b45d5b5409ba862c9757c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMjgxNg_6a653b4b-172c-404e-8c8b-2c5cd61c9173"
      unitRef="usd">152000000</lgnd:DebtInstrumentRepurchasedAmountDuringPeriod>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ibc028f1c7d9b45d5b5409ba862c9757c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMjg1NA_f2f0817e-5484-4dd4-a255-340cd73818b5"
      unitRef="usd">156000000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="ibc028f1c7d9b45d5b5409ba862c9757c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMjg5Ng_14e718b5-08e5-4765-b00b-45393001056b"
      unitRef="usd">300000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="idbf91b4ebd6f491a92e85e1fc1d051d9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMjkzNw_0ef2ccd4-cd48-4ab0-b0f6-03b78a529853"
      unitRef="usd">343300000</us-gaap:DebtInstrumentCarryingAmount>
    <lgnd:DebtInstrumentRepurchasedAmountDuringPeriod
      contextRef="ic0c4e811de974223a7854588c77071f0_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTY0OTI2NzQ0MjU4MTg_4a71e579-561e-4fbc-95fd-1a3c1f3e8ac7"
      unitRef="usd">62000000</lgnd:DebtInstrumentRepurchasedAmountDuringPeriod>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ic0c4e811de974223a7854588c77071f0_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTY0OTI2NzQ0MjU4NTQ_94dc60ea-f25d-42c3-b17c-7c7888862948"
      unitRef="usd">60000000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="ic0c4e811de974223a7854588c77071f0_D20220401-20220630"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTY0OTI2NzQ0MjU4OTE_71e09491-9372-4231-be69-258bef0f7253"
      unitRef="usd">10000.00</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic0c4e811de974223a7854588c77071f0_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTY0OTI2NzQ0MjU5MjE_f7e9c759-75f9-4f96-b1da-614d5673d512"
      unitRef="usd">1800000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <lgnd:IncreaseDecreaseInDebtDiscount
      contextRef="ic0c4e811de974223a7854588c77071f0_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMTY0OTI2NzQ0MjU5NjE_c4498419-fd5f-43fc-be01-71077ef88c16"
      unitRef="usd">-300000</lgnd:IncreaseDecreaseInDebtDiscount>
    <lgnd:DebtInstrumentRepurchasedAmountDuringPeriod
      contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzA4Mg_4c0a584f-a660-47cd-bdf1-c3a1f022d3fa"
      unitRef="usd">227800000</lgnd:DebtInstrumentRepurchasedAmountDuringPeriod>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzEyMA_009bc7ef-16c9-4925-a2a1-db2f9fd74b64"
      unitRef="usd">223700000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzE2Mg_081bbb17-2e2a-483b-b13a-450a82e53e96"
      unitRef="usd">400000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzI1Mg_d1e58c77-4e61-4ecf-9c5f-f2e6b0296093"
      unitRef="usd">3300000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <lgnd:IncreaseDecreaseInDebtDiscount
      contextRef="id2eb4df35a1c48439c53be8ce3d67c61_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzQwMA_e0711de7-7b39-44bf-9e90-33be2caeac34"
      unitRef="usd">-1200000</lgnd:IncreaseDecreaseInDebtDiscount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzU5Nw_0bc9d8e3-1488-486b-ab8f-0f07686fc3da"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzg3MQ_7d68b408-9161-44ec-9c31-63db50f50778"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <lgnd:PaymentsForConvertibleBondHedges
      contextRef="i1bdef6e83d484a31ae28be0288d4014a_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfMzk1NA_9ebf3c7e-fa91-477d-9bbd-1c1eb0fe1d68"
      unitRef="usd">140300000</lgnd:PaymentsForConvertibleBondHedges>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNDg1NA_4dd05c04-2b70-4a0a-baa5-947daa51dd6b"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNDkyMA_556f8c0b-8f71-4320-9eca-284a69b92161"
      unitRef="usdPerShare">315.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i1bdef6e83d484a31ae28be0288d4014a_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNDk3OA_565746ea-86de-48c4-af43-115d8f1752a6"
      unitRef="usd">90000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <lgnd:DebtInstrumentRepurchasedAmountDuringPeriod
      contextRef="i7d97584fcd39416497ac8ddc28dccf83_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNTYyMQ_10333565-ceb9-435f-848b-75c624375e6b"
      unitRef="usd">20300000</lgnd:DebtInstrumentRepurchasedAmountDuringPeriod>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i7d97584fcd39416497ac8ddc28dccf83_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNTY3Mw_74a0084d-12f8-4063-ba9e-8cdfc393f632"
      unitRef="usd">19100000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="i7d97584fcd39416497ac8ddc28dccf83_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNTcxNQ_827fc832-ca78-4cba-94e0-c9cf3d875d38"
      unitRef="usd">100000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <lgnd:DebtInstrumentRepurchasedAmountDuringPeriod
      contextRef="ibc028f1c7d9b45d5b5409ba862c9757c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjI1Mg_6e451f7e-0991-4047-99c5-0ac93691bf48"
      unitRef="usd">152000000</lgnd:DebtInstrumentRepurchasedAmountDuringPeriod>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ibc028f1c7d9b45d5b5409ba862c9757c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjI5MA_30e02ea6-3192-4920-b734-c3371748343c"
      unitRef="usd">156000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="ibc028f1c7d9b45d5b5409ba862c9757c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjMzMg_dbeb3560-552c-4893-93c3-68cc16c96387"
      unitRef="usd">300000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <lgnd:PaymentsToUnwindWarrants
      contextRef="i35897df76b71438cbfcc21f5fd8c25ba_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjYzNg_34215cd8-f96e-4da0-8a29-cb157789a60e"
      unitRef="usd">18400000</lgnd:PaymentsToUnwindWarrants>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i206dc67e487f44bfa1e9279e7b7981b7_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjc0NQ_0bc9d8e3-1488-486b-ab8f-0f07686fc3da"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="idbf91b4ebd6f491a92e85e1fc1d051d9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjc1MQ_07016dbc-6423-4d71-929d-3708e467c022"
      unitRef="shares">2559254</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <lgnd:ProceedsFromUnwindingConvertibleBondHedges
      contextRef="i35897df76b71438cbfcc21f5fd8c25ba_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjc2Nw_7de30d43-c51b-4ca6-a252-f1436e93b101"
      unitRef="usd">18900000</lgnd:ProceedsFromUnwindingConvertibleBondHedges>
    <lgnd:NumberOfOptionsUnderConvertibleBondHedges
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjg4OA_2e5e283c-42ea-43cf-84d4-b2b7db9944c2"
      unitRef="option">598021</lgnd:NumberOfOptionsUnderConvertibleBondHedges>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i35897df76b71438cbfcc21f5fd8c25ba_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNjkzMg_44e31381-d9f0-4966-b40c-7a70d0229cf0"
      unitRef="usd">500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RleHRyZWdpb246MTU3ODIzMDVkM2NhNGUzZGE5ZTU3MWI5YWEyYmZhZTlfNzIxMw_63844e74-87d6-4795-8693-0405531917f5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the 2023 Notes (in thousands): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of the 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;343,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term portion of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of the 2023 Notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) - Balances as of December 31, 2021 reported before the adoption of ASU 2020-06.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5474a312fb154f69820ca3cc97e950a7_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RhYmxlOjVhYmE4NWYzYWMxYzQ2ZTc4YTE2MjI4NjAwZjhhYmZmL3RhYmxlcmFuZ2U6NWFiYTg1ZjNhYzFjNDZlNzhhMTYyMjg2MDBmOGFiZmZfMS0xLTEtMS03NzE3MQ_db13b21c-74cc-41e8-bd24-350ee5659882"
      unitRef="usd">115499000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="idbf91b4ebd6f491a92e85e1fc1d051d9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RhYmxlOjVhYmE4NWYzYWMxYzQ2ZTc4YTE2MjI4NjAwZjhhYmZmL3RhYmxlcmFuZ2U6NWFiYTg1ZjNhYzFjNDZlNzhhMTYyMjg2MDBmOGFiZmZfMS0zLTEtMS03NzE3MQ_5ddc16af-e62b-4716-99fa-eec23bfa9ac1"
      unitRef="usd">343301000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i5474a312fb154f69820ca3cc97e950a7_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RhYmxlOjVhYmE4NWYzYWMxYzQ2ZTc4YTE2MjI4NjAwZjhhYmZmL3RhYmxlcmFuZ2U6NWFiYTg1ZjNhYzFjNDZlNzhhMTYyMjg2MDBmOGFiZmZfMi0xLTEtMS03NzE3MQ_8753bf35-cfb0-4aea-aabd-6d2e93a786a8"
      unitRef="usd">525000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="idbf91b4ebd6f491a92e85e1fc1d051d9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RhYmxlOjVhYmE4NWYzYWMxYzQ2ZTc4YTE2MjI4NjAwZjhhYmZmL3RhYmxlcmFuZ2U6NWFiYTg1ZjNhYzFjNDZlNzhhMTYyMjg2MDBmOGFiZmZfMi0zLTEtMS03NzE3MQ_4ccb050e-245a-4ba6-8e3b-a7de5509d41a"
      unitRef="usd">22584000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:LongTermNotesPayable
      contextRef="i5474a312fb154f69820ca3cc97e950a7_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RhYmxlOjVhYmE4NWYzYWMxYzQ2ZTc4YTE2MjI4NjAwZjhhYmZmL3RhYmxlcmFuZ2U6NWFiYTg1ZjNhYzFjNDZlNzhhMTYyMjg2MDBmOGFiZmZfMy0xLTEtMS03NzE3MQ_13bdd71a-9878-4f74-965f-b54324183a61"
      unitRef="usd">114974000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="idbf91b4ebd6f491a92e85e1fc1d051d9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RhYmxlOjVhYmE4NWYzYWMxYzQ2ZTc4YTE2MjI4NjAwZjhhYmZmL3RhYmxlcmFuZ2U6NWFiYTg1ZjNhYzFjNDZlNzhhMTYyMjg2MDBmOGFiZmZfMy0zLTEtMS03NzE3MQ_acf4c557-d33d-4b6f-ac33-37f0af718ccf"
      unitRef="usd">320717000</us-gaap:LongTermNotesPayable>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i5474a312fb154f69820ca3cc97e950a7_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RhYmxlOjVhYmE4NWYzYWMxYzQ2ZTc4YTE2MjI4NjAwZjhhYmZmL3RhYmxlcmFuZ2U6NWFiYTg1ZjNhYzFjNDZlNzhhMTYyMjg2MDBmOGFiZmZfNi0xLTEtMS03NzE3MQ_ae39229e-358b-4841-ac79-153cb2d27839"
      unitRef="usd">110590000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="idbf91b4ebd6f491a92e85e1fc1d051d9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80My9mcmFnOjE1NzgyMzA1ZDNjYTRlM2RhOWU1NzFiOWFhMmJmYWU5L3RhYmxlOjVhYmE4NWYzYWMxYzQ2ZTc4YTE2MjI4NjAwZjhhYmZmL3RhYmxlcmFuZ2U6NWFiYTg1ZjNhYzFjNDZlNzhhMTYyMjg2MDBmOGFiZmZfNi0zLTEtMS03NzE3MQ_cadc0b8d-78cb-4fb3-b49c-560d7c5c3cae"
      unitRef="usd">341801000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80OS9mcmFnOjY5ZjBlNmExOGM4NzQyNjU5ZDM4NTkwZGU2NzI4MjdhL3RleHRyZWdpb246NjlmMGU2YTE4Yzg3NDI2NTlkMzg1OTBkZTY3MjgyN2FfMTExNg_aaa9106f-4472-4105-99ba-ff75f88818e4">Income TaxOur effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three and six months ended June&#160;30, 2022 and 2021 was (40.7)% and 7.7%, and 21.6% and (25.0)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three and six months ended June&#160;30, 2022 was due primarily to the tax deductions related to foreign derived intangible income tax credit as well as the research and development tax credits, which were partially offset by Section 162(m) limitation and non-deductible ISO related stock compensation expense during the period. The variance from the U.S. federal tax rate of 21% for the three and six months ended June 30, 2021 was significantly impacted by tax benefits related to (1) a $34.1&#160;million Pfenex CVR adjustment recorded during Q2 2021 due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR, and (2) net excess tax benefits from share-based compensation resulting from increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80OS9mcmFnOjY5ZjBlNmExOGM4NzQyNjU5ZDM4NTkwZGU2NzI4MjdhL3RleHRyZWdpb246NjlmMGU2YTE4Yzg3NDI2NTlkMzg1OTBkZTY3MjgyN2FfNDM4_92de70a4-f92a-4e30-bb4d-e3a8e9668a51"
      unitRef="number">-0.407</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i1c38966b8ac644af95925191dc813a7a_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80OS9mcmFnOjY5ZjBlNmExOGM4NzQyNjU5ZDM4NTkwZGU2NzI4MjdhL3RleHRyZWdpb246NjlmMGU2YTE4Yzg3NDI2NTlkMzg1OTBkZTY3MjgyN2FfNDQ1_7b4e5de6-3db4-4ab8-8e5b-27daa0e33eed"
      unitRef="number">0.077</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80OS9mcmFnOjY5ZjBlNmExOGM4NzQyNjU5ZDM4NTkwZGU2NzI4MjdhL3RleHRyZWdpb246NjlmMGU2YTE4Yzg3NDI2NTlkMzg1OTBkZTY3MjgyN2FfMjc0ODc3OTA3MDU3MQ_fa49bddf-769a-47df-95f8-ee12caa91ac3"
      unitRef="number">0.216</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ibe32258725164e3b85f6158d0f4aaf80_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80OS9mcmFnOjY5ZjBlNmExOGM4NzQyNjU5ZDM4NTkwZGU2NzI4MjdhL3RleHRyZWdpb246NjlmMGU2YTE4Yzg3NDI2NTlkMzg1OTBkZTY3MjgyN2FfMjc0ODc3OTA3MDU4Mg_ddf7b54b-8524-4de2-b23e-739d13c3d5af"
      unitRef="number">-0.25</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <lgnd:EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount
      contextRef="i965fba54a35142f48c2ec3ae55ae973f_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF80OS9mcmFnOjY5ZjBlNmExOGM4NzQyNjU5ZDM4NTkwZGU2NzI4MjdhL3RleHRyZWdpb246NjlmMGU2YTE4Yzg3NDI2NTlkMzg1OTBkZTY3MjgyN2FfMTY0OTI2NzQ0MjA2Nzc_5132a7cd-be12-4cba-9e64-83707b24ed33"
      unitRef="usd">34100000</lgnd:EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfMTU1OA_cecb8c84-f4ad-40de-b2a8-06f5fad99f3f">Stockholders&#x2019; Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 9, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, of the Notes to Consolidated Financial Statements in our 2021 Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,199,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;734,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(133,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,877,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;316,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, outstanding options to purchase 1.6 million shares were exercisable with a weighted average exercise price per share of $102.10.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of June&#160;30, 2022, 38,007 shares were available for future purchases under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $500.0 million of our common stock from time to time over the next three years. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. We did not have any share repurchases during the three and six months ended June&#160;30, 2022. Authorization to repurchase $248.8 million of our common stock remained available as of June&#160;30, 2022.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfMTU1OQ_b0879abf-e387-4b3b-924d-8d985e6dd938">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,199,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;734,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(133,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,877,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;316,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfMTU2Mg_74c6c961-2185-49cf-be1a-bcadd8a58b5f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,199,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;734,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;186,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(133,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;137.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,877,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;316,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ice70706143fc4fa587f3b05dfc86607f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfMi0xLTEtMS03NzE3MQ_82c349e5-95bf-44de-883a-cc9b9a0a5f75"
      unitRef="shares">2199598</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ice70706143fc4fa587f3b05dfc86607f_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfMi0zLTEtMS03NzE3MQ_5238496c-d922-48aa-a870-339cb3cc5690"
      unitRef="usdPerShare">106.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if55454c1b587475f8f377fec9eb04748_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfMi01LTEtMS03NzE3MQ_2d72d923-d33a-4a80-b084-e6f8689db0cf"
      unitRef="shares">264143</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if55454c1b587475f8f377fec9eb04748_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfMi03LTEtMS03NzE3MQ_af695132-c3ff-40ce-9b39-320757e0c3f5"
      unitRef="usdPerShare">138.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i0275f925a31840af927726857ad4931a_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfMy0xLTEtMS03NzE3MQ_d85c1b34-b4f8-4a7a-9057-6b404b27faba"
      unitRef="shares">734218</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i0275f925a31840af927726857ad4931a_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfMy0zLTEtMS03NzE3MQ_adbda466-67da-4650-9adf-0ca242582ba8"
      unitRef="usdPerShare">91.58</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i94c20b531d9a49f3ba7f9be28e443ebb_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfMy01LTEtMS03NzE3MQ_cfaa128e-6cda-4477-a6e9-28076bc2da29"
      unitRef="shares">186526</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i94c20b531d9a49f3ba7f9be28e443ebb_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfMy03LTEtMS03NzE3MQ_3efd526b-3335-4f87-b2e6-a2fed19c70d1"
      unitRef="usdPerShare">87.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0275f925a31840af927726857ad4931a_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNC0xLTEtMS03NzE3MQ_27bc0027-10cf-4245-9f3b-3634005f7e7f"
      unitRef="shares">25798</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i0275f925a31840af927726857ad4931a_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNC0zLTEtMS03NzE3MQ_6399b307-a324-4089-8cf2-ec8980553d2a"
      unitRef="usdPerShare">20.53</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i94c20b531d9a49f3ba7f9be28e443ebb_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNC01LTEtMS03NzE3MQ_af96120d-5afe-4574-a1b5-25a66a16b7c8"
      unitRef="shares">133173</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i94c20b531d9a49f3ba7f9be28e443ebb_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNC03LTEtMS03NzE3MQ_037bd503-635c-45ff-a630-662ac3274f76"
      unitRef="usdPerShare">120.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i0275f925a31840af927726857ad4931a_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNS0xLTEtMS03NzE3MQ_852675db-1a59-4099-9a52-0285873dddad"
      unitRef="shares">30417</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i0275f925a31840af927726857ad4931a_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNS0zLTEtMS03NzE3MQ_034a4007-d96b-4f2e-a202-aecbf907cf8d"
      unitRef="usdPerShare">67.60</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i94c20b531d9a49f3ba7f9be28e443ebb_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNS01LTEtMS03NzE3MQ_19972bee-516c-4f8c-8d95-83f95d00f307"
      unitRef="shares">1378</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i94c20b531d9a49f3ba7f9be28e443ebb_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNS03LTEtMS03NzE3MQ_d238979c-3f30-40af-b747-d3175e4d94bc"
      unitRef="usdPerShare">137.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iab997394326847b98b9a6709dde8df9e_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNi0xLTEtMS03NzE3MQ_f014f0a4-8788-4e3a-9fe3-ab47dc5266c8"
      unitRef="shares">2877601</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iab997394326847b98b9a6709dde8df9e_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNi0zLTEtMS03NzE3MQ_27ed8c55-3b45-4798-995c-0bf77497e494"
      unitRef="usdPerShare">103.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i81905d26e9e4434aa6c656e2d1a052fd_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNi01LTEtMS03NzE3MQ_8824ba0c-6b72-4a1a-9bed-b27912f664c0"
      unitRef="shares">316118</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i81905d26e9e4434aa6c656e2d1a052fd_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RhYmxlOjU3YzhkOTI3NDJkNjQwMDJiNjJkYmMxOGI1ZDE5NTYyL3RhYmxlcmFuZ2U6NTdjOGQ5Mjc0MmQ2NDAwMmI2MmRiYzE4YjVkMTk1NjJfNi03LTEtMS03NzE3MQ_82d19230-2b84-44f6-be6d-99f1259fbb42"
      unitRef="usdPerShare">115.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfNDUw_9b839e10-57fd-4f7d-b1ac-89979c77efe5"
      unitRef="shares">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfNTI5_4b09e0e3-c5cc-412f-a086-0b534ca53465"
      unitRef="usdPerShare">102.1</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="i898678e2c6ba4a73a10091c6fa20543d_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfNjc4_91598672-b83b-4721-97bb-d8f6a5402bf3"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod
      contextRef="i898678e2c6ba4a73a10091c6fa20543d_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfODA1_c242b2e1-8aa9-4580-be35-b0fef6c5ae7a"
      unitRef="shares">38007</us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ifae3653e5fe6429a946af263fcc4fd84_I20190911"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfMTAyNg_06435fd6-f77a-4e36-bab3-4d2425fa9c35"
      unitRef="usd">500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1
      contextRef="i93f3ccedcca8446095a986546e891de8_D20190911-20190911"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfMTA4MQ_290d6990-c87a-4971-9a00-b0cf1d93b7b2">P3Y</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfMTQyNw_3e9291a8-af08-4228-bbbf-efbe7cc5c0e4"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfMTQyNw_511565c0-d0c9-4051-8157-42ed680a3887"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81Mi9mcmFnOmNhMzA1NDg1YmFkNzQ1ZjBhYjhkNDZmNWJkNTBkZjJlL3RleHRyZWdpb246Y2EzMDU0ODViYWQ3NDVmMGFiOGQ0NmY1YmQ1MGRmMmVfMTUwNA_e92853d3-1d4d-4573-a8c4-262c1a860248"
      unitRef="usd">248800000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81NS9mcmFnOmFjYTA4ZjAzMTNiYTRkMmNhNDlmYjJhNzdlYWY1NmM3L3RleHRyZWdpb246YWNhMDhmMDMxM2JhNGQyY2E0OWZiMmE3N2VhZjU2YzdfMjg5Ng_8948242b-b4a3-48ac-a788-6eb48e1b6b6b">Commitment and Contingencies: Legal Proceedings&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 31, 2019, we received three civil complaints filed in the U.S. District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#x201c;JPML&#x201d;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#x201c;MDL&#x201d;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the Company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CyDex and Baxter Healthcare Corp. (&#x201c;Baxter&#x201d;) are parties to a license agreement relating to Ligand&#x2019;s Captisol technology and, more specifically, relating to Captisol-enabled Nexterone (amiodarone HCl premixed injection). Baxter contends that it has overpaid royalties for several years, and seeks both refunds of those overpayment and that its royalty payments end as of May 4, 2022, the expiration date of one of the patents licensed under the agreement. CyDex contends that Baxter has not paid the royalties due to CyDex under the terms of the license agreement. On April 6, 2021, Baxter initiated an arbitration with the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;American Arbitration Association pursuant to the arbitration provision of the license agreement. On April 21, 2021, CyDex filed an Answering Statement and Counterdemand. On December 2, 2021, Baxter filed an Amended Notice of Arbitration Demand also seeking a declaration limiting the &#x201c;royalty term&#x201d; of the license agreement to &#x201c;the later of i) the expiration of the licensed patent; or ii) when there are no longer any CyDex patents listed in the Orange Book for Nexterone.&#x201d;  Baxter has subsequently clarified this position, and asserts that royalties ceased being due when CyDex&#x2019;s U.S. Patent No. 6,869,939 expired on May 4, 2022. On December 16, 2021, CyDex filed an Answer to Baxter&#x2019;s Amended Demand. The parties conducted a three-day arbitration hearing between May 24 and May 26, 2022, and subsequently submitted two sets of post-hearing briefs. The arbitrator&#x2019;s decision is expected before the end of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we may also become subject to other legal proceedings or claims arising in the ordinary course of our business. We currently believe that none of the claims or actions pending against us is likely to have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Given the unpredictability inherent in litigation, however, we cannot predict the outcome of these matters.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i2ad65c5ebdff424fb802e081f2da87ec_D20191031-20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81NS9mcmFnOmFjYTA4ZjAzMTNiYTRkMmNhNDlmYjJhNzdlYWY1NmM3L3RleHRyZWdpb246YWNhMDhmMDMxM2JhNGQyY2E0OWZiMmE3N2VhZjU2YzdfNjcw_89676062-a340-43bf-a900-f83cda9ca747"
      unitRef="civil_complaint">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i2ad65c5ebdff424fb802e081f2da87ec_D20191031-20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81NS9mcmFnOmFjYTA4ZjAzMTNiYTRkMmNhNDlmYjJhNzdlYWY1NmM3L3RleHRyZWdpb246YWNhMDhmMDMxM2JhNGQyY2E0OWZiMmE3N2VhZjU2YzdfMTI1Nw_f1ad32a5-7bbd-4941-a9bd-de2a24935040"
      unitRef="civil_complaint">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RleHRyZWdpb246MjhkZWU5NGU1YzhhNDU3NjkxYjkxN2IyYzdmYmE1ZTBfMjI2Mg_06679c26-bfa0-45a5-855a-ef8b1aa342ce">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Finance Lease Assets and Liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity of Operating and Finance Lease Liabilities as of June&#160;30, 2022 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remaining six months ending December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less estimated tenant improvement allowance:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RleHRyZWdpb246MjhkZWU5NGU1YzhhNDU3NjkxYjkxN2IyYzdmYmE1ZTBfMjI2Mg_7d451bae-14fc-4834-ab97-e1b9c2bd1661">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Finance Lease Assets and Liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity of Operating and Finance Lease Liabilities as of June&#160;30, 2022 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remaining six months ending December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less estimated tenant improvement allowance:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="ida31ec29c0a64e779c80ba3c979f2b18_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RleHRyZWdpb246MjhkZWU5NGU1YzhhNDU3NjkxYjkxN2IyYzdmYmE1ZTBfMTU4_c2b45d0f-f4b6-4561-8f08-4249e3e57df8">P10Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ida31ec29c0a64e779c80ba3c979f2b18_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RleHRyZWdpb246MjhkZWU5NGU1YzhhNDU3NjkxYjkxN2IyYzdmYmE1ZTBfMjIz_daa6caf0-ed70-4299-bdb8-373da6f52d67">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <lgnd:AssetsAndLiabilitiesLeasesTableTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RleHRyZWdpb246MjhkZWU5NGU1YzhhNDU3NjkxYjkxN2IyYzdmYmE1ZTBfMjI2Mw_46050be6-4842-4c8b-9cef-6eab270581a0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Finance Lease Assets and Liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</lgnd:AssetsAndLiabilitiesLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMS0xLTEtMS03NzE3MQ_847623a4-ddc4-4d0f-b13b-08497b08900c"
      unitRef="usd">24711000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMS0zLTEtMS03NzE3MQ_cc351b17-0a0f-40be-9e6e-2931f0670232"
      unitRef="usd">16542000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMi0xLTEtMS03NzE3MQ_391a98e2-ddf8-406b-9d0d-baa5ae468ffa"
      unitRef="usd">15032000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMi0zLTEtMS03NzE3MQ_b892d14d-8ad5-49f1-99aa-d56e91034f98"
      unitRef="usd">16207000</us-gaap:FinanceLeaseRightOfUseAsset>
    <lgnd:LeaseRightOfUseAsset
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMy0xLTEtMS03NzE3MQ_5d0b1afc-42ee-4008-a449-0eef5bc7d239"
      unitRef="usd">39743000</lgnd:LeaseRightOfUseAsset>
    <lgnd:LeaseRightOfUseAsset
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMy0zLTEtMS03NzE3MQ_7e57e192-3149-468f-9805-ef52b2f9adeb"
      unitRef="usd">32749000</lgnd:LeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfNi0xLTEtMS03NzE3MQ_756655ab-44f2-4402-94e6-87d359575cbb"
      unitRef="usd">2501000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfNi0zLTEtMS03NzE3MQ_3c38bae6-0f83-4b3f-a7bc-f8d89fe03b37"
      unitRef="usd">2053000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfNy0xLTEtMS03NzE3MQ_7deff037-8524-4c40-a69e-d31ca37412bf"
      unitRef="usd">50000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfNy0zLTEtMS03NzE3MQ_1ce99229-50ce-479e-ab66-31ee91a30a26"
      unitRef="usd">46000</us-gaap:FinanceLeaseLiabilityCurrent>
    <lgnd:LeaseLiabilityCurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfOC0xLTEtMS03NzE3MQ_f3c4a5e5-bb24-4448-bf90-c52c01ffac98"
      unitRef="usd">2551000</lgnd:LeaseLiabilityCurrent>
    <lgnd:LeaseLiabilityCurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfOC0zLTEtMS03NzE3MQ_03ca8850-eee9-499d-b22c-fca757367a69"
      unitRef="usd">2099000</lgnd:LeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfOS0xLTEtMS03NzE3MQ_1b623de9-95ad-49bf-b7f2-718769408ddc"
      unitRef="usd">27088000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfOS0zLTEtMS03NzE3MQ_2ec6a5f5-10f3-4630-9441-4a5e633eaa6e"
      unitRef="usd">15494000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMTAtMS0xLTEtNzcxNzE_033478ab-c6e2-4b1f-ba51-3ce627f1fee5"
      unitRef="usd">27000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMTAtMy0xLTEtNzcxNzE_6eb76a1a-42ba-4ee5-a07c-7da6938ef85c"
      unitRef="usd">58000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <lgnd:LeaseLiability
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMTEtMS0xLTEtNzcxNzE_5da4b63c-d0e0-4953-a734-7c654b2976f0"
      unitRef="usd">29666000</lgnd:LeaseLiability>
    <lgnd:LeaseLiability
      contextRef="i245a60f5c38a4697983ab57c4578e9d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOmE3YjM0MjlmYzg0NDQ0ODk5MGJjZGIyNjcwOTRmMjgzL3RhYmxlcmFuZ2U6YTdiMzQyOWZjODQ0NDQ4OTkwYmNkYjI2NzA5NGYyODNfMTEtMy0xLTEtNzcxNzE_7f4ddc7c-048c-45a6-ac77-6c46e8d04e7a"
      unitRef="usd">17651000</lgnd:LeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RleHRyZWdpb246MjhkZWU5NGU1YzhhNDU3NjkxYjkxN2IyYzdmYmE1ZTBfMjI2MQ_eae8dcf1-14e9-42ee-81d6-4094b3e1446f">Maturity of Operating and Finance Lease Liabilities as of June&#160;30, 2022 (in thousands): &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remaining six months ending December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less estimated tenant improvement allowance:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfMS0xLTEtMS03NzE3MQ_3c0d5ee3-4f7f-410f-b09b-dd26a88a290f"
      unitRef="usd">2459000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfMi0xLTEtMS03NzE3MQ_e5cfd636-8b2a-4b93-a801-1c73eadd1f7b"
      unitRef="usd">4634000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfMy0xLTEtMS03NzE3MQ_6d39599c-fb1f-4564-af86-82b672b6003b"
      unitRef="usd">3873000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfNC0xLTEtMS03NzE3MQ_477de1ad-4aeb-4c8f-9d42-7987fa8ed392"
      unitRef="usd">3811000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfNS0xLTEtMS03NzE3MQ_85521e48-9b25-4045-b60e-3c65e60d91fa"
      unitRef="usd">4024000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfNi0xLTEtMS03NzE3MQ_b2cd22dd-546f-459b-ae53-d372dc6a5b1a"
      unitRef="usd">4128000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfNy0xLTEtMS03NzE3MQ_e9620eee-153c-40b1-9f91-de7a12cdeb31"
      unitRef="usd">14760000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfOC0xLTEtMS03NzE3MQ_170ab805-d6d4-4d79-88a4-f4afee734521"
      unitRef="usd">37689000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <lgnd:LesseeOperatingLeaseLiabilityTenantImprovementAllowance
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfOS0xLTEtMS05MDEyMA_e84e3f57-cfa1-4b18-8c22-36b4fcfdd328"
      unitRef="usd">1358000</lgnd:LesseeOperatingLeaseLiabilityTenantImprovementAllowance>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfOS0xLTEtMS03NzE3MQ_6330c661-a701-4156-80e9-89328c63fee2"
      unitRef="usd">6742000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI2OWE0YTljYjkyYTQ3MjViNThhZGEwYjI1ZWZlNTQwL3NlYzpiNjlhNGE5Y2I5MmE0NzI1YjU4YWRhMGIyNWVmZTU0MF81OC9mcmFnOjI4ZGVlOTRlNWM4YTQ1NzY5MWI5MTdiMmM3ZmJhNWUwL3RhYmxlOjNlZjRkN2NmMGRiMDRjOWI4ZTQ1ZDk3M2U3ZTQ0MTY0L3RhYmxlcmFuZ2U6M2VmNGQ3Y2YwZGIwNGM5YjhlNDVkOTczZTdlNDQxNjRfMTAtMS0xLTEtNzcxNzE_9470a3ed-2b41-4632-918c-4ed0fc0ef60d"
      unitRef="usd">29589000</us-gaap:OperatingLeaseLiability>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>62
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MVF^!,@/G .2 VMA2<.&/J2*0BOI[5'W!>S87OV#IY(95!12/M>8XGN^K60[
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M'U'?-.J.XJNJE,ZYPL)<-3.\G('0 /R^X%R]='2 ]KH7_ 102P,$%     @
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M&"HW51^=?>%/GW+X"[4QH+0YE)9 :2F4QJ"T#$KC*)JZ,4KG=@1VM^,;V1_
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M/>BW%O*F?_ZQ(?TMF.&1N=VGNV<L3_LG"T>??_0_G U/2NIAA@<WOZ<2T-U
M2[J$(;WW$<RB')Z%'-ZT]:9_G'!1MVV][E^N1 HUKS* [Y<U=.#;-^H'=D^D
MGOP/4$L#!!0    ( *>!"57'E7$W R,  /5H   8    >&PO=V]R:W-H965T
M<R]S:&5E=#@N>&ULS5U9D]M&DOXK"(T\T1T!4@1X2[8C6I+MT:P/K=JR'C;V
M 02*)$8@0.-HJOWK]\O,NL"CU9H93^R#Q&X"5965]U757Q^J^F.S5:H-/NV*
MLOGFR;9M]\^?/6O2K=HES;#:JQ)/UE6]2UK\6F^>-?M:)1D/VA7/XM%H]FR7
MY.63;[_F[][6WWY==6V1E^IM'33=;I?4]R]541V^>1(],5^\RS?;EKYX]NW7
M^V2C;E7[?O^VQF_/["Q9OE-EDU=E4*OU-T]NHN<O)_0^O_!;K@Z-]W- .UE5
MU4?ZY4WVS9,1 :0*E;8T0X*/._5*%05-!#!^UW,^L4O20/]G,_OWO'?L994T
MZE55?,BS=OO-D\63(%/KI"O:=]7A;TKO9TKSI571\/_!0;\[>A*D7=-6.ST8
M$.SR4CZ33QH/CQD0ZP$QPRT+,92ODS;Y]NNZ.@0UO8W9Z ?>*H\&<'E)1+EM
M:SS-,:[]]F72Y$U0K8.WM6I4V2:"JS(+;H5,].PVWY3Y.D^3L@UNTK3JRC8O
M-\';JLC37#5?/VL!"<WW+-6KOI15XPNKSH*?JK+=-L%W9::R_OAGV('=1FRV
M\3)^<,*_=^4P&(_"(![%\0/SC2U:QCS?^,)\O]2;I,S_8&R$P:NJ;+#7S"&G
MARU@Z/N\3,HT3XK@%E\J<&W;!/]SLVK:&GSWO^<P) !,S@- LOB\V2>I^N;)
MGM:J[]23;__ZEV@V>O' ]B9V>Y.'9O_3J/[GKQJ<G^27K@[2"LQ4-BJCGS2]
M\,O:DJ9QI,G+M.@R%;1;=?X%+/!COB'8Z%^.;P[;JBCN!]6AQ*1-MVKR+$]J
M@#0,;@J,]>#.RU;5:;7;)^4]] YOHN&)P YED[!":H)M<J>"E5)EH(H<LLW@
MYJ4'/EX;!A^4O*EA!D18+LG^ >7 L(8\(&\83U59,!I+4ED%U&;:U34]Z TX
M;/-T&QR4C,Q4C5E+E:JF(2I U0=)L$[R.M@?\7D%/#M\X2&4'Q#PZQ:O!5V9
M=%G>"@$>30K&<:JQ19"650LZ-]NJ*S*@)R!;$[351H%8-=1CNV6R>6L]CMB,
M6]H =$04W)1EA]?>J7U5M\/@#9$LWYUN+DAJ12!9_.1 <%YFH#39$T(*06/>
M;K=)"_U\3X"K3WO8'H(*"&5.ZT"Y>Y74P\^RN2%ZIIJTSE>8A"#WF2QQH_9F
M%#;X,[ 71.$%.?E"8=.;^YDITE:>(@1 9W7> RA^WS"VO@.CPIIB0G -,=@^
MJ2U_?9D,TTODE^3MO?#%#S<W;T&*W[N\)H Q?R>+*KLHLUL#'V0O0L@$2]9K
M4$K8:B?26C/4PC3T_9>R-,]UPM;0%6G;>=Q%K)+E6!YR55<[#*L L05W".RE
M!>!E*@G$KU3=PMNRD&H ]W4.-MN#BZLO$T"GAFJ[EB*),^AU,D?*!&/,*KYV
M $N#VQE,J,DP^.M?%G$\>E%4Y68 T=J1JZ1J4C2UNE-EI_B%Z 66;V3U),MD
MV0?0O4H*;$ %[/"$02/,0SLCY.DU*U84;N4B3U9YD;?@:+.H9M,>SOJ[\<0!
M[%UF29TUP?L]@0$%"JK@56B"FZS:T_IORN"FVT##$NO##Z$]?']S^S+(P6MX
M?G/[GI\,1K,P>*U6;3"0#\8MY.I.U8V1T%]X []H#KVZ[59MM<_38#(?#>+1
M-;_S&D#?L0H2?ON;RC8$[( F8Z^#.>,[;*&]IVU'\Q=-\,L!7T$\(#!NVD4T
M'4Q&U\_]/9/*$JC:?%4H[ ^N3.?8N[=(\N ZFBH>!C05KMEP!)L.Q&6BYKM]
M0<S7:!; K^H3S0&FK,"VA&C&5[+?%RQ4[X>W0Y%Z CC5DN'8//? YI'I-B&P
M@3R(6,H:SF,/WIIBN(=P4:'YFQY3BX)0928SKBMXZ#"Y_+W=!D/BH2X_0EUF
M*1<T*:(KV(E4,:W-T!YF51^S\#\LA*2.\3-S8@B3[:^:$7.YI2$K'4Q^(JA]
M)6K)3@JZC$7+PS?(8:16RM@7;;XP, &!R@VF-@B[#W8J:3J2:>A0\I&@DK#\
M'RRU#=;,R1$)1![7*FD[4LM:/P>K?-W5J;-+T#X5S)'\WGAH$@<#!OC@D)P4
M3=77]/EZH/>/Y7=P%BI6)K03<$MN]H'-/40<.R6T$8,")LKR)BTJVBCI;\?&
MD.U L>4@6M+L:[R9B(DGI0:!+-GW6H/A(+&IVJWP0S3E. 5&6CP3>B77_H?H
M(F%65NQD#OQIV1],M-;!.XW#B8/E[PDL+TQ\) $1/#-@D[&TJS)1[[5JZXJX
MFP< 1765$(-HT\6&JQ8NS4L)_HDPI*W)&]+V@LV(^,C$MSGT>J.QKM6I$N^N
MYEWBB>>V-%:O8J<"O':5:-,:$T+[M-MUA4"C7]2N">2YW*C@D#2&?XC[B%M+
MS^4U5H5R&;2R,2.8!'B RL 8()>>-<3+]"YI>GJ!<6UX5/LV6EBT;\BF!O@U
M#,U. U8TULD3&*=?&,-528PWU)X0N"'?@\YBV,T.O>5 ;,] ?UXD^^+X&4^F
M9UJMRZIMHZ(X/4"4K6R4#8=N3U@QZ &XOFS@&\N%_'Y(\0;1J.88YAQYO*VZ
M#5D\A<Z%:)-/OMH.?6G=)WDVR,M!FNSSEK#)4GU$9$)YWO@@$ =!R%)B,\8&
M(4BK]C2I:S8W%RF#P=!U>0OYH/CLD-QKIZ9%]-+^$\0:!M]W->E-?*L>@3I1
M]_ UF(8T0Z,MR7GNN[J,L6N/-3W-T<#PD5#O\@8 R8;/K?H@!DY HG@5G*17
M 4DX0A8C($H\U)[G!07@Z1.M"R!&6+)1V2-IM[H/GL:CX238P?)QO@<4Z5*5
M7>0W'C(Y-^(4JX'A0QHSC8:1&22)!0OKJ1ZB >.I&V"L8.NKKV,^;$]T/S'V
MT_'$7UG"?Y=/*"ETM^Q'YLZ@ZFD\C-WZ[\1SYVR+]N)))VU4J<0+AP[;283,
M_GA=W2<%(PR+-DDA$24L#9#%_+G;J9K\-%X7^V6?/*E;S >A?I5 LT!!!10*
MU1RUT!RA-3?D)EE 2&-1GBQ/Z14$L*3CX'4HXW7=J:+:BR]4JPUQ4U6+3 AH
M(O+8+*P:N!^ W.]$/7\0'^)>@OBJ**H#^\C@QD'3JCU9556PO\:FCHG#[N;-
M[:M@1BZ_01WCQ3G/XOUSFI>W3'%)S;)0 6**7L 3.L' $SP/KO+K(,_(*S0A
MH>$#():$,PLV%;D0'CX\U<\+O\ LF,:L8&<Y;"7)\IG9R.S!,+!7P'RX*O*-
M1*>^3^/-=L]C,DY2I;XE:M4G9\M]Z ">UHZLYO0K7OZ,F"U5_GIZ#LJYYC2D
M#.[ C FY>2;/Q4#2_'?7Y I6?02>S&ZTZX7-OF#NN<)<ON_*3H50&Q@H@RMV
MGZ]]QQL<!\[F2$>1UW5^?@B<%: /;  4Z3^1JGN[B)6M(P$ZDK4[SO+AG3VD
MJ32I*A@6@-<?=BBUVC<$H81%LJF5<O*05>P&<NY@W9%C?PE)SH0TRHHEE#+I
M:C>?Z! $61HULA4W#5%B4YOD:D%%'8(*^\.RA RJOMA8S'G"QHOS^6L8_*TZ
M 'DUVU4GV0ZQCI@>/^G0(/-L8B_F8R(,1(LXS2>ZUH45=A7QDJU5AQO95% [
M-'$BN^!U),ZEN8,J3;M:O,5:K=DO^)<T+,NDYS5KJ?P=YJ-U2H!F(BT/19P-
M6?7;\8YHDBW3$/CQ G8I(7(2D$XU<Q?)AO;1-4P"D^X2VIFLJ4$48$B5RAKG
MDY$'!!-[KS.<<!N@RBE&Y\%UKCA"9/,J416X(*%Y[O+L#!IZ&H22WAW8+BW(
M-I0PA&37>6/#X#5GZFAZ<F[: Z>MM'R0;Z7WD1W+J$VYL[S8^,G8M9 I(4Z=
MHX-VO7-CKUF-KD N^&$?2T@I/*/[O:0FCBR31O/0F=!;IDS?"IEGFFJ]"(HU
M%PL,7@".3VVQ\=6TBP0!."^91N2UA-).69 EUT>$2(W]TQD/[:FQ?@*CTXR-
M5>Y6BS/C,*_0/$8Y\LY.)E6?M&_HA9=&1O"-@(;8_H(.X\#+54JL&9/%V,;Y
M"H]VX?P3QB0B \U^I )6D)MU;GUW VJ@<IFKY&0*Z6$"MU?YD-6@2;#'5)GT
M=2U5$G*\DKLD+]CF'<_. M'8J)3*&-J-Z&6YM8K\GA* )T1_))5#O[8DPG8>
ML<8.DEB3SZ2K'CYC>4SH:R1 8MF(LC\/6(60/(G2>@@&'UN=##.A"*LJT1O5
MBO.(]-302B__SZ)DJ"VXR%??:;4XN&1!N:C'?'10?;>0U(;D($A/<?:3K0$<
MW$12+MJ+#6@0,[O!K2ZW$&Z'6CU0F,/;%[<M^43VBPC)FZ.W30& >5%O8B D
MX1B+C*[.I-:<V)0(0Z(!>=T5-+DU0]2 PXQP8<,(7]?<5"$^^C;?[[57Z6DF
M6/$S-&'2>CQT(@J<'R+M000"I5_I%<U4#*1[GHH7FA0ZQJ5**+,(;_I8U@5+
M&07(/8.F0RSA?*W=313;-*JU'MF!2Y^,(]\\-VQ"*0M(= 3!A)ZV:$5OY#N#
M!''3\HS-#<,4D.?Y^,UD76UDQF0E35%L:$.87DR8]N,:IX*K=2N(X:+[>:_<
MJ""N.&G>Q/K$;1=B,C/?@V^::9UM/O7RC8H&_L#+*X8MZ15;B7?KA@L*/L()
M3)>8,$+MFU%*IA,!V'<SA7*O&DEY<./6G/5C*-IM<TH,LE]ABM(Z%[G"5,$_
MNFS#,JXSEY@<4O;&.;V7D$,;MJOKV/I+/&*3M:^S?L1SSGEED4P^XNF^2%+5
MKX";'33!CDIH\(MW2<:":;2=X<13XJUU_&*]W[/:>!B\5&FBJ\&\M;SY* )G
M/0%>SF8)M+WU'45+S9JC-O]EBUMQ*$RHYN49*,-^1[[>0?4<9Z/X2#@]8EG^
M%:5@FB&R3FF?NMOK8.<L& +%R>IP81646B:M(H)1,0Q:#[FXC &E\C276C@5
M!J$@^?<BYKX$ZVVSYK.FO+(176(B16?;C%_L'%D)<ASRG4XA0K_[:[+;OWAM
M4Q'BIQQ_:]*E?5O+MH)D@_F6-B?Y!5T)KA#@0J-V#:M!4D?[KM4Y2$F]^=_P
M&NPN^!*L8T\*A;1W6K)G+(KVH+0>;JL#K+/.JA)N-$/K!IM+V8 /1Y&24T+'
M:QYG17C7>2L,3%)(#,0%?BJQFNFL\0Z-7;%P$Q\([.S<;D!E8\(HFZ85H#:S
MGJJMR,QHZ"P>/):XG%S1&7JC\'A9O$EE]V2CK*F$\FUS4E>K^\LIG'XFS:'-
M*BV?74Q")A>R4Y7 %,=L%"_8VQ$BRPX6KL(7_1838HWF2,.Q6+%B)BJ[]X$8
M^[@Q66SA5J8!Y,'+813P[JM:2P_'A"RDKH.EI5ZRC32ZG&S5X,WMUWC^VK.C
M82ZA(Q6X6PHYK?/D)))XO^%@F?RDHUR'(Q&AR:FSBO/-^X;J COM)+.R*C3+
M]'*WH:]9V=X<958.+C'&7J9U.JBG2XK>*<13)QJ@ CLC/B?9STU=-8W%%-<K
M7%&.[#^H3.EW_PVP):MK\8RDMJB5 3,2=8HA[.MET$@):\?4>$__$:V\TA;P
M<:I9=)YF)H^#/%\@#%94&N"B*:7DDV9K@@6.6SSAI1=U*5BW5Q%0Y&F%<!7T
M4_=E$UQ9/Y1]X^9:I_VM"Y_=)9R'D>3^OFHH9G:CO'+-M:WC7:QW#H/ON F#
MC<QQ@I77U:TEVL289Z?6G#G1^%?:(=M7Y"T=U*7<)@6!%>6UUIRT\?)[!YMI
M=8MP1<NZ"PY%9D?#X ;/N/"A\4K*4]!%A%PIHBB5F8@@M5]9;$ZZM,"K+@QH
MM^#@8">MVV=*PHPIZ6SP%&V_+M]71 EYW.HNAP+%SNSB7+.:N(J5T/YI-!J.
M_9J;:5^@$J('9I-_^H\!.3L%LO?5$9!YDVPV%)P;<34*X-=>_J[E$ 0Z17HH
M&DHY'0VT>M"KDYVMBUU)&TG7X&ES_1PKG1#Q]B+"^ICCKD[WDZM._-<]+&0!
M4_DTF(=1/,?G-)Q,1OB,HG ^6>*'93C'@^_N(+U%$L3A>#G!_]%RC%='RVDP
M":?Q+/@5-D<:3]C__X<^O#$-IR.L.IL$BW 2C?FG=_=% ON%F:(YM_Y%\8M@
M'"YG,_N;--+-HF4PQ[\XG(RC( KC*"+ YN%R2H MPEDTP^<X"F?3"3V9 M2%
M0ZO]@7KK("]X-1S'4][3;!'SYW3*<X["Y7C:&_#+;V]>!U?1-4 .XW@43.-P
M 3R,L76LNL!O$UH\QA03FG(68ZL$U@3@S B3RW$X7T0NXC:$O=6JR+ 0XWPZ
M9AJ,9R,!9[JDN2):- Y^U(;U>](-F'ZTP/^CZ0BXGS$U1J#&3S:$ *;F4^QU
M-AK15&/@'!.-@&W!:Q1.YTOZ?T(S1.,)X64Q87PL(]I,- 9B1K*]^9(P!%X:
M8]^_LF,(B.<@)Q,!(,QYR&@,S,0\> FHIXR\$XQZLN'5P5Q*N_-ZOCK)\9"3
MR:$ZY8XE?[7+5 /S7(=24B#_%SI66A98@7,;)"TXB);P@[:PL])3^J:\4[J=
MGE,?C7N4>X]T9[XQS$["J5!_HI5LA]A8BO?1B?#>]#MZ?F"/I2L!KU1X-K!1
MS>G7!7X'R;^SCCDW]Y,SI([ >)F4'YTY!>' C411(U%/@ZL9Z$$/)I,QR<.^
MXAZG504(P09+O&Y>OHIBO#L!^_IOZ@Z4AHXF2*YP&BY&$ G\NP*OC\;7-#N$
M]*>.8_AU!]R )\(I9,O-#7%:7./[**21[V^##?G,)=/-FSP.XXG3"%=S$L4P
M J]]8+<*NS3/HGC9^YGD!DIB2?(Y&=/_5],P6DRN^<D8\RZ"W_*/W'I2[7:4
M0VFK]&,0+<,)(!(>O\ 8F&$20]],SQ#]F 8S$BL&AX3[*F;\\Y?1"0$@:&,2
M:T(EL(-?X\6<RLZZ#@C79$]KS<(17HN)1-?!>(I=+AY!H@F4\!540#PGLD;0
M?3T20;=%8P_7\60) DVC<+%X@$#0[?.Y-PCDQU?0Q"<$F@!D_V?2*R OJ^+%
M)&;DA./YB/ES.8)2FY\E$+A] 81^AD!CN C3Q2SX@?R^*Q*A:PDQ+HS0/>47
MVNOZ9XLH*66K19S%A+-6L4[2(LM!9%^P>T!4EY4.WI02IJ$CYSL$F1[B^=Q2
M==!>M.\'<J.LJ2,-\-N 4WC<[>41CI7HB9;103.=:-)E.R]9"K\I;XTZ8N\*
MT;&I@VO_ZY&KZV2#GGQUK^-!V^\EVHUZJZEV["F\7INO::WAY"Z7SJVCYX'4
MASM?^].9%B[;QEG=Y8V4;70TUAMLFEYM:IY#L<2KJ^[V9.4KX:9'("([=M"Y
M7/*@#SP\ZV_*P5QLN'GLTBL7@Y 6V%&'-W<7'IFMOHUQ1HS++M\3+G]C7'Z0
MKF=;YH":"R?QF#_C^22XX49J^QC;K;K-EANQ=-,UM/)XA/_)"35.!KPT=HM(
M+4=LK9VTR-FI>Z[PZD8]?=[2-:93CTS)I[YH%(D7'3L89)2*J8&3LG*']ZP4
M2IE+%9!DG08#.RP"5NK,'29]42M=]CZ2)/LJ!208>T3 #U2:A(MSYQ(MG-TS
MQ;JVWU)LFB%H YDX2T3C$Z&BJ80CRS/MPR1-#4/C!$!XZ=39((T"_&RHT*RS
MUI+:8@5E@:EMRHR$@5+;Y3JY@QGB I$;X$G2[^"U<Z="I,7H>#<B3TKJ)10H
M-XUTE)4&5[87=7T!8W['$WU7<IJJ491,/5Y3CHL2/]';U+T[*/*/0,* ^GH&
MO$F?7JS[=&/1Q4E7G [0RHI;N>YM;JA/I!4=^Y/32US_I8,A976D@YCICC3N
MEZF/&Y/'>6=3-CS.6A3QG&75'V55$KPS^1\P2L[]&+W645W-*0WDQ#TNLR>9
M<(S.FRUS:F_9(RM3F:,(O$=*X#F#= X>6Z^5#BW-)$H7 =Q2>>,2R]Q4)*4#
M6H26'K G97J8C]O 2I/_U>$\2[S(@B00N;SC503Y!;^]R70+\;D3<'A5][I!
M"G672'OX<0G-[N^4_<^@0V=_A=LH*:N7,L7779+6%5B)E&#*SD_N':P$%TIB
M5R3T\GZHN;_(2SK,!&V,  R& U$9'VE;*6@D.JC'64B7(N1TA]":?BQR(#>C
MG1@%H8_I$KAK;M/(@#*(S@9F8T_GIFU*NV#%(+T<-F'K,=Q)$NSS0M+K@3'-
MZ%Z2W9T.ELRKQ2$]A"A\5*V/3EO0"8-5U[)R81>+^52GLKQ"L:]%10-:?\3$
MLP@% #6MJ(W!BAB8]+NKZYX<-Z">\*O1$"&(W\9.7\7N*^*DRQ+93XJ%Y\T;
MQ=<EER[M3T:(=$PM9@ALW6Q-DW+(_4WZ2%*K)?%@6ET:+D%) I],%>-&F[ /
M?E\-O^J$>9W733O(RU#_5-DBH"F3F4."QWW9IGA(_>/4K_B'U!ISN[>"2K>-
M+K3H BA['-#[9'$.I?<R1/D<\/;@26.: ZL5P@[L)N0O$\\P]&TX^>>6"\].
M3?)P-,BU9XHNV]D33+42PP)SP_ /"/[&+^P8P+Q-]6*.+Q$OF\:%,3IE(&\%
MGUUL?HB/G=_;<.QIM!@N^WE<X<K3X/P+)XXGPYD[0/$#N)2MOCOE^T:S3"*G
M;!$=;/A@X@U7/?HCI"\K]T?D;H3422ZGG"XZY<>;U.G=-T ZR5=+'LR='&H[
M6LM"]S2(%E$8CV;>3Z_UZ.#2Z%>V^JS2;5D5U>8^B!>455S@$^%[- ]^!-L]
M)[LD;3;'7517BUDXGR#@OYHOPN42:NG7FCI'2CJL%(>S2:S__]P\6#6B::)P
M,IE<VR,9NK8-E&[S?1-,1N%\-#(?GYT3@<<HIDD783R;7]L4KEP X$\\GL7A
M"%.:S\]-/24( .?5&(%1A*DEUME\*;>$+/=/@_EH";13IG8^EH396SX:#Z&U
MMHQC(#K=1?&7JW=V96XZ@>@KB2351M>ZN5^HU%E\=W>';JR6)J0R^"FIH=B9
M]70/!+O9IH/<'J2DL;_LROQFY8S5OJOI_!F[.@GWYM8Y+*0>*I>XV(/.G/_9
M5D6FST<</]XFM80;>A61'G'O$*.K>F,:<6_>WKP*8:?+1 JSW!TIW8[&OR^K
M ^.K/51'^&HN(*P)!F?W:$[EZBMI4@H&S$,X:$JNZ "KXV=I!7OC]>"'DE)Q
M1].\!GTV3KH#@[BLGRC1/?; )NR":0_<K;R:.=P2,CF]\\/:>;'?G71@>&N0
M1:%W- )Z!Z!X L0%TJRLC^O(#);131<^FV&#Q,15SGU&HT3<^<R'K25PC-@[
M%^16TO7BU;T%]EBC>ID,JQG/D8S+'--P-A^?4'H^#:?CL:=%O=2M*=^\DTYZ
M[\E1C_V7FP 6O5-C)X6$&W=U$!=C?E;MN2>Q/+GY([^O]!T1]4\)I/&35-MF
MG$B_6H:3>'K-=;=X'AT_DN("'HVGX&6Z_D&X_W6>D'=,=:@9):$7^)A=!Q&G
MY]V7<\I,1^%B/K79GQB3+2E73&IX-.;Y,2#FVEKO8;18Z(=1-.*=WKC+8'0(
M>5$E<YAID@?L4D3#:<])]IQ@_S8F?GGFOWO.'R;L_HO0S/\%:$Y88_@ ^WGP
M<6<*^"^OV%N72,<U*;J&GGO;,V'.B:0Z*<+I ,T*T&_#&R!#_WI-ZN(&&RT
M4S26#(3Y=1IZ#/B*NN&KNZ2A\]UU"/688AK[_%J,T#V-F]GKL;!U0FWM8('L
M"WOC=;PZ#WN\23YPLE<=72RBE\C=*7B\OWP(:W81/@MT?/F&N])$.T\7#IN.
MP;U>4J;A\&HM1\GY9&_7--(1\O_WHJ@/O1;"DPRZCNS\SBIN?^%@2J>D.>CV
MNM=M@V'"%5*3'JTV=;)K] ES?313EV;HZ(0_3EO@?KJ#LG)ITHBC8PQL:!NL
M3%NSQ'6Z(NT+'C<AV^2-%#1,.L#$63:<D)[Z7FN7]&'J@:Y5BS<GPQ!SR#OX
M:@M&(X^PI%B-/!:!A($XSJ7J*RVXME3[['1P]ZDD.KKV=F%;0),:K]0Z*4_(
M,PVV'/0;4,[M7T1.WW7RS^9=#,?_^_(O#8:"[6U+;5D1MT$ X5'=Y74' V@2
M*]<NLZ([<K1CB,C8 '9T\T2I5.9:B!]*9YZU#A#)FFZ9^M&[H\!\Y]];\&^+
M#2ET@_(2+GQ*_2.S)5=IIN,8BJ1:$Z79UUQ+K\DB7E!_"0(+8\78K0;-V?.L
MC3;D@OUL/@EFXY'78&1>;K=YG7%#/GUKB_63)90'J,A7TM!=F?91#&]C!%Q
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M2H 6>@'/UQ4VI'^A!>Q?.OKV_P!02P,$%     @ IX$)53XR.#0\"0  ?!8
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M'EW.!\*&CZWAP9N*/W NC?>FX-N-DB@/- 'O5P9H%A^(0?O%^_J_4$L#!!0
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M08 GF?Z&G(&DZ2.B/AW&X^FT/FX-#7XQBN(X/F@FOR/W2B<KY%WV[\*[(RR
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M3ZI]\.FE*8#PG@L-GWG3(UQPR@!9<>,(O<,2VPW%/&-1B$<:L9.3:'ZR@)?
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M2Q>]_ZSI987:*=#^5M&0&Q;N@.-;;?DO4$L#!!0    ( *>!"57%L<5:PP<
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M"F;?4'"F;B&S".I?-J?\D'\*8WN+9YW%U[-G!7YH[$2='(W5[&@V>T;>28_
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MXULC!/E@6::9TL[C()^YVJ-"@$0"$!B2&2&[YT4MV+;FABLG!$#U99R1OCW
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M29<'\[Y00GZ#C#AA93A+^$RPH9RHHU,AF>Q00&M>>.?]<2<4/#UNP+5-P9*
M-NZ%7Z#MABIDVC>L^UAW]4H$,&K%U(!>T-9+$92/UJ;GF>B#?D.TW/3J>MAJ
M<UUD5%L&MCJ6"EE*%U*Z=26E>;^Q'4K3^'+D# "5W0 15;)T6!JN535V"MYE
MYV,I#/$V5;%]=500Q-?-[A$*Z.Z _6VOSSWS98 # E[8YU>M&,YNHCN[L9\$
M]HHUP$UC_R3NK73$S/<LF47+.,8@7D3S6=*!.!*+Y]%DFI!(,EFBZ*GK#>Q,
M+Z/E;$J#!(/+(\RO* MIYQJ Z/=O((GFD]C_3^;33N=H2SW2F$_8;$%:\YAT
M+K&F5MN0<J=62I;19+4BGV:7LY[.TRLE2S9?';D]0'X9+18+XG 9+8#F'7>U
MH2,&@GTJQ'V.T%H@?1S&8:P[N[AG0.5@NBGO#]V!T,J'MJ+16>C),"42S_1L
M?DF3*9M%B^F,AC,VC5;+*0WG-$1N8+B  +W#<(EAG*RH\I#>&U#'8N308G)$
M4->&IJ!DA=!0^>"0)\MP#O,GO'XI8OO"[93(N6+/XF@Z7ST/2I"I286:*QT3
MV;,%$BQYSMX_OI=_$YHYEC]Q69AWEX7Y?[PLG-0[7Q;.EX7S9>%\63A?%LZ7
MA?-EX7Q9.%\6SI>%\V7A?W=9&/>^[Y3";/U7+(LF72L7/O5T3[L/97?A^]!!
M/'QE>\?-%AL#$&R@.KE8XOY@PI>K,'&Z\E^+UMHY7?IACAU=&!+ ^XW6KIW0
M MWGP]M_ 5!+ P04    " "G@0E5L914CK\8  !W2@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970Q-BYX;6R]7-F2V\:2_96*OO*-[@B2(MFKUHA6R]L-V]*H
MK:N'B7D @2)95R! HX"FZ*^?DYFU@<VF%GOFP29% +7D<O)D5J*?;^KFHUUJ
MW:I/J[*R+XZ6;;M^^OBQS9=ZE=E1O=85KLSK9I6U^&>S>&S7C<X*?FA5/IZ.
MQQ>/5YFICEX^Y]_>-B^?UUU;FDJ_;93M5JNLV;[29;UY<30Y\C^\,XME2S\\
M?OE\G2WTK6[?K]\V^-?C,$IA5KJRIJY4H^<OCJXG3U]-3ND!ON/?1F]L\EW1
M5F9U_9'^\7/QXFA,*]*ESEL:(L/'G;[194DC81U_N$&/PIST8/K=C_X#;QZ;
MF656W]3E!U.TRQ='5T>JT/.L*]MW]>8G[39T3N/E=6GY_VKC[AT?J;RS;;UR
M#V,%*U/)9_;)">)+'IBZ!Z:\;IF(5_DZ:[.7SYMZHQJZ&Z/1%]XJ/XW%F8JT
M<MLVN&KP7/OR56:-5?5<O6VTU56;B:RJ0MV*GNC:K5E49F[RK&K5=9[77=6:
M:J'>UJ7)C;;JV'\[>?ZXQ:)HZ,>Y6\ K6<#T@05<J%_KJEU:]7U5Z*+__&-L
M)NQHZG?T:GIPP']UU4B=C@=J.IY.#XQW&B1TRN.=/C#>FV:15>9/%LQ W=25
MQ6:+**>>X""L'TR55;G)2G6+'S4LN+7JOZ]GMFU@@O^S3T*R@+/]"R"_?&K7
M6:Y?'*UIKN9.'[W\YS\F%^-G![9W%K9W=FCT_0:P;Y'?,,R;KE%Y#;U65A?T
MS8D._Y@'*=DH)5/E95=HU2[U_ALP_B]F05*G_PQ^V2SKLMP.ZTV%06TWLZ8P
M60-3'*GK$L\FEFNJ5C=YO5IGU19HP&9L>2!HIK(9PX15R^Q.JYG6E=*E@<?Q
M<DV5+!^WC=0'+7>Z-6-%F"XK_@.7Y;4.^ %CV5/JJF1'J@A(2J!9WC4-7>@]
ML%F:?*DV6IXL=(-1*YUK:\D/@< J4_/,-&J]8W(UY!SEA8N ) C@]R5N4UV5
M=85I10%?K J6<>ZD12NMZA:>;I=U5Q80CZ(0H-IZH:&L!J#5+EEMR5Q?IFR6
M+6T [CI1UU75X;9W>ETW[4C]3"HSJ_N;4UFC:4E!/@8"-E4!31/*DU!H-?[N
M=IFU0,TM+5Q_6B,BT*H@4+:T#IK;ZJP9'7"G\^!.YP?]X+WER;^'WA$RM-WG
M25\W JF1-+[.FJ#PKW,JNHGBMVFWHJ@?KZ_?0C9_= 8"8AET,JD.D[+^+6+U
M6KR")9C-YQ"=Z'DE[M.PID2+]/O7VAB/=<_.X+QYVR7J)MT5!M/#T)MZA<=J
MK#@L]Y#F+H+F+@[*_9W.2^R8T8+WO$]U7SF$NM%-"VH4Q.6DM&X,C&\-VZZ_
MSBTC.#5A+DU^Z'4</9$@!L_X65+,&*E;^  O$^ Y4/_\Q]5T.GY6UM5B"(=;
M$:W1#<%/H^]TU6F^8?(,TUN9/2L*F?: SF=9B0UHQ>1DH*Q8,.V,-.CFK!D^
MXLRER6:F-"T0W$_J\*$GL]YN#BC_,BC_\J#F$E:#J%T565-8]7Y-&P$P0Z^8
M# AS7=3K=I>EB&7\G>,#]]1UMT!D(%0$E2$I_W!]^TH9N"2N7]^^YRO#\<5
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MJC<07L-Q/GIV%&Q49F)/+E4IDAC=RT%9"4-!D8A\@OTQS0FS"&L/+ .TUM:
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M1K0\VM07[S"];I5XHZ SD'=3_+J1"]G'K T7VGBO 4C60.^05!+AK+'K$JD
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MJ%%VR!M1<&](;F ]<3RL'EA/ )*NN!PX+F][ G2,U?G5U[SL2(RSQE1;VBT
M0M;P=X>C<96:S> 0R)R2+*0O8VE"S2B7O]&DX4[P/=GXB(W4:<Z?ZBE$(K;W
MW[/'M^.? YSU'\'7T_N_)7@OFSEUZTLUPU+W.(D.^GIJ>+!FR9_$KXRUIN+;
MA9*%:F@"QF<&HE@]T ;C'TF<_A]02P,$%     @ IX$)5=V63LAR!   N@D
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MIP5XOU3HP>&&%#3_KW']/U!+ P04    " "G@0E5._&M8C(#  "L!@  &0
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MCRX&K_5E>+1!*M1KOR<-^ RVRZ23=JMXUFZ@?]7;/7['])I+ P)79!H-1L,
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M[_.\>ONEZ> Y+[ZM=^?R_U!+ P04    " "G@0E5PF9N<(\'   500  &0
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M<K&=0]V\>9P5OW_L0M&'5JZ:/UQ=WW*9F]M+Y5FSSF;R8K3N)VE])T>3K[[
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M6ZV&ATN9S67=!W3OWU95^_BD/\#^/R%,_@-02P,$%     @ IX$)51+9]X?
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M2*!H[8(<+:[]ZOX\(?D#]$[75'\\BES$A;3^([_^GTY<_D"]\['T$XY<=)>
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M*+BF? .6@M&4$@4&8"[RG,B48@9^I:F990+*%:' ZP71F#+UIAW%ZBA910W
MA]4"O'[U!KP"E(,_MJ)01H2:^MJ8M%+]M#9T7QD*.@R]+?@-&,+O0 "#P &?
M]\,7)#5P5,)1&^Z;U#;Y#9K\!B7?L(//D1B;W-_UEDCP0RJXR&E:Y\IEMF(?
MN=GM'K]5.YR2F;>S\R<?B9=\^PT*X?<NZU<B:R5BV"1BV,>>_"2%<CJL8&$)
MLT7G,0GB8!)/_<=CZ9>B6II&C:91KZ:[[&^SPTQ1<N>^ H^/WCE ,1RB$VG.
M,!1W:!LWVL:]VGXCVJ5I?/8R!(,P.I'DBD((NA6%C:*P/UMI6N0%PYID .="
M:OJYJA;F;TTYU63 3$G.S ;6F&_H S-K72GB3FYX+A&-(3PQXHJ*8(>1J#$2
M]1J92Y)1#9A9D  ?EH"M="_W$9TI#,]M7 AJN8@;%W'_='RFGT193.9"OL-:
MTB>7OEZ2EQ:0*Y&U_$X:OY.O6DDGUTS$E<A:B4#PT+/A?ZNE-:ZU7Z)P$IXL
MQXMA;5U'WQ+H_]33&MVJE)-1,#Y5YPP+48>Z0R=&O?VMJZ+6J./7Q4%T6N2=
M4<-QAZ9#4T3]77%EOF>?S >87<D+BNT:=FKL97GIXKT66]OSH>FBT5?=R*BW
MJ;\X&5=B:R?CT.51?YOOWLJN'A["X'1=7@IKZSKT>G2AV5_8RN>->1"'\*S0
MN,*B(.I0=VC@J+^#=VWEZ.PK$4W.JY\C*HY.M[)_=*:R!]IW6&XH5X"1M8'!
MF\B8DM49L1IHL2N/60]"FT-;>;DUYVHB;8!YOA9"/P_LR:TYJ2=? %!+ P04
M    " "G@0E5P42U1HP#  "8"P  &0   'AL+W=O<FMS:&5E=',O<VAE970S
M,"YX;6RMEEV/FS@4AO^*1:M5*VT'3("$V01I)J.JN^IJH\FTO7:("5:-36TS
M:?_]VH9ADF#(7NQ-@NWS'C_G^.-X>>3BNRPQ5N!G19E<>:52]:WOR[S$%9(W
MO,9,CQ1<5$CIICCXLA88[:VHHGX8!(E?(<*\;&G[-B);\D91PO!& -E4%1*_
M[C'EQY4'O9>.1W(HE>GPLV6-#GB+U9=Z(W3+[[WL2869))P!@8N5=P=OUW!F
M!-;B*\%'>?(-3"@[SK^;QI_[E1<8(DQQKHP+I/^>\1I3:CQICA^=4Z^?TPA/
MOU^\?[3!ZV!V2.(UI]_(7I4K;^&!/2Y00]4C/W["74"Q\9=S*NTO.':V@0?R
M1BI>=6)-4!'6_J.?72).!# :$82=(/RO@EDGL)GS6S(;U@-2*%L*?@3"6&MO
MYL/FQJIU-(299=PJH4>)UJGL'DDB 2_ 1F")F4)M<MD>;-N%-6-;<F"D(#EB
M"MSE.6^8(NP -IR2G& )/IA>T> ]^$S0CE"B3*]Q\H\JL0"?.3M\>,*B.AM_
M]X 5(E2^U_HOVP?P[NU[\!80!IY*WDBMEDM?Z1 -J)]WX=RWX80CX?S5L!LP
M"WX'81"&#OEZ6OZ <RV'5@[/Y;Y.;)_=L,]N:/W-1OPYTN**J742N9V8@WPK
M:Y3CE5>;11+/V,M^>P.3X ]7A/^3L[-X9WV\LRGOV9I7^GZ1=A.Y FW5B56;
M"^8YBY(D7?K/IP$,C9)X%O9&9V!1#Q9-@FT$+[ T=P^BH,#N96A=Q"<3PT6X
MN* ;&H5!E+CIXIXNGJ2[J\R1TL?PJ/>*XL#<SOK8Z-.EDSD"&P\YDGET 3LT
M2F:!FS7I69-)UD?^"U%[?E]H54G$'M1(C&WO9$ 17' .+6"4NCGG/>=\FA.K
M1IA*8_>X"VM^%6MH$4;A2/X6/==B>JWS'PV11+5ED"*EDTBGKX?%5="A!0R"
M$="T!TTG0;?-+N=,"5UHN7!AI<-)YW%R0>8T&EE:&+P6K> *6UU3@IU8G?1L
MRC2-+[@<5HMH,<)U4DSAE<5M[WO"%-8[3SGYX-7E=)B$*1R!>ZU%</+JSVPM
M=A*%PXPEX>6U[+)*@VB$ZK5BP.F2\<25OI)1E[@K)P$.:P.,XAA>HCK,YO'\
M<MOY)\\F\V;]&XD#81)07&A=<#/7L8KV&=@V%*_M2VK'E7Z7V<]2/YVQ, 9Z
MO.!<O33,XZQ_C&?_ E!+ P04    " "G@0E5OE#"]I<#  "4$   &0   'AL
M+W=O<FMS:&5E=',O<VAE970S,2YX;6RUF%N/FS@4@/^*Q595*VV'2X!)I@G2
M)-";ME(TV>X^K/;! R?!*MA9VTEF_WUM0RA)F6AFUWT)MCGGL\^% R?3 ^-?
M10D@T4-=43%S2BFW-ZXK\A)J+*[8%JBZLV:\QE)-^<856PZX,$IUY0:>%[LU
M)M1)IF9MR9,IV\F*4%AR)'9UC?F_<ZC88>;XSG'ACFQ*J1?<9+K%&UB!_+)=
M<C5S.TI!:J"",(HXK&?.K7^3^9Y6,!)_$#B(WAAI4^X9^ZHG'XN9X^D3006Y
MU BL+GM80%5IDCK'/RW4Z?;4BOWQD?[.&*^,N<<"%JSZDQ2RG#EC!Q6PQKM*
MWK'#!V@-BC0O9Y4PO^C0RGH.RG="LKI55B>H"6VN^*%U1$]!<885@E8A.%<(
M'U$8M0JCI^X0M@KA4W>(6@5CNMO8;AR78HF3*6<'Q+6THNF!\;[15OXB5"?*
M2G)UER@]F<RQ( *Q-5IR$$ E;L)'"[1J4D??6Y$-)6N28RK1;9ZS'96$;M"2
M520G(-";_JI*7K0J,8<WB@T%6K!:9;5HP*]2D)A4XK72^;)*T:L7K]$+1"CZ
MO60[H;854U<JL_3AW+PU8=Z8$#QBP@A]9E26 F6T@&) /[VL'U_0=Y4[.Y\&
M1Y_.@XO 3SMZA4;>KRCP@F#@/(NGJ_M#YOR_W;/_O/N),T9=@HT,;_2L!/OK
M-R6&/DJHQ=]#$6^8X3!3%\\;L<4YS)RMIO(].,G+7_S8>SOD;INPU"8LLP0[
M"4S8!2:\1$^:9_3>/*-Y_QF%!SV&H; TQ-@0]2MHGTS"R63J[OON_E'(5ZD4
MGTJE U+C*!R=2F5#4K'.R_V Y5%G>739\OE"E9\[Y5',\](4NP+VZIVY56]
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M&VY,XXS2"IC]E1#Z;6(5-*UX\A502P,$%     @ IX$)5=>4;X]3!   @!0
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MU$7-?ATM^<)$"64CF'R*99Q8/D"..: 96#/$$1&P*1])P::1CGJVP5N",YQ
M(L!]DM"*"$RV8$USG&#$P2V((2/2Q,'-)\KY![!&#&QVD"%P$R$!<2YMMX K
M"S_^80+^V-&*R\'XW!8R&34E.VDG_M!,W'MEXB/PF1*QXR F*4HU\=%P?#@0
M;TL2.R:](Y,/WB#@;Q6Y R/G)^ YGJ>9S^K]X:XNG>\;/?[?H_?(&'6R&M5X
MHU?P[J5"4IQ7J@N #4HJAH522OR2Y)7D&V2,%F!%B[)J)2=EUHGHI)Z_/TE@
M\%&@@O^CTT@S"U\_"]5D9[R$"5I8I9(WVR-K^>,/;NC\K"N02;#()%AL"*Q7
M2K\KI3^$OOQ2]UI9,KA'3.X=Q^4K=QTNY-I5G>"FL7W0E:A!#VITM6WMEVXX
M"2=S>W_.O<XK#*9]KTB+Y8=]KUCG%?BG$7LT!!T-P:"BHZ.:2RIDG\0P!PDM
M"JG<)O>9+O? I#Q-@D4FP6)#8+VZA%U=PD%Y;AHU5EPJ5%!5$]E2$*B;CS1A
M(BVR:+*C\&8_&I!J^"ZI:KS&[MB[D*H6ZTJJ.BS/=?12'7>4C <I61\5FG\%
M71-N5RWJ-> $YDF5-PTXK9 B4.[Q^+:+0EDFW^@&21M?I1".I_X%9]=.@3,9
M7U"F0?(=YX*Q:R=?\JHG;-(1-ADD[!%QP7"B]")?N))G79J#"-^ZE$V"12;!
M8D-@O3),NS),S;?8J<FZF 2+3(+%AL!Z=7&=TT>",[A WJK,8(-HL<^7[,6B
M7FE<PLN]_VV86.,R?:67NF<?2.[P!J,Z OB]5$U2_YTR&/^M$C2*%AE%BTVA
M]2OAG2KAF>\/+::IZIA$BXRBQ:;0^M4Y??&Y@U\AW]DC1F_WB&L7W_<OF\2;
M.+'&)3A[>VNRM\].5 K$MO51%@?UT4?S%=Q9N^.R^_J0Z,+^X,Y6KL8>J>.U
M^@3G!-^<S7V&;(L)!SG*Y%#.W5C.E#7'7<V-H&5]GO-$A:!%?;E#,$5,.<CG
M&94%:&_4 -VAX_(_4$L#!!0    ( *>!"54,DQ3,\ D  +UC   9    >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;+V=76^C2!:&_PKRCE8]4J=-5?'E;!*I
M$PHVJ^GI5J=G]F*T%\2NQ&ALR ))>J3]\5-@QYBBJ)C)N[Y)_''.<\#G4(=Z
M79BSY[SXO5P*45G?UZNL/)\LJ^KA=#HMYTNQ3LH/^8/(Y#MW>;%.*OFTN)^6
M#X5(%HW3>C6EMNU-UTF:32[.FM>^%!=G^6.U2C/QI;#*Q_4Z*?ZX%*O\^7Q"
M)B\O?$WOEU7]PO3B["&Y%S>B^N7A2R&?37>41;H669GFF56(N_/)1W(:NW;M
MT%C\FHKG<N^Q5>_*;9[_7C^Y7IQ/['J+Q$K,JQJ1R']/XDJL5C5);L=_M]#)
M+F;MN/_XA1XU.R]WYC8IQ56^^G>ZJ);GDV!B+<1=\KBJON;/_Q3;'7)KWCQ?
ME<U?ZWECZ_H3:_Y85OEZZRRW8)UFF__)]^T'L>= Z8 #W3K00QW8UH$=ZN!L
M'9Q#'=RM@WNH@[=U\ YU\+<.?I.LS:?;I"9,JN3BK,B?K:*VEK3Z09/?QEMF
M),WJ4KRI"OEN*OVJBQMQ+PNKLJZS35G7Y?$N%%62KLH?K1^L-+.^+?/',LD6
MY=FTDA%KO^E\2[_:T.D G5F?\JQ:EA;/%F*A\8_,_I[!?RKW=+>[]&5W+ZD1
M^"DI/EB,O+>H3:E5;G9>MU]FS+\>,XFQMYA?;D+KW0\_:C#A 5M#Z:M;PP_?
M&F+8F@BS4_&;MZ:3.K:K5-9PV2N5^E4\Y$659O?6;Q]ORZJ0@]E_-%MYN:$Y
M>EH]PI^6#\E<G$_D$%Z*XDE,+O[^-^+9_]"5 Q(6(F$<"8N0L!@$ZQ2+LRL6
MQT2_^/EQ?2L**[^3[;(NE^1V)5X.L-+ZG^%8N]R W09<-_*G"WHV?=HO!F/H
ML<70#T>ZX3@R7(2$Q2!8)\/N+L/NN.'@O7SX)+)'(?_/\VR>KNHQXKH2:^NW
MGZ1S\[#4#A4N<JA PD(DC"-A$1(6@V"=0O)VA>09AXIO>96LY##1U(ZN.HSN
M8ZMC _/V#G?7=\BL>\B'R)"\'S)P/-_MAHSZ5L1FA"AC7ZPQ8[. MK1.#OQ=
M#OP#<K =E"TYSRJ2IL.GV3Q?:Y-BY(U-BM\;@T\\YBDY04;D_8B,,5L9^2/-
M=E';]Y4MBS6PF>T-I"38I20X("5M*N9Y*3NGG 98XKN<!Y="-QVX-#+'IB7H
M[9?K!T&@Y 49DO=#LF"FED+4MY('2A#X2E[Z9I+E$WU>9KN\S(QYN6X.">O=
M*B_E!.VNR-<O2<HS;4J,N+$IF?4KTO'4T0L9D?<C.J[/E)"19KMFOCK&Q7TK
MUW9<1Y\08K=3:-N8DL^[@V1[4J+-@QDR-A%06@BE<2@M@M)B%*U;*GMJ"SG:
M6>LV%*J@D+002N-06@2EQ2A:MZ!H6U#T;6>O9O_154(U/;E__@H-RC5!=6>P
M&C/M*:S.SG .2UJ!BA@EC;]P%FL&CDX.ZW].MD/4W$#E)TU,U[%IH.:F;T9(
MX# U-7TSSP]\>R SK1I$S'+055[(\3:IQ'OKYSP[N1E6?\R@T1F!2D50&H?2
M(B@M1M&ZY=)*2^1XVA*!BDM06@BE<2@M@M)B%*U;4*W$1,P:T\TR*<3BI/[.
M="%GTNMZ MW,V+05 Q6<MK3. $UZX@8T)M?%])U>3^A;$=N?]7J"SLPCP4!/
M:"4G8M:</E=+4<AD;#N#4=8PHT:G1*?^^(Z:$JC@I(E)7?7<(-)8$7O_S&B;
MDKZ9Y\^&,M(J3N3_(3F9H:-SHQ%M7&*KN8&*3KJ8-% E#HT5)?O'P38W&G%*
MGJ%[ \EI92=BUIV^YG\DJRH=R %49(+20BB-0VD1E!:C:-V5%:T,1NVCG351
MJ%@&I850&H?2(B@M1M&Z!=6*9=2HG;RN;9C]1U<)T8R<,U?5-J!!N29HX!'U
M"P>-%2.>JYPRQ+H]<'TZT)AI*S)1L\ATE3Q4:9FOK!-+SJ3UJ8#*3%!:"*5Q
M*"V"TF(4K5LGK0!&1R[1>DL'@$IC4%H(I7$H+8+28A2M6U"M;D?-NMWK'0 J
MU]'^8BS&U-E/"(W)-3%G7D#5!J"Q<EVBCO^:Q63VC T(V[35PZA1'NF,_Y]_
MO0ZUF8#J7%!:"*5Q*"V"TF(4K5LHK<Y%O>,U *@,!J6%4!J'TB(H+4;1N@75
MBG3TD(5AI@8 5>:H1B7S*%7E'VA0K@GJTH#Z:@O0J(:4J%.%6&,6T, 9T']H
M*\Y1LSAWE6?-6GMM$J 2')060FD<2HN@M!A%ZQ9(*Q#2V?'&?JB>"*6%4!J'
MTB(H+4;1NI?[M'HB,R^K>W7L-_N/OL3'[I]BSXAZ\@^-R34Q"7-=I=]$&C,Z
M\V?JZ;_&C-EL2/IGK0['S#K<YW66?KRUOHGY,LM7^7TJZDMH#EOU:$:/SA%T
MD1J4QJ&T"$J+4;1N ;7Z(:-':PT,*C1":2&4QJ&T"$J+4;1N0>U="GK(2CM3
M:\!>_=E?EN;3&55; _:Z3LW"NH"J7]AKK(CG^+;:&31F#@L&UM6Q5I]CA^AS
M8U8\FH&C$],7O$Z"V4R]1 0:E.N"^H&M?F>C,R,NZ5TEHK6C#AE*3JO:,;-J
MIV_;N^_Q#V_A4&4/2@NA- ZE15!:C*)UBZE5]MCQE#T&5?:@M!!*XU!:!*7%
M*%JWH%IEC[U1V3/[CZX2S<HV]2JR$!J2:T+V)G9]$\=6KU<P<KJ??JOF,;.:
MI^\-+QK?X:T!*OQ!:2&4QJ&T"$J+4;1N+;7"'SN>\,>@PA^4%D)I'$J+H+08
M1>O^=$LK_#EO%/[,_F.KQ.G+9CYQE67H(30FU\34S.XT5A+HJ4M^=6;#LSNG
MU?T<L^[W4WI?+[ZNEWQ9EX^E?+<\?-9@9H_.$53X@](XE!9!:3&*UJV@5OAS
MCB?\.5#A#TH+H30.I4506HRB=0NJ%?Z<-PI_9O_15:(1X6RB?C4?0H-R35 _
M"-3%OI'&+/ \1YT]:,P(=1UG8%&8L_<+:VCMSPP<G1O-8C??[LWIH$&Y)JA'
M M;+3=^,RFU395F-66#3P<;=*G^.6?D;:-SCI3]SG-$9@TI_4!J'TB(H+4;1
MNM742G_.\:0_!RK]06DAE,:AM A*BU&T;D&UTI_S1NG/[#^Z2C32GQ_T%O5!
M@W)-4,UU/1HK)KMSKX=K]F#XNAZG50$=LPHXT"=&RX#F,*/S!94!H30.I450
M6HRB=8NIE0&=X\F #E0&A-)"*(U#:1&4%J-HW=_W;65 ]XTRH-E_;)5L:?L_
M;4I]3UWD 8W)-3%]GZI7_FNL"/.I^D,9.C-W_\<K-WF8[MTL8"V*^^8^$*4U
MSQ^S:O-K[+M7=_>:^-C<84%Y_8J<<J)Y/2*G\>9.$BU^<V.+3TEQGV:EM1)W
M,I3]P9<=K=C<*V+SI,H?FEL5W.95E:^;ATN1+$11&\CW[_*\>GE2!]C=L>/B
M3U!+ P04    " "G@0E5>'-V+_0/  "7R0  &0   'AL+W=O<FMS:&5E=',O
M<VAE970S-2YX;6S-G6MOVT86AO\*X5T472"IQ>%%8NH82,S3W2R:(DC2[(?%
MHF#DL<6-)+HD9<>+_O@E=?%PR-$A1WT#L!\:63Y\ACHO><QW;KIXR/(OQ4+*
MTOFZ6JZ+EV>+LKQ[<7Y>S!=RE10_9'=R7?WF)LM725G]F-^>%W>Y3*ZW!ZV6
MYV(R"<]72;H^N[S8OO<NO[S(-N4R7<MWN5-L5JLD?WPME]G#RS/W[/#&^_1V
M4=9OG%]>W"6W\H,L?[U[EU<_G3]1KM.57!=IMG9R>?/R[)7[@EPQJX_8AGQ*
MY4/1>.W4G^5SEGVI?WAS_?)L4I^27,IY63.2ZI][>267RQI5G<CO>^K94Z/U
M@<W7!_I/VT]??9K/22&OLN6_TNMR\?)L=N9<RYMDLRS?9P__D/M/%-2\>;8L
MMO]W'O:QDS-GOBG*;+4_N#J#5;K>_9M\W6>B<4 X/7* V!\@6@<(<>0 ;W^
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M!+1;@/-KI>Q#QQ7,X;U3_@-02P,$%     @ IX$)597AY6]* P  UA0   T
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " "G@0E5F5R<(Q &  "<)P  $P
M            @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M *>!"55)OVU0Y@4  .,>   8              " @0T(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " "G@0E55+:H)8D'   V(@  &
M            @($I#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#
M%     @ IX$)5?//4C<% P  "0H  !@              ("!Z!4  'AL+W=O
M<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( *>!"54%!K2[M0<  $(K
M   8              " @2,9  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q0
M2P$"% ,4    " "G@0E5N<-L5$(#  #Z"0  &               @($.(0
M>&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ IX$)5:)OIF=Q
M#@  (J@  !@              ("!AB0  'AL+W=O<FMS:&5E=',O<VAE970V
M+GAM;%!+ 0(4 Q0    ( *>!"54?J"X7<@D  )TJ   8              "
M@2TS  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "G@0E5
MQY5Q-P,C  #U:   &               @('5/   >&PO=V]R:W-H965T<R]S
M:&5E=#@N>&UL4$L! A0#%     @ IX$)53XR.#0\"0  ?!8  !@
M     ("!#F   'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    (
M *>!"55BN(M#KPL  /T>   9              " @8!I  !X;"]W;W)K<VAE
M971S+W-H965T,3 N>&UL4$L! A0#%     @ IX$)5;R/D7,C#    "8  !D
M             ("!9G4  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"
M% ,4    " "G@0E57I7IY&\$  !+"@  &0              @(' @0  >&PO
M=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( *>!"55^M1C(A@0
M +<)   9              " @6:&  !X;"]W;W)K<VAE971S+W-H965T,3,N
M>&UL4$L! A0#%     @ IX$)5<6QQ5K#!P  2Q(  !D              ("!
M(XL  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " "G@0E5
M;BZ=J=P&  !*'   &0              @($=DP  >&PO=V]R:W-H965T<R]S
M:&5E=#$U+GAM;%!+ 0(4 Q0    ( *>!"56QE%2.OQ@  '=*   9
M      " @3":  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%
M  @ IX$)546H '@D#   ,"$  !D              ("!)K,  'AL+W=O<FMS
M:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " "G@0E5W99.R'($  "Z"0
M&0              @(&!OP  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+
M 0(4 Q0    ( *>!"57%2-F%A@D  .,8   9              " @2K$  !X
M;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ IX$)53OQK6(R
M P  K 8  !D              ("!Y\T  'AL+W=O<FMS:&5E=',O<VAE970R
M,"YX;6Q02P$"% ,4    " "G@0E5ICF-_TL#  !<"0  &0
M@(%0T0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( *>!
M"55(>UN\B ,  .<(   9              " @=+4  !X;"]W;W)K<VAE971S
M+W-H965T,C(N>&UL4$L! A0#%     @ IX$)5?=35<85#@  H+4  !D
M         ("!D=@  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
M    " "G@0E5PF9N<(\'   500  &0              @('=Y@  >&PO=V]R
M:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( *>!"542V?>'P 8  ",K
M   9              " @:/N  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL
M4$L! A0#%     @ IX$)5=N%<_2\ @  <0<  !D              ("!FO4
M 'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " "G@0E5^:O(
M228$   0%   &0              @(&-^   >&PO=V]R:W-H965T<R]S:&5E
M=#(W+GAM;%!+ 0(4 Q0    ( *>!"57U\5+&\ (  ,\*   9
M  " @>K\  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @
MIX$)5=K=*O7; P  M0\  !D              ("!$0 ! 'AL+W=O<FMS:&5E
M=',O<VAE970R.2YX;6Q02P$"% ,4    " "G@0E5P42U1HP#  "8"P  &0
M            @($C! $ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4
M Q0    ( *>!"56^4,+VEP,  )00   9              " @>8' 0!X;"]W
M;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ IX$)5>^.\EYD P
ME@L  !D              ("!M L! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX
M;6Q02P$"% ,4    " "G@0E5UY1OCU,$  " %   &0              @(%/
M#P$ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( *>!"54,
MDQ3,\ D  +UC   9              " @=D3 0!X;"]W;W)K<VAE971S+W-H
M965T,S0N>&UL4$L! A0#%     @ IX$)57AS=B_T#P  E\D  !D
M     ("! !X! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *>!"55T6; X"0,  '\,   9              "
M@29" 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ IX$)
M589(&!I>!   61,  !D              ("!9D4! 'AL+W=O<FMS:&5E=',O
M<VAE970T,2YX;6Q02P$"% ,4    " "G@0E5MS_OL#X$   G$P  &0
M        @('[20$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0
M   ( *>!"54,.FFA1@(   P%   9              " @7!. 0!X;"]W;W)K
M<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ IX$)5?00U)X: @  X00
M !D              ("![5 ! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q0
M2P$"% ,4    " "G@0E5*3W7R3\#  !5#   &0              @($^4P$
M>&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( *>!"56^RH*>
M%@,  /L(   9              " @;16 0!X;"]W;W)K<VAE971S+W-H965T
M-#8N>&UL4$L! A0#%     @ IX$)597AY6]* P  UA0   T
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;72YX;6Q02P4&     #8 -@"Q#@  *68!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>305</ContextCount>
  <ElementCount>322</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>73</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2115102 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2118103 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2123104 - Disclosure - Convertible Senior Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotes</Role>
      <ShortName>Convertible Senior Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2127105 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2129106 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2133107 - Disclosure - Commitment and Contingencies: Legal Proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings</Role>
      <ShortName>Commitment and Contingencies: Legal Proceedings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2135108 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2316302 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/SegmentInformation</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2319303 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/FairValueMeasurements</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2324304 - Disclosure - Convertible Senior Notes (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesTables</Role>
      <ShortName>Convertible Senior Notes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/ConvertibleSeniorNotes</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2330305 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/StockholdersEquity</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2336306 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/Leases</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2414411 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2417412 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/SegmentInformationTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2420413 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2421414 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2422415 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2425416 - Disclosure - Convertible Senior Notes - Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails</Role>
      <ShortName>Convertible Senior Notes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2426417 - Disclosure - Convertible Senior Notes - Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails</Role>
      <ShortName>Convertible Senior Notes - Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2428418 - Disclosure - Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTaxDetails</Role>
      <ShortName>Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/IncomeTax</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2431419 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails</Role>
      <ShortName>Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2432420 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2434421 - Disclosure - Commitment and Contingencies: Legal Proceedings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails</Role>
      <ShortName>Commitment and Contingencies: Legal Proceedings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2437422 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2438423 - Disclosure - Leases - Operating and Finance Lease Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails</Role>
      <ShortName>Leases - Operating and Finance Lease Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="lgnd-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2439424 - Disclosure - Leases - Maturity of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturity of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="lgnd-20220630.htm">lgnd-20220630.htm</File>
    <File>exhibit104_ligand-formofrs.htm</File>
    <File>exhibit_102xligand-2022ind.htm</File>
    <File>exhibit_103xligand-formofs.htm</File>
    <File>exhibit_105xligand-formofp.htm</File>
    <File>lgnd-20220630.xsd</File>
    <File>lgnd-20220630_cal.xml</File>
    <File>lgnd-20220630_def.xml</File>
    <File>lgnd-20220630_lab.xml</File>
    <File>lgnd-20220630_pre.xml</File>
    <File>lgnd_63022exhibit311.htm</File>
    <File>lgnd_63022exhibit312.htm</File>
    <File>lgnd_63022exhibit321.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>lgnd-20220630_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="892">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>68
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lgnd-20220630.htm": {
   "axisCustom": 0,
   "axisStandard": 25,
   "contextCount": 305,
   "dts": {
    "calculationLink": {
     "local": [
      "lgnd-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lgnd-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "lgnd-20220630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lgnd-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lgnd-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lgnd-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 517,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 3,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 8
   },
   "keyCustom": 45,
   "keyStandard": 277,
   "memberCustom": 31,
   "memberStandard": 38,
   "nsprefix": "lgnd",
   "nsuri": "http://www.ligand.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.ligand.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118103 - Disclosure - Fair Value Measurements",
     "role": "http://www.ligand.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123104 - Disclosure - Convertible Senior Notes",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotes",
     "shortName": "Convertible Senior Notes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127105 - Disclosure - Income Tax",
     "role": "http://www.ligand.com/role/IncomeTax",
     "shortName": "Income Tax",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129106 - Disclosure - Stockholders' Equity",
     "role": "http://www.ligand.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133107 - Disclosure - Commitment and Contingencies: Legal Proceedings",
     "role": "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings",
     "shortName": "Commitment and Contingencies: Legal Proceedings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135108 - Disclosure - Leases",
     "role": "http://www.ligand.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316302 - Disclosure - Segment Information (Tables)",
     "role": "http://www.ligand.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319303 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324304 - Disclosure - Convertible Senior Notes (Tables)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesTables",
     "shortName": "Convertible Senior Notes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330305 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.ligand.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lgnd:AssetsAndLiabilitiesLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336306 - Disclosure - Leases (Tables)",
     "role": "http://www.ligand.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lgnd:AssetsAndLiabilitiesLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxLiabilitiesNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "iff72851b58aa45ffa732bbda41560b3d_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "lgnd:ScheduleOfShortTermInvestmentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "lgnd:ScheduleOfShortTermInvestmentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "if91b70357fb44a83b104d251dcf482de_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock",
       "lgnd:CommercialLicenseRightsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "icc20f2ad27ad4526a19a3ed221aa03e3_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock",
       "lgnd:CommercialLicenseRightsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "icc20f2ad27ad4526a19a3ed221aa03e3_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414411 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "iab8c600366d6408f8d68011ffa0eefb3_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "iebd5e1dca73546bab3c7f7e7fd807132_D20220323-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417412 - Disclosure - Segment Information (Details)",
     "role": "http://www.ligand.com/role/SegmentInformationDetails",
     "shortName": "Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "ifb5402adc253464eb373188274f50300_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i704ccd2c79674fa98ab76165119a7944_D20100101-20100131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfContingentValueRightsSeries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contingent_value_right_series",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420413 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i704ccd2c79674fa98ab76165119a7944_D20100101-20100131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfContingentValueRightsSeries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contingent_value_right_series",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "idf6982ebd2184a96b2c741ac8887e7ba_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421414 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails",
     "shortName": "Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "idf6982ebd2184a96b2c741ac8887e7ba_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unitRef": "reporting_unit",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422415 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425416 - Disclosure - Convertible Senior Notes - Narrative (Details)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
     "shortName": "Convertible Senior Notes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i35897df76b71438cbfcc21f5fd8c25ba_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i5474a312fb154f69820ca3cc97e950a7_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426417 - Disclosure - Convertible Senior Notes - Notes Payable (Details)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails",
     "shortName": "Convertible Senior Notes - Notes Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i5474a312fb154f69820ca3cc97e950a7_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostDirectMaterial",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428418 - Disclosure - Income Tax (Details)",
     "role": "http://www.ligand.com/role/IncomeTaxDetails",
     "shortName": "Income Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "ice70706143fc4fa587f3b05dfc86607f_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431419 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)",
     "role": "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails",
     "shortName": "Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "ice70706143fc4fa587f3b05dfc86607f_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432420 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "role": "http://www.ligand.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "ifae3653e5fe6429a946af263fcc4fd84_I20190911",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i2ad65c5ebdff424fb802e081f2da87ec_D20191031-20191031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyNewClaimsFiledNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "civil_complaint",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434421 - Disclosure - Commitment and Contingencies: Legal Proceedings (Details)",
     "role": "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails",
     "shortName": "Commitment and Contingencies: Legal Proceedings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i2ad65c5ebdff424fb802e081f2da87ec_D20191031-20191031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyNewClaimsFiledNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "civil_complaint",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "ida31ec29c0a64e779c80ba3c979f2b18_I20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437422 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.ligand.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "ida31ec29c0a64e779c80ba3c979f2b18_I20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:AssetsAndLiabilitiesLeasesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438423 - Disclosure - Leases - Operating and Finance Lease Assets and Liabilities (Details)",
     "role": "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails",
     "shortName": "Leases - Operating and Finance Lease Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:AssetsAndLiabilitiesLeasesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "lgnd:LeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439424 - Disclosure - Leases - Maturity of Operating Lease Liabilities (Details)",
     "role": "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturity of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i9a872d7cbf8049c6a8c62bb4b77baad2_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "if9e6dc6e35f547788e170e486ce2911c_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "ie007cd8b0d0a49a8b243568f89c18ee8_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i1df447ab25dd46908c81e1e59a7690f4_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115102 - Disclosure - Segment Information",
     "role": "http://www.ligand.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220630.htm",
      "contextRef": "i70afdf6d529d47509b962bfaa05617ed_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 73,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "lgnd_AccruedAssetAcquisitionsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Asset Acquisitions, Current",
        "label": "Accrued Asset Acquisitions, Current",
        "terseLabel": "Acquisition related liabilities"
       }
      }
     },
     "localname": "AccruedAssetAcquisitionsCurrent",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedInventoryPurchases": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Inventory Purchases",
        "label": "Accrued Inventory Purchases",
        "terseLabel": "Accrued inventory purchases"
       }
      }
     },
     "localname": "AccruedInventoryPurchases",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedSubcontractorExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Subcontractor Expenses, Current",
        "label": "Accrued Subcontractor Expenses, Current",
        "terseLabel": "Subcontractor"
       }
      }
     },
     "localname": "AccruedSubcontractorExpensesCurrent",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedSupplierExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Supplier Expenses, Current",
        "label": "Accrued Supplier Expenses, Current",
        "terseLabel": "Supplier"
       }
      }
     },
     "localname": "AccruedSupplierExpensesCurrent",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions",
        "label": "Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions",
        "terseLabel": "Warrant and bond hedge unwind transactions"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Of Commercial License And Other Economic Rights",
        "label": "Amortization Of Commercial License And Other Economic Rights",
        "verboseLabel": "Amortization of commercial license rights"
       }
      }
     },
     "localname": "AmortizationOfCommercialLicenseAndOtherEconomicRights",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AssetsAndLiabilitiesLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets and Liabilities Leases",
        "label": "Assets and Liabilities Leases [Table Text Block]",
        "terseLabel": "Schedule of Operating and Finance Lease Assets and Liabilities"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLeasesTableTextBlock",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_AziyoAndCorMatrixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aziyo and CorMatrix",
        "label": "Aziyo and CorMatrix [Member]",
        "terseLabel": "Aziyo and CorMatrix"
       }
      }
     },
     "localname": "AziyoAndCorMatrixMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_BasisOfPresentationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of presentation.",
        "label": "Basis of Presentation [Line Items]",
        "terseLabel": "Basis of Presentation [Line Items]"
       }
      }
     },
     "localname": "BasisOfPresentationLineItems",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BasisOfPresentationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of Presentation.",
        "label": "Basis of Presentation [Table]",
        "terseLabel": "Basis of Presentation [Table]"
       }
      }
     },
     "localname": "BasisOfPresentationTable",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency",
        "label": "Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency",
        "terseLabel": "Earnout rights recognized"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders",
        "label": "Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders",
        "terseLabel": "Frequency of cash payments to CVR holders"
       }
      }
     },
     "localname": "BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series",
        "label": "Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series",
        "terseLabel": "Number of CVRs issued from each CVR series"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number of Contingent Value Rights Issued per Acquiree Share",
        "label": "Business Combination, Number of Contingent Value Rights Issued per Acquiree Share",
        "terseLabel": "Number of CVRs issued per acquiree share"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "label": "COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "terseLabel": "Additional allowance for credit losses recorded related to COVID-19"
       }
      }
     },
     "localname": "COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseAndOtherEconomicRightsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License and Other Economic Rights",
        "label": "Commercial License and Other Economic Rights [Abstract]",
        "verboseLabel": "Commercial License and Other Economic Rights"
       }
      }
     },
     "localname": "CommercialLicenseAndOtherEconomicRightsAbstract",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_CommercialLicenseRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial License Rights",
        "terseLabel": "Commercial license rights, net"
       }
      }
     },
     "localname": "CommercialLicenseRights",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseRightsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License Rights",
        "label": "Commercial License Rights [Policy Text Block]",
        "terseLabel": "Commercial License Rights"
       }
      }
     },
     "localname": "CommercialLicenseRightsPolicyTextBlock",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ContractRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Revenue",
        "label": "Contract Revenue [Member]",
        "terseLabel": "Contract"
       }
      }
     },
     "localname": "ContractRevenueMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractRevenueServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Revenue, Service",
        "label": "Contract Revenue, Service [Member]",
        "terseLabel": "Service Revenue"
       }
      }
     },
     "localname": "ContractRevenueServiceMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ConvertibleSeniorNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes due 2023",
        "label": "Convertible Senior Notes due 2023 [Member]",
        "terseLabel": "2023 Convertible Senior Notes"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2023Member",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_CurrentPortionOfLiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CurrentPortionOfLiabilityForContingentValueRights",
        "verboseLabel": "Current contingent liabilities"
       }
      }
     },
     "localname": "CurrentPortionOfLiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
        "terseLabel": "Maximum threshold of debt trading price trigger (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_DebtInstrumentRepurchasedAmountDuringPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Repurchased Amount During Period",
        "label": "Debt Instrument, Repurchased Amount During Period",
        "terseLabel": "Repurchased amount of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedAmountDuringPeriod",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale And Equity Securities, FV-NI",
        "label": "Debt Securities, Available-For-Sale And Equity Securities, FV-NI",
        "totalLabel": "Total short-term investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]",
        "terseLabel": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties"
       }
      }
     },
     "localname": "DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnout Rights for Partner Research and Development",
        "label": "Earnout Rights for Partner Research and Development [Member]",
        "terseLabel": "Earnout Rights for Partner Research and Development"
       }
      }
     },
     "localname": "EarnoutRightsForPartnerResearchAndDevelopmentMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, CVR Adjustment, Amount",
        "label": "Effective Income Tax Rate Reconciliation, CVR Adjustment, Amount",
        "terseLabel": "Pfenex CVR adjustment amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_EmployeeStockPurchasePlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Abstract]",
        "label": "Employee Stock Purchase Plan [Abstract]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanAbstract",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EmployeeStockPurchasePlanMember",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EvomelaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Evomela",
        "label": "Evomela [Member]",
        "terseLabel": "Evomela"
       }
      }
     },
     "localname": "EvomelaMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition",
        "terseLabel": "Contingent liabilities from xCella asset acquisition"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease And Operating Lease, Right-of-Use Asset, Amortization",
        "label": "Finance Lease And Operating Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Lease amortization expense"
       }
      }
     },
     "localname": "FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments",
        "negatedTerseLabel": "Adjustments"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "label": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "terseLabel": "Credit loss adjustments of finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_GainLossOnShortTermInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Short-term Investments",
        "label": "Gain (Loss) on Short-term Investments",
        "negatedLabel": "Loss (gain) from short-term investments"
       }
      }
     },
     "localname": "GainLossOnShortTermInvestments",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_IncreaseDecreaseInDebtDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Debt Discount",
        "label": "Increase (Decrease) in Debt Discount",
        "negatedLabel": "Increase (decrease) in debt discount"
       }
      }
     },
     "localname": "IncreaseDecreaseInDebtDiscount",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_KyprolisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kyprolis",
        "label": "Kyprolis [Member]",
        "terseLabel": "Kyprolis"
       }
      }
     },
     "localname": "KyprolisMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability",
        "label": "Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "LeaseLiability",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Current",
        "label": "Lease, Liability, Current",
        "totalLabel": "Current lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilityCurrent",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Right-Of-Use Asset",
        "label": "Lease, Right-Of-Use Asset",
        "totalLabel": "Total lease assets"
       }
      }
     },
     "localname": "LeaseRightOfUseAsset",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Tenant Improvement Allowance",
        "label": "Lessee, Operating Lease, Liability, Tenant Improvement Allowance",
        "negatedTerseLabel": "Less estimated tenant improvement allowance:"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityTenantImprovementAllowance",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LiabilityForContingentValueRights",
        "verboseLabel": "Long-term contingent liabilities"
       }
      }
     },
     "localname": "LiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyCydexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Cydex",
        "label": "Liability For Contingent Value Rights Company, Cydex [Member]",
        "verboseLabel": "Contingent liabilities - CyDex"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyCydexMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyIcagenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Icagen",
        "label": "Liability For Contingent Value Rights Company, Icagen [Member]",
        "terseLabel": "Contingent liabilities - Icagen"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyIcagenMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Metabasis",
        "label": "Liability For Contingent Value Rights Company, Metabasis [Member]",
        "terseLabel": "Contingent liabilities - Metabasis"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyMetabasisMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyXCellaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, xCella",
        "label": "Liability For Contingent Value Rights Company, xCella [Member]",
        "terseLabel": "Contingent liabilities - xCella"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyXCellaMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability for Restricted Investments Owed to Former Licensees [Member]",
        "label": "Liability for Restricted Investments Owed to Former Licensees [Member]",
        "terseLabel": "Amounts owed to former licensor"
       }
      }
     },
     "localname": "LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees",
        "label": "License Fees [Member]",
        "terseLabel": "License Fees"
       }
      }
     },
     "localname": "LicenseFeesMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees, Milestones, and Product, Other, Product, Other",
        "label": "License Fees, Milestones, and Product, Other, Product, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "LicenseFeesMilestonesAndProductOtherProductOtherMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseeAccrualCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensee Accrual, Current",
        "label": "Licensee Accrual, Current",
        "terseLabel": "Amounts owed to former licensees"
       }
      }
     },
     "localname": "LicenseeAccrualCurrent",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LigandCoreBusinessSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ligand Core Business Segment",
        "label": "Ligand Core Business Segment [Member]",
        "terseLabel": "Ligand Core Business"
       }
      }
     },
     "localname": "LigandCoreBusinessSegmentMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolCOVIDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol, COVID",
        "label": "Material Sales, Captisol, COVID [Member]",
        "terseLabel": "Captisol - COVID"
       }
      }
     },
     "localname": "MaterialSalesCaptisolCOVIDMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolCoreMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol, Core",
        "label": "Material Sales, Captisol, Core [Member]",
        "terseLabel": "Captisol - Core"
       }
      }
     },
     "localname": "MaterialSalesCaptisolCoreMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol",
        "label": "Material Sales, Captisol [Member]",
        "terseLabel": "Captisol"
       }
      }
     },
     "localname": "MaterialSalesCaptisolMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MetabasisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Metabasis",
        "label": "Metabasis [Member]",
        "terseLabel": "Metabasis"
       }
      }
     },
     "localname": "MetabasisMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone",
        "label": "Milestone [Member]",
        "terseLabel": "Milestone"
       }
      }
     },
     "localname": "MilestoneMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
        "negatedLabel": "Change in estimated fair value of contingent liabilities"
       }
      }
     },
     "localname": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_NumberOfContingentValueRightsSeries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Contingent Value Rights Series",
        "label": "Number of Contingent Value Rights Series",
        "terseLabel": "Number of CVR Series"
       }
      }
     },
     "localname": "NumberOfContingentValueRightsSeries",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_NumberOfOptionsUnderConvertibleBondHedges": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Options under Convertible Bond Hedges",
        "label": "Number of Options under Convertible Bond Hedges",
        "terseLabel": "Number of options under convertible bond hedges"
       }
      }
     },
     "localname": "NumberOfOptionsUnderConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_OmniAbTechnologiesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OmniAb Technologies Segment",
        "label": "OmniAb Technologies Segment [Member]",
        "terseLabel": "OmniAb Technologies"
       }
      }
     },
     "localname": "OmniAbTechnologiesSegmentMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_PaymentsForConvertibleBondHedges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Convertible Bond Hedges",
        "label": "Payments for Convertible Bond Hedges",
        "terseLabel": "Payments for convertible bond hedges"
       }
      }
     },
     "localname": "PaymentsForConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHolders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Contingent Value Right Holders",
        "label": "Payments to Contingent Value Right Holders",
        "negatedTerseLabel": "Payments to CVR holders and other contingent payments"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHolders",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHoldersFinancingActivity": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Contingent Value Right Holders, Financing Activity",
        "label": "Payments to Contingent Value Right Holders, Financing Activity",
        "negatedLabel": "Payments to CVR Holders"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHoldersFinancingActivity",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToUnwindWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Unwind Warrants",
        "label": "Payments to Unwind Warrants",
        "terseLabel": "Payments to unwind warrants"
       }
      }
     },
     "localname": "PaymentsToUnwindWarrants",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PfenexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pfenex",
        "label": "Pfenex [Member]",
        "terseLabel": "Pfenex"
       }
      }
     },
     "localname": "PfenexMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_Phase3ClinicalTrialMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phase 3 Clinical Trial",
        "label": "Phase 3 Clinical Trial [Member]",
        "terseLabel": "Phase 3 Clinical Trial"
       }
      }
     },
     "localname": "Phase3ClinicalTrialMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ProceedsFromUnwindingConvertibleBondHedges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Unwinding Convertible Bond Hedges",
        "label": "Proceeds from Unwinding Convertible Bond Hedges",
        "terseLabel": "Proceeds from unwinding convertible bond hedges"
       }
      }
     },
     "localname": "ProceedsFromUnwindingConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_RepaymentsOfNotesPayableInterestPortion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments Of Notes Payable, Interest Portion",
        "label": "Repayments Of Notes Payable, Interest Portion",
        "terseLabel": "Accrued interest portion of repurchased amount of debt instrument"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayableInterestPortion",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ReturnsAccrual": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Returns Accrual",
        "label": "Returns Accrual",
        "terseLabel": "Return reserve"
       }
      }
     },
     "localname": "ReturnsAccrual",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_RoyaltyOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty, Other",
        "label": "Royalty, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RoyaltyOtherMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_RylazeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rylaze",
        "label": "Rylaze [Member]",
        "terseLabel": "Rylaze"
       }
      }
     },
     "localname": "RylazeMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlock [Table Text Block]",
        "verboseLabel": "Schedule of Accounting for Share-Based Compensation"
       }
      }
     },
     "localname": "ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Commercial License Rights",
        "label": "Schedule of Commercial License Rights [Table Text Block]",
        "terseLabel": "Schedule of Commercial License Rights"
       }
      }
     },
     "localname": "ScheduleOfCommercialLicenseRightsTableTextBlock",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleOfShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Short-Term investments",
        "label": "Schedule of Short-Term investments [Table Text Block]",
        "terseLabel": "Schedule of Short-Term Investments"
       }
      }
     },
     "localname": "ScheduleOfShortTermInvestmentsTableTextBlock",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_SelexisAndDianomiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selexis and Dianomi",
        "label": "Selexis and Dianomi [Member]",
        "terseLabel": "Selexis and Dianomi"
       }
      }
     },
     "localname": "SelexisAndDianomiMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent",
        "label": "Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent",
        "terseLabel": "Payout range (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_TeriparatideInjectionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Teriparatide Injection",
        "label": "Teriparatide Injection [Member]",
        "terseLabel": "Teriparatide injection"
       }
      }
     },
     "localname": "TeriparatideInjectionMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US District Court for the Northern District of Ohio",
        "label": "US District Court for the Northern District of Ohio [Member]",
        "terseLabel": "US District Court for the Northern District of Ohio"
       }
      }
     },
     "localname": "USDistrictCourtForTheNorthernDistrictOfOhioMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_XCellaBiosciencesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "xCella Biosciences, Inc.",
        "label": "xCella Biosciences, Inc. [Member]",
        "terseLabel": "xCella"
       }
      }
     },
     "localname": "XCellaBiosciencesIncMember",
     "nsuri": "http://www.ligand.com/20220630",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r121",
      "r170",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r192",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r299",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r121",
      "r170",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r192",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r297",
      "r299",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r49",
      "r51",
      "r119",
      "r120",
      "r310",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": {
     "auth_ref": [
      "r2",
      "r126",
      "r133",
      "r228",
      "r451",
      "r452",
      "r453",
      "r472",
      "r473",
      "r507",
      "r512",
      "r513",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]",
        "terseLabel": "Adjusted Balance"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r126",
      "r133",
      "r139",
      "r228",
      "r451",
      "r452",
      "r453",
      "r472",
      "r473",
      "r507",
      "r510",
      "r512",
      "r513",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r126",
      "r133",
      "r139",
      "r228",
      "r451",
      "r452",
      "r453",
      "r472",
      "r473",
      "r507",
      "r510",
      "r512",
      "r513",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r126",
      "r133",
      "r139",
      "r228",
      "r451",
      "r452",
      "r453",
      "r472",
      "r473",
      "r507",
      "r510",
      "r512",
      "r513",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r279",
      "r281",
      "r282",
      "r283",
      "r309",
      "r350",
      "r407",
      "r409",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r605",
      "r655",
      "r657",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r279",
      "r281",
      "r282",
      "r283",
      "r309",
      "r350",
      "r407",
      "r409",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r605",
      "r655",
      "r657",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r195",
      "r281",
      "r282",
      "r386",
      "r389",
      "r608",
      "r654",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r195",
      "r281",
      "r282",
      "r386",
      "r389",
      "r608",
      "r654",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r270",
      "r279",
      "r281",
      "r282",
      "r283",
      "r309",
      "r350",
      "r397",
      "r407",
      "r409",
      "r443",
      "r444",
      "r445",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r605",
      "r655",
      "r657",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r270",
      "r279",
      "r281",
      "r282",
      "r283",
      "r309",
      "r350",
      "r397",
      "r407",
      "r409",
      "r443",
      "r444",
      "r445",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r605",
      "r655",
      "r657",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r50",
      "r51",
      "r119",
      "r120",
      "r310",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "auth_ref": [
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.",
        "label": "Accounting Standards Update 2020-06 [Member]",
        "terseLabel": "Accounting Standards Update 2020-06"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202006Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r127",
      "r128",
      "r129",
      "r130",
      "r205",
      "r206",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r451",
      "r452",
      "r453",
      "r472",
      "r473",
      "r489",
      "r490",
      "r491",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r544",
      "r545",
      "r553",
      "r554",
      "r555",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r38",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r200",
      "r201"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of premium on investments, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities [Abstract]",
        "verboseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "verboseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r13",
      "r41"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Royalties owed to third parties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r30",
      "r55",
      "r56",
      "r57",
      "r642",
      "r665",
      "r669"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r54",
      "r57",
      "r63",
      "r64",
      "r65",
      "r123",
      "r124",
      "r125",
      "r497",
      "r571",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r28",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r123",
      "r124",
      "r125",
      "r451",
      "r452",
      "r453",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r127",
      "r128",
      "r129",
      "r130",
      "r139",
      "r205",
      "r206",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r451",
      "r452",
      "r453",
      "r470",
      "r471",
      "r472",
      "r473",
      "r489",
      "r490",
      "r491",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r544",
      "r545",
      "r553",
      "r554",
      "r555",
      "r556",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r610",
      "r611",
      "r612",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r305"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "verboseLabel": "Reacquisition of equity due to 2023 debt extinguishment, net of tax"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Reacquisition of equity due to 2023 debt extinguishment, net of tax"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r411",
      "r455",
      "r456"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r304",
      "r364",
      "r372"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "verboseLabel": "Adjustments to additional paid-in-capital from warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net (loss) income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r447"
     ],
     "calculation": {
      "http://www.ligand.com/role/SegmentInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Shared-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, after Tax",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r72",
      "r101",
      "r329",
      "r549"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortized issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r101",
      "r329",
      "r340",
      "r341",
      "r549"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and issuance fees"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r19",
      "r115",
      "r178",
      "r184",
      "r190",
      "r224",
      "r289",
      "r290",
      "r291",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r300",
      "r302",
      "r303",
      "r493",
      "r498",
      "r528",
      "r572",
      "r574",
      "r616",
      "r640"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r11",
      "r37",
      "r115",
      "r224",
      "r289",
      "r290",
      "r291",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r300",
      "r302",
      "r303",
      "r493",
      "r498",
      "r528",
      "r572",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r516"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "verboseLabel": "Assets, fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross unrealized gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r213"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross unrealized losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r209",
      "r236"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "auth_ref": [
      "r214",
      "r215",
      "r633"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r207",
      "r210",
      "r236",
      "r622"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r414",
      "r415",
      "r416",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r438",
      "r439",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "verboseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r406",
      "r408",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r406",
      "r408",
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r105",
      "r106",
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accrued fixed asset purchases"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r8",
      "r15",
      "r103"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r95",
      "r103",
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r95",
      "r537"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Warrant exercise price (USD per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "verboseLabel": "Warrants issued in public offering (shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r47",
      "r624",
      "r646"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r284",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitment and Contingencies: Legal Proceedings"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r123",
      "r124",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r26",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)",
        "terseLabel": "Common stock outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r26",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.001 par value; 60,000 shares authorized; 16,882 and 16,767 shares issued and outstanding at June\u00a030, 2022 and December\u00a031, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r59",
      "r61",
      "r62",
      "r69",
      "r627",
      "r650"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive (loss) income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetGross": {
     "auth_ref": [
      "r202",
      "r233",
      "r374",
      "r376"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss",
        "terseLabel": "Gross contract asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r374",
      "r375",
      "r387"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r374",
      "r375",
      "r387"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Long-term deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized that was previously deferred"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Contractual relationships"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Convertible Debt, Current",
        "terseLabel": "2023 convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "verboseLabel": "Fair value of the 2023 Notes outstanding (Level 2)"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "2023 convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayable": {
     "auth_ref": [
      "r23",
      "r618",
      "r641",
      "r671"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable",
        "terseLabel": "Convertible notes payable"
       }
      }
     },
     "localname": "ConvertibleNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "auth_ref": [
      "r20",
      "r617",
      "r637",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable [Member]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r398",
      "r405",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r192",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate, Non-Segment"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostDirectMaterial": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of material used for good produced and service rendered.",
        "label": "Cost, Direct Material",
        "terseLabel": "Cost of Captisol"
       }
      }
     },
     "localname": "CostDirectMaterial",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "terseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r111",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r323",
      "r330",
      "r331",
      "r333",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Convertible Senior Notes"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r20",
      "r22",
      "r23",
      "r114",
      "r121",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r338",
      "r339",
      "r340",
      "r341",
      "r551",
      "r617",
      "r618",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r23",
      "r334",
      "r618",
      "r637"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Outstanding principal amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r308",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Initial conversion price (USD per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r44",
      "r308",
      "r365",
      "r368",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Initial conversion rate (shares per $1,000)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Stock price trigger to classify convertible debt as current (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r306",
      "r338",
      "r339",
      "r548",
      "r551",
      "r552"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal amount of the 2023 Notes outstanding",
        "verboseLabel": "Aggregate principal amount outstanding"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.",
        "label": "Debt Instrument, Increase, Accrued Interest",
        "terseLabel": "Accrued Interest"
       }
      }
     },
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r43",
      "r336",
      "r548",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r43",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r45",
      "r114",
      "r121",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r338",
      "r339",
      "r340",
      "r341",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r45",
      "r114",
      "r121",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r332",
      "r338",
      "r339",
      "r340",
      "r341",
      "r365",
      "r369",
      "r370",
      "r371",
      "r547",
      "r548",
      "r551",
      "r552",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r319",
      "r547",
      "r548",
      "r549",
      "r550",
      "r552"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "negatedTerseLabel": "Unamortized discount (including unamortized debt issuance cost)",
        "terseLabel": "Unamortized discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r211",
      "r236",
      "r240",
      "r241"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "terseLabel": "Credit losses related to available-for-sale debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Schedule of Available-for-Sale Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r219",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Number of positions in an unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r549"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r459",
      "r460"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r459",
      "r460"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes, net",
        "verboseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DemandDepositsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts that may or may not bear interest and that depositor is entitled to withdraw at anytime without prior notice. Checking and negotiable order of withdrawal (NOW) accounts are the most common forms of demand deposits.",
        "label": "Demand Deposits [Member]",
        "terseLabel": "Bank deposits"
       }
      }
     },
     "localname": "DemandDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r101",
      "r173"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization of intangible assets"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]",
        "terseLabel": "Dilutive potential common shares:"
       }
      }
     },
     "localname": "DilutiveSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r386",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Revenue by Source"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "verboseLabel": "Earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r70",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r140",
      "r142",
      "r147",
      "r148",
      "r149",
      "r152",
      "r153",
      "r513",
      "r514",
      "r628",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic net (loss) income per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r70",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r142",
      "r147",
      "r148",
      "r149",
      "r152",
      "r153",
      "r513",
      "r514",
      "r628",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net (loss) income per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r150",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "verboseLabel": "Net (Loss) Income Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate (as a percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares to be repurchased in accordance with a policy to use treasury stock to satisfy share-award conversions.",
        "label": "Share-Based Payment Arrangement, Shares Expected to be Repurchased, Next Fiscal Period",
        "verboseLabel": "Shares available for future purchases (shares)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r63",
      "r64",
      "r65",
      "r123",
      "r124",
      "r125",
      "r128",
      "r136",
      "r138",
      "r155",
      "r228",
      "r364",
      "r372",
      "r451",
      "r452",
      "r453",
      "r472",
      "r473",
      "r512",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r571",
      "r660",
      "r661",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r10",
      "r21",
      "r527"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Viking common stock"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r220",
      "r638",
      "r673",
      "r674",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Corporate equity securities",
        "verboseLabel": "Investment in Viking common stock"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r516",
      "r517",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r516",
      "r517",
      "r518",
      "r524",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "verboseLabel": "Schedule of Assets and Liabilities Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Fair Value by Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r516",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r321",
      "r338",
      "r339",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r517",
      "r578",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r523",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r516",
      "r517",
      "r519",
      "r520",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r321",
      "r398",
      "r399",
      "r404",
      "r405",
      "r517",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r321",
      "r338",
      "r339",
      "r398",
      "r399",
      "r404",
      "r405",
      "r517",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r321",
      "r338",
      "r339",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r517",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "verboseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r521",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Level 3 Financial Instruments"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Fair value adjustments to contingent liabilities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r521"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value of level 3 financial instruments as of June\u00a030, 2022",
        "periodStartLabel": "Fair value of level 3 financial instruments as of December\u00a031, 2021"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r321",
      "r338",
      "r339",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r578",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r523",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "verboseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r558"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_LeaseLiabilityCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r558"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r559",
      "r563"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Payments under financing lease obligations"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r557"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_LeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Financing lease right-of-use assets",
        "verboseLabel": "Finance lease assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r217",
      "r218",
      "r221",
      "r222",
      "r223",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r238",
      "r239",
      "r242",
      "r243",
      "r332",
      "r362",
      "r502",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r17",
      "r265"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Less: accumulated amortization",
        "terseLabel": "Accumulated amortization on finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r261",
      "r262",
      "r265",
      "r266",
      "r609",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r265",
      "r613"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      },
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "netLabel": "Gross",
        "verboseLabel": "Definite lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r261",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r265",
      "r609"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r77",
      "r101",
      "r208"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "verboseLabel": "Gain (loss) from short-term investments"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r101",
      "r342",
      "r343"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss (gain) on debt extinguishment",
        "terseLabel": "Gain on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "verboseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "verboseLabel": "SBC - General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r16",
      "r247",
      "r248",
      "r255",
      "r259",
      "r574",
      "r615"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis": {
     "auth_ref": [
      "r216",
      "r632"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r67",
      "r178",
      "r183",
      "r186",
      "r189",
      "r192",
      "r614",
      "r625",
      "r630",
      "r652"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Total segment operating income",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r268",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r464",
      "r465",
      "r467",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r116",
      "r463",
      "r466",
      "r468",
      "r474",
      "r476",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTax"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r117",
      "r137",
      "r138",
      "r176",
      "r461",
      "r475",
      "r477",
      "r653"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (expense)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r97",
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r27",
      "r623",
      "r648"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income tax receivable and payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r149",
      "r413"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive potential common shares (shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r260",
      "r263"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "totalLabel": "Total goodwill and other identifiable intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Including Goodwill) [Abstract]",
        "verboseLabel": "Summary of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r66",
      "r172",
      "r546",
      "r549",
      "r629"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r79",
      "r327",
      "r337",
      "r340",
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Total interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r81",
      "r328",
      "r340",
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Contractual interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r92",
      "r96",
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r9",
      "r35",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r14",
      "r34",
      "r109",
      "r154",
      "r244",
      "r245",
      "r246",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r76",
      "r171"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r647"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturity of Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 7.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remaining six months ending December 31, 2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term of operating leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Lease renewal term of operating leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r40",
      "r115",
      "r185",
      "r224",
      "r289",
      "r290",
      "r291",
      "r294",
      "r295",
      "r296",
      "r298",
      "r300",
      "r302",
      "r303",
      "r494",
      "r498",
      "r499",
      "r528",
      "r572",
      "r573"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r33",
      "r115",
      "r224",
      "r528",
      "r574",
      "r619",
      "r644"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r42",
      "r115",
      "r224",
      "r289",
      "r290",
      "r291",
      "r294",
      "r295",
      "r296",
      "r298",
      "r300",
      "r302",
      "r303",
      "r494",
      "r498",
      "r499",
      "r528",
      "r572",
      "r573",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "netLabel": "Current liabilities:",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.",
        "label": "Liabilities, Fair Value Adjustment",
        "terseLabel": "Mark-to-market adjustment of CVR liability"
       }
      }
     },
     "localname": "LiabilitiesFairValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "verboseLabel": "Liabilities, fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Noncurrent liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Commercial license rights"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "totalLabel": "Total long-term portion of notes payable"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r45",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable, Current and Noncurrent [Abstract]",
        "terseLabel": "Notes Payable, Current and Noncurrent [Abstract]"
       }
      }
     },
     "localname": "LongtermNotesPayableCurrentAndNoncurrentTotalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r285",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r278",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Number of civil complaints filed against entity"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MutualFundMember": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.",
        "label": "Mutual Fund [Member]",
        "terseLabel": "Mutual fund"
       }
      }
     },
     "localname": "MutualFundMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r95",
      "r98",
      "r102"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r7",
      "r58",
      "r60",
      "r65",
      "r68",
      "r102",
      "r115",
      "r127",
      "r131",
      "r132",
      "r133",
      "r134",
      "r137",
      "r138",
      "r146",
      "r178",
      "r183",
      "r186",
      "r189",
      "r192",
      "r224",
      "r289",
      "r290",
      "r291",
      "r294",
      "r295",
      "r296",
      "r298",
      "r300",
      "r302",
      "r303",
      "r514",
      "r528",
      "r626",
      "r649"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net (loss) income",
        "verboseLabel": "Net (loss) income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Accounting Standards Updates, Recently Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental schedule of non-cash activity:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://www.ligand.com/role/SegmentInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "totalLabel": "Total operating costs and expenses"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "verboseLabel": "Operating costs and expenses:"
       }
      }
     },
     "localname": "OperatingCostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r178",
      "r183",
      "r186",
      "r189",
      "r192"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Income (loss) from operations",
        "totalLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r558"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r558"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_LeaseLiabilityCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r558"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "lgnd_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r557"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_LeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "netLabel": "Operating lease right-of-use assets",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r36",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r52",
      "r53",
      "r55"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized net loss on available-for-sale securities, net of deferred tax",
        "verboseLabel": "Unrealized net loss on available-for-sale securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.ligand.com/role/SegmentInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Cost and Expense, Operating",
        "terseLabel": "Other corporate expenses"
       }
      }
     },
     "localname": "OtherCostAndExpenseOperating",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedTerseLabel": "Other operating income"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentedTechnologyMember": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patented technology to exploit the technology for a period of time specified by law.",
        "label": "Patented Technology [Member]",
        "verboseLabel": "Complete technology"
       }
      }
     },
     "localname": "PatentedTechnologyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Operating Activities",
        "terseLabel": "Payment for contingent consideration liabilities"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForHedgeFinancingActivities": {
     "auth_ref": [
      "r91",
      "r99"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Payments for Hedge, Financing Activities",
        "negatedTerseLabel": "Payments to convertible bond holders for warrant purchases"
       }
      }
     },
     "localname": "PaymentsForHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r82",
      "r85"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Cash paid for equity method investment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-Term Investments",
        "negatedTerseLabel": "Purchase of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r414",
      "r415",
      "r416",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r438",
      "r439",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r414",
      "r415",
      "r416",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r438",
      "r439",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r25",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r25",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at June\u00a030, 2022 and December\u00a031, 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from debt, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromHedgeFinancingActivities": {
     "auth_ref": [
      "r88",
      "r99"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Proceeds from Hedge, Financing Activities",
        "terseLabel": "Proceeds from convertible bond hedge settlement"
       }
      }
     },
     "localname": "ProceedsFromHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": {
     "auth_ref": [
      "r82",
      "r85"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Maturities, Prepayments and Calls of Short-Term Investments",
        "terseLabel": "Proceeds from maturity of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r88",
      "r91"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Payments for OmniAb transaction costs"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Sale of Short-Term Investments",
        "verboseLabel": "Proceeds from sale of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r86",
      "r450"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Net proceeds from stock option exercises and ESPP"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r7",
      "r58",
      "r60",
      "r65",
      "r94",
      "r115",
      "r127",
      "r137",
      "r138",
      "r178",
      "r183",
      "r186",
      "r189",
      "r192",
      "r224",
      "r289",
      "r290",
      "r291",
      "r294",
      "r295",
      "r296",
      "r298",
      "r300",
      "r302",
      "r303",
      "r492",
      "r495",
      "r496",
      "r500",
      "r501",
      "r514",
      "r528",
      "r630"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net (loss) income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r267",
      "r574",
      "r634",
      "r645"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Allowance for Credit Losses"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r182",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r182",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Revenue from Segments to Consolidated"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Repurchase of 2023 Notes"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "terseLabel": "Repayments of notes"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r458",
      "r607",
      "r679"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "verboseLabel": "SBC - Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r15",
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash in other current assets"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock Awards",
        "verboseLabel": "Restricted stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r29",
      "r372",
      "r574",
      "r643",
      "r664",
      "r669"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r123",
      "r124",
      "r125",
      "r128",
      "r136",
      "r138",
      "r228",
      "r451",
      "r452",
      "r453",
      "r472",
      "r473",
      "r512",
      "r660",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r169",
      "r170",
      "r182",
      "r187",
      "r188",
      "r195",
      "r196",
      "r198",
      "r385",
      "r386",
      "r608"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenue",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r110",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "verboseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalties",
        "verboseLabel": "Royalties"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "verboseLabel": "Schedule of Carrying Values and Coupon Rates on Financing Arrangements"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Schedule of Computation of Basic and Diluted Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r261",
      "r264",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "verboseLabel": "Schedule of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "verboseLabel": "Schedule of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r410",
      "r412",
      "r414",
      "r415",
      "r416",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r438",
      "r439",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r418",
      "r434",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Schedule of Stock Option Plan Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Schedule of Fair-Value Options Awarded to Employees and Directors"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r112",
      "r156",
      "r157",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r353",
      "r357",
      "r362",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r370",
      "r371",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r165",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r192",
      "r198",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r259",
      "r272",
      "r273",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r165",
      "r167",
      "r168",
      "r178",
      "r181",
      "r186",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r197",
      "r198",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Revenue Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period",
        "terseLabel": "Performance period for awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on purchase date that participants pay for shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date",
        "terseLabel": "Share purchase price as percent of market price (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r428",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period (shares)",
        "periodStartLabel": "Nonvested at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "verboseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r428",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period (USD per share)",
        "periodStartLabel": "Nonvested at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "RSUs vested (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "RSUs vested (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Outstanding options that are exercisable (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Outstanding options that are exercisable, weighted average exercise price (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r419",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "verboseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r419",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance at end of period (USD per share)",
        "periodStartLabel": "Balance at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r414",
      "r415",
      "r416",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r436",
      "r438",
      "r439",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Options exercised (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r417",
      "r440",
      "r441",
      "r442",
      "r443",
      "r446",
      "r454",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "verboseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r36",
      "r620",
      "r621",
      "r639"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r672",
      "r673",
      "r674",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-Term Investments [Member]",
        "verboseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r6",
      "r165",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r192",
      "r198",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r259",
      "r269",
      "r272",
      "r273",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r48",
      "r63",
      "r64",
      "r65",
      "r123",
      "r124",
      "r125",
      "r128",
      "r136",
      "r138",
      "r155",
      "r228",
      "r364",
      "r372",
      "r451",
      "r452",
      "r453",
      "r472",
      "r473",
      "r512",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r571",
      "r660",
      "r661",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r123",
      "r124",
      "r125",
      "r155",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-Based Payment Arrangement [Member]",
        "terseLabel": "Share-based Compensation"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r25",
      "r26",
      "r364",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r25",
      "r26",
      "r364",
      "r372",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r25",
      "r26",
      "r372",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Authorized stock repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Stock Repurchase Program, Period in Force",
        "terseLabel": "Period in force of stock repurchase program"
       }
      }
     },
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized stock repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r25",
      "r26",
      "r364",
      "r372"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "terseLabel": "Stock repurchased during period"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r26",
      "r31",
      "r32",
      "r115",
      "r204",
      "r224",
      "r528",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Stockholders' equity",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r113",
      "r349",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r363",
      "r372",
      "r373",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r386",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r386",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Transferred over Time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r217",
      "r218",
      "r221",
      "r222",
      "r223",
      "r332",
      "r362",
      "r502",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r127",
      "r128",
      "r129",
      "r130",
      "r139",
      "r205",
      "r206",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r451",
      "r452",
      "r453",
      "r470",
      "r471",
      "r472",
      "r473",
      "r489",
      "r490",
      "r491",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r544",
      "r545",
      "r553",
      "r554",
      "r555",
      "r556",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r610",
      "r611",
      "r612",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r118",
      "r398",
      "r405",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "US government securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "verboseLabel": "Unrealized loss on AFS investments"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "verboseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r141",
      "r149"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used in diluted per share calculations (shares)",
        "totalLabel": "Shares used to compute diluted income per share (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r140",
      "r149"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used in basic per share calculations (shares)",
        "verboseLabel": "Weighted average shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466103&loc=SL6014347-161799"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r680": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r681": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r682": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r683": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r684": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r685": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r686": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r687": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r688": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r689": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r690": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r691": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r692": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(ee)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3581-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>69
<FILENAME>0000886163-22-000117-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000886163-22-000117-xbrl.zip
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MY3A=EK/!H$WD&'Z/?=F'284R!?$.3TD6*I5>(,?P/GMUS]DU]ANS+<B; .T
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M_FYGICD\.JV.I0['W0R<?%2 DZ>)G<1,3.3>*)'BXYX8 TN=B' AENFSOPB
M>;TJWRI2]N)_?[W\&1&O:(O<OO-:\+"_GUV_J>!GR72!_S=CHGM54'0[SI:>
M>S?:]D'90N]K 8!U4(2*5.A^>MT=;B=RZ4!B3IRO,3+KH(\' ,SI%F !T4X&
M*-/SGI#BWQ?-#!8M09G1%=$5&QB)R?5&\$4B?:D,H".NQO]+X[0)"/@$/?]Z
M^P0<#Y]0.\9_J_I6?S7()HZS"^M"B$T*X!M54#CICD\+DLH!'U9#"FV!A_M
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M)^3CV=Y19R"!3\C')^3CPT ^HE\XWBTJ@>;K-0&Z)RK^0L'5:U&%J!I4%,E
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M3V,X_V>9%^1H@<S$,RVF!R@^@:RP8/K8<K(K2%61/AB,M4<;Q0?6N2Y4AI:
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MX&X0+E&ND30$\]IF[N& <:D: 0SY(MK['&4AA W5["'+%]D/YA!;8W!122:
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MT\/M<Q18#XXPV9=>JP.OY'.NXDB_&W.'(T6ARMO?@QL^<*,7>E9E-5U<';E
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M>;JJ!F@:(4'-<80J1JA7;0D0%A7:ZJ8'/GRWRNMLNC4E'!B3&]*R4F:^;(D
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MJN4EFAXS%>88F[C4M'W42SE1!G&&NXD(*)@$A*0<'G_O-K#S>B)S\7TR(K>
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M0/7,L\I2-,0S=R'+/_VD=X=ZWIST7T?3=^_&IR>CL[?!=/"/X45-(5NL>93
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M*]/-@^7@\-$2/5HT)>&CQ(%%[8^G9<+487)A]31L&-,DDK@9V>LPNYG"B.?
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MY6KFE;RGDL;,UJ_%B5;W!3:D36-99>?SES4U$C:JW8<NRVJDC3L3,6.+4(<
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M5_8(EPY9GBC?G#F6!@K=!T>1?Z*Q<Q4.BPG 4-Z TTF!&H-P)->.BE>SCIC
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MG2@Q;<M_4K?4VH7=.7XVD\QRO-WH/18SZ3YC:1.;1<./23+UW_P_4$L#!!0
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MBLWWC#/7Q-G[Q!+(YF1)&PXQG/.>I!,<2]I$*DB9YN 3&^&&9-(^6!L])@N
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MFN1#0KB4?119< R,/JI:B- 7'Y+T' 9.Y",6<=A_09V2N+:!?9\210-!*QO
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MAF40S7P6:UW;#"&'TH6@%6D"IH9>)W#\EP6#)>OET:!YYPZN3V0DM &5$LG
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M:Y0,U='FR+%_W>M6LN?W]3^7O3118%D"R<PHAKD^F9#TJIJL!,F *0J+S1F
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MY4E[@))BH,(^3Q5B>$6G5XRMN8":"X=*SN1"S):\X\@5C0>5E,W1*0C!1=D
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M_HI(/JS%G@BE(>(0BF40E$$M/0CDC\XIZXW##$%+;% .;9ZJ,O_4%<; 3BF
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M1_N]+<WM?+MUO/'FX'A-,W$YXC9^3E2"JQ-0K6UG1:8-WI=VC(':LE:S*P%
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M?AC)_Z]1:X^Z=%(1<#[9Y]?69C]U3ZM1;E6%G=JW]Y.9YF&7OCZ3Z@=G<2R
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M[2*+S!$D!%]GMC[>_L;4U17$;]K,7RRTF4[!_G3^8?6[C9]Z.#LMV/QD93M
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M&",\^2?(@%38*D0#XI2NK3,Q+;A63CR;BM9&A!FN8[18%C4">/)J)4'!8*/
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M8JRVHL5@*K34B$[?RUXBC@;'E$HTE#P!;1@CV%E&HC;6VD)+C:"ER7,WQY#
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M!$9<FX1LZ6T4I#2.I 2KO+5-<5?</$JGBFAM[59G^/',\'4J[!(GI)118\L
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M;P_A8S^GYY9IN4!O'A\.3_H!I@>>8F'BA@>Q9!5_Z4T.R[+-/>MJBUWF-K]
MMFEU=@:PQ?J=UX7M/>F4$DR]H^67Z]A1S$.:S0]L>KA1@)7.^G:>E#R:]M.3
M0SOI'-G3//#X]3B6O.@\H66GG<#*G48[>E)D<WZC;P,96@_YO.;1\L-S>BU>
MZKN@TPI8 % =]1PL6-XE\P)MSU[L>/IB>3.UXU\/E2<KO1W2[:R&7MWJFWWW
M/5J1FE?BOZ^Z?T^PKT<,;Y$DO1O'_?0<4/H(ACU^C&3H[=\?B;>".1$0U5KF
M*AX.&:<8LIS1S*6=6"8WZX1VL(AY>\Z6<1/@#0[G?(X?V]'L&+\>5<H?RK%&
MO<EI<_S^OK/SZLR<DF7UI)F7V,Y+<ZJ/QR='QPW7*>>B+5TYF]/[J"%%C;6E
M.9NGQIIK,8=RKR7V )3,3T[F#O%\(H=>RD:6-!H>P=>&,.+9<!<,)HO$^1Y1
MX]6H-QPUC4]?1]^'*2VH74P9,T;WK!Q<9:8?&:[L?7LO]F LNV___+KW"3#F
MX*-.7G)/)=(FY */0B"G2]E9$32)V"MJUAEB%I=Y(S#F:1Q-+(AP*]93:3[.
MNW?:&^M:HGVF&HUFTQ&S%M!BT9D>T)89FCYE7F-YTGD##+S,)*ANW=;NVA\.
M#A#0_2-@?( (6?D9Q<\1M._6''MHQ\W3<^V3\MCO8).S?7B!"!I+C)-N9]P@
M;7ZSC#2MK;<H+V=/[O>LZ_5[$^!:[4.G).;<G)U[F[4%*=A$<[:?T7  /_IF
M):LEJ"$_^V\//B8 HT1E1-Y3BKCA"6G%$HI>$.^(<4[&=4:F.3T!N/<@V%$8
M=]X=9RD8=X%P9X\3*,<[87@,VW_-8:OX(%X..CLG!W"*9M4!=XN4O]AY\Z].
M#Z@+2/#.FW?E"L*RNS[:7AGZL^@F'=0I?Q4L!"WI<QR-6UUOOP#._I1^_>/-
MB9L,CT'VN<(@Q[^4SSR#P7PN9HR&3/T[AH.\NBC?;))#1PJ2/X<UGYR6\D_J
MMW%G_PO\"K@?L,&SVVJ2F]_^\NN\,IG-'LVH)KW<7N;E8 R;^HR[G7N(_<YS
M[DD;+?/<^<<4P>?VPA2Q?RF&K\[!"1P$Y0#H'1WW\T'5^AWAG_%KGB<XP(9P
MQ.5#H:R5/3[N%[;Z[LF;)PV=SI/EIZ?HV9'8FYNR\DU_:/.4P;L =_5%S9\[
M2LJTQC)G3SJ[PQ&,Z=P!V##O. C-'=/0GY1XY,G\:Y21S"U;;V'9PFS7=,9^
M>)SM7#Z6?=9^]=RJQO.K.H15;4>8%7OXN<!&MV///37DC7WV:#A73SQ,7#.U
M4Z?J[*:P+JRQ%W1AFOK];'V;VFRFYC?XHH4%&AS K=L).^T<19M[Q83<R#/;
M>(&^P.._E1-^#,_L94/JM)QABK9DV;:*3\?UTLG(GUE7@*D,#P:]YM_CN6EJ
M#*2= 6S(V23;_GAX7H7J)31]?WC\400-I1"/_":P6WKM>\#+?6]Q9K?,X5MY
M*.>:XF3%Z&P; \IU8E')\EKFNZ=>CL\K)LKQ7 OX$AP#: %GNH,?B.@64TMW
M:EG-'^E-[:<-;VDV:R&!6<^:O^VU+#+W=C#\!;/>'&--4,!LW<[FZS]V<)*-
M::1,!NV< #ELS+Q'P]#0U5&<C(99 LL78!E'0YLW\51O+5KKJ)&DN09%A7UF
MB_.4_Q9:W/@A6B_1>+HSIO0P-A;T45D)N#)GKAS/#FI8C6;P4W-T7ICI:C7[
MTY\<G31!9.T'IX8XP)S!0>Q\L>-VCW\K%5>R=)^Y%5J6#(A0-DU+B^$F, \
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M=!I&E+.<VSJ"36T2"L1BD@RCA K@#Y1TA+YSLL<E:E:++>[VU7,N5R[WRB(
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MM_;(]N8GH22GD45$6<PI')U$)E@,;$;X0%R21@&1(7K]I@30$R+3:61H3$^
M3L:\7UHQT@@/N4?AT=(Z3I6E3"9.N#*4IAB-3HEB9@R^(;=H$9Z?,9W8SN'F
M)Z>M4%YJY!0-B&-+D%5.@,0D2\ >5C$!)Z%\_::,GQ.)N<X=T1+2L"#G>0T$
MH=G%S"K0N+2K-Y/5NED$WO1&MK=?YU\W@=1?RK[]V&3]@P>"<]*-;]-%&\=-
MW.R%:;>>>VHFEC<?B5(B&A:02]PB'G&6>L]1M)A)Z9,&LZ\]J9FN2&2_D<CZ
MLD36%Q)IF^F>XO+4C7:1U^E'>9B^JZ%/)4D3I3^7,>E1DC0)=O-+5R!)T_RE
M*Y$\9YJDZ18YAY[J$%SF??>4IFJEQF,N7=>SZSYY;HFDWH"%G1U'HQSO]J4)
M@YU9:>]276PYR<KNLS;7@BU\!HD7OE]^;DK4[G)J](D=E[FNA^78RU6[;2HV
MS^$0RRN^?;9Y]O'H+[#-/GZ&-GS;V_V[WCO;Q-N'_MO>T=ZW[=U7XNW6Q^[L
M(9;MW?VS[:T=:,?[PYVC=V1GZ_>#G7_^.-S>>G>Z<_9[_1%LO+Q/LW/T]W4)
M(*@E7"3MD$K*(TX\0]HXA8(G*1O>DC.;76.D S/6HM/@#U3\J4!0>[KV"&6-
M"P3= P3-GJ.S)D@:!<W>>8<X<$ND.5>(:4:]YX%P;]H(0<^ Z6]->'YU#SR_
M+6R^</;K?K[L'QTWVZ^CZ ]ZT*+]TQLG^[FG3^)$,QDM911''GUP-@89@.]&
MJAUQ_K:$]_=&U_Z356UVI^+U8.[05%F%?GX5VODP1X2EIEXYYA%8+ &(L%3(
M&(Y1C#0Q@IVE0J]M4%B%@$.T:!4JN="63!T3<5)(92(6'+-@<'!" /M06M(0
M;MIK+\K\F,H\2RD=BU1*F9 +7@.E)!IIFCCB%M/D D^$IJS,N"/)$\QQMKJT
MX_L__Q.'PQ?YY,O)T<DX4&QR)+J)K/@I?G+- *X&I"T2CO\ !&7S8E(V+\U)
M0;FEH=Q\PG[LL+41 $ZE)#+*,>1TA#^E8AR^L4'YM0TM.XK/9V_]9='D,RW*
MSU4T^P'92M'L^]?L6?Z21$HV28Y,% EQ@P4R(>2#.%X*S!/%@:UM*-TQYIK#
M6X^AV<_>8=*<]F^TJOA);HJ!U[!$@3'MC5*<<*Z#D-$DDJ*B1)J;8N"+:?5X
MT#2_80CS9(3A @682H F&9#VPB&7O(@F^H29 -.J(_G\L<#B)7DJJHQM2 '#
MFN2TY$E[$Z4( E/'B4C.WWJ#K:CR ZKR7(4;H["-+B#CG$+<Q8 <"P)1;&E(
MGC.=SX>W396+CZ3X2.[!DGH <E(LJ7O&N+?S^<\)5;!(<8R"4X!QGE($NA&1
MQCB8H(1-*@<7= 0I+I*GJ=@/0%6*8M^_8L^2%QJ]"D2#X1'!^LAY"I&Q5B&A
M:-2.:H,CSHK-^7QYON(A>920DFD*KW%6T'YO>% ?EY)\-Q[Z]MJI"'(<@(8[
MR;61Q&,J+'7$ DDIWI+6H=1\5 GSAC(A#"*8!<1UWI+F/B&3N-#",J\4H!3'
M'85+@;VGJ\N<$,\DMIBDP*64EN=,#M$F9T")@RKNDA;J\BSC4(&%H)-#@EB&
M>% !624QPM(KXKV3AM$6ZG+QEQ1_R3V850] 3XI9==^',78W,\ UI&7GS'\#
MH/N$@W***XE(LF!7^4"1#5P@'FD0.B3M2 "[RG0DOB;O8_&8/ '5?@"V4E3[
M(53[]*IJTR2E]M@CBQU!G&N.K&44$24=QSQ$ZU(^:-6A<CXHMOA,'N<83F^4
M9R#G."]ND]N %RQ?023"J Z&4ZV,42Q&RHVR(B>I+6Z3]D'5JSD6XA(02IPT
M"L0KQ)F-R!'BD,($,QX8H1*O;3!).[A5QE9QG"Q7FRU3-DI-K3.!YRT[12-/
M.BG-&1;)%,=)*[5YAGAX2JQ66" 7F$<\^T,=-@0IP&EL1+!,BS9J<W&=%-?)
M/=A7#T!1BGUU[S#W9HZT2&Z8T3PA*B.0EJ %LDI19"-Q0G ._X2U#9$=Q"W9
MDRZNDR6K]@/PE:+:#Z':,PS&"FXHK'E(!9SM$6Z1\R(?*)82!Z%UX#HSF Z]
MYCQQ<9W<CV+N-F76]Q=- ]W)]2L6I9.3G(^3;,P,)B7T3_(SF[R//\X(^703
MB"UE9%J] #Q"[L-9T-^)HS?3\H$E*=GR$7][CLP1++V6,2+L+$'<&(L,B0)A
M%0)-42L>Y=J&PJ8CU+)LUF6H4LL3*A8<+3CZ@ D<"XX^.(Z>SL838$TI]PCL
MGX@X%@PYH2-BDFK*$O,F5])1C'8H7U9VQ\?$T1_P[FFI#^AD_#[T/M2538/_
MW=0<6:T*>W\.<J'I4?^B5G._USVM#FRH;D2:03S.)G-O_U/^:/8(F-!&A:2D
M4X0S#23.>TJ22$%[*IQM:@V1::VA.?1YL_/[+/S "+HX>)O>3U_[%[SUZF8#
M]-YGT/D*4CF,O7.\P:N)-W<HV[8G=J MV[OO3K>W-L7;S4_::6FH]DB9;'1;
M29"C-" "2&*9380(O+8!HCP'&]7Y/#=3/RF'G3\:U^.)^[D.VWKUII<EH!?'
M4M+4/1^7X>X!JOBF7F&N:+AM!_Y@7"&PGR9E&4?9Q(2;0/Z&\=@V%>3SO6^/
M>O6FNZC$?7PR&)Y,RKO;"A1P-*C=R?36_]3[T+;_^W\T)>K77'NS[S\?]+N
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M<8W') \\HNMZGA@Z.XSY 6L;_R*_S)C\[96+]FG4SOSQT (V!6P*V-P -K2
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MNZ/3ZMB>9D&=/L3Z_SVI09"K-.@?59,,"YWJP_KF>O6OR9^_5'6OV@3,[L(
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M8:G)6>(Z(' M4N-GX'CX<.*RI@V:(_3%[_  '.+*B+_ZEL](E9"JI6/0V_E
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M^W#OV\[6Q^O*A4GL ['<(\R]1)P&B2R6&%%).66&:.)8+MLJ\)(#&DK9UI8
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MCDZ!MAU?&+W:V*W10Z.'ZU?V:?2P.?1P[N#A_H,78+SQ7 F6O"1S(A(S!*N
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M0RT*(X6@,A1N!<PL"-K8[2:(.Q &VKXTJ0M;R\QK"N9W<7B2:F^YVGWE;(>
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M2/82PF8[]^5A+4TC>5T"T-4V0[$>/>B"@MSFS$$I\IF_*1BZ.]X?'!,-Q$O
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M-T-*RP4%@R+/68=:K"+6!/G$2*DDEM$$R)!2\;R14B.E#9C:%4@I")5=<:9
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MKUZGOY&P)1+V\0J,2.-D(3)M29YA U*C,Z(Q&0'H-W:B!-YGS;,7^7R.[$C
M*NZ5=$,3%KNI:V>&;KP]!;W18 W;@D_PE&" @+_=:.R._;*#4P"M*')C50Y
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MA;WS7_D6T(-%0!TWT^0,1)]KSW?AJ^E ?>%@8K7;6"%I<CNM0 < >ZN&!FO
M?GH]\D_PL)>CH;_%D>>K;:P?[N![:*OR;(<><VMI+B/K-2)M+"V#)19V'%-6
M"8^X3WFYS>?[($=IJXJ7Q\UUKD$XAN>S@KQ \IK]AMBF+)??+;&+'KI88*_'
M_R6RZK3.9)!E4>K '1.E,F4H"L>8*< >9QM9?1@/B 59]8S[4I<D*W)/.,T,
M4;:4Q D07N]S+ZAZ]B)7^78^7PUS^Y9^N!]C>%7)% L$'RO(58HJ?A09%:H5
MK-,^@#&@T&,=]"K'O86MS> V(P][U8UK]&_LR#7I+N]BL?AXSK??^9H*@.2B
M]IZF@N83)>%3LB]>/75F^?PV175^N39>Y1-IXW5[=]Z-[KD9=YX56<9Y9DM6
M%CQWN2ER51I3".<RG6&UA\F7G:KOPXKU%U=:<7?^EO]>M];#K1":B,:CWGJ_
M14.DC77]TS7QP'OZHM]3Z7'0<GB/:.F,Z^VDPPITN31#ZA,2V_-A^[REBFNN
M9(YFF7.P%K+D//=:6\VDMB:PC$GCBQO,EAOMZPG-=7@*.A@3]0Y[&I=G%Z7T
M5U50>X>O+O9VCI6@QN:@DX [@8H*6%C<,D$DIIG"_PNAD$XM*&0R2).(L-QO
M_'9QZM.Y82]&0\ 28VM*Q,7?)YL[/FJQ>#D>](2$Y+^RB.3[)\>%#K94M"2%
MRACAB@5B=,&)X%9E0L$B"8FI+O,B,B$%D^)2-=3$.ERQ=<M$U\W)JRK%O5CE
M3Z/4UO@.Z<0:+-78)&;$JV/OTPD#%Y\:X6[RB<#QISJYWLY!^"-$=NPK/ @?
M\+TB)S],W6Q^90_A7AZSYS/EO5:DS$-)N)/ OP7 ')78FT@6.2P&L)P%HONO
MB?+3,S;:O-S\<=L3\\?&$NC=,%HX,&Z$R6P>-)=%9K+ ;"8%S'-A"V?N774_
MA2"H!Y?\=]\ LZT6RN=,$ND5GA)B=ZZLU+ 16.$XU[G&PY0 P#R/VE,&5P75
MDR \MJ204SYJ:=EH]#GIP!8=TAJK2U#F3G!!N"\T,<(H8I0K;7 9_)]=W$WF
M>HV^%5N%1X=7++Y979" \P:W67(/8-N %LK>'?3O^@0LIBXNE:Z]Y+Y;H(,[
M ;]42=I&$R>)^XA!F852M@!V1##GB& A6U(ZI@DVR.*P)#R4^MD+->^Q'2GB
M;J^#!VRCPF_?R_7J^K5SGM]V:G8YK^3!M'GB>I[]GMH_Q?-+C-7O^:IZ?=TZ
M LM I@!8V^G!Y.*,I(:(& @__K1JIY$23+##V$D'9K%=4XCJ]/21.S!S\:]4
M/[D]/EV+G0=UPS5;">1\U?@B.2D!:U+S0[@&FQJ>^*G^BN/CA=GSM.0<:9S
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M97L[Q\)I5L*4$]1S&-8)I%_(DN29RTTI**A&O;B\_K\6M7*XH85#2NX;=XT
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M/-&I(Q!?Z1XPBX_MBR:PEIV3GO?G5=][-QFT.'_!ZO1H!3XT3+?7H\)E"V(
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M/X+7FU_N^^8!VUTOG86'#!I<;9+FM%0]46L=B]@NQ0K#61"F.>ATGQ.VG2]
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MW&&'L4M\J],^(9A*/AFWV8[.L&X*!M\XPC9FXCU3J[]!" ]!!F^?@[ !Y!4
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M#Z#_Q_Q@Y]AZ:TI;<@(<WQ&>.9!%JDN2%4$$[90*+,QZ6\M,TQP6I@ %CG4
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MM33\[?1E?7$G!!^[LZ?.[%5G70\PCY(8F]UO-Y;3K5LZF]8NH?6F^N![7T'
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M:H5$<_/,5;#!"J#FQ]PXI92J!VI*H)S:*F"W"[#7E<I$$_V%7":)'R01<Z]
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M35L@V3;CK1F8#[8P<UL_JP:->WDD<=%6O6_KN/2L/44/'[QM,]Y#16UO[U%
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M5*9<.]GX04XV,'L5)UMG?..!3[8N)!Y:84E>[>'PQF64^"AMWQ"UP/N*F8W
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M6<7L*WT(HIN4!@)L>7A0[C&>3TL\S'D,:X6G"-[$QR$&!:+%$!Z9U._&.)@
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M.Z#4OX.62V.@#E=$5?2CJ^]^S0+.K.ZDW['PN_39,H!GI&V%NI/B#-J:)2@
MM,E*N :/Q9#FFK\0_CW\5\0UX*?<9<DAHYU'WR7H<6#/"0IAE /*:0=2!T$D
MA_ D8OX/V878H#]W@.0. 90"0+#!_%3D$6U@Q& !D'D NP&QJ9K?%Z.@I'DI
MCJ'!FJ)%842ORCO"NUN,9Y.=XQ0;*<Y3%;]8XM 4,G(2GJ8!EVLE! 6%(!!'
M$]"@=$#Q-=RBLI]!E\)O(F(% C,*0&;FHDY2/*IE.*"*1N8TNL2Q-%+MH(*
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M2]8%J5?A:1+'*;.P\LNRQ"E8W>HQNTC:22J]9D*)3+"17Y!X]1.^+AL5SZN
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M[1+P_R6/(U'/A2@EN8H"80H;=>$O].$[8=G""ZR6UVO'ZUMC6?)4'23R-\Z
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MLH5S.07]3/'G>S8?X[7@:_$"_@+I4IL?4!Q;SBD7.62YA_X_QH(OLPQ;S<K
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MMZ6J8F_XRSIV)6R\Z)Y:8*,F;+\'W[>]Z]D2"P'\L=[ZV7&[!J^<P](%G39
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MDK;UNFWRJ'.KY#Q64)*>OOX8;DH[YFT&MP%;A)N8F,'[PKOQ4>:^YC-G@,S
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M7K4#HC?M>/I&-Q?FSW/ZZ:?_ U!+ P04    " "G@0E5 G[Z7[(D  !U: $
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MBRHV9TK+T(K/E&)G#[EJTFH3H<\F;K)QM_1L!3*FL)N'#Y?"J+WESSK1\ C
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M%_M-B,4&VT06_(<7=\0VA@/Z=T2@2T?*AE ?FVN^M-POKZ:3Y)0GMQ @&=O
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M<=T06BA.,!F40:F-<:YU:O@]8#YM>G6MMTXNQ]9"_CL,SG #8I)/S,86AEB
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M,@I5+P1UAEE];J2S+8KJ;@M ZW.Q6W'@COK%;; \8C^R$W$WW BVP;=\![9
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M(7Q(=7R[$.#&-/;N]'*P:C\(*<KBZM@<)(O2:[(&R!ME=497S:#&P.]=?/I
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MZ,QV8)7A17$(S EE:3O6DD5PBB6%2/NK@VA;#[<Z(H'NB-(\#/[LHI(N>+,
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M HYTX+@5FC8;3BZX\(Z!M'6P7D8MI#=AN]9"QU;@!JNOO?YV$5ACO2TZFBV
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ME"E:YK6K4^(BI_^+GB43:!LV3GC1^K9L TD_ DKVDW\/UR:/LWX5@6FOM*3
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M957UEX;&IN:6UK;VGMZ^_H'!H1_#DU/3,[,_Y^87%HGK&YM;VSO@[MXOO1@
M1H;?CW^H%P]=KWWT-6""_-*+85_0KPMXF)B/*._GU;>$./GR2:A$LO"?27E5
M7,\J>?(20>"&7S?;02G5R:/$7ZK]IMG_FF)1_RG-_E#L7_4:!C@8&>B+Q\@#
MP  *.3M>%O@?^=\7;!K,$P7*8R-IP"V,H"/H:MJKA'"9,E/KU/@PTJE0='Q&
MU#DDOEB14X5'B%-?/$I^29L:4$;QGFL<7EE]'7(D8\,B<]75OW_F[O$6HE2O
M,=?'&A\:P/P=S'M_<2E['LG]O0@]^K5F\#*V?_AT'!44:'2D ?5.2-VQW"B8
M@/MVTT9I2_8P'[0WP'7K*Z+!P.HA],(0_0IXK=[PV7)S(5L'=?]:AX.M&KVS
M][EZJG&L]+_Y()7G+\MLQU3<4ZN,XU14W7DPY/N]22("M4]K 2[:;1!!,:=D
MP?"567Q$ZB?77'"I80/4L\OC.7">'5-V59ZO_J& S8,PUSG&M^(WT563SQ2=
M3"0#4[7X53Z^B(6\@E1BYZ1Q?BC\\UJ)3T3S92W"U.*V=49 S]</-TQ.'7EB
M['QX3T*6+*<*J>@V$!#GMS0 ?HEK<$E3M6L$62WLW9+&=O6MQWGG7*NJJQX:
M\;-H/Y$A9Y '*44X?/GPP*>W8VX3K$5IQKT2M]"DN]L,1\>^+U3+V@L\,+>P
M/\D3?4]+H)FNI ,-\.K )<$$O&O%YFV\H/<01_V</JUC9ON5'D[^*.Z7T#(0
MU=CO[5>Y30- Z2XR7]@YT(:P-S&5USC"@E5S+=-^'/L\D.O90;0W?V6&,2'H
MVQ5O(/J#<Q(-"!RIA,H%!VV[4')17J:!_7,?B<C/>>-<:DJ!7\^-#+=^UD^\
MN"CLW]MQ"79L< "&?XB#ZHARUQ9_?^=SZ]Y)KF7*#>9G)[2:M\^8,!%RT[K*
MD=U$&?+!#7QMW*FC[_1.#EPY#"GIE;3RKD%K7^U:&'^[@"$X<$4/[KSEKX:A
MEU.2.7K=!YKX1N]5W2)'YMV%-(EQ4,IA;DI#A<TFN4NVZ/OIRT,J;EG'XNWN
MYZ)?_O@)5;;8=LO4WY+ &:%N0$'9EGNHVYFGEEER&J@J9>CP;VA?61]-ALXG
M:RT9T95U+JO*L:?, PE!5#8KPMW%@4.9&DT99[B%LI_Z;#ZXBGC'R""EM/[B
ML%-4RH:B =("V0L'=*[1 *8]2NY465F?]\N,+U9]-;"BTSHE_@>GRT@1B_HV
M9U,>AA;N,ZNC=&;7H+9%*&]74)Y=/T@7B&?>6>_5'+\=F. &VH65 N7=E!:.
M]S4O((Q:^^,?ZD;%SR*/D7T)J+J5(THU\"D':,/ ^ER[1H7\H6]&4H:8D-9-
M"S/$UK0/>)R^X%RL[0NN^<%QC2Z<)]\L7'A5&^O/K7J5JW >&Z-F#BH9-8!!
MX0GU2.7*ADG$=GF<_**O)'YS&E-D74H#HK9!A55^<[PYOQ'/MY_)/R%.+=>-
MN_0VE^M(/?$@K@%%L%^[%UH:G[X'2U9]H^MH*GOTOO]BVD$:T.(Y@N1%U9^N
MY21[?8[MU2>.)_O,'7$NK9UPTDE$Q5@'FJTL5[V^KIL<+_MRW__(?TYP+T*I
MR?*[+07WF?DMKS 8\%LPP"LP!-.NW1.X./C6'(SZ^"O\?B IA&Z'-30@C1T,
MI &._C1@P;XO%U)K:2#P&\0(U%/[8/Q2H ))&QQL.L&MN.D@-C4U*"G9-73N
MVO8&V\]/[00T*/?Y404-^(!N=)L\LUK.8VSH&V-Z_QD:_Q+SY1YDUHC,MX,?
MA9<JK3S K_!=3AQ;^!H\_"1;:O>)VTO#9RD;?<:MW#0 !PZNP)MANU*.Q^B/
MTIV@/@@E8^AF)N]A/0 K7WEW.49E?+[BPTA:G_$^K9;:1M0 [JJ>,@UHDR#:
M4")7:<"F:>]#:#R.<''B7JT8.$=R#C[U9?Q8;W/ART6,%\D*BY'2\TEW]CV&
M('ZL;,C.8OEVPH]58,=FY0=]!CZ#^I/H'RU-CG*$\2<ZHN^"/<W3+>+=UMX$
M*W9ZIC#FOF]0VKGROO=SNE2R_ 9FVZ6''%Y OM63/GF_E@;<ZY'*7+;]9CS]
MS*;-5\[:CQ^Y7*FERXH]3<'.4%YM>AUK[IIF[DH2/%^%VG1;>Z\Q9"K>!EUL
MN]^ZW[BK<W^8E6[="@J?,'ZT?Q,UXFI>W#OLG.>QYS)CFRVWJY-[OS6QX<VY
M0B%(_KB1'Q<]3!%L45';$]RPFWG$$_=%S>L%BQV,Q.VKHH*,CYJ_4N##[,W(
MI].G3<:!K-A7*[ID-EDDL61.I&2T'/RD1JFKS)HZJ&48^27_*KM<.S.3RONI
M(4.].7KT5.KSVL0-V4SI5!P]YY4G):E)6M,QSD0-N^3N,$[Z@!+PEGP]880-
M,3FFP"'!ZY!-SR4:H(@_-JJO(H$74VD[-0<=%;USPN8^LGZ8>><^5<G#POTG
M_D*&SOOQ"TXC/AA@7G]:RM)D%8)!>(%M[Q'A8&8AB&W42'-8U'ZW(O-M]LFX
M3N;#O&SQ+Q&GV&9EL]_];LA<0TJ@I%'S5]>IG>77NF^J@G0I73%JUU0_A3UX
M48/VF34Z[M$9<M3T8^*F14Y9N!>< U6_'S4SIN-, YR%:4#/5<_5T+A*N@\8
M_Q]WR?^.\O\5C$02+]<=Q G4"H-Q#8)#![..]+Y77; 3EOW8W%89EO1##&]-
MX6< %0C1S1FX95>2S8+M:TKAFSQ\N/O+/H7TV !K-V_)2[X[.2I **)N<"4O
M2<<N+WAG.V0@\+/$JOR*DC6!TC3VNM%57M7<N_.=WLO!%CC!A@N4B9EK''P^
MA8Y<%EFRJ[AW(,@L\J0"V:W2[GZ?7\^Q"&&CXP4LLW<F-%'U,!S^]0X-^/BZ
M,/ALD[4_&#=)&4UZ?H?1WMVE;8/C_*B.5ZJMM+BK%+?I_KQ\?A@^F0:L([,$
M:0#V% V@2*7B+L#PKU"LD&;,T'1+Z)G3KC45O<\OE5C9XS)OGUL4I+QAN3P_
M$Y2S'0C&$"2G;@\,XQIR"&2/,&-]%Q<?U_SZRNO1PE;/5%A%3X0L.=87>CS)
M4,0H?-WZ^OEU[GE;$]<4YR2(WU4"9"#M.E*+'KG%D+)*#=@13\/2#!_IP29K
M&VV=>YA'GV2?B(=W/LQ&!V'?P/!5J-*8\@>$#4/0V>D.-G_)_\W; HD73[UN
MR+0;[H0@G6B ?7AS(,X#.X+#"R[/>AUW9"9@(\@.TV&WN&[M>3^^?;MT-[*]
M?4>V\JAQZ]6GY8:L%W,FT=&8_=0CJ'I#E-NG//=5I2W12W@'S]"^A:>JX -&
M?V? R7!HVM[5C1'@A3Z%VM"'"J$R=TH3T8VFK6PC;;SS(F$J1(W.$GN>K+IW
M ,_$G16#\!4"?)(S@2 X>3=A$LI5=[VGU-27R:XJQ*ZP=>[3IX.W]-X%,\;+
MG8!E[?T9&/JAH'@7^7E>(FK9&;9G>B"\ZW^<__]*Y_\- -;75MSIEV6#020S
M#T'MKW'/\#C^49?<VMY)ZXIJ?_)ENQEY]9#C,4)I;6I; OP,NSQ$=BI+&C'A
M2[JWJBMA,%ZA2KFLC ;\>"U)>?U4(GI9..ZS_UTHP9@&#'/95R;+XU@;W ^?
MYY&J'KR=*6F_R2#M!VSNP]V:S^N$_&RIPX+B6YL5*0X((V)@J?JBOA=,WSIE
M1GC>]?%I^!U)[QJ>>!()3S=6<W8$(\%>#$I(3G#-=K_C/UN76_/U>TVR7X\6
M=8,W^##1P8S?GCXYN9 -M &_=<3O^B'SZ3?_Q?9 9RK+21H@O3 -)0EU45,;
MX/Y]NG6RV?&G?[_OOTH$HJ=1\7HBH.=M:2(G+L?-]\/HF[UU30WT]EEN\TDX
ME#[ZTS0 GUV-CJHQ"\'#@3%VNY&#)Q:'/P)=')GXN'R.S\)[L:U"XAD@S'90
M"6%28!:>/^X 'Q]5W_56='%W>;17HBR%>8MM!7.:$(H.]Y]P,9H/?U/\6N&6
M]\-[K'JYY@=)D"W8(+[S ['9>3%,UL1!"BM=K?$Q:<^;G++W^3VJW@C)X7:Q
ME:H:.V4@S.[E%'C")^>X"\JVG0;$Y2!$:,"K*!I 3U1L8&0#I+4EG!$F[/]F
M320@E09PX'9/;LH&RZ6\=K<JF !S:$ KM$B;B\SO@^^Z+V4\3<P]N'[BVTCA
MH:?[*-=RV/<&WP9+3@7%4H_^*&N)"UR!VL< B@,:*5TEL/'ABS 1\KG"#,A]
M'[)\X5G4&\>QA<&!K[7R">X9<C?T"MKUH3&A0E 1W^[4O9]BO/ Q;R6BGPX9
M%0FRZE-,>30[2&TF2#:951<!(HK,UTME$\Q'F VND-FG"V,J!Q091*P+KASY
M),XWTY%X (1X^GX2@JFSA[^"5Q!H +?3R42)YNOCSU5WS$LV8"Q3BJ+--RM;
MHIJQ80$#/0Z]*V!>#IML]N>2+_2?$?^MA.J[M*>)G1,K^%6[L*"CR6EFY#BJ
M7@DV\X4JBAI\00/V;-201P97YLB\&]0+2I.#E) N&O#:_])#L5T#_BN I0'_
M/Q(&\G2W@<#+WQY(%V@!C*"/V=4P%Z(!0\VHS2<BI*Q:^GD4!YTG5 >W4)OI
MWIC[87!TB^L.?5P/?[_OOT3\8&)42?0].'.-Y91]?KI1[ZW*" W#IW(\<GM5
MEN"@ UR'[H266WD]..>D4/Y6ZO=/)>4W='4VTVB ^V!*H]"/Z^N=AL<.?>'U
M[)?Q:=P.#F(\?,L]]HOYY(LI3$XJ#H^\-C'153!A'NA_/&UTM+6G0[[\9\K0
M3+%NFU1&;+P\F%0^]H/2EWJ^E8X_9W^MBF)P&/P3X3W.Y>W0A>W!X8 %?Y]C
MAU4O2>ZWAIYAP(YPQ3JJQTW9-"1!&D_(&I=]U6/?.NU?TID$]^ESA<;0%VO)
MA\R'O9IF3TE$<.G@0A16%5I@#0)]W=CY:'I:!"\+5DAZX3N4*+KYB+_6UQVU
MTC(YKGG=Z?C^0X>\G#6@C[(GJ,-A#OR6\&ZCC>O_9'W_KQ6;#32\NPFEN64)
M9,<?BZ!/*2"_O4%EI8=":4'"$K6&SJEZJ@KI6.L#PZ=CUIU0G+BE;RB*?,:C
MB)UVV>Q_&G2YYL3B98N 7P_\)13+?V2]A!8RMRO5K+<9MJV,H1R-K9W+#XN@
M#ROB]]O^*T1^=@V43S236<YCM;K%L_3D72-'C)A]@TQO*F0:;C'8-4&X/,&E
M]XET"$PVKK_5ZUKZJ6Z5^<L1<G0:://5][',98FF)E17%:P*OJF7$U50$$+E
MI'-*3 H\K&(1>86>/)"OH[S_\![D.U3]"87<Z.T3A ;86$;8(/H%&>?Y&)61
M0<[##N*&E!K,)F$_&.ONOH_AJ X:.6&HF67T MIHS#4-QP:?-*F9*KH8_YSL
M EUWG4:J#UBVN?4N+F*K#%$_T0[9\?)[5ZGP_^,@^3^@^N^(C?R4>7(6"\%3
M<T#'>=)!MB7SRX9U1;3W_I#1Z</<*!%@,1\KUP?SQD3;WDP]CN$C<S8?29OU
M('1R">-SN%$<>]9PLHXK'D7AQQZ@ 1,M-&#*C7&8?D\)I8IZ 'XA):^1!C 6
MPLY*%W-XZ+U^R@ .FKVD?A\'B);ZK\&Y^KT4I,UR]=?2D:J60_8[4Q&GV(X=
M$CUSX%*_3'G6H:=2WWY(W)D?TM24C&Z5>/.O#EVUEJ 'Q$WE-7!Q!WM/1AF\
M=]^XYB.I9QEP#+MU29\L_RJ[I.B\@'O[8X- J=[-L(SN(FTK2>OGI=F]YE\]
MT UP/M!CI[Y6$M<3*!]4UJ?:$5=6%4/=O"0IX ([<\ 2VXL:B:.R_O D&2RJ
M!.<T:*COF2<@/E3P="I[%3 +79KAR'U:-]%ZY+1X()0184%)1XJ3#U6FZ)R=
MU+W1+M2E8<*0U4>11OLAJ[ S8K+X%RTRC2;GGS^6)Y6<7WB?7MY5C9+/(<G'
M!"\I?+M#\,W/L1[?/%1B7H2M7A[\UG4VDNXWT^9E;'+.2:]3+/E+E.N FVD+
MCJ\(.=O*8#KQR:):-UGN;9/GD9_;>R?=;^<,(IZ.H<^-AA=B(1&-4XMAQQ6T
M+CID/T=%MB6V3'YX-&9O9?Q%=Z8'_J"5? 1TS4<X@\^R06?3I*R-:]7&#(P2
M4M\<SU+;Q6_IM7MNYS54'ZB(J8$YO[DF\]@USZ[%<Q_*3]6B  8P!_LL7R.Q
M+, ^%CVJSISMM!U,P&:OO_E\1?Y KBM3$XL._J'*'/,'3<L41PJ\ERI"B+F=
M#M&N;/(H\PK$';-3<K"[N[Z,.@9BFJ_XU]R4Q8_-]WS.&NT)^W2W^RA*HX\.
M?!19<MU?\+! >RY>M8OCC%1?V:$#VNKS@QJL;%EC5]&V4VKH8=*D8<2A%0PO
MF9E1EL-B:>#-&2YA-J@OF1D(51"8'HXC\W/AWV04W 2?34I/]+9_YJ6&G40W
M9_\JLL<A>#Y77DV;@L?T/]=4L1<:?!-R"^!J_ XIL72T<R+Y( [WY=Y$3Z$C
M^O+;-@(_!<?]7&9XGW,&7,*C^1^+N";6R.>G-T]\7!S8<)64/&2_]9*S(/[V
MI7?$PASYG(CV=C\AL7LB@?\;S,(^+A[FIL00+'99K&P:Q>*VFL?L$_@\S(^K
M>]0" C<(WGY%3]D90;DW!<_TI(--*C;7L>=P69W3Q!QSNG:19/Z^QXDH/AVI
M3]J[%=E*'<B3H 7D0[<]9PS)&J%$/"6Q,,%3PQXF&2.A&3ABC0S=]VJ=JUCX
M_<B%_J+ 0H.L;S_'5_<O2*FP<N\L:JZ=/OB?"F7OZ)EW<,5Y0F;E<ZN^38H*
M7VO8IWLQ*'5QFP/OJ$,T@!6AUUF!XD- ^.-/NS5_NKVN:&AH99_24@:$F@E,
MV^ (%EU1UGR[?@A30LD)X<X@/0^J!TNAML_*"@%N?;43SE<CDN7I)7;W]6%-
MK993K74[FOP,2X]LE";A251VXDC!/%*)4/NQ*RF[Q2H*7Q[J["RR^'?]TCDQ
M7$X\U7<QFT[!K?Z6?OP%TVVF1/\*_G(,:X\L#?XIJD*_Z?);VOX!^WMTXL1$
MIZYI 40T)=&5!I@X8:N6)M%_7V:QV*$/2^Y_-55BV%A;\:4;@3080I+P,#+J
MF_D\B+CHS(MR<2]XMST9>Z5S^4PS2WV+4A3G*+?G#)P^@/HPLE7(\>B&<8!
MS7IQ_UM.F-KD_!UC?4'$X7##L,%6>)EW6> 4=#AH2G1VN<O75^G^UH%O<S+[
M)OM/;P( L P(U%GE0GYH3!#L,8E!_FMH,\+1@NE#$KW>;!2D^Q"UC)?^&7?T
M3NZ'+->R:BX'M-&SMM9^XAC_-88=Q4CZ6&? %*\[G&\GN9@<#;*L^Q6+GD.M
M,\QG'7=),%2]=PTC4?Y:6:^.<PX<%%E<N.<9W)OP5=?NY83XE>!ZW78!T2&&
M#')6=H(X+,<N[/XJWN1&P!.Y*]K:W.WXQ"B619:\P4A4O6*-9<@4/: J38Z-
MD;_J$&U'KQ4JMZWC/V6QQ$T>=H.Q[0S_@ZC__N0T>@6"IP$_&NJQ[\$6N]+N
MY5AK@8>K62MUWUISH*I)RR_Q?G=4W!A+Z)<*KO#@43]H@#'))['&/'>>1V4M
M^=2#$IUIZK,O5:GFX+X,\BBE@$[[RVH5P82CWQX3AOMK1'/4+19/,J=?J13+
M*3C#LOSI:2"GMDT34HJH_GI:U'OZ<O_:6J"9(9'<MOK^I_N;9Y^O#:6:]_7+
M1NZY$_.H[!637@P_RP@R,6I*W.VX8^.+EQ+D;]. 8/$#DES.'V@ /%U/YK=>
MNP;9,-6@;/"=CH(;64@UC!]- R1,?Y[GZFY"U!N<$M=&'T9X$S&- \Y3L(/!
MZ8[C?H:OWG[UPZ45 V$V2@;\?T!P'Z$B.1#'.!Z><VY S4QLFAHZ--;F30,R
MN,-LJL@*=)3)(]\!KQ(+@MO#D=W:(TMWB@AI2_)(TOI#FRY^"\B"3ST,5!)[
MGF]Z -L(W=^5=W!R;=,$,5_?<IGIGDKBGG$+).\P)9-@NHTA0%8$WSS'[ _.
M.S_0_GY!83JMHSHBM(:3*5ZW/>*.+SSBL>?909\:Y4*[11&OV7$,RH-Z4U"]
M5_7RF8EQFTLL>OB>6<8]Q6R<+,I%"5102JP5;/-ZC3@792XR[WF/Y"> OE(.
M=Q@]#HIB//GZES9S\#8K?/B)8=/ZA2)0P[ZT?T63SS#/JRD'@W]R<D,RW)#+
MPOCGZY>G//XEZ1(:GFM <P5GCI4I0 S[;,UKO6]G/ZW0FO-[L?'U%NI+-$&)
MPHK\9?H&.!K X^ B\%5'3,PGXX[9GF2!T.@YP>/'3)2D.[^RUVMKQ! ISW+=
M,^Y^YP]_,J!Y!ZB#RHH67HR7=SMSPOZ#M:,AWUNY6O=/N!-T[M/Z+Y9I/K73
MX@,A,Q$6^A%.4PHG3W^D,OHKK4GKI32KK$-O7G)C?)>-T\&YP4#%K[%9O4/D
MDX2&B58]J_[ FA;.<.LQSI]B,9E<!8--J$,TP(L&Q*-*3W9F21.3BW3OC060
MKNFUN20_/=%29L?X:5_HQE<]"QB<>@(Y@6'1@^A\6*K5ZOZZK'7 Y?K/O5D[
MTKN'L;*HB1&X"N(7?=H,=KVP(4$(BE)+<MBUJNSW=OZ8"%UC,E=^&L:;MP!_
M^LC*+W(+UV@.*L":,<(^9L>F&\;Y'Z#; RA:MQYRG1G<KX^Y RF7;T3XDFZ0
MK< 4^?(2(E?3CON1MIA +:=HO>XC5Z!1@\\M+]:9! 8I;#68JGXTDU__MGSM
M^:*9T9^ L'C2Y[XM#8A\LZ%JYG^U>P9R=^E0F\*W<+][-N^#(50V.V++9*_2
M#[TC2S;=B2YJ<"5+3LB-WL(/>U%<GX,=^!EV*KY@0"5H0D!0/%08U#@W*"YD
M7=DK'29,I$P5_92$.GT(EU^<H.,7P=H\&B8B=L@]<$%'\FU'Y+97J++'L[4'
M]6Z^6<\S35JGRY"*EN=;N>9[OJV+&O9HK<PF!TM;$-L.[3>ZW"J>S*)7=A3)
M0>V"E:,:43]0%DEDF2G3UN,".VVO1XLK>W]VV7]I 3!KT@,TP -GC+H)!8]K
M1%&UOWIE!_=HZG!-7;OSX/C'N0LU/MM'O6\X4WYHS@#+%X_9,B[;R@E$RXI'
M<8DG;Y;^A:KN%FZWTQ<+ T*WSPW ]3T]L?Q@F>0UJ=[CLU=S2CE4:A&-/,*2
M#U]=^Z OOH]UEZ]Q@N#H<S_=)G%8([I&T,DGBW?3?JQ2['GJU=CP[<%V3-G%
M(M_WR%X4]^KJZY"\YXW5D:[.:30 J@+H1@# *8#YCI4[P[;DKTB /'DJ54&'
M]^4+O'LJ/LQ?S80>^YA;P#;/.Z*;:_M&\VG $S_WDAC83B>>6D;\_"M,S$6@
M\)]KCY5\OA^<5Y<%[5-H:XP[7Y7QM6YKWUE9S4TIUSZ;<>C'M157_-KP7%U2
M$7AQW=#SUM6U=XI7CHYCC@BS2^PSY-)T.6H'@8A'@C)P5U3] ;6.0J[A.>N/
M\=9V=C2 TUYXNJM]5CKB;4M^6_VF\Y+)2YAM?G;\P]_\S>5KYUWK'C/5!_S*
M<D%!UPOB]YM($0#1I9]*(^Q4MCP\]$>4:1'4+)"(3CS2KHYQ.7%PVV=!9^B(
ML:[E63U#%ON?.!4:X(X9Z9BR6;$).1:<YI Z8NC\J#M@:F OE&/&^[3)P^CN
MW.-&-R#\/8R;'=MTJXJJ1DB"4AO7%H8?C:OW3TTO[RG^4.BC 65WS-/1.^PI
M"W!AQ$WZ92-D*^),:L-DF(-@O;K9%R$GP<'K86VR/WHK'Y@OH)/R"XPYNZ9@
M*P+3$PD]K>,R1/2#P,9'J4Z?^HZF"G19%,_=0%\'WJO$R_TJ: !6](D L5<(
M,6 UG0-1%!>,)3Q-XZ).&YD_,U8[$P_L8&.AA,L^21-L/]'+X]I]96$W20-[
MK0X&-\5B9O?KTP &7_@5,IWQ11$;?%75,3PUHMMW1O5R7K9>T]^I>/P1\I8W
M;;YLM\I 7AR&JH50>\68*#F;MSX3X \"5KQN6/3J'WI450ZAAIZI,\YZ=HQA
MV2S(BKP<;-ZTAXT@ZWL5NF4\WDXIN*8'*B[/N=UZ\-GJ493\VL30$I7=.3#/
MQ/,E&7YO;"15$MUH;<%P')'L?<0REO%%S75U8%=HIL>7<;,@OHN0EZ#:)1KL
MUV737<:N:V/:)\D[XC#<_K%!6VRQ(9H&#!2Q/?SW:P'83-QM+E#.-0)V,W^N
M-Q=#Y84+BG^9'^!]/W](&.J6EL(R<T<?J<]FI,JP>;:Z.>9IC)6PU M ?@X^
M3#>6=$(TGJGD1QL6RN]YPL4L]M[!Y9R AHX4WH?!DLC)KHYAG#+=T;E V;S&
MB>%LTP0'^%4OR8:/J8(&/1WZ'C8?'LTAQFIWY5,>%CH*7,F&C,&%8/AJJA;Q
M<&H]'L<QGR5<)A63M?7<HKKEAMZ,1QB^,-S\\D90H\](R317D_M1Z@\P;LHU
M_G9<5,_RT,B'367]8I:]^'4/N2%6'^Q<O^+XU$_W]S*/9F<>=WS"^(6H"?!?
M_BTK?K\SB5TQ(4+Q)#J79QE,(IOE&@BW5L12SWHCBY65,4UF=ZY80(8GF.GY
M326*MT;@^(G@!M-NA/O-&A-9_;SQBEJP/H&P7M5B.5 [1,F$X?-QK"BW!]<_
M)MCJ"0U*'[&Y.+ ]HIH89J1XX:()'AA![W@2#>/-&"B'+>'Q-. CG,Q/ Z8T
MELNWA_W', >#+QZ6ZU&3N_J4KX>URNUS7.<+3)K.X*+Y\EO2G6#(=LWWFHD#
M'HZ&Q4Q.:ZJ>G09AGHMWYWAE2&[&,ZZ0^"<16WN_@CA*<XMRV&8#;<5-7]C\
MO_7@_KY^B.->^FNA\:TQ%X(>B_\IR:'ZSF?'?___MW7*-;>Q30?8M 3B#B4Q
M%$U];&)O=1=7BB&_@*-QR\Y]J,V"\U.%YWYK(](%LF)#YC6G6FX0: !U"K;G
M5XW-*9R#@E(8<L[<) V@-*(V9P/A1E=._-NBDDTSAG!Y#90[CBI!IBM%Z0@$
M,E%/X1(HQV:-?5^>J^-N##CY0<L*%N!T?_8L$#!144'FGV[ ?30KW=M__TFM
M)'$I[Z#=AM>;FRZ.,V^_W='GV2>4;&*A#TN=$**J!^=-[R2M(LY.K=Q:N]:O
MR*G1.2'%_N+^M/YZ<_3'?$:B=-68C57U8."IA)&EYPD=(VTB[JLR#]N.KRMW
MG%)NNR65:C*39K78\X$^T@O_=*JJT?>@PF1S@F#S]K@$X4EQ4(Y'>=Z#(SY/
MK+Z=-XZ3ESC,4;B/Z[7?I@5D.6Z9CES,6O096G'W@<25]943UM YYN F5X*7
M#? DS.^B'R#5;"+NQPX8[V7C7HR=LJSL49JL+LWRM"MTY6U05;QD_.)PK/5A
M>LR-I[C04? &JO[\Y>WD7CP!EN1])+I%_00-R!XKOF)V5^WPPU,7<YY8[D0<
MUS[!^QUZZ\\[37]K(3Z>AA^:I^.QCG)(D>=PYI.4W"&99[Y!@;+QLG%5NFUX
MSMR'$+6S=%+3%"Z(#VIP<&[*.E)U,,/P@;=KYEZ)W[[LY-5.JRM!QYF1LM0?
MT/*Y!-1ME*A)6.&HB?,DZ9I)S^;57)CKQXN1S_.>R8G:)ZZ?'JZTZ&%<7!N>
MIK('Z396:,M\.76$25*YXGZ@D-_:B#I!@TV;NV?F!:5^H'8?L0N]U?5@_&CE
M ,*@<%%[O## 7Z%_>46U:%ZE$<]9=^>4M8& R:\T[*^UF[^3/=(V(WVFWGK2
M@!*'?DRLCK/"Q'W$_O--PK=4'-T2O@L]F)UB?'>.  P9LE4L:435>.:2#0F9
ML9]>P4<\,@S?LF0-+.X?.]P:ACX[%-TJ'L7 9+-1 ;^,JE>E(]'+=,Q'G^2<
M[X&D!ZM(J&=:9*#PT6]I\K[;3UORS!;U",+"+D#':62;I<7"<%(M-J\^R%W5
M1KW"\MWWKWP0$\M8JT?)+.)1+%MO"T[_&_]&P=QANYHX*&JHA9ZN+%QYW&3C
M23*A 6U-((G:K&M$ \[GOC]6^EO?66 ;2N9AI)JK+U&;.G"40\R($+@3/0_B
MALUL>..6[3_1@.X/E\(8]I8,!.J0/;#2BAB8"RIV4.PHT6$MQ3NWQ=-+Z(!_
MOEGB_6S'Y;"TB)S4TS]?<CZ?@C3J<DW:W/,)7.-9?!*JA\ZC6T>@'XD'XK1X
M-6M?8JHQP.NYWKL]0Y_<S\%QTS<KL@Z!04?78LC2(Z\R0*B29;_@J]VX$\VH
MZCQ?:##^L9@DR9DZ*J9(^5CCYJ/VS.[B]]NCF1H&49>\E@=+E*<['R5_Y%G>
MERS?[-$#2!73G6_1+3O^^C^K587E+5\FA8(5VVK$&\^%X=:$US.ORD1YW;D>
M*YV^>9\&=,CYDL]&1PAQ[X?=1.Y#A!$&5V0(/2U-C@*U=E^U"5X!MX\/I$9H
MG#TV-QO8VCJOS\3+(K.[AW6A/* !MXO"MM7 HH/%UWL=YS6:;@P$%(')VX<I
MDT/GGQT]-"A.?J=OQD#*,[A.5@8?9Y.=")SI4SY<CBWY;GN-^Z:&;TZ+;UW2
M+I1C$M")8M&5#_W'N/&J3PG?\TZFNCKKD*>=V_"U-X^_&/'*=IQ4Q@,,4ED
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MI89NW8ZHMABR-@W :M& S?<>EQ@GZ#[Z3_,WV(M0V>S2WZM]C%M&?]DS,M@
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M5VLCL=? O#,?^S:7[F-5*88LJT5YB;,R#_I4M#%G<GFV\MW8 RP-Q'_W>SV
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MK/'RE;Y2B($!_Y6(/YK_5&0/:MT7J4<#BM&6=";X5C[^_>!?F)W;W_:\+,-
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MQ$T%D;D[)M/C)5+-#W@BCQ**>AF+;<_ARN$%FKQ0TJ[Y4ZZV1?E%^+ ,E56
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MZ2N91,G$4M6IG9:>(KJEZ:'8*,5ON3>23'6>),:XL@$S[R51.\X^'N3P0CO
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MZB;P2:6QP+TE2')9'T3;$V]H^@6*NP@+S)B"K61,-"J?MX(UI&V24GV0XSG
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M-Q&S0\;^JOT7&;=1/WGXNR;_=V43_<3_T(C&64-9F,8&*QI\BLYW9!.C7-M
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M,J^J-+2XK%4KG;N_=*YP93*:R9M5B],PYVJ46MUE,##]?:]R;T&@1 ?2/H0
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M*IY2C67MC&E01-0A);K@&3 VU'C FS"[Q 8X:]?C75!^>>_&)"/E9E@T:FT
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MU30D[V]X\H;II5?]7VZS>BS-!#\X-RW;NG2!=AE+/(HB<^QT$ QQ=!94K N
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M!M8H(<,7%M^P<^]]MJ VH:MZ8Q?DE)REYF/%:7CE+[T>$^ ?LJR68'^V\?\
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M+^[_XW>_WKV'V>_^]W_^TS_]^_\#X?_Y^?-'\';)5X]R48$WA:25%.!;7CV
MOPA9_A6H8OD(_K(L_II_I1#^9WW3F^73<Y'?/U0@#,+PY5^+/R0H"V6*"0P$
MCR&6*(%4Z1^C$ G!.!9A$EW=_P%C$<52I3#!J808\0RRD')(B< L"ED81'$]
MZ#Q?_/4/YG\8+270RBW*^L?_^-U#53W]X:>?OGW[]OOOK)C_?EG<_Q0&0?33
M^NK?M9=_/[C^6U1?C0@A/]5_W5Q:YL<NU,.BG_[/+Q^_\ ?Y2&&^*"NZX&:"
M,O]#6?_RXY+3JL;\K%S@Y!7F)[B^#)I?013""/W^>RE^]Y__!$ #1[&<R\]2
M ?/?7S]_.#DE^<E<\=-"WIN5O95%OA1?*EI4'RF3<RU]/5KU_"3_XW=E_O@T
ME^O?/112'1]V7A1[HQHIB9$2)4;*?SXUV4\7B.])WNI05@_"U>I^\B5C%Z:?
MO(E[I_E!#B_PSC07B]P\4.\68JQG=S/5Q:(/+[&OQV)9T?D(C\5VFAV1Y^87
M'_6_VFG,0!UD6L_34O>.J/)[)1="-FRY-S3(Q7_\3O]KMBKA/:5/L[>255\D
M7Q5YE<OR^BO-]5_G4BV+DL[E]>.RJ/*_2_%F65;7K*P*RJN9(C0F)",P91Q!
M'/( $J*_76E&(X23A#!"9M7FL9_)!?SURUK"6HR+9?B= S[5B?>\D.5R5?#M
M%_)Q?NRSI[]XYAN9_;2@C[)\HNT-6A%C3#2Z_>=&2&"D_/>?MJH.LP3S*0 [
M'Q93(SW8BG\%-@I K0'\HE70O]L#'ORVUN/_.[D&2[XG\=R8+,OB)8I+[@/%
M+4N4&H :0D5+5F/0#O^3L2!_DO.J7/\&FM_45'&)!#\=/'C7Q5IS6O SZ]M>
M\1-?:@OOJ8)[2VTL8F\054MOSVRSH%KTWX%E(62A+?\C,&S>O_G]0LQNE5S(
M[[_(1R:+&:.8Q8PD$!$1:K,]SB!!A$/.6< S;9'+,+8AMH.1IT97C6QV-'4(
M4S?Y7*3\P)32B 5^:P0[S1%G !#M=K'>ZPP#Q-X4K_8@6'/E25T;!C1_KFDM
M2**@IK;#&T8AK)-RKFGH] 5NY+*FLY]79;Z097G-_[;*R]RLYO7WO)RE&HA,
MX!2RB,80,QE#*M,4ACA,)!>*$(I<;*@3\TR->-9B@ATY]4=;2VKY,I[#U<XP
M\H#6P$S5!RAGR^8,#)ZLEU.SC&JAG%'UI15R[O)^9+"Q9MXO"V.^;NT<8_7\
M0JOVI\_+N1[E_K\D+>Z^+>\>BN7J_N%]_G7?_/F9EOJ!EX&V4X(PADHAO1DC
M9C.F%(.1RE2,XH3'C+D0R0 R3HV$KI6>!2P7$CQKZ4'5R Z4%K[^3>E&14.L
MJAV-O?):36'_URKYK/\ZKPE/[P3I0H O6M^YW/P9O-5_N0(M$(#63\"-?@):
M,(!! QB RI=[2G]T.^!R>:+J(20<E>8'A/CE)V+(J?I]7CXL>"%I*=_*YK\?
M%E^J)?_KPW*NQRC?Z2]9]6RDT0)_HX6893Q0 <H"R!C'$/,XA@PA_?W0R,LD
M)CB-,I=/A^/\4_LLK,4'/ZP5^!'D"["KP[^"1@OPF]$#M(HXFJZNRV3W+1@0
M_(%Y?@#<G:FY)WJ>:-=U]E$IM2<T+^FR[S#]J/"CMMVEO'F2!:TT^7XT,W[,
M*<OG>II;^FR.5LJW*SGC*0ED%H20B(1!G"@!J;:D(4U"$861Y&DF9]7&5W/V
M-;2=V(G\3GBD?+Z$M3L*S.OW\*D5TXW6K"&WX[,A@!R8R!J1K\!&:%!+?04V
M<E^!:@F8!+<T%_[(RQ4J3ZQE/>VH=.4*QDN><KZ_'T'=%DN55Q^793E3(D8R
M12E,A>(0LRS6%EBF8);0*,M2QB+D9(9MAYZ:A?5)5N"'N1;,?.#Y\E&Z,<P.
M9G8<T@^)@5G"@/"AUA[\8$3[\<K\.%^9X#1P:[8$RP6XKJHB9ZO*["\,9WS2
M#_]R417M_O7#0B^7]+DW/83*$TOL##PJ#QPJ]/)-/W)%OW?YK52R**1H5O6.
M?K_6%%*5>J%GF$<LYC&%89@(;5ZDQJ.8!%#@@(59&H=)X'3,?WJJJ;WK:TG;
M-QU4]+LYPUE(Y^B(D^#:D8 ?R 8_ZVK1:IE!BPD:.:_ IP[(>@0SG$/#6\S"
MR8E&#DTXI_!A!,+9._KR!*L^+,JJJ#V[;VA1/&LROWY<KA;5+(Z%BFB"H$"(
M0BQ$ %E,(ZA$)-) T$A&SD%5IR:;&E?<K"H32UQ_ 9\*31CYD]Z,T%I6L%1
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MK@)"K)(!;"><&DMO90:-T%=M91[S)J\%=[(SK:'OIM0A !W:RO2!I5/!-1>
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MEC"GH_7NZ:9F)/0/$3@):/^=S:3#!%YL888-%#B'RX [DM<-%CBGN,T>X^*
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M("A.0DPPC'D:Z1<^SB E*H"A(%(1EI DSARSF\_-.3UORN[AHV/ ^5F [6C
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M;THPA@3+%&9("HQCEN L<PD!.IQBFK$_Y8Z<_PID+:GCN=(AF'&@$8OU#L]
M"G&H$*2(9I!D8<:2.%$\)NZEH2^#=+RZSNL@;%H!)N_SA7%'FUCBI^Z3'%MP
M%8ZYH#2$,D@1Q"*FYB&5VE!6D4A4*E&4NI9:]@'M\'62=X"5"^$14IQAI3<7
M!"+)]/,:L$AO0)!^^055,481$J%3)]T+7_XQL@>&>.TMSX(O F?H@]P]7-K&
M?-=55>1L5=49 -42W%*_#OS3B/@Z3SV<8-S#T),*'IQDGKYR:CU1WR\+)?-J
MI1^_OTB3Z23%]5=9T'M9][DSI0$VM9AG(8JS  D%32<ZB W-L( 3F!&:95%
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M26[G!/$38+K>$;XK7N.\'?*<# MR'13@@5G76?9 M.*-62_?N#]U/"+RUOB
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M\_[^8FBFWAAKB>_ _7J]*MEF77="6"_!%QHZW_LJ7.$*1UP<:>SB$==4/E-
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MY)HR4U.Q]<,7$B<8%R;H"RF(:,P@2U(!:481I7E:("2LPSR/'CZUCW4KGD.
MXC%>_5_GK2@,_&EN)?-I4'V,A$-LY@V(C!2,>?W5<(NYO*!Q;Y#E\3WC155>
MD/8@C/+2-3><N_Y8SO4=59-;;XKPORTK/E^:.K&[!D Y4P1%&=46A(BT08$Y
M9%3D,,],*B*7N:32+8/%>FR7]W2<?)9]T?]'6V?#XTS6"GB[/= @8 Y,@^=0
MK)M @)W<X+=!VB\YPQ7R&-=JW/$/=5W@.'O$Z_2 <#T3WJ_D?V_D@C^WM=IB
MDI*"YRED19%J4TIED&&B8($$CF*2,T[R6[L='(TY-0OK4A7[K=B>M?)LX+?C
MJ\"@#FZP>6$8I&S_!50&++A_/.*+E\J_ (%-D?M+M_K1SZ>-L;D^JZ_R:;DR
ME4%^793K:B;3@J:2(IB(M(#(T YAB80)9P61,<L$42Z,<WZ8J9%,(Z4)[5QU
M<H*-$=2-4RY@:D<CMR,U,'/L0-J*"'[M!<F9-/HQ",03%P89E1KZ%3UF@RM7
M^[9RJ]VVN[;)*4LCE+ (QM($IR9) DF1,$@BD46QWB5ES+$*S_$0T]O]=!+^
MQ;57VQ%V=I_X+7@,_'%WH@V23'=)[V"MV(X>/W(+MO/*G;9>NW"=Y_:AU!P@
M/Y8_37W M9[*DLUE$UIBNHP2F3(1%0H*3"A$>1Y!FJ4$QGFD(I)2EB2I2]!6
M_W!.Z_D(45Q]?4=]T+3<" 3#:."/O1$4UI*"G:B@"_<*VK;5#I50>X#^P<8U
M_ZT4/['\[>[RJ<[Q:(R'?]5N[\_*E "1*U[J;['D)GW]?M%DQ[S3ZBT?2_ZU
M_/Y#&Z^%XJC *H*<Y(5)EV6:2+#F%905C,5,%2JVLPK\A9B>W;"OAK&(^581
M,&\T :M:=)?"%5[S8W%Z-#CF ]/5 =B?ZR( '=BM"D#KT.;O=5J K^/@[U)/
M9.AY&*O,R!#SX5B Y!8H^^N2>#UYQ'(EMVA^6,7DIB=Y+$"FL>)RLVX>]'ZY
M^D)7ZX5<?965U \R60UOM8T\7]:]RKLC84QIFJD,1BR/(<IH C%7&!8H4P6*
M8D%):AU,X"' U#Q5K0KMUP34<@5:+4"G1IW7LZ>( P7ZS)#% C0P[@,O/QZ0
M^P1#>'T=]HO/P',PTM(3\O5W6W%NP*]WO?%Y[GBKS0U:'ZPUMSPG1#NR-\N%
MWABLS5[J04]'9<YW'U94E(OO;^ES-4M83*D4"N92,8A4'$.*)8*(,!ZI#!.)
MG?)JG4:?VAJSE1&L&R&!T%+>THKL&OQV_I7!0!UX 3EI3K8G^AW8H=U*#][V
MH7UCDS)+U ;I5G9M[!=L6V8)2W__,MN'C-S(K&TG\WFSKM9Z;=32?%W.YYJ$
MS1]G"45IG+$(2IYJ UN9.'NE.*1"KU,L+A(ID6,PW"""3L\'U%3.':DE6?\D
MVO'GRT_,P$0;H-'8MI78GK+@-Z,N:/4-&;HWZ(2\=/.P?B'_''W"K( .UA+,
M;C2_Y>/#@J^D'O"M;/[[87'/^7*S6%=?)9?E3Y.R.F,X)FE:"!@C54 4809)
MRDVIS*1(L2 L9IE; TN;8:T89-3.DYV,)G.T%=*C#9@5Y';4'0S&<8BX$Q>\
MZ@3^Q71DW,*Z$SH<F;I %(@:K88<E>A<0#BF+:=[W5,[VW8ESW'"'LJU?O-S
MA5B41Q)J^U-;GCP1D&!--EAAD<6XH*2P"FX^]_#);:F-4.:@,$Y>L5^Z%D&6
MB19GT>OGC5LQ&9@?7.%P2NF\I+=7/N?)PT9+YKRDQGXFY\5K_&R$C\O%=_TU
M/)J$AZ,R%O<+\4G+W/Q2%TG:QKZ)3*(L8CE$F100Y9)"AI#^540IISFB62)=
M?&=>4DSM@Z^%/ZF[4ONF=QK8!-L%G"@[4V-P^ ?FEF#(.UL@-R$7R"3QDV%4
M&^4FF(Z-EML>YNN)6Z[6#WK0#XN?LNF[5LV$R+(42P;U?[4UDZ8*8EXP;=P@
M*2-*4$ZMJE3T#3(UDJMEA 9^;=UOI73UB)T!T]:?=1M$@WNC##I&/O#! AT/
M[]%E]8/Y?LX,,;+GYK*2IWZ7GFM#G")^+!?RPUH^5K,DXCQ-2 &Q-GI,C3T)
M:8PQ9(6VAJB049PZ)69>&&=J'_S121;XS4@*:E$=+9A+P/J<!'K!->Z9GQU2
M-Y[MG> PR"G>;I07/*\[4;7_9.[T<L]J?'-:59]5G2*^>V=QEN>81Q)&BB.]
M]$<1)"(N8$%1CN,\ISQR*[IW;I2I44$MI-G"UV+>P 3G,;7C@9N1&I@%?$!R
MKWW7!T*H$G=GQQBWDEV?FB<%ZWHO]CY!63[*!_J'J897+KZ;5.S="YOG@A91
M$<%$F<J;2/\?5BR!62+SE!(BXZAP(8'>T:9&!FW]72TMV!/W!E+HQ]KZS"0,
M@L,?EGB#YW-*<AV4<,<C/6.-?2YR7>TS!R(6-]U0K>I#56VD>+M9Z8=_D:MR
M*9J8DO,'R+,H4SFB2:;M#-/\@V,$B2GLS6.9Q%F2RH([48R'#),C'BT]U6]
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MPV>/^@F?5>OXDSU_D=LG*F0Y>[=8FS8CY5RNWM"U_+Y</<^*O,@30E,8):*
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MQL;-BQ@.ZI'"&DO];\#6 E":< .V1MR MAF@LB/XF?Q5.(8*C>REP[BQD]?
M=!1<>=7#>I09^K68FX]WN=T#2$B6J93;V&K-(8D%A50A#A6/A<Y3(2+NWM[E
MX.%3<X"VZGF4OSG$JYN2KD5A8*;9:M:G$- A$AZ%?ZY 9*1"/Y=?#;^J/F<L
M[JSB<WC/>%5[SFB[5Z7GW#4]3Y3.=RCY4"S4^XUZ6L\TY2FA.(&"$..:Z93"
MG&H,D0T#ESJCTJ_8IHO0J7%6W7WGP^GN.^!WJS@H-?<,_G8: <=SJ,"X#GT@
M%0!2_W,I#XQ"'5"YB!SWI,H#A*,C*Y][^Y'26[:RD8_K3ZJJF5,&8RDY$^:-
MXE1IF$=809)F$N9<4HBC*->:*$-*7NEH9^1,C7IJM<JR7C_9EG<_-QV+C+M:
M%_KZZ;>'-[N_>@83GL/;C74"H#@PT30:VC.G*HSO!M1:AB.6"S $XI)S4D:E
MCPNF'C+&I<O[1B_OD\]'M3%KL_F++;9ETU#^*.;S640DB4BDH([MIE)B?!A&
M.89IKDF<2H(SF?L%Q;B(G5YT3&MV976[0,,FOB''#H"[449H$ ?FCQ/-%C]:
M+M[J#!JESQ-OCR!@=XR"A?DZB!PYD-<=A.-078][>Y;;V+5N?%S>2EG8Q3&;
M?V*%\8WNV'.Q8?.2\OAAU;_/MCS5VCA2=:Y<=9S^68GEET7YE#(J:)9RE&+!
M#&&E<6Q67A&&-$\YY%1SE<9)S+/<JV3'P I/S76J8O9+8VS:Q=8:S[(?0P^S
M&VM.:? &9MS;3^_O+A9.M6&,=0M*O5R514E RZ: ]4E& CY4C9.AU1VW3LI(
MX!_56AE+;H_#@_V@K+OEPGB1&SO3_<J^%T\O3X_F35K;DG&?JCXN[(M:ZK)N
MQ(K9Z>_3RJCUN"J^?+'[QYQ0G5$!TSA%U<D#XYF F5E.YS0V3C-WFF.":S:U
MR:0V 6P:&[;UXS:5\N#9:F_^5JK?JY5.^.%U."AYK4$;>!():5:@XX@AD.X\
MRP@J<+R#D"%PVCM%&42 'Y.O5YO97B)1N75:5HFB.$H4RS,HE:VX8_NTYXKD
MML&L1"K.TSARHN3S(J;&K?O)>*6:7D6W.L#L)L P$ W,9#W0<>:ERP!TN:7F
M[I9+:OZV<T<['CP*D5PVK&$$ARO[[0]8GV\ABGE19P9^5M_4XD6],SK6K56,
M;[F3K.2C32">$:PTHXGY\I$-A8T8@L9'(U E2%!"6$J$5^![/S6F1A'[5EC?
MJ[8#V#%ON@&M;?9^VQ;P>VF-YZELSY%S6\@//QX#\]%00^&],K\.R4#K[9Y*
MC+J*O@ZHP[7QE4_KV4!JM11*R;65\C<EOZAM_=-;L2F^E>729U$:FR6KBF"4
MF24LD1&'-#(_Y4A'A*<L2B.OWB<N0J=&E(W.U<<H=KXMX,N%!%^M&:W.4)Z-
MH%Q&P8T&0V,[,.GMPUHJ? .V*H.=S@$;.GD@%*IYDXO(<1LU>8!PU)3)Y]ZK
MF[74^10SPS\QTBR&F> Q))P0R*FDD+,XTQG-$B9DS_8LM0@ORAFM(8NHDW9:
MC5EZ]U]IL'2CDNL0&I@X6LK=@%J]03JL')@>OJ=*(^"UNJ@<&-C1-^7PRO[-
MU:JBIF4CEFH[?_VPG,MV)?:9RF0BM%"0Q38]F3/;H3(G$ O.[19ZG"GBVW#M
MLMBIN1V'+0.*[?F[)PLXHN[&#.&Q''ROQ_9M:RL7MFF;.Q@!&[DY"!V]N9L[
M$*<:OGG</4 69=-L\LV+LGF;CW\L9S0CL<II!%-DJR4P'$&>1@*FG"9<\B1)
MB%>HB*?\J;&1>0U)P-3($X [>B;#P3BTV^*0#KE9 JZ /1._J7*TC0DC)4*>
MQVZ,%,@3TJ>3_'@>&J^TQX[']*Q=N?FJ5E4P7N/>YZG6PJR5H))I:GM2&=;B
M-M0MS6D622&I\BH@?"QB:L14:KA=*E71N'Y$=0)&-RZZ#IR!Z:;"I8FO#;Y,
M.F][J'J9QP+&+7YYUL"C2I;GK^S?.\JV _JXW*BU88WR*"1.>)IIH:'".3+?
M<YI!:E.;&<T8DYDP_U->FR GA$QS&V2^[2#U;+W!:C6TL&J#YTIO_T921_ Z
M>A]7@C;P-U^J!6J];L!'\Z8'WQ[I0"!@&ZDC$:.WD3IGY*DV4F>O[9FO5W:E
M?5!F\,K-ESHQ':,$H=Q\]XK;;5"-):1:2<,%.L8IQCI27J4E3XN9VOQ^MUR9
MSYYM5-V!&JRW"GMFY9U&U5@C5938!KV:VMZ=AE*-!P4EIH@BGJ(LP7XI3=?C
M.E82TS=51>2"8@'^7OS3KDF:9@JVB480?-V(]7K,!J;62D&PTW" JGG=((3*
M>#PM9-R$QTY#C_(=NZ_NNQ5=TXH-0CQZ:464*HV9@CC)!20BCB"3",,HS1.A
M4<9EZA4QU"EMNHQKS[>]-YN[<'7=8PZ$UN!;RPU0967>0;G!"9-@.\Q=LD;>
M6'8P^W@_V>6F'M'%+T\O<V;;V%1=;.J:O?I6+LL:OKL4E_IUCXB.HR1E,(X9
MAL2&'%,:I5#D$3>>!4FS*'&.._84/C56V>GG$8'L"W@WOPP-X]!TLU6][J*T
M+?IMUL.-_C=@9T% &KH&NFOBG7U%CA<)W1.,O1CIOL\8X 3L5[:Q-/FCC"Q\
M5-\WOQA+_SEC&=/2QMIDFIJ59IXQ2'&:P"17F68DR6GLU['<7X>I$=F#^*KD
MRUS9KZ[1V/Y\<*X#/O2.VNDQ3@$.SZY'?P(':-L!J4*C@;4#E(:$;*7>'\8Q
MSM+.:#"=\[1NB+S.U"X\RK^R^MO%QCSN5LJ5+4M:_?&A6"@T0R3+=(843./$
M]N8D&E*F8T@R+K!QZQ"53A5%.Z5,C>PJ14&MXDWS [#*NC=PZ0:VF[N"P37T
M!E%?I+RJK%]$HE>9]?-/':W.^D7#VH76+U_<=U-H4;:5^T>Q^7IG7*_E4WVP
M]]?5<KV>X9AF.LTSF%&-;/4K!GG,$R@E$X+:Y#+L5;>S6]S4J*!4RJ8_E#I7
M)^V^>T.=\+IN#H4";?#=H1JI/XRFH%'UICJ2OP%<Z>5*@=OY?/D',Y]'57-E
MI62Q 1^,)2&WCEP0"[9WU"ELY,TC%\./=X^<[NI19J25%O^@%L5R59X9OGE1
M!D7<'/+A/"'(^!8*$0P)YK:!2\)ASGB:8(T5)TX[SZX"I\8R5C/0TAM4BH-2
M<X^:'RY8=Q/.$ @.3SDG<0/R18$2V1[UT5V0]*B9'AC1D>JH7T0V4$$3#W0Z
MZY2X/&>\\B,>5NU5%?&Y[_HDV"8^\]UR589TG<K$1!$G.M$$9C@C=C],0AI1
M!+,LC12/,YFY+0)[RI\:6S<JE\[+_=.BN.6V>--B;>9/&Z@EEFO?:$S?$7'S
M&@?$>6!.WT^3_:F-^,^@"O(<+VG6 [H!\F==I+]:*JT'-%U9M3Z/Z>&"OGUZ
MGB]_*/5@XWL^F7?T*UNK3^:%JR=RK7,B(I%"G#'+;Q&#>1['4#!%L,Q4)G*G
M^'$785,CLT9=4.H+&H6!U=C#7[H$L8/7&1"XH7>]NC4-Y!4YXM'I$5UZQGC>
MD*,U>YZ0ZSW]O*#?%BO%YL6_E/PK*Q9V]^%^L8L.7,^8C*1*"8.(4 4)1Q3R
MC,<PTIRE44)E9!:E7C&2%R3ZO.'C!$ON% :V900PSLWMNP=0['3V<W,N0>[F
MU@2$<6"B:.%G504_?2@;;]CR:PX0>CLMCL $<E(N21O5*7$T_= )<;W-/VS*
MN#?R16SN5W5F;UE%4"J2:XDCJ&/)C*-!**38K*O,W8F6:1HGU"G'_YR J3D7
MM8[ -MZNU?0NR'@2R&ZB" '/\ L<7V2\PI:ZS+\B-.GD8T<+/^HRJAUBU'E=
MSQ9WK%B5%;??%&MAYL(7\S+<\G6Y9SX3YNLEL:)0L32')*4$\B2-8<Q(AE.5
M9%'$O5K;=0B;VB=N=06ELJ"EK7F7:WU]&]EUX>SF'H1";V &Z ^<?[LZ!T1"
MM:GK$C5N>SH'HX_:TKG<T[O35-EI^^UW6^)?S5B41#RB'$JD4[.ZP GD7$50
MRBA3"=5II$73J=R--0XD.+WJ^^W'!Z:*1D&@*@V].T?M >A&!GU &:T?5(7&
MVPMH]&GZ=,KF</V=]IX^=BNG4Z:=Z-IT\K)^GZZMUJX^VJ%L,AR88IQ@"C.A
M-"14<,ARE!BLHB1)E!22$[^=@4,1T]L**#4$]@J_S_8(/+?O]AI !OYP*R1*
MW09(>3IG>*"O]^CQHWZ^YXP[_'[/7M<O_J2<O^ORPO62H'X9$X33B&093"CF
MD$1*P3P2"FJ-&$.8*I$X>>X7)4W-;6_6G+6N?I$1Y_%TV.8/A=+ 7_DVD*W6
M\V:W3.\537(>,[\PDB#8C1<_<AK#<'$C%^&X%#!R_@&C1HI<M.,P1.3R#?V<
MG2;1YU[?"K%Z,8N"74;/0?H-Q@F*=:0@SYCM,"$D9&E*8"YXEN8HMYF>?FZ0
MN_#I.4CM#*E:^_[94!ZCX.9/#8/LP!Q\ =)!TYW\ 0ODH7D('M5W\P?DT*OK
M\81K2@EY;AONWS2AKZ NPC+$QN!IFX/67'F=S;_3AIVNL1)H@Z]LX_G+81O/
M5J?97W[L+JD#GF[_8"M9:;'K([<N0Z >O[+%?9D0O?Z[6F^4?+^H,J5GB28:
M8<0AM[5:"!,84HQL:@[B)$<1QAGWVSD<2_7I;4E^?OAM#;Z52H*?UM;&M6./
MS=&'W7&>G])0CN0EM!H\MXUN=WD&_,?I1M#6]!M04VS+^CK(=&/L!S4 -Z""
MP-8-JT (Z&V,/&RA?)6QU![7TQEY,([\I+'E]TT8?V3?WTLCI]"%*'7\^%*E
M<T4XD['((.-"0!+',60QEE#P&!$BX@0IIUVUBY*FMJM6IT,;;<&^NJ#2US=Q
M_!S W7-!4-B&=F[[(M8C@?P"&E<DD9][\LB)Y!<,/$XFOW3#R)ZP/75?OBPV
M-B7@5[;ZI]J4'9*;R-\WQB&<J5RDD;*E2D460V(;G+(DY5!C215)F(ZU5R[2
MD,I.C9Y*0\!S$^)?-9IGZZ:[O-UF>2HMJ7_5I_?\*"_!P+YPX*&=OO_;&%RE
M6U4F@]+FFUU&B#5[ AZOQ^"\MI?KHNJ?P[/U #V8-^LCL\>Y\"[@^^'K<K6Q
MU<S;J0A")[F*,@)%2A D.::0,H1AGLA,T3RC$E&W718':=/;&+&Z@I^^&*U_
MKDAA;=6N&A)XIW^XX.UP<AP PW$8^2#7XV$'G4O:AS=T'@?(X2 <Z0CY.BC]
MCI/=P.D\4+[PB/&.E-ULV3M4=KRE!]7>_JOXL;Q=F E@]2O;K(KO=>0#BK"(
M>:2ATE)"(K7A6&F(5N"8ZPQ33:+,.?KFC)"I^>"EFF7:QU91#R8XAZ0#>P;
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MX%TYRO:_H&71#=@9"ZI+[+@?_./^'76SS@8&\%,#Q,\W8(L%:,  %HVZT6?
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M=I(Z=@]L'RA.-,/VNOT<;[7']H/YZ3__K?D7\Q];+>D__^W_ U!+ P04
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M"R(=QT=5('*0,'N%0;E)')32/9B6NY0WPPCC&7PHK;UG QJT%M2B*+@NM[<
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M!=IQR'@<9ITIJ0DDWK3B.9_,%J?]RV]?RI#46Q%J=,305_>$^[)30^F:F/&
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MF$3F\G"^<",3&)#9<9++Q:I,P9% K2!19)<,IXSJVIOM=O5^(=2UIB=5A-Z
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M/-0>Y;&=FMVP]+U>,U320@-X>O9-UI-/LCX RA7C'5@51"T/<S;@PO&DI2*
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M<L<81I6UC5]-^OL%;!5 31K1;@/(?@&7Z(>]@"^EE]8ZL<E 4U%*)YCU#H,
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M:1!Y-7VX2<"B$#RE)#AD0IK$B<]HEAU-H%D SEWMB[WMU/3;'[D9N%525P/
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M"#"^,%"T&"$*9, 3CP&]B3*9QD#;BK"QIZH-!;7V6AF_;.;)-K4A6Q$LB\1
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M\NV=8<*BM,%A;7>B2;JR&* U[R&79!T7&I-L/2![1Q+'M:X# 7-(-74P(N;
M/>G5MWJX.:G]Y9AG$7CR@J0< W@32 9<:Y,8*N9:8[,)X2,WJNW!'S@^ /JL
M>_@-O]1MY-VLS!??5L_:IV1APU,:5!L\1UNC0H'U:S[A]SI1:/;EVG[*;(P)
M*,BF!0?*8P'GM086LDJ,&RF;CY]]C):#C_/O/?>GZ3*=S9<7"_Q,4GQ-'_UC
MHKG*@6D&.M5[;MEK\"@,9)8,U]E[5,T+)I\G:^0#Q1;8>'"6WE@9IV)95HFQ
MO4JB'GW6(%9F$YV#VYJ81%3DP!<5=;V*3+Z:XP&8<9BX8X79UEU,AK(UGS#-
M9VEZ-EWOG9_P3YQ=8-U3UZ]<?I[?5+'4&L(KU,N2G./6@>>^7L@N#B(K&6R4
M:*PEY(?6U5;[4]NK9=H!20^/Y8ZBNE,Q6 <4<3[^L$%,UI"%E(\BC38A9[6@
M@%+)4(\X: ]D44!$5UO<^J1UZV$M0]FLJ_CV\L'5_E_A?2*]%98G6QO.5V K
M1NZ]5U <XSYPHVUJ79_U.#6=VIQ=D'#?YC02?0>IK=VMY^5)H>&\"". 8ZH]
M0EP&+\AT%Y'1!IU8#JV7T7Z4CGP^.P3XCJ"R#H!Y70O\^F(YG>%R><7;JB#,
M9(;:<@N<L;K**,KPL3;URD'[9*U6N?65^"<)&M?&'0,1]^/!9NKI 6N7M*]K
M>UCV090BZYT@0V$L*Q"2E<#)4])2,<E+\]O,MPD8>;]LI]C-*80]I#SVB(H/
MWV;35_$SIJ^S^=G\RQ2OA+*NVRJ<UHI$"YDQ"E^DBA"CLZ ]L4+_Q(+;#3EY
MYD5=>%+[Z&\^D##'!L;[59#S9K[ >ZOEJJ O!Q^-0C"2DY"8X!"#1&!")FT+
MBTK$K8#QS(NZ\'(.!49+88X(C.7B?/)Q,<\7Z?S#XC=<_#E-N+*=&8T1-D?P
MWM8FCCX0_5@A7A)R::)F6]5^T0MN[2GTIYO]Y+%WCXN/([HG383?!WB6KV9Y
MS<%RO;2"UC['%(!BR-K%-G#PM*+ %DOB0,-TV&K0XW8(>DC ./M/&YT^!,B!
M N[ ;[T</_GCJDFL\&@%*A!%EGK/WI%@ZO)AB3&CO(W8/!%]FX#1T7&H0N_'
MV7M+=VRWY!<RHHMZGS:<X?)-^'X^)=-:-]:K.RLEIV1< 6Y8!&4UN5@^*N"^
M>*:$P"C,5F[),R\:9]MICXCF0NT3(!_^^>ZG-3,\F\#KU9:BR;[6,<F$=A$A
MF)10%4([>_8X8:LWC5/6<U2(["G6L3'R9CU=<NVMK3GPQFIGF()L:@* %4T<
M> -688@Q9:G,=L#8^/AQVMT,A(;#!3BR(WJG:\.J?&WE=D5$EPR9-\>JVU7'
MK04I'# =0Q1<.96V:K#TC!>Z^>WCE@$>.9)IH(#N('2]JH(5AA845UJ RMF!
MRX[7+(%0*C.F]%:U(SN#:.Q(IH5.GX3('@+N()3Y\!WK+(+9EZMU=#6,('-%
M?K<&@\F0VRT=A" -F**4XIX6SGU7]?!>1IM)Z0DR^^CX_DS-!@+O #?D@'^?
M$R/XZWQV-UTHN4S9,@:>Y  J!@5127+*+3/")>9)>(V1\R@QXP5"@V"GC= [
M0,_]\_GU?GZ]S<^^5)&]OZ[>YXZ)0)LVU(OZM1L5)WM-;IPCIRTAJW+CC3&U
M(XGC-HP<XR!Z0!5V@-!;$KR*)_XU/?_ZYF)Y/O]6)[C7RQ^ULF2Y1/HWUR$9
M.47F@Z_-7P6G15@L>,T]+6UGC:(U'W+K2=5[D-G%8>8PL'E0L#.L#CN Z>7,
MJMHF\XK+Z>R"6%I[&;3B7V.9+_#R<\1@O;=$DB U3V=A\6,EY#K5N<IG?K:2
M_[KE_D1$+X1&$@#Y(.0:\P0^%P3+!%J90I&^M0LX(#M='-4>!?:]8**#Y;'=
ME*.)CBH+HQUDU*6>GP?PBE:^Y5E*8103S<MVMZ-LW*S+,4$[@*8ZP-^'\Z^X
M>#-?GK^:Y34+U_'?1#FMI'(6T-=)S45*<-H[X-Q("O\*>5^M4?<4/>-ZL,?$
M6C.M]("P*\(K/\L;AI83=+;4WF60,H9:SU4H)-0&D(>B"[$8>>M&F8\2LQ6V
M](O 5A-]=-#UX)J1&W=B@CXZC8E#XM&!8EJ"#[1 I$P%DR-Q:344I&[(V I,
MYD6!:4\=]'EW[GI$Q"\8ZD7FR\M*=TC>[M[<Y@<UN#.W!86-[LM=O^GF7O>M
M 1[1VX*$FHS*@N+"D]LM"TA60LDNNJ1:3U1YBIY#+<JF9]_<"0U96A6= ,:,
M)UP3N*,V F*4QDF=/?>M4WQ/$C1NFJ09+NZ;E'9*:-A5;WCSLG\[@:<>-Y2I
M&;"IP)/ PJ!+_8<VI]7T:DG1E>4"#/>^I)("NM:W"X]B<&J";^6,O9^&6&=W
M37&YEG?^,/M46_HL:AYPEG^=SQ97?UP-L%FIXF:!^&B"14M+SV1RX@I/$# 5
M"$XDH80QWK9N\]*>BXY-VRX(?-2TC:/N+KJ,7LO@:=97O/X^F\<E+OZL++^;
M?;\XOWN*=",%8VRTQ"MP)A@H:VO2+RHH*7)KB8CB6Q<X#\''N!G@X6$_ELI/
M*,JXM QAHV4(Y]>_,K\GM@-Z>PQ!QE!N1TOI',-=X<GRD).B92)6I11DG8LQ
M$ 1/Q48EVS?U/@EW98*U=#8' <754QH"(WBO)%@?DF#<"-Y\@EHSXCMV3G;!
MVV#.R4[*[2!!?<WXZQ^W;,W;!?[G!<[2CU41)N<F!<\M. H_00F=H4YZI[ S
MJ^A3-"RU[BJQ!5F=(/&X@'D,MHVTUQ,@-S&T+M+S2ANL-QPU-Z&6T]%*U\R!
M=<7PXNJ_@P'R<;(Z 60K*#P&M49ZZ11JR^L5>W6]WKNHK+=@E2CK,<V940 0
M+:]77Y)2K8^!MZ&K$["U L,68#M(,WU%_Z]_7'_['U-<$%E??[S'/_'L<I4&
MI9BJS:]9KGZ,-,27%."9P:1T2GPXZ_8D99U$Z+WLN*UTV*LE?,C?>F47BUX5
M'FJ# 9)?MG4>%JULC :U$B3#YI=/=B*P$]O8$"';F,<FZNH)BZL,V'(E,7YE
M\F,H)5O:25RNMW \(Z$E!"ZRLY$IG7&K3A_[(.\A.9W@K#T('H/;@1KI:Q.^
MQ8Q8,Z.#MYD+ PYI82I.?#A3!.208E*,*R5:WQ!X@IQ.MMM1X+6/1KJ%E[QB
M1G-KM=.09,HU:Q\@J(QU)$ 6F'A*H?6,F2?(&;=X>5QX[:.1ON#U^L?*#7YS
M%I;KF](BFF2, DGA#RC).<1"UCA*:4).)A?=>N3'H\1T JU> H4#--63/W8I
MSCW/+F]+8;VH;;2HBHG@7)UNX&0B*Q\#H!76.1]3\H/%N8UYZ<03/ QJ3Q^)
MC*/W#O#_V]?YXOPS+KZ]F_V)R_/;30$\"J:L0\C>25"H*'Q#I8#, PNVSKCG
MS:<F/$I-)Q@<%2WW+T&W45T7.__/_WDQ/?]Q,]_NJB^%0RX+CV!XC*"2*$![
M%2=I\6BU]3KKUC[E9DHZB59Z@E\#E74!O5O[RY4G]>-FC[&&62$R>>2VIN&%
M]?4&A8$4HJ6UQ4(<KBIU$T'C7I3KSOD\4&,=;, -*^CNBV.]R%U2*1IA@=,:
M!,5)Z-$6!Q(-*T(+E>1@EQN&8JH3=^!P  Y73]D #6-WH[QFX.U\<=E*X MI
M9R6?3W7J\[+>T@ZS'V]^9/S[RO7AWO/H.2176UE%F2%H+, 2UX7)$J.Y=V_I
MT>[[.[^\$U3V@9WY$14YJB.Q$X>_X'F(50-K+D5DHB#C$'+(]9C?@X^T#XK
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MU*X*7 @IM@L,'G_'N)F5 2'12*PC#RGY%"CJ6%E+C:448RUH-)%\0:YK4_P
MOF#@.BH;TU8S YZ92G+]PG%;R(WKM.PO^1[@LD:YE5[5FDSRVUTB&R@T1)$9
M""<,ULK*F+8J1MP&,&./(=E36??5O8?D1E;X+^'OZ;>+;U?SJ;4523D!NL14
M&[-F<-XR2$Z6*,GF:=9B<M&=EXZL]'U4-F\AOPZ"D<_3;[5G>?F\"+,E4?"A
M_&,^SW<'T2KFDJPS<U!(1^N!U>%-(1!+!;V5(FO=NC'1%F1M!1K[,C>7H;37
M/R#7+IW4K$@6/%@N#:U5)2 &*R%)1%I\-D33>OK15H2-&QTUA\-N<-M#-ST
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MJJI.D$4DP(ELDM"M3]R>HF=<K[P5)A[VRVFD@3X+BF[8V[]NZ,$S6AJ0(:N
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M L@-1VO(KH;V74Z.Q-N)YDA?TEH\ &PO?%/\YTJ#UY(1,BN5=*2@@.1!#K<
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M @K;.:!RBL(Q+G38RA79!@)CG^KLJ:S[ZMY#<B,K_)?P]_3;Q;<UX49$4\O
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M(+.N%&2634%/_W&QAP<TLNMS>%;G4%DU\W,&..*^NOXP+YMM9HN3[1W>T>Q
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M 9S%Z9 +;J:8(*V;%OG2DHGE"4=U3TR7:BY6XCUF"TI2E0!/:9O0>1XPA'7
M5E]&+(8\30!=00M+D ?1)(V-HR3@2YZ RMJ3TIZ4WAZ[WJZ2$AM3D5I5@8AE
M0< \P\> -;VF_G&HM]%';G=],<2R#W0$;:-=R64H4[-Y[FT4')U;,ZPG!2]7
M9\EP5JFRA)K% /RQY($3[ ED3R!O>_/?50+)$+J*='SNDY5 ;,O:@M KM QF
M4=+S4H5X7DI9UHP:26W@.+ZO 6-IB!7YW3WR)4<;N@1 3* RGEEGCGM %_:1
M%3[-BM.Y7Q^=5R'5\_P.]8DE,N9;X6;CD8FJ*1'\@8GL^=4S^_R?#M%ND]>^
MV/Q&@#W>\6+SX8ME9OM&R)RW\@LU@.)DF3L6P@#1_XJ,;:6> T[1U.=&*CU/
MC^P!&"R*N#&,K95;0PFI%[;X''RRW8^ 54#=:%1/\!^K23,J9+^G'%RVM)?&
MGGVH]7%?0=[KF7T%>?N%"4&P7L*!,?!!##[2\3@#B&>IS;R2.V'T 7,55Z^P
MV8JMM-@W668/E5]%'%G1U3T&6R,:J \=-9MKAC4DDU5FP!CX L";=ZF2ACQ)
MIQ$ %$)AEY&IM+4/WG=;2>QI8U_<?7O:@&PG4'!+SP.(F=4?0 /V-;*,+_(N
M6>#Q6(HQPXPAIJ/L;3B52186)4).&;1.0NET"GW"1L >:]*IPU=D"<578/K/
MO.?^__)^_!6<'BN1/AQ4&N4UOZUTE&KCML_R[F.C=W];O@'I4*7Q1^CO[+1X
M5GX/GG+^/Z6JIRM?I:KW(RK[D8RVOZO?3VR"T.9891<$D%030D7LLUPR6\5.
M!_(-@K?3\>D\,B_%LC?Y%Z2HI*= 0_H,WP"XMN3MU%H[Y"S(CB"=W[F$=A_+
M)[$\ZKG'@!"@E5"M$QZOO^_-5K3\Y6<BW7>O3?<ZQYAM_!8T"UEYT84.@0I2
ML]KEA0_4LE_W):O]IO;ROU!+ P04    " "G@0E5\ T@<+<&  #8*P  &
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M;F0N:'1M4$L! A0#%     @ IX$)54O8DQ)L)P  BBT! !X
M ( !T6\  &5X:&EB:71?,3 S>&QI9V%N9"UF;W)M;V9S+FAT;5!+ 0(4 Q0
M   ( *>!"57:'\T&/R(   KT   >              "  7F7  !E>&AI8FET
M7S$P-7AL:6=A;F0M9F]R;6]F<"YH=&U02P$"% ,4    " "G@0E500N#:[ N
M @!TDAH $0              @ 'TN0  ;&=N9"TR,#(R,#8S,"YH=&U02P$"
M% ,4    " "G@0E5?FV#0T$1   >L@  $0              @ '3Z ( ;&=N
M9"TR,#(R,#8S,"YX<V102P$"% ,4    " "G@0E5 G[Z7[(D  !U: $ %0
M            @ %#^@( ;&=N9"TR,#(R,#8S,%]C86PN>&UL4$L! A0#%
M  @ IX$)52GN#2566P  6NH# !4              ( !*!\# &QG;F0M,C R
M,C V,S!?9&5F+GAM;%!+ 0(4 Q0    ( *>!"54_CMR#@Y(  "K*   4
M          "  ;%Z P!L9VYD+3(P,C(P-C,P7V<Q+FIP9U!+ 0(4 Q0    (
M *>!"577GY;G+O$  %/Q"0 5              "  68-! !L9VYD+3(P,C(P
M-C,P7VQA8BYX;6Q02P$"% ,4    " "G@0E5P2!*<&".  !%908 %0
M        @ ''_@0 ;&=N9"TR,#(R,#8S,%]P<F4N>&UL4$L! A0#%     @
MIX$)5:%OAL*Z"   Q3H  !@              ( !6HT% &QG;F1?-C,P,C)E
M>&AI8FET,S$Q+FAT;5!+ 0(4 Q0    ( *>!"57;((BOKP@  *X[   8
M          "  4J6!0!L9VYD7S8S,#(R97AH:6)I=#,Q,BYH=&U02P$"% ,4
M    " "G@0E5\ T@<+<&  #8*P  &               @ $OGP4 ;&=N9%\V
H,S R,F5X:&EB:70S,C$N:'1M4$L%!@     .  X S@,  !RF!0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
